
<html lang="en"     class="pb-page"  data-request-id="1e0f1084-a50c-44d0-bad7-2570d19718b1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-21;article:article:10.1021/jm901885s;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Direct Renin Inhibitors as a New Therapy for Hypertension" /></meta><meta name="dc.Creator" content="Randy L.  Webb" /></meta><meta name="dc.Creator" content="Nikolaus  Schiering" /></meta><meta name="dc.Creator" content="Richard  Sedrani" /></meta><meta name="dc.Creator" content="Jürgen  Maibaum" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 23, 2010" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901885s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901885s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901885s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901885s" /></link>
        
    
    

<title>Direct Renin Inhibitors as a New Therapy for Hypertension | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901885s" /></meta><meta property="og:title" content="Direct Renin Inhibitors as a New Therapy for Hypertension" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901885s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901885s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901885s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901885s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901885s&amp;href=/doi/10.1021/jm901885s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 7490-7520</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901742e" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm100387d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Direct Renin Inhibitors as a New Therapy for Hypertension</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randy+L.++Webb">Randy L. Webb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikolaus++Schiering">Nikolaus Schiering</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Sedrani">Richard Sedrani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Maibaum">Jürgen Maibaum</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Pharmaceuticals Corp., Institutes for BioMedical Research, East Hanover, New Jersey</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +41-61-6965560. Fax: +41-61-6967155. E-mail: <a href="/cdn-cgi/l/email-protection#422837273025272c1d292e2337316c2f232b2023372f022c2d342330362b316c212d2f"><span class="__cf_email__" data-cfemail="e28897879085878cbd898e839791cc8f838b8083978fa28c8d948390968b91cc818d8f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901885s&amp;href=/doi/10.1021%2Fjm901885s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 7490–7520</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 23, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 December 2009</li><li><span class="item_label"><b>Published</b> online</span>23 August 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 November 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901885s" title="DOI URL">https://doi.org/10.1021/jm901885s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7490%26pageCount%3D31%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRandy%2BL.%2BWebb%252C%2BNikolaus%2BSchiering%252C%2BRichard%2BSedrani%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D21%26contentID%3Djm901885s%26title%3DDirect%2BRenin%2BInhibitors%2Bas%2Ba%2BNew%2BTherapy%2Bfor%2BHypertension%26numPages%3D31%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7520%26publicationDate%3DNovember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901885s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3436</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">61</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901885s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Direct Renin Inhibitors as a New Therapy for Hypertension&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Randy&quot;,&quot;last_name&quot;:&quot;L. Webb&quot;},{&quot;first_name&quot;:&quot;Nikolaus&quot;,&quot;last_name&quot;:&quot;Schiering&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Sedrani&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Maibaum&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7490-7520&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901885s&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901885s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901885s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901885s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901885s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901885s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901885s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901885s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901885s&amp;href=/doi/10.1021/jm901885s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901885s" /></input><a href="/doi/pdf/10.1021/jm901885s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901885s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901885s%26sid%3Dliteratum%253Aachs%26pmid%3D20731374%26genre%3Darticle%26aulast%3DWebb%26date%3D2010%26atitle%3DDirect%2BRenin%2BInhibitors%2Bas%2Ba%2BNew%2BTherapy%2Bfor%2BHypertension%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D21%26spage%3D7490%26epage%3D7520%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290914" title="Peptidomimetics">Peptidomimetics</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jmcmar.2010.53.issue-21/production/jmcmar.2010.53.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The history of the renin angiotensin system (RAS<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ADME, absorption, distribution, metabolism, and excretion; ACE(i), angiotensin converting enzyme (inhibitor); Ang, angiotensin; ARB, angiotensin II receptor blocker; BACE, β-site of β-amyloid precursor protein cleaving enzyme; BP, blood pressure; CYP, cytochrome P450; DRI, direct renin inhibitor(s); dTGM, double-transgenic mouse; dTGR, double-transgenic rat; GRAB, group replacement assisted binding; H-bond, hydrogen bond; HTS, high-throughput screening; ITC, isothermal titration calorimetry; PK, pharmacokinetics; PRA, plasma renin activity; PRC, plasma renin concentration; (P)RR, (pro)renin receptor; RAS, renin angiotensin system; rh-renin, recombinant human renin; SAR, structure−activity relationship; SHR, spontaneously hypertensive rat; TS, transition state; TSA, transition-state analogue.</p></div> traces its roots to the seminal experiments of Tigerstedt and Bergman describing a pressor response in the rabbit following injection of a rabbit kidney homogenate.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These studies were the first to describe the hypertensive effect of renin and laid the foundation for future investigations into the RAS pathway. Several crucial studies followed over the next 50 years that further elaborated additional key components of the RAS, including the identification of angiotensin II (AngII) as the principal substance mediating the activity of this system (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Angiotensinogen, the endogenous renin substrate, was first described in an elegant series of experiments in which the serial components of the system were clearly delineated.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Skeggs went on to explain how therapeutic benefit could be achieved by interfering with this system at several distinct points: by blocking the receptor for AngII, by inhibiting angiotensin converting enzyme (ACE) as the enzymatic step required for generation of AngII, or by preventing the formation of AngI through direct inhibition of renin. Interestingly, these investigators realized early on that “Since renin is the initial and rate-limiting substance in the renin−hypertensin system, it would seem that this last approach would be the most likely to succeed.”</div><div class="NLM_p">It has been shown consistently that blockade of the RAS, either with an ACE inhibitor (ACEi) or with an AngII AT1 receptor blocker (ARB) reduces blood pressure (BP). However, a powerful counter-regulatory mechanism is activated during RAS blockade and is in part responsible for the “flat” dose−response relationship observed with the use of these inhibitors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Under normal physiologic conditions, AngII inhibits renin release through stimulation of the AT1 receptor. Therapeutic interventions that either reduce AngII (ACEi) or attenuate AT1 signaling (ARB) ultimately result in enhanced release of renin. Consequently, the historical depiction of this system as a linear cascade is an inappropriate representation of the pathway. The RAS is now better portrayed as a physiological circuit encompassing a negative feedback “loop” whereby renin levels are controlled by the amount of AngII present in plasma and tissues (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This renders renin a highly attractive target from a therapeutic standpoint, as it would provide the only tactic to reduce plasma renin activity and thus offers a novel approach for the management of hypertension. While a compensatory rise in renin occurs as a result of RAS blockade with an ACEi, ARB, or a renin inhibitor, renin is rendered ineffective only by renin inhibition. Renin inhibitors bind to the active site of renin, a member of the aspartic protease family with high specificity for its endogenous substrate angiotensinogen, and are now commonly referred to as “direct renin inhibitors” (DRI), as opposed to drugs interfering with other components of the RAS, like ACE inhibitors, ARBs, or β-adrenoceptor antagonists.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Despite many treatment options available to the clinician, hypertension remains an important public health issue. Hypertension affected more than 65 million Americans and more than 25% of adults worldwide and is a key risk factor for myocardial infarction, stroke, and heart and renal failure.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Its prevalence is expected to increase by 60% to >1.5 billion people worldwide by 2025.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Renin−angiotensin system (RAS).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Academic institutions and major pharmaceutical companies have committed substantial resources over the past 50 years in an effort to discover the best therapeutic tactic for modulating the RAS. Initial therapeutic success was achieved with the introduction of ACEi<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and then with the identification of ARBs a decade later.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> While it was widely recognized that direct renin inhibition held great therapeutic potential, the design of small nonpeptidic molecules that effectively interact with the catalytic domain of renin and that demonstrate oral efficacy in humans remained elusive for more than 2 decades.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Compound <b>1</b> (aliskiren, CGP60536B, SPP100; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) represents a new generation of orally highly effective DRIs of a unique structural class designed by molecular modeling and X-ray crystallography.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> This drug was introduced in the United States as Tekturna and in Europe as Rasilez in 2007<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and hence became the first new therapy for the treatment of hypertension in more than 10 years.</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> (aliskiren), the first marketed direct renin inhibitor (DRI).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the late 1990s, a resurgence of interest in DRIs in the industry became increasingly evident and was driven by several major advancements.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Emerging new insights at the molecular level related to human renin−inhibitor active site interactions have paved new avenues for designing distinct chemotype inhibitors. The introduction of transgenic rodent models provided the capability to assess biological actions in small animals and thus reduced reliance on the use of non-human primates.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Also, the advanced clinical testing of <b>1</b> offered promise that this long sought after therapeutic approach might finally become a reality. Most importantly, extensive clinical trial results are now available and demonstrate its benefit.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Previous DRIs had been evaluated in limited clinical testing with short-term administration.</div><div class="NLM_p last">The objective of this review is to highlight key events and recent advances in the evolution of non-peptide peptidomimetic DRIs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Special emphasis will be placed on the successful structure-based strategies that enabled the discovery of several novel classes of DRIs.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> The potential limitations associated with these inhibitors and opportunities for future directions of renin inhibitor design will be discussed from a chemical and biological perspective. Lessons learned will also be discussed in an effort to provide a unique perspective on the development of <b>1</b>. With its introduction, it is now very important to distinguish this mechanism of action from indirect means of inhibiting renin. In this regard, ongoing clinical trials designed to demonstrate a clear benefit, beyond an effect on blood pressure, by reduction in morbidity and mortality are of paramount importance.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Medicinal Chemistry of DRIs: A Historical View</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The search for clinically efficacious DRIs with druglike properties has a remarkable and long history. It has required tremendous investments in research and development in industry and has spanned more than 3 decades.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> The first potent inhibitor of renin in plasma, reported as early as 1980, was completely peptidic in nature.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This decapeptide substrate analogue, labeled “RIP” (for <u class="uu">r</u>enin <u class="uu">i</u>nhibitor <u class="uu">p</u>eptide), allowed the first in vivo pharmacology studies of a DRI in monkeys. The design of orally efficacious non-peptide DRIs remained a formidable task with incremental progress made by the early 1990s, when several peptide-based peptidomimetic DRIs (<b>2</b>−<b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) had entered into clinical trials as investigational drugs.<a onclick="showRef(event, 'cit21b ref22 cit23b'); return false;" href="javascript:void(0);" class="ref cit21b ref22 cit23b">(21b, 22, 23b)</a></div><div class="NLM_p">Structure-based drug design (SBDD) involving X-ray crystallography and computer-assisted molecular modeling emerged as one of the most preeminent paradigms in drug discovery<a onclick="showRef(event, 'cit24a cit24b'); return false;" href="javascript:void(0);" class="ref cit24a cit24b">(24a, 24b)</a> in the 1980s, and the successful design of highly potent and selective DRIs represents one hallmark example. Numerous X-ray crystal structures of native aspartic proteases and enzyme−inhibitor complexes in combination with elegant mechanistic studies have provided detailed insight into fundamental aspects of the three-dimensional architecture and conformational dynamics of this class of endoproteases, as well as into the general acid−general base mechanism of enzyme-catalyzed peptide bond hydrolysis.<a onclick="showRef(event, 'ref20 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref20 ref25 ref26 ref27 ref28 ref29">(20, 25-29)</a> This information, together with computational modeling methods, has been of invaluable importance for developing a rational design approach toward potent DRIs, initially by the use of renin homology models.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Notably, the X-ray structure of human apo-renin was reported only in 1989,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the first renin−inhibitor complexes became available shortly thereafter.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30, 32)</a></div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Second generation peptide-based peptidomimetic DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the early reports describing angiotensinogen substrate-derived peptides as low affinity inhibitors of renin in the mid-1970s, the design of highly potent and selective DRIs as potentially useful drug candidates has witnessed a remarkable transition through various stages of structure-guided medicinal chemistry approaches. On the basis of the increasing knowledge about the three-dimensional structure and the enzymatic mechanism of substrate cleavage, several generations of DRIs have evolved over the years. These range from modified peptide inhibitors as target-validating pharmacology tools followed by more druglike second generation peptidic inhibitors to the more recent discovery of diverse classes of non-peptide DRIs.</div><div class="NLM_p">The incorporation of mimetics of the putative transition-state of the enzyme-catalyzed amide bond hydrolysis as nonhydrolyzable replacements of the scissile cleavage site represents a general inhibitor design principle originating in the postulates by Pauling and Wolfenden.<a onclick="showRef(event, 'ref20 ref33'); return false;" href="javascript:void(0);" class="ref ref20 ref33">(20, 33)</a> The application of this approach to N-terminal angiotensinogen substrate-derived peptide sequences has been instrumental in generating potent and proteolytically stable inhibitors of renin. Key structural features of these transition-state analogues (TSAs) are hydroxyl or (pro)hydroxyl groups that interact via hydrogen bonding with the catalytic Asp<sub>32</sub> and Asp<sub>215</sub> carboxylates by extrusion of the enzyme-bound cosubstrate water of the catalytic center in native renin. The entropically favored water displacement by the TSA hydroxyl and further evidence would suggest that these analogues function at least in part as “collected-substrate” inhibitors rather than as tetrahedral intermediates of enzyme-catalyzed peptide cleavage.<a onclick="showRef(event, 'ref25 ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref27 ref29">(25, 27, 29)</a> Most prominent early representatives are the nonproteinogenic amino acid statine, identified from the pepstatin family of natural product aspartic protease inhibitors,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the hydroxyethylene (HE) dipeptide isostere first introduced by Szelke et al. (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>B and Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>A, respectively).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Key strategies of extensive structural modifications of first generation DRIs included the elimination of their peptidic nature, optimization of critical binding interactions to the renin specificity pockets spanning S<sub>3</sub>/S<sub>4</sub> to S<sub>2</sub>′ of the extended enzyme cleft, and variation of the central TSA moiety. These concepts aimed to accomplish a minimal molecular size sufficient for strong binding affinity.</div><div class="NLM_p">The vast majority of these potent peptide-derived peptidomimetics had limited druglike properties and hence multiple drawbacks, such as poor intestinal absorption and high liver first-pass metabolic inactivation resulting in low oral bioavailability, as well as high cost of goods due to synthetic complexity and high clinically effective doses. Excellent review articles<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> and historical cases, including the discovery of <b>7</b> (CP-108,671) exhibiting uniformly high oral bioavailability in dog and marmoset,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> provide a comprehensive overview on these design efforts, the characterization of second generation DRIs, and their failure in clinical development.</div><figure id="cht1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0016.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Aspartic Protease TSAs and Basic Amine TS Surrogates (Preferred Absolute Configurations Shown)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">A New Era of Non-Peptide DRI Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several key developments during recent years have contributed to a rapid and fascinating evolution of medicinal chemistry approaches aimed at the design of promising new classes of DRIs. Both the druggable topographical space at the enzyme protein level and, in part as a direct consequence, the chemical diversity space at the ligand level have dramatically expanded. This has evidently opened ample avenues toward the discovery of new structural classes of potent and selective non-peptide peptidomimetic DRIs. The early notion that the large contiguous S<sub>3</sub>−S<sub>1</sub> pocket constitutes a key hydrophobic ”hot spot” for ligand binding has been successfully employed for a topological inhibitor design concept. Ligand binding sites in the renin active site have been identified, which are distinct from the substrate specificity pockets or even fundamentally different from the extended β-strand substrate binding topography resulting from major conformational movements adjacent to the catalytic center.<a onclick="showRef(event, 'ref29 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref36">(29, 36)</a> Most notably, the classical dipeptide TSA concept, the dominating theme of inhibitor design over many years, has vanished. Novel privileged basic amine scaffolds that act as TS surrogates by a combination of electrostatic and H-bonding interactions to the catalytic aspartates have been uncovered and provide versatile templates for decoration with recognition site pharmacophores.</div><div class="NLM_p">These major scientific advances are best illustrated by the discoveries of the orally active topological peptidomimetic <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), an aminohydroxyethylene dipeptide isostere (AHE, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>D) of a unique chemical class described by Ciba-Geigy (now Novartis),<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> and the new type of 3,4-disubstituted piperidine-derived DRIs reported by Hoffmann-La Roche.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The DRI <b>1</b> resulted from an entirely structure-based design concept using a renin homology model, by addressing the S<sub>3</sub>/S<sub>3</sub><sup>sp</sup>−S<sub>1</sub> active site topography in an unprecedented way (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In contrast, the novel structural principle of 4-arylpiperidine peptidomimetics emerged from high-throughput screening (HTS), followed by hit-to-lead elaboration based on crystallographic elucidation of renin−inhibitor complex structures. These inhibitors target a fundamentally different conformational topography of the renin active site. Both critical accomplishments and the positive outcome of late stage clinical trials with <b>1</b><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> have triggered intense efforts to identify “best-in-class” DRIs and have provided several new clinical development candidates.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The structural diversity of non-peptide DRIs is anticipated to further expand in the future with the application of evolving state-of-the art drug discovery concepts.</div><div class="NLM_p">Major advances in renin inhibitor design will first be reviewed in the following sections by focusing, on one hand, on the identification of core scaffolds binding to the catalytic aspartates and, on the other hand, on specific approaches taken to address the individual binding pockets of the active site, i.e., the S<sub>3</sub>−S<sub>1</sub> “superpocket”, the S<sub>3</sub><sup>sp</sup> and other nonsubstrate binding pockets, as well as the S<sub>2</sub> and S<sub>1</sub>′−S<sub>2</sub>′ sites. Subsequently, considerations regarding the optimization of ADME and safety properties of different novel chemotype DRIs and their preclinical pharmacology will be addressed, and finally aspects of the clinical pharmacology of <b>1</b> are reviewed.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of rh-renin in complex with inhibitor <b>1</b> (orange). Renin is shown in gray (ribbon diagram and surface) with the side chains of the catalytic aspartates Asp<sub>32</sub> and Asp<sub>215</sub> with gray carbon atoms (flap residues Ser<sub>76</sub> and Thr<sub>77</sub> were omitted from the surface calculation). The peptide-based peptidomimetic <b>4</b> (CGP38560) is shown superimposed (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Novel Lead Discovery Approaches</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery and optimization of DRIs have for many years relied mainly on rational substrate-based design by targeting the extended β-strand binding active site topography. Since the mid-1990s, HTS of large historical corporate collections, often containing more than 1 million compounds, has been used as one of the standard methods for identifying starting points for medicinal chemistry against a drug target of interest. In the case of aspartic proteases, as well as for other protease families, HTS has been perceived to suffer from low success rates in the identification of hits having a good potential for further optimization.<a onclick="showRef(event, 'ref13 ref37'); return false;" href="javascript:void(0);" class="ref ref13 ref37">(13, 37)</a> This is certainly related to the fact that the active sites of these enzymes are designed to recognize peptide sequences in an extended conformation and therefore are generally characterized by rather large van der Waals volumes. Remarkably, several pharmaceutical companies have been successful in their search for new chemotype scaffolds inhibiting renin, by performing large-scale HTS campaigns based on biochemical assays.<a onclick="showRef(event, 'ref36 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref38">(36, 38)</a> More recently, alternative technologies based mainly on biophysical methods (nuclear magnetic resonance (NMR), surface plasmon resonance, X-ray crystallography, mass spectrometry) and used in large part for fragment-based screening, as well as in silico computational approaches, were also successfully applied to identify novel active site binding motifs for aspartic proteases, including renin<a onclick="showRef(event, 'cit38d ref39'); return false;" href="javascript:void(0);" class="ref cit38d ref39">(38d, 39)</a> and BACE-1.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0018.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. 4-Phenylpiperidine DRIs discovered by high-throughput screening (HTS).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 1999, researchers at Hoffmann-La Roche described the discovery by HTS of the first non-peptide small molecule DRI.<a onclick="showRef(event, 'cit36a'); return false;" href="javascript:void(0);" class="ref cit36a">(36a)</a> The original hit, <i>rac</i>-<b>8</b> (IC<sub>50</sub> = 50 μM), showed only weak affinity against the purified enzyme, with the <i>R</i>,<i>R</i>-enantiomer accounting for the activity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'cit36b'); return false;" href="javascript:void(0);" class="ref cit36b">(36b)</a> The low resolution X-ray structures obtained for <i>R</i>,<i>R</i>-<b>8</b> and its close analogue <i>R</i>,<i>R</i>-<b>9</b> revealed the piperidine nitrogen atom to be positioned between the catalytic aspartates, with the naphthyl occupying the S<sub>3</sub>−S<sub>1</sub> subsite. This finding has guided the initial structure−activity relationship (SAR) exploration using combinatorial chemistry.<a onclick="showRef(event, 'cit36a cit36b cit36c'); return false;" href="javascript:void(0);" class="ref cit36a cit36b cit36c">(36a-36c)</a> As will be detailed later, modifications at the 4′-position afforded prototype leads with dramatically improved in vitro potencies. Their X-ray crystal structures in complex with recombinant human (rh) renin revealed features very distinct from the binding mode of peptide-derived TSA inhibitors. The terminology of “group replacement assisted binding’’ (GRAB) peptidomimetics was introduced to account for the topographical and dynamic aspects of these renin−inhibitor interactions.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The attractiveness of this remarkable class of DRIs has subsequently fueled drug discovery programs at several other pharmaceutical companies.</div><div class="NLM_p">A HTS conducted at Pfizer led to the discovery of the 5-phenyl substituted 6-ethyl-2,4-diaminopyrimidine <b>10</b> as a weak inhibitor of rh-renin (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'cit38a'); return false;" href="javascript:void(0);" class="ref cit38a">(38a)</a> Variation of the benzylic moiety employing parallel chemistry led to <b>11</b> with 7-fold improved activity. The X-ray cocrystal structure of the renin−<b>11</b> complex revealed an active site conformation in which the flap (residues Thr<sub>72</sub>−Ser<sub>81</sub>) is closed. Notably, the 2,4-diaminopyrimidine was identified as a novel planar center scaffold forming H-bonds with the two catalytic aspartates, while also providing constrained, favorable trajectories for both the 6-ethyl group binding into the S<sub>1</sub> pocket and for the difluorobenzylaminophenyl moiety extending into the S<sub>3</sub> and partly into the S<sub>4</sub> subsites (vide infra). This series was further optimized by conformational rigidification of the benzyl portion and introduction of a P<sub>3</sub><sup>sp</sup> side chain (<b>12</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), with additional modifications of the bicyclic (S<sub>3</sub>−S<sub>1</sub>)-motif leading to inhibitors exhibiting high in vitro potency and oral bioavailability (<b>34</b>−<b>37</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>).<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a></div><div class="NLM_p">Fragment-based drug discovery (FBDD) has become an approach of increasing importance over the past years in pharmaceutical research.<a onclick="showRef(event, 'cit24b cit24c'); return false;" href="javascript:void(0);" class="ref cit24b cit24c">(24b, 24c)</a> The group at Pfizer has reported on an in silico docking approach using GOLD, combined with a NMR auxiliary binding screen of a fragment library, to target specifically the renin S<sub>2</sub> pocket as part of the lead optimization efforts in the 6-ethyl-2,4-diaminopyrimidine series.<a onclick="showRef(event, 'cit38c cit38d'); return false;" href="javascript:void(0);" class="ref cit38c cit38d">(38c, 38d)</a> The identified single fragment hit was shown by saturated transfer difference NMR via interligand NOEs in the presence of renin to be an active site coligand of the C4 aminomethyl analogue of compound <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Fragment-linking via a two-carbon spacer and cocrystallization of the resulting inhibitor confirmed the tethered fragment to be positioned in the S<sub>2</sub> pocket. Further elaboration using X-ray crystallographic data in combination with isothermal titration calorimetry (ITC) analyses resulted in significant potency improvement (cf. section “<a class="ref internalNav" href="#sec9" aria-label="S2 Specificity Pocket">S2 Specificity Pocket</a>”).<a onclick="showRef(event, 'cit38c'); return false;" href="javascript:void(0);" class="ref cit38c">(38c)</a> This example highlights the potential of fragment-based approaches for mapping the renin active site. Future applications may uncover new promising lead templates and possibly so far unrecognized binding hot spots for renin.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0019.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 2,4-Diaminopyrimidine-based DRIs originating from HTS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various in silico screening approaches have emerged recently and found application for renin hit discovery, as either alternative or complementary methods to the screening of physically available compound libraries. Researchers at Vitae Pharmaceuticals disclosed a novel class of DRIs, identified by a de novo structure-based design approach<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> using their computational tool Contour and starting from the X-ray structure of the peptidic inhibitor <b>4</b> bound to renin.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Interestingly, defined criteria for inhibitor design were to target exclusively the S<sub>3</sub>−S<sub>1</sub> and S<sub>3</sub><sup>sp</sup> pockets while leaving the S<sub>2</sub>, S<sub>4</sub>, and the prime-site pockets unoccupied. Furthermore, incorporation of a solubilizing basic amine that could interact with the catalytic aspartates was envisaged. Potent DRIs exhibiting reasonable pharmacokinetic (PK) properties and in vivo efficacy were identified as a result of design and synthesis iterations and further optimization of prototype leads.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The experimental X-ray structure of a renin−inhibitor complex was reportedly in close agreement with the predicted design model. It is noteworthy that de novo in silico design approaches targeting alternative, potentially pre-existing conformational ensembles of the renin active site<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> remain an extremely challenging task.</div><div class="NLM_p">The tremendous progress in high sensitivity assay technologies and emerging powerful new enabling methodologies not only are providing new opportunities to enlarge the chemical space but also allow early validation of very low-affinity small molecule hits as active site binders. Furthermore, computational modeling approaches in combination with timely structural elucidation of an increasing number of renin−ligand complexes by X-ray crystallography have become even more indispensable for an efficient iterative drug discovery process. These approaches encompass hit finding and validation, hit selection, and progression toward enhanced inhibitory potency, all the way through to lead optimization and identification of preclinical candidates. This is most evident for the development of novel class DRIs in view of the multiple pre-existing conformational topographies of the renin active site.<a onclick="showRef(event, 'ref29 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref36">(29, 36)</a></div><div class="NLM_p">The impressive power of new screening technologies and advanced approaches in modern drug discovery is similarly reflected by the rapid development of nonpeptidic inhibitors of β-secretase (BACE-1, memapsin 2), a type-I membrane associated human aspartic proteases. BACE-1 is implicated in the proteolytic cleavage of β-amyloid precursor protein (APP) and subsequent formation of amyloid plaques and has attracted attention as a target for the treatment of Alzheimer’s disease.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Since the first report of the potent octapeptide HE isostere inhibitor <span class="smallcaps smallerCapital">l</span>-α-glutamyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-asparaginyl-(2<i>R</i>,4<i>S</i>,5<i>S</i>)-5-amino-4-hydroxy-2,7-dimethyloctanoyl-<span class="smallcaps smallerCapital">l</span>-alanyl-<span class="smallcaps smallerCapital">l</span>-α-glutamyl-<span class="smallcaps smallerCapital">l</span>-phenylalanine (OM99-2) and its X-ray crystal structure in complex with the protease domain of β-secretase,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> it took only a few years to bring forth a number of distinct classes of potent non-peptide inhibitors, incorporating either classical TSAs or alternative TS surrogates.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> While tremendous advancements were made toward the design of BACE-1 inhibitors leading to significant reductions of Aβ<sub>40−42</sub> levels in animal models,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> major hurdles such as brain penetration still need to be overcome with more promising development candidates.<a onclick="showRef(event, 'cit40a'); return false;" href="javascript:void(0);" class="ref cit40a">(40a)</a></div><div class="NLM_p last">The structural divergence of peptidomimetic inhibitors of renin and BACE-1 is striking and has limited a target enzyme family approach<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> beyond the application of some fundamental enzyme mechanism-related design principles. Non-peptide BACE-1 inhibitors show high selectivity toward renin,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and vice versa, non-peptide DRIs have been reported to be inactive against BACE-1.<a onclick="showRef(event, 'ref13 ref39'); return false;" href="javascript:void(0);" class="ref ref13 ref39">(13, 39)</a> This can be rationalized by both the distinct substrate specificity and the active site architecture of the two enzymes. Relationships between renin and BACE-1 inhibitors with respect to enzyme−inhibitor interactions will be briefly cross-referenced in cases where this could be particularly instructive to emphasize the impact on specific inhibitor design.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">(S<sub>3</sub>−S<sub>1</sub>)-Topographical Hot Spot</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first X-ray crystal structure reported for rh-renin revealed the S<sub>3</sub> and S<sub>1</sub> recognition sites to form a large and contiguous space without an apparent division between the two pockets.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A similar spacious and open topography of the S<sub>3</sub>−S<sub>1</sub> site had been observed previously for several fungal aspartic proteases with and without bound peptide TSA inhibitors.<a onclick="showRef(event, 'ref25 ref28 ref30 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref30 ref44 ref45">(25, 28, 30, 44, 45)</a> Furthermore, these enzyme−ligand complexes revealed the substrate-based inhibitors to bind in an extended β-strand conformation with the hydrophobic P<sub>3</sub> and P<sub>1</sub> residues being tightly constrained and positioned close to each other. Both P<sub>3</sub> and P<sub>1</sub> residues are shielded from solvent space by the flap β-hairpin in its “closed conformation”. This S<sub>3</sub>−S<sub>1</sub> binding topography was subsequently confirmed by the X-ray structures of peptide peptidomimetic DRIs, such as <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30, 32)</a></div><div class="NLM_p">Different structure-based concepts have been investigated independently by several research groups based on the notion that the renin S<sub>3</sub> and S<sub>1</sub> pockets form a spacious hydrophobic cavity. The formation of large-surface van der Waals contacts to the hydrophobic amino acids lining the S<sub>3</sub>−S<sub>1</sub> cavity was considered to be energetically favorable as a driving force for binding affinity. Design efforts therefore were aimed at maximizing the hydrophobic interactions to this key binding site by covalently linking the P<sub>3</sub> and P<sub>1</sub> side chains and ultimately at identifying novel structural classes of small-molecule DRIs with enhanced oral efficacy.<a onclick="showRef(event, 'ref13 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref13 ref46 ref47 ref48">(13, 46-48)</a> Conformational constraints have been introduced in peptide-based peptidomimetics by cross-linking alternate side chains to enhance potency and selectivity by locking the inhibitor in the bound conformation and in addition to potentially improve the PK properties of the more flexible acyclic congeners.<a onclick="showRef(event, 'ref13 cit23a cit23b ref46'); return false;" href="javascript:void(0);" class="ref ref13 cit23a cit23b ref46">(13, 23a, 23b, 46)</a> The macrocyclic inhibitor <b>15</b> bearing a ψ[CH<sub>2</sub>NH]-reduced amide isostere (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) was 5 times more potent in vitro compared to the acyclic P<sub>1</sub> cyclohexylalanine-based analogue.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> While macrocyclization between the P<sub>3</sub> and P<sub>1</sub> side chains of peptidomimetic DRIs has found only limited application, in contrast to substantial efforts made for the design of P<sub>3</sub>−P<sub>1</sub>-linked BACE-1 macrocyclic inhibitors,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the spatial proximity of other recognition sites has attracted more interest and provided potent macrocyclic TSA inhibitors of renin.<a onclick="showRef(event, 'cit23a cit23b'); return false;" href="javascript:void(0);" class="ref cit23a cit23b">(23a, 23b)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0020.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Peptide-based macrocyclic and (S<sub>3</sub>−S<sub>1</sub>)-topological DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dihydroxyethylene isostere peptidomimetics with topographically modified P<sub>1</sub>(→P<sub>3</sub>) side chains (<b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) have been explored by extending the P<sub>1</sub> cyclohexyl directly toward the S<sub>3</sub> binding pocket and by removing the linkage of P<sub>3</sub> to the peptide backbone. The P<sub>3</sub> glycine derivative <b>16</b> was found to be a potent inhibitor of monkey plasma renin.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Further truncation of the N-terminal backbone of these inhibitors was believed to be difficult to achieve without reducing the binding affinity.<a onclick="showRef(event, 'cit47a'); return false;" href="javascript:void(0);" class="ref cit47a">(47a)</a> A similar design concept based on the X-ray structure of a tetrapeptide TSA in complex with rh-renin afforded inhibitors spanning the S<sub>3</sub>−S<sub>1</sub> pocket, such as <b>17</b>, that were up to >200-fold more potent than the respective P<sub>1</sub> phenyl analogues lacking S<sub>3</sub> interactions.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> X-ray crystallography revealed the meta-biphenyl moiety of <b>17</b> to intrude into S<sub>3</sub>−S<sub>1</sub> without completely filling this cavity, suggesting that additional lipophilic substituents could lead to more potent analogues. Removal of the P<sub>4</sub> residue produced analogues with a 14-fold drop in potency (cf. <b>18</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0021.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nonpeptide (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetic TSAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Novartis has reported the structure-based design of several unique structural series of non-peptide aminohydroxyethylene (AHE, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>D) isosteres spanning the S<sub>3</sub>−S<sub>2</sub>′ recognition sites and lacking the P<sub>4</sub>−P<sub>2</sub> peptide backbone of previous inhibitors (<b>19</b>−<b>22</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). These efforts have culminated in the discovery of <b>1</b>, a remarkably potent and highly selective first-in-class oral DRI.<a onclick="showRef(event, 'ref11 ref12 ref13 ref49'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref49">(11-13, 49)</a> The stepwise evolution of the design concept was primarily driven by the S<sub>3</sub>−S<sub>1</sub> topography derived from the predicted active site conformation of <b>4</b> using a renin homology model. Weakly active AHE isostere fragments were grown directly into the large contiguous S<sub>3</sub>−S<sub>1</sub> site, considered as a hydrophobic hot spot<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> for ligand binding, by extending at the P<sub>1</sub> position.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Most intriguingly, these novel classes of DRIs were discovered by X-ray crystallography to bind into a small and rigid cavity that extends from S<sub>3</sub> toward the enzyme core perpendicular to the binding cleft and is not utilized by known substrate-based inhibitors.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The interaction to this nonsubstrate S<sub>3</sub><sup>sp</sup> subpocket is essential for strong renin inhibition by these topological TSA inhibitors.</div><div class="NLM_p">The X-ray structure of <b>1</b> in complex to rh-renin is depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>.<a onclick="showRef(event, 'ref12 ref51'); return false;" href="javascript:void(0);" class="ref ref12 ref51">(12, 51)</a> The ligand is bound in an extended conformation spanning the S<sub>3</sub>−S<sub>2</sub>′ recognition sites, leaving the S<sub>4</sub> and S<sub>2</sub> pockets unoccupied. Its P<sub>1</sub> isopropyl residue is more deeply positioned in the S<sub>1</sub> site compared to the P<sub>1</sub> cyclohexyl of the peptide-based inhibitor <b>4</b>, while the hydrophobic space-filling phenyl residue positions the methoxy group into the S<sub>3</sub> pocket. Remarkably, the ether oxygen is involved in a H-bond interaction with the hydroxyl of Thr<sub>12</sub> mediated by S<sub>3</sub> bound water molecules. The extended flexible methoxypropoxy side chain penetrates deeply into the newly discovered S<sub>3</sub><sup>sp</sup> cavity of renin (vide infra). The AHE isostere portion (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) forms reversible noncovalent tight binding interactions to both Asp<sub>35</sub> and Asp<sub>215</sub> via H-bonding and possibly electrostatic interactions. The structurally diverse (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores of <b>19</b> and <b>21</b>−<b>22</b> also fully occupy the S<sub>3</sub>−S<sub>1</sub> cavity, forming close van der Waals contacts to the large surface, as shown by the X-ray complex structures of related analogues.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0022.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (S<sub>3</sub>−S<sub>1</sub>)-Topological tripeptide-based amino alcohol DRI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitor <b>1</b> and related AHE isosteres <b>19</b>−<b>22</b> represent landmark examples of a successful (S<sub>3</sub>−S<sub>1</sub>)-topography design concept supported by computer-aided molecular modeling and X-ray crystallography. Notably, the design of tetrapeptide-based aminohydroxyethylamine (AHEA, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>H) isosteres spanning the S<sub>1</sub>−S<sub>3</sub>′ sites and lacking the P<sub>4</sub>−P<sub>2</sub> peptide portion was reported as early as 1989 and was similarly based on an endothiapepsin-derived renin homology model.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Inhibitor <b>23</b> (BW586C, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) bearing a tethered P<sub>1</sub> biphenyl moiety was remarkably potent in vitro. SAR data for related amino alcohols with preferred (2<i>R</i>)(3<i>S</i>)-configuration indicated a significant potency increase when the P<sub>1</sub> residue was more lipophilic and extended.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> An X-ray structure of <b>23</b> in complex with rh-renin, or any other aspartic protease, that could confirm the predicted occupancy of the S<sub>3</sub>−S<sub>1</sub> cavity has not been reported.</div><div class="NLM_p">Inhibitor <b>1</b> showed remarkable in vitro potency under more physiological conditions.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> The methoxypropoxy side chain binding to S<sub>3</sub><sup>sp</sup> turned out to be optimal for this inhibitor class, leading to high inhibitory affinity for plasma renin.<a onclick="showRef(event, 'ref12 ref49'); return false;" href="javascript:void(0);" class="ref ref12 ref49">(12, 49)</a> Significant increases in the IC<sub>50</sub> of up to several orders of magnitude have been observed for analogues of <b>1</b> and other (S<sub>3</sub>−S<sub>1</sub>)-topological inhibitors<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in the presence of plasma (“plasma shift”). Such plasma shifts have also been reported for peptide-derived<a onclick="showRef(event, 'cit21a ref54'); return false;" href="javascript:void(0);" class="ref cit21a ref54">(21a, 54)</a> and non-peptide DRIs from various structural classes.<a onclick="showRef(event, 'ref36 ref39 ref55'); return false;" href="javascript:void(0);" class="ref ref36 ref39 ref55">(36, 39, 55)</a> The drop in potency toward plasma renin has been attributed to low solubility and high lipophilicity and/or high unspecific binding to plasma proteins reducing the free fraction in blood.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> However, other yet to be uncovered factors may also contribute to this phenomenon.<a onclick="showRef(event, 'cit21a ref49 ref56'); return false;" href="javascript:void(0);" class="ref cit21a ref49 ref56">(21a, 49, 56)</a> The relevance of in vitro plasma IC<sub>50</sub> values as predictive descriptors for BP lowering potency of a given DRI in vivo has been under debate,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> in particular in view of the emerging evidence for the importance of local renin inhibition in the kidney and other tissues.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Notably, an increase in plasma renin concentration (PRC) has been generally accepted as an important clinical surrogate marker for RAS blockade and inhibition of plasma renin activity (PRA) for the effectiveness of drug treatment using a DRI.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Novel (S<sub>3</sub>−S<sub>1</sub>)-topological binding motifs have been identified from weakly active HTS hits (<b>8</b> and <b>10</b>, Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>),<a onclick="showRef(event, 'cit36a cit38a'); return false;" href="javascript:void(0);" class="ref cit36a cit38a">(36a, 38a)</a> and structure-based design has subsequently generated an array of privileged (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores (<b>I</b>−<b>VI</b>, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>). These structural moieties have in common that they have been linked to a basic center scaffold such as a piperidine or related mono- or bicyclic ring analogues (Figures <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a> and <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>)<a onclick="showRef(event, 'ref36 ref55 ref58'); return false;" href="javascript:void(0);" class="ref ref36 ref55 ref58">(36, 55, 58)</a> and 2,4-diaminopyrimidines (<b>12</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> occupying the pivotal position between Asp<sub>32</sub> and Asp<sub>215</sub> by forming electrostatically enforced H-bonds (vide infra). These templates provide trajectories different from the P<sub>1</sub>-tethering vector of AHE isosteres for extensions into the S<sub>3</sub>−S<sub>1</sub> cavity. Optionally substituted naphthalene or tetrahydroquinoline as equipotent replacement (<b>I</b> and <b>II</b>, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>), when bridged by a 3-methyleneoxy group to the 4-phenyl-piperidine scaffold, resulted in potent inhibitors classified as GRAB peptidomimetics<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (cf. section “<a class="ref internalNav" href="#sec8" aria-label="GRAB Peptidomimetic Class of DRIs">GRAB Peptidomimetic Class of DRIs</a>”). The naphthalene occupies the S<sub>3</sub>−S<sub>1</sub> site forming an edge-to-face interaction with the Phe<sub>117</sub> residue.<a onclick="showRef(event, 'cit38a cit38c'); return false;" href="javascript:void(0);" class="ref cit38a cit38c">(38a, 38c)</a> The position of the oxymethylene spacer and the proximal edge of the naphthyl partially overlap with the binding position of the P<sub>1</sub> isopropyl of <b>1</b>.</div><div class="NLM_p">The nitrogen atom of the tetrahydroquinoline heterocycle provides an attachment point for side chains that can penetrate into the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity in a similar fashion as previously discovered for AHE isostere inhibitors <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and <b>19</b>−<b>22</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The 1,4-benzoxazin-3-one motif (<b>III</b>, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) was identified as a less hydrophobic tetrahydroquinoline replacement, being well accommodated by the S<sub>3</sub>−S<sub>1</sub> site and providing an equally efficient trajectory for tethered P<sub>3</sub><sup>sp</sup> residues.<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a> When attached to a 2-ketopiperazine center scaffold by a two-atom (thio)ether linkage, high affinity DRIs were obtained (vide infra). Subsequently, the 1,4-benzoxazinone pharmacophore and modifications thereof have attracted major interest by other groups.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="cht2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0023.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Topological (P<sub>3</sub>−P<sub>1</sub>)-Pharmacophores Used in Combination with Five- and Six-Membered Center Basic TS Surrogate Scaffolds of Non-Peptide DRIs (See Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, and <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 5-aryl-2,4-diaminopyrimidine (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> constitutes a remarkable scaffold that functions as a basic TS surrogate by interacting with the catalytic dyad and in addition is part of a conformationally constrained (P<sub>3</sub>−P<sub>1</sub>)-pharmacophore. The X-ray structures of renin-bound <b>12</b> and related analogues revealed the C6 ethyl group to be positioned in the S<sub>1</sub> pocket closely overlapping with the P<sub>1</sub> isopropyl of <b>1</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The 1,4-benzoxazinone of <b>34</b> (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>) extends into the S<sub>3</sub> pocket, with small alkyl groups at its (<i>S</i>)-configured C2 position fitting into a small indentation of the S<sub>3</sub> site, superimposing with the P<sub>3</sub> methoxy of <b>1</b>. The C2 phenyl of <b>35</b> is positioned within the hydrophobic but solvent exposed S<sub>4</sub> pocket, resulting in enhanced van der Waals contacts and hence increased binding affinities (<b>34</b> vs <b>35</b>).<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a> The C3 carbonyl favors a rigid conformation of the bicyclic moiety that directs the C2 phenyl toward S<sub>4</sub> and furthermore is involved in enzyme-water mediated H-bond interactions. Notably, a geminal disubstitution at C2 blocks this metabolical weak point prone to oxidative hydroxylation.</div><div class="NLM_p">Researchers at Actelion were first to report the design of N-benzylated tertiary amides (<b>IV</b>, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) as a new pharmacophore tightly filling the hydrophobic S<sub>3</sub>−S<sub>1</sub> pocket when attached to a 7-aryl substituted 3,9-diazabicyclo[3.3.1]nonene template (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) and related monocyclic core scaffolds.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> These findings resulted from a structure-based design effort to identify GRAB peptidomimetics with superior pharmacokinetic properties. The nature of the bicyclic scaffold with its vinylic double bond at the 6,7-position required a replacement of the ether linkage of previous (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores (for example, compare <b>25</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, with <b>30</b> and <b>31</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>)<a onclick="showRef(event, 'ref36 ref58'); return false;" href="javascript:void(0);" class="ref ref36 ref58">(36, 58)</a> by a chemically stable functional spacer group. A parallel chemistry approach uncovered 2,3-disubstituted benzylamides with a <i>N</i>-cyclopropyl group to be optimal for in vitro potency, particularly in the presence of plasma.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The X-ray structure of <b>52</b> (ACT-077825/MK-8141, Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> in complex with rh-renin revealed the <i>N</i>-cyclopropyl to be positioned in a small subpocket of the open-flap conformational topography of renin. Remarkably, the cyclopropyl binding position closely superimposes with that of the P<sub>1</sub> isopropyl residue of <b>1</b> in complex with the β-strand binding active site conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). Also, the 2,3-disubstituted phenyl of <b>52</b> overlays with the P<sub>3</sub> phenyl group of <b>1</b> with close to perfect overlap of the 3-methyl and the 4-methoxy groups, respectively. Introduction of tethered H-bond acceptor groups to the C5 phenyl position of <b>52</b>, or related analogues, to target the S<sub>3</sub><sup>sp</sup> pocket has also been investigated to optimize for potency.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">The tertiary benzylamide P<sub>3</sub>−P<sub>1</sub> motif has been further investigated in combination with 3,4-disubstituted piperidines and related basic monocyclic center scaffolds by several other groups.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These include analogues bearing extended side chains with terminal functional groups capable of forming a H-bond to Tyr<sub>14</sub> of the S<sub>3</sub><sup>sp</sup> subpocket (vide infra), such as N-tethered indoles (<b>V</b>, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Novartis has disclosed <i>N</i>-cyclopropyl-<i>N</i>-1,4-benzoxazinone carboxamides (<b>VI</b>) attached to a 3,5-disubstituted piperidine center scaffold leading to a new class of DRIs.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0024.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Renin inhibitor (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores incorporating basic residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The design of less hydrophobic (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores has been explored by incorporation of basic amines or aromatic heterocycles into different chemotype DRIs.<a onclick="showRef(event, 'cit36c cit55a ref56 cit58a cit58d'); return false;" href="javascript:void(0);" class="ref cit36c cit55a ref56 cit58a cit58d">(36c, 55a, 56, 58a, 58d)</a> Analogues of <b>1</b> bearing a basic P<sub>1</sub> tertiary amine motif were reported to be potent toward plasma renin in vitro.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The group at Speedel has claimed P<sub>3</sub><sup>sp</sup>-substituted pyridine analogues of <b>1</b> exhibiting high potency in vitro, albeit no detailed information on their potential was disclosed.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In the 2-ketopiperazine series of GRAB peptidomimetics, replacement of bicyclic P<sub>3</sub> motifs by simplified benzyl and pyridinyl ethers has been investigated using a Topliss approach.<a onclick="showRef(event, 'cit58d'); return false;" href="javascript:void(0);" class="ref cit58d">(58d)</a> Notably, the 3-pyridinyl derivative <b>24</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) was the only regioisomer shown to be active against rh-renin. The critical position of the pyridyl nitrogen atom was rationalized by H-bonding to Ser<sub>219</sub> suggested by modeling. Inhibitor <b>24</b> had a more favorable profile with respect to solubility, cell permeability, and affinity to CYP3A4 in comparison to its phenyl congener.<a onclick="showRef(event, 'cit58d'); return false;" href="javascript:void(0);" class="ref cit58d">(58d)</a> More hydrophilic 4-pyridinyl substituted P<sub>3</sub> tertiary amides were well tolerated when combined with the 3,9-diazabicyclo[3.3.1]nonene scaffold.<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> Inhibitor <b>25</b> exhibited only a 10-fold plasma IC<sub>50</sub> shift, while a 50-fold drop in plasma renin potency was observed for its 3-methoxy-2-methylphenyl analogue (buffer rh-renin IC<sub>50</sub> = 0.62 nM). While increasing evidence has emerged for the feasibility to design less hydrophobic S<sub>3</sub>−S<sub>1</sub> binding motifs, it remains to be seen whether this strategy will lead to the design of novel DRIs with more promising characteristics.</div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0025.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Conformational rigidity of the large contiguous S<sub>3</sub>−S<sub>1</sub> binding site of renin, as illustrated by the overlay of several X-ray crystal structures of enzyme-bound inhibitors from distinct compound classes. Shown are the hydrophobic side chains lining the boundaries of S<sub>3</sub> (Thr<sub>12</sub>, Gln<sub>13</sub>, <u class="uu">Pro</u><sub>111</sub>, <u class="uu">Phe</u><sub>112</sub>, <u class="uu">Leu</u><sub>114</sub>, <u class="uu">Ala</u><sub>115</sub>, <u class="uu">Phe</u><sub>117</sub>, Ser<sub>219</sub>) and S<sub>1</sub> (<u class="uu">Val</u><sub>30,</sub> Asp<sub>32</sub>, <u class="uu">Tyr</u><sub>75</sub>, Thr<sub>77</sub>, <u class="uu">Phe</u><sub>112</sub>, <u class="uu">Phe</u><sub>117</sub>, <u class="uu">Val</u><sub>120</sub>, Asp<sub>215</sub>; the residues shown in the figure are underlined), as observed for <b>1</b> (orange), the GRAB peptidomimetic <b>52</b> (gray), the 2,4-diaminopyrimidine <b>34</b>, and the <i>N</i>-ureapiperidine <b>38</b>. Inhibitors <b>34</b> and <b>38</b> were omitted for clarity. A partial ribbon diagram is shown for the complex with <b>1</b> (gray) and in addition for the flap β-hairpin as observed for <b>52</b> (dark gray). Phe<sub>112</sub> in the complex with <b>52</b> (flap pocket binder) is shifted significantly with respect to the other complexes. Large movements are observed only for the flap β-hairpin (e.g., 5.1 Å for the Cα of Tyr<sub>75</sub> in the complex with <b>1</b> vs <b>52</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The S<sub>3</sub>−S<sub>1</sub> binding topography of renin recognized by structurally diverse classes of non-peptide peptidomimetics emulating the extended β-strand binding conformation of the active site is remarkably conserved and very similar to the topography recognized by substrate-based DRIs. The hydrophobic amino acids lining the S<sub>3</sub> and S1 pockets are located on four different sections of the protein chain (β-3, flap region, α h<sub>N2</sub>, β-8). Their peptide backbone and side chains reveal only minor conformational differences in the X-ray crystal structures of various renin−inhibitor complexes (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). The carboxy-terminal boundary of the S<sub>1</sub> pocket is occupied by the aromatic ring of Tyr<sub>75</sub>, which separates the S<sub>1</sub> from the S<sub>2</sub>′ pocket when the β-hairpin is in a closed conformation.</div><div class="NLM_p">4-Phenylpiperidine GRAB peptidomimetics stabilize a renin active site conformation that is substantially different from the extended β-strand binding conformation observed for classical peptide-like inhibitors.<a onclick="showRef(event, 'ref29 ref36 ref55 ref58'); return false;" href="javascript:void(0);" class="ref ref29 ref36 ref55 ref58">(29, 36, 55, 58)</a> The distinct topography results from major movements of the β-hairpin, in particular of the backbone and side chains of Tyr<sub>75</sub>, Leu<sub>73</sub>, and Trp<sub>39</sub>. This places the inhibitor C4 phenyl into the space vacated by the Tyr<sub>75</sub> aromatic ring, thereby reconstituting the carboxy-terminal boundary of the S<sub>1</sub> pocket (vide infra). Most notably, these rearrangements have little impact on the conformation of the residues defining the boundaries of the S<sub>3</sub> pocket and major portions of S<sub>1</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). Moderate shifts, for example, of the Phe<sub>112</sub> side chain deeper toward the bottom of the S<sub>3</sub> site (by ∼1.5 Å) and of Val<sub>120</sub> have been observed in some cases.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In the X-ray complexes with GRAB peptidomimetics, the renin flap region is in a more “open” conformation than observed for DRIs targeting the substrate-binding active site topography. The largest backbone displacement of ∼6 Å away from the ligand position is noted for the Cα of Thr<sub>77</sub> at the tip of the flap β-turn (Tyr<sub>75</sub>-Ser<sub>76</sub>-Thr<sub>77</sub>-Gly<sub>78</sub>). However, the Tyr<sub>75</sub> phenyl side chain, rotated outward from its buried former position, is now directed toward the active site cleft, thereby closing the spatial gap to the enzyme-bound inhibitors (Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a> and <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0026.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Hydrogen-bond interactions of the (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetic <b>28</b> (gray) and a close analogue of <b>22</b> (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v12">2v12</a>),<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> as well as peptidic inhibitor <b>4</b> (green), with Thr<sub>77</sub> of the flap β-turn. Portions of the enzyme chain in the complex with <b>28</b> are shown as a ribbon diagram in gray, and the Thr<sub>77</sub> side chains in the different complexes are shown with the color coding of the respective inhibitors. Flap domains are in closed conformations. The hydroxyl of the flap Tyr<sub>75</sub> (cyan) in complex with the GRAB peptidomimetic <b>32</b> (inhibitor not shown) is in a similar position as the Thr<sub>77</sub> hydroxyl (0.9 Å distance) in complex with <b>28</b>. The H-bond between the carbonyl of <b>28</b> and the Thr<sub>77</sub> hydroxyl is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The X-ray crystal structures of the topological peptidomimetics <b>28</b> and <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) and a close analogue of <b>22</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>),<a onclick="showRef(event, 'ref13 ref51'); return false;" href="javascript:void(0);" class="ref ref13 ref51">(13, 51)</a> bearing a carbonyl group bridging the P<sub>1</sub> and P<sub>3</sub> residues, revealed a H-bond interaction to the Thr<sub>77</sub> hydroxyl at the tip of the flap region in its closed conformation. In vitro SAR data suggested this Thr<sub>77</sub> flap−inhibitor interaction to provide an important contribution to binding affinity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In the case of peptide-derived inhibitors, the hydroxyl of Thr<sub>77</sub> forms H-bonds to the nitrogen of the P<sub>2</sub>/P<sub>3</sub> carboxamide and to the P<sub>2</sub> carbonyl.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30, 32)</a> In the renin-bound complex of several GRAB peptidomimetics, the reoriented Tyr<sub>75</sub> phenylhydroxyl overlaid within a remarkably close ∼1−2 Å distance with the hydroxyl side chain of Thr<sub>77</sub> in the closed substrate-derived flap conformation observed for <b>4</b>, <b>28</b>, and <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). This may suggest a potential role of the Tyr<sub>75</sub> hydroxyl for the future design of novel GRAB peptidomimetic DRIs.</div><div class="NLM_p last">The hydrophobic and contiguous S<sub>3</sub>−S<sub>1</sub> recognition pocket of renin is now well established as a key hot spot for high affinity ligand binding. All potent DRIs reported to date closely interact with this spacious topography of the target enzyme. The hydrophobic solvent exposed S<sub>4</sub> and the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity are directly accessible from S<sub>3</sub> and have been successfully exploited for novel inhibitor design. Also, both the S<sub>3</sub>−S<sub>1</sub> subsite and the Trp<sub>39</sub> “deep flap pocket” form a large open cleft in the renin conformational topography stabilized by GRAB peptidomimetics, as will be discussed in more detail in a later section devoted to this class of DRIs. This large accessible surface area may allow generation of unprecedented structural motifs binding to these, or possibly alternative, conformations, which could be combined with known center scaffolds interacting with the catalytic dyad. Conversely, it appears conceivable that the identification of new TS surrogates may offer distinct trajectories for novel (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores with high ligand binding efficacy. Very likely, the S<sub>3</sub>−S<sub>1</sub>-topography of renin will remain a major target for future design of diverse non-peptide DRIs with possibly enhanced druglike characteristics.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Nonsubstrate S<sub>3</sub><sup>sp</sup> Binding Pocket</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several investigators have independently discovered the presence of a distinct narrow cavity in native renin, extending from the S<sub>3</sub> site perpendicular to the active site cleft toward the center of the enzyme.<a onclick="showRef(event, 'ref13 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref13 ref61 ref62 ref63">(13, 61-63)</a> This pocket, now generally termed S<sub>3</sub><sup>sp</sup>, is occupied by ordered water molecules and is not involved in substrate or peptide-based inhibitor binding. To our knowledge, Hanson et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> were first to postulate this cavity as a potential auxiliary binding site based on computational energy surface analysis of a renin−peptide inhibitor complex and SAR data. The X-ray structure of <b>26</b> (SC-51106, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> in complex with deglycosylated rh-renin demonstrated the β-(<i>S</i>)-methyl of the hydrocinnamoyl portion to occupy S<sub>3</sub><sup>sp</sup> by replacing one enzyme-bound water. Lefker et al.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> have reported the design of <b>27</b> (CP-305,202, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>) and showed by X-ray that the flexible 3-pyridylpropoxy side chain was binding into the S<sub>3</sub><sup>sp</sup> cavity.</div><figure id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0027.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Early examples of DRIs binding to the S<sub>3</sub><sup>sp</sup> subpocket of renin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers at Ciba-Geigy/Novartis have described the design of topological AHE dipeptide isosteres bearing distinct hydrophobic (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores.<a onclick="showRef(event, 'ref12 ref13 ref49'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref49">(12, 13, 49)</a> The potent inhibitors <b>20</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) and <b>28</b> and <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) were discovered by X-ray crystallography to interact with the nonsubstrate S<sub>3</sub><sup>sp</sup> pocket of renin. A key element of the evolving design concept at Novartis has been to target H-bond interactions to Ser<sub>219</sub> of renin.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This position is highly conserved as either serine or threonine in all aspartic proteases. Interactions with this residue had been recognized by in vitro SAR data and X-ray crystallography of multiple enzyme−inhibitor complexes to be important for the alignment of substrate-based peptidomimetics within the active site,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> including renin and BACE-1 inhibitors.<a onclick="showRef(event, 'cit40b'); return false;" href="javascript:void(0);" class="ref cit40b">(40b)</a> Hence, substitution of hydrophobic (P<sub>3</sub>−P<sub>1</sub>)-scaffolds of weakly active leads with suitable H-bond acceptors/donors was considered to mimic the conserved H-bond of the main chain P<sub>3</sub>/P<sub>2</sub> carboxamide known to be essential for the tight binding of peptide-based inhibitors. The carboxylic ester <b>28</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>), a precursor analogue of <b>19</b>, was indeed shown by X-ray to interact with both the NH and OH of Ser<sub>219</sub> (vide infra). Inhibitor <b>1</b>, but not the P<sub>2</sub>′ analogue <b>20</b>, forms a water-mediated H-bond between the proximal ether oxygen of the P<sub>3</sub><sup>sp</sup> side chain and the Ser<sub>219</sub> hydroxyl, which however is not critical for binding.<a onclick="showRef(event, 'ref12 ref13 ref49'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref49">(12, 13, 49)</a></div><div class="NLM_p">The carboxylic ester of the tetrahydroquinoline analogue <b>28</b> is filling the S<sub>3</sub><sup>sp</sup> cavity only partially with the methyl group being suboptimal in length and in addition forms a direct H-bond to Ser<sub>219</sub> at the entrance of this site. In contrast, both the hydrophobic <i>N</i>-benzyl residue of the indole derivative <b>29</b> and the more polar flexible methoxypropoxy side chain of <b>20</b> penetrate deeply inside and fully occupy the S<sub>3</sub><sup>sp</sup> pocket. Moreover, the terminal methoxy group of <b>20</b>, and likewise of <b>1</b>, is involved in H-bonding to the NH of Tyr<sub>14</sub> at the bottom of the channel (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref12 ref49 ref51'); return false;" href="javascript:void(0);" class="ref ref12 ref49 ref51">(12, 49, 51)</a> Most notably, these unprecedented binding interactions to the nonsubstrate S<sub>3</sub><sup>sp</sup> site had not been predicted by molecular modeling. Further SAR efforts resulted in the identification of the preclinical candidates <b>19</b> and <b>22</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) which exhibited high potency in vivo.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0001.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetics binding to the nonsubstrate S<sub>3</sub><sup>sp</sup> pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The three-dimensional architecture of the renin S<sub>3</sub><sup>sp</sup> subsite and its electrostatic surface properties are now well-defined by multiple enzyme−inhibitor X-ray crystal structures (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). This cavity constitutes a narrow channel extending from the P<sub>3</sub> pocket by about 10 Å in depth, flanked by residues located on five different segments of the enzyme. The hydrophilic nature of the channel is reflected by its capability to bind up to three water molecules in native renin and to accommodate inhibitors with a range of polar residues, including basic aliphatic amines.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Several lipophilic side chains lining the cavity boundaries explain the propensity of S<sub>3</sub><sup>sp</sup> to accommodate equally well hydrophobic aliphatic and aryl ligands. Filling the S<sub>3</sub><sup>sp</sup> pocket while displacing one or more bound water molecules and extruding them into bulk solvent is considered to be favorable because of entropic and enthalphic energy gains.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0002.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Illustration of the conformational rigidity of the renin S<sub>3</sub><sup>sp</sup> pocket. Shown are the superimposed X-ray structures of rh-renin in complex with <b>1</b> (orange) (protein ribbon diagram in gray), <i>N</i>-benzylindole <b>29</b> (brown), and the <i>N</i>-ethylacetamide-substituted 2,4-diaminopyrimidine <b>34</b> (gray). Of the key side chains lining the boundaries of S<sub>3</sub><sup>sp</sup> (Thr<sub>12</sub>, Gln<sub>13</sub>, <u class="uu">Tyr</u><sub>14</sub>, <u class="uu">Val</u><sub>30</sub>, <u class="uu">Tyr</u><sub>155</sub>, <u class="uu">Thr</u><sub>216</sub>, Gly<sub>217</sub>, <u class="uu">Ser</u><sub>219</sub>, and <u class="uu">Ala</u><sub>303</sub>) those underlined are shown with the color codes used for the inhibitors. In addition, the corresponding side chains are shown for the renin complexes with inhibitor <b>4</b> (green), the <i>N</i>-hydroxypropyl analogue of 2-ketopiperazine <b>48</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fs4">2fs4</a>, cyan), and native renin (yellow).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The H-bond of the methoxypropoxy side chain of <b>1</b> to the backbone amide nitrogen of Tyr<sub>14</sub> is highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Targeting binding interactions to the nonsubstrate S<sub>3</sub><sup>sp</sup> pocket has significantly enlarged the arsenal for designing potent and selective DRIs and has been a key element in lead optimization of several new classes of non-peptide peptidomimetics including piperidines (<b>30</b> and <b>31</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> 2,4-diaminopyrimidines (<b>34</b>−<b>37</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>),<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a><i>N</i>-ureapiperidine-based reduced amide isosteres (<b>38</b>−<b>41</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and 2-ketopiperazines (<b>46</b>−<b>50</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Substituting distinct (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores of various non-peptide peptidomimetics with optimized S<sub>3</sub><sup>sp</sup>-binding residues has generated DRIs with a ≥50-fold increased potency,<a onclick="showRef(event, 'ref13 ref19 ref39 cit58c'); return false;" href="javascript:void(0);" class="ref ref13 ref19 ref39 cit58c">(13, 19, 39, 58c)</a> illustrating the importance of S<sub>3</sub><sup>sp</sup>−ligand interactions for tight binding. Terminal alkyl ethers, acetamides, and alkyl carbamates were, in general, found to be optimal for in vitro potency toward rh-renin and more importantly often provided inhibitors with small in vitro plasma IC<sub>50</sub> shifts (vide supra).<a onclick="showRef(event, 'ref36 ref39 ref49'); return false;" href="javascript:void(0);" class="ref ref36 ref39 ref49">(36, 39, 49)</a> Conversely, combinations with hydrophobic P<sub>3</sub><sup>sp</sup> motifs resulted in a significant loss of potency in the presence of plasma, even within inhibitor classes that generally demonstrated low lipophilicity and high solubility, as represented by <b>19</b>−<b>22</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref13 ref49'); return false;" href="javascript:void(0);" class="ref ref13 ref49">(13, 49)</a> The specific structure−activity relationship for P<sub>3</sub><sup>sp</sup> side chain modifications may be depending, to some extent, on the class of DRIs.<a onclick="showRef(event, 'ref36 cit38b ref39'); return false;" href="javascript:void(0);" class="ref ref36 cit38b ref39">(36, 38b, 39)</a></div><div class="NLM_p">Introducing more hydrophilic P<sub>3</sub><sup>sp</sup> side chains has also been explored as a strategy to modulate physicochemical and ADME properties of various classes of DRIs.<a onclick="showRef(event, 'ref36 ref38 ref58'); return false;" href="javascript:void(0);" class="ref ref36 ref38 ref58">(36, 38, 58)</a> The group at Hoffmann-La Roche was the first to investigate this approach as part of the optimization of their highly lipophilic (log <i>P</i> > 5) GRAB peptidomimetic series (<b>30</b> and <b>31</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The tetrahydroquinoline moiety of <b>30</b> (RO-65-2349) provides an ideal vector for hydrophilic extensions toward S<sub>3</sub><sup>sp</sup>, as was suggested by the X-ray structure of <b>32</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>) bound to rh-renin.<a onclick="showRef(event, 'cit36b cit36d'); return false;" href="javascript:void(0);" class="ref cit36b cit36d">(36b, 36d)</a> The less lipophilic and more soluble <b>31</b> (RO-66-1168), bearing a polar <i>N</i>-acetylaminoethyl residue, showed picomolar IC<sub>50</sub> against rh-renin and most notably a 50-fold increase in potency against plasma renin. This compound demonstrated potent BP lowering efficacy in vivo but had poor PK properties in rat.<a onclick="showRef(event, 'cit36d'); return false;" href="javascript:void(0);" class="ref cit36d">(36d)</a></div><div class="NLM_p">The group at Pfizer has subsequently used a similar concept to enhance the in vitro potency of related 2-ketopiperazine GRAB peptidomimetics and to address their strong affinities for CYP3A4.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Various linear side chain functionalities were investigated to probe the requirements for efficient S<sub>3</sub><sup>sp</sup> binding interactions. These modifications resulted in subnanomolar inhibitors of rh-renin (cf. <b>46</b> vs <b>47</b>−<b>50</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>), albeit no IC<sub>50</sub> values for plasma renin were reported. While a terminal hydroxyl, and particularly a carboxylic acid residue, reduced the affinity for CYP450 enzymes, these modifications were not well-tolerated in this series leading to modest in vitro potencies.<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a> The acidic carboxylate of these inhibitors does not interact with the S<sub>3</sub><sup>sp</sup> cavity but rather is solvent exposed, as was shown by X-ray analysis (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2g26">2g26</a>) of a 2-ketopiperazine analogue bearing a (1<i>H</i>-indol-1-yl)acetate moiety.<a onclick="showRef(event, 'cit58f'); return false;" href="javascript:void(0);" class="ref cit58f">(58f)</a></div><figure id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0003.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. 3,4-Piperidine GRAB peptidomimetics: P<sub>3</sub><sup>sp</sup> side chain approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extensive efforts were conducted at Pfizer to optimize the 2,4-diaminopyrimidine class of DRIs via modification of the P<sub>3</sub><sup>sp</sup> side chain with the aim to modulate the physicochemical profile, CYP450 affinity, metabolic clearance, Caco-2 permeability, and in vivo PK.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Inhibitors <b>34</b>−<b>37</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>) illustrate key examples for an expanded exploration of S<sub>3</sub><sup>sp</sup> binding motifs in combination with variations of the 1,4-benzoxazinone scaffold targeting the S<sub>4</sub> pocket. The persisting challenge to accomplish a proper balance between inhibitory potency and desirable ADME properties within this series will be further discussed in later sections.</div><div class="NLM_p">The buried human renin S<sub>3</sub><sup>sp</sup> cavity is characterized by high rigidity and hence a conserved van der Waals volume. Multiple X-ray crystal structures of apo-renin and renin-bound non-peptide inhibitors from different classes and bearing a diversity range of hydrophobic vs more polar S<sub>3</sub><sup>sp</sup> binding motifs revealed only minor conformational movements for the amino acid side chains forming the boundaries of this pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). Linear small side chains extending by about four to six atoms in length are preferred for optimal interactions with S<sub>3</sub><sup>sp</sup>, in line with its well-defined elongated shape. Terminal H-bond acceptors form a favorable binding interaction with the NH of Tyr<sub>14</sub>, by extruding the ordered water of apo-renin, as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a> for <b>1</b> and the 2,4-diaminopyrimidine <b>34</b>.<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a> The formation of a S<sub>3</sub><sup>sp</sup> bound water-mediated H-bond to Thr<sub>216</sub> has been observed for the <i>N</i>-hydroxypropyl analogue of 2-ketopiperazine <b>48</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>).<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a> An additional H-bonding opportunity involving Gly<sub>217</sub> at the entrance of the S<sub>3</sub><sup>sp</sup> site has been identified for a terminal methyl carbamate residue.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The lack of conformational flexibility of the S<sub>3</sub><sup>sp</sup> cavity explains why sterically more demanding ligands are less tolerated, limiting the scope for structural modifications. Notably, the S<sub>3</sub><sup>sp</sup> channel is present in other human aspartic proteases,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> which in principle could have implications for the selectivity of DRIs (vide infra).</div><div class="NLM_p last">The discovery of the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity of renin as a targetable ligand binding site has contributed considerably to the recent advancements toward identifying several attractive new DRI chemotypes. The preferred P<sub>3</sub><sup>sp</sup> pharmacophores reported to date, however, contain features such as a relatively high number of rotatable bonds and H-bond acceptors/donors that could limit oral absorption and in vivo metabolic stability or enhance the drug−drug interaction (DDI) potential. This is most evident when they are combined with unfavorable characteristics predominating in the basic pharmacophore of an inhibitor class. On the other hand, the design of potent non-peptide DRIs that are not dependent on interactions with S<sub>3</sub><sup>sp</sup> has been successful. The most prominent example, the GRAB peptidomimetic <b>52</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>),<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> had advanced to clinical trials. Future work will show whether novel class DRIs lacking a P<sub>3</sub><sup>sp</sup> pharmacophore could offer advantages with respect to PK, in vivo efficacy, safety, and tolerability.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Basic Amine Transition-State Surrogates</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The conceptual idea of modifying the dipeptide cleavage site of a peptide substrate sequence and of introducing a basic amino group at this position was reported as early as 1972 by Szelke et al. for the design of DRIs.<a onclick="showRef(event, 'ref20 ref65'); return false;" href="javascript:void(0);" class="ref ref20 ref65">(20, 65)</a> Replacing the scissile Leu-Val dipeptide of a minimal substrate sequence derived from angiotensinogen by a nonhydrolyzable reduced peptide bond isostere (ψ[CH<sub>2</sub>NH], Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>C) generated the potent decapeptide <span class="smallcaps smallerCapital">l</span>-prolyl-<span class="smallcaps smallerCapital">l</span>-histidyl-<span class="smallcaps smallerCapital">l</span>-prolyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">l</span>-histidyl-<span class="smallcaps smallerCapital">l</span>-leucyl-ψ(CH<sub>2</sub>-NH)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-isoleucyl-<span class="smallcaps smallerCapital">l</span>-histidyl-<span class="smallcaps smallerCapital">l</span>-lysine (H-142),<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> one of the first DRIs that underwent investigational clinical studies and that was shown to reduce BP and circulating AngI and AngII levels in humans.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The geometry of the reduced amide methylene was considered to be a mimic of the tetrahedral transition state for the proposed mechanism of peptide bond hydrolysis.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> X-ray crystal structures of this and other peptidic inhibitors in complex with fungal aspartic proteases revealed the likely protonated nitrogen atom of the reduced amide to be in H-bond distance to only Asp<sub>215</sub> of the catalytic dyad.<a onclick="showRef(event, 'ref28 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref28 ref44 ref45">(28, 44, 45)</a></div><div class="NLM_p">Hydroxyl-containing dipeptide isosteres such as statine (Sta, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>B)<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> of the pepstatin family of natural aspartic protease inhibitors<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the hydroxyethylene isostere (HE, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>A)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> have subsequently attracted the most attention and emerged as the key paradigm of aspartic protease inhibitor design. These TSAs, considered to resemble the geometry of the tetrahedral intermediate of enzyme-catalyzed amide bond hydrolysis, are engaged in a close H-bond network between the isostere hydroxyl and the active site Asp<sub>35</sub> and Asp<sub>215</sub> carboxylates. The binding position of the hydroxyl group is very similar to the site occupied by the extruded enzyme-bound “substrate” water molecule of native renin, suggesting at least in part a collected-substrate mechanism of inhibition.<a onclick="showRef(event, 'ref25 ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref27 ref29">(25, 27, 29)</a> A rich collection of highly effective acyclic hydroxyl-containing TSAs has evolved, and these have found wide application in the design of highly potent peptide-derived peptidomimetic DRIs (<b>2</b>−<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a></div><div class="NLM_p">Relatively few attempts were made initially to design basic amine-based TSAs as a concept to overcome the limitations associated with peptide-derived peptidomimetic inhibitors. Several modified TSAs in which the hydroxyl is replaced by an isosteric NH<sub>2</sub> have been investigated anticipating favorable electrostatic interactions between a positively charged ammonium group and the Asp<sub>32</sub>/Asp<sub>215</sub> carboxylates. Incorporation of the aminoethylene (AE) motif (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>E) into angiotensinogen-based peptide sequences has generated potent inhibitors of human renin and notably the first in vivo active inhibitors of rat renin.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The AE isostere approach was recently revisited for the design of soluble non-peptide isonicotinamide-derived BACE-1 inhibitors with good intracellular potency.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The cocrystal structure of an enzyme-bound analogue<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> has demonstrated the NH<sub>2</sub> to be in a binding position identical to that for the hydroxyl of an octapeptide BACE-1 inhibitor bearing a central hydroxyethylene dipeptide isostere and forming H-bonds to both catalytic aspartates.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Peptide-derived analogues containing aminostatine (AmSta, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>F)<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> displayed potencies toward rh-renin similar to that of their Sta congeners and superior inhibition of rat renin.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Potent 1,2,4-triazolo[4,3-<i>a</i>]pyrazine-based inhibitors bearing a P<sub>1</sub> cyclohexyl-modified AmSta have been reported to reduce BP in Na-depleted marmosets when given parenterally.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> For both Sta and AmSta, the 3(<i>S</i>)-configuration was preferred for binding, albeit the relative potency difference for the (<i>S</i>)- vs (<i>R</i>)-AmSta isostere was not very pronounced depending on the inhibitor framework. The lack of superior inhibitory affinity for AmSta vs Sta analogues was rationalized by unfavorable partial desolvation energy required for the ammonium group upon binding to the active site.<a onclick="showRef(event, 'cit72c'); return false;" href="javascript:void(0);" class="ref cit72c">(72c)</a></div><div class="NLM_p">The hydroxyethylamine (HEA, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>G) isostere has been envisaged to retain the favorable interactions of the tetrahedral carbon bearing the hydroxyl group and to mimic the dipeptide nitrogen atom during substrate hydrolysis. Initially, octapeptide HEA inhibitors of high potency against human renin have been reported.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Tripeptide-based (P<sub>3</sub>−P<sub>1</sub>)-spanning amino alcohols with a terminal NH<sub>2</sub> at the prime site showed only weak inhibitory affinities.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> On the other hand, truncation of the nonprime site has generated moderately active P<sub>1</sub>−P<sub>3</sub>′ tetrapeptides with primary or secondary amines at the P<sub>1</sub> position (AHEA, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>H).<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Interestingly, the reversed (<i>R</i>)-configuration is preferred for the AHEA hydroxyl. The cocrystal structure of a (<i>S</i>)-AHEA containing inhibitor bound to endothiapepsin has revealed the terminal amine to be in weak contact with Gly<sub>217</sub> and the hydroxyl group to interact with both aspartates. By use of a human renin homology model, optimization of the occupancy of the S<sub>1</sub> pocket was achieved by extending the hydrophobic P<sub>1</sub> residue to afford the potent inhibitor <b>23</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a></div><figure id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0004.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Overlay of different chemotype basic amine TS surrogate DRIs interacting with Asp<sub>32</sub> and Asp<sub>215</sub> of the catalytic center. Inhibitors shown are <b>1</b> (orange), the GRAB peptidomimetic <b>33</b> (yellow), the 2,4-diaminopyrimidine <b>34</b> (gray), and the ψ[CH<sub>2</sub>NH]-reduced isostere <b>38</b> (green). For the rh-renin−<b>1</b> complex, residues Asp<sub>32</sub>/Asp<sub>215</sub> and a partial ribbon diagram are shown. To better distinguish the inhibitors, portions of their structures were omitted and nitrogen atoms were colored using different shades of blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Incorporation of the HEA dipeptide isostere has been very successful for development of several marketed antiviral HIV-1 protease inhibitors<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> and more recently for the design of BACE-1 inhibitors.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Furthermore, tertiary carbinamines have been designed as TS surrogates by simplification of the HEA motif to a primary amine, which in combination with a bioisosteric replacement of the P<sub>1</sub> carboxamide has culminated in a CNS penetrating BACE-1 inhibitor orally active in rhesus monkeys.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">The aminohydroxyethylene (AHE, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>D) isostere of <b>1</b> and <b>19</b>−<b>22</b> constitutes an interesting variant of a basic amine central motif. Binding interactions to the catalytic dyad were found to be partially distinct from the H-bond pattern of classical hydroxyethylene (HE) isosteres. When incorporated into peptide-derived peptidomimetics, the HE hydroxyl is positioned symmetrically between Asp<sub>32</sub> and Asp<sub>215</sub> within the plane formed by the two carboxylates. In contrast, the X-ray structures of renin−bound <b>1</b> (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>) and the tetrahydroquinoline analogue <b>28</b> revealed the NH<sub>2</sub> to be within binding distance of both the Gly<sub>217</sub> carbonyl and the Asp<sub>215</sub> carboxylate, possibly forming an electrostatic interaction.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The AHE isostere hydroxyl formed H-bonds to both aspartates, albeit its binding distance was closer to Asp<sub>32</sub>. The hydroxyl of <b>20</b>, an analogue of <b>1</b> with modifications at P<sub>1</sub>′ and P<sub>2</sub>′, was engaged in a H-bond exclusively to Asp<sub>32</sub>, while the NH<sub>2</sub> was within binding distance to the carbonyl of Gly<sub>217</sub> but not to the aspartates.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> These markedly altered H-bond patterns of the AHE moiety resulted from a positional shift of the ligands within the enzyme cleft and conformational adaptations of the isostere backbones. In addition, a slight movement of the Asp<sub>215</sub> side chain was observed for <b>28</b>.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> It is conceivable that novel amino alcohol motifs, possibly as part of a cyclic framework, will be designed in the future, leading to novel non-peptide DRIs.</div><div class="NLM_p">The 4-phenylpiperidine scaffold was discovered by HTS as a novel druglike basic amine TS surrogate, first reported in 1999 by Hoffmann-La Roche.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> X-ray crystallography of the potent prototype leads <b>32</b> and <b>33</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>), derived from the weakly active hit (<i>rac</i>)-<b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), demonstrated the piperidine nitrogen atom to symmetrically occupy the pivotal position between the catalytic Asp<sub>32</sub> and Asp<sub>215</sub> of renin, similar to the hydroxyl group of classical dipeptide TS isosteres (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>).<a onclick="showRef(event, 'cit36a cit36b'); return false;" href="javascript:void(0);" class="ref cit36a cit36b">(36a, 36b)</a> The endocyclic nitrogen is most likely protonated, thus forming two enthalpically favorable electrostatically enforced H-bonds to both aspartates. In retrospect, it is remarkable that this intriguing new principle of efficiently blocking the catalytic site of an aspartic protease had not been uncovered earlier by de novo design considerations.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> More strikingly, inhibitors <b>32</b> and <b>33</b> revealed a noncanonical ligand binding mode to a previously not observed conformational active site topography that is fundamentally different from the renin conformation targeted by substrate-derived peptidomimetics (vide infra). The C4 phenyl and substituents extending at its para-position are accommodated by a newly formed large hydrophobic binding site under the flap β-hairpin.<a onclick="showRef(event, 'ref29 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref36">(29, 36)</a> Furthermore, compared to the peptide-derived framework, the piperidine template provides a very distinct trajectory for topological extensions into the hydrophobic S<sub>3</sub>−S<sub>1</sub> “superpocket”, such as the naphthalene of <b>32</b> and <b>33</b> tethered at the C3 position.</div><figure id="fig18" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0005.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Early prototype 4-phenylpiperidine TS surrogate DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From a conceptual perspective, piperidine and ring-size congeners have been postulated to constitute enzyme family directed privileged TS surrogates<a onclick="showRef(event, 'cit36a ref43'); return false;" href="javascript:void(0);" class="ref cit36a ref43">(36a, 43)</a> for the design of more druglike inhibitors of human and nonmammalian aspartic proteases. Indeed, novel non-peptide inhibitors based on mono- or bicyclic secondary amine center scaffolds have been described for the antimalarial target plasmepsin-II and -IV,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> pepsin,<a onclick="showRef(event, 'ref29 ref78'); return false;" href="javascript:void(0);" class="ref ref29 ref78">(29, 78)</a> cathepsin D,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and the viral HIV-1 protease.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Intriguingly, the successful application of the piperidine core motif for the design of potent BACE-1 inhibitors has not been documented to the best of our knowledge.</div><div class="NLM_p">Cyclic basic amine TS surrogates constitute highly versatile modules to attach structurally diverse peripheral pharmacophores that could reach into the enzyme specificity pockets flanking the core catalytic center or possibly target other yet uncovered ligand binding topographies of renin. Various piperidine-based inhibitors with distinct substitution patterns, including <i>trans</i>-2,5-, <i>cis</i>-3,5- and <i>trans</i>-3,5-disubstituted piperidines, and structurally diversified ring substitutions have been disclosed in the patent literature.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Related 3,4-<i>trans</i>-disubstituted pyrrolidines have also been explored by several groups and were claimed to be potent DRIs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This is indicative of the intense interest in the design of such cyclic amine scaffolds and may suggest that the potential of diversely decorating such TS surrogates has not been fully exploited yet. Some evidence, based on the resemblance of common structural features, is emerging indicating that the design of such inhibitors with a binding pose allowing access to the prime site of renin is likely feasible.<a onclick="showRef(event, 'ref15 ref36'); return false;" href="javascript:void(0);" class="ref ref15 ref36">(15, 36)</a></div><div class="NLM_p">Predicting the binding interactions of unprecedented inhibitor chemotypes designed by de novo computational modeling relying on the enzyme structure−knowledge base and ligand structure commonalities remains challenging.<a onclick="showRef(event, 'ref13 cit40b ref79'); return false;" href="javascript:void(0);" class="ref ref13 cit40b ref79">(13, 40b, 79)</a> Potent pyrrolidine-based HIV-1 protease inhibitors have been designed by decorating the 3,4-positions with side chains known from substrate-based inhibitors to optimally fill the S<sub>2</sub>−S<sub>2</sub>′ recognition sites.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> X-ray crystallography confirmed the pyrrolidine nitrogen of a prototype analogue to be positioned in binding distance to the catalytic dyad of the enzyme; however, the inhibitor adopted an unexpected binding pose which was distinct from the model on which the design was based. It was characterized by replacement of the structural flap water, a distinct H-bond pattern and altered occupation of the enzyme subsites, as well as a distortion of the geometry of the flap region.<a onclick="showRef(event, 'cit36a ref79'); return false;" href="javascript:void(0);" class="ref cit36a ref79">(36a, 79)</a> Hence, novel TS surrogates may potentially address previously unobserved energetically favored active site conformations, including deviations in the position and geometry of the catalytic aspartates.<a onclick="showRef(event, 'cit40b ref51 ref80'); return false;" href="javascript:void(0);" class="ref cit40b ref51 ref80">(40b, 51, 80)</a></div><div class="NLM_p">The 2,4-diaminopyrimidine TS surrogate, discovered at Pfizer from an HTS hit (<b>10</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), forms multiple H-bond interactions within the catalytic center of rh-renin, as shown by the X-ray crystal structures for several analogues of this inhibitor class (e.g., for <b>11</b>, <b>34</b>, and <b>36</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>).<a onclick="showRef(event, 'ref19 ref38'); return false;" href="javascript:void(0);" class="ref ref19 ref38">(19, 38)</a> The pyrimidine NH<sub>2</sub> at C2 is in binding distance to both catalytic Asp<sub>32</sub> and Asp<sub>215</sub>, and the N1 nitrogen interacts with the Asp<sub>32</sub> carboxylate. Interactions of the pyrimidine NH<sub>2</sub> at C4 with Thr<sub>77</sub> and Ser<sub>76</sub> of the β-hairpin and of the N3 nitrogen with an enzyme-bound water contribute to the strong network of H-bonds and a significant gain in binding enthalpy as determined by ITC.<a onclick="showRef(event, 'cit38c'); return false;" href="javascript:void(0);" class="ref cit38c">(38c)</a> The 2,4-diaminopyrimidine framework, which is reminiscent of that of 2-aminopyridine and 2-aminoquinoline-based BACE-1 inhibitors,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> was considered as a highly effective “recognition unit” for renin, and no efforts were made for further optimization of this particular subunit.<a onclick="showRef(event, 'cit38a'); return false;" href="javascript:void(0);" class="ref cit38a">(38a)</a> Combining the TS surrogate scaffold at its 5-position with 2,2-disubstituted 1,4-benzoxazin-3-ones bearing a P<sub>3</sub><sup>sp</sup> side chain resulted in analogues (<b>34</b>−<b>37</b>) exhibiting high potency in vitro. These inhibitors span the S<sub>4</sub>/S<sub>3</sub> and S<sub>1</sub> sites of the extended β-strand binding active site conformation with closed flap conformation.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Various challenges to accomplish a proper balance between potency and desirable physicochemical and ADME properties were encountered for this class of DRIs (vide infra).<a onclick="showRef(event, 'ref15 ref19 cit38b'); return false;" href="javascript:void(0);" class="ref ref15 ref19 cit38b">(15, 19, 38b)</a></div><div class="NLM_p">More than 30 years after the pioneering work by Szelke,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> the incorporation of a ψ[CH<sub>2</sub>NH]-reduced amide isostere has regained attraction as a viable concept for the design of new chemotype inhibitors of drug target aspartic proteases. First, this approach demonstrated success in generating open-chain and macrocyclic BACE-1 inhibitors with improved solubility, cell-permeability, and intracellular potency.<a onclick="showRef(event, 'cit40b ref82'); return false;" href="javascript:void(0);" class="ref cit40b ref82">(40b, 82)</a></div><figure id="fig19" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0006.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. 2,4-Diaminopyrimidine-based peptidomimetics (IC<sub>50</sub> in buffer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, Vitae Pharmaceuticals has reported a new class of DRIs, exemplified by <b>38</b>−<b>40</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>), that emerged from an iterative structure-based de novo design (vide supra).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> These inhibitors comprise a rigid 3-substituted <i>N</i>-ureapiperidine skeleton bridging the solubilizing basic amine TS surrogate and a substituted P<sub>3</sub> phenyl extended by a flexible P<sub>3</sub><sup>sp</sup> side chain. Inhibitor <b>38</b> was confirmed by X-ray to emulate the enzyme-bound β-strand conformation of peptide-derived peptidomimetics, as predicted by modeling. The piperidine scaffold serves to connect the hydrophobic P<sub>1</sub> cyclohexyl and the P<sub>3</sub> meta-Cl-phenyl in a nontopological fashion. The chlorine atom fills an additional hydrophobic subcavity formed by Pro<sub>118</sub>, Phe<sub>119</sub>, Ala<sub>122</sub>, and Phe<sub>124</sub>, resulting in a 15-fold potency increase.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Interestingly, the ψ[CH<sub>2</sub>NH] nitrogen atom is positioned between both catalytic Asp<sub>32</sub> and Asp<sub>215</sub> carboxylates, in contrast to the binding mode observed for other reduced amide isostere inhibitors of aspartic proteases.<a onclick="showRef(event, 'ref28 ref44 ref82'); return false;" href="javascript:void(0);" class="ref ref28 ref44 ref82">(28, 44, 82)</a> The tertiary hydroxyl of <b>38</b> was in H-bond distance (2.5 Å) to the γ-oxygen of Ser<sub>219</sub> at the entrance of the S<sub>3</sub><sup>sp</sup> cavity. This again illustrates the key role of Ser<sub>219</sub> for the design of non-peptide DRIs by serving as a potential anchor position for the ligand framework within the enzyme cleft.<a onclick="showRef(event, 'ref13 cit40b ref44 ref51'); return false;" href="javascript:void(0);" class="ref ref13 cit40b ref44 ref51">(13, 40b, 44, 51)</a> Hence, the tertiary phenylcarbinol moiety of <b>38</b> constitutes a remarkably compact pharmacophore combining three key structural features important for strong inhibitor binding. Attachment of the P<sub>3</sub><sup>sp</sup> side chain via an ether linkage and removal of the tertiary hydroxyl gave <b>39</b> with inferior potency but improved oral bioavailability in rat. Removal of the P<sub>3</sub><sup>sp</sup> ethoxypropoxy chain resulted in a 70-fold IC<sub>50</sub> increase, emphasizing the importance of binding to the S<sub>3</sub><sup>sp</sup> cavity. The methylcarbamate analogue <b>40</b> showed a remarkably high potency toward plasma renin. Inhibitors <b>38</b> and <b>40</b> elicited a sustained BP reduction orally in a double-transgenic rat (dTGR) model.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig20" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0007.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Non-peptide peptidomimetic ψ[CH<sub>2</sub>NH]-reduced amide isosteres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further exploration of this chemotype has been a continued effort at Vitae, as judged from the patent literature.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Analogue <b>41</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>), bearing a regioisomeric modification of the basic amine TS surrogate and a more polar P<sub>1</sub> pyranyl ring, was claimed to be orally efficacious in a dTGR model.<a onclick="showRef(event, 'cit83a'); return false;" href="javascript:void(0);" class="ref cit83a">(83a)</a> The <i>N</i>-carbonylpiperidine and related heterocyclic skeletons have been combined with various classical and novel TSAs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Furthermore, the proximity of the P<sub>3</sub> phenyl and the P<sub>1</sub> cyclohexyl of renin-bound <b>38</b> and <b>40</b> has suggested growth of the phenyl template into S<sub>1</sub> in a topological fashion;<a onclick="showRef(event, 'cit83b'); return false;" href="javascript:void(0);" class="ref cit83b">(83b)</a> however, no biological results have been reported to date.</div><div class="NLM_p">Inhibitors <b>38</b>−<b>41</b> are reminiscent of the vicinal-diol TSA inhibitor <b>42</b> (CP-265,671) previously reported by Pfizer.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The tetrasubstituted cyclohexane provides a rigid vector for the phenethyl chain to reach into S<sub>3</sub> and for the ethyl to fill the S<sub>2</sub> pocket. The tertiary hydroxyl was incorporated to mimic the P<sub>3</sub>/P<sub>2</sub> carbonyl of a peptidic inhibitor for Ser<sub>219</sub> H-bonding.<a onclick="showRef(event, 'ref44 ref63'); return false;" href="javascript:void(0);" class="ref ref44 ref63">(44, 63)</a> Such compounds were abandoned because of low solubility, weak potency in plasma, and synthetic complexity but laid the foundation for the design of P<sub>3</sub><sup>sp</sup>-tethered inhibitors like <b>27</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p last">A diverse array of novel cyclic or acyclic basic “warheads” have been reported to potently inhibit BACE-1<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and other aspartic proteases.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Some of these TS surrogates were utilized for the design of DRIs, such as <i>N</i>-acylamidines and <i>N</i>-acylguanidines;<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> however, no biological results were disclosed to date. Non-peptide inhibitors displaying a nonclassical binding mode without engaging in direct interactions to the catalytic dyad were identified for BACE-1<a onclick="showRef(event, 'ref64 ref80'); return false;" href="javascript:void(0);" class="ref ref64 ref80">(64, 80)</a> and plasmepsin-II (PM-II).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> X-ray crystallography revealed a single water-mediated H-bonding between the two aspartates and either an amide NH, as for the BACE-1 ligand,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> or the basic nitrogen of an <i>N</i>-alkylpiperidine as for the PM-II inhibitor.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Notably, the water molecules were in a position similar to that of the “catalytic” water of the native enzymes. Spiropiperidine-iminohydantoin BACE-1 inhibitors were found to interact with Asp<sub>32</sub> and Asp<sub>228</sub> via two bridging water molecules, forming a complex H-bonding network involving the N-benzylated piperidine and the exocyclic imino nitrogen atom.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Remarkably, BACE-1 adopted a different active site conformational topography by forming a new binding site under the flap β-hairpin.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> While such atypical inhibitors of renin have not been reported, the possibility for a water-mediated mechanism to block the catalytic center may in principle exist also for renin.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">GRAB Peptidomimetic Class of DRIs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of 3-substituted 4-arylpiperidines as a unique class of potent DRIs, bearing several key structural features unrelated to peptide-derived TSA inhibitors, constitutes a major breakthrough.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> As already discussed, the finding that the center piperidine acts as a TS surrogate by interacting with the catalytic aspartates has created a new paradigm for the design of non-peptide inhibitors of renin and other aspartic proteases.<a onclick="showRef(event, 'cit36a ref43'); return false;" href="javascript:void(0);" class="ref cit36a ref43">(36a, 43)</a> Most intriguingly, these inhibitors bind to a renin active site topography that is very different from the enzyme conformation targeted by substrate-derived peptidomimetics.</div><figure id="fig21" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0008.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Advanced 3,4-piperidine-based GRAB peptidomimetics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitors <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>), <b>43</b> (RO-66-7219), and <b>44</b> (RO-66-1132, Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>) represent advanced potent and selective analogues of this new class of inhibitors,<a onclick="showRef(event, 'cit36d'); return false;" href="javascript:void(0);" class="ref cit36d">(36d)</a> which were derived from the HTS hit <i>rac</i>-<b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) via further optimization of the prototype leads <b>32</b> and <b>33</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>).<a onclick="showRef(event, 'cit36a cit36b cit36c'); return false;" href="javascript:void(0);" class="ref cit36a cit36b cit36c">(36a-36c)</a> The bicyclic pharmacophores attached to the piperidine C3 span and partially fill the hydrophobic S<sub>3</sub>−S<sub>1</sub> hot spot and can be further substituted by residues targeting the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity. The lipophilic piperidine C4 phenyl and its extension at the C4′ position occupy a large hydrophobic cleft located underneath the S<sub>3</sub>−S<sub>1</sub> pocket at the core of the N-terminal domain, as unveiled by X-ray crystallography of <b>32</b> and <b>33</b> bound to rh-renin (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>). This cavity results from major conformational movements of the flap adopting a more open conformation, which specifically involve concerted side chain rotations of the Tyr<sub>75</sub>, Leu<sub>73</sub>, and Trp<sub>39</sub> residues. As a consequence, the H-bond between the phenolic OH of Tyr<sub>75</sub> and the indole NH of Trp<sub>39</sub> is disrupted, and the reorientation of the Trp<sub>39</sub> indolylmethyl opens up a buried “deep flap pocket”. Interestingly, this movement of Trp<sub>39</sub> is not observed for the weak affinity inhibitors <b>8</b> and <b>9</b>, lacking the C4′ extension.<a onclick="showRef(event, 'cit36a cit36b'); return false;" href="javascript:void(0);" class="ref cit36a cit36b">(36a, 36b)</a></div><div class="NLM_p">The piperidine C4 phenyl of <b>32</b> and <b>33</b> occupies, in a similar planar orientation, the space of the “gate-keeper” Tyr<sub>75</sub> side chain<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and thus reconstitutes the carboxy-terminal boundary of the S<sub>1</sub> pocket by forming an aromatic cluster of edge-to-face interactions with Tyr<sub>75</sub> and Phe<sub>112</sub>.<a onclick="showRef(event, 'cit36a cit36b'); return false;" href="javascript:void(0);" class="ref cit36a cit36b">(36a, 36b)</a> The lipophilic C4′ flexible spacer spans the position previously occupied by the Trp<sub>39</sub> indole, while the terminal phenyl moiety is accommodated by an extension of the deep flap cavity generated by additional subtle local rearrangements, particularly by Met<sub>107</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>). Initial lead optimization included attempts to rigidify the conformational flexibility of the polyether side chain by incorporation of cyclic constraints; however, the ortho-methoxy-benzyloxypropoxy residue (<b>30</b>, <b>31</b>, <b>43</b>, <b>44</b>) was found to be optimal for high affinity interactions to the flap binding topography.<a onclick="showRef(event, 'cit36b'); return false;" href="javascript:void(0);" class="ref cit36b">(36b)</a> The assisting role of the inhibitor C4 phenyl in stabilizing the enzyme complex by replacing the Tyr<sub>75</sub> aromatic ring has inspired to coin this class of DRIs as “group replacement assisted binding” or GRAB peptidomimetics.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">The explicitly hydrophobic nature of the early GRAB peptidomimetics is mainly attributed to the large lipophilic (P<sub>3</sub>−P<sub>1</sub>)-scaffold and the C4′ extended side chain, both being key contributors to high affinity interactions to renin. Various SAR strategies have been explored to improve the limitations of their physicochemical properties, recognized as the major culprit for significant plasma renin IC<sub>50</sub> shifts, affinity to cytochrome P450 isozymes, and high metabolic clearance. Modifications of the core pharmacophore by replacing either the piperidine C4 phenyl or the side chain terminal phenyl by hydrophilic heteroaryl groups resulted mostly in significant in vitro potency loss.<a onclick="showRef(event, 'cit36b cit36c'); return false;" href="javascript:void(0);" class="ref cit36b cit36c">(36b, 36c)</a> Attachment of solubilizing residues, which could either bind to the renin active site or alternatively point out into bulk solvent was found to be more promising.<a onclick="showRef(event, 'cit36c cit36d'); return false;" href="javascript:void(0);" class="ref cit36c cit36d">(36c, 36d)</a> Inhibitor <b>31</b> with a hydrophilic extension into the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity is the most potent GRAB peptidomimetic toward plasma renin reported to date. The piperidine C5 position proved to be amenable for the introduction of polar substituents with up to two hydroxyl and/or alkoxy groups. The methoxymethyl of <b>32</b> was shown by X-ray to point toward the reoriented Tyr<sub>75</sub> of the flap, while the C(4)−C(5)-<i>trans</i>-configured <b>43</b> and <b>44</b> potentially extend into the S<sub>2</sub>′ pocket. This has generated less hydrophobic analogues, albeit with limited impact on the in vitro potency against plasma renin (cf. <b>30</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>).<a onclick="showRef(event, 'cit36c'); return false;" href="javascript:void(0);" class="ref cit36c">(36c)</a> The preclinical candidate <b>44</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>) demonstrated a superior PK profile and displayed a potent sustained BP reduction in dTGR and in monkeys.<a onclick="showRef(event, 'cit36d cit36e cit85b'); return false;" href="javascript:void(0);" class="ref cit36d cit36e cit85b">(36d, 36e, 85b)</a></div><figure id="fig22" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0009.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Piperidine-derived GRAB peptidomimetic inhibitors (IC<sub>50</sub> in buffer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This first generation of <i>trans</i>-3,4-piperidine GRAB peptidomimetics has inspired other investigators to further exploit this chemotype with the aim to improve the in vitro and in vivo ADME profile. Pfizer has described initially 3-amino-4-arylpiperidines with preferred relative <i>cis</i>-configuration, by replacing the ether linkage at the piperidine C3 with a secondary amine spacer.<a onclick="showRef(event, 'cit58a'); return false;" href="javascript:void(0);" class="ref cit58a">(58a)</a> The most potent analogue, <i>rac</i>-<b>45</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>), was shown by X-ray crystallography to bind to renin in a similar fashion compared to the 3,4-<i>trans</i>-disubstituted alkoxyarylpiperidines but with an additional H-bond formed between Gly<sub>217</sub> and the exocyclic nitrogen atom. Further modifications of the center scaffold were subsequently described by eliminating one chirality center, leading to piperazine and 2-ketopiperazine analogues <b>46</b>−<b>50</b> with a “reversed” ether linkage.<a onclick="showRef(event, 'cit58b cit58c cit58d cit58e cit58f'); return false;" href="javascript:void(0);" class="ref cit58b cit58c cit58d cit58e cit58f">(58b-58f)</a> Ketopiperazine <b>46</b> showed moderate in vitro activity and short-lasting oral BP lowering effects in hypertensive double-transgenic mice.<a onclick="showRef(event, 'cit58b cit58c'); return false;" href="javascript:void(0);" class="ref cit58b cit58c">(58b, 58c)</a> The 3,4-dihydro-2<i>H</i>-quinoline derivatives <b>47</b><a onclick="showRef(event, 'cit58c'); return false;" href="javascript:void(0);" class="ref cit58c">(58c)</a> and <b>48</b><a onclick="showRef(event, 'cit58d'); return false;" href="javascript:void(0);" class="ref cit58d">(58d)</a> bearing a P<sub>3</sub><sup>sp</sup><i>N</i>-acetylaminoethyl side chain revealed markedly enhanced in vitro potencies. Further variations of the (P<sub>3</sub>−P<sub>1</sub>)-bicyclic moiety afforded the potent 1,4-benzoxazin-3-ones <b>49</b> and <b>50</b>.<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a> The lipophilicity of these inhibitors was reduced but remained noncompliant with Lipinski’s rule,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> suggesting a marked potency drop toward plasma renin to be very likely. Furthermore, most of the potent inhibitors of these series suffered from high affinities to CYP450 isozymes.<a onclick="showRef(event, 'ref19 ref58'); return false;" href="javascript:void(0);" class="ref ref19 ref58">(19, 58)</a> Modifications of the terminal ortho-methoxyphenyl and the propylenedioxy spacer were not envisaged, as this pharmacophore was considered to be optimal for binding into the flap pocket.<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a></div><div class="NLM_p">Actelion has reported a novel class of GRAB peptidomimetics based on a 3,9-diazabicyclo[3.3.1]nonene center scaffold (<b>51</b> and <b>52</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>), as well as modified bicyclic bridged templates.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Furthermore, related monocyclic tetrahydropyridine analogues were disclosed, representing the first achiral and in vitro potent DRIs known to date.<a onclick="showRef(event, 'cit55c'); return false;" href="javascript:void(0);" class="ref cit55c">(55c)</a> Optimized inhibitors <b>51</b> and <b>52</b> were identified from a structure-based design approach involving multiparallel chemistry. Both analogues were potent toward rh-renin but showed a significant ∼100-fold IC<sub>50</sub> shift leading to moderate inhibitory affinities against plasma renin in vitro. This was explained by high plasma protein binding (>99% for <b>52</b>) in human, dog, and monkey.<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> The absolute configuration of the dibasic bicyclic core determines which of the two secondary ring nitrogen atoms interacts with the catalytic aspartates by forming H-bonds and expelling the enzyme-bound water, as shown by X-ray for renin-bound <b>51</b> and its equipotent (−)-(1<i>S</i>,5<i>R</i>)-enantiomer. The second nitrogen in turn is exposed toward bulk water and has served as anchor point for solubilizing groups, albeit none of the resulting inhibitors had a superior profile. This class of inhibitors comprise a benzylated <i>N</i>-cyclopropylcarboxamide as a novel P<sub>3</sub>−P<sub>1</sub> motif (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) providing high potencies toward plasma renin. Emphasis on rigidifying the conformational flexibility of the side chain in para of the 4-phenyl substituent led to the identification of the propyloxy (as in <b>51</b>) and 1,2-ethylenedioxy (as in <b>52</b>) spacers. A strained 2,6-substitution pattern with at least one ortho-chloro atom at the terminal phenyl, considered as a potential soft spot for metabolism, provided inhibitors with superior potencies. Inhibitors <b>51</b> and <b>52</b> were well absorbed in Wistar rats and proved to be orally efficacious in a dTGR model,<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> as well as in salt-restricted, furosemide pretreated rhesus monkeys.<a onclick="showRef(event, 'cit55b'); return false;" href="javascript:void(0);" class="ref cit55b">(55b)</a> The most preferred analogue, <b>52</b>, was progressed to phase IIa clinical trials.</div><figure id="fig23" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0010.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Second generation GRAB peptidomimetic DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The class of GRAB peptidomimetics is continuing to attract interest, as is implied by the large number of recent patent claims.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Design efforts are further exploring modifications of the flap binding motif in combination with new (P<sub>3</sub>−P<sub>1</sub>)-scaffolds and central piperidine replacements, including new substitution patterns like 2,4,5-trisubstituted piperidines. Design concepts that address the Trp<sub>39</sub> flap pocket pharmacophore aim to reduce the number of rotatable bonds and to replace the lipophilic C4′ portion by small polar side chains lacking the terminal aryl residue. Since more detailed biological data are currently not available, predictions of whether these approaches are likely to succeed in providing clinical candidates would be premature.</div><div class="NLM_p">Notably, exploration of potent GRAB peptidomimetics, as reported to date, has been restricted to hydrophobic side chains of variable conformational flexibility that are exclusively attached to the para-position of the C4 phenyl binding into the Tyr<sub>75</sub> pocket. Not surprisingly, analysis of X-ray crystal structures showed overall similar van der Waals contacts for such inhibitors to the open flap conformational topography and a conserved alignment of the side chains of Tyr<sub>75</sub>, Leu<sub>73</sub>, and Trp<sub>39</sub> in the renin−inhibitor complexes (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>).<a onclick="showRef(event, 'ref36 cit55a'); return false;" href="javascript:void(0);" class="ref ref36 cit55a">(36, 55a)</a> The 1,2-ethylenedioxy spacer of <b>52</b> adopted a more compact gauche conformation compared to the propyloxy spacer of <b>51</b>. Both terminal aryl groups are similarly positioned in the hydrophobic Trp<sub>37</sub> flap pocket, albeit in the case of <b>52</b> the phenyl is not entirely filling out the cavity. In both cases, the ortho-chlorine occupied a hydrophobic indent, while the second ortho-halogen pointed straight toward the <i>N</i>-cyclopropyl in the S<sub>1</sub> site. The SAR of GRAB peptidomimetic inhibitors of plasmepsin II was shown to correlate with the degree to which the narrow well-defined flap pocket is filled by flexible ligand alkyl chains, in line with the principle of ideal volume occupancy for host−guest recognition.<a onclick="showRef(event, 'cit77a'); return false;" href="javascript:void(0);" class="ref cit77a">(77a)</a></div><div class="NLM_p">The conformational mobility of the flap β-hairpin characterized by major spatial movements is part of its critical function to open and close the catalytic site, thereby enabling ligand binding and release. The disruption of flap domain H-bonds, such as between Tyr<sub>75</sub> and Trp<sub>39</sub>, is considered to be part of this dynamic process and hence to be at low energy cost involving low barrier conformational changes.<a onclick="showRef(event, 'ref29 cit36a'); return false;" href="javascript:void(0);" class="ref ref29 cit36a">(29, 36a)</a> It has been suggested that distinct pre-existing conformations of the renin active site are stabilized upon binding of complementary ligand structures rather than by an induced-fit adaptation binding mechanism.<a onclick="showRef(event, 'ref29 ref87'); return false;" href="javascript:void(0);" class="ref ref29 ref87">(29, 87)</a> Energetically favorable conformational ensembles with topographies distinct from that stabilized by known GRAB peptidomimetics may exist, which could be exploited for inhibitor design. Notably, 3,4-piperidine-based inhibitors that comprise a meta-extended C4 phenyl or more space-filling meta-biphenyl, benzothiophene, and N-substituted indole moieties at the C4 position of the TS surrogate have been claimed as novel DRIs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Inspection by modeling would suggest that these residues could not be readily accommodated by the small Tyr<sub>75</sub> pocket or may extend into the Trp<sub>37</sub> deep flap pocket in a different manner as in the case of GRAB peptidomimetics bearing a para-phenyl substitution. Hence, distinct conformations of the flap region that could be stabilized by structurally distinct flap-binding pharmacophores are indeed likely to be accessible.</div><figure id="fig24" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0011.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Superposition of X-ray structures of rh-renin complexed with GRAB peptidomimetics <b>33</b> (orange) and <b>51</b> (gray) binding to the open flap conformational topography. Partial peptide backbones and the side chains for Trp<sub>39</sub>, Leu<sub>73</sub>, and Tyr<sub>75</sub> are shown for the two complexes using the same color code. The corresponding portions of the rh-renin−<b>1</b> complex are overlaid in brown. For the complex with <b>51</b> the portion of the active site behind the inhibitor is shown as a transparent surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">S<sub>2</sub> Specificity Pocket</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Structural modification of the P<sub>2</sub> portion in peptide-derived peptidomimetics has played an important role for optimizing their potency and selectivity, as well as for designing analogues with improved pharmaceutical properties.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> The large and bifurcated hydrophobic S<sub>2</sub> pocket of renin (Ser<sub>76</sub>, Thr<sub>77</sub>, Tyr<sub>220</sub>, Phe<sub>242</sub>, and His<sub>290</sub>-Met<sub>292</sub>), like that of related aspartic proteases, can accommodate a variety of both hydrophobic and polar pharmacophores and thus allows considerable variations in enzyme-ligand interactions. Indeed, a number of peptide-derived DRIs were shown by X-ray crystallography of their complexes to endothiapepsin to adopt a range of distinct P<sub>2</sub> side chain orientations as a consequence of the permissiveness of the S<sub>2</sub> pocket.<a onclick="showRef(event, 'ref28 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref28 ref44 ref45">(28, 44, 45)</a> The fact that P<sub>2</sub> side chain conformations are not tightly constrained within this binding site has rendered accurate modeling predictions of ligand−enzyme interactions to S<sub>2</sub> rather difficult.<a onclick="showRef(event, 'ref13 cit38c'); return false;" href="javascript:void(0);" class="ref ref13 cit38c">(13, 38c)</a> The topography of both the S<sub>2</sub> and S<sub>1</sub>′ pockets forming a spacious open subsite has been exploited for the design of potent macrocyclic DRIs.<a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">(23a)</a></div><div class="NLM_p">Most non-peptide classes of DRIs reported to date, including piperidine-based GRAB peptidomimetics (<b>43</b>, <b>44</b>, and <b>46</b>−<b>52</b>), as well as the (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetics <b>1</b>, <b>19</b>−<b>22</b>, are not engaged in binding interactions to the S<sub>2</sub> specificity site. Topographic characteristics and promiscuity have suggested a limited attractiveness for explicitly targeting the S<sub>2</sub> pocket by rational de novo design of DRIs.<a onclick="showRef(event, 'ref13 ref39'); return false;" href="javascript:void(0);" class="ref ref13 ref39">(13, 39)</a> Such considerations, among other key aspects (vide supra), have formed the initial conceptual idea toward the design of (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetic inhibitors that eventually led to the discovery of <b>1</b>.<a onclick="showRef(event, 'ref12 ref13 ref49'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref49">(12, 13, 49)</a> Noteworthy, targeting optimized interactions to the S<sub>2</sub> pocket has been seminal in identifying potent inhibitors of BACE-1 with high selectivity against other human aspartic proteases.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Analogues of 5-aryl-2,4-diaminopyrimidines (<b>34</b>−<b>37</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>) were shown by X-ray to be positioned with their 4-NH<sub>2</sub> group in close distance to Thr<sub>77</sub> and Ser<sub>76</sub> at the entry of the large S<sub>2</sub> pocket.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This suggested extending this position into the S<sub>2</sub> cavity as a strategy for lead optimization. A fragment-based NMR “second-site screening approach” using the 4-aminomethyl analogue of <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) as the first-site ligand probe in combination with in silico GOLD docking to assess fragments as potential S<sub>2</sub> binders identified the (4-amino-3-methoxyphenyl)benzamide as single hit from a small library. Saturated transfer difference NMR via interligand NOEs in the presence of renin demonstrated this fragment to be an active site coligand.<a onclick="showRef(event, 'cit38c cit38d'); return false;" href="javascript:void(0);" class="ref cit38c cit38d">(38c, 38d)</a> Modeling suggested tethering of the ortho-phenyl position of the fragment to the 4-NH<sub>2</sub> of <b>12</b> by an ethylene spacer. Cocrystallization of the resulting inhibitor <b>56</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a>) with rh-renin confirmed the attached moiety to occupy a significant portion of the S<sub>2</sub> pocket.<a onclick="showRef(event, 'cit38d'); return false;" href="javascript:void(0);" class="ref cit38d">(38d)</a> However, <b>56</b> was found to be 4-fold less potent compared to its direct 4-NH<sub>2</sub> analogue.<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a> ITC data suggested a substantial loss of binding enthalpy for <b>56</b>, which is largely compensated by a gain in binding entropy. This was attributed to flexing of the protein to accommodate the extension into S<sub>2</sub> and removal of ordered water from the pocket.<a onclick="showRef(event, 'cit38c'); return false;" href="javascript:void(0);" class="ref cit38c">(38c)</a></div><figure id="fig25" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0012.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Non-peptide peptidomimetic DRIs binding to the S<sub>2</sub> pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Guided by both X-ray and thermodynamics considerations, subsequent modifications of the spacer length and incorporation of functional groups predicted to interact more properly with the S<sub>2</sub> polar surface led to inhibitor <b>57</b> with improved enzyme inhibition and binding affinity (by ITC). Interestingly, the cocrystal structure of renin-bound <b>57</b> revealed two different orientations of the naphthalene extending into the S<sub>2</sub> pocket and alternative H-bonding patterns for the polar sulfonamide functionality at the bottom of this site. Furthermore, a portion of the renin active site determined by the peptide loop of residues Lys<sub>238</sub>-Tyr<sub>244</sub> adopted both a closed and a more open conformation, depending on the orientation of the ligand naphthalene.<a onclick="showRef(event, 'cit38c'); return false;" href="javascript:void(0);" class="ref cit38c">(38c)</a></div><div class="NLM_p last">ITC and X-ray data for <b>56</b> and <b>57</b> and related analogues suggested that binding to the large hydrophobic S<sub>2</sub> pocket is both enthalpy and entropy driven. A proper balance between nonpolar and polar interactions via correctly positioned functional groups that could compensate for displacement of ordered water molecules will likely be required for optimizing the interactions to the S<sub>2</sub> cavity.<a onclick="showRef(event, 'cit38c'); return false;" href="javascript:void(0);" class="ref cit38c">(38c)</a> Noteworthy, it has been suggested that improving binding affinity is more difficult to achieve for inhibitors with entropically driven interactions, while inhibitors exhibiting favorable binding enthalpy may have a better potential for lead optimization.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">S<sub>1</sub>′−S<sub>2</sub>′ Prime Site Specificity Pockets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Optimizing the interactions to the S<sub>1</sub>′ and S<sub>2</sub>′ recognition sites has played an important role for the initial development of peptide-based peptidomimetic DRIs. The introduction of polar or basic P<sub>2</sub>′ moieties has provided less lipophilic and more soluble analogues with improved PK properties.<a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">(23a)</a> Dipeptide isostere TSAs with a truncated C-terminal portion have been designed to seek second generation DRIs with reduced molecular size (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>),<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> and as a consequence, targeting the prime site became less attractive. In contrast, optimal interactions to both the S<sub>1</sub>′ and S<sub>2</sub>′ pockets were found to be critical for tight binding affinity of the (S<sub>3</sub>−S<sub>1</sub>)-topological class of TSAs such as <b>1</b> and <b>19</b>−<b>22</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Truncated analogues with an optimized (P<sub>3</sub>−P<sub>1</sub>)-pharmacophore, but lacking the prime-site portion, were only moderately potent. The α,α-diMe β-alanine carboxamide of <b>1</b> constitutes a unique P<sub>2</sub>′ motif contributing significantly to the picomolar inhibition of plasma renin. Its terminal CONH<sub>2</sub> group forms a network of direct and water-mediated H-bonds to S<sub>2</sub>′ residues including Arg<sub>74</sub> of the flap.<a onclick="showRef(event, 'ref12 ref51'); return false;" href="javascript:void(0);" class="ref ref12 ref51">(12, 51)</a></div><div class="NLM_p">More recent design approaches toward non-peptide DRIs have centered around the S<sub>3</sub>−S<sub>1</sub> hydrophobic hot spot, the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity, and the flap β-hairpin binding sites. The prime-site portion of the active site has received much less attention and was even excluded conceptually for de novo inhibitor design.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Piperidine-based GRAB peptidomimetics bearing polar residues at the piperidine C5 position, like <b>43</b> and <b>44</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>) potentially extend into the S<sub>2</sub>′ pocket. Such modifications aimed to reduce the high lipophilicity of this class of DRIs.<a onclick="showRef(event, 'cit36c cit36d'); return false;" href="javascript:void(0);" class="ref cit36c cit36d">(36c, 36d)</a></div><div class="NLM_p last">The primarily hydrophobic S<sub>1</sub>′ site and the more polar S<sub>2</sub>′ pocket are flanked by Ser<sub>76</sub> and Leu<sub>73</sub>-Arg<sub>74</sub>-Tyr<sub>75</sub>, respectively, of the flexible flap β-hairpin in the inhibitor-bound closed conformation. The known dynamic flexibility of the flap region, and possibly other regions close to S<sub>2</sub>′, would suggest that distinct conformational ensembles of the renin prime site may well exist. Such alternative binding topographies could possibly be exploited for the design of new high-affinity pharmacophores. Interestingly, the renin S<sub>2</sub>′ subsite was described recently as a hot spot for binding of fragment-ligand probes using a computational approach based on the FTMAP algorithm for protein mapping.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Hence, the potential of the renin S<sub>2</sub>′ pocket of the renin active site may not have been fully recognized, albeit emerging evidence suggests that targeting this site has gained more interest recently.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The more hydrophilic nature of the S<sub>2</sub>′ pocket may offer attractive opportunities for modulating ADME properties or to address off-target selectivity.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Renin Selectivity Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The gastric pepsins A and C, the lysosomal cathepsin D, as well as cathepsin E, are key off-targets within the human aspartic protease family for any clinical DRI.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> High selectivity of a DRI against related human aspartic proteases including BACE-1 and -2 is generally considered as an essential criterion in view of a safe, life-long treatment for cardiovascular diseases such as hypertension. The significance of partial inhibition of these enzymes for clinical tolerability and safety, however, has not yet been fully elucidated. Successful design strategies to generate highly selective inhibitors of renin have relied mainly on structural differences of the substrate recognition sites within the enzyme family.<a onclick="showRef(event, 'ref30 ref91'); return false;" href="javascript:void(0);" class="ref ref30 ref91">(30, 91)</a> The emergence of renin active site topographies diverging from the β-strand binding catalytic cleft conformation and the discovery of diverse chemotype DRIs deserve further considerations with respect to enzyme selectivity design.</div><div class="NLM_p">Piperidine-based TS surrogates have been demonstrated to serve as aspartic protease family specific warheads,<a onclick="showRef(event, 'ref43 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref43 ref78 ref79">(43, 78, 79)</a> which may imply a potential risk in achieving adequate selectivity within this protease family for DRIs comprising these and related structural features. Very limited in vitro structure−selectivity relationship data are currently available for newly disclosed potent non-peptide peptidomimetic DRIs.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For example, the 3,9-diazabicyclononene <b>51</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>) was reported to be a weak inhibitor of cathepsins D and E (IC<sub>50</sub> = 2.7 and 8.1 μM, respectively).<a onclick="showRef(event, 'cit55b'); return false;" href="javascript:void(0);" class="ref cit55b">(55b)</a> The 3,4-bis(aminomethyl)pyrrolidine has served as basic center scaffold to generate a submicromolar cathepsin D inhibitor and was predicted by modeling to bind into the S<sub>2</sub>−S<sub>2</sub>′ specificity pockets.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> On the other hand, the 2,4-diaminopyrimidine <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and related analogues with moderate affinity to renin were devoid of in vitro activity against cathepsins D and E and pepsin up to 100 μM.<a onclick="showRef(event, 'cit38a'); return false;" href="javascript:void(0);" class="ref cit38a">(38a)</a> Also, prototype alkylamines <b>38</b> and <b>40</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>) of a novel class of S<sub>3</sub><sup>sp</sup>-binding DRIs, showed greater than 1000-fold selectivity over pepsin, BACE-1, and cathepsins D and E.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Competitive inhibition of porcine pepsin by a 3-alkoxy-4-arylpiperidine derivative structurally related to <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) was shown to be pH-dependent with maximal inhibition at pH 5 (IC<sub>50</sub> = 1.5 μM) and complete loss of in vitro activity at lower pH values.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Steady-state enzyme-kinetic studies demonstrated active site-directed inhibition of pepsin and significant conformational changes and perturbation of the ionization state of the catalytic aspartates upon binding of the ligand.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Reduced binding affinities under physiologically relevant conditions toward human aspartic proteases that function at low pH range could be a contributing factor leading to renin selectivity for basic TS surrogate classes of non-peptide DRIs.</div><div class="NLM_p last">The nonsubstrate S<sub>3</sub><sup>sp</sup> binding cavity (vide supra) is not unique to renin within the human aspartic protease family. Inspection of the known X-ray crystal structures of human pepsin A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1qrp">1qrp</a>), cathepsin D (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1lyb">1lyb</a>), and cathepsin E (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1tzs">1tzs</a>) revealed the presence of a conserved S<sub>3</sub><sup>sp</sup> channel of similar size and topography compared to renin.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Interestingly, an aspartic acid (Asp<sub>303</sub> in pepsin A; Asp<sub>323</sub> in cathepsin D; Asp<sub>319</sub> in cathepsin E) is located at the bottom of this channel in all cases, replacing the smaller hydrophobic Ala<sub>303</sub> of renin. This suggests that the design of enzyme-specific ligand binding to the S<sub>3</sub><sup>sp</sup> subsite is feasible and that such interactions could significantly contribute to the selectivity toward renin. However, the specific contributions of binding into the renin S<sub>3</sub><sup>sp</sup> subsite to the selectivity of reported DRIs against other human aspartic proteases and to human vs nonprimate renin specificity appear less well-defined. Functional groups that could form H-bond or salt bridge interactions to Asp<sub>323</sub>/Asp<sub>319</sub> of the S<sub>3</sub><sup>sp</sup> site of cathepsins D and E, respectively, may conceivably reduce renin selectivity. Conversely, the design of selective cathepsin D, E inhibitors by target-specific optimization of interactions to the nonsubstrate S<sub>3</sub><sup>sp</sup> site could be explored. To our knowledge, aspects of structure−selectivity relationship related to the conserved S<sub>3</sub><sup>sp</sup> channel of human aspartic proteases based on enzyme−inhibitor complex structures have not been studied in more detail.</div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Preclinical ADME Properties and Safety Profiling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A key driving force to identify new scaffolds potentially leading to orally efficacious DRIs was the desire to overcome the generally poor PK properties of most substrate-based peptidomimetics. The oral bioavailability of <b>1</b> was low to moderate in rat, dog, and marmoset (2.4%, 32%, and 16−30%), with the rat predicting best the human bioavailability.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> Preclinical oral bioavailability data reported for representatives from different new classes of non-peptide DRIs in various species often ranged from low to moderate, albeit significantly higher oral bioavailability has been achieved in some cases.<a onclick="showRef(event, 'cit38b cit55c'); return false;" href="javascript:void(0);" class="ref cit38b cit55c">(38b, 55c)</a> The 3,9-diazabicyclo[3.3.1]nonene GRAB peptidomimetic <b>51</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>) showed bioavailability of 33%, 36%, and 9% in Wistar rat, dog, and rhesus monkey, respectively, with the elimination half-life being shortest in rat (5.5 h) and more sustained in dog and primates (10−11 h).<a onclick="showRef(event, 'cit55b'); return false;" href="javascript:void(0);" class="ref cit55b">(55b)</a> The close analogue <b>52</b> displayed similar PK properties with sustained oral absorption in Wistar rats (24%, <i>t</i><sub>1/2</sub> = 6.6 h, <i>t</i><sub>max</sub> = 10 h).<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> The oral bioavailability of tetrahydropyridine analogues of <b>51</b> and <b>52</b>, disclosed by the same investigators, reached as high as 70% in rats.<a onclick="showRef(event, 'cit55c'); return false;" href="javascript:void(0);" class="ref cit55c">(55c)</a> Oral bioavailability of the alkylamine inhibitor <b>38</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>) was modest in cynomolgus monkey (17%) and in rat (13%) because of incomplete GI absorption and high clearance but was significantly higher in dog (38%), with long terminal half-lives of ∼16 h in monkey and dog.<a onclick="showRef(event, 'cit39a'); return false;" href="javascript:void(0);" class="ref cit39a">(39a)</a> All these reports hint at significant efforts invested in improving PK properties and highlight the difficulties in achieving this goal while maintaining other desired properties including potency. It remains to be seen whether any clinical candidate of such novel DRIs will exhibit acceptable ADME properties in humans.</div><div class="NLM_p">The design of high-affinity DRIs exhibiting optimal ADME characteristics has become more demanding in line with the general paradigm shift in modern drug discovery that requires early evaluation and rigorous optimization of multiple additional parameters that predict, for example, the potential for toxicity.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> High selectivity against antitargets including proteases, other enzyme classes as well as receptors, low potential for drug−drug interactions, and an acceptable in vitro/in vivo safety profile are considered to be key attributes of successful novel DRIs.</div><div class="NLM_p">Many of the novel chemotype DRIs reported to date are characterized by relatively high molecular weight (MW > 500) and high lipophilicity (log <i>P</i> ≥ 5). A rather large contact surface area within the renin active site appears to be generally required to achieve maximal ligand binding efficacy for each inhibitor class, independent of the targeted enzyme conformation and recognition sites. Unfavorable physicochemical properties such as low aqueous solubility and lipophilicity may affect the in vitro potency against human plasma renin and hence could limit the in vivo efficacy of DRIs at reasonable dose levels.<a onclick="showRef(event, 'ref36 ref38 ref49 ref55'); return false;" href="javascript:void(0);" class="ref ref36 ref38 ref49 ref55">(36, 38, 49, 55)</a> Lipophilicity, molecular size, and H-bonding potential determine the ADME space predicting favorable PK properties, i.e., the potential to be delivered by the oral route.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Furthermore, high lipophilicity of compounds has recently been shown to be associated with increased promiscuity, i.e., a higher propensity to bind to multiple targets,<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> and with an increased likelihood of adverse or toxic events in vivo.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">A number of inhibitors from different new classes of non-peptide DRIs showed a significant in vitro affinity to cytochrome P450 isozymes, indicating a potential risk for high P450-mediated metabolic clearance and for in vivo drug−drug interactions (DDI). These include aminoarylpiperidines (e.g., <b>45</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>),<a onclick="showRef(event, 'cit58a'); return false;" href="javascript:void(0);" class="ref cit58a">(58a)</a> 2-ketopiperazines (e.g., <b>47</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>),<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a> and 5-aryl-2,4-diaminopyrimidines (e.g., <b>36</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>).<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a> The in vitro metabolism of the <i>N</i>-alkyl-1,2,3,4-tetrahydroquinoline moiety, which has been incorporated as a common P<sub>3</sub>−P<sub>1</sub> pharmacophore into several series of potent inhibitors by human liver microsomes, has shown this moiety to be prone to metabolic aromatization.<a onclick="showRef(event, 'cit58g'); return false;" href="javascript:void(0);" class="ref cit58g">(58g)</a> Compound <b>43</b> and the preclinical candidate <b>44</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>), both 3-arylmethoxy-4-arylpiperidine GRAB peptidomimetics, showed only moderate oral bioavailability (27% and 6−15%, respectively) in dogs due to extensive CYP3A4 mediated metabolism and/or P-glycoprotein-mediated efflux.<a onclick="showRef(event, 'cit36e'); return false;" href="javascript:void(0);" class="ref cit36e">(36e)</a> The more soluble P<sub>3</sub><sup>sp</sup>-substituted analogue <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>) was reported to have significantly inferior PK properties.<a onclick="showRef(event, 'cit36d'); return false;" href="javascript:void(0);" class="ref cit36d">(36d)</a> The GRAB peptidomimetic <b>51</b> showed only weak CYP3A4 affinity (IC<sub>50</sub> > 10 μM). However, analogues in which one nitrogen of the center scaffold was replaced by nonpolar groups proved to be rather potent CYP3A4 inhibitors, and inhibition of CYP3A4 emerged as a selection criteria within this series.<a onclick="showRef(event, 'cit55c'); return false;" href="javascript:void(0);" class="ref cit55c">(55c)</a> Inhibitor <b>51</b> revealed a potential for activation to reactive metabolites and for protein adduct formation in vitro in rat and human liver microsomes. Such effects were apparently less significant for the related clinical phase IIa inhibitor <b>52</b>.<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a></div><div class="NLM_p">Major hurdles have been encountered by Pfizer during lead optimization of the 2,4-diaminopyrimidine class of DRIs <b>34</b>−<b>37</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>) in an attempt to accomplish a favorable inhibitor profile for in vitro potency, CYP450 affinity, and metabolic stability, as well as PK properties.<a onclick="showRef(event, 'ref19 ref38'); return false;" href="javascript:void(0);" class="ref ref19 ref38">(19, 38)</a> Shortcomings of the most potent analogues identified were again attributed to their high lipophilicity. Various approaches for structural modifications were explored to render these inhibitors compliant with Lipinski’s rule.<a onclick="showRef(event, 'ref38 ref86'); return false;" href="javascript:void(0);" class="ref ref38 ref86">(38, 86)</a> For example, inhibitor <b>35</b> bearing a polar <i>N</i>-(2-ethyl)acetamide P<sub>3</sub><sup>sp</sup> side chain exhibited excellent in vitro potency toward rh-renin, good aqueous solubility, high human liver microsomal stability, as well as low affinity for CYP450 isozymes (>30 μM) rendering it superior to hydrophobic congeners. However, rat oral bioavailability of <b>35</b> was low (10%), likely due to low cell permeability and poor intestinal absorption. In contrast, inhibitors bearing an <i>N</i>-methoxypropyl P<sub>3</sub><sup>sp</sup> residue and a more lipophilic S<sub>4</sub> residue, such as <b>36</b>, demonstrated strong CYP450 interactions, high microsomal clearance due to O-demethylation, and high liver first-pass elimination in rats (oral bioavailability of 0.4%). The 3-hydroxypropyl analogue of <b>36</b> showed no CYP450 inhibition (>30 μM), excellent stability toward liver microsomes, and good rat oral bioavailability (44%) but only moderate renin inhibition (IC<sub>50</sub> = 0.9 μM). Similarly, the CF<sub>3</sub>-analogue <b>37</b> revealed high in vitro metabolic stability and improved oral bioavailability in rat (74%; <i>t</i><sub>1/2</sub> = 3 h) and dog (19%; <i>t</i><sub>1/2</sub> = 10 h) but again had only moderate potency and in addition suffered from strong CYP2D6 affinity.<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a> Remarkably, no in vivo pharmacology data have been reported for any analogues exhibiting high in vitro potency in the double-transgenic mouse (dTGM) model.<a onclick="showRef(event, 'cit58c ref96'); return false;" href="javascript:void(0);" class="ref cit58c ref96">(58c, 96)</a> The challenges of accomplishing a proper balance between desired target profile criteria, such as potency and ADME properties, have persisted throughout lead optimization. A preclinical development candidate was not identified from this class of DRIs at the time this research program was terminated.<a onclick="showRef(event, 'ref15 ref19 cit38b'); return false;" href="javascript:void(0);" class="ref ref15 ref19 cit38b">(15, 19, 38b)</a></div><div class="NLM_p">Many of the novel DRIs comprise structural motifs, like the 4-arylpiperidine subunit of GRAB peptidomimetics, which are found in a number of other molecules known to bind to and modulate various types of drug targets or antitargets including G-protein-coupled receptors (GPCRs), transporters, and ion channels.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Cardiac ion channels play an increasingly important role. The hERG voltage-gated K<sup>+</sup> channel is widely recognized as a critical antitarget to be avoided from a drug safety perspective, as blocking this channel carries an increased risk of causing arrhythmias and torsades de pointes (TdP).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Several emerging non-peptide DRI chemotypes are characterized by a pharmacophore comprising a basic nitrogen atom, being crucial for the interaction with the catalytic aspartates of renin, in combination with one or more aromatic rings. These structural features may potentially match a well-accepted pharmacophore for hERG channel blockade.<a onclick="showRef(event, 'cit97b cit97c'); return false;" href="javascript:void(0);" class="ref cit97b cit97c">(97b, 97c)</a><i>N</i>-Ureapiperidine-based basic amine DRIs (<b>38</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>) were reported to be inactive against hERG (patch clamp IC<sub>50</sub> > 30 μM), while no in vitro affinity profile against GPCRs was disclosed.<a onclick="showRef(event, 'cit39a'); return false;" href="javascript:void(0);" class="ref cit39a">(39a)</a> The in vitro cardiac safety profile of <b>1</b> indicated a very low risk of impacting cardiac repolarization and conduction time. The human hERG channel was very weakly inhibited (patch-clamp IC<sub>25</sub> = 671 μM), and no effects were observed on the action potential in the isolated rabbit heart up to 100 μM, suggesting no interaction of <b>1</b> with cardiac ion channels in tissues at clinically relevant concentrations.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><div class="NLM_p">Early in vitro profiling for the potential to interfere with other ion channels such as the cardiac voltage-gated sodium (Na<sub>v1.5</sub>) and calcium (Ca<sub>v1.2</sub>) channels has received more attention recently.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a> Interfering with the physiological function of the Na<sub>v1.5</sub> channel may exert a malignant proarrhythmic potential in vivo.<a onclick="showRef(event, 'cit99b'); return false;" href="javascript:void(0);" class="ref cit99b">(99b)</a> Assessment of the potential of novel chemotype DRIs to bind particularly to the Na<sub>v</sub>1.5 channel needs to be considered in cases where specific structural alerts have been identified.<a onclick="showRef(event, 'cit99a'); return false;" href="javascript:void(0);" class="ref cit99a">(99a)</a> Reports describing the binding affinities across antitarget panels of receptors and cardiac ion channels for key representatives of novel class DRIs have remained generally scarce to date.<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a> It will be interesting to learn more about the selectivity and safety profiles of advanced candidates from these series and about the medicinal chemistry path taken to optimize such compounds.</div><div class="NLM_p last">Significant advances have been made in the development of novel non-peptide DRIs with potent in vitro activity and oral efficacy in animal models (vide infra). While the structural diversity has increased remarkably during recent years, lead optimization to identify suitable drug candidates remains a challenge within each compound class. The criteria for candidate selection for cardiovascular indications such as hypertension have become increasingly demanding. Therefore, requirements needed for a long-term safe drug treatment are expected to further raise the hurdles for achieving the desirable preclinical target profile of any new DRI. As a result, the number of novel-class DRIs having reportedly entered clinical trials has remained remarkably low to date and none has progressed toward late stage development.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Preclinical Pharmacology of Direct Renin Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Historically, the determination of in vivo potency and efficacy for antihypertensive agents has relied mainly on the use of rodents and dogs and to a lesser extent on other species. Numerous models of hypertension in the rat have been well characterized and are predictive of responses seen in hypertensive patients. However, the high specificity of human renin for human angiotensinogen was widely recognized as a significant limitation to the study of DRIs across species,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and the early in vivo assessment of human-specific DRIs has required the use of primates.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> These animals are typically normotensive, and therefore, to detect effects on BP or changes in plasma renin activity (PRA) or total renin concentration, the use of a low sodium diet or diuretic pretreatment to activate the RAS is required.</div><div class="NLM_p">The first DRI to demonstrate BP lowering effects following oral administration was <i>N</i>2-[(phenylmethoxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-arginyl-<span class="smallcaps smallerCapital">l</span>-arginyl-<span class="smallcaps smallerCapital">l</span>-prolyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">l</span>-histidyl-(3<i>S</i>,4<i>S</i>)-4-amino-3-hydroxy-6-methylheptanoyl-<span class="smallcaps smallerCapital">l</span>-isoleucyl-<span class="smallcaps smallerCapital">l</span>-histidyl-<i>N</i>6-[(1,1-dimethylethoxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-lysinemethyl ester (CGP29287).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> This modified peptide produced a substantial hypotensive effect in furosemide-treated normotensive marmosets when given at a dose of 100 mg/kg. Several other less peptidic DRIs became available using chemical modifications intended to reduce the overall size and complexity and resulted in second generation inhibitors, including <b>2</b>, <b>4</b>, and <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'cit21b cit23b'); return false;" href="javascript:void(0);" class="ref cit21b cit23b">(21b, 23b)</a> Early studies demonstrating BP lowering with <b>1</b> also relied on the use of marmosets.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><div class="NLM_p">Although species other than non-human primates have been used less frequently, their value is nevertheless apparent from their acceptance as screening models for SAR studies or for basic mechanistic experiments. Early work by Pfizer utilized sodium-depleted guinea pigs or rats infused with hog renin.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Pfizer scientists also used the sodium-depleted guinea pig to assess the BP effects of the DRI <b>3</b> in combination with an ACEi or ARB, since enzyme affinities in this species are reportedly similar to those in man.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> These RAS combinations, administered acutely to conscious, unrestrained guinea pigs, resulted in synergistic reductions in BP and were observed over a range of intravenous doses.</div><div class="NLM_p">The development of transgenic rodent models began in the late 1980s and subsequently offered the potential to assess efficacy of DRIs in small animals. Techniques to measure BP and RAS biomarkers in the rat were already routinely utilized and therefore facilitated a more widespread use of such transgenic models. Early utilization of these transgenic techniques relied on the use of RAS gene constructs that interacted with the host RAS and therefore circumvented concerns of species specificity.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Separate lines of normotensive transgenic rats harboring either the human renin or angiotensinogen genes were first established. These strains were subsequently cross bred, yielding the double-transgenic rat (dTGR) characterized by severe hypertension and end organ damage.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> To our knowledge, <b>5</b> was the first DRI shown to reduce arterial BP in this rat model.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Subsequent development and phenotyping of the double transgenic mouse (dTGM) essentially revealed pathology similar to that of the dTGR.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p">These transgenic animals have become valuable tools for the evaluation of various DRI, including <b>1</b>. Renin inhibitor programs at several companies have identified novel, potent, and orally active compounds using these models. Piperidine-based GRAB peptidomimetic DRIs<a onclick="showRef(event, 'cit36b cit36c cit36d'); return false;" href="javascript:void(0);" class="ref cit36b cit36c cit36d">(36b-36d)</a> have been studied at Hoffmann-LaRoche in the dTGR model. For example, inhibitor <b>43</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>) elicited a slight reduction in BP and substantially reduced the progression of albuminuria.<a onclick="showRef(event, 'cit85a'); return false;" href="javascript:void(0);" class="ref cit85a">(85a)</a> Furthermore, inhibitor <b>44</b> was shown to normalize BP and to prevent cardiac hypertrophy and albuminuria over a period of 4 weeks.<a onclick="showRef(event, 'cit85b'); return false;" href="javascript:void(0);" class="ref cit85b">(85b)</a> The related analogue <b>30</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>) was evaluated by Pfizer and was shown to reduce BP, albuminuria, and left ventricular hypertrophy when administered to dTGM over a period of 4 weeks<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The group at Pfizer has also reported novel aminoarylpiperidines and 2-ketopiperazines, including <b>45</b> and <b>46</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>), shown to reduce BP in the same dTGM model.<a onclick="showRef(event, 'cit58a cit58c'); return false;" href="javascript:void(0);" class="ref cit58a cit58c">(58a, 58c)</a> Advanced analogues from the class of diazabicyclononene-based DRIs described by Actelion<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and the alkylamine inhibitor series discovered by Vitae<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> were shown to elicit long-lasting BP reductions in the dTGR.</div><div class="NLM_p">A desire to pursue more extensive profiling and ultimately differentiate <b>1</b> from other RAS blockers and other antihypertensive agents in general prompted testing in the spontaneously hypertensive rat (SHR), a well established hypertensive rat model. Although a reduction in BP was observed in the SHR, this effect was modest (∼25 mmHg), required high doses (100 mg/kg per day), and subcutaneous delivery via osmotic minipump.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The moderate in vitro potency of <b>1</b> for rat renin (IC<sub>50</sub> = 80 nM)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> was consistent with its weak in vivo potency, thus limiting the use of the SHR model for further pharmacological evaluation, for example, for evaluating BP independent effects. Despite these limitations, it was possible to demonstrate a synergistic BP reduction when <b>1</b> was given in combination with either an ACEi or an ARB.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> These findings in the rat corroborated those reported previously by Pfizer using the guinea pig.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><div class="NLM_p">The availability of the dTGR overcomes limitations resulting from species cross-reactivity and now makes it feasible to explore potential additional benefits of renin inhibition. In contrast to the mild antihypertensive effect seen in SHR, subsequent studies with <b>1</b> in the dTGR demonstrated a potent and substantial BP response.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> These studies also clearly revealed cardiac and renal benefits, including an improvement in cardiac hypertrophy and function, as well as a reduction in albuminuria and serum creatinine.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As already mentioned, similar effects were also observed with two different classes of DRIs, exemplified by <b>30</b><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and <b>44</b>.<a onclick="showRef(event, 'cit85b'); return false;" href="javascript:void(0);" class="ref cit85b">(85b)</a> Experiments using a very low chronic dose of <b>1</b> (0.03 mg/kg per day) in dTGR showed only minimal effects on BP, yet a reduction in cardiac and renal damage.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> These results implicate the RAS as an important pathophysiologic regulator of organ function and structure and moreover suggest that some of these benefits may be BP independent.</div><div class="NLM_p">The transgenic (mRen-2)27 rat expressing the murine renin transgene Ren-2 also has become an important rodent model to study the pharmacology of DRIs. Diabetes can be induced readily in these hypertensive rats by the injection of streptozotocin and therefore provides a unique opportunity to assess the therapeutic potential of direct renin inhibition in an animal with the comorbid conditions of hypertension and diabetes. Compound <b>1</b> is a potent inhibitor of mouse renin (IC<sub>50</sub> = 4.5 nM) and therefore makes possible the use of the (mRen-2)27 rat.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Chronic administration of <b>1</b> resulted in substantial antihypertensive and renal protective effects in this model<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> and was also shown to reduce albuminuria, glomerulosclerosis, and interstitial fibrosis<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> and to improve insulin sensitivity and skeletal muscle glucose transport.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Inhibitor <b>1</b> also decreased oxidative stress, induced beneficial remodeling of pancreatic structure,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and resulted in favorable effects on cardiac function and structure in diabetic, hypertensive mRen-2 rats.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> These data provide evidence supporting organ protective benefits and extend the concept that direct renin inhibition, analogous to RAS inhibition, results in important tissue protective effects.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">Evidence to support differentiation is now being gathered as <b>1</b> is tested more extensively in animal models. Recent compelling data demonstrating an antiatherosclerotic effect in low density lipoprotein receptor null mice suggest that direct renin inhibition may provide optimal RAS blockade.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Inhibitor <b>1</b> (25 and 50 mg/kg per day) resulted in substantial reductions in lesion size in both the aortic root and arch. Although this study did not directly compare other RAS blockers, the effects reported with direct renin inhibition appeared to be greater than those described previously for ACEi and ARBs. Another study using hypertensive apolipoprotein E null mice showed that <b>1</b> decreased BP, inhibited lesion progression, stabilized plaques, and reduced lipid core.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Improvements in atherosclerotic lesion size have also been demonstrated in Watanabe hypercholesterolemic rabbits.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Chronic administration of <b>1</b> (40 mg/kg per day; rabbit renin IC<sub>50</sub> = 11 nM)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> preserved endothelial function, as determined by increased cellular levels of nitric oxide, and reduced plaque area in this model. The overall benefit derived from RAS blockade in atherosclerosis is likely due to preventing the actions of AngII. However, a DRI may provide additional benefit by preventing the generation of AngI, AngII, and Ang breakdown products.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p">The intracellular RAS is a new and emerging concept with potential therapeutic relevance<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120, 121)</a> that extends our understanding beyond the classical concept of a systemic and tissue RAS. The importance of this system and its overall regulation are only now being defined. Stimulation of cardiac fibroblasts by high glucose activates the intracellular RAS resulting in elevated levels of intracellular AngII and in turn increased transforming growth factor-β and collagen I.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> These biochemical changes were only partially attenuated by an ARB, whereas <b>1</b> completely prevented them. The same investigators also demonstrated that diabetes activates this system in cardiomyocytes and <b>1</b> was more effective at preventing increased oxidative stress and fibrosis than either ACE inhibition or AT1 receptor blockade.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Consequently, renin inhibition with <b>1</b> may offer additional tissue protective benefit in the setting of diabetes.</div><div class="NLM_p">The prominent role of the RAS, specifically AngII, in the control of renal function has been known for many decades. The conventional view of the RAS had been that of a classical endocrine system. However, as specific pharmacologic tools became available to block the system at various points, evidence began to accrue suggesting the existence of an intrarenal RAS.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> It soon became clear that the renal effects of AngII, such as renal vasoconstriction, are the result of both a systemic and tissue effect. AngII infused directly into the kidney, at doses that did not alter BP, resulted in renal vasoconstriction.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Blocking the effects of AngII therefore offered obvious therapeutic benefit. The early use of ACEi confirmed this idea as a substantial renal vasodilatation was noted.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Since it is widely recognized that ACE inhibition can alter the metabolism of several other vasoactive substances, including bradykinin, the ACEi-induced renal vasodilation may not be due only to the prevention of AngII formation. AngII antagonists available at that time were known to also possess agonist activity, rendering them of limited value in confirming the actions of AngII within the kidney.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Comparative studies in the marmoset using the ACEi enalaprilat and a modified peptide renin inhibitor indicated that the renal vasodilatation was primarily due to preventing the formation of AngII.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Renal vasodilation in response to direct renin inhibition was later confirmed using inhibitor 2.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><div class="NLM_p">It was noted that the BP response to <b>5</b>, as well as to <i>N</i>-[(1<i>S</i>,2<i>R</i>,3<i>S</i>)-1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]-α-[[(2<i>S</i>)-2-[[[1,1-dimethyl-2-(4-morpholinyl)-2-oxoethyl]sulfonyl]methyl]-1-oxo-3-phenylpropyl]amino]-(α<i>S</i>)-1<i>H</i>-imidazole-4-propanamide (ciprokiren), in squirrel monkeys outlasted their effects on RAS biomarkers.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> In another study, <b>5</b> was shown to induce greater renal vasodilation in squirrel monkeys than inhibitors <b>2</b> and <b>4</b>.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> A study with radiolabeled <b>5</b> revealed a renal distribution and retention of the compound in the kidney long after its disappearance from the plasma compartment, suggesting a more pronounced inhibition of kidney renin.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Comparative experiments in guinea pigs demonstrated that for an equal effect on BP, <b>5</b> increased renal blood flow more than an ARB or an ACEi.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Subsequent studies in normal volunteers with <b>2</b> showed a greater increase in renal blood flow than with ACE inhibition, a response attributed to a local effect in renal tissue.<a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(133, 134)</a> A marked renal vasodilatory response was also demonstrated with inhibitor <b>6</b> in normotensive men,<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> and could be explained by the propensity for this compound to penetrate tissues and consequently inhibit the renal RAS. The potential therapeutic benefit of intrarenal RAS inhibition, exclusive of a prominent effect within the plasma compartment, is suggested from comparative results obtained with the DRI <b>43</b>, cilazapril, and valsartan in dTGRs.<a onclick="showRef(event, 'cit85a'); return false;" href="javascript:void(0);" class="ref cit85a">(85a)</a> Despite minimal effects on systemic BP, oral administration of <b>43</b> was equally efficacious in reducing albuminuria and in decreasing various biomarkers of renal inflammation. One possible explanation is that the kidney acts as a reservoir to sequester the DRI and thus provides for greater or more prolonged renin inhibition.</div><div class="NLM_p">Further evidence supporting a unique renal specificity for DRIs has emerged from recent preclinical and clinical profiling studies with <b>1</b>. In healthy volunteers, <b>1</b> was shown to induce an increase in renal blood flow exceeding that observed with either an ACEi or an ARB.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> In the rat, <b>1</b> distributed extensively to the kidney and was localized in the glomerulus.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Three weeks after stopping administration of <b>1</b>, drug levels in the kidney remained well above the IC<sub>50</sub> for inhibition of renin, while plasma levels were below the limits of quantitation.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Interestingly, <b>1</b> was shown to accumulate in renin secretory granules and therefore to bind to renin and prorenin prior to release.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Taken together, these data provide a possible explanation for the observed long-lasting BP lowering effect of <b>1</b> in hypertensive patients and may support the idea of more complete blockade of the intrarenal RAS with DRIs.</div><div class="NLM_p last">It will be important ultimately to demonstrate that these potentially differentiating characteristics of <b>1</b> result in tangible therapeutic benefits. Preclinical data suggest that this is likely to occur. Inhibitor <b>1</b> was shown to lower BP, albuminuria, and serum creatinine in the hypertensive dTGR<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and to reduce cystatin C and neutrophil gelatinase-associated lipocalin, two biomarkers of glomerular filtration and tubular damage, respectively.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> In this same animal model, <b>1</b> reduced albuminuria at a dose that had only minimal effects on BP, suggesting a BP-independent renal protective effect.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Inhibitor <b>1</b> also reduced BP and albuminuria and suppressed renal transforming growth factor-β and collagen I expression in hypertensive, diabetic mRen-2 rats.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> In a comparative study, <b>1</b> and the ACEi perindopril attenuated albuminuria and glomerulosclerosis to a similar extent in diabetic mRen-2 rats, even though BP was reduced to a greater extent by perindopril. Surprisingly, renal interstitial fibrosis was diminished more by <b>1</b>.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> These results support the notion of an intrarenal action of <b>1</b> and a BP-independent effect. Increased generation of AngII occurs in renal podocytes in response to high glucose in the diabetic kidney.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Elevated AngII levels within the podocyte are causative for inducing podocyte injury, a principal feature of diabetic kidney disease. The DRI <b>1</b>, but not the ACEi captopril, decreased AngII production within the podocyte. This finding provides direct mechanistic evidence to functionally distinguish ACE inhibition from renin inhibition in the kidney. The clinical relevance of these findings awaits the outcome of several large ongoing clinical trials with <b>1</b>. However, a small study in type 2 diabetic patients who are already on high dose losartan as background therapy (AVOID Study) has demonstrated an additional renal protective effect (reduction in albuminuria) with the addition of <b>1</b> to their daily drug regimen.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Prorenin, Renin, and the (Pro)Renin Receptor</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is well recognized that the kidney is the primary source of renin and the only tissue capable of processing prorenin to renin. Notably, the kidney also releases prorenin.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> In other tissues expressing the renin gene, prorenin is both the primary and final product.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Interestingly, prorenin represents 80−90% of all renin present in plasma, yet a physiologic or pathophysiologic role has not yet been demonstrated for this protein.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Plasma levels of prorenin are elevated in diabetic patients with underlying microvascular complications such as retinopathy and nephropathy,<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> thus implicating prorenin as a biomarker for vascular disease. However, convincing evidence to indicate a pathophysiologic role for plasma prorenin beyond that of a biomarker of disease has yet to be demonstrated.</div><div class="NLM_p">Prorenin/renin binding proteins within tissues have been known for many years; however, their exact role is unclear.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146, 147)</a> Mesangial cells in culture have been shown to specifically bind renin and subsequently induce an increase in plasminogen activator inhibitor-1. These results suggest a potential biologic role for these receptors.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Mannose 6-phosphate/insulin-like growth factor II has been identified as another receptor for prorenin and renin<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> but appears to serve primarily as a clearance receptor.</div><div class="NLM_p">Nguyen et al.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> identified a novel receptor that binds prorenin and renin, induced intracellular signaling, and is designated as the (pro)renin receptor (P)RR. The (P)RR was localized to the glomerular mesangium and the subendothelium of coronary and renal arteries. Agonist binding resulted in a 4-fold increase in the catalytic activity of the enzyme−receptor complex. In addition to the proteolytic conversion of AngI to AngII, binding also resulted in initiation of an intracellular extracellularly regulated kinase 1/2 cascade that was independent of AngII. The identification of this receptor and the demonstration of an integrated response involving Ang-dependent and -independent mechanisms stimulated intense research into this novel RAS signaling cascade. Further investigation revealed that prorenin binding to this receptor resulted in increased expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells, again an effect independent of AngII.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Renin binding was also shown to increase transforming growth factor-β and matrix proteins in mesangial cells, an effect that was not blocked by an ACEi, an ARB, or a DRI.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">Prorenin harbors a 43-amino-acid N-terminal propeptide that is believed to obstruct substrate access to the active site. Prorenin can be activated either by proteolytic cleavage of the propeptide or by a nonproteolytic mechanism. The latter can be induced by low temperature, low pH, or binding of prorenin to the (pro)renin receptor, all believed to trigger unfolding of the propeptide from the enzymatic cleft. The prosegment contains a “gate and handle” region that is critical for receptor binding during nonproteolytic activation.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Although renin and prorenin both have high affinity for the (P)RR, prorenin is considered the endogenous agonist.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> A condition of mild obesity and impaired glucose tolerance is observed in transgenic rats and mice overexpressing the human renin gene, and these effects are independent of AngII.<a onclick="showRef(event, 'ref155 ref156'); return false;" href="javascript:void(0);" class="ref ref155 ref156">(155, 156)</a> Overexpression of the human (P)RR, an alternative approach for modulating this system, results in elevations in BP in the rat.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Recently, a decoy peptide, presumably binding to the active site of the (P)RR, denoted as the “handle region peptide” was shown to provide organ protective benefits in the kidney, eye, and heart when administered subcutaneously to rodents.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> However, these results have not been consistently reproduced by other laboratories.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> In addition, two recent studies have shown that prorenin does not induce any specific organ pathology or vasculopathy. Despite chronically elevated prorenin levels in transgenic mice overexpressing prorenin, no cardiac fibrosis or renal sclerotic changes were evident.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> These investigators conclude that the mildly increased prorenin levels observed clinically in diabetic patients (3-fold) and those reported in their transgenic mice are insufficient to induce pathological responses. Similarly, glomerulosclerosis did not occur in transgenic rats despite substantial incremental increases in prorenin.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> These results, taken together with the substantial body of clinical data from thousands of patients receiving chronic therapy with the DRI <b>1</b>, do not support a direct pathologic role for elevated prorenin or renin.</div><div class="NLM_p last">The recognition that the (P)RR binds both renin and prorenin and that the catalytic activity of bound renin increases 4-fold raises the intriguing question of whether or not a DRI could modify these effects. Initial studies indicate that <b>1</b> does not block the binding of prorenin or renin to the (P)RR.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Moreover, it has been shown in rat aortic vascular smooth muscle cells that the half-life of both prorenin and renin is increased by <b>1</b> binding to the receptor.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> While several studies have begun to describe the biological effects that occur following agonist binding to the receptor, its pathophysiological relevance remains to be more fully characterized.</div></div><div id="sec15" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Clinical Pharmacology of the Direct Renin Inhibitor <b>1</b></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A remarkable research effort has been put forth over the past decades directed at the discovery and development of DRIs. Initial clinical characterization of the effects of direct renin inhibition was accomplished with the use of various investigational drugs possessing suboptimal physicochemical and PK properties.<a onclick="showRef(event, 'ref21 ref22 ref23 ref162'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref162">(21-23, 162)</a> The opportunity to gain considerably more insight into the pharmacodynamic efficacy of DRIs became available with the clinical introduction of <b>1</b>.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Although the bioavailability of <b>1</b> was shown to be only 2.6% in humans, this represents a substantial improvement over that shown historically for DRIs as a class.<a onclick="showRef(event, 'ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref164 ref165">(164, 165)</a> This enhancement represents more than a simple incremental improvement, especially when coupled with the remarkable potency of <b>1</b> for human renin, long duration of action, and the potential for distribution to the kidney. Steady-state <i>C</i><sub>max</sub> values are in the range 330−660 nM following a 300 mg dose of <b>1</b> and represent concentrations greater than 2 orders of magnitude above the IC<sub>50</sub> for renin inhibition.<a onclick="showRef(event, 'ref164 ref166'); return false;" href="javascript:void(0);" class="ref ref164 ref166">(164, 166)</a> Importantly, <b>1</b> was also shown to have a long terminal half-life in human plasma.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> From a functional standpoint and consistent with PK parameters, <b>1</b> was shown to induce dose-dependent and long-lasting inhibition of the RAS in humans.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Further confirmation of the anticipated benefit of oral renin inhibition came with the demonstration of a dose-dependent (75−300 mg of <b>1</b>) BP reduction in patients with mild to moderate hypertension.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><div class="NLM_p">Early clinical results demonstrated that <b>1</b> has placebo-like tolerability and provides comparable or improved efficacy compared to angiotensin AT1 receptor blockade with losartan<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> or irbesartan<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> and greater BP reductions than ramipril.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> The antihypertensive response to <b>1</b> is sustained over 24 h (ambulatory BP) with high trough-to-peak ratios and thus represents a true once daily RAS blocker.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> In a head-to-head comparative study, <b>1</b> (150 mg) was shown to reduce BP to a similar extent as 150 mg of irbesartan. Higher doses of <b>1</b> provided additional RAS blockade and greater BP reductions.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> This study also demonstrated a potentially important biomarker divergence, showing that irbesartan and <b>1</b> both raised PRC; however, only <b>1</b> effectively inhibited PRA. In heart failure patients, an association between high PRA and increased cardiovascular risk has been shown.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></div><div class="NLM_p">Combination therapy has become a cornerstone of the physician’s approach to effective management of hypertension. Despite the vast armamentarium of antihypertensive drugs available today, high BP remains difficult to treat, especially in elderly individuals and in patients with existing comorbidities such as diabetes.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Inhibitor <b>1</b> has been shown to provide additive BP lowering efficacy when administered in combination with the diuretic hydrochlorothiazide, the ACEi ramipril, the ARBs irbesartan and valsartan,<a onclick="showRef(event, 'ref176 ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref176 ref177 ref178">(176-178)</a> and amlodipine.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> These results indicate that <b>1</b> effectively reduced BP when administered alone or in combination with other antihypertensive agents. In summary, <b>1</b> offers an effective option for treating hypertensive patients.</div><div class="NLM_p">With a wide variety of effective therapeutic options available, the decision of which agent to use can be a challenge for the physician. Efficacy and safety are clearly important factors. However, additional benefit that could be directly attributed to the use of a specific agent would be important in decision making. Unfortunately, with the introduction of any new agent, additional or unique benefit is usually theoretical rather than proven. It should be emphasized that the ultimate goal for controlling BP is to reduce the overall incidence of end organ failure. To this end, evidence is sought to demonstrate reduced cardiovascular morbidity and mortality.</div><div class="NLM_p">Results from several small clinical studies have demonstrated a benefit beyond BP lowering. The intent is to use these findings to support larger, pivotal outcome studies that will ultimately demonstrate the long-term value of <b>1</b>. Collectively, the clinical program to evaluate the potential long-term benefit of <b>1</b> has been initiated and is known as the “Aspire Higher” clinical trial program.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> It consists of a set of small scale studies focused on demonstrating cardiorenal protection in a short-term setting. These will then be followed by larger, long-term outcome studies aimed at directly demonstrating an organ protective benefit. One such acute study in healthy volunteers has recently demonstrated that <b>1</b> elicits a prominent renal vasodilation and that this response surpasses that seen with ACEi and ARBs.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> This effect was long-lasting and associated with a natriuretic response. The now completed AVOID study demonstrated that <b>1</b>, when added to background therapy (losartan), further reduced the albumin/creatinine ratio in patients with type 2 diabetes and nephropathy.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> This effect was independent of an effect on BP. These results further extend the preclinical observations and suggest a potentially important role for direct renin inhibition in renal (patho)physiology.</div><div class="NLM_p last">Two additional studies, ALLAY and ALOFT, provided early evidence to support a role for <b>1</b> in cardiac protection. The DRI <b>1</b> was shown to be as effective as losartan in attenuating left ventricular hypertrophy in hypertensive patients.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> In patients with symptomatic heart failure (New York Heart Association class II to class IV), the addition of <b>1</b> to conventional therapy (ACEi or ARB, and a β-adrenoceptor antagonist) resulted in a further decrease in N-terminal pro-Brain natriuretic peptide, a proven biomarker that correlates with severity of cardiac severity.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a></div></div><div id="sec16" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Future Directions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The disclosure of new classes of nonpeptide DRIs has continued over the past decade, suggesting that the opportunities offered by the newly uncovered topographical space and the increasing druglike ligand chemical space have not been fully exploited yet. The structural diversity of small-molecule DRIs is likely to further expand, and novel inhibitors are anticipated to be discovered in the future that may hold promise as candidates for clinical investigations. Future DRIs will need to demonstrate a favorable and differential clinical profile over existing therapies at attractive cost-benefit while facing increasingly demanding safety and tolerability standards by the regulatory authorities for cardiovascular drugs.</div><div class="NLM_p">Several DRIs have reportedly progressed recently to the stage of early clinical investigations, indicating a revival of interest by several pharmaceutical companies in the development of DRIs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The prospect of such more advanced DRIs reaching the patient for the treatment of cardiovascular diseases is difficult to predict, since only limited preclinical information is currently available. Preliminary data have been reported by Speedel on SPP635, SPP676, and SPP1148 (structures not disclosed) from phase I and on SPP635 from phase II clinical trials.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> After a single dose in normal volunteers, SPP635 (100 mg) and SPP676 (30 mg) inhibited PRA to a similar extent as a 150 mg dose of <b>1</b>. SPP676 and SPP1148 were shown to be safe and well tolerated up to doses of 1800 and 600 mg, respectively. While SPP676 had a relatively short terminal half-life (∼8 h), SPP1148 was reported to have a longer half-life of ∼30 h and to maximally inhibit PRA at the 50 mg single oral dose. SPP635, derived from the 3,4-piperidine GRAB peptidomimetics, showed an oral bioavailability of ∼30% and an elimination half-life of ∼24 h in phase I studies, in good agreement with the PK parameters determined by a microdosing approach. These data may suggest the potential for a favorable PK profile of SPP635 at clinically effective doses.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> In a phase IIa study in patients with mild to moderate hypertension, SPP635 significantly reduced PRA and resulted in double-digit reductions in daytime ambulatory BP.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> Novartis acquired Speedel and its portfolio of follow-up DRIs in 2008.</div><div class="NLM_p">VTP-27999 (Vitae Pharmaceuticals, structure not disclosed) represents another novel DRI that has just entered phase I clinical trials.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> VTP-27999 will be evaluated in a randomized double blind placebo controlled study in healthy volunteers to assess efficacy based on relevant biomarkers, as well as safety, tolerability, and PK.</div><div class="NLM_p">The second generation GRAB peptidomimetic <b>52</b><a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> has been reported by Actelion and Merck to be under codevelopment for the treatment of cardiovascular indications including renal and heart failure and hypertension.<a onclick="showRef(event, 'cit184a'); return false;" href="javascript:void(0);" class="ref cit184a">(184a)</a> A randomized double-blind placebo and active comparator-controlled (enalapril 20 mg/day) study to determine the effectiveness and tolerability of <b>52</b> was completed. The drug candidate was given at 250 and 500 mg once daily over a 4-week treatment period to hypertensive patients. Results of this phase IIa trial have not been disclosed yet; however, further development of <b>52</b> has been recently discontinued.<a onclick="showRef(event, 'cit184b'); return false;" href="javascript:void(0);" class="ref cit184b">(184b)</a></div><div class="NLM_p">As with any first-in-class drug, it is imperative that further characterization of <b>1</b> be undertaken. The intent is to more comprehensively define its clinical actions and to enhance our understanding of direct renin inhibition as a novel point of clinical intervention along the RAS cascade. With its market introduction, it now becomes possible for the first time to define in humans what had been for decades only a theoretical promise for direct renin inhibition. From a scientific perspective, <b>1</b> represents a novel and important pharmacologic probe that can be used to further expand our knowledge on the RAS in normal and diseased states. From a therapeutic point of view, it is important now to fully profile the effects of <b>1</b> in different patient populations and to clearly define the benefit derived from such an approach. The ultimate goal is to optimize therapy and to provide maximum benefit to the patient.</div><div class="NLM_p last">The accumulated evidence to date with <b>1</b> in cardiorenal disease indicates a potential for long-term benefit and provides a strong foundation on which to build our understanding of direct renin inhibition in cardiovascular disease. Outcome data from the planned and ongoing end point trials will provide definitive proof. One such study, ALTITUDE, aims to determine the effect of <b>1</b> added to conventional standard of care therapy (ACEi or ARB) in patients with type 2 diabetes and varying degrees of renal dysfunction.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> The upcoming years will be an exciting time, as new data are forthcoming. This will hopefully provide evidence to support the hypothesis put forth more than 50 years ago that inhibition of AngI generation from angiotensinogen is the therapeutic approach “most likely to succeed” because renin is the initial and rate-limiting step of the RAS cascade.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div></div><div id="sec17" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">PDB codes, space groups, and resolution of the X-ray structures discussed in this article are as follows: glycosylated rh-renin (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ren">2ren</a>, space group <i>I</i>4, 2.5 Å resolution);<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>1</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z">2v0z</a>, <i>P</i>2<sub>1</sub>3, 2.2 Å);<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a><b>4</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rne">1rne</a>, <i>P</i>4<sub>1</sub>2<sub>1</sub>2, 2.4 Å);<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>29</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v11">2v11</a>, <i>P</i>2<sub>1</sub>3, 3.1 Å);<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> analogue of <b>22</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v12">2v12</a>, <i>P</i>2<sub>1</sub>3, 3.2 Å);<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a><b>28</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v16">2v16</a>, <i>P</i>2<sub>1</sub>3, 2.8 Å);<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a><b>34</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2g1r">2g1r</a>, <i>P</i>2<sub>1</sub>3, 2.4 Å);<a onclick="showRef(event, 'cit38b'); return false;" href="javascript:void(0);" class="ref cit38b">(38b)</a><b>38</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gw5">3gw5</a>, <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, 2.0 Å);<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a><i>N</i>-hydroxypropyl analogue of <b>48</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fs4">2fs4</a>, <i>P</i>2<sub>1</sub>3, 2.2 Å);<a onclick="showRef(event, 'cit58e'); return false;" href="javascript:void(0);" class="ref cit58e">(58e)</a><b>51</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g70">3g70</a>, <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, 2.0 Å);<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a><b>52</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g6z">3g6z</a>, <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, 2.0 Å).<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> The X-ray structures (PDB codes, space groups, resolution) for <b>9</b> (<a href="https://" class="ext-link">1pr7</a>, <i>P</i>2<sub>1</sub>3, 3.65 Å),<a onclick="showRef(event, 'cit36a'); return false;" href="javascript:void(0);" class="ref cit36a">(36a)</a><b>32</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1pr8">1pr8</a>, <i>P</i>4<sub>1</sub>2<sub>1</sub>2, 2.9 Å),<a onclick="showRef(event, 'cit36a'); return false;" href="javascript:void(0);" class="ref cit36a">(36a)</a> and <b>33</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uhq">1uhq</a>)<a onclick="showRef(event, 'cit36b'); return false;" href="javascript:void(0);" class="ref cit36b">(36b)</a> had been made publicly available by the Protein Data Bank during a restricted time period. These data have been retracted in the meantime for unknown reasons. Shown X-ray structures were aligned onto the aliskiren complex using Coot (<contrib-group>Emsley, P.; Cowtan, K.</contrib-group>Coot: model-building tools for molecular graphics.  <cite>Acta Crystallogr.</cite> <span class="NLM_year">2004</span>, <em>D60</em>, 2126−2132). Figures were generated using PyMOL (<contrib-group>DeLano, W. L.</contrib-group> <cite>The PyMOL Molecular Graphics System</cite>; DeLano Scientific: San Carlos, CA, <span class="NLM_year">2002</span>; <a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>).</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Maibaum</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#721807170015171c2d191e1307015c1f131b1013071f321c1d041300061b015c111d1f"><span class="__cf_email__" data-cfemail="3e544b5b4c595b506155525f4b4d10535f575c5f4b537e5051485f4c4a574d105d5153">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randy L. Webb</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharmaceuticals Corp., Institutes for BioMedical Research, East Hanover, New Jersey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolaus Schiering</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Sedrani</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901885s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Randy L. Webb</b> is Executive Director in the Cardiovascular and Metabolic Disease area. He graduated from the University of Iowa and received his Ph.D. in Pharmacology. He was a postdoctoral fellow in 1984 in the Departement of Physiology at the Medical College of Wisconsin. He joined Ciba-Geigy (now Novartis) in 1984 where he worked on various cardiovascular drug discovery and late-stage development projects. He has performed studies supporting the regulatory submissions for benazepril, valsartan, and aliskiren.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nikolaus Schiering</b> received his Ph.D. from the University of Heidelberg (Germany) in 1991 for work conducted at the Max-Planck-Institute for Medical Research, Department of Biophysics, in the group of Emil F. Pai. From 1992 to 1995 he pursued postdoctoral studies at the Rosenstiel Center of Brandeis University, Waltham, MA, under the guidance of Gregory A. Petsko and Dagmar Ringe. He joined Pharmacia (Nerviano, Italy) in 1995 as a Research Scientist in the Department of Structural Chemistry. Since 2003, he has been working in the Structural Sciences Unit of the Expertise Platform Proteases at Novartis in Basel, Switzerland, as a Research Investigator.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Richard Sedrani</b> is Executive Director in the Expertise Platform Proteases at Novartis in Basel, Switzerland. He studied at the Université Pierre et Marie Curie in Paris, France, where he obtained his Ph.D. in Organic Chemistry in 1990 working under the guidance of Professor Alexandre Alexakis. From 1990 to 1991 he was a postdoctoral fellow at the University of South Carolina working in the group of Professor James A. Marshall. He joined Sandoz Pharma, now Novartis, in 1991, where he has been working in drug discovery projects in various therapeutic areas. He is co-inventor of everolimus, the active principle in Certican, used for the prevention of transplant rejection, and in Afinitor, a treatment for patients with advanced kidney cancer.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jürgen Maibaum</b> is Director and Leading Scientist within the Expertise Platform Proteases at NIBR in Basel, Switzerland. He graduated from the University of Münster, Germany, where he received his Ph.D. in Medicinal Chemistry in 1983 under the guidance of Professor Gottfried Blaschke. He was postdoctoral fellow between 1985 and 1987 at the University of Wisconsin, Madison, under the guidance of Professor Daniel H. Rich. He joined Ciba-Geigy (now Novartis) in 1989, where he has been engaged in drug discovery projects in the areas of cardiovascular disease, osteoporosis, metabolic disorders and obesity, and ophthalmology. In 2009, Jürgen was honored with the “Hero of Chemistry Award” by the American Chemical Society for his contributions to the discovery of aliskiren.</p></figure></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 185 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Tigerstedt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, P. G.</span><span> </span><span class="NLM_article-title">Niere und Kreislauf</span> <span class="citation_source-journal">Skand. Arch. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1898</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1748-1716.1898.tb00272.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1898&pages=223-271&author=R.+Tigerstedtauthor=P.+G.+Bergman&title=Niere+und+Kreislauf"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1748-1716.1898.tb00272.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1748-1716.1898.tb00272.x%26sid%3Dliteratum%253Aachs%26aulast%3DTigerstedt%26aufirst%3DR.%26aulast%3DBergman%26aufirst%3DP.%2BG.%26atitle%3DNiere%2520und%2520Kreislauf%26jtitle%3DSkand.%2520Arch.%2520Physiol.%26date%3D1898%26volume%3D8%26spage%3D223%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Aurell, M.</span><span> </span><span class="NLM_article-title">The renin−angiotensin system: the centenary jubilee</span> <span class="citation_source-journal">Blood Pressure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=71-75&author=M.+Aurell&title=The+renin%E2%88%92angiotensin+system%3A+the+centenary+jubilee"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAurell%26aufirst%3DM.%26atitle%3DThe%2520renin%25E2%2588%2592angiotensin%2520system%253A%2520the%2520centenary%2520jubilee%26jtitle%3DBlood%2520Pressure%26date%3D1998%26volume%3D7%26spage%3D71%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Skeggs, L. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, N. P.</span><span> </span><span class="NLM_article-title">The preparation, purification, and amino acid sequence of a polypeptide renin substrate</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1957&pages=439-453&author=L.+T.+Skeggsauthor=J.+R.+Kahnauthor=K.+Lentzauthor=N.+P.+Shumway&title=The+preparation%2C+purification%2C+and+amino+acid+sequence+of+a+polypeptide+renin+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%2BT.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DLentz%26aufirst%3DK.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DThe%2520preparation%252C%2520purification%252C%2520and%2520amino%2520acid%2520sequence%2520of%2520a%2520polypeptide%2520renin%2520substrate%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1957%26volume%3D106%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Azizi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Renin inhibition with aliskiren: Where are we now, and where are we going?</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F01.hjh.0000202812.72341.99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=16508564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslamtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=243-256&author=M.+Aziziauthor=R.+Webbauthor=J.+Nussbergerauthor=N.+K.+Hollenberg&title=Renin+inhibition+with+aliskiren%3A+Where+are+we+now%2C+and+where+are+we+going%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition with aliskiren: where are we now, and where are we going?</span></div><div class="casAuthors">Azizi, Michel; Webb, Randy; Nussberger, Juerg; Hollenberg, Norman K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-256</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  With the development of aliskiren, blockade of the renin-angiotensin-aldosterone system (RAAS) at the level of the interaction of renin with a substrate has become a clin. reality.  This review covers the specific features of the first agent likely to achieve widespread clin. exposure, aliskiren.  The potential of renin inhibition must be viewed in the context of the remarkable efficacy of both angiotensin-converting enzyme (ACE) inhibition and angiotensin receptor blockers (ARBs).  The implications of blockade of the renin system at its rate-limiting step are reviewed, with the therapeutic implications for both the renin inhibitor employed alone or the renin inhibitor combined with an ACE inhibitor or ARB.  The relevant and necessary studies are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRs5P2dISfLVg90H21EOLACvtfcHk0lhqG_p-nq6Jog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslamtL0%253D&md5=56802278b84a703062e1940dc910b910</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2F01.hjh.0000202812.72341.99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.hjh.0000202812.72341.99%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DR.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DRenin%2520inhibition%2520with%2520aliskiren%253A%2520Where%2520are%2520we%2520now%252C%2520and%2520where%2520are%2520we%2520going%253F%26jtitle%3DJ.%2520Hypertens.%26date%3D2006%26volume%3D24%26spage%3D243%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sever, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azizi, M.</span><span> </span><span class="NLM_article-title">Managing cardiovascular and renal risk: the potential of direct renin inhibition</span> <span class="citation_source-journal">J. Renin−Angiotensin−Aldosterone Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1177%2F1470320309104662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19502253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVChtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=65-76&author=P.+S.+Severauthor=A.+H.+Gradmanauthor=M.+Azizi&title=Managing+cardiovascular+and+renal+risk%3A+the+potential+of+direct+renin+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Managing cardiovascular and renal risk: the potential of direct renin inhibition</span></div><div class="casAuthors">Sever, Peter S.; Gradman, Alan H.; Azizi, Michel</div><div class="citationInfo"><span class="NLM_cas:title">JRAAS</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-76</span>CODEN:
                <span class="NLM_cas:coden">JRAAAG</span>;
        ISSN:<span class="NLM_cas:issn">1470-3203</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Aliskiren is the first direct renin inhibitor for the treatment of hypertension.  Clin. experience from studies in over 14,000 patients has shown that aliskiren, alone or in combination with other antihypertensive therapies, provides effective blood pressure lowering with a good safety and tolerability profile.  The ultimate aim of antihypertensive therapy, however, is to reduce the risk of adverse cardiovascular and renal outcomes.  The effect of aliskiren on surrogate markers of organ damage and clin. outcomes is being assessed in the ongoing ASPIRE HIGHER program, the largest clin. trials program in the cardio-renal disease area.  Results from the ALOFT, AVOID and ALLAY studies suggest that aliskiren has pos. effects on markers of cardiovascular and renal damage in patients with type 2 diabetes and nephropathy, heart failure and left ventricular hypertrophy.  ASPIRE HIGHER also includes four large-scale studies assessing the potential outcome benefits of aliskiren, and the results of these trials will help define the clin. utility of aliskiren in the treatment of cardiovascular and renal diseases.  In this article, we review the antihypertensive efficacy of aliskiren and explore its potential in the management of cardiovascular and renal risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDBNL9_Fo57Vg90H21EOLACvtfcHk0lhdFBvm0La4nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVChtL7M&md5=13512d8238309e35df87ac1bd0d39b17</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1177%2F1470320309104662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1470320309104662%26sid%3Dliteratum%253Aachs%26aulast%3DSever%26aufirst%3DP.%2BS.%26aulast%3DGradman%26aufirst%3DA.%2BH.%26aulast%3DAzizi%26aufirst%3DM.%26atitle%3DManaging%2520cardiovascular%2520and%2520renal%2520risk%253A%2520the%2520potential%2520of%2520direct%2520renin%2520inhibition%26jtitle%3DJ.%2520Renin%25E2%2588%2592Angiotensin%25E2%2588%2592Aldosterone%2520Syst.%26date%3D2009%26volume%3D10%26spage%3D65%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Brown, M. J.</span><span> </span><span class="NLM_article-title">Direct renin inhibition−a new way of targeting the renin system</span> <span class="citation_source-journal">J. Renin−Angiotensin−Aldosterone Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span><span class="NLM_x">–</span> <span class="NLM_lpage">S11</span><div class="note"><p class="first last">. The terminology “direct renin inhibition” indicates an action that directly involves renin inhibition rather than an “indirect inhibition” that can occur somewhere along the pathway and will result in suppression of the cascade and eventually of renin release. The term DRI does not refer to the mechanism of ligand−enzyme interaction, e.g., active site vs allosteric site binders. To the best of our knowledge, allosteric renin inhibitors have not been reported to date.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=S7-S11&author=M.+J.+Brown&title=Direct+renin+inhibition%E2%88%92a+new+way+of+targeting+the+renin+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26atitle%3DDirect%2520renin%2520inhibition%25E2%2588%2592a%2520new%2520way%2520of%2520targeting%2520the%2520renin%2520system%26jtitle%3DJ.%2520Renin%25E2%2588%2592Angiotensin%25E2%2588%2592Aldosterone%2520Syst.%26date%3D2006%26volume%3D7%26spage%3DS7%26epage%3DS11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ong, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, B. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S. L.</span><span> </span><span class="NLM_article-title">Prevalence, awareness, treatment, and control of hypertension among United States adults 1999−2004</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=69-75&author=K.+L.+Ongauthor=B.+M.+Y.+Cheungauthor=Y.+B.+Manauthor=C.+P.+Lauauthor=K.+S.+L.+Lam&title=Prevalence%2C+awareness%2C+treatment%2C+and+control+of+hypertension+among+United+States+adults+1999%E2%88%922004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOng%26aufirst%3DK.%2BL.%26aulast%3DCheung%26aufirst%3DB.%2BM.%2BY.%26aulast%3DMan%26aufirst%3DY.%2BB.%26aulast%3DLau%26aufirst%3DC.%2BP.%26aulast%3DLam%26aufirst%3DK.%2BS.%2BL.%26atitle%3DPrevalence%252C%2520awareness%252C%2520treatment%252C%2520and%2520control%2520of%2520hypertension%2520among%2520United%2520States%2520adults%25201999%25E2%2588%25922004%26jtitle%3DHypertension%26date%3D2007%26volume%3D49%26spage%3D69%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kearney, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muntner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span> </span><span class="NLM_article-title">Global burden of hypertension: analysis of worldwide data</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0140-6736%2805%2917741-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=15652604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FislCjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=217-223&author=P.+M.+Kearneyauthor=M.+Wheltonauthor=K.+Reynoldsauthor=P.+Muntnerauthor=P.+K.+Wheltonauthor=H.+He&title=Global+burden+of+hypertension%3A+analysis+of+worldwide+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Global burden of hypertension: analysis of worldwide data</span></div><div class="casAuthors">Kearney Patricia M; Whelton Megan; Reynolds Kristi; Muntner Paul; Whelton Paul K; He Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9455</span>),
    <span class="NLM_cas:pages">217-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition.  We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.  METHODS:  We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles.  We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples.  All data were obtained independently by two investigators with a standardised protocol and data-collection form.  RESULTS:  Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]).  The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries.  The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion).  INTERPRETATION:  Hypertension is an important public-health challenge worldwide.  Prevention, detection, treatment, and control of this condition should receive high priority.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmyTZQBk0Ftv6xYuD7tu2XfW6udTcc2eZxFZnhYMVRxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FislCjsg%253D%253D&md5=e48f0f930ce08e584b231cc4eda055da</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2917741-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252917741-1%26sid%3Dliteratum%253Aachs%26aulast%3DKearney%26aufirst%3DP.%2BM.%26aulast%3DWhelton%26aufirst%3DM.%26aulast%3DReynolds%26aufirst%3DK.%26aulast%3DMuntner%26aufirst%3DP.%26aulast%3DWhelton%26aufirst%3DP.%2BK.%26aulast%3DHe%26aufirst%3DH.%26atitle%3DGlobal%2520burden%2520of%2520hypertension%253A%2520analysis%2520of%2520worldwide%2520data%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D217%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ondetti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, D. W.</span><span> </span><span class="NLM_article-title">Inhibition of the renin angiotensin system: a new approach to the therapy of hypertension</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00136a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=355-361&author=M.+A.+Ondettiauthor=D.+W.+Cushman&title=Inhibition+of+the+renin+angiotensin+system%3A+a+new+approach+to+the+therapy+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm00136a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00136a001%26sid%3Dliteratum%253Aachs%26aulast%3DOndetti%26aufirst%3DM.%2BA.%26aulast%3DCushman%26aufirst%3DD.%2BW.%26atitle%3DInhibition%2520of%2520the%2520renin%2520angiotensin%2520system%253A%2520a%2520new%2520approach%2520to%2520the%2520therapy%2520of%2520hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D355%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Timmermans, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncia, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, W. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. L.</span><span> </span><span class="NLM_article-title">Angiotensin II receptor antagonists: from discovery to antihypertensive drugs</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl., III</span><span class="NLM_x">) </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1991&pages=136-142&issue=Suppl.%2C+III&author=P.+B.+Timmermansauthor=D.+J.+Cariniauthor=A.+T.+Chiuauthor=J.+V.+Dunciaauthor=W.+A.+Priceauthor=G.+J.+Wellsauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=A.+L.+Johnson&title=Angiotensin+II+receptor+antagonists%3A+from+discovery+to+antihypertensive+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%26aulast%3DCarini%26aufirst%3DD.%2BJ.%26aulast%3DChiu%26aufirst%3DA.%2BT.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DPrice%26aufirst%3DW.%2BA.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DJohnson%26aufirst%3DA.%2BL.%26atitle%3DAngiotensin%2520II%2520receptor%2520antagonists%253A%2520from%2520discovery%2520to%2520antihypertensive%2520drugs%26jtitle%3DHypertension%26date%3D1991%26volume%3D18%26issue%3DSuppl.%252C%2520III%26spage%3D136%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span> </span><span class="NLM_article-title">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0006-291X%2803%2901451-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12927775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2003&pages=698-705&author=J.+M.+Woodauthor=J.+Maibaumauthor=J.+Rahuelauthor=M.+G.+Gr%C3%BCtterauthor=N.+C.+Cohenauthor=V.+Rasettiauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=S.+Stutzauthor=W.+Fuhrerauthor=W.+Schillingauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=H.+P.+Baumauthor=C.+R.+Schnellauthor=P.+Heroldauthor=R.+Mahauthor=C.+Jensenauthor=E.+O%E2%80%99Brienauthor=A.+Stantonauthor=M.+P.+Bedigian&title=Structure-based+design+of+aliskiren%2C+a+novel+orally+effective+renin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span></div><div class="casAuthors">Wood, Jeanette M.; Maibaum, Juergen; Rahuel, Joseph; Gruetter, Markus G.; Cohen, Nissim-Claude; Rasetti, Vittorio; Rueger, Heinrich; Goeschke, Richard; Stutz, Stefan; Fuhrer, Walter; Schilling, Walter; Rigollier, Pascal; Yamaguchi, Yasuchika; Cumin, Frederic; Baum, Hans-Peter; Schnell, Christian R.; Herold, Peter; Mah, Robert; Jensen, Chris; O'Brien, Eoin; Stanton, Alice; Bedigian, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Hypertension is a major risk factor for cardiovascular diseases such as stroke, myocardial infarction, and heart failure, the leading causes of death in the Western world.  Inhibitors of the renin-angiotensin system (RAS) have proven to be successful treatments for hypertension.  As renin specifically catalyzes the rate-limiting step of the RAS, it represents the optimal target for RAS inhibition.  Several peptide-like renin inhibitors have been synthesized previously, but poor pharmacokinetic properties meant that these compds. were not clin. useful.  We employed a combination of mol. modeling and crystallog. structure anal. to design renin inhibitors lacking the extended peptide-like backbone of earlier inhibitors, for improved pharmacokinetic properties.  This led to the discovery of aliskiren, a highly potent and selective inhibitor of human renin in vitro, and in vivo; once-daily oral doses of aliskiren inhibit renin and lower blood pressure in sodium-depleted marmosets and hypertensive human patients.  Aliskiren represents the first in a novel class of renin inhibitors with the potential for treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5YmV3cdr0LVg90H21EOLACvtfcHk0liTsH8ip3CN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D&md5=20b71ca3ccfe2324752cb2bb541d9ba2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901451-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901451-7%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DHerold%26aufirst%3DP.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DStanton%26aufirst%3DA.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26atitle%3DStructure-based%2520design%2520of%2520aliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D308%26spage%3D698%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span> </span><span class="NLM_article-title">Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4832</span><span class="NLM_x">–</span> <span class="NLM_lpage">4844</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070316i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4832-4844&author=J.+Maibaumauthor=S.+Stutzauthor=R.+G%C3%B6schkeauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=J.+Rahuelauthor=H.+P.+Baumauthor=N.+C.+Cohenauthor=C.+R.+Schnellauthor=W.+Fuhrerauthor=M.+G.+Gr%C3%BCtterauthor=W.+Schillingauthor=J.+M.+Wood&title=Structural+modification+of+the+P2%E2%80%B2+position+of+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamides%3A+the+discovery+of+aliskiren%2C+a+potent+nonpeptide+human+renin+inhibitor+active+after+once+daily+dosing+in+marmosets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm070316i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070316i%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520modification%2520of%2520the%2520P2%25E2%2580%25B2%2520position%2520of%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamides%253A%2520the%2520discovery%2520of%2520aliskiren%252C%2520a%2520potent%2520nonpeptide%2520human%2520renin%2520inhibitor%2520active%2520after%2520once%2520daily%2520dosing%2520in%2520marmosets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4832%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span> </span><span class="NLM_article-title">Case history on Tekturna/Rasilez (aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span> <span class="citation_source-journal">Annu. Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0065-7743%2809%2904405-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=105-127&author=J.+Maibaumauthor=D.+L.+Feldman&title=Case+history+on+Tekturna%2FRasilez+%28aliskiren%29%2C+a+highly+efficacious+direct+oral+renin+inhibitor+as+a+new+therapy+for+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Case history on Tekturna Rasilez (Aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span></div><div class="casAuthors">Maibaum, Jurgen; Feldman, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-127</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The rationale for the use of direct renin inhibitors, pre-clin. models to study direct renin inhibitors, and the early renin inhibitor program at Ciba-Geigy are shown.  The first convergent and scalable synthesis development, pre-clin. properties of aliskiren, effects of aliskiren in disease models, and clin. studies with aliskiren are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOCbXc9SNs7LVg90H21EOLACvtfcHk0liTsH8ip3CN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM&md5=7fb4459d367392233e0569a8809a3f41</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2809%2904405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252809%252904405-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26atitle%3DCase%2520history%2520on%2520Tekturna%252FRasilez%2520%2528aliskiren%2529%252C%2520a%2520highly%2520efficacious%2520direct%2520oral%2520renin%2520inhibitor%2520as%2520a%2520new%2520therapy%2520for%2520hypertension%26jtitle%3DAnnu.%2520Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D105%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. R.</span><span> </span><span class="NLM_article-title">Aliskiren: the first renin inhibitor for clinical treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnrd2550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18340340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=399-410&author=C.+Jensenauthor=P.+Heroldauthor=H.+R.+Brunner&title=Aliskiren%3A+the+first+renin+inhibitor+for+clinical+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren: the first renin inhibitor for clinical treatment</span></div><div class="casAuthors">Jensen, Chris; Herold, Peter; Brunner, Hans Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-410</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The renin-angiotensin system, which is a key regulator of blood pressure, has been successfully targeted by several classes of drugs for the treatment of cardiovascular disease.  However, renin - the protease at the top of the cascade - although highly attractive as a target, has also proved to be challenging.  Here, we describe how these challenges were tackled in the discovery and development of aliskiren, the first renin inhibitor to be approved for clin. use.  The first evidence of the existence of renin was presented over 100 years ago.  However, the importance of renin and the renin-angiotensin system in the pathogenesis of cardiovascular disease was only fully realized in the 1970s.  It was another 20 years before the first inhibitors of renin were available for clin. research.  Here, we describe the discovery and development of aliskiren, an orally active renin inhibitor, which became the first drug in its class to receive regulatory approval.  In 2007, it was approved for the treatment of hypertension by the US Food and Drug Administration and the European Medicines Agency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwW8kGNQazBbVg90H21EOLACvtfcHk0lhXaocMepFq_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbg%253D&md5=891d7f8266f9b03954ae40e028a8cd42</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd2550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2550%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DHerold%26aufirst%3DP.%26aulast%3DBrunner%26aufirst%3DH.%2BR.%26atitle%3DAliskiren%253A%2520the%2520first%2520renin%2520inhibitor%2520for%2520clinical%2520treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D399%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yokokawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000−2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span><div class="note"><p class="first last">. A total of 62 new patents claiming novel renin inhibitors have been disclosed in the years 2008−2009, as based on a search in SciFinder. For more recent reports on DRI clinical development compounds, see refs <a onclick="showRef(event, 'ref182 ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref182 ref183 ref184">182−184</a></p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F13543776.18.6.581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1OktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=581-602&author=F.+Yokokawaauthor=J.+Maibaum&title=Recent+advances+in+the+discovery+of+non-peptidic+direct+renin+inhibitors+as+antihypertensives%3A+new+patent+applications+in+years+2000%E2%88%922008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000 - 2008</span></div><div class="casAuthors">Yokokawa, Fumiaki; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">581-602</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The renin-angiotensin-aldosterone system (RAAS) is essential for the regulation of blood pressure and may play a crit. role in the pathogenesis of cardiovascular diseases.  A strong rationale suggests a more efficient control of RAAS by direct rather than downstream blockade of renin, an angiotensinogen-specific aspartic protease acting at the first, rate-limiting step of the pathway.  Vast research efforts since the late 1970s have aimed at developing clin. useful renin inhibitors for the treatment of hypertension and assocd. co-morbidities.  In 2007, aliskiren (Tekturna, Rasilez; Novartis) was launched as the first orally efficacious direct renin inhibitor.  The evolution of non-peptide renin inhibitors interacting with non-substrate recognition sites of the enzyme, such as aliskiren and the 4-aryl-piperidines, during the 1990s encouraged an increasing no. of pharmaceutical companies to resume, or newly embark on, drug discovery programs.  Objective: This review summarizes the various structural design concepts and the apparent focus of activities presently employed to develop follow-up generations of oral renin inhibitors.  Methods: Information was collected from patents, scientific literatures and public sources disclosed during the years 2000 - 2008.  Results/conclusion: The structural diversity of small-mol. inhibitors has further increased, including novel basic surrogate transition-state mimetic motifs.  Several inhibitors emerged as (pre)clin. candidates, the most advanced having entered Phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_YIMBZDqTyrVg90H21EOLACvtfcHk0lhXaocMepFq_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1OktrY%253D&md5=101c7650e96d98257a9cb7d4d7028060</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.6.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.6.581%26sid%3Dliteratum%253Aachs%26aulast%3DYokokawa%26aufirst%3DF.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520non-peptidic%2520direct%2520renin%2520inhibitors%2520as%2520antihypertensives%253A%2520new%2520patent%2520applications%2520in%2520years%25202000%25E2%2588%25922008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D581%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Pilz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shagdarsuren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=569-576&author=B.+Pilzauthor=E.+Shagdarsurenauthor=M.+Wellnerauthor=A.+Fiebelerauthor=R.+Dechendauthor=P.+Gratzeauthor=S.+Meinersauthor=D.+L.+Feldmanauthor=R.+L.+Webbauthor=I.+M.+Garreldsauthor=A.+H.+J.+Danserauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=Aliskiren%2C+a+human+renin+inhibitor%2C+ameliorates+cardiac+and+renal+damage+in+double-transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPilz%26aufirst%3DB.%26aulast%3DShagdarsuren%26aufirst%3DE.%26aulast%3DWellner%26aufirst%3DM.%26aulast%3DFiebeler%26aufirst%3DA.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DGratze%26aufirst%3DP.%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DAliskiren%252C%2520a%2520human%2520renin%2520inhibitor%252C%2520ameliorates%2520cardiac%2520and%2520renal%2520damage%2520in%2520double-transgenic%2520rats%26jtitle%3DHypertension%26date%3D2005%26volume%3D46%26spage%3D569%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">A revised definition of “peptide-derived peptidomimetic” and “non-peptide peptidomimetic” protease inhibitors has been proposed by Rich et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Non-peptide peptidomimetics can be further distinguished in two major classes: those accessing exclusively the substrate-derived extended β-strand binding active site topography and those binding to a distinct active site conformational topography not recognized by substrate-derived inhibitors. We use this terminology throughout the discussion in this article.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tice, C. M.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=155-167&author=C.+M.+Tice&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26atitle%3DRenin%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kasai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span> </span><span class="NLM_article-title">Cardiovascular agents: renin inhibitors and factor Xa inhibitors</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=47-85&author=A.+Kasaiauthor=R.+Subediauthor=M.+Stierauthor=D.+D.+Holsworth&title=Cardiovascular+agents%3A+renin+inhibitors+and+factor+Xa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DA.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DCardiovascular%2520agents%253A%2520renin%2520inhibitors%2520and%2520factor%2520Xa%2520inhibitors%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D73%26spage%3D47%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Inhibitors of Aspartic Proteinases</span>. In  <span class="citation_source-book">Research Monographs in Cell and Tissue Physiology, Vol. 12, Proteinase Inhibitors</span>; <span class="NLM_contrib-group">Barrett, A. J.; Salvesen, G.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>pp <span class="NLM_fpage">179</span>− <span class="NLM_lpage">217</span> and references therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=179-217&author=D.+H.+Richauthor=A.+J.+Barrett&author=G+Salvesen&title=Research+Monographs+in+Cell+and+Tissue+Physiology%2C+Vol.+12%2C+Proteinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DInhibitors%2520of%2520Aspartic%2520Proteinases%26btitle%3DResearch%2520Monographs%2520in%2520Cell%2520and%2520Tissue%2520Physiology%252C%2520Vol.%252012%252C%2520Proteinase%2520Inhibitors%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26pub%3DElsevier%26date%3D1986%26spage%3D179%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1002%2Fmed.2610100203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1990&pages=173-236&author=W.+J.+Greenlee&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610100203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610100203%26sid%3Dliteratum%253Aachs%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DRenin%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1990%26volume%3D2%26spage%3D173%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Hypertension: Treatment by Blockade of the Renin−Angiotensin System</span>. In  <span class="citation_source-book">Proceedings of the 14th International Symposium on Medicinal Chemistry</span>; <span class="NLM_contrib-group">Awouters, F.</span>, Ed.; <span class="NLM_publisher-name">Elsevier Science</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">97</span>− <span class="NLM_lpage">107</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0165-7208%2897%2980056-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=97-107&author=W.+J.+Greenleeauthor=F.+Awouters&title=Proceedings+of+the+14th+International+Symposium+on+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2FS0165-7208%2897%2980056-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0165-7208%252897%252980056-6%26sid%3Dliteratum%253Aachs%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DHypertension%253A%2520Treatment%2520by%2520Blockade%2520of%2520the%2520Renin%25E2%2588%2592Angiotensin%2520System%26btitle%3DProceedings%2520of%2520the%252014th%2520International%2520Symposium%2520on%2520Medicinal%2520Chemistry%26aulast%3DAwouters%26aufirst%3DF.%26pub%3DElsevier%2520Science%26date%3D1997%26spage%3D97%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raddatz, P.</span><span> </span><span class="NLM_article-title">Recent developments in renin inhibitors: Part 1</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F13543776.4.5.489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVClsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=489-504&author=P.+Raddatz&title=Recent+developments+in+renin+inhibitors%3A+Part+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in renin inhibitors: Part 1</span></div><div class="casAuthors">Raddatz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">489-504</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">0962-2594</span>.
    </div><div class="casAbstract">A review with 153 refs. of recent developments in the renin inhibitor area including patent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2QLVLR4dumrVg90H21EOLACvtfcHk0lh5xx1DTBg0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVClsLw%253D&md5=41be029416257e40e416bb774db7f632</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1517%2F13543776.4.5.489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.4.5.489%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DP.%26atitle%3DRecent%2520developments%2520in%2520renin%2520inhibitors%253A%2520Part%25201%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D1994%26volume%3D4%26spage%3D489%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raddatz, P.</span><span> </span><span class="NLM_article-title">Recent developments in renin inhibitors: Part II</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F13543776.4.11.1347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2MXitlGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=1347-1359&author=P.+Raddatz&title=Recent+developments+in+renin+inhibitors%3A+Part+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in renin inhibitors: part II</span></div><div class="casAuthors">Raddatz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1347-59</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">0962-2594</span>.
    </div><div class="casAbstract">A review with 75 refs. of the structures and activities of renin inhibitors that are under exptl. and clin. investigation and that have been proposed in recent patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqypp6bYZgmD7Vg90H21EOLACvtfcHk0lh5xx1DTBg0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlGrt70%253D&md5=45a597b2c93aeb2d1dc7fcef27e85d63</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1517%2F13543776.4.11.1347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.4.11.1347%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DP.%26atitle%3DRecent%2520developments%2520in%2520renin%2520inhibitors%253A%2520Part%2520II%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D1994%26volume%3D4%26spage%3D1347%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Progr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0079-6468%2808%2970452-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8577921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2MXpt12it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1995&pages=37-114&author=S.+H.+Rosenberg&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibitors</span></div><div class="casAuthors">Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-114</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 296 refs. on renin-angiotensin system and pharmacol. of renin inhibitors as antihypertensive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_7GRpnwZ6bVg90H21EOLACvtfcHk0lh5xx1DTBg0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpt12it7g%253D&md5=82740dd1db4822d1bb67357172af6199</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970452-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970452-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DRenin%2520inhibitors%26jtitle%3DProgr.%2520Med.%2520Chem.%26date%3D1995%26volume%3D32%26spage%3D37%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rosenberg, S. H.; Boyd, S. A.</span><span> </span><span class="NLM_article-title">Renin Inhibitors</span>. In  <span class="citation_source-book">Antihypertensive Drugs</span>; <span class="NLM_contrib-group">Van Zwieten, P. A.; Greenlee, W. J.</span>, Eds.; <span class="NLM_publisher-name">Harwood</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">77</span>− <span class="NLM_lpage">111</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=77-111&author=S.+H.+Rosenberg&author=S.+A.+Boydauthor=P.+A.+Van+Zwieten&author=W.+J.+Greenlee&title=Antihypertensive+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DRenin%2520Inhibitors%26btitle%3DAntihypertensive%2520Drugs%26aulast%3DVan%2BZwieten%26aufirst%3DP.%2BA.%26pub%3DHarwood%26date%3D1997%26spage%3D77%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinert, H. D.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2F0-306-47384-4_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9760674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=7-28&author=S.+H.+Rosenbergauthor=H.+D.+Kleinert&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibitors</span></div><div class="casAuthors">Rosenberg, Saul H.; Kleinert, Hollis D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">Integration of Pharmaceutical Discovery and Development</span>),
    <span class="NLM_cas:pages">7-28</span>CODEN:
                <span class="NLM_cas:coden">PHBIEB</span>;
        ISSN:<span class="NLM_cas:issn">1078-0467</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">A review with many refs.  The authors illustrate the decision-making processes that are assocd. with a drug discovery effort.  The success of the renin inhibitor project was the direct result of the tight integration of the medicinal chem. biochem., pharmacol. and pharmacokinetics groups.  As obstacles arose, a variety of approaches, often simultaneous, were taken to overcome them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFJHD3ufSbsrVg90H21EOLACvtfcHk0lh5xx1DTBg0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFyrsLc%253D&md5=a86ce0dbd58c744a2a79a649da6db952</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1007%2F0-306-47384-4_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F0-306-47384-4_2%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DKleinert%26aufirst%3DH.%2BD.%26atitle%3DRenin%2520inhibitors%26jtitle%3DPharm.%2520Biotechnol.%26date%3D1998%26volume%3D11%26spage%3D7%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Appelt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacquet, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhry, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howland, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathardekar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzoni, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oatley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoettlin, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villafranca, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span> </span><span class="NLM_article-title">Design of enzyme inhibitors using iterative protein crystallographic analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1925</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00111a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3MXksVCltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1925-1934&author=K.+Appeltauthor=R.+J.+Bacquetauthor=C.+A.+Bartlettauthor=C.+L.+Boothauthor=S.+T.+Freerauthor=M.+A.+Fuhryauthor=M.+R.+Gehringauthor=S.+M.+Herrmannauthor=E.+F.+Howlandauthor=C.+A.+Jansonauthor=T.+R.+Jonesauthor=C.-C.+Kanauthor=V.+Kathardekarauthor=K.+K.+Lewisauthor=G.+P.+Marzoniauthor=D.+A.+Matthewsauthor=C.+Mohrauthor=E.+W.+Moomawauthor=C.+A.+Morseauthor=S.+J.+Oatleyauthor=R.+C.+Ogdenauthor=M.+R.+Reddyauthor=S.+H.+Reichauthor=W.+S.+Schoettlinauthor=W.+W.+Smithauthor=M.+D.+Varneyauthor=J.+E.+Villafrancaauthor=R.+W.+Wardauthor=S.+Webberauthor=S.+E.+Webberauthor=K.+M.+Welchauthor=J.+White&title=Design+of+enzyme+inhibitors+using+iterative+protein+crystallographic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Design of enzyme inhibitors using iterative protein crystallographic analysis</span></div><div class="casAuthors">Appelt, Krzysztof; Bacquet, Russell J.; Bartlett, Charlotte A.; Booth, Carol L. J.; Freer, Stephan T.; Fuhry, Mary Ann M.; Gehring, Michael R.; Herrmann, Steven M.; Howland, Eleanor F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1925-34</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review and discussion with 48 refs., of successful applications of an iterative cycle of ligand design, synthesis, biochem. evaluation, and crystallog. anal. of the protein-ligand complex in the development of enzyme inhibitors.  Three series of structurally distinct compds. have been designed as inhibitors of Escherichia coli thymidylate synthase.  The ability to study in detail the binding mode of each successive mol. in a series greatly facilitates the anal. of those forces which dominate receptor-ligand interactions.  The methodol. described may speed the discovery of lead compds. and assist their development into drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxFzVLiIumNLVg90H21EOLACvtfcHk0lh_uYFe3ZdmQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVCltLs%253D&md5=59843c2d15034277e136820850660265</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm00111a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00111a001%26sid%3Dliteratum%253Aachs%26aulast%3DAppelt%26aufirst%3DK.%26aulast%3DBacquet%26aufirst%3DR.%2BJ.%26aulast%3DBartlett%26aufirst%3DC.%2BA.%26aulast%3DBooth%26aufirst%3DC.%2BL.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26aulast%3DFuhry%26aufirst%3DM.%2BA.%26aulast%3DGehring%26aufirst%3DM.%2BR.%26aulast%3DHerrmann%26aufirst%3DS.%2BM.%26aulast%3DHowland%26aufirst%3DE.%2BF.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DKan%26aufirst%3DC.-C.%26aulast%3DKathardekar%26aufirst%3DV.%26aulast%3DLewis%26aufirst%3DK.%2BK.%26aulast%3DMarzoni%26aufirst%3DG.%2BP.%26aulast%3DMatthews%26aufirst%3DD.%2BA.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DMoomaw%26aufirst%3DE.%2BW.%26aulast%3DMorse%26aufirst%3DC.%2BA.%26aulast%3DOatley%26aufirst%3DS.%2BJ.%26aulast%3DOgden%26aufirst%3DR.%2BC.%26aulast%3DReddy%26aufirst%3DM.%2BR.%26aulast%3DReich%26aufirst%3DS.%2BH.%26aulast%3DSchoettlin%26aufirst%3DW.%2BS.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DVarney%26aufirst%3DM.%2BD.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26aulast%3DWard%26aufirst%3DR.%2BW.%26aulast%3DWebber%26aufirst%3DS.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWelch%26aufirst%3DK.%2BM.%26aulast%3DWhite%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520enzyme%2520inhibitors%2520using%2520iterative%2520protein%2520crystallographic%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1925%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">The rise of fragment-based drug discovery</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnchem.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=21378847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=187-192&author=C.+W.+Murrayauthor=D.+C.+Rees&title=The+rise+of+fragment-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of fragment-based drug discovery</span></div><div class="casAuthors">Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The search for new drugs is plagued by high attrition rates at all stages in research and development.  Chemists have an opportunity to tackle this problem because attrition can be traced back, in part, to the quality of the chem. leads.  Fragment-based drug discovery (FBDD) is a new approach, increasingly used in the pharmaceutical industry, for reducing attrition and providing leads for previously intractable biol. targets.  FBDD identifies low-mol.-wt. ligands (∼150 Da) that bind to biol. important macromols.  The three-dimensional exptl. binding mode of these fragments is detd. using X-ray crystallog. or NMR spectroscopy, and is used to facilitate their optimization into potent mols. with drug-like properties.  Compared with high-throughput-screening, the fragment approach requires fewer compds. to be screened, and, despite the lower initial potency of the screening hits, offers more efficient and fruitful optimization campaigns.  Here, we review the rise of FBDD, including its application to discovering clin. candidates against targets for which other chem. approaches have struggled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3ip2FKcYJbVg90H21EOLACvtfcHk0lh_uYFe3ZdmQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D&md5=0bd1a40fd927cce9200f0fa296a7462f</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1038%2Fnchem.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.217%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DThe%2520rise%2520of%2520fragment-based%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">de Kloe, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span> </span><span class="NLM_article-title">Transforming fragments into candidates: small becomes big in medicinal chemistry</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.drudis.2009.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19443265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD1MvmtFOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=630-646&author=G.+E.+de+Kloeauthor=D.+Baileyauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Transforming+fragments+into+candidates%3A+small+becomes+big+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming fragments into candidates: small becomes big in medicinal chemistry</span></div><div class="casAuthors">de Kloe Gerdien E; Bailey David; Leurs Rob; de Esch Iwan J P</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">630-46</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fragment-based drug discovery (FBDD) represents a logical and efficient approach to lead discovery and optimisation.  It can draw on structural, biophysical and biochemical data, incorporating a wide range of inputs, from precise mode-of-binding information on specific fragments to wider ranging pharmacophoric screening surveys using traditional HTS approaches.  It is truly an enabling technology for the imaginative medicinal chemist.  In this review, we analyse a representative set of 23 published FBDD studies that describe how low molecular weight fragments are being identified and efficiently transformed into higher molecular weight drug candidates.  FBDD is now becoming warmly endorsed by industry as well as academia and the focus on small interacting molecules is making a big scientific impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPxy6qg7uE4oxhnOQkIHOxfW6udTcc2eaCn_p5_b_ccLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvmtFOquw%253D%253D&md5=10ed9629dece190be12712f4862b3699</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.03.009%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BKloe%26aufirst%3DG.%2BE.%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DTransforming%2520fragments%2520into%2520candidates%253A%2520small%2520becomes%2520big%2520in%2520medicinal%2520chemistry%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D630%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analog inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00381a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=263-273&author=D.+H.+Rich&title=Pepstatin-derived+inhibitors+of+aspartic+proteinases.+A+close+look+at+an+apparent+transition-state+analog+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00381a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00381a001%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DPepstatin-derived%2520inhibitors%2520of%2520aspartic%2520proteinases.%2520A%2520close%2520look%2520at%2520an%2520apparent%2520transition-state%2520analog%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D263%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Guruprasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanaraj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span> </span><span class="NLM_article-title">Aspartic proteinases: the structures and functions of a versatile superfamily of enzymes</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=329-341&author=K.+Guruprasadauthor=V.+Dhanarajauthor=M.+Grovesauthor=T.+L.+Blundell&title=Aspartic+proteinases%3A+the+structures+and+functions+of+a+versatile+superfamily+of+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuruprasad%26aufirst%3DK.%26aulast%3DDhanaraj%26aufirst%3DV.%26aulast%3DGroves%26aufirst%3DM.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DAspartic%2520proteinases%253A%2520the%2520structures%2520and%2520functions%2520of%2520a%2520versatile%2520superfamily%2520of%2520enzymes%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D1995%26volume%3D2%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_contrib-group">Dunn, B.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the pepsin-like family of aspartic peptidases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4431</span><span class="NLM_x">–</span> <span class="NLM_lpage">4458</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010167q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFWhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4431-4458&author=B.+Dunn&title=Structure+and+mechanism+of+the+pepsin-like+family+of+aspartic+peptidases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the pepsin-like family of aspartic peptidases</span></div><div class="casAuthors">Dunn, Ben M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4431-4458</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include the cloning and expression of new aspartic endopeptidases, structural aspects of aspartic peptidases, the N-terminal prosegment region of aspartic peptidases, active site engineering, substrate and inhibitor design, and synthetic and naturally occurring inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU2C94Lnni_LVg90H21EOLACvtfcHk0lh858jVxFMJfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFWhtLk%253D&md5=0e6b1f501111075667ea562d9d3ca132</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fcr010167q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010167q%26sid%3Dliteratum%253Aachs%26aulast%3DDunn%26aufirst%3DB.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520pepsin-like%2520family%2520of%2520aspartic%2520peptidases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4431%26epage%3D4458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><div class="note"><p class="first last">See also the following: </p></div><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span> </span><span class="NLM_article-title">Molecular recognition of protein−ligand complexes: applications to drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr960370z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=1359-1472&author=R.+E.+Babineauthor=S.+L.+Bender&title=Molecular+recognition+of+protein%E2%88%92ligand+complexes%3A+applications+to+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fcr960370z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr960370z%26sid%3Dliteratum%253Aachs%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DBender%26aufirst%3DS.%2BL.%26atitle%3DMolecular%2520recognition%2520of%2520protein%25E2%2588%2592ligand%2520complexes%253A%2520applications%2520to%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D1359%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cooper, J. B.</span><span> </span><span class="NLM_article-title">Aspartic proteinases in disease: a structural perspective</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.2174%2F1389450024605382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=11958298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFSmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=155-173&author=J.+B.+Cooper&title=Aspartic+proteinases+in+disease%3A+a+structural+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aspartic proteinases in disease: a structural perspective</span></div><div class="casAuthors">Cooper, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-173</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The aspartic proteinases are a family of enzymes involved in a no. of important biol. processes.  In animals the enzyme renin has a hypertensive action through its role in the renin-angiotensin system.  The retroviral aspartic proteinases, such as the HIV proteinase, are essential for maturation of the virus particle and inhibitors have a proven therapeutic record in the treatment of AIDS.  The lysosomal aspartic proteinase cathepsin D has been implicated in tumorigenesis and the stomach enzyme pepsin, which plays a major physiol. role in hydrolysis of acid-denatured proteins, is responsible for much of the tissue damage in peptic ulcer disease.  Since aspartic proteinases also play major roles in amyloid disease, malaria and common fungal infections such as candidiasis, inhibitors to these enzymes are much sought after as potential therapeutic agents.  In all aspartic proteinases, the catalytic aspartate residues are involved in an intricate arrangement of hydrogen bonds involving a solvent mol. which is presumed to be water.  The catalytic mechanism is thought to involve nucleophilic attack of the active site water mol. on the scissile bond carbonyl generating a tetrahedral gem-diol intermediate.  The design of inhibitors generally involves the use of short oligopeptides contg. a transition state analog which mimic this tetrahedral intermediate.  The application of structure-based drug design to members of the aspartic proteinase family is the main subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWCNtimORwbVg90H21EOLACvtfcHk0lh858jVxFMJfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFSmsLg%253D&md5=30264f31342e6be9ef5a591e9526ba08</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1389450024605382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450024605382%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DJ.%2BB.%26atitle%3DAspartic%2520proteinases%2520in%2520disease%253A%2520a%2520structural%2520perspective%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2002%26volume%3D3%26spage%3D155%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010425b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=541-558&author=M.+G.+Bursavichauthor=D.+H.+Rich&title=Designing+non-peptide+peptidomimetics+in+the+21st+century%3A+inhibitors+targeting+conformational+ensembles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Non-Peptide Peptidomimetics in the 21st Century: Inhibitors Targeting Conformational Ensembles</span></div><div class="casAuthors">Bursavich, Matthew G.; Rich, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The goal of this Perspective is to outline for medicinal chemists the potential impact of receptor conformational mobility on rational drug design.  While others have postulated receptor-based conformational selection of ligands and successfully designed inhibitors to emulate the -strand binding motif of native ligands , we show that novel protein conformations (not obsd. in either native or enzyme-inhibitor complexes) can be exploited to create nonpeptide enzyme inhibitors.  We begin with a review of the development of peptidomimetic aspartic peptidase inhibitors and conclude with a new proposal for discovering fundamentally novel nonpeptide peptidomimetics by targeting conformational ensembles.  Although we focus on the aspartic peptidases, the lessons derived therein are applicable to other peptidase and receptor-ligand systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1URmBiLvD97Vg90H21EOLACvtfcHk0lh858jVxFMJfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D&md5=8f00dc08b4d51c3021dd22a247bd56c0</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fjm010425b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010425b%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DDesigning%2520non-peptide%2520peptidomimetics%2520in%2520the%252021st%2520century%253A%2520inhibitors%2520targeting%2520conformational%2520ensembles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D541%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, C. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">From peptides to non-peptide peptidomimetics: design and synthesis of new piperidine inhibitors of aspartic peptidases</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2320</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol016092u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=2317-2320&author=M.+G.+Bursavichauthor=C.+W+Westauthor=D.+H.+Rich&title=From+peptides+to+non-peptide+peptidomimetics%3A+design+and+synthesis+of+new+piperidine+inhibitors+of+aspartic+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1021%2Fol016092u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016092u%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DWest%26aufirst%3DC.%2BW%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DFrom%2520peptides%2520to%2520non-peptide%2520peptidomimetics%253A%2520design%2520and%2520synthesis%2520of%2520new%2520piperidine%2520inhibitors%2520of%2520aspartic%2520peptidases%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D2317%26epage%3D2320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dhanaraj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dealwis, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badasso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibanda, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driessen, H. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobart, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, D. J.</span><span> </span><span class="NLM_article-title">X-ray analyses of peptide−inhibitor complexes define the structural basis of specificity for human and mouse renins</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1992&pages=466-472&author=V.+Dhanarajauthor=C.+G.+Dealwisauthor=C.+Frazaoauthor=M.+Badassoauthor=B.+L.+Sibandaauthor=I.+J.+Tickleauthor=J.+B.+Cooperauthor=H.+P.+C.+Driessenauthor=M.+Newmanauthor=C.+Aguilarauthor=S.+P.+Woodauthor=T.+L.+Blundellauthor=P.+M.+Hobartauthor=K.+F.+Geogheganauthor=M.+J.+Ammiratiauthor=D.+E.+Danleyauthor=B.+A.+O%E2%80%99Connorauthor=D.+J.+Hoover&title=X-ray+analyses+of+peptide%E2%88%92inhibitor+complexes+define+the+structural+basis+of+specificity+for+human+and+mouse+renins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhanaraj%26aufirst%3DV.%26aulast%3DDealwis%26aufirst%3DC.%2BG.%26aulast%3DFrazao%26aufirst%3DC.%26aulast%3DBadasso%26aufirst%3DM.%26aulast%3DSibanda%26aufirst%3DB.%2BL.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DCooper%26aufirst%3DJ.%2BB.%26aulast%3DDriessen%26aufirst%3DH.%2BP.%2BC.%26aulast%3DNewman%26aufirst%3DM.%26aulast%3DAguilar%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DS.%2BP.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DHobart%26aufirst%3DP.%2BM.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DAmmirati%26aufirst%3DM.%2BJ.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%2BA.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26atitle%3DX-ray%2520analyses%2520of%2520peptide%25E2%2588%2592inhibitor%2520complexes%2520define%2520the%2520structural%2520basis%2520of%2520specificity%2520for%2520human%2520and%2520mouse%2520renins%26jtitle%3DNature%26date%3D1992%26volume%3D357%26spage%3D466%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sielecki, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carilli, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewicki, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span> </span><span class="NLM_article-title">Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 Å resolution</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1989&pages=1346-1351&author=A.+R.+Sieleckiauthor=K.+Hayakawaauthor=M.+Fujinagaauthor=M.+E.+P.+Murphyauthor=M.+Fraserauthor=A.+K.+Muirauthor=C.+T.+Carilliauthor=J.+A.+Lewickiauthor=J.+D.+Baxterauthor=M.+N.+G.+James&title=Structure+of+recombinant+human+renin%2C+a+target+for+cardiovascular-active+drugs%2C+at+2.5+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%2BP.%26aulast%3DFraser%26aufirst%3DM.%26aulast%3DMuir%26aufirst%3DA.%2BK.%26aulast%3DCarilli%26aufirst%3DC.%2BT.%26aulast%3DLewicki%26aufirst%3DJ.%2BA.%26aulast%3DBaxter%26aufirst%3DJ.%2BD.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26atitle%3DStructure%2520of%2520recombinant%2520human%2520renin%252C%2520a%2520target%2520for%2520cardiovascular-active%2520drugs%252C%2520at%25202.5%2520%25C3%2585%2520resolution%26jtitle%3DScience%26date%3D1989%26volume%3D243%26spage%3D1346%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestle, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1991&pages=227-236&author=J.+Rahuelauthor=J.+P.+Priestleauthor=M.+G.+Gr%C3%BCtter&title=The+crystal+structures+of+recombinant+glycosylated+human+renin+alone+and+in+complex+with+a+transition+state+analog+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DPriestle%26aufirst%3DJ.%2BP.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DThe%2520crystal%2520structures%2520of%2520recombinant%2520glycosylated%2520human%2520renin%2520alone%2520and%2520in%2520complex%2520with%2520a%2520transition%2520state%2520analog%2520inhibitor%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D1991%26volume%3D107%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wolfenden, R.</span><span> </span><span class="NLM_article-title">Transition state analog inhibitors and enzyme catalysis</span> <span class="citation_source-journal">Annu. Rev. Biophys. Bioengin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1146%2Fannurev.bb.05.060176.001415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=7991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaE28Xksleqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1976&pages=271-306&author=R.+Wolfenden&title=Transition+state+analog+inhibitors+and+enzyme+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Transition state analog inhibitors and enzyme catalysis</span></div><div class="casAuthors">Wolfenden, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Bioengineering</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-306</span>CODEN:
                <span class="NLM_cas:coden">ABPBBK</span>;
        ISSN:<span class="NLM_cas:issn">0084-6589</span>.
    </div><div class="casAbstract">A review with 164 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFTfzop2iX3rVg90H21EOLACvtfcHk0lhvt9sthzQEbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xksleqt7w%253D&md5=2f12e20cf2c68d7fff5189b6a96653e9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bb.05.060176.001415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bb.05.060176.001415%26sid%3Dliteratum%253Aachs%26aulast%3DWolfenden%26aufirst%3DR.%26atitle%3DTransition%2520state%2520analog%2520inhibitors%2520and%2520enzyme%2520catalysis%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Bioengin.%26date%3D1976%26volume%3D5%26spage%3D271%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wiley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Peptidomimetics derived from natural products</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1002%2Fmed.2610130305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8483337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3sXksVSjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=327-384&author=R.+A.+Wileyauthor=D.+H.+Rich&title=Peptidomimetics+derived+from+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetics derived from natural products</span></div><div class="casAuthors">Wiley, Robert A.; Rich, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-84</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review with 220 refs.  Peptidomimetics are small, nonpeptide substances designed to contain the information contained in peptides.  This review discusses natural-product-derived enzyme inhibitors and receptor-binding substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr36L31ICJj9bVg90H21EOLACvtfcHk0lhvt9sthzQEbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVSjt70%253D&md5=d71e8fdaf4203047bb773c0637a1ccc6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610130305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610130305%26sid%3Dliteratum%253Aachs%26aulast%3DWiley%26aufirst%3DR.%2BA.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DPeptidomimetics%2520derived%2520from%2520natural%2520products%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D1993%26volume%3D13%26spage%3D327%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hoover, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosati, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinman, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindra, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiapane, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockel, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocerini, M. R.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors of human renin with high oral bioavailability</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1995&pages=167-180&author=D.+J.+Hooverauthor=B.+A.+Lefkerauthor=R.+L.+Rosatiauthor=R.+T.+Westerauthor=E.+F.+Kleinmanauthor=J.+S.+Bindraauthor=W.+F.+Holtauthor=W.+R.+Murphyauthor=M.+L.+Mangiapaneauthor=G.+M.+Hockelauthor=I.+H.+Williamsauthor=W.+H.+Smithauthor=M.+J.+Gumkowskiauthor=R.+M.+Shepardauthor=M.+J.+Gardnerauthor=M.+R.+Nocerini&title=Discovery+of+inhibitors+of+human+renin+with+high+oral+bioavailability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DRosati%26aufirst%3DR.%2BL.%26aulast%3DWester%26aufirst%3DR.%2BT.%26aulast%3DKleinman%26aufirst%3DE.%2BF.%26aulast%3DBindra%26aufirst%3DJ.%2BS.%26aulast%3DHolt%26aufirst%3DW.%2BF.%26aulast%3DMurphy%26aufirst%3DW.%2BR.%26aulast%3DMangiapane%26aufirst%3DM.%2BL.%26aulast%3DHockel%26aufirst%3DG.%2BM.%26aulast%3DWilliams%26aufirst%3DI.%2BH.%26aulast%3DSmith%26aufirst%3DW.%2BH.%26aulast%3DGumkowski%26aufirst%3DM.%2BJ.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DGardner%26aufirst%3DM.%2BJ.%26aulast%3DNocerini%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520human%2520renin%2520with%2520high%2520oral%2520bioavailability%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1995%26volume%3D362%26spage%3D167%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span> </span><span class="NLM_article-title">Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS1074-5521%2899%2989004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=10074464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=127-131&author=C.+Oefnerauthor=A.+Binggeliauthor=V.+Breuauthor=D.+Burauthor=J.-P.+Clozelauthor=A.+D%E2%80%99Arcyauthor=A.+Dornauthor=W.+Fischliauthor=F.+Gr%C3%BCningerauthor=R.+G%C3%BCllerauthor=G.+Hirthauthor=H.+P.+M%C3%A4rkiauthor=S.+Mathewsauthor=M.+M%C3%BCllerauthor=R.+G.+Ridleyauthor=H.+Stadlerauthor=E.+Vieiraauthor=M.+Wilhelmauthor=F.+K.+Winklerauthor=W.+Wostl&title=Renin+inhibition+by+substituted+piperidines%3A+a+novel+paradigm+for+the+inhibition+of+monomeric+aspartic+proteinases%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?</span></div><div class="casAuthors">Oefner, C.; Binggeli, A.; Breu, V.; Bur, D.; Clozel, J.-P.; D'Arcy, A.; Dorn, A.; Fischli, W.; Gruninger, F.; Guller, R.; Hirth, G.; Marki, H. P.; Mathews, S.; Muller, M.; Ridley, R. G.; Stadler, H.; Vieira, E.; Wilhelm, M.; Winkler, F. K.; Wostl, W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">127-131</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">The aspartic proteinase renin catalyzes the first and rate-limiting step in the conversion of angiotensinogen to the hormone angiotensin II, and therefore plays an important physiol. role in the regulation of blood pressure.  Numerous potent peptidomimetic inhibitors of this important drug target have been developed, but none of these compds. have progressed past clin. phase II trials.  Limited oral bioavailability or excessive prodn. costs have prevented these inhibitors from becoming new antihypertensive drugs.  We were interested in developing new nonpeptidomimetic renin inhibitors.  High-throughput screening of the Roche compd. library identified a simple 3,4-disubstituted piperidine lead compd.  We detd. the crystal structures of recombinant human renin complexed with two representatives of this new class.  Binding of these substituted piperidine derivs. is accompanied by major induced-fit adaptations around the enzyme's active site.  The efficient optimization of the piperidine inhibitors was facilitated by structural anal. of the renin active site in two renin-inhibitor complexes (some of the piperidine derivs. have picomolar affinities for renin).  These structural changes provide the basis for a novel paradigm for inhibition of monomeric aspartic proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIEMz9YB6oLVg90H21EOLACvtfcHk0liH3gL2N2CFuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D&md5=071dd0984f8880eb09ee26c878d47e61</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2989004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252989004-8%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DClozel%26aufirst%3DJ.-P.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DMathews%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DRidley%26aufirst%3DR.%2BG.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DWostl%26aufirst%3DW.%26atitle%3DRenin%2520inhibition%2520by%2520substituted%2520piperidines%253A%2520a%2520novel%2520paradigm%2520for%2520the%2520inhibition%2520of%2520monomeric%2520aspartic%2520proteinases%253F%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span> </span><span class="NLM_article-title">Substituted piperidines: highly potent renin inhibitors due to induced fit adaptation of the active site</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1397-1402&author=E.+Vieiraauthor=A.+Binggeliauthor=V.+Breuauthor=D.+Burauthor=W.+Fischliauthor=R.+G%C3%BCllerauthor=G.+Hirthauthor=H.+P.+M%C3%A4rkiauthor=M.+M%C3%BCllerauthor=C.+Oefnerauthor=M.+Scaloneauthor=H.+Stadlerauthor=M.+Wilhelmauthor=W.+Wostl&title=Substituted+piperidines%3A+highly+potent+renin+inhibitors+due+to+induced+fit+adaptation+of+the+active+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26atitle%3DSubstituted%2520piperidines%253A%2520highly%2520potent%2520renin%2520inhibitors%2520due%2520to%2520induced%2520fit%2520adaptation%2520of%2520the%2520active%2520site%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1397%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span> </span><span class="NLM_article-title">Piperidine−renin inhibitors compounds with improved physicochemical properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1403-1408&author=R.+G%C3%BCllerauthor=A.+Binggeliauthor=V.+Breuauthor=D.+Burauthor=W.+Fischliauthor=G.+Hirthauthor=C.+Jennyauthor=M.+Kansyauthor=F.+Montavonauthor=M.+M%C3%BCllerauthor=C.+Oefnerauthor=H.+Stadlerauthor=E.+Vieiraauthor=M.+Wilhelmauthor=W.+Wostlauthor=H.+P.+M%C3%A4rki&title=Piperidine%E2%88%92renin+inhibitors+compounds+with+improved+physicochemical+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DJenny%26aufirst%3DC.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMontavon%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26atitle%3DPiperidine%25E2%2588%2592renin%2520inhibitors%2520compounds%2520with%2520improved%2520physicochemical%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1403%26epage%3D1408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohner-Lang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebeli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foricher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanwald-Ducray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdenaire, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand-Chou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, R.</span><span> </span><span class="NLM_article-title">Piperidine renin inhibitors: from leads to drug candidates</span> <span class="citation_source-journal">Il Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=21-27&author=H.+P.+M%C3%A4rkiauthor=A.+Binggeliauthor=B.+Bittnerauthor=V.+Bohner-Langauthor=V.+Breuauthor=D.+Burauthor=P.+Coassoloauthor=J.+P.+Clozelauthor=A.+D%E2%80%99Arcyauthor=H.+Doebeliauthor=W.+Fischliauthor=C.+Funkauthor=J.+Foricherauthor=T.+Gillerauthor=F.+Gr%C3%BCningerauthor=A.+Guenziauthor=R.+G%C3%BCllerauthor=T.+Hartungauthor=G.+Hirthauthor=C.+Jennyauthor=M.+Kansyauthor=U.+Klinkhammerauthor=T.+Laveauthor=B.+Lohriauthor=F.+C.+Luftauthor=E.+M.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=M.+M%C3%BCllerauthor=F.+Montavonauthor=C.+Oefnerauthor=C.+Qiuauthor=A.+Reichelauthor=P.+Sanwald-Ducrayauthor=M.+Scaloneauthor=M.+Schleimerauthor=R.+Schmidauthor=H.+Stadlerauthor=A.+Treiberauthor=O.+Valdenaireauthor=E.+Vieiraauthor=P.+Waldmeierauthor=R.+Wiegand-Chouauthor=M.+Wilhelmauthor=W.+Wostlauthor=M.+Zellauthor=R.+Zell&title=Piperidine+renin+inhibitors%3A+from+leads+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DB.%26aulast%3DBohner-Lang%26aufirst%3DV.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DCoassolo%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDoebeli%26aufirst%3DH.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DForicher%26aufirst%3DJ.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DGuenzi%26aufirst%3DA.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DJenny%26aufirst%3DC.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKlinkhammer%26aufirst%3DU.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DLohri%26aufirst%3DB.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DMontavon%26aufirst%3DF.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DReichel%26aufirst%3DA.%26aulast%3DSanwald-Ducray%26aufirst%3DP.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DSchleimer%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DR.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DValdenaire%26aufirst%3DO.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWaldmeier%26aufirst%3DP.%26aulast%3DWiegand-Chou%26aufirst%3DR.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DZell%26aufirst%3DR.%26atitle%3DPiperidine%2520renin%2520inhibitors%253A%2520from%2520leads%2520to%2520drug%2520candidates%26jtitle%3DIl%2520Farmaco%26date%3D2001%26volume%3D56%26spage%3D21%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bittner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenroth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavé, T.</span><span> </span><span class="NLM_article-title">Preformulation approaches to improve the oral bioavailability of two novel piperidine renin inhibitors in dog</span> <span class="citation_source-journal">Arzneim.-Forsch./Drug Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36e&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12236046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36e&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVentLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2002&pages=593-599&author=B.+Bittnerauthor=R.+Chouauthor=M.+Schleimerauthor=B.+Morgenrothauthor=M.+Zellauthor=T.+Lav%C3%A9&title=Preformulation+approaches+to+improve+the+oral+bioavailability+of+two+novel+piperidine+renin+inhibitors+in+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36eR"><div class="casContent"><span class="casTitleNuber">36e</span><div class="casTitle"><span class="NLM_cas:atitle">Preformulation approaches to improve the oral bioavailability of two novel piperidine renin inhibitors in dog</span></div><div class="casAuthors">Bittner, Beate; Chou, Ruby; Schleimer, Michael; Morgenroth, Brita; Zell, Manfred; Lave, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">593-599</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">Different exptl. formulations based on aq. and oily systems, water miscible solvents, and solid dispersions were investigated for their potential to increase the oral bioavailability (F) of 2 novel piperidine renin inhibitors (R)-1-methoxy-3-[(3S,4R,5R)-4-[4-[3-(2-methoxybenzyloxy)propoxy]phenyl]-5-(4-methoxy-naphthalen-2-ylmethoxy)-piperidin-3-yloxy]propan-2-ol (Ro-X1) and (R)-3-[(3S,4R,5R)-4-[4-[3-(2-methoxybenzyloxy)propoxyphenyl]-5-(4-methoxynaphthalen-2-ylmethoxy)piperidin-3-ylmethoxy]propane-1,2-diol] (Ro-X2) in dogs compared to their administration as acidic aq. soln.  The compds. were characterized by a low soly. at pH 7 (Ro-X1: 3 μg/mL, Ro-X2: 24 μg/mL) and a high lipophilicity (Ro-X1: LogP 5.7, Ro-X2: LogP = 3.7).  For Ro-X1 oil-based vehicles resulted in an improvement in the oral bioavailability compared to the aq. soln. (F = 6 %) with the best result being achieved with a soln. in Capmul (F = 14.6%).  By contrast, for Ro-X2 the highest bioavailability (F = 27.1%) was achieved using an aq. soln.  Computer simulations based on the physicochem. parameters of the compds. only predicted that the fraction of compd. absorbed in man should be almost quant. for Ro-X2 and only about 28% for Ro-Xl.  Other factors such as extensive gut and/or hepatic metab. as well as exclusion by intestinal transporters such as p-glycoprotein, rather than incomplete solubilization in the gut, are the major reasons for the limited oral bioavailability of both compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYXcXITiH2xbVg90H21EOLACvtfcHk0ljnk1vdHLi3XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVentLg%253D&md5=ca2ed32b43a1a7ba109b9b0998836389</span></div><a href="/servlet/linkout?suffix=cit36e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBittner%26aufirst%3DB.%26aulast%3DChou%26aufirst%3DR.%26aulast%3DSchleimer%26aufirst%3DM.%26aulast%3DMorgenroth%26aufirst%3DB.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DLav%25C3%25A9%26aufirst%3DT.%26atitle%3DPreformulation%2520approaches%2520to%2520improve%2520the%2520oral%2520bioavailability%2520of%2520two%2520novel%2520piperidine%2520renin%2520inhibitors%2520in%2520dog%26jtitle%3DArzneim.-Forsch.%252FDrug%2520Res.%26date%3D2002%26volume%3D52%26spage%3D593%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Keserü, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C3%BCauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belliotti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3575</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3575-3580&author=D.+D.+Holsworthauthor=M.+Jalaieauthor=T.+Belliottiauthor=C.+Caiauthor=W.+Collardauthor=S.+Ferreiraauthor=N.+A.+Powellauthor=M.+Stierauthor=E.+Zhangauthor=P.+McConnellauthor=I.+Mochalkinauthor=M.+J.+Ryanauthor=J.+Bryantauthor=T.+Liauthor=A.+Kasaniauthor=R.+Subediauthor=S.+N.+Maitiauthor=J.+J.+Edmunds&title=Discovery+of+6-ethyl-2%2C4-diaminopyrimidine-based+small+molecule+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DBelliotti%26aufirst%3DT.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DCollard%26aufirst%3DW.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DKasani%26aufirst%3DA.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DMaiti%26aufirst%3DS.%2BN.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%25206-ethyl-2%252C4-diaminopyrimidine-based%2520small%2520molecule%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3575%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciske, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Huis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastronardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5912-5949&author=N.+A.+Powellauthor=F.+L.+Ciskeauthor=C.+Caiauthor=D.+D.+Holsworthauthor=K.+Mennenauthor=C.+A.+Van+Huisauthor=M.+Jalaieauthor=J.+Dayauthor=M.+Mastronardiauthor=P.+McConnellauthor=I.+Mochalkinauthor=E.+Zhangauthor=M.+J.+Ryanauthor=J.+Bryantauthor=W.+Collardauthor=S.+Ferreiraauthor=C.+Guauthor=R.+Collinsauthor=J.+J.+Edmunds&title=Rational+design+of+6-%282%2C4-diaminopyrimidinyl%29-1%2C4-benzoxazin-3-ones+as+small+molecule+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DCiske%26aufirst%3DF.%2BL.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DMennen%26aufirst%3DK.%26aulast%3DVan%2BHuis%26aufirst%3DC.%2BA.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DJ.%26aulast%3DMastronardi%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DCollard%26aufirst%3DW.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DRational%2520design%2520of%25206-%25282%252C4-diaminopyrimidinyl%2529-1%252C4-benzoxazin-3-ones%2520as%2520small%2520molecule%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5912%26epage%3D5949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sarver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peevers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciske, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagadorn, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastronardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Huis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span> </span><span class="NLM_article-title">Binding thermodynamics of substituted diaminopyrimidine renin inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2007&pages=30-40&author=R.+W.+Sarverauthor=J.+Peeversauthor=W.+L.+Codyauthor=F.+L.+Ciskeauthor=J.+Dyerauthor=S.+D.+Emersonauthor=J.+C.+Hagadornauthor=D.+D.+Holsworthauthor=M.+Jalaieauthor=M.+Kaufmanauthor=M.+Mastronardiauthor=P.+McConnellauthor=N.+A.+Powellauthor=J.+Quinauthor=C.+A.+Van+Huisauthor=E.+Zhangauthor=I.+Mochalkin&title=Binding+thermodynamics+of+substituted+diaminopyrimidine+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarver%26aufirst%3DR.%2BW.%26aulast%3DPeevers%26aufirst%3DJ.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DCiske%26aufirst%3DF.%2BL.%26aulast%3DDyer%26aufirst%3DJ.%26aulast%3DEmerson%26aufirst%3DS.%2BD.%26aulast%3DHagadorn%26aufirst%3DJ.%2BC.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DMastronardi%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DVan%2BHuis%26aufirst%3DC.%2BA.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DMochalkin%26aufirst%3DI.%26atitle%3DBinding%2520thermodynamics%2520of%2520substituted%2520diaminopyrimidine%2520renin%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2007%26volume%3D360%26spage%3D30%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Holsworth, D. D.; Bury, M.; Cody, W. L.; Emerson, D.; Van Huis, C.; Jalaie, M.; Kaufman, M.; McConnell, P.; Powell, N. A.; Sahasrabudhe, P.; Sarver, R. W.; Thanabal, V.; Zhang, E.</span><span> </span><span class="NLM_article-title">NMR Auxillary Binding Screen for Lead Optimization: Design of Novel Renin Inhibitors That Access Both the S2 and S3 Pockets of Renin</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 231st National Meeting of the American Chemical Society: Atlanta, GA, March 26−30,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span><span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>MEDI-086.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+D.+Holsworth&author=M.+Bury&author=W.+L.+Cody&author=D.+Emerson&author=C.+Van+Huis&author=M.+Jalaie&author=M.+Kaufman&author=P.+McConnell&author=N.+A.+Powell&author=P.+Sahasrabudhe&author=R.+W.+Sarver&author=V.+Thanabal&author=E.+Zhang&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DNMR%2520Auxillary%2520Binding%2520Screen%2520for%2520Lead%2520Optimization%253A%2520Design%2520of%2520Novel%2520Renin%2520Inhibitors%2520That%2520Access%2520Both%2520the%2520S2%2520and%2520S3%2520Pockets%2520of%2520Renin%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2006%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacatian, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishchenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panemangalore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Design and optimization of renin inhibitors: orally bioavailable alkyl amines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3541</span><span class="NLM_x">–</span> <span class="NLM_lpage">3545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3541-3545&author=C.+M.+Ticeauthor=Z.+Xuauthor=J.+Yuanauthor=R.+D.+Simpsonauthor=S.+T.+Cacatianauthor=P.+T.+Flahertyauthor=W.+Zhaoauthor=J.+Guoauthor=A.+Ishchenkoauthor=S.+B.+Singhauthor=Z.+Wuauthor=B.+B.+Scottauthor=Y.+Bukhtiyarovauthor=J.+Berbaumauthor=J.+Masonauthor=R.+Panemangaloreauthor=M.+G.+Cappielloauthor=D.+Muellerauthor=R.+K.+Harrisonauthor=G.+M.+McGeehanauthor=L.+W.+Dillardauthor=J.+J.+Baldwinauthor=D.+A.+Claremon&title=Design+and+optimization+of+renin+inhibitors%3A+orally+bioavailable+alkyl+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DCacatian%26aufirst%3DS.%2BT.%26aulast%3DFlaherty%26aufirst%3DP.%2BT.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DBerbaum%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DPanemangalore%26aufirst%3DR.%26aulast%3DCappiello%26aufirst%3DM.%2BG.%26aulast%3DMueller%26aufirst%3DD.%26aulast%3DHarrison%26aufirst%3DR.%2BK.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DDesign%2520and%2520optimization%2520of%2520renin%2520inhibitors%253A%2520orally%2520bioavailable%2520alkyl%2520amines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3541%26epage%3D3545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacatian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishchenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panemangalore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Optimization of orally bioavailable alkyl amine renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=694-699&author=Z.+Xuauthor=S.+Cacatianauthor=J.+Yuanauthor=R.+D.+Simpsonauthor=L.+Jiaauthor=W.+Zhaoauthor=C.+M.+Ticeauthor=P.+T.+Flahertyauthor=J.+Guoauthor=A.+Ishchenkoauthor=S.+B.+Singhauthor=Z.+Wuauthor=B.+M.+McKeeverauthor=B.+B.+Scottauthor=Y.+Bukhtiyarovauthor=J.+Berbaumauthor=J.+Masonauthor=R.+Panemangaloreauthor=M.+G.+Cappielloauthor=R.+Bentleyauthor=C.+P.+Doeauthor=R.+K.+Harrisonauthor=G.+M.+McGeehanauthor=L.+W.+Dillardauthor=J.+J.+Baldwinauthor=D.+A.+Claremon&title=Optimization+of+orally+bioavailable+alkyl+amine+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DCacatian%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DFlaherty%26aufirst%3DP.%2BT.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DBerbaum%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DPanemangalore%26aufirst%3DR.%26aulast%3DCappiello%26aufirst%3DM.%2BG.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHarrison%26aufirst%3DR.%2BK.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DOptimization%2520of%2520orally%2520bioavailable%2520alkyl%2520amine%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D694%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hills, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Progress toward a practical BACE-1 inhibitor</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17659479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFCnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=383-391&author=I.+D.+Hillsauthor=J.+P.+Vacca&title=Progress+toward+a+practical+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward a practical BACE-1 inhibitor</span></div><div class="casAuthors">Hills, Ivory D.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-391</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Over the last six years, numerous research groups in both academia and industry have synthesized inhibitors of β-amyloid cleaving enzyme-1 (BACE-1) in the hope of developing a therapy to halt or even reverse the progression of Alzheimer's disease.  While several compds. have been demonstrated to be potent in vitro inhibitors of BACE-1, only a small subset of these compds. are able to satisfy other practical considerations essential for the development of a preclin. drug candidate.  These considerations include selectivity of the inhibitor toward BACE-1 over other enzymes, cellular activity, and in vivo activity in an animal model.  This review will summarize the recent development of BACE-1 inhibitors with particular focus placed on inhibitors that address some of the requirements necessary for a practical drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ5yiuIeRYybVg90H21EOLACvtfcHk0lhg9BglBc0Ocw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFCnsrc%253D&md5=56a59c856df6eee2bb7105b4af699655</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHills%26aufirst%3DI.%2BD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DProgress%2520toward%2520a%2520practical%2520BACE-1%2520inhibitor%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D383%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1002%2Fmed.20132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18651582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=295-338&author=R.+Silvestri&title=Boom+in+the+development+of+non-peptidic+%CE%B2-secretase+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-338</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  β-Amyloid cleaving enzyme-1 (BACE1) has become a significant target for the therapy of Alzheimer's disease.  After the discovery of the first non-peptidomimetic β-secretase inhibitors by Takeda Chems. in 2001, several research teams focused on SAR development of these agents.  The non-peptidic BACE1 inhibitors may potentially overcome the classical problems assocd. with the peptide structure of first generation, such as blood-brain barrier crossing, poor oral bioavailability and susceptibility to P-glycoprotein transport.  In the past 6 years a boom in research of non-peptidic BACE1 inhibitors has disseminated findings over hundreds of publications and patents.  The rapidly growing literature has been reviewed with particular emphasis on literature of pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmzl8ONz3LVg90H21EOLACvtfcHk0lhg9BglBc0Ocw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D&md5=1e92f25f055def1c1c56b3650f4cc40a</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1002%2Fmed.20132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20132%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DBoom%2520in%2520the%2520development%2520of%2520non-peptidic%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D295%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28%CE%B2-secretase%29+complexed+with+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528%25CE%25B2-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeiser, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Evolution of tertiary carbinamine BACE-1 inhibitors: Aβ reduction in rhesus CSF upon oral dosing</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=37-40&author=P.+G.+Nantermetauthor=H.+A.+Rajapakseauthor=M.+G.+Stantonauthor=S.+R.+Staufferauthor=J.+C.+Barrowauthor=A.+R.+Gregroauthor=K.+P.+Mooreauthor=M.+A.+Steinbeiserauthor=J.+Swestockauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=G.+B.+McGaugheyauthor=D.+Colussiauthor=M.-T.+Laiauthor=S.+Sankaranarayananauthor=A.+J.+Simonauthor=S.+Munshiauthor=J.+J.+Cookauthor=M.+A.+Holahanauthor=M.+S.+Michenerauthor=J.+P.+Vacca&title=Evolution+of+tertiary+carbinamine+BACE-1+inhibitors%3A+A%CE%B2+reduction+in+rhesus+CSF+upon+oral+dosing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DSteinbeiser%26aufirst%3DM.%2BA.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DEvolution%2520of%2520tertiary%2520carbinamine%2520BACE-1%2520inhibitors%253A%2520A%25CE%25B2%2520reduction%2520in%2520rhesus%2520CSF%2520upon%2520oral%2520dosing%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D37%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Target Family-Directed Masterkeys in Chemogenomics</span>. In  <span class="citation_source-book">Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective</span>; <span class="NLM_contrib-group">Kubinyi, H.; Mueller, G.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">7</span>− <span class="NLM_lpage">41</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=7-41&author=G.+M%C3%BCllerauthor=H.+Kubinyi&author=G.+Mueller&title=Chemogenomics+in+Drug+Discovery%3A+A+Medicinal+Chemistry+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DTarget%2520Family-Directed%2520Masterkeys%2520in%2520Chemogenomics%26btitle%3DChemogenomics%2520in%2520Drug%2520Discovery%253A%2520A%2520Medicinal%2520Chemistry%2520Perspective%26aulast%3DKubinyi%26aufirst%3DH.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D7%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Foundling, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibanda, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norey, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span> </span><span class="NLM_article-title">High resolution X-ray analyses of renin inhibitor−aspartic proteinase complexes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=1987&pages=349-352&author=S.+I.+Foundlingauthor=J.+Cooperauthor=F.+E.+Watsonauthor=A.+Cleasbyauthor=L.+H.+Pearlauthor=B.+L.+Sibandaauthor=A.+Hemmingsauthor=S.+P.+Woodauthor=T.+L.+Blundellauthor=M.+J.+Vallerauthor=C.+G.+Noreyauthor=J.+Kayauthor=J.+Bogerauthor=B.+M.+Dunnauthor=B.+J.+Leckieauthor=D.+M.+Jonesauthor=B.+Atrashauthor=A.+Hallettauthor=M.+Szelke&title=High+resolution+X-ray+analyses+of+renin+inhibitor%E2%88%92aspartic+proteinase+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoundling%26aufirst%3DS.%2BI.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DF.%2BE.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DSibanda%26aufirst%3DB.%2BL.%26aulast%3DHemmings%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DS.%2BP.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DValler%26aufirst%3DM.%2BJ.%26aulast%3DNorey%26aufirst%3DC.%2BG.%26aulast%3DKay%26aufirst%3DJ.%26aulast%3DBoger%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26aulast%3DLeckie%26aufirst%3DB.%2BJ.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DHallett%26aufirst%3DA.%26aulast%3DSzelke%26aufirst%3DM.%26atitle%3DHigh%2520resolution%2520X-ray%2520analyses%2520of%2520renin%2520inhibitor%25E2%2588%2592aspartic%2520proteinase%2520complexes%26jtitle%3DNature%26date%3D1987%26volume%3D327%26spage%3D349%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foundling, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span> </span><span class="NLM_article-title">On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5585</span><span class="NLM_x">–</span> <span class="NLM_lpage">5590</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00392a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1987&pages=5585-5590&author=T.+L.+Blundellauthor=J.+Cooperauthor=S.+I.+Foundlingauthor=D.+M.+Jonesauthor=B.+Atrashauthor=M.+Szelke&title=On+the+rational+design+of+renin+inhibitors%3A+X-ray+studies+of+aspartic+proteinases+complexed+with+transition-state+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbi00392a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00392a001%26sid%3Dliteratum%253Aachs%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DFoundling%26aufirst%3DS.%2BI.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DSzelke%26aufirst%3DM.%26atitle%3DOn%2520the%2520rational%2520design%2520of%2520renin%2520inhibitors%253A%2520X-ray%2520studies%2520of%2520aspartic%2520proteinases%2520complexed%2520with%2520transition-state%2520analogs%26jtitle%3DBiochemistry%26date%3D1987%26volume%3D26%26spage%3D5585%26epage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Brotherton-Pleiss, C. E.; Newman, S. R.; Waterbury, L. D.; Schwartzberg, M. S.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Conformationally Restricted Renin Inhibitors</span>.  <span class="citation_source-book">Peptides: Chemistry and Biology</span>, Proceedings of the 12th American Peptide Symposium, Cambridge, MA, 1991; <span class="NLM_contrib-group">Smith, J. A.; Rivier, J. E.</span>, Eds.; <span class="NLM_publisher-name">Escom Science</span>, <span class="NLM_publisher-loc">Leiden, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">816</span>− <span class="NLM_lpage">817</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=816-817&author=C.+E.+Brotherton-Pleiss&author=S.+R.+Newman&author=L.+D.+Waterbury&author=M.+S.+Schwartzbergauthor=J.+A.+Smith&author=J.+E.+Rivier&title=Peptides%3A+Chemistry+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrotherton-Pleiss%26aufirst%3DC.%2BE.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Conformationally%2520Restricted%2520Renin%2520Inhibitors%26btitle%3DPeptides%253A%2520Chemistry%2520and%2520Biology%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26pub%3DEscom%2520Science%26date%3D1992%26spage%3D816%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Plummer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahripour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltenbronn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E.A .</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbaugh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapundalo, S. T.</span><span> </span><span class="NLM_article-title">Design and synthesis of renin inhibitors: Incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2893-2905&author=M.+S.+Plummerauthor=A.+Shahripourauthor=J.+S.+Kaltenbronnauthor=E.A+.+Lunneyauthor=B.+A.+Steinbaughauthor=J.+M.+Hambyauthor=H.+W.+Hamiltonauthor=T.+K.+Sawyerauthor=C.+Humbletauthor=A.+M.+Dohertyauthor=M.+D.+Taylorauthor=G.+Hingoraniauthor=B.+L.+Batleyauthor=S.+T.+Rapundalo&title=Design+and+synthesis+of+renin+inhibitors%3A+Incorporation+of+transition-state+isostere+side+chains+that+span+from+the+S1+to+the+S3+binding+pockets+and+examination+of+P3-modified+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DShahripour%26aufirst%3DA.%26aulast%3DKaltenbronn%26aufirst%3DJ.%2BS.%26aulast%3DLunney%26aufirst%3DE.A%2B.%26aulast%3DSteinbaugh%26aufirst%3DB.%2BA.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DHamilton%26aufirst%3DH.%2BW.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DHingorani%26aufirst%3DG.%26aulast%3DBatley%26aufirst%3DB.%2BL.%26aulast%3DRapundalo%26aufirst%3DS.%2BT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520renin%2520inhibitors%253A%2520Incorporation%2520of%2520transition-state%2520isostere%2520side%2520chains%2520that%2520span%2520from%2520the%2520S1%2520to%2520the%2520S3%2520binding%2520pockets%2520and%2520examination%2520of%2520P3-modified%2520renin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2893%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Plummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapundalo, S. T.</span><span> </span><span class="NLM_article-title">Peptidomimetic inhibitors of renin incorporating topographically modified isosteres spanning the P1(<b>→</b>P3)-P1 sites</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2119</span><span class="NLM_x">–</span> <span class="NLM_lpage">2124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=2119-2124&author=M.+Plummerauthor=J.+M.+Hambyauthor=G.+Hingoraniauthor=B.+L.+Batleyauthor=S.+T.+Rapundalo&title=Peptidomimetic+inhibitors+of+renin+incorporating+topographically+modified+isosteres+spanning+the+P1%28%E2%86%92P3%29-P1+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DHingorani%26aufirst%3DG.%26aulast%3DBatley%26aufirst%3DB.%2BL.%26aulast%3DRapundalo%26aufirst%3DS.%2BT.%26atitle%3DPeptidomimetic%2520inhibitors%2520of%2520renin%2520incorporating%2520topographically%2520modified%2520isosteres%2520spanning%2520the%2520P1%2528%25E2%2586%2592P3%2529-P1%2520sites%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D2119%26epage%3D2124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hada, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneddon, S. F.</span><span> </span><span class="NLM_article-title">Rational design, synthesis and X-ray structure of renin inhibitors with extended P1 side-chains</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2623</span><span class="NLM_x">–</span> <span class="NLM_lpage">2626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2623-2626&author=B.+A.+Lefkerauthor=W.+A.+Hadaauthor=A.+S.+Wrightauthor=W.+H.+Martinauthor=I.+A.+Stockauthor=G.+K.+Schulteauthor=J.+Panditauthor=D.+E.+Danleyauthor=M.+J.+Ammiratiauthor=S.+F.+Sneddon&title=Rational+design%2C+synthesis+and+X-ray+structure+of+renin+inhibitors+with+extended+P1+side-chains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DStock%26aufirst%3DI.%2BA.%26aulast%3DSchulte%26aufirst%3DG.%2BK.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DAmmirati%26aufirst%3DM.%2BJ.%26aulast%3DSneddon%26aufirst%3DS.%2BF.%26atitle%3DRational%2520design%252C%2520synthesis%2520and%2520X-ray%2520structure%2520of%2520renin%2520inhibitors%2520with%2520extended%2520P1%2520side-chains%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D2623%26epage%3D2626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgiarini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Novel 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4818</span><span class="NLM_x">–</span> <span class="NLM_lpage">4831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070314y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4818-4831&author=R.+G%C3%B6schkeauthor=S.+Stutzauthor=V.+Rasettiauthor=N.+C.+Cohenauthor=J.+Rahuelauthor=P.+Rigollierauthor=H.+P.+Baumauthor=P.+Forgiariniauthor=C.+R.+Schnellauthor=T.+Wagnerauthor=M.+G.+Gr%C3%BCtterauthor=W.+Fuhrerauthor=W.+Schillingauthor=F.+Cuminauthor=J.+M.+Woodauthor=J.+Maibaum&title=Novel+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamide+transition+state+peptidomimetics+are+potent+and+orally+active+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm070314y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070314y%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DForgiarini%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DNovel%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamide%2520transition%2520state%2520peptidomimetics%2520are%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4818%26epage%3D4831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W. D.</span><span> </span><span class="NLM_article-title">Druggability indices for protein targets derived from NMR-based screening data</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2518</span><span class="NLM_x">–</span> <span class="NLM_lpage">2525</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049131r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslajtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2518-2525&author=P.+J.+Hajdukauthor=J.+R.+Huthauthor=S.+W.+D.+Fesik&title=Druggability+indices+for+protein+targets+derived+from+NMR-based+screening+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability Indices for Protein Targets Derived from NMR-Based Screening Data</span></div><div class="casAuthors">Hajduk, Philip J.; Huth, Jeffrey R.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2518-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An anal. of heteronuclear-NMR-based screening data is used to derive relationships between the ability of small mols. to bind to a protein and various parameters that describe the protein binding site.  It is found that a simple model including terms for polar and apolar surface area, surface complexity, and pocket dimensions accurately predicts the exptl. screening hit rates with an R2 of 0.72, an adjusted R2 of 0.65, and a leave-one-out Q2 of 0.56.  Application of the model to predict the druggability of protein targets not used in the training set correctly classified 94% of the proteins for which high-affinity, noncovalent, druglike leads have been reported.  In addn. to understanding the pocket characteristics that contribute to high-affinity binding, the relationships that have been defined allow for quant. comparative analyses of protein binding sites for use in target assessment and validation, virtual ligand screening, and structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0d3V84DZMK7Vg90H21EOLACvtfcHk0lghXWLqkQetGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslajtr0%253D&md5=134793e571e8ef1858a734c1a15ce343</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm049131r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049131r%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DFesik%26aufirst%3DS.%2BW.%2BD.%26atitle%3DDruggability%2520indices%2520for%2520protein%2520targets%2520derived%2520from%2520NMR-based%2520screening%2520data%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2518%26epage%3D2525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS1074-5521%2800%2900134-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=10903938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=493-504&author=J.+Rahuelauthor=V.+Rasettiauthor=J.+Maibaumauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=N.+C.+Cohenauthor=S.+Stutzauthor=F.+Cuminauthor=W.+Fuhrerauthor=J.+M.+Woodauthor=M.+G.+Gr%C3%BCtter&title=Structure-based+drug+design%3A+the+discovery+of+novel+nonpeptide+orally+active+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span></div><div class="casAuthors">Rahuel, J.; Rasetti, V.; Maibaum, J.; Rueger, H.; Goschke, R.; Cohen, N-C.; Stutz, S.; Cumin, F.; Fuhrer, W.; Wood, J. M.; Grutter, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The aspartic proteinase renin plays an important physiol. role in the regulation of blood pressure.  It catalyzes the first step in the conversion of angiotensinogen to the hormone angiotensin II.  In the past, potent peptide inhibitors of renin have been developed, but none of these compds. has made it to the end of clin. trials.  Our primary aim was to develop novel nonpeptide inhibitors.  Based on the available structural information concerning renin-substrate interactions, we synthesized inhibitors in which the peptide portion was replaced by lipophilic moieties that interact with the large hydrophobic S1/S3-binding pocket in renin.  Results: Crystal structure anal. of renin-inhibitor complexes combined with computational methods were employed in the medicinal-chem. optimization process.  Structure anal. revealed that the newly designed inhibitors bind as predicted to the S1/S3 pocket.  In addn., however, these compds. interact with a hitherto unrecognized large, distinct, sub-pocket of the enzyme that extends from the S3-binding site towards the hydrophobic core of the enzyme.  Binding to the S3sp sub-pocket was essential for high binding affinity.  This unprecedented binding mode guided the drug-design process in which the mostly hydrophobic interactions within subsite S3sp were optimized.  Conclusions: Our design approach led to compds. with high in vitro affinity and specificity for renin, favorable bioavailability and excellent oral efficacy in lowering blood pressure in primates.  These renin inhibitors are therefore potential therapeutic agents for the treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp__RrHxd--o7Vg90H21EOLACvtfcHk0lghXWLqkQetGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D&md5=69eb034c059696b97faf830727ce924a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900134-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900134-4%26sid%3Dliteratum%253Aachs%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DStructure-based%2520drug%2520design%253A%2520the%2520discovery%2520of%2520novel%2520nonpeptide%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Cooper, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foundling, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champness, J. N.</span><span> </span><span class="NLM_article-title">A rational approach to the design of antihypertensives: X-ray studies of complexes between aspartic proteinases and aminoalcohol renin inhibitors</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1988&pages=308-313&author=J.+B.+Cooperauthor=S.+I.+Foundlingauthor=T.+L.+Blundellauthor=R.+J.+Arrowsmithauthor=C.+J.+Harrisauthor=J.+N.+Champness&title=A+rational+approach+to+the+design+of+antihypertensives%3A+X-ray+studies+of+complexes+between+aspartic+proteinases+and+aminoalcohol+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A rational approach to the design of antihypertensives:  x-ray studies of complexes between aspartic proteinases and aminoalcohol renin inhibitors</span></div><div class="casAuthors">Cooper, J. B.; Foundling, S. I.; Blundell, T. L.; Arrowsmith, R. J.; Harris, C. J.; Champness, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Special Publication - Royal Society of Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">Top. Med. Chem.</span>),
    <span class="NLM_cas:pages">308-13</span>CODEN:
                <span class="NLM_cas:coden">SROCDO</span>;
        ISSN:<span class="NLM_cas:issn">0260-6291</span>.
    </div><div class="casAbstract">X-ray studies of the primary structure of the complex of the diastereoisomers BW 624 and BW 625 (tetrapeptide inhibitors of renin) with endothiapepsin (an aspartic proteinase homologous to renin) are described.  As the co-crystals of the BW 624 complex were isomorphous with the native enzyme, the structure was solved using the difference Fourier method and least squares refinement.  Crystals of the BW 625 complex were not isomorphous, but mol. replacement methods were used to obtain a promising difference map at 2.2 Å.  The interactions between the aminoalc. inhibitor (BW 625) and endothiapepsin are essentially the same as those obsd. with reduced bond and hydroxyethylene inhibitors.  The different conformation of the P3' Phe relative to polar sidechains at this subsite indicates that this is yet another pocket where the substrate is allowed sufficient flexibility to optimize favorable interactions with the enzyme.  Structure-activity relations are discussed for inhibition of renin by peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNjhzDtF0jlbVg90H21EOLACvtfcHk0lj83QQMswwSDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCit7Y%253D&md5=68bbf2f504b53b5ea7eaa335628f97e7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DJ.%2BB.%26aulast%3DFoundling%26aufirst%3DS.%2BI.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DChampness%26aufirst%3DJ.%2BN.%26atitle%3DA%2520rational%2520approach%2520to%2520the%2520design%2520of%2520antihypertensives%253A%2520X-ray%2520studies%2520of%2520complexes%2520between%2520aspartic%2520proteinases%2520and%2520aminoalcohol%2520renin%2520inhibitors%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D1988%26volume%3D65%26spage%3D308%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champness, J. N.</span><span> </span><span class="NLM_article-title">The discovery and design of substrate-based proteinase inhibitors−problems and lessons from the development of renin inhibitors as potential antihypertensive drugs</span> <span class="citation_source-journal">Spec. Publ.−R. Soc. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">Mol. Recognit.: Chem. Biochem. Probl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3cXhtlWktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1989&pages=112-122&issue=Mol.+Recognit.%3A+Chem.+Biochem.+Probl.&author=R.+J.+Arrowsmithauthor=C.+J.+Harrisauthor=D.+E.+Daviesauthor=J.+A.+Mortonauthor=J.+G.+Dannauthor=J.+N.+Champness&title=The+discovery+and+design+of+substrate-based+proteinase+inhibitors%E2%88%92problems+and+lessons+from+the+development+of+renin+inhibitors+as+potential+antihypertensive+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and design of substrate-based proteinase inhibitors - problems and lessons from the development of renin inhibitors as potential antihypertensive drugs</span></div><div class="casAuthors">Arrowsmith, R. J.; Harris, C. J.; Davies, D. E.; Morton, J. A.; Dann, J. G.; Champness, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Special Publication - Royal Society of Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Mol. Recognit.:  Chem. Biochem. Probl.</span>),
    <span class="NLM_cas:pages">112-22</span>CODEN:
                <span class="NLM_cas:coden">SROCDO</span>;
        ISSN:<span class="NLM_cas:issn">0260-6291</span>.
    </div><div class="casAbstract">A review with 12 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGEGBdwLrHTLVg90H21EOLACvtfcHk0lj83QQMswwSDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtlWktr0%253D&md5=b408676430ea002d941b5b99a8d03e80</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DMorton%26aufirst%3DJ.%2BA.%26aulast%3DDann%26aufirst%3DJ.%2BG.%26aulast%3DChampness%26aufirst%3DJ.%2BN.%26atitle%3DThe%2520discovery%2520and%2520design%2520of%2520substrate-based%2520proteinase%2520inhibitors%25E2%2588%2592problems%2520and%2520lessons%2520from%2520the%2520development%2520of%2520renin%2520inhibitors%2520as%2520potential%2520antihypertensive%2520drugs%26jtitle%3DSpec.%2520Publ.%25E2%2588%2592R.%2520Soc.%2520Chem.%26date%3D1989%26volume%3D78%26issue%3DMol.%2520Recognit.%253A%2520Chem.%2520Biochem.%2520Probl%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaMont, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaine, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanelli, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stabilito, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. V.</span><span> </span><span class="NLM_article-title">A uniquely potent renin inhibitor and its unanticipated plasma binding component</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00150a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1755-1756&author=B.+E.+Evansauthor=K.+E.+Rittleauthor=M.+G.+Bockauthor=C.+D.+Bennettauthor=R.+M.+DiPardoauthor=J.+Bogerauthor=M.+Poeauthor=E.+H.+Ulmauthor=B.+I.+LaMontauthor=E.+H.+Blaineauthor=G.+M.+Fanelliauthor=I.+I.+Stabilitoauthor=D.+V.+Veber&title=A+uniquely+potent+renin+inhibitor+and+its+unanticipated+plasma+binding+component"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm00150a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00150a001%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DBennett%26aufirst%3DC.%2BD.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DBoger%26aufirst%3DJ.%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DLaMont%26aufirst%3DB.%2BI.%26aulast%3DBlaine%26aufirst%3DE.%2BH.%26aulast%3DFanelli%26aufirst%3DG.%2BM.%26aulast%3DStabilito%26aufirst%3DI.%2BI.%26aulast%3DVeber%26aufirst%3DD.%2BV.%26atitle%3DA%2520uniquely%2520potent%2520renin%2520inhibitor%2520and%2520its%2520unanticipated%2520plasma%2520binding%2520component%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1755%26epage%3D1756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bezencon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3702</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900022f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3689-3702&author=O.+Bezenconauthor=D.+Burauthor=T.+Wellerauthor=S.+Richard-Bildsteinauthor=L.+Reme%C5%88author=T.+Sifferlenauthor=O.+Corminboeufauthor=C.+Grisostomiauthor=C.+Bossauthor=L.+Pradeauthor=S.+Delahyeauthor=A.+Treiberauthor=P.+Stricknerauthor=C.+Binkertauthor=P.+Hessauthor=B.+Steinerauthor=W.+Fischli&title=Design+and+preparation+of+potent%2C+nonpeptidic%2C+bioavailable+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1021%2Fjm900022f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900022f%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DDelahye%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520potent%252C%2520nonpeptidic%252C%2520bioavailable%2520renin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3689%26epage%3D3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bezencon, O.; Bur, D.; Weller, T.; Richard-Bildstein, S.; Remen, L.; Sifferlen, T.; Corminboeuf, O.; Grisostomi, C.; Prade, L.; Delahaye, S.; Treiber, A.; Strickner, P.; Hess, P.; Steiner, B.; Fischli, W.</span><span> </span><span class="NLM_article-title">Potent, Non-Peptidic, Bioavailable Renin Inhibitors</span>. Presented at the 20th International Symposium on Medicinal Chemistry, EFMC-ISMC 2008, Vienna, Austria, Aug 31−Sep 4,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Poster P012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=O.+Bezencon&author=D.+Bur&author=T.+Weller&author=S.+Richard-Bildstein&author=L.+Remen&author=T.+Sifferlen&author=O.+Corminboeuf&author=C.+Grisostomi&author=L.+Prade&author=S.+Delahaye&author=A.+Treiber&author=P.+Strickner&author=P.+Hess&author=B.+Steiner&author=W.+Fischli&title=Potent%2C+Non-Peptidic%2C+Bioavailable+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26atitle%3DPotent%252C%2520Non-Peptidic%252C%2520Bioavailable%2520Renin%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezencon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">New classes of potent and bioavailable human renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6762</span><span class="NLM_x">–</span> <span class="NLM_lpage">6765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6762-6765&author=L.+Reme%C5%88author=O.+Bezenconauthor=S.+Richard-Bildsteinauthor=D.+Burauthor=L.+Pradeauthor=O.+Corminboeufauthor=C.+Bossauthor=C.+Grisostomiauthor=T.+Sifferlenauthor=P.+Stricknerauthor=P.+Hessauthor=S.+Delahyeauthor=A.+Treiberauthor=T.+Wellerauthor=C.+Binkertauthor=B.+Steinerauthor=W.+Fischli&title=New+classes+of+potent+and+bioavailable+human+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DBezencon%26aufirst%3DO.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DDelahye%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DNew%2520classes%2520of%2520potent%2520and%2520bioavailable%2520human%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6762%26epage%3D6765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">The P1 <i>N</i>-isopropyl motif bearing hydroxyethylene dipeptide isostere analogs of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4863</span><span class="NLM_x">–</span> <span class="NLM_lpage">4867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4863-4867&author=Y.+Yamaguchiauthor=K.+Menearauthor=N.-C.+Cohenauthor=R.+Mahauthor=F.+Cuminauthor=C.+Schnellauthor=J.+M.+Woodauthor=J.+Maibaum&title=The+P1+N-isopropyl+motif+bearing+hydroxyethylene+dipeptide+isostere+analogs+of+aliskiren+are+in+vitro+potent+inhibitors+of+the+human+aspartyl+protease+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DThe%2520P1%2520N-isopropyl%2520motif%2520bearing%2520hydroxyethylene%2520dipeptide%2520isostere%2520analogs%2520of%2520aliskiren%2520are%2520in%2520vitro%2520potent%2520inhibitors%2520of%2520the%2520human%2520aspartyl%2520protease%2520renin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4863%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Levens, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, R. M.</span><span> </span><span class="NLM_article-title">Role of the intrarenal renin−angiotensin system in the control of renal function</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1981&pages=157-167&author=N.+R.+Levensauthor=M.+J.+Peachauthor=R.+M.+Carey&title=Role+of+the+intrarenal+renin%E2%88%92angiotensin+system+in+the+control+of+renal+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevens%26aufirst%3DN.%2BR.%26aulast%3DPeach%26aufirst%3DM.%2BJ.%26aulast%3DCarey%26aufirst%3DR.%2BM.%26atitle%3DRole%2520of%2520the%2520intrarenal%2520renin%25E2%2588%2592angiotensin%2520system%2520in%2520the%2520control%2520of%2520renal%2520function%26jtitle%3DCirc.%2520Res.%26date%3D1981%26volume%3D48%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=59-68&author=W.+L.+Codyauthor=D.+D.+Holsworthauthor=N.+A.+Powellauthor=M.+Jalaieauthor=E.+Zhangauthor=W.+Wangauthor=B.+Samasauthor=J.+Bryantauthor=R.+Ostroskiauthor=M.+J.+Ryanauthor=J.+J.+Edmunds&title=The+discovery+and+preparation+of+disubstituted+novel+amino-aryl-piperidine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DOstroski%26aufirst%3DR.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520discovery%2520and%2520preparation%2520of%2520disubstituted%2520novel%2520amino-aryl-piperidine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D59%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2371</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2371-2374&author=N.+A.+Powellauthor=E.+H.+Clayauthor=D.+D.+Holsworthauthor=J.+W.+Bryantauthor=M.+J.+Ryanauthor=M.+Jalaieauthor=E.+Zhangauthor=J.+J.+Edmunds&title=Equipotent+activity+in+both+enantiomers+of+a+series+of+ketopiperazine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DClay%26aufirst%3DE.%2BH.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DBryant%26aufirst%3DJ.%2BW.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DEquipotent%2520activity%2520in%2520both%2520enantiomers%2520of%2520a%2520series%2520of%2520ketopiperazine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2371%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downing, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Discovery of novel non-peptidic ketopiperazine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2657-2664&author=D.+D.+Holsworthauthor=N.+A.+Powellauthor=D.+M.+Downingauthor=C.+Caiauthor=W.+L.+Codyauthor=J.+M.+Ryanauthor=R.+Ostroskiauthor=M.+Jalaieauthor=J.+W.+Bryantauthor=J.+J.+Edmunds&title=Discovery+of+novel+non-peptidic+ketopiperazine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DDowning%26aufirst%3DD.%2BM.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DRyan%26aufirst%3DJ.%2BM.%26aulast%3DOstroski%26aufirst%3DR.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DJ.%2BW.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520non-peptidic%2520ketopiperazine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2657%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Benzyl ether structure−activity relationships in a series of ketopiperazine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4713</span><span class="NLM_x">–</span> <span class="NLM_lpage">4716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4713-4716&author=N.+A.+Powellauthor=E.+H.+Clayauthor=D.+D.+Holsworthauthor=J.+W.+Bryantauthor=M.+J.+Ryanauthor=M.+Jalaieauthor=J.+J.+Edmunds&title=Benzyl+ether+structure%E2%88%92activity+relationships+in+a+series+of+ketopiperazine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DClay%26aufirst%3DE.%2BH.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DBryant%26aufirst%3DJ.%2BW.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DBenzyl%2520ether%2520structure%25E2%2588%2592activity%2520relationships%2520in%2520a%2520series%2520of%2520ketopiperazine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4713%26epage%3D4716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downing, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erasga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, S.</span><span> </span><span class="NLM_article-title">Ketopiperazine-based renin inhibitors: optimization of the “C” ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2500</span><span class="NLM_x">–</span> <span class="NLM_lpage">2504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2500-2504&author=D.+D.+Holsworthauthor=C.+Caiauthor=X.-M.+Chengauthor=W.+L.+Codyauthor=D.+M.+Downingauthor=N.+Erasgaauthor=C.+Leeauthor=N.+A.+Powellauthor=J.+J.+Edmundsauthor=M.+Stierauthor=M.+Jalaieauthor=E.+Zhangauthor=P.+McConnellauthor=M.+J.+Ryanauthor=J.+Bryantauthor=T.+Liauthor=A.+Kasaniauthor=E.+Hallauthor=R.+Subediauthor=M.+Rahimauthor=S.+Maiti&title=Ketopiperazine-based+renin+inhibitors%3A+optimization+of+the+%E2%80%9CC%E2%80%9D+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DX.-M.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DDowning%26aufirst%3DD.%2BM.%26aulast%3DErasga%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DKasani%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DE.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DRahim%26aufirst%3DM.%26aulast%3DMaiti%26aufirst%3DS.%26atitle%3DKetopiperazine-based%2520renin%2520inhibitors%253A%2520optimization%2520of%2520the%2520%25E2%2580%259CC%25E2%2580%259D%2520ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2500%26epage%3D2504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cai, C.; Bryant, J.; Cheng, X. M.; Cody, W. L.; Collard, W.; Downing, D. M.; Erasga, N.; Ferreira, S.; Hall, E.; Holsworth, D. D.; Jalaie, M.; Kasani, A.; Lee, C.; Li, T.; Maiti, S.; McConnell, P.; Powell, N. A.; Rahim, M.; Ryan, M.; Stier, M. A.; Subedi, R.; Zhang, E.; Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Ketopiperazine-Based Renin Inhibitors: Incorporation of Indole Rings</span>. Presented at the 231st National Meeting of the American Chemical Society, Atlanta, GA, March 26−30,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>MEDI-091. PDB code <span class="NLM_ext-link">2g27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+Cai&author=J.+Bryant&author=X.+M.+Cheng&author=W.+L.+Cody&author=W.+Collard&author=D.+M.+Downing&author=N.+Erasga&author=S.+Ferreira&author=E.+Hall&author=D.+D.+Holsworth&author=M.+Jalaie&author=A.+Kasani&author=C.+Lee&author=T.+Li&author=S.+Maiti&author=P.+McConnell&author=N.+A.+Powell&author=M.+Rahim&author=M.+Ryan&author=M.+A.+Stier&author=R.+Subedi&author=E.+Zhang&author=J.+J.+Edmunds&title=Ketopiperazine-Based+Renin+Inhibitors%3A+Incorporation+of+Indole+Rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DC.%26atitle%3DKetopiperazine-Based%2520Renin%2520Inhibitors%253A%2520Incorporation%2520of%2520Indole%2520Rings%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Gu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voorman, R. L.</span><span> </span><span class="NLM_article-title">Metabolic aromatization of <i>N</i>-alkyl-1,2,3,4-tetrahydroquinoline substructures to quinolinium by human liver microsomes and horseradish peroxidase</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2044</span><span class="NLM_x">–</span> <span class="NLM_lpage">2055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=2044-2055&author=C.+Guauthor=R.+Collinsauthor=D.+D.+Holsworthauthor=G.+S.+Walkerauthor=R.+L.+Voorman&title=Metabolic+aromatization+of+N-alkyl-1%2C2%2C3%2C4-tetrahydroquinoline+substructures+to+quinolinium+by+human+liver+microsomes+and+horseradish+peroxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DVoorman%26aufirst%3DR.%2BL.%26atitle%3DMetabolic%2520aromatization%2520of%2520N-alkyl-1%252C2%252C3%252C4-tetrahydroquinoline%2520substructures%2520to%2520quinolinium%2520by%2520human%2520liver%2520microsomes%2520and%2520horseradish%2520peroxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D2044%26epage%3D2055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ehara, T.; Grosche, P.; Irie, O.; Iwaki, Y.; Kanazawa, T.; Kawakami, S.; Konishi, K.; Mogi, M.; Suzuki, M.; Yokokawa, F.</span><span> </span><span class="NLM_article-title">Preparation of 3,5-Substituted Piperidine Compounds as Renin Inhibitors</span>. PCT Int. Appl. WO 2007/077005A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Ehara&author=P.+Grosche&author=O.+Irie&author=Y.+Iwaki&author=T.+Kanazawa&author=S.+Kawakami&author=K.+Konishi&author=M.+Mogi&author=M.+Suzuki&author=F.+Yokokawa&title=Preparation+of+3%2C5-Substituted+Piperidine+Compounds+as+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEhara%26aufirst%3DT.%26atitle%3DPreparation%2520of%25203%252C5-Substituted%2520Piperidine%2520Compounds%2520as%2520Renin%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Herold, P.; Mah, R.; Tschinke, V.; Stutz, S.; Stojanovic, A.; Marti, C.; Behnke, D.; Jelakovic, S.</span><span> </span><span class="NLM_article-title">Preparation of 5-Amino-4-hydroxy-7-[imidazo[1,2-<i>a</i>]pyridin-6-ylmethyl]-8-methylnonanamides and Related Compounds as Renin Inhibitors for Treatment of Hypertension</span>. PCT Int. Appl. WO2007/031558A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+Herold&author=R.+Mah&author=V.+Tschinke&author=S.+Stutz&author=A.+Stojanovic&author=C.+Marti&author=D.+Behnke&author=S.+Jelakovic&title=Preparation+of+5-Amino-4-hydroxy-7-%5Bimidazo%5B1%2C2-a%5Dpyridin-6-ylmethyl%5D-8-methylnonanamides+and+Related+Compounds+as+Renin+Inhibitors+for+Treatment+of+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHerold%26aufirst%3DP.%26atitle%3DPreparation%2520of%25205-Amino-4-hydroxy-7-%255Bimidazo%255B1%252C2-a%255Dpyridin-6-ylmethyl%255D-8-methylnonanamides%2520and%2520Related%2520Compounds%2520as%2520Renin%2520Inhibitors%2520for%2520Treatment%2520of%2520Hypertension%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span> </span><span class="NLM_article-title">Renin inhibitor SC-51106 complexed with human renin: discovery of a new binding site adjacent to P3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=909-918&author=G.+J.+Hansonauthor=M.+Clareauthor=N.+L.+Summersauthor=L.+W.+Limauthor=D.+J.+Neidhartauthor=H.+S.+Shiehauthor=A.+M.+Stevens&title=Renin+inhibitor+SC-51106+complexed+with+human+renin%3A+discovery+of+a+new+binding+site+adjacent+to+P3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DSummers%26aufirst%3DN.%2BL.%26aulast%3DLim%26aufirst%3DL.%2BW.%26aulast%3DNeidhart%26aufirst%3DD.%2BJ.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26atitle%3DRenin%2520inhibitor%2520SC-51106%2520complexed%2520with%2520human%2520renin%253A%2520discovery%2520of%2520a%2520new%2520binding%2520site%2520adjacent%2520to%2520P3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1994%26volume%3D2%26spage%3D909%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, G.</span><span> </span><span class="NLM_article-title">High resolution crystal structures of recombinant human renin in complex with polyhydroxymonoamide inhibitors</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1995&pages=211-222&author=L.+Tongauthor=S.+Pavauthor=D.+Lamarreauthor=L.+Piloteauthor=S.+LaPlanteauthor=P.+C.+Andersonauthor=G.+Jung&title=High+resolution+crystal+structures+of+recombinant+human+renin+in+complex+with+polyhydroxymonoamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DPilote%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DJung%26aufirst%3DG.%26atitle%3DHigh%2520resolution%2520crystal%2520structures%2520of%2520recombinant%2520human%2520renin%2520in%2520complex%2520with%2520polyhydroxymonoamide%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D250%26spage%3D211%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Lefker, B.</span><span> </span><span class="NLM_article-title">Structure Based Drug Design. Rational Design of Non-Peptide Enzyme Inhibitors</span>. Presented at the 1st Winter Conference on Medicinal and Bioorganic Chemistry, Steamboat Springs, CO, January 29−February 2,<span class="NLM_x"> </span><span class="NLM_year">1995</span>. <div class="note"><p class="first last">The author (J.M.) is grateful to Dr. Hans-Peter Märki (Hoffman-La Roche, Basel, Switzerland) for bringing this paper to his attention and to Dr. Bruce Lefker (Pfizer, Groton, CT) for providing a copy of the 1995 presentation. The X-ray structure of <b>27</b> in complex with renin has not been published to date.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=B.+Lefker&title=Structure+Based+Drug+Design.+Rational+Design+of+Non-Peptide+Enzyme+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLefker%26aufirst%3DB.%26atitle%3DStructure%2520Based%2520Drug%2520Design.%2520Rational%2520Design%2520of%2520Non-Peptide%2520Enzyme%2520Inhibitors%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="note"><p class="first last">For the first report on the presence of the S<sub>3</sub> subpocket (S<sub>3</sub><sup>sp</sup>) in BACE-1: </p></div><div class="NLM_citation" id="cit64a"><span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen-Dodson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadikonda, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6117</span><span class="NLM_x">–</span> <span class="NLM_lpage">6119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6117-6119&author=C.+A.+Coburnauthor=S.+J.+Stachelauthor=Y.-M.+Liauthor=D.+M.+Rushauthor=T.+G.+Steeleauthor=E.+Chen-Dodsonauthor=M.+K.+Hollowayauthor=M.+Xuauthor=Q.+Huangauthor=M.-T.+Laiauthor=J.+DiMuzioauthor=M.-C.+Crouthamelauthor=X.-P.+Shiauthor=V.+Sardanaauthor=Z.+Chenauthor=S.+Munshiauthor=L.+Kuoauthor=G.+M.+Makaraauthor=D.+A.+Annisauthor=P.+K.+Tadikondaauthor=H.+M.+Nashauthor=J.+P.+Vacca&title=Identification+of+a+small+molecule+nonpeptide+active+site+%CE%B2-secretase+inhibitor+that+displays+a+nontraditional+binding+mode+for+aspartyl+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64a&amp;dbid=16384&amp;doi=10.1021%2Fjm049388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049388p%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DRush%26aufirst%3DD.%2BM.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DChen-Dodson%26aufirst%3DE.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DShi%26aufirst%3DX.-P.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DTadikonda%26aufirst%3DP.%2BK.%26aulast%3DNash%26aufirst%3DH.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DIdentification%2520of%2520a%2520small%2520molecule%2520nonpeptide%2520active%2520site%2520%25CE%25B2-secretase%2520inhibitor%2520that%2520displays%2520a%2520nontraditional%2520binding%2520mode%2520for%2520aspartyl%2520proteases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6117%26epage%3D6119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit64b"><span><div class="note"><p class="first last">See also the following: </p></div><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeiser, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collusi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1788-1792&author=S.+R.+Staufferauthor=M.+G.+Stantonauthor=A.+R.+Gregroauthor=M.+A.+Steinbeiserauthor=J.+R.+Shafferauthor=P.+G.+Nantermetauthor=J.+C.+Barrowauthor=K.+E.+Rittleauthor=D.+Collusiauthor=A.+S.+Espesethauthor=M.-T.+Laiauthor=B.+L.+Pietrakauthor=M.+K.+Hollowayauthor=G.+B.+McGaugheyauthor=S.+K.+Munshiauthor=J.+H.+Hochmanauthor=A.+J.+Simonauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=Discovery+and+SAR+of+isonicotinamide+BACE-1+inhibitors+that+bind+%CE%B2-secretase+in+a+N-terminal+10s-loop+down+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DSteinbeiser%26aufirst%3DM.%2BA.%26aulast%3DShaffer%26aufirst%3DJ.%2BR.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DCollusi%26aufirst%3DD.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520isonicotinamide%2520BACE-1%2520inhibitors%2520that%2520bind%2520%25CE%25B2-secretase%2520in%2520a%2520N-terminal%252010s-loop%2520down%2520conformation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1788%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Parry, M. J.; Russel, A. B.; Szelke, M.</span><span> </span><span class="NLM_article-title">Bio-Isosteres of a Peptide Renin Inhibitor</span>. In  <span class="citation_source-book">Chemistry and Biology of Peptides</span>; <span class="NLM_contrib-group">Meinehofer, J.</span>, Ed.; <span class="NLM_publisher-name">Ann Arbor Science Publishers</span>: <span class="NLM_publisher-loc">Ann Arbor, MI</span>,<span class="NLM_x"> </span><span class="NLM_year">1972</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">541</span>− <span class="NLM_lpage">544</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1972&pages=541-544&author=M.+J.+Parry&author=A.+B.+Russel&author=M.+Szelkeauthor=J.+Meinehofer&title=Chemistry+and+Biology+of+Peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DM.%2BJ.%26atitle%3DBio-Isosteres%2520of%2520a%2520Peptide%2520Renin%2520Inhibitor%26btitle%3DChemistry%2520and%2520Biology%2520of%2520Peptides%26aulast%3DMeinehofer%26aufirst%3DJ.%26pub%3DAnn%2520Arbor%2520Science%2520Publishers%26date%3D1972%26spage%3D541%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Szelke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sueiras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, A. F.</span><span> </span><span class="NLM_article-title">Potent new inhibitors of human renin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=1982&pages=555-557&author=M.+Szelkeauthor=B.+Leckieauthor=A.+Hallettauthor=D.+M.+Jonesauthor=J.+Sueirasauthor=B.+Atrashauthor=A.+F.+Lever&title=Potent+new+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzelke%26aufirst%3DM.%26aulast%3DLeckie%26aufirst%3DB.%26aulast%3DHallett%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DSueiras%26aufirst%3DJ.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DLever%26aufirst%3DA.%2BF.%26atitle%3DPotent%2520new%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DNature%26date%3D1982%26volume%3D299%26spage%3D555%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Webb, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhem, P. J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span> </span><span class="NLM_article-title">A study of the renin inhibitor H142 in man</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-198512000-00013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=3910726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaL28Xht1ektLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=653-658&author=D.+J.+Webbauthor=P.+J.+O.+Manhemauthor=S.+G.+Ballauthor=G.+Inglisauthor=B.+J.+Leckieauthor=A.+F.+Leverauthor=J.+J.+Mortonauthor=J.+I.+S.+Robertsonauthor=G.+D.+Murrayauthor=J.+M%C3%A9nardauthor=A.+Hallettauthor=D.+M.+Jonesauthor=M.+Szelke&title=A+study+of+the+renin+inhibitor+H142+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A study of the renin inhibitor H142 in man</span></div><div class="casAuthors">Webb, David J.; Manhem, Per J. O.; Ball, Stephen G.; Inglis, Gordon; Leckie, Brenda J.; Lever, Anthony F.; Morton, James J.; Robertson, J. Ian S.; Murray, Gordon D.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-8</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    </div><div class="casAbstract">The inhibitor of human renin  [9015-94-5], H142 (I)  [85139-12-4] was studied in male volunteers.  On three occasions, in random order, volunteers were infused with 5% dextrose or with I at 1.0 or 2.5 mg/kg per h for 30 min while supine and thereafter with dextrose for 11/2 h.  There was a marked redn. in plasma active renin concn. as assayed by an enzyme-kinetic method, with parallel falls in the circulating concns. of angiotensin I  [9041-90-1] and II  [11128-99-7], all of which rebounded transiently to values above basal after the I infusion was stopped.  In contrast, total renin concn. as measured by radio-immunoassay rose whereas angiotensin I and II fell, subsiding when I was discontinued.  There was a slight but significant increase in plasma noradrenaline  [51-41-2] as renin became inhibited; plasma adrenaline  [51-43-4] was unchanged.  I produced a slight fall in systolic blood pressure (SBP) and a clearer, highly significant, dose-related fall in diastolic blood pressure (DBP).  There was a modest but significant increase in the heart rate.  These studies confirm I as an effective inhibitor of human renin in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2GrO3_cUeLVg90H21EOLACvtfcHk0ljJZMoPmskiFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1ektLo%253D&md5=d85492fac52a9755ab4113e087c44d14</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1097%2F00004872-198512000-00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-198512000-00013%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DD.%2BJ.%26aulast%3DManhem%26aufirst%3DP.%2BJ.%2BO.%26aulast%3DBall%26aufirst%3DS.%2BG.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DLeckie%26aufirst%3DB.%2BJ.%26aulast%3DLever%26aufirst%3DA.%2BF.%26aulast%3DMorton%26aufirst%3DJ.%2BJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BI.%2BS.%26aulast%3DMurray%26aufirst%3DG.%2BD.%26aulast%3DM%25C3%25A9nard%26aufirst%3DJ.%26aulast%3DHallett%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DSzelke%26aufirst%3DM.%26atitle%3DA%2520study%2520of%2520the%2520renin%2520inhibitor%2520H142%2520in%2520man%26jtitle%3DJ.%2520Hypertens.%26date%3D1985%26volume%3D3%26spage%3D653%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68a"><span><span class="NLM_contrib-group">James, M. N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielecki, A. R.</span><span> </span><span class="NLM_article-title">Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3701</span><span class="NLM_x">–</span> <span class="NLM_lpage">3713</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00335a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1985&pages=3701-3713&author=M.+N.+G.+Jamesauthor=A.+R.+Sielecki&title=Stereochemical+analysis+of+peptide+bond+hydrolysis+catalyzed+by+the+aspartic+proteinase+penicillopepsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1021%2Fbi00335a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00335a045%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26atitle%3DStereochemical%2520analysis%2520of%2520peptide%2520bond%2520hydrolysis%2520catalyzed%2520by%2520the%2520aspartic%2520proteinase%2520penicillopepsin%26jtitle%3DBiochemistry%26date%3D1985%26volume%3D24%26spage%3D3701%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit68b"><span><div class="note"><p class="first last">The high-resolution X-ray structure of porcine pepsinogen (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2psg">2psg</a>) has shown the N-terminal sequence of the zymogen to fold back into the intact active site conformation, forming electrostatic interactions of the Lys<sub>36</sub> side chain amine with both Asp<sub>32</sub> and Asp<sub>215</sub> as a self-inhibitory mechanism preventing substrate binding: </p></div><span class="NLM_contrib-group">Sielecki, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span> </span><span class="NLM_article-title">Refined structure of porcine pepsinogen at 1.8 Å resolution</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1991&pages=671-692&author=A.+R.+Sieleckiauthor=M.+Fujinagaauthor=R.+J.+Readauthor=M.+N.+G.+James&title=Refined+structure+of+porcine+pepsinogen+at+1.8+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26atitle%3DRefined%2520structure%2520of%2520porcine%2520pepsinogen%2520at%25201.8%2520%25C3%2585%2520resolution%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1991%26volume%3D219%26spage%3D671%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Boger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohr, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaine, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanelli, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorn, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaMont, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassil, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabilito, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boparai, A. S.</span><span> </span><span class="NLM_article-title">Novel renin inhibitors containing the amino acid statine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=1983&pages=81-84&author=J.+Bogerauthor=N.+S.+Lohrauthor=E.+H.+Ulmauthor=M.+Poeauthor=E.+H.+Blaineauthor=G.+M.+Fanelliauthor=T.-Y.+Linauthor=L.+S.+Payneauthor=T.+W.+Schornauthor=B.+I.+LaMontauthor=T.+C.+Vassilauthor=I.+I.+Sabilitoauthor=D.+F.+Veberauthor=D.+H.+Richauthor=A.+S.+Boparai&title=Novel+renin+inhibitors+containing+the+amino+acid+statine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DJ.%26aulast%3DLohr%26aufirst%3DN.%2BS.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DBlaine%26aufirst%3DE.%2BH.%26aulast%3DFanelli%26aufirst%3DG.%2BM.%26aulast%3DLin%26aufirst%3DT.-Y.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DLaMont%26aufirst%3DB.%2BI.%26aulast%3DVassil%26aufirst%3DT.%2BC.%26aulast%3DSabilito%26aufirst%3DI.%2BI.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DRich%26aufirst%3DD.%2BH.%26aulast%3DBoparai%26aufirst%3DA.%2BS.%26atitle%3DNovel%2520renin%2520inhibitors%2520containing%2520the%2520amino%2520acid%2520statine%26jtitle%3DNature%26date%3D1983%26volume%3D303%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sueiras-Diaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. J.</span><span> </span><span class="NLM_article-title">Potent in vivo inhibitors of rat renin: analogs of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site</span> <span class="citation_source-journal">J. Pept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1399-3011.1997.tb01465.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9352462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2sXmslGhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1997&pages=239-247&author=J.+Sueiras-Diazauthor=D.+M.+Jonesauthor=M.+Szelkeauthor=B.+J.+Leckieauthor=S.+R.+Beattieauthor=C.+Beattieauthor=J.+J.+Morton&title=Potent+in+vivo+inhibitors+of+rat+renin%3A+analogs+of+human+and+rat+angiotensinogen+sequences+containing+different+classes+of+pseudodipeptides+at+the+scissile+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70aR"><div class="casContent"><span class="casTitleNuber">70a</span><div class="casTitle"><span class="NLM_cas:atitle">Potent in vivo inhibitors of rat renin: analogs of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site</span></div><div class="casAuthors">Sueiras-Diaz, Javier; Jones, D. Michael; Szelke, Michael; Leckie, Brenda J.; Beattie, Sheila R.; Beattie, C.; Morton, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-247</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">Using solid-phase methodol., peptides based on the 8-14 or 6-14 human and rat angiotensinogen sequences were prepd. contg. the following different isosteric units at the P1-P1' cleavage site: Leu-ψ[CH2NH]Leu, Leu-ψ[CH(OH)CH2]Val, Leu-ψ[CH(OH)CH2]Leu, and Leu-ψ[CH(NH2)CH2]Val.  In vitro, peptide Piv-His-Pro-Phe-His-Leu-ψ[CH(OH)CH2]Leu-Tyr-Tyr-Ser-NH2 (XXI) is the most potent inhibitor of rat plasma renin reported, having IC50 = 0.21 nM; it is a much weaker inhibitor of human renin (IC50 = 45 nM).  Peptide Boc-His-Pro-Phe-His-Leu-ψ[CH(OH)CH2] Leu-Val-Ile-His-NH2 (XX) was a highly effective inhibitor of rat renin in vivo.  When infused (1 mg/kg/h) into two-kidney, one-clip chronic renal hypertensive rats, XX lowered blood pressure and suppressed both plasma renin and angiotensin II.  When given as a bolus (1 mg/kg) there was a divergence between the rapid rebound of renin levels and blood pressure, which remained suppressed.  These results indicate that potent in vivo inhibitors of rat renin could be useful not only in examg. the role of circulating renin but also in elucidating the equally important involvement of extracirculatory renin pools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1-xeo5_guWbVg90H21EOLACvtfcHk0liGElw3_8N2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslGhs7Y%253D&md5=0d581adc8da8b1ff4f61ddf57ae0b589</span></div><a href="/servlet/linkout?suffix=cit70a&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.1997.tb01465.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.1997.tb01465.x%26sid%3Dliteratum%253Aachs%26aulast%3DSueiras-Diaz%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DSzelke%26aufirst%3DM.%26aulast%3DLeckie%26aufirst%3DB.%2BJ.%26aulast%3DBeattie%26aufirst%3DS.%2BR.%26aulast%3DBeattie%26aufirst%3DC.%26aulast%3DMorton%26aufirst%3DJ.%2BJ.%26atitle%3DPotent%2520in%2520vivo%2520inhibitors%2520of%2520rat%2520renin%253A%2520analogs%2520of%2520human%2520and%2520rat%2520angiotensinogen%2520sequences%2520containing%2520different%2520classes%2520of%2520pseudodipeptides%2520at%2520the%2520scissile%2520site%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D1997%26volume%3D50%26spage%3D239%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit70b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, D. M.; Leckie, B. J.; Svensson, L.; Szelke, M.</span><span> </span><span class="NLM_article-title">A Novel Non-Hydrolyzable Isostere of the Peptide Transition State and a New Synthesis of the Hydroxy-ethylene Isostere</span>.  <span class="citation_source-book">Peptides: Chemistry, Structure and Biology</span>, Proceedings of the 11th Peptide Symposium; <span class="NLM_publisher-name">Escom</span>: <span class="NLM_publisher-loc">Leiden, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">971</span>− <span class="NLM_lpage">972</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=971-972&author=D.+M.+Jones&author=B.+J.+Leckie&author=L.+Svensson&author=M.+Szelke&title=Peptides%3A+Chemistry%2C+Structure+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BM.%26atitle%3DA%2520Novel%2520Non-Hydrolyzable%2520Isostere%2520of%2520the%2520Peptide%2520Transition%2520State%2520and%2520a%2520New%2520Synthesis%2520of%2520the%2520Hydroxy-ethylene%2520Isostere%26btitle%3DPeptides%253A%2520Chemistry%252C%2520Structure%2520and%2520Biology%26pub%3DEscom%26date%3D1990%26spage%3D971%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fucini, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinger, M. D.</span><span> </span><span class="NLM_article-title">Aminoethylenes, a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509142" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=839-842&author=W.+Yangauthor=W.+Luauthor=Y.+Luauthor=M.+Zhongauthor=J.+Sunauthor=A.+E.+Thomasauthor=J.+M.+Wilkinsonauthor=R.+V.+Fuciniauthor=M.+Lamauthor=M.+Randalauthor=X.-P.+Shiauthor=J.+W.+Jacobsauthor=R.+S.+McDowellauthor=E.+M.+Gordonauthor=M.+D.+Ballinger&title=Aminoethylenes%2C+a+tetrahedral+intermediate+isostere+yielding+potent+inhibitors+of+the+aspartyl+protease+BACE-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm0509142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509142%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DA.%2BE.%26aulast%3DWilkinson%26aufirst%3DJ.%2BM.%26aulast%3DFucini%26aufirst%3DR.%2BV.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DRandal%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.-P.%26aulast%3DJacobs%26aufirst%3DJ.%2BW.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DGordon%26aufirst%3DE.%2BM.%26aulast%3DBallinger%26aufirst%3DM.%2BD.%26atitle%3DAminoethylenes%252C%2520a%2520tetrahedral%2520intermediate%2520isostere%2520yielding%2520potent%2520inhibitors%2520of%2520the%2520aspartyl%2520protease%2520BACE-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D839%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, M.; Sueiras-Diaz, J.; Szelke, M.; Leckie, B.; Beattie, S.</span><span> </span><span class="NLM_article-title">Renin Inhibitors Containing the Novel Amino Acid 3-Aminodeoxystatine</span>.  <span class="citation_source-book">Peptides: Structure and Function</span>, Proceedings of the 9th American Peptide Symposium; <span class="NLM_publisher-name">Pierce Chemical Company</span>: <span class="NLM_publisher-loc">Rockford, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">1985</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">759</span>− <span class="NLM_lpage">762</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=759-762&author=M.+Jones&author=J.+Sueiras-Diaz&author=M.+Szelke&author=B.+Leckie&author=S.+Beattie&title=Peptides%3A+Structure+and+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%26atitle%3DRenin%2520Inhibitors%2520Containing%2520the%2520Novel%2520Amino%2520Acid%25203-Aminodeoxystatine%26btitle%3DPeptides%253A%2520Structure%2520and%2520Function%26pub%3DPierce%2520Chemical%2520Company%26date%3D1985%26spage%3D759%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit72b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lister, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. J.</span><span> </span><span class="NLM_article-title">Novel renin inhibitors: synthesis of aminostatine and comparison with statine-containing analogs</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1986&pages=755-757&author=R.+J.+Arrowsmithauthor=K.+Carterauthor=J.+G.+Dannauthor=D.+E.+Daviesauthor=C.+J.+Harrisauthor=J.+A.+Mortonauthor=P.+Listerauthor=J.+A.+Robinsonauthor=D.+J.+Williams&title=Novel+renin+inhibitors%3A+synthesis+of+aminostatine+and+comparison+with+statine-containing+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DCarter%26aufirst%3DK.%26aulast%3DDann%26aufirst%3DJ.%2BG.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DMorton%26aufirst%3DJ.%2BA.%26aulast%3DLister%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BJ.%26atitle%3DNovel%2520renin%2520inhibitors%253A%2520synthesis%2520of%2520aminostatine%2520and%2520comparison%2520with%2520statine-containing%2520analogs%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1986%26volume%3D10%26spage%3D755%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit72c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Thaisrivongs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schostarez, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pals, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. R.</span><span> </span><span class="NLM_article-title">alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin-inhibitory peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1837</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00393a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1837-1842&author=S.+Thaisrivongsauthor=H.+J.+Schostarezauthor=D.+T.+Palsauthor=S.+R.+Turner&title=alpha%2Calpha-Difluoro-beta-aminodeoxystatine-containing+renin-inhibitory+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72c&amp;dbid=16384&amp;doi=10.1021%2Fjm00393a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00393a026%26sid%3Dliteratum%253Aachs%26aulast%3DThaisrivongs%26aufirst%3DS.%26aulast%3DSchostarez%26aufirst%3DH.%2BJ.%26aulast%3DPals%26aufirst%3DD.%2BT.%26aulast%3DTurner%26aufirst%3DS.%2BR.%26atitle%3Dalpha%252Calpha-Difluoro-beta-aminodeoxystatine-containing%2520renin-inhibitory%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1837%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Bradbury, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivett, J. E.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-<i>a</i>]pyrazine derivatives with human renin inhibitory activity. 3. Synthesis and biological properties of aminodeoxystatine and difluorostatone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=151-157&author=R.+H.+Bradburyauthor=J.+E.+Rivett&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyrazine+derivatives+with+human+renin+inhibitory+activity.+3.+Synthesis+and+biological+properties+of+aminodeoxystatine+and+difluorostatone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a022%26sid%3Dliteratum%253Aachs%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DRivett%26aufirst%3DJ.%2BE.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyrazine%2520derivatives%2520with%2520human%2520renin%2520inhibitory%2520activity.%25203.%2520Synthesis%2520and%2520biological%2520properties%2520of%2520aminodeoxystatine%2520and%2520difluorostatone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Dann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. A.</span><span> </span><span class="NLM_article-title">Human renin: a new class of inhibitors</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1986&pages=71-77&author=J.+G.+Dannauthor=D.+K.+Stammersauthor=C.+J.+Harrisauthor=R.+J.+Arrowsmithauthor=D.+E.+Daviesauthor=G.+W.+Hardyauthor=J.+A.+Morton&title=Human+renin%3A+a+new+class+of+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDann%26aufirst%3DJ.%2BG.%26aulast%3DStammers%26aufirst%3DD.%2BK.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DHardy%26aufirst%3DG.%2BW.%26aulast%3DMorton%26aufirst%3DJ.%2BA.%26atitle%3DHuman%2520renin%253A%2520a%2520new%2520class%2520of%2520inhibitors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1986%26volume%3D134%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arrowsmith, R. J.; Dann, J. G.; Davies, D. E.; Fogden, Y. C.; Harris, C. J.; Morton, J. A.; Ogden, H.</span><span> </span><span class="NLM_article-title">Inhibitors of Human Renin: Synthesis and Comparative SAR of P3-P1 Tripeptide-Based Aminoalcohols</span>.  <span class="citation_source-book">Peptides 1988</span>, Proceedings of the 20th European Peptide Symposium, Sep 4−9, 1988; <span class="NLM_publisher-name">W. de Gruyter</span>: <span class="NLM_publisher-name">Berlin, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">1989</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">393</span>− <span class="NLM_lpage">395</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&pages=393-395&author=R.+J.+Arrowsmith&author=J.+G.+Dann&author=D.+E.+Davies&author=Y.+C.+Fogden&author=C.+J.+Harris&author=J.+A.+Morton&author=H.+Ogden&title=Peptides+1988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26atitle%3DInhibitors%2520of%2520Human%2520Renin%253A%2520Synthesis%2520and%2520Comparative%2520SAR%2520of%2520P3-P1%2520Tripeptide-Based%2520Aminoalcohols%26btitle%3DPeptides%25201988%26pub%3DW.%2520de%2520Gruyter%26pub%3DBerlin%252C%2520Germany%26date%3D1989%26spage%3D393%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit75b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Breipohl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeman, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoelkens, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegmann, H.</span><span> </span><span class="NLM_article-title">Studies on renin inhibitors</span> <span class="citation_source-journal">Spec. Publ.−R. Soc. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">Top. Med. Chem.</span><span class="NLM_x">) </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaL1cXkvVGnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1988&pages=101-127&issue=Top.+Med.+Chem.&author=G.+Breipohlauthor=R.+Geigerauthor=S.+Henkeauthor=H.+W.+Kleemanauthor=J.+Knolleauthor=D.+Ruppertauthor=B.+A.+Schoelkensauthor=H.+Urbachauthor=A.+Wagnerauthor=H.+Wegmann&title=Studies+on+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75bR"><div class="casContent"><span class="casTitleNuber">75b</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on renin inhibitors</span></div><div class="casAuthors">Breipohl, G.; Geiger, R.; Henke, S.; Kleeman, H. W.; Knolle, J.; Ruppert, D.; Schoelkens, B. A.; Urbach, H.; Wagner, A.; Wegmann, H.</div><div class="citationInfo"><span class="NLM_cas:title">Special Publication - Royal Society of Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">Top. Med. Chem.</span>),
    <span class="NLM_cas:pages">101-27</span>CODEN:
                <span class="NLM_cas:coden">SROCDO</span>;
        ISSN:<span class="NLM_cas:issn">0260-6291</span>.
    </div><div class="casAbstract">A review with 36 refs. and discussion of the authors' results on prepn. of peptides and their renin-inhibiting activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps3jr6697XsbVg90H21EOLACvtfcHk0ljVbKJZZgNGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvVGnurY%253D&md5=5dcae63db5bf9f8a63bc54c9cbce25d5</span></div><a href="/servlet/linkout?suffix=cit75b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreipohl%26aufirst%3DG.%26aulast%3DGeiger%26aufirst%3DR.%26aulast%3DHenke%26aufirst%3DS.%26aulast%3DKleeman%26aufirst%3DH.%2BW.%26aulast%3DKnolle%26aufirst%3DJ.%26aulast%3DRuppert%26aufirst%3DD.%26aulast%3DSchoelkens%26aufirst%3DB.%2BA.%26aulast%3DUrbach%26aufirst%3DH.%26aulast%3DWagner%26aufirst%3DA.%26aulast%3DWegmann%26aufirst%3DH.%26atitle%3DStudies%2520on%2520renin%2520inhibitors%26jtitle%3DSpec.%2520Publ.%25E2%2588%2592R.%2520Soc.%2520Chem.%26date%3D1988%26volume%3D65%26issue%3DTop.%2520Med.%2520Chem%26spage%3D101%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit75c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luly, J. R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderquist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perun, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span> </span><span class="NLM_article-title">New inhibitors of human renin that contain novel Leu-Val replacements</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00392a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1609-1616&author=J.+R+Lulyauthor=N.+Yiauthor=J.+Soderquistauthor=H.+Steinauthor=J.+Cohenauthor=T.+J.+Perunauthor=J.+J.+Plattner&title=New+inhibitors+of+human+renin+that+contain+novel+Leu-Val+replacements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75c&amp;dbid=16384&amp;doi=10.1021%2Fjm00392a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00392a015%26sid%3Dliteratum%253Aachs%26aulast%3DLuly%26aufirst%3DJ.%2BR%26aulast%3DYi%26aufirst%3DN.%26aulast%3DSoderquist%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DH.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DPerun%26aufirst%3DT.%2BJ.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DNew%2520inhibitors%2520of%2520human%2520renin%2520that%2520contain%2520novel%2520Leu-Val%2520replacements%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1609%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wlodawer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vondrasek, J.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 protease: a major success of structure-assisted drug design</span> <span class="citation_source-journal">Annu. Rev. Biophys. Biomol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1146%2Fannurev.biophys.27.1.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9646869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1cXktVSltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1998&pages=249-284&author=A.+Wlodawerauthor=J.+Vondrasek&title=Inhibitors+of+HIV-1+protease%3A+a+major+success+of+structure-assisted+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76aR"><div class="casContent"><span class="casTitleNuber">76a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 protease: a major success of structure-assisted drug design</span></div><div class="casAuthors">Wlodawer, Alexander; Vondrasek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Biomolecular Structure</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">249-284</span>CODEN:
                <span class="NLM_cas:coden">ABBSE4</span>;
        ISSN:<span class="NLM_cas:issn">1056-8700</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">Retroviral protease (PR) from the human immunodeficiency virus type 1 (HIV-1) was identified over a decade ago as a potential target for structure-based drug design.  This effort was very successful.  Four drugs are already approved, and others are undergoing clin. trials.  The techniques used in this remarkable example of structure-assisted drug design included crystallog., NMR, computational studies, and advanced chem. synthesis.  The development of these drugs is discussed.  Other approaches to designing HIV-1 PR inhibitors, based on the concepts of symmetry and on the replacement of a H2O mol. that had been found tetrahedrally coordinated between the enzyme and the inhibitors, are also discussed.  The emergence of drug-induced mutations of HIV-1 PR leads to rapid loss of potency of the existing drugs and to the need to continue the development process.  The structural basis of drug resistance and the ways of overcoming this phenomenon are mentioned.  A review with 137 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogX9NcjolGjLVg90H21EOLACvtfcHk0ljVbKJZZgNGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVSltLo%253D&md5=127d0908067674c91336aaf388b7b63d</span></div><a href="/servlet/linkout?suffix=cit76a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biophys.27.1.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biophys.27.1.249%26sid%3Dliteratum%253Aachs%26aulast%3DWlodawer%26aufirst%3DA.%26aulast%3DVondrasek%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease%253A%2520a%2520major%2520success%2520of%2520structure-assisted%2520drug%2520design%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D1998%26volume%3D27%26spage%3D249%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit76b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wlodawer, A.</span><span> </span><span class="NLM_article-title">Rational approach to AIDS drug design through structural biology</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=595-614&author=A.+Wlodawer&title=Rational+approach+to+AIDS+drug+design+through+structural+biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWlodawer%26aufirst%3DA.%26atitle%3DRational%2520approach%2520to%2520AIDS%2520drug%2520design%2520through%2520structural%2520biology%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D595%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zürcher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschalk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Exploring the flap pocket of the antimalarial target plasmepsin II: the “55 % rule” applied to enzymes</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=237-240&author=M.+Z%C3%BCrcherauthor=T.+Gottschalkauthor=S.+Meyerauthor=D.+Burauthor=F.+Diederich&title=Exploring+the+flap+pocket+of+the+antimalarial+target+plasmepsin+II%3A+the+%E2%80%9C55+%25+rule%E2%80%9D+applied+to+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DM.%26aulast%3DGottschalk%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DExploring%2520the%2520flap%2520pocket%2520of%2520the%2520antimalarial%2520target%2520plasmepsin%2520II%253A%2520the%2520%25E2%2580%259C55%2520%2525%2520rule%25E2%2580%259D%2520applied%2520to%2520enzymes%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D237%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit77b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bjelic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nervall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez-de-Teran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ersmark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaqvist, J.</span><span> </span><span class="NLM_article-title">Computational inhibitor design against malaria plasmepsins</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2285</span><span class="NLM_x">–</span> <span class="NLM_lpage">2305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2Fs00018-007-7102-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17585371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFygtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=2285-2305&author=S.+Bjelicauthor=M.+Nervallauthor=H.+Gutierrez-de-Teranauthor=K.+Ersmarkauthor=A.+Hallbergauthor=J.+Aaqvist&title=Computational+inhibitor+design+against+malaria+plasmepsins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77bR"><div class="casContent"><span class="casTitleNuber">77b</span><div class="casTitle"><span class="NLM_cas:atitle">Computational inhibitor design against malaria plasmepsins</span></div><div class="casAuthors">Bjelic, S.; Nervall, M.; Gutierrez-de-Teran, H.; Ersmark, K.; Hallberg, A.; Aaqvist, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2285-2305</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Plasmepsins are aspartic proteases involved in the degrdn. of the host cell Hb that is used as a food source by the malaria parasite.  Plasmepsins are highly promising as drug targets, esp. when combined with the inhibition of falcipains that are also involved in Hb catabolism.  In this review, we discuss the mechanism of plasmepsins I-IV in view of the interest in transition state mimetics as potential compds. for lead development.  Inhibitor development against plasmepsin II as well as relevant crystal structures are summarized in order to give an overview of the field.  Application of computational techniques, esp. binding affinity prediction by the linear interaction energy method, in the development of malarial plasmepsin inhibitors has been highly successful and is discussed in detail.  Homol. modeling and mol. docking have been useful in the current inhibitor design project, and the combination of such methods with binding free energy calcns. is analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKmqtG9_aZMbVg90H21EOLACvtfcHk0liRfKsi47xPsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFygtr3E&md5=d2e8487a0151e1c18e9ffafa30294199</span></div><a href="/servlet/linkout?suffix=cit77b&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7102-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7102-2%26sid%3Dliteratum%253Aachs%26aulast%3DBjelic%26aufirst%3DS.%26aulast%3DNervall%26aufirst%3DM.%26aulast%3DGutierrez-de-Teran%26aufirst%3DH.%26aulast%3DErsmark%26aufirst%3DK.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DAaqvist%26aufirst%3DJ.%26atitle%3DComputational%2520inhibitor%2520design%2520against%2520malaria%2520plasmepsins%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26spage%3D2285%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit77c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luksch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, N.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, W. E.</span><span> </span><span class="NLM_article-title">Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1323</span><span class="NLM_x">–</span> <span class="NLM_lpage">1336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1323-1336&author=T.+Lukschauthor=N.-S.+Chanauthor=S.+Brassauthor=C.+A.+Sotrifferauthor=G.+Klebeauthor=W.+E.+Diederich&title=Computer-aided+design+and+synthesis+of+nonpeptidic+plasmepsin+II+and+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DN.-S.%26aulast%3DBrass%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DDiederich%26aufirst%3DW.%2BE.%26atitle%3DComputer-aided%2520design%2520and%2520synthesis%2520of%2520nonpeptidic%2520plasmepsin%2520II%2520and%2520IV%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1323%26epage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopcho, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falahatpisheh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L.</span><span> </span><span class="NLM_article-title">Novel inhibition of porcine pepsin by a substituted piperidine. Preference for one of the enzyme conformers</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">28677</span><span class="NLM_x">–</span> <span class="NLM_lpage">28682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=28677-28682&author=J.+Marcinkevicieneauthor=L.+M.+Kopchoauthor=T.+Yangauthor=R.+A.+Copelandauthor=B.+M.+Glassauthor=A.+P.+Combsauthor=N.+Falahatpishehauthor=L.+Thompson&title=Novel+inhibition+of+porcine+pepsin+by+a+substituted+piperidine.+Preference+for+one+of+the+enzyme+conformers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DKopcho%26aufirst%3DL.%2BM.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DGlass%26aufirst%3DB.%2BM.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DFalahatpisheh%26aufirst%3DN.%26aulast%3DThompson%26aufirst%3DL.%26atitle%3DNovel%2520inhibition%2520of%2520porcine%2520pepsin%2520by%2520a%2520substituted%2520piperidine.%2520Preference%2520for%2520one%2520of%2520the%2520enzyme%2520conformers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D28677%26epage%3D28682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Specker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böttcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebenow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=106-117&author=E.+Speckerauthor=J.+B%C3%B6ttcherauthor=S.+Brassauthor=A.+Heineauthor=H.+Lilieauthor=A.+Schoopauthor=G.+M%C3%BCllerauthor=N.+Griebenowauthor=G.+Klebe&title=Unexpected+novel+binding+mode+of+pyrrolidine-based+aspartyl+protease+inhibitors%3A+design%2C+synthesis+and+crystal+structure+in+complex+with+HIV+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DBrass%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DLilie%26aufirst%3DH.%26aulast%3DSchoop%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26aulast%3DGriebenow%26aufirst%3DN.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DUnexpected%2520novel%2520binding%2520mode%2520of%2520pyrrolidine-based%2520aspartyl%2520protease%2520inhibitors%253A%2520design%252C%2520synthesis%2520and%2520crystal%2520structure%2520in%2520complex%2520with%2520HIV%2520protease%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D106%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80a"><span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6259</span><span class="NLM_x">–</span> <span class="NLM_lpage">6262</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800914n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6259-6262&author=J.+C.+Barrowauthor=S.+R.+Staufferauthor=K.+E.+Rittleauthor=P.+L.+Ngoauthor=Z.+Yangauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=S.+Munshiauthor=G.+B.+McGaugheyauthor=M.+K.+Hollowayauthor=A.+J.+Simonauthor=E.+A.+Priceauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.-T.+Laiauthor=A.+S.+Espesethauthor=M.+Xuauthor=Q.+Huangauthor=A.+Wolfeauthor=B.+Pietrakauthor=P.+Zuckauthor=D.+A.+Levorseauthor=D.+Hazudaauthor=J.+P.+Vacca&title=Discovery+and+X-ray+crystallographic+analysis+of+a+spiropiperidine+iminohydantoin+inhibitor+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80a&amp;dbid=16384&amp;doi=10.1021%2Fjm800914n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800914n%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DLevorse%26aufirst%3DD.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520X-ray%2520crystallographic%2520analysis%2520of%2520a%2520spiropiperidine%2520iminohydantoin%2520inhibitor%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6259%26epage%3D6262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit80b"><span><div class="note"><p class="first last">See also: </p></div><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enderle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span> </span><span class="NLM_article-title">Tyramine fragment binding to BACE-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1304-1307&author=A.+Kuglstatterauthor=M.+Stahlauthor=J.-U.+Petersauthor=W.+Huberauthor=M.+Stihleauthor=D.+Schlatterauthor=J.+Benzauthor=A.+Rufauthor=D.+Rothauthor=T.+Enderleauthor=M.+Hennig&title=Tyramine+fragment+binding+to+BACE-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DD.%26aulast%3DEnderle%26aufirst%3DT.%26aulast%3DHennig%26aufirst%3DM.%26atitle%3DTyramine%2520fragment%2520binding%2520to%2520BACE-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1304%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to β-Secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1116-1123&author=C.+W.+Murrayauthor=O.+Callaghanauthor=G.+Chessariauthor=A.+Cleasbyauthor=M.+Congreveauthor=M.+Fredericksonauthor=M.+J.+Hartshornauthor=R.+McMenaminauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+%CE%B2-Secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening by X-ray Crystallography to β-Secretase</span></div><div class="casAuthors">Murray, Christopher W.; Callaghan, Owen; Chessari, Gianni; Cleasby, Anne; Congreve, Miles; Frederickson, Martyn; Hartshorn, Michael J.; McMenamin, Rachel; Patel, Sahil; Wallis, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1116-1123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes an application of fragment screening to the aspartyl protease enzyme, β-secretase (BACE-1), using high throughput x-ray crystallog.  Three distinct chemotypes were identified by X-ray crystallog. as binding to the catalytic aspartates either via an aminoheterocycle (such as 2-aminoquinoline), a piperidine, or an aliph. hydroxyl group.  The fragment hits were weak inhibitors of BACE-1 in the millimolar range but were of interest because most of them displayed relatively good ligand efficiencies.  The aminoheterocycles exhibited a novel recognition motif that has not been seen before with aspartic proteases.  Virtual screening around this motif identified an aminopyridine with increased potency and attractive growth points for further elaboration using structure-based drug design.  The companion paper illustrates how sub-micromolar inhibitors were developed starting from this fragment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZHjESbj93LVg90H21EOLACvtfcHk0ljyxn7UHtNudQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D&md5=1ff92bcf5bcb8f265709e3571e25ae8e</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1021%2Fjm0611962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611962%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520%25CE%25B2-Secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1116%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">BACE-1 inhibition by a series of ψ[CH<sub>2</sub>NH] reduced amide isosteres</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3635</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3635-3638&author=C.+A.+Coburnauthor=S.+J.+Stachelauthor=K.+G.+Jonesauthor=T.+G.+Steeleauthor=D.+M.+Rushauthor=J.+DiMuzioauthor=B.+L.+Pietrakauthor=M.-T.+Laiauthor=Q.+Huangauthor=J.+Linebergerauthor=L.+Jinauthor=S.+Munshiauthor=M.+K.+Hollowayauthor=A.+Espesethauthor=A.+Simonauthor=D.+Hazudaauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=BACE-1+inhibition+by+a+series+of+%CF%88%5BCH2NH%5D+reduced+amide+isosteres"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DK.%2BG.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DRush%26aufirst%3DD.%2BM.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DBACE-1%2520inhibition%2520by%2520a%2520series%2520of%2520%25CF%2588%255BCH2NH%255D%2520reduced%2520amide%2520isosteres%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3635%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baldwin, J. J.; Claremon, D. A.; Tice, C.; Cacatian, S.; Dillard, L .W.; Ishchenko, A. V.; Yuan, J.; Xu, Z.; McGeehan, G.; Simpson, R. D.; Singh, S. B.; Zhao, W.; Flaherty, P. T.</span><span> </span><span class="NLM_article-title">Piperidine Derivatives as Aspartic Protease Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Aspartic Protease Mediated Diseases</span>. PCT Int. Appl. WO2007/070201A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+J.+Baldwin&author=D.+A.+Claremon&author=C.+Tice&author=S.+Cacatian&author=L+.W.+Dillard&author=A.+V.+Ishchenko&author=J.+Yuan&author=Z.+Xu&author=G.+McGeehan&author=R.+D.+Simpson&author=S.+B.+Singh&author=W.+Zhao&author=P.+T.+Flaherty&title=Piperidine+Derivatives+as+Aspartic+Protease+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Aspartic+Protease+Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPiperidine%2520Derivatives%2520as%2520Aspartic%2520Protease%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Aspartic%2520Protease%2520Mediated%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit83b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See, for example, the following:</p></div><span class="NLM_contrib-group">Baldwin, J. J.; Cacatian, S.; Claremon, D.; Dillard, L. W.; Flaherty, P. T.; Ghavimi-Alagha, B.; Ghirlanda, D.; Ishchenko, A. V.; Kallander, L. S.; Lawhorn, B.; Lu, Q.; Mcgeehan, G.; Terrell, L. R.; Zhang, J.; Leach, C. A.; Stoy, P.; Patterson, J. R.; Simpson, R. D.; Singh, S. B.; Tice, C.; Xu, Z.; Yuan, C. C. K.; Zhao, W.</span><span> </span><span class="NLM_article-title">Preparation of Substituted Benzoylpiperidine Derivatives and Analogs as Renin Inhibitors</span>. PCT Int. Appl. WO2008/124575A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+J.+Baldwin&author=S.+Cacatian&author=D.+Claremon&author=L.+W.+Dillard&author=P.+T.+Flaherty&author=B.+Ghavimi-Alagha&author=D.+Ghirlanda&author=A.+V.+Ishchenko&author=L.+S.+Kallander&author=B.+Lawhorn&author=Q.+Lu&author=G.+Mcgeehan&author=L.+R.+Terrell&author=J.+Zhang&author=C.+A.+Leach&author=P.+Stoy&author=J.+R.+Patterson&author=R.+D.+Simpson&author=S.+B.+Singh&author=C.+Tice&author=Z.+Xu&author=C.+C.+K.+Yuan&author=W.+Zhao&title=Preparation+of+Substituted+Benzoylpiperidine+Derivatives+and+Analogs+as+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPreparation%2520of%2520Substituted%2520Benzoylpiperidine%2520Derivatives%2520and%2520Analogs%2520as%2520Renin%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Blichstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span> </span><span class="NLM_article-title">X-ray structure of plasmepsin II complexed with a potent achiral inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">23837</span><span class="NLM_x">–</span> <span class="NLM_lpage">23843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1074%2Fjbc.M501519200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=15840589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlKhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23837-23843&author=L.+Pradeauthor=A.+F.+Jonesauthor=C.+Bossauthor=S.+Richard-Blichsteinauthor=S.+Meyerauthor=S.+Binkertauthor=D.+Bur&title=X-ray+structure+of+plasmepsin+II+complexed+with+a+potent+achiral+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Structure of Plasmepsin II Complexed with a Potent Achiral Inhibitor</span></div><div class="casAuthors">Prade, Lars; Jones, Andrew F.; Boss, Christoph; Richard-Bildstein, Sylvia; Meyer, Solange; Binkert, Christoph; Bur, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">23837-23843</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The malaria parasite Plasmodium falciparum degrades host cell Hb inside an acidic food vacuole during the blood stage of the infectious cycle.  A no. of aspartic proteinases called plasmepsins (PMs) have been identified to play important roles in this degrdn. process and therefore generated significant interest as new antimalarial targets.  Several x-ray structures of PMII have been described previously, but thus far, structure-guided drug design has been hampered by the fact that only inhibitors comprising a statine moiety or derivs. thereof have been published.  The authors' drug discovery efforts to find innovative, cheap, and easily synthesized inhibitors against aspartic proteinases yielded some highly potent non-peptidic achiral inhibitors.  A highly resolved (1.6 Å) x-ray structure of PMII is presented, featuring a potent achiral inhibitor in an unprecedented orientation, contacting the catalytic aspartates indirectly via the "catalytic" water.  Major side chain rearrangements in the active site occur, which open up a new pocket and allow a new binding mode of the inhibitor.  Moreover, a second inhibitor mol. could be located unambiguously in the active site of PMII.  These newly obtained structural insights will further guide the authors' attempts to improve compd. properties eventually leading to the identification of mols. suitable as antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe_jI7n_4mJbVg90H21EOLACvtfcHk0ljyxn7UHtNudQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlKhs7s%253D&md5=a0e68be3942c9ab9849f6175b9731465</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501519200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501519200%26sid%3Dliteratum%253Aachs%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DA.%2BF.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DRichard-Blichstein%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26atitle%3DX-ray%2520structure%2520of%2520plasmepsin%2520II%2520complexed%2520with%2520a%2520potent%2520achiral%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D23837%26epage%3D23843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mervaala, E. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=389-395&author=E.+M.+A.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=J.+K.+Parkauthor=F.+Schmidtauthor=M.+Lohnauthor=V.+Breuauthor=D.+Dragunauthor=D.+Gantenauthor=H.+Hallerauthor=F.+C.+Luft&title=Monocyte+infiltration+and+adhesion+molecules+in+a+rat+model+of+high+human+renin+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMervaala%26aufirst%3DE.%2BM.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DLohn%26aufirst%3DM.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DDragun%26aufirst%3DD.%26aulast%3DGanten%26aufirst%3DD.%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DMonocyte%2520infiltration%2520and%2520adhesion%2520molecules%2520in%2520a%2520rat%2520model%2520of%2520high%2520human%2520renin%2520hypertension%26jtitle%3DHypertension%26date%3D1999%26volume%3D33%26spage%3D389%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit85b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mervaala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Blood pressure-independent effects in rats with human renin and angiotensinogen genes</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=587-594&author=E.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=F.+Schmidtauthor=J.+K.+Parkauthor=V.+Grossauthor=M.+Baderauthor=V.+Breuauthor=D.+Gantenauthor=H.+Hallerauthor=F.+C.+Luft&title=Blood+pressure-independent+effects+in+rats+with+human+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMervaala%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DGross%26aufirst%3DV.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DGanten%26aufirst%3DD.%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DBlood%2520pressure-independent%2520effects%2520in%2520rats%2520with%2520human%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DHypertension%26date%3D2000%26volume%3D35%26spage%3D587%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0li9vLm6yqIVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Boehr, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussinov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, P. E.</span><span> </span><span class="NLM_article-title">The role of dynamic conformational ensembles in biomolecular recognition</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnchembio.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19841628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=789-796&author=D.+D.+Boehrauthor=R.+Nussinovauthor=P.+E.+Wright&title=The+role+of+dynamic+conformational+ensembles+in+biomolecular+recognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The role of dynamic conformational ensembles in biomolecular recognition</span></div><div class="casAuthors">Boehr, David D.; Nussinov, Ruth; Wright, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">789-796</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mol. recognition by biomols. is central to all biol. processes.  For the past 50 yr, the 'induced fit' hypothesis of D. E. Koshland (1958) has been the textbook explanation for mol. recognition events.  However, recent exptl. evidence supports an alternative mechanism.  The 'conformational selection' model postulates that all conformations pre-exist, and that the ligand selects the most favored conformation.  Following binding, the ensemble undergoes a population shift, redistributing the conformational states.  Both conformational selection and induced fit appear to play roles.  Following binding by a primary conformational selection event, optimization of side-chain and backbone interactions is likely to proceed by an induced fit mechanism.  Conformational selection has been obsd. for protein-ligand, protein-protein, protein-DNA, protein-RNA and RNA-ligand interactions.  These data support a new mol. recognition paradigm for processes as diverse as signaling, catalysis, gene regulation, and protein aggregation in disease, which has the potential to significantly impact researchers' views and strategies in drug design, biomol. engineering, and mol. evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGputCrvx3HqSLVg90H21EOLACvtfcHk0li9vLm6yqIVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsLrJ&md5=984e03a4380d9dafd19048a4b45589c6</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.232%26sid%3Dliteratum%253Aachs%26aulast%3DBoehr%26aufirst%3DD.%2BD.%26aulast%3DNussinov%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DP.%2BE.%26atitle%3DThe%2520role%2520of%2520dynamic%2520conformational%2520ensembles%2520in%2520biomolecular%2520recognition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D789%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Isothermal titration calorimetry: controlling binding forces in lead optimization</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=295-299&author=E.+Freire&title=Isothermal+titration+calorimetry%3A+controlling+binding+forces+in+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DIsothermal%2520titration%2520calorimetry%253A%2520controlling%2520binding%2520forces%2520in%2520lead%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D295%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Brenke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozakov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, G.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beglov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landon, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajda, S.</span><span> </span><span class="NLM_article-title">Fragment-based identification of druggable “hot-spots” of proteins using Fourier domain correlation techniques</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=621-627&author=R.+Brenkeauthor=D.+Kozakovauthor=G.-Y.+Chuangauthor=D.+Beglovauthor=D.+Hallauthor=M.+R.+Landonauthor=C.+Mattosauthor=S.+Vajda&title=Fragment-based+identification+of+druggable+%E2%80%9Chot-spots%E2%80%9D+of+proteins+using+Fourier+domain+correlation+techniques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrenke%26aufirst%3DR.%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DChuang%26aufirst%3DG.-Y.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DLandon%26aufirst%3DM.%2BR.%26aulast%3DMattos%26aufirst%3DC.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DFragment-based%2520identification%2520of%2520druggable%2520%25E2%2580%259Chot-spots%25E2%2580%259D%2520of%2520proteins%2520using%2520Fourier%2520domain%2520correlation%2520techniques%26jtitle%3DBioinformatics%26date%3D2009%26volume%3D25%26spage%3D621%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dash, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M.</span><span> </span><span class="NLM_article-title">Aspartic peptidase inhibitors: implications in drug development</span> <span class="citation_source-journal">Crit. Rev. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1080%2F713609213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12749695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlKitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=89-119&author=C.+Dashauthor=A.+Kulkarniauthor=B.+Dunnauthor=M.+Rao&title=Aspartic+peptidase+inhibitors%3A+implications+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90aR"><div class="casContent"><span class="casTitleNuber">90a</span><div class="casTitle"><span class="NLM_cas:atitle">Aspartic peptidase inhibitors: Implications in drug development</span></div><div class="casAuthors">Dash, Chandravanu; Kulkarni, Aarohi; Dunn, Ben; Rao, Mala</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-119</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">CRC Press LLC</span>)
        </div><div class="casAbstract">A review.  The last decade has witnessed an effervescence of research interest in the development of potent inhibitors of various aspartic peptidases.  As an enzyme family, aspartic peptidases are relatively a small group that has received enormous interest because of their significant roles in human diseases like involvement of renin in hypertension, cathepsin D in metastasis of breast cancer, β-Secretase in Alzheimer's Disease, plasmepsins in malaria, HIV-1 peptidase in acquired immune deficiency syndrome, and secreted aspartic peptidases in candidal infections.  There have been developments on clin. active inhibitors of HIV-1 peptidase, which have been licensed for the treatment of AIDS.  The inhibitors of plasmepsins and renin are considered a viable therapeutic strategy for the treatment of malaria and hypertension.  Relatively few inhibitors of cathepsin D have been reported, partly because of its uncertain role as a viable target for therapeutic intervention.  The β-secretase inhibitors OM99-2 and OM003 were designed based on the substrate specificity information.  The present article is a comprehensive state-of-the-art review describing the aspartic peptidase inhibitors illustrating the recent developments in the area.  In addn., the homologies between the reported inhibitor sequences have been analyzed.  The understanding of the structure-function relationships of aspartic peptidases and inhibitors will have a direct impact on the design of new inhibitor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruhIW2rMcEoLVg90H21EOLACvtfcHk0lg8bJEYo4B17A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlKitLk%253D&md5=5d4c58c9b985ede5f657f10fe6af4f92</span></div><a href="/servlet/linkout?suffix=cit90a&amp;dbid=16384&amp;doi=10.1080%2F713609213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F713609213%26sid%3Dliteratum%253Aachs%26aulast%3DDash%26aufirst%3DC.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DDunn%26aufirst%3DB.%26aulast%3DRao%26aufirst%3DM.%26atitle%3DAspartic%2520peptidase%2520inhibitors%253A%2520implications%2520in%2520drug%2520development%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D38%26spage%3D89%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit90b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zaidi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalbacher, H.</span><span> </span><span class="NLM_article-title">Emerging functional roles of cathepsin E</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=327-330&author=N.+Zaidiauthor=C.+Hermannauthor=T.+Herrmannauthor=H.+Kalbacher&title=Emerging+functional+roles+of+cathepsin+E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZaidi%26aufirst%3DN.%26aulast%3DHermann%26aufirst%3DC.%26aulast%3DHerrmann%26aufirst%3DT.%26aulast%3DKalbacher%26aufirst%3DH.%26atitle%3DEmerging%2520functional%2520roles%2520of%2520cathepsin%2520E%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D377%26spage%3D327%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Rao, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapundalo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutchko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B. M.</span><span> </span><span class="NLM_article-title">Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1′-P2′ variation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2614</span><span class="NLM_x">–</span> <span class="NLM_lpage">2620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00070a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2614-2620&author=C.+M.+Raoauthor=P.+E.+Scarboroughauthor=J.+Kayauthor=B.+Batleyauthor=S.+Rapundaloauthor=S.+Klutchkoauthor=M.+D.+Taylorauthor=E.+A.+Lunneyauthor=C.+C.+Humbletauthor=B.+M.+Dunn&title=Specificity+in+the+binding+of+inhibitors+to+the+active+site+of+human%2Fprimate+aspartic+proteinases%3A+analysis+of+P2-P1-P1%E2%80%B2-P2%E2%80%B2+variation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm00070a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00070a004%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DC.%2BM.%26aulast%3DScarborough%26aufirst%3DP.%2BE.%26aulast%3DKay%26aufirst%3DJ.%26aulast%3DBatley%26aufirst%3DB.%26aulast%3DRapundalo%26aufirst%3DS.%26aulast%3DKlutchko%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DHumblet%26aufirst%3DC.%2BC.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26atitle%3DSpecificity%2520in%2520the%2520binding%2520of%2520inhibitors%2520to%2520the%2520active%2520site%2520of%2520human%252Fprimate%2520aspartic%2520proteinases%253A%2520analysis%2520of%2520P2-P1-P1%25E2%2580%25B2-P2%25E2%2580%25B2%2520variation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2614%26epage%3D2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Faller, B.; Urban, L.</span>, Eds.  <span class="citation_source-book">Hit and Lead Profiling, Identification and Optimization of Drug-like Molecules</span>. Methods and Principles in Medicinal Chemistry, Vol.  <span class="NLM_volume">43</span>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Faller&author=L.+Urban&title=Hit+and+Lead+Profiling%2C+Identification+and+Optimization+of+Drug-like+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFaller%26aufirst%3DB.%26btitle%3DHit%2520and%2520Lead%2520Profiling%252C%2520Identification%2520and%2520Optimization%2520of%2520Drug-like%2520Molecules%26volume%3D43%26pub%3DWiley-VCH%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit92b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hamon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Techer-Etienne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Coq, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzaoui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span> </span><span class="NLM_article-title">In vitro safety pharmacology profiling: What else beyond hERG?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.4155%2Ffmc.09.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=645-665&author=J.+Hamonauthor=S.+Whitebreadauthor=V.+Techer-Etienneauthor=H.+Le+Coqauthor=K.+Azzaouiauthor=L.+Urban&title=In+vitro+safety+pharmacology+profiling%3A+What+else+beyond+hERG%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92bR"><div class="casContent"><span class="casTitleNuber">92b</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro safety pharmacology profiling: what else beyond hERG?</span></div><div class="casAuthors">Hamon, Jacques; Whitebread, Steven; Techer-Etienne, Valerie; Le Coq, Helene; Azzaoui, Kamal; Urban, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">645-665</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the main reasons for drug failures in clin. development, or postmarket launch, is lacking or compromised safety margins at therapeutic doses.  Organ toxicity with poorly defined mechanisms and adverse drug reactions assocd. with on- and off-target effects are the major contributors to safety-related shortfalls of many clin. drug candidates.  Therefore, to avoid high attrition rates in clin. trials, it is imperative to test compds. for potential adverse reactions during early drug discovery.  Beyond a small no. of targets assocd. with clin. acknowledged adverse drug reactions, there is little consensus on other targets that are important to consider at an early stage for in vitro safety pharmacol. assessment.  We consider here a limited no. of safety-related targets, from different target families, which were selected as part of in vitro safety pharmacol. profiling panels integrated in the drug-development process at Novartis.  The best way to assess these targets, using a biochem. or a functional readout, is discussed.  In particular, the importance of using cell-based profiling assays for the characterization of an agonist action at some GPCRs is highlighted.  A careful design of in vitro safety pharmacol. profiling panels allows better prediction of potential adverse effects of new chem. entities early in the drug-discovery process.  This contributes to the selection of the best candidate for clin. development and, ultimately, should contribute to a decreased attrition rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdXUdqWitZC7Vg90H21EOLACvtfcHk0lh44Wi2tx3NnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgtbbJ&md5=85e16bf431d07804e6bce443ffab0ed6</span></div><a href="/servlet/linkout?suffix=cit92b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.51%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DWhitebread%26aufirst%3DS.%26aulast%3DTecher-Etienne%26aufirst%3DV.%26aulast%3DLe%2BCoq%26aufirst%3DH.%26aulast%3DAzzaoui%26aufirst%3DK.%26aulast%3DUrban%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520safety%2520pharmacology%2520profiling%253A%2520What%2520else%2520beyond%2520hERG%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D645%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span> </span><span class="NLM_article-title">Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research ?</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=61-71&author=K.+Beaumontauthor=D.+A.+Smith&title=Does+human+pharmacokinetic+prediction+add+significant+value+to+compound+selection+in+drug+discovery+research+%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26atitle%3DDoes%2520human%2520pharmacokinetic%2520prediction%2520add%2520significant%2520value%2520to%2520compound%2520selection%2520in%2520drug%2520discovery%2520research%2520%253F%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D61%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lh44Wi2tx3NnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhXFSBZa3rDpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Major, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszewski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosebury, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowala, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadley, R.</span><span> </span><span class="NLM_article-title">A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes</span> <span class="citation_source-journal">Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2Fs10557-008-6131-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18679781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=469-478&author=T.+C.+Majorauthor=B.+Olszewskiauthor=W.+Roseburyauthor=C.+Okerbergauthor=T.+Carlsonauthor=R.+Ostroskiauthor=R.+Schroederauthor=M.+C.+Kowalaauthor=R.+Leadley&title=A+nonpeptide%2C+piperidine+renin+inhibitor+provides+renal+and+cardiac+protection+in+double-transgenic+mice+expressing+human+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">A Nonpeptide, Piperidine Renin Inhibitor Provides Renal and Cardiac Protection in Double-Transgenic Mice Expressing Human Renin and Angiotensinogen Genes</span></div><div class="casAuthors">Major, Terry C.; Olszewski, Bronia; Rosebury, Wendy; Okerberg, Carlin; Carlson, Tage; Ostroski, Robert; Schroeder, Richard; Kowala, Mark C.; Leadley, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Drugs and Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">469-478</span>CODEN:
                <span class="NLM_cas:coden">CDTHET</span>;
        ISSN:<span class="NLM_cas:issn">0920-3206</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clin. afforded protection against cardiac and renal disease.  In order to det. if blocking the RAS rate-limiting step of angiotensin II generation via renin inhibition could afford similar end organ protection in a human-relevant preclin. model, this study investigated the cardiac and renal effects of a nonpeptide, piperidine renin inhibitor (RI; 100 mg/kg/day PO) in double transgenic mice (dTGM) which express both human renin and angiotensinogen genes.  RI was compared to the ARB, candesartan (3 mg/kg/day PO), and to the ACEI, enalapril (60 mg/kg/day PO) in a 4-wk dosing paradigm.  These doses of RI, ACEI and ARB were previously found to normalize mean blood pressure (MBP) to 110 + 3, 109 + 7 and 107 + 6 mmHg, resp., after 1 day of treatment.  In the dTGM, PRA, plasma aldosterone, GFR, microalbuminuria and left ventricular free wall thickness (LVH) were higher than in the wild type C57BL/6 mice.  Microalbuminuria and LVH were significantly reduced by 93% and 9% for the RI, 83% and 13% for enalapril and 73% and 6% for candesartan, resp.  PRA and aldosterone were reduced by the RI 56% and 23%, resp.  These results suggest that the RI provides protection against cardiac and renal disease, similar to ARB and ACEI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps963vjFKgbLVg90H21EOLACvtfcHk0lgWUqHtuGFm8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb%252FE&md5=78d52f0c5777984736d2c1e9ba99892f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2Fs10557-008-6131-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10557-008-6131-x%26sid%3Dliteratum%253Aachs%26aulast%3DMajor%26aufirst%3DT.%2BC.%26aulast%3DOlszewski%26aufirst%3DB.%26aulast%3DRosebury%26aufirst%3DW.%26aulast%3DOkerberg%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DOstroski%26aufirst%3DR.%26aulast%3DSchroeder%26aufirst%3DR.%26aulast%3DKowala%26aufirst%3DM.%2BC.%26aulast%3DLeadley%26aufirst%3DR.%26atitle%3DA%2520nonpeptide%252C%2520piperidine%2520renin%2520inhibitor%2520provides%2520renal%2520and%2520cardiac%2520protection%2520in%2520double-transgenic%2520mice%2520expressing%2520human%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DCardiovasc.%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D469%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rossenbacker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priori, S.</span><span> </span><span class="NLM_article-title">New insights into the long-QT syndrome</span> <span class="citation_source-journal">Rev. Esp. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1157%2F13108271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17663850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD2svmvFyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=675-682&author=T.+Rossenbackerauthor=S.+Priori&title=New+insights+into+the+long-QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97aR"><div class="casContent"><span class="casTitleNuber">97a</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the long-QT syndrome</span></div><div class="casAuthors">Rossenbacker Tom; Priori Silvia G</div><div class="citationInfo"><span class="NLM_cas:title">Revista espanola de cardiologia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">675-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA9TlTJBl0iCXXDYhVZBdlfW6udTcc2eaq0eERzs0G27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svmvFyitQ%253D%253D&md5=b7a76770e9c3ca8ac20e7a085b3e68e4</span></div><a href="/servlet/linkout?suffix=cit97a&amp;dbid=16384&amp;doi=10.1157%2F13108271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1157%252F13108271%26sid%3Dliteratum%253Aachs%26aulast%3DRossenbacker%26aufirst%3DT.%26aulast%3DPriori%26aufirst%3DS.%26atitle%3DNew%2520insights%2520into%2520the%2520long-QT%2520syndrome%26jtitle%3DRev.%2520Esp.%2520Cardiol.%26date%3D2007%26volume%3D60%26spage%3D675%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit97b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ponti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a COMFA study of hERG K<sup>+</sup> channel blockers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3844</span><span class="NLM_x">–</span> <span class="NLM_lpage">3853</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3844-3853&author=A.+Cavalliauthor=E.+Poluzziauthor=F.+De+Pontiauthor=M.+Recanatini&title=Toward+a+pharmacophore+for+drugs+inducing+the+long+QT+syndrome%3A+insights+from+a+COMFA+study+of+hERG+K%2B+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97bR"><div class="casContent"><span class="casTitleNuber">97b</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers</span></div><div class="casAuthors">Cavalli, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio; Recanatini, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3844-3853</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present a pharmacophore for QT-prolonging drugs, along with a 3D QSAR (CoMFA) study for a series of very structurally variegate HERG K+ channel blockers.  The blockade of HERG K+ channels is one of the most important mol. mechanisms through which QT-prolonging drugs increase cardiac action potential duration.  Since QT prolongation is one of the most undesirable side effects of drugs, we first tried to identify the min. set of mol. features responsible for this action and then we attempted to develop a quant. model correlating the 3D stereoelectronic characteristics of the mols. with their HERG blocking potency.  Having considered an initial set of 31 QT-prolonging drugs for which the HERG K+ channel blocking activity was measured on mammalian transfected cells, we started the construction of a theor. screening tool able to predict whether a new mol. can interact with the HERG channel and eventually induce the long QT syndrome.  This in silico tool might be useful in the design of new drug candidates devoid of the physicochem. features likely to cause the above-mentioned side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WFt3kf6ZVLVg90H21EOLACvtfcHk0liATGK23gR4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D&md5=5e980476ccc9a8a6244aaab230eeb701</span></div><a href="/servlet/linkout?suffix=cit97b&amp;dbid=16384&amp;doi=10.1021%2Fjm0208875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208875%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPoluzzi%26aufirst%3DE.%26aulast%3DDe%2BPonti%26aufirst%3DF.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DToward%2520a%2520pharmacophore%2520for%2520drugs%2520inducing%2520the%2520long%2520QT%2520syndrome%253A%2520insights%2520from%2520a%2520COMFA%2520study%2520of%2520hERG%2520K%252B%2520channel%2520blockers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3844%26epage%3D3853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit97c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pearlstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">Understanding the structure−activity relationship of the human ether-a-go-go-related gene cardiac K<sup>+</sup> channel. A model for bad behavior</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2017</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2017-2022&author=R.+Pearlsteinauthor=R.+Vazauthor=D.+Rampe&title=Understanding+the+structure%E2%88%92activity+relationship+of+the+human+ether-a-go-go-related+gene+cardiac+K%2B+channel.+A+model+for+bad+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97c&amp;dbid=16384&amp;doi=10.1021%2Fjm0205651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205651%26sid%3Dliteratum%253Aachs%26aulast%3DPearlstein%26aufirst%3DR.%26aulast%3DVaz%26aufirst%3DR.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DUnderstanding%2520the%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520the%2520human%2520ether-a-go-go-related%2520gene%2520cardiac%2520K%252B%2520channel.%2520A%2520model%2520for%2520bad%2520behavior%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2017%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Ayalasomayajula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flannery, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieterich, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span> </span><span class="NLM_article-title">Effects of aliskiren, a direct renin inhibitor, on cardiac repolarization and conduction in healthy subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1177%2F0091270008319330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18490495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFyht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=799-811&author=S.+Ayalasomayajulaauthor=C.-M.+Yehauthor=S.+Vaidyanathanauthor=B.+Flanneryauthor=H.+A.+Dieterichauthor=D.+Howardauthor=M.+P.+Bedigianauthor=W.+P.+Dole&title=Effects+of+aliskiren%2C+a+direct+renin+inhibitor%2C+on+cardiac+repolarization+and+conduction+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of aliskiren, a direct renin inhibitor, on cardiac repolarization and conduction in healthy subjects</span></div><div class="casAuthors">Ayalasomayajula, Surya; Yeh, Ching-Ming; Vaidyanathan, Sujata; Flannery, Brian; Dieterich, Hans Armin; Howard, Dan; Bedigian, Martin P.; Dole, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">799-811</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">This multicenter, double-blind study evaluated the effects of aliskiren, a direct renin inhibitor approved for hypertension, on cardiac repolarization and conduction.  Healthy volunteers (n = 298) were randomized to aliskiren 300 mg, aliskiren 1200 mg, moxifloxacin 400 mg (pos. control), or placebo once daily for 7 days.  Digitized electrocardiograms were obtained at baseline and day 7 of treatment over 23 h postdose.  Placebo-adjusted mean changes from baseline in QTcF (Fridericia cor.), QTcI (individualized correction), PR, and QRS intervals were compared at each time point (time-matched anal.) and for values averaged across the dosing period (baseline-averaged anal.).  In time-matched anal., mean changes in QTcF with aliskiren were below predefined limits for QTc prolongation (mean increase <5 ms; upper 90% confidence interval [CI] <10 ms) except aliskiren 1200 mg at 23 h (5.2 ms; 90% CI 2.2, 8.1).  With moxifloxacin, significant QTcF prolongation occurred at most time points, confirming the sensitivity of the assay.  Baseline-averaged anal. was consistent with time-matched anal.  Instances of QTcF interval >450 ms or a >30-ms increase from baseline with aliskiren (≤1 %) were similar or lower than placebo (≤4 %).  Results were similar for QTcI.  Aliskiren had no effect on PR or QRS duration.  In conclusion, aliskiren at the highest approved dose (300 mg) and a 4-fold higher dose had no effect on cardiac repolarization or conduction in healthy volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozwxY7oDfZurVg90H21EOLACvtfcHk0liATGK23gR4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFyht7Y%253D&md5=c60c2b5f1f563bf5830d75239539c396</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1177%2F0091270008319330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270008319330%26sid%3Dliteratum%253Aachs%26aulast%3DAyalasomayajula%26aufirst%3DS.%26aulast%3DYeh%26aufirst%3DC.-M.%26aulast%3DVaidyanathan%26aufirst%3DS.%26aulast%3DFlannery%26aufirst%3DB.%26aulast%3DDieterich%26aufirst%3DH.%2BA.%26aulast%3DHoward%26aufirst%3DD.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26aulast%3DDole%26aufirst%3DW.%2BP.%26atitle%3DEffects%2520of%2520aliskiren%252C%2520a%2520direct%2520renin%2520inhibitor%252C%2520on%2520cardiac%2520repolarization%2520and%2520conduction%2520in%2520healthy%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D48%26spage%3D799%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harootunian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, J. E.</span><span> </span><span class="NLM_article-title">Characterization of voltage-gated sodium-channel lockers by electrical stimulation and fluorescence detection of membrane potential</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=439-446&author=C.-J.+Huangauthor=A.+Harootunianauthor=M.+P.+Maherauthor=C.+Quanauthor=C.+D.+Rajauthor=K.+McCormackauthor=R.+Numannauthor=P.+A.+Negulescuauthor=J.+E.+Gonz%C3%A1lez&title=Characterization+of+voltage-gated+sodium-channel+lockers+by+electrical+stimulation+and+fluorescence+detection+of+membrane+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-J.%26aulast%3DHarootunian%26aufirst%3DA.%26aulast%3DMaher%26aufirst%3DM.%2BP.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DRaj%26aufirst%3DC.%2BD.%26aulast%3DMcCormack%26aufirst%3DK.%26aulast%3DNumann%26aufirst%3DR.%26aulast%3DNegulescu%26aufirst%3DP.%2BA.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DJ.%2BE.%26atitle%3DCharacterization%2520of%2520voltage-gated%2520sodium-channel%2520lockers%2520by%2520electrical%2520stimulation%2520and%2520fluorescence%2520detection%2520of%2520membrane%2520potential%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D439%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit99b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Balser, J. R.</span><span> </span><span class="NLM_article-title">The cardiac sodium channel: gating function and molecular pharmacology</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1006%2Fjmcc.2000.1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=11273715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFyls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=599-613&author=J.+R.+Balser&title=The+cardiac+sodium+channel%3A+gating+function+and+molecular+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99bR"><div class="casContent"><span class="casTitleNuber">99b</span><div class="casTitle"><span class="NLM_cas:atitle">The Cardiac Sodium Channel: Gating Function and Molecular Pharmacology</span></div><div class="casAuthors">Balser, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">599-613</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 127 refs.  Cardiac sodium (Na) channels are dynamic mols. that undergo rapid structural changes in response to the changing elec. field in the myocardium.  Inherited mutations in SCN5A, the gene encoding the cardiac Na channel, provoke life-threatening cardiac arrhythmias, often by modifying these voltage-dependent conformational changes.  These disorders (i.e. the long QT syndrome and Brugada syndrome) may serve as valuable models for understanding the mechanistic linkages between Na channel dysfunction and cardiac arrhythmias in more common, acquired conditions such as cardiac ischemia.  In addn., the balance between therapeutic and adverse effects from Na channel blockade by antiarrhythmic compds. may be shifted by subtle alterations in Na channel function.  This review examines recent studies that tie key loci in the Na channel primary sequence to its dynamic function, while examg. the emerging themes linking Na channel structure, function, and pharmacol. to inherited and acquired disorders of cardiac excitability.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPSEXQi3ImrVg90H21EOLACvtfcHk0lh79adH5DaNMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFyls70%253D&md5=a32e6cdeb2ec35bf8b26c91ee69162b0</span></div><a href="/servlet/linkout?suffix=cit99b&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2000.1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2000.1346%26sid%3Dliteratum%253Aachs%26aulast%3DBalser%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520cardiac%2520sodium%2520channel%253A%2520gating%2520function%2520and%2520molecular%2520pharmacology%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2001%26volume%3D33%26spage%3D599%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Splawski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timothy, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachse, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span> </span><span class="NLM_article-title">Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8089</span><span class="NLM_x">–</span> <span class="NLM_lpage">8096</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8089-8096&author=I.+Splawskiauthor=K.+W.+Timothyauthor=N.+Decherauthor=P.+Kumarauthor=F.+B.+Sachseauthor=A.+H.+Beggsauthor=M.+C.+Sanguinettiauthor=M.+T.+Keating&title=Severe+arrhythmia+disorder+caused+by+cardiac+L-type+calcium+channel+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSplawski%26aufirst%3DI.%26aulast%3DTimothy%26aufirst%3DK.%2BW.%26aulast%3DDecher%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DSachse%26aufirst%3DF.%2BB.%26aulast%3DBeggs%26aufirst%3DA.%2BH.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26atitle%3DSevere%2520arrhythmia%2520disorder%2520caused%2520by%2520cardiac%2520L-type%2520calcium%2520channel%2520mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D8089%26epage%3D8096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Oliver, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, F.</span><span> </span><span class="NLM_article-title">Unique specificity of mouse angiotensinogen to homologous renin</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">926</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=4288259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaF28XksF2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1966&pages=923-926&author=W.+J.+Oliverauthor=F.+Gross&title=Unique+specificity+of+mouse+angiotensinogen+to+homologous+renin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Unique specificity of mouse angiotensinogen to homologous renin</span></div><div class="casAuthors">Oliver, W. J.; Gross, F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-6</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">Angiotensinogen contained in mouse plasma reacted exclusively with mouse kidney ext. contg. renin to release angiotensin.  Renin or kidney exts. from other species (pig, rat, hamster, rabbit), as well as from man, did not liberate angiotensin when incubated with the mouse plasma substrate.  The specificity of the mouse angiotensinogen for homologous renin was not due to inactivation of the heterologous renin, since hog renin retained its enzymic activity for other substrates after incubation with mouse plasma.  Plasma from nephrectomized mice, when incubated with mouse kidney ext., gave 6-7-fold higher yields of angiotensin-like substances than did plasma from normal mice.  Subcutaneous administration of deoxycorticosterone acetate (200 mg./kg. weekly) in conjunction with salt loading (1% saline as drinking fluid) for 3 weeks reduced renin activity in mouse kidney exts., but not as markedly as in rats.  That the bond of mouse angiotensinogen was not split by heterologous renin enzymes was suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc3viPm-bN5LVg90H21EOLACvtfcHk0lh79adH5DaNMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XksF2isb4%253D&md5=a7d94301d114292cdb3eef61a5879153</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DW.%2BJ.%26aulast%3DGross%26aufirst%3DF.%26atitle%3DUnique%2520specificity%2520of%2520mouse%2520angiotensinogen%2520to%2520homologous%2520renin%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1966%26volume%3D122%26spage%3D923%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frishman, W. H.</span><span> </span><span class="NLM_article-title">Renin inhibition: a novel therapy for cardiovascular disease</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1996&pages=1024-1034&author=C.+Linauthor=W.+H.+Frishman&title=Renin+inhibition%3A+a+novel+therapy+for+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3DRenin%2520inhibition%253A%2520a%2520novel%2520therapy%2520for%2520cardiovascular%2520disease%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1996%26volume%3D131%26spage%3D1024%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgiarini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, K. G.</span><span> </span><span class="NLM_article-title">Effects of a specific and long-acting renin inhibitor in the marmoset</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1985&pages=797-803&author=J.+M.+Woodauthor=N.+Gulatiauthor=P.+Forgiariniauthor=W.+Fuhrerauthor=K.+G.+Hofbauer&title=Effects+of+a+specific+and+long-acting+renin+inhibitor+in+the+marmoset"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DGulati%26aufirst%3DN.%26aulast%3DForgiarini%26aufirst%3DP.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DHofbauer%26aufirst%3DK.%2BG.%26atitle%3DEffects%2520of%2520a%2520specific%2520and%2520long-acting%2520renin%2520inhibitor%2520in%2520the%2520marmoset%26jtitle%3DHypertension%26date%3D1985%26volume%3D7%26spage%3D797%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-200502000-00025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=15662231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=417-426&author=J.+M.+Woodauthor=C.+R.+Schnellauthor=F.+Cuminauthor=J.+Menardauthor=R.+L.+Webb&title=Aliskiren%2C+a+novel%2C+orally+effective+renin+inhibitor%2C+lowers+blood+pressure+in+marmosets+and+spontaneously+hypertensive+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats</span></div><div class="casAuthors">Wood, Jeanette M.; Schnell, Christian R.; Cumin, Frederic; Menard, Joel; Webb, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-426</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Aliskiren is a new renin inhibitor of a novel structural class that has recently been shown to be efficacious in hypertensive patients after once-daily oral dosing.  We report the results of animal expts. performed in marmosets and rats to characterize aliskiren before its recent investigation in humans.  The effects of aliskiren were investigated in sodium-depleted marmosets (oral dosing) and in spontaneously hypertensive rats (dosing via s.c. osmotic minipumps).  Blood pressure (BP) and heart rate were measured by radiotelemetry.  In sodium-depleted marmosets, single oral doses of aliskiren (1-30 mg/kg) dose-dependently lowered BP.  At a dose of 3 mg/kg, peak effects were obsd. 1 h after dosing (-30±4 mmHg, n = 6) and the response persisted for more than 12 h.  A single oral dose of 3 mg/kg aliskiren was more effective than the same dose of either remikiren or zankiren, two orally active renin inhibitors previously tested in humans.  Aliskiren (10 mg/kg) was at least as effective as equal doses of the AT1-receptor blocker valsartan or the angiotensin-converting enzyme inhibitor benazepril.  In spontaneously hypertensive rats, aliskiren dose-dependently (10-100 mg/kg per day) decreased BP.  Aliskiren also potentiated the antihypertensive effects of low doses of valsartan or benazeprilat (1 or 3 mg/kg per day).  Aliskiren is an orally effective, long-lasting renin inhibitor that shows antihypertensive efficacy in animals superior to previous renin inhibitors and at least equiv. to angiotensin-converting enzyme inhibitors and AT1-receptor blockers.  Aliskiren may therefore represent an effective, novel approach to the treatment of hypertension and related disorders, alone or in combination with other antihypertensive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWe-dL5dfgb7Vg90H21EOLACvtfcHk0lh79adH5DaNMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFCgtw%253D%253D&md5=a18e83e1bac88fc6195f70d0f8986996</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1097%2F00004872-200502000-00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200502000-00025%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26atitle%3DAliskiren%252C%2520a%2520novel%252C%2520orally%2520effective%2520renin%2520inhibitor%252C%2520lowers%2520blood%2520pressure%2520in%2520marmosets%2520and%2520spontaneously%2520hypertensive%2520rats%26jtitle%3DJ.%2520Hypertens.%26date%3D2005%26volume%3D23%26spage%3D417%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Fossa, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePasquale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winslow, R. L.</span><span> </span><span class="NLM_article-title">Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1994&pages=422-428&author=A.+A.+Fossaauthor=M.+J.+DePasqualeauthor=L.+J.+Ringerauthor=R.+L.+Winslow&title=Synergistic+effect+on+reduction+in+blood+pressure+with+coadministration+of+a+renin+inhibitor+or+an+angiotensin-converting+enzyme+inhibitor+with+an+angiotensin+II+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFossa%26aufirst%3DA.%2BA.%26aulast%3DDePasquale%26aufirst%3DM.%2BJ.%26aulast%3DRinger%26aufirst%3DL.%2BJ.%26aulast%3DWinslow%26aufirst%3DR.%2BL.%26atitle%3DSynergistic%2520effect%2520on%2520reduction%2520in%2520blood%2520pressure%2520with%2520coadministration%2520of%2520a%2520renin%2520inhibitor%2520or%2520an%2520angiotensin-converting%2520enzyme%2520inhibitor%2520with%2520an%2520angiotensin%2520II%2520receptor%2520antagonist%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1994%26volume%3D33%26spage%3D422%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Ohkubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakehi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">5153</span><span class="NLM_x">–</span> <span class="NLM_lpage">5157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=5153-5157&author=H.+Ohkuboauthor=H.+Kawakamiauthor=Y.+Kakehiauthor=T.+Takumiauthor=H.+Araiauthor=Y.+Yokotaauthor=M.+Iwaiauthor=Y.+Tanabeauthor=M.+Masuauthor=J.+Hataauthor=H.+Iwaoauthor=H.+Okamotoauthor=M.+Yokoyamaauthor=T.+Nomuraauthor=M.+Katsukiauthor=S.+Nakanishi&title=Generation+of+transgenic+mice+with+elevated+blood+pressure+by+introduction+of+the+rat+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DH.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DKakehi%26aufirst%3DY.%26aulast%3DTakumi%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYokota%26aufirst%3DY.%26aulast%3DIwai%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DY.%26aulast%3DMasu%26aufirst%3DM.%26aulast%3DHata%26aufirst%3DJ.%26aulast%3DIwao%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DKatsuki%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DGeneration%2520of%2520transgenic%2520mice%2520with%2520elevated%2520blood%2520pressure%2520by%2520introduction%2520of%2520the%2520rat%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D5153%26epage%3D5157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Bohlender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippoldt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span> </span><span class="NLM_article-title">High human renin hypertension in transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=428-434&author=J.+Bohlenderauthor=A.+Fukamizuauthor=A.+Lippoldtauthor=T.+Nomuraauthor=R.+Dietzauthor=J.+Menardauthor=K.+Murakamiauthor=F.+C.+Luftauthor=D.+Ganten&title=High+human+renin+hypertension+in+transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohlender%26aufirst%3DJ.%26aulast%3DFukamizu%26aufirst%3DA.%26aulast%3DLippoldt%26aufirst%3DA.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DR.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DGanten%26aufirst%3DD.%26atitle%3DHigh%2520human%2520renin%2520hypertension%2520in%2520transgenic%2520rats%26jtitle%3DHypertension%26date%3D1997%26volume%3D29%26spage%3D428%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Shimokama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haraoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span> </span><span class="NLM_article-title">The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis</span> <span class="citation_source-journal">Virchows Arch</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2Fs004280050152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9504863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1cXos12isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=1998&pages=169-175&author=T.+Shimokamaauthor=S.+Haraokaauthor=H.+Horiguchiauthor=F.+Sugiyamaauthor=K.+Murakamiauthor=T.+Watanabe&title=The+Tsukuba+hypertensive+mouse+%28transgenic+mouse+carrying+human+genes+for+both+renin+and+angiotensinogen%29+as+a+model+of+human+malignant+hypertension%3A+development+of+lesions+and+morphometric+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis</span></div><div class="casAuthors">Shimokama, Tatsuro; Haraoka, Seij; Horiguchi, Hisashi; Sugiyama, Fumihiro; Murakami, Kazuo; Watanabe, T.</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-175</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The renin-angiotensin system has a pivotal role in hypertension.  The Tsukuba hypertensive mouse (THM; a transgenic mouse carrying human genes for both renin and angiotensinogen) was generated to allow further examn. of the renin-angiotensin system in a variety of pathol. conditions.  We evaluated the development of renal lesions in these mice and in controls by morphometric, immunohistochem. and ultrastructural methods.  Blood pressure was significantly higher in THM than in control mice; 1 yr after birth, it was ∼40 mmHg higher.  The kidney-to-body wt. ratio was also higher in THM than in control.  Morphometric anal. revealed that the glomerular sclerosis index was significantly elevated in THM with 10 of the glomeruli sclerotic at 18 mo.  The grade of vascular lesion and the frequency of fibrinoid arteritis of the kidney exhibited the same tendency as the glomerular sclerosis index.  Murine renin was located exclusively in the juxtaglomerular app., whereas human renin was expressed not only in the juxtaglomerular app., but also in periarteriolar smooth muscle cells and in mesangial and epithelial cells of the glomeruli.  Light and electron microscopy revealed significant fibrinoid arteritis of the kidney in THM and also "onion skinning", both pathognomonic for malignant nephrosclerosis.  THM may be an excellent model of human malignant hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog-D9cPZEPrrVg90H21EOLACvtfcHk0liIYQfYkVKD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXos12isg%253D%253D&md5=e86071b97857a9dac36c760258d3c119</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1007%2Fs004280050152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004280050152%26sid%3Dliteratum%253Aachs%26aulast%3DShimokama%26aufirst%3DT.%26aulast%3DHaraoka%26aufirst%3DS.%26aulast%3DHoriguchi%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DF.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26atitle%3DThe%2520Tsukuba%2520hypertensive%2520mouse%2520%2528transgenic%2520mouse%2520carrying%2520human%2520genes%2520for%2520both%2520renin%2520and%2520angiotensinogen%2529%2520as%2520a%2520model%2520of%2520human%2520malignant%2520hypertension%253A%2520development%2520of%2520lesions%2520and%2520morphometric%2520analysis%26jtitle%3DVirchows%2520Arch%26date%3D1998%26volume%3D432%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shagdarsuren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Low dose inhibitor and low dose AT1 receptor blocker therapy ameliorate target organ change in rats harbouring renin and angiotensinogen genes</span> <span class="citation_source-journal">J. Renin−Angiotenin−Aldosterone Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=81-84&author=R.+Dechendauthor=E.+Shagdarsurenauthor=P.+Gratzeauthor=A.+Fiebelerauthor=B.+Pilzauthor=S.+Meinersauthor=W.+Dererauthor=D.+L.+Feldmanauthor=R.+L.+Webbauthor=D.+N.+M%C3%BCller&title=Low+dose+inhibitor+and+low+dose+AT1+receptor+blocker+therapy+ameliorate+target+organ+change+in+rats+harbouring+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DShagdarsuren%26aufirst%3DE.%26aulast%3DGratze%26aufirst%3DP.%26aulast%3DFiebeler%26aufirst%3DA.%26aulast%3DPilz%26aufirst%3DB.%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DDerer%26aufirst%3DW.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DLow%2520dose%2520inhibitor%2520and%2520low%2520dose%2520AT1%2520receptor%2520blocker%2520therapy%2520ameliorate%2520target%2520organ%2520change%2520in%2520rats%2520harbouring%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DJ.%2520Renin%25E2%2588%2592Angiotenin%25E2%2588%2592Aldosterone%2520Syst.%26date%3D2007%26volume%3D8%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contrepas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span> </span><span class="NLM_article-title">Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=130-136&author=D.+L.+Feldmanauthor=L.+Jinauthor=H.+Xuanauthor=A.+Contrepasauthor=Y.+Zhouauthor=R.+L.+Webbauthor=D.+N.+M%C3%BCllerauthor=S.+Feldtauthor=F.+Cuminauthor=W.+Maniaraauthor=E.+Persohnauthor=H.+Schuetzauthor=A.+H.+J.+Danserauthor=G.+Nguyen&title=Effects+of+aliskiren+on+blood+pressure%2C+albuminuria%2C+and+%28pro%29renin+receptor+expression+in+diabetic+TG%28mRen-2%2927+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DXuan%26aufirst%3DH.%26aulast%3DContrepas%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DSchuetz%26aufirst%3DH.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DNguyen%26aufirst%3DG.%26atitle%3DEffects%2520of%2520aliskiren%2520on%2520blood%2520pressure%252C%2520albuminuria%252C%2520and%2520%2528pro%2529renin%2520receptor%2520expression%2520in%2520diabetic%2520TG%2528mRen-2%252927%2520rats%26jtitle%3DHypertension%26date%3D2008%26volume%3D52%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Kelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, R. E.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2398</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2398-2404&author=D.+J.+Kellyauthor=Y.+Zhangauthor=G.+Moeauthor=G.+Naikauthor=R.+E.+Gilbert&title=Aliskiren%2C+a+novel+renin+inhibitor%2C+is+renoprotective+in+a+model+of+advanced+diabetic+nephropathy+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoe%26aufirst%3DG.%26aulast%3DNaik%26aufirst%3DG.%26aulast%3DGilbert%26aufirst%3DR.%2BE.%26atitle%3DAliskiren%252C%2520a%2520novel%2520renin%2520inhibitor%252C%2520is%2520renoprotective%2520in%2520a%2520model%2520of%2520advanced%2520diabetic%2520nephropathy%2520in%2520rats%26jtitle%3DDiabetologia%26date%3D2007%26volume%3D50%26spage%3D2398%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Lastra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habibi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley-Connell, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manrique, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, J. R.</span><span> </span><span class="NLM_article-title">Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">2561</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2009&pages=2561-2568&author=G.+Lastraauthor=J.+Habibiauthor=A.+T.+Whaley-Connellauthor=C.+Manriqueauthor=M.+R.+Haydenauthor=J.+Rehmerauthor=K.+Patelauthor=C.+Ferrarioauthor=J.+R.+Sowers&title=Direct+renin+inhibition+improves+systemic+insulin+resistance+and+skeletal+muscle+glucose+transport+in+a+transgenic+rodent+model+of+tissue+renin+overexpression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLastra%26aufirst%3DG.%26aulast%3DHabibi%26aufirst%3DJ.%26aulast%3DWhaley-Connell%26aufirst%3DA.%2BT.%26aulast%3DManrique%26aufirst%3DC.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DRehmer%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DFerrario%26aufirst%3DC.%26aulast%3DSowers%26aufirst%3DJ.%2BR.%26atitle%3DDirect%2520renin%2520inhibition%2520improves%2520systemic%2520insulin%2520resistance%2520and%2520skeletal%2520muscle%2520glucose%2520transport%2520in%2520a%2520transgenic%2520rodent%2520model%2520of%2520tissue%2520renin%2520overexpression%26jtitle%3DEndocrinology%26date%3D2009%26volume%3D150%26spage%3D2561%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Habibi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley-Connell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarco, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karuparthi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, J. R.</span><span> </span><span class="NLM_article-title">Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">5643</span><span class="NLM_x">–</span> <span class="NLM_lpage">5653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=5643-5653&author=J.+Habibiauthor=A.+Whaley-Connellauthor=M.+R.+Haydenauthor=V.+G.+DeMarcoauthor=R.+Schneiderauthor=S.+D.+Sowersauthor=P.+Karuparthiauthor=C.+M.+Ferrarioauthor=J.+R.+Sowers&title=Renin+inhibition+attenuates+insulin+resistance%2C+oxidative+stress%2C+and+pancreatic+remodeling+in+the+transgenic+Ren2+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHabibi%26aufirst%3DJ.%26aulast%3DWhaley-Connell%26aufirst%3DA.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DDeMarco%26aufirst%3DV.%2BG.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSowers%26aufirst%3DS.%2BD.%26aulast%3DKaruparthi%26aufirst%3DP.%26aulast%3DFerrario%26aufirst%3DC.%2BM.%26aulast%3DSowers%26aufirst%3DJ.%2BR.%26atitle%3DRenin%2520inhibition%2520attenuates%2520insulin%2520resistance%252C%2520oxidative%2520stress%252C%2520and%2520pancreatic%2520remodeling%2520in%2520the%2520transgenic%2520Ren2%2520rat%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D5643%26epage%3D5653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Whaley-Connell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habibi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarco, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, J. R.</span><span> </span><span class="NLM_article-title">Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">E103</span><span class="NLM_x">–</span> <span class="NLM_lpage">E109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2008&pages=E103-E109&author=A.+Whaley-Connellauthor=J.+Habibiauthor=S.+A.+Cooperauthor=V.+G.+DeMarcoauthor=M.+R.+Haydenauthor=C.+S.+Stumpauthor=D.+Linkauthor=C.+M.+Ferrarioauthor=J.+R.+Sowers&title=Effect+of+renin+inhibition+and+AT1R+blockade+on+myocardial+remodeling+in+the+transgenic+Ren2+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhaley-Connell%26aufirst%3DA.%26aulast%3DHabibi%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DS.%2BA.%26aulast%3DDeMarco%26aufirst%3DV.%2BG.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DStump%26aufirst%3DC.%2BS.%26aulast%3DLink%26aufirst%3DD.%26aulast%3DFerrario%26aufirst%3DC.%2BM.%26aulast%3DSowers%26aufirst%3DJ.%2BR.%26atitle%3DEffect%2520of%2520renin%2520inhibition%2520and%2520AT1R%2520blockade%2520on%2520myocardial%2520remodeling%2520in%2520the%2520transgenic%2520Ren2%2520rat%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2008%26volume%3D295%26spage%3DE103%26epage%3DE109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Direct renin inhibition with aliskiren in hypertension and target organ damage</span> <span class="citation_source-journal">Clin. J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD2svotF2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=221-228&author=D.+N.+M%C3%BCllerauthor=F.+C.+Luft&title=Direct+renin+inhibition+with+aliskiren+in+hypertension+and+target+organ+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Direct renin inhibition with aliskiren in hypertension and target organ damage</span></div><div class="casAuthors">Muller Dominik N; Luft Friedrich C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical journal of the American Society of Nephrology : CJASN</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">221-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Joint National Committee and the World Health Organization are in agreement that hypertension in most patients who are treated is controlled inadequately and that rates of cardiovascular morbidity remain high.  Additional pharmacologic treatments could ameliorate this situation.  The renin-angiotensin-aldosterone system has been a highly successful pharmacologic target, as the system is strongly implicated in the development of hypertension-related target organ damage.  However, compensatory increases in plasma renin levels that lead to adjustments in angiotensin production and conversion present limitations for existing renin-angiotensin-aldosterone system inhibitors.  A once-daily, orally effective, small-molecule renin inhibitor, aliskiren, is now available to address angiotensin production directly at its rate-limiting step.  Studies in humans attest to an effective BP-lowering effect, a side effect profile no different from AT1 receptor blockers, and the option of combination therapies.  A novel animal model of high human renin hypertension in the rat attest to target organ protection.  Because angiotensin receptor blockade, angiotensin-converting enzyme inhibition, calcium channel blockade, and diuretic therapy all lead to sharp increases in plasma renin activity, aliskiren offers a novel circumvention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_VeHAyBnlYJotVjB3IRIyfW6udTcc2eZWvbNE2ZyJqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svotF2itw%253D%253D&md5=b86d2df441ff4fd985bd488dbbc17702</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DDirect%2520renin%2520inhibition%2520with%2520aliskiren%2520in%2520hypertension%2520and%2520target%2520organ%2520damage%26jtitle%3DClin.%2520J.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2006%26volume%3D1%26spage%3D221%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rateri, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnigo, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oesterling, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassis, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugherty, A.</span><span> </span><span class="NLM_article-title">Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=984-993&author=H.+Luauthor=D.+L.+Rateriauthor=D.+L.+Feldmanauthor=R.+J.+Charnigoauthor=A.+Fukamizuauthor=J.+Ishidaauthor=E.+G.+Oesterlingauthor=L.+A.+Cassisauthor=A.+Daugherty&title=Renin+inhibition+reduces+hypercholesterolemia-induced+atherosclerosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DRateri%26aufirst%3DD.%2BL.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DCharnigo%26aufirst%3DR.%2BJ.%26aulast%3DFukamizu%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DJ.%26aulast%3DOesterling%26aufirst%3DE.%2BG.%26aulast%3DCassis%26aufirst%3DL.%2BA.%26aulast%3DDaugherty%26aufirst%3DA.%26atitle%3DRenin%2520inhibition%2520reduces%2520hypercholesterolemia-induced%2520atherosclerosis%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubert, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzourene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haypz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzolai, L.</span><span> </span><span class="NLM_article-title">Renin inhibition by aliskiren prevents atherosclerosis progression</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1306-1311&author=J.+Nussbergerauthor=J.+F.+Aubertauthor=K.+Bouzoureneauthor=M.+Pellegrinauthor=D.+Haypzauthor=L.+Mazzolai&title=Renin+inhibition+by+aliskiren+prevents+atherosclerosis+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DAubert%26aufirst%3DJ.%2BF.%26aulast%3DBouzourene%26aufirst%3DK.%26aulast%3DPellegrin%26aufirst%3DM.%26aulast%3DHaypz%26aufirst%3DD.%26aulast%3DMazzolai%26aufirst%3DL.%26atitle%3DRenin%2520inhibition%2520by%2520aliskiren%2520prevents%2520atherosclerosis%2520progression%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D1306%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Imanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujioka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikejima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takarada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitabata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muragaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akasaka, T.</span><span> </span><span class="NLM_article-title">Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=563-572&author=T.+Imanishiauthor=H.+Tsujiokaauthor=H.+Ikejimaauthor=A.+Kuroiauthor=S.+Takaradaauthor=H.+Kitabataauthor=T.+Tanimotoauthor=Y.+Muragakiauthor=S.+Mochizukiauthor=M.+Gotoauthor=K.+Yoshidaauthor=T.+Akasaka&title=Renin+inhibitor+aliskiren+improves+impaired+nitric+oxide+bioavailability+and+protects+against+atherosclerotic+changes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImanishi%26aufirst%3DT.%26aulast%3DTsujioka%26aufirst%3DH.%26aulast%3DIkejima%26aufirst%3DH.%26aulast%3DKuroi%26aufirst%3DA.%26aulast%3DTakarada%26aufirst%3DS.%26aulast%3DKitabata%26aufirst%3DH.%26aulast%3DTanimoto%26aufirst%3DT.%26aulast%3DMuragaki%26aufirst%3DY.%26aulast%3DMochizuki%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DAkasaka%26aufirst%3DT.%26atitle%3DRenin%2520inhibitor%2520aliskiren%2520improves%2520impaired%2520nitric%2520oxide%2520bioavailability%2520and%2520protects%2520against%2520atherosclerotic%2520changes%26jtitle%3DHypertension%26date%3D2008%26volume%3D52%26spage%3D563%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Renin inhibition and atherosclerosis</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1093%2Fndt%2Fgfn184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18430802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD1cvotVOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=2474-2476&author=F.+C.+Luft&title=Renin+inhibition+and+atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition and atherosclerosis</span></div><div class="casAuthors">Luft Friedrich C</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2474-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-SZnNmcTbrT69zv1FsJFMfW6udTcc2eZWvbNE2ZyJqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvotVOjtQ%253D%253D&md5=5915d59bb13a0e21b75553ea5e25b211</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfn184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfn184%26sid%3Dliteratum%253Aachs%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DRenin%2520inhibition%2520and%2520atherosclerosis%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2008%26volume%3D23%26spage%3D2474%26epage%3D2476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span> </span><span class="NLM_article-title">The intracellular renin−angiotensin system: a new paradigm</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.tem.2007.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17509892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFejtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=208-214&author=R.+Kumarauthor=V.+P.+Singhauthor=K.+M.+Baker&title=The+intracellular+renin%E2%88%92angiotensin+system%3A+a+new+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The intracellular renin-angiotensin system: A new paradigm</span></div><div class="casAuthors">Kumar, Rajesh; Singh, Vivek P.; Baker, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  More than a century after its discovery, the physiol. implications of the renin-angiotensin system (RAS) continue to expand, with the identification of new components, functions and subsystems.  These advancements have led to better management and understanding of a broad range of cardiovascular and metabolic disorders.  The RAS has traditionally been viewed as a circulatory system, involved in the short-term regulation of vol. and blood pressure homeostasis.  Recently, local RASs have been described as regulators of chronic tissue effects.  Most recently, studies have provided evidence of a complete, functional RAS within cells, described as an intracrine' or intracellular system.  A more comprehensive understanding of the intracellular RAS provides for new strategies in system regulation and a more efficacious approach to the management of RAS-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra2J0RmYOdpbVg90H21EOLACvtfcHk0ljsGg_7MzIkDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFejtr0%253D&md5=cd0c44454a684204c2c7323ead88bae7</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2007.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2007.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26atitle%3DThe%2520intracellular%2520renin%25E2%2588%2592angiotensin%2520system%253A%2520a%2520new%2520paradigm%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D18%26spage%3D208%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Cook, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re, R. N.</span><span> </span><span class="NLM_article-title">In vitro evidence for an intracellular site of angiotensin action</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2001&pages=1138-1146&author=J.+L.+Cookauthor=Z.+Zhangauthor=R.+N.+Re&title=In+vitro+evidence+for+an+intracellular+site+of+angiotensin+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRe%26aufirst%3DR.%2BN.%26atitle%3DIn%2520vitro%2520evidence%2520for%2520an%2520intracellular%2520site%2520of%2520angiotensin%2520action%26jtitle%3DCirc.%2520Res.%26date%3D2001%26volume%3D89%26spage%3D1138%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Activation of the intracellular renin−angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">H1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">H1684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=H1675-H1684&author=V.+P.+Singhauthor=K.+M.+Bakerauthor=R.+Kumar&title=Activation+of+the+intracellular+renin%E2%88%92angiotensin+system+in+cardiac+fibroblasts+by+high+glucose%3A+role+in+extracellular+matrix+production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DActivation%2520of%2520the%2520intracellular%2520renin%25E2%2588%2592angiotensin%2520system%2520in%2520cardiac%2520fibroblasts%2520by%2520high%2520glucose%253A%2520role%2520in%2520extracellular%2520matrix%2520production%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DH1675%26epage%3DH1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khode, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3297</span><span class="NLM_x">–</span> <span class="NLM_lpage">3306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=3297-3306&author=V.+P.+Singhauthor=B.+Leauthor=R.+Khodeauthor=K.+M.+Bakerauthor=R.+Kumar&title=Intracellular+angiotensin+II+production+in+diabetic+rats+is+correlated+with+cardiomyocyte+apoptosis%2C+oxidative+stress%2C+and+cardiac+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DLe%26aufirst%3DB.%26aulast%3DKhode%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DIntracellular%2520angiotensin%2520II%2520production%2520in%2520diabetic%2520rats%2520is%2520correlated%2520with%2520cardiomyocyte%2520apoptosis%252C%2520oxidative%2520stress%252C%2520and%2520cardiac%2520fibrosis%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D3297%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Navar, L. G.; Langford, H. G.</span><span> </span><span class="NLM_article-title">Effects of Angiotensin on the Renal Circulation</span>. In  <span class="citation_source-book">Angiotensin</span>; <span class="NLM_contrib-group">Page, I. H.; Bumpus, F. M.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1974</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">455</span>− <span class="NLM_lpage">474</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1974&pages=455-474&author=L.+G.+Navar&author=H.+G.+Langfordauthor=I.+H.+Page&author=F.+M.+Bumpus&title=Angiotensin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNavar%26aufirst%3DL.%2BG.%26atitle%3DEffects%2520of%2520Angiotensin%2520on%2520the%2520Renal%2520Circulation%26btitle%3DAngiotensin%26aulast%3DPage%26aufirst%3DI.%2BH.%26pub%3DSpringer-Verlag%26date%3D1974%26spage%3D455%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Johnston, C. I.</span><span> </span><span class="NLM_article-title">Angiotensin Converting Enzyme Inhibitors</span>. In  <span class="citation_source-book">Handbook of Hypertension. Clinical Pharmacology of Antihypertensive Drugs</span>; <span class="NLM_contrib-group">Doyle, A. E.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1984</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">5</span>, pp  <span class="NLM_fpage">272</span>− <span class="NLM_lpage">311</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=272-311&author=C.+I.+Johnstonauthor=A.+E.+Doyle&title=Handbook+of+Hypertension.+Clinical+Pharmacology+of+Antihypertensive+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DC.%2BI.%26atitle%3DAngiotensin%2520Converting%2520Enzyme%2520Inhibitors%26btitle%3DHandbook%2520of%2520Hypertension.%2520Clinical%2520Pharmacology%2520of%2520Antihypertensive%2520Drugs%26aulast%3DDoyle%26aufirst%3DA.%2BE.%26pub%3DElsevier%26date%3D1984%26volume%3D5%26spage%3D272%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Zimmerman, B. G.</span><span> </span><span class="NLM_article-title">Blocking and agonistic actions of angiotensin antagonists in normotensive and hypertensive dogs</span> <span class="citation_source-journal">Cardiovasc. Med. N.Y.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1979&pages=231-241&author=B.+G.+Zimmerman&title=Blocking+and+agonistic+actions+of+angiotensin+antagonists+in+normotensive+and+hypertensive+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmerman%26aufirst%3DB.%2BG.%26atitle%3DBlocking%2520and%2520agonistic%2520actions%2520of%2520angiotensin%2520antagonists%2520in%2520normotensive%2520and%2520hypertensive%2520dogs%26jtitle%3DCardiovasc.%2520Med.%2520N.Y.%26date%3D1979%26volume%3D4%26spage%3D231%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Neisius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, K. G.</span><span> </span><span class="NLM_article-title">Renal vasodilatation after inhibition of renin or converting enzyme in marmoset</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">H897</span><span class="NLM_x">–</span> <span class="NLM_lpage">H902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1986&pages=H897-H902&author=D.+Neisiusauthor=J.+M.+Woodauthor=K.+G.+Hofbauer&title=Renal+vasodilatation+after+inhibition+of+renin+or+converting+enzyme+in+marmoset"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeisius%26aufirst%3DD.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DHofbauer%26aufirst%3DK.%2BG.%26atitle%3DRenal%2520vasodilatation%2520after%2520inhibition%2520of%2520renin%2520or%2520converting%2520enzyme%2520in%2520marmoset%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1986%26volume%3D251%26spage%3DH897%26epage%3DH902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Verburg, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinert, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chekal, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadam, J. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, G. A.</span><span> </span><span class="NLM_article-title">Renal hemodynamic and excretory responses to renin inhibition induced by A-64662</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=2179529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3cXhslajsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1990&pages=449-455&author=K.+M.+Verburgauthor=H.+D.+Kleinertauthor=M.+A.+Chekalauthor=J.+R.+C.+Kadamauthor=G.+A.+Young&title=Renal+hemodynamic+and+excretory+responses+to+renin+inhibition+induced+by+A-64662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Renal hemodynamic and excretory responses to renin inhibition induced by A-64662</span></div><div class="casAuthors">Verburg, Kenneth M.; Kleinert, Hollis D.; Chekal, Marcia A.; Kadam, Jill R. C.; Young, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-55</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Systemic A 64662 (I) infusion in sodium-depleted anesthetized monkeys elicits dose-related increases in renal blood flow.  Renal vasodilation accompanied inhibition of plasma renin activity and preceded changes in mean arterial pressure.  Changes in glomerular filtration rate were not obsd. resulting in a fall in the filtration fraction.  Renal excretory function was unaltered during A-64662 infusion except when hypotension was obsd.  The results are compatible with the concept that the renal hemodynamic and excretory effects of A-64662 are related, at least in part, to renin inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3ynC_4cFeYLVg90H21EOLACvtfcHk0lijJM3dB2k07Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslajsb4%253D&md5=1d2c81efbf701476f9b04766895f455e</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerburg%26aufirst%3DK.%2BM.%26aulast%3DKleinert%26aufirst%3DH.%2BD.%26aulast%3DChekal%26aufirst%3DM.%2BA.%26aulast%3DKadam%26aufirst%3DJ.%2BR.%2BC.%26aulast%3DYoung%26aufirst%3DG.%2BA.%26atitle%3DRenal%2520hemodynamic%2520and%2520excretory%2520responses%2520to%2520renin%2520inhibition%2520induced%2520by%2520A-64662%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1990%26volume%3D252%26spage%3D449%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Amrani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branca, Z.</span><span> </span><span class="NLM_article-title">Ro 42-5892 is a potent orally active renin inhibitor in primates</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1991&pages=22-31&author=W.+Fischliauthor=J.+P.+Clozelauthor=K.+El+Amraniauthor=W.+Wostlauthor=W.+Neidhartauthor=H.+Stadlerauthor=Z.+Branca&title=Ro+42-5892+is+a+potent+orally+active+renin+inhibitor+in+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DEl%2BAmrani%26aufirst%3DK.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DBranca%26aufirst%3DZ.%26atitle%3DRo%252042-5892%2520is%2520a%2520potent%2520orally%2520active%2520renin%2520inhibitor%2520in%2520primates%26jtitle%3DHypertension%26date%3D1991%26volume%3D18%26spage%3D22%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit129b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span> </span><span class="NLM_article-title">Ciprokiren (Ro 44-9375): a renin inhibitor with increasing effects on chronic treatment</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=163-169&author=W.+Fischliauthor=J.+P.+Clozelauthor=V.+Breuauthor=S.+Buchmannauthor=S.+Mathewsauthor=H.+Stadlerauthor=E.+Vieiraauthor=W.+Wostl&title=Ciprokiren+%28Ro+44-9375%29%3A+a+renin+inhibitor+with+increasing+effects+on+chronic+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DS.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWostl%26aufirst%3DW.%26atitle%3DCiprokiren%2520%2528Ro%252044-9375%2529%253A%2520a%2520renin%2520inhibitor%2520with%2520increasing%2520effects%2520on%2520chronic%2520treatment%26jtitle%3DHypertension%26date%3D1994%26volume%3D24%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">Comparative effects of three different potent renin inhibitors in primates</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=9-17&author=J.+P.+Clozelauthor=W.+Fischli&title=Comparative+effects+of+three+different+potent+renin+inhibitors+in+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DComparative%2520effects%2520of%2520three%2520different%2520potent%2520renin%2520inhibitors%2520in%2520primates%26jtitle%3DHypertension%26date%3D1993%26volume%3D22%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Richter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R. C.</span><span> </span><span class="NLM_article-title">Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=243-254&author=W.+F.+Richterauthor=B.+R.+Whitbyauthor=R.+C.+Chou&title=Distribution+of+remikiren%2C+a+potent+orally+active+inhibitor+of+human+renin%2C+in+laboratory+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DW.%2BF.%26aulast%3DWhitby%26aufirst%3DB.%2BR.%26aulast%3DChou%26aufirst%3DR.%2BC.%26atitle%3DDistribution%2520of%2520remikiren%252C%2520a%2520potent%2520orally%2520active%2520inhibitor%2520of%2520human%2520renin%252C%2520in%2520laboratory%2520animals%26jtitle%3DXenobiotica%26date%3D1996%26volume%3D26%26spage%3D243%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">El Amrani, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, J. B.</span><span> </span><span class="NLM_article-title">Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=231-239&author=A.+K.+El+Amraniauthor=J.+Menardauthor=M.+F.+Gonzalesauthor=J.+B.+Michel&title=Effects+of+blocking+the+angiotensin+II+receptor%2C+converting+enzyme%2C+and+renin+activity+on+the+renal+hemodynamics+of+normotensive+guinea+pigs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BAmrani%26aufirst%3DA.%2BK.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DGonzales%26aufirst%3DM.%2BF.%26aulast%3DMichel%26aufirst%3DJ.%2BB.%26atitle%3DEffects%2520of%2520blocking%2520the%2520angiotensin%2520II%2520receptor%252C%2520converting%2520enzyme%252C%2520and%2520renin%2520activity%2520on%2520the%2520renal%2520hemodynamics%2520of%2520normotensive%2520guinea%2520pigs%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1993%26volume%3D22%26spage%3D231%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Cordero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1991&pages=510-516&author=P.+Corderoauthor=N.+D.+Fisherauthor=T.+J.+Mooreauthor=R.+Gleasonauthor=G.+H.+Williamsauthor=N.+K.+Hollenberg&title=Renal+and+endocrine+responses+to+a+renin+inhibitor%2C+enalkiren%2C+in+normal+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCordero%26aufirst%3DP.%26aulast%3DFisher%26aufirst%3DN.%2BD.%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DGleason%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DRenal%2520and%2520endocrine%2520responses%2520to%2520a%2520renin%2520inhibitor%252C%2520enalkiren%252C%2520in%2520normal%2520humans%26jtitle%3DHypertension%26date%3D1991%26volume%3D17%26spage%3D510%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kifor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaboury, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Responses to converting enzyme and renin inhibition</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1994&pages=44-51&author=N.+D.+L.+Fisherauthor=D.+Allanauthor=I.+Kiforauthor=C.+L.+Gabouryauthor=G.+H.+Williamsauthor=T.+J.+Mooreauthor=N.+K.+Hollenberg&title=Responses+to+converting+enzyme+and+renin+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DAllan%26aufirst%3DD.%26aulast%3DKifor%26aufirst%3DI.%26aulast%3DGaboury%26aufirst%3DC.%2BL.%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DResponses%2520to%2520converting%2520enzyme%2520and%2520renin%2520inhibition%26jtitle%3DHypertension%26date%3D1994%26volume%3D23%26spage%3D44%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N.</span><span> </span><span class="NLM_article-title">Renal vascular responses to renin inhibition with zankiren in men</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2F0009-9236%2895%2990160-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=7697952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2MXlt1ektLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=342-348&author=N.+D.+L.+Fisherauthor=N.+Hollenberg&title=Renal+vascular+responses+to+renin+inhibition+with+zankiren+in+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Renal vascular responses to renin inhibition with zankiren in men</span></div><div class="casAuthors">Fisher, Naomi D. L.; Hollenberg, Norman</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-8</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Renin inhibition represents an alternative to angiotensin-converting enzyme (ACE) inhibition for pharmacol. interruption of the renin-angiotensin system.  In addn. to inhibiting the formation of angiotensin II, ACE inhibitors also inhibit the degrdn. of kinin and result in accumulation of powerful renal vasodilator prostaglandins and bradykinin.  We were therefore surprised by the large renal vasodilator response achieved with the renin inhibitor enalkiren, because substrate-specific renin inhibitors reduce the formation of angiotensin II without affecting other vasodilator mechanisms.  To det. whether previous findings were reflective of the renin inhibitor class, we studied 12 healthy men on a sodium-restricted diet, each of whom received two or three escalating oral doses of zankiren, a new agent.  Plasma renin activity decreased with the smallest dose (5 mg), and this effect was sustained.  The increase in renal plasma flow was clearly related to dose (r = 0.86, F = 9.67), reaching a max. of 134 ± 26 mL/min/1.73 m2 at 250 mg, the highest dose.  Renin inhibition exerts a remarkable renal vasodilator action, perhaps reflecting the lipophilicity of the agents developed to date, an action that may have clin. implications for the prevention of renal injury in patients at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjANAaP52o-LVg90H21EOLACvtfcHk0lgNUL9sDqGZEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlt1ektLs%253D&md5=f7550a73b4aceb2539f8fdfec715ca8a</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2F0009-9236%2895%2990160-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9236%252895%252990160-4%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DHollenberg%26aufirst%3DN.%26atitle%3DRenal%2520vascular%2520responses%2520to%2520renin%2520inhibition%2520with%2520zankiren%2520in%2520men%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D57%26spage%3D342%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=3199-3205&author=N.+D.+L.+Fisherauthor=A.+H.+J.+Danserauthor=J.+Nussbergerauthor=W.+P.+Doleauthor=N.+K.+Hollenberg&title=Renal+and+hormonal+responses+to+direct+renin+inhibition+with+aliskiren+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DDole%26aufirst%3DW.%2BP.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DRenal%2520and%2520hormonal%2520responses%2520to%2520direct%2520renin%2520inhibition%2520with%2520aliskiren%2520in%2520healthy%2520humans%26jtitle%3DCirculation%26date%3D2008%26volume%3D117%26spage%3D3199%26epage%3D3205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miserendino-Moltini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span> </span><span class="NLM_article-title">Renal localization of the renin inhibitor aliskiren</span> <span class="citation_source-journal">J. Clin. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">A80</span><span class="NLM_x">–</span> <span class="NLM_lpage">A81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=A80-A81&author=D.+L.+Feldmanauthor=E.+Persohnauthor=H.+Schuetzauthor=L.+Jinauthor=R.+Miserendino-Moltiniauthor=H.+Xuanauthor=S.+Zhuangauthor=W.+Zhou&title=Renal+localization+of+the+renin+inhibitor+aliskiren"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DSchuetz%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMiserendino-Moltini%26aufirst%3DR.%26aulast%3DXuan%26aufirst%3DH.%26aulast%3DZhuang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DW.%26atitle%3DRenal%2520localization%2520of%2520the%2520renin%2520inhibitor%2520aliskiren%26jtitle%3DJ.%2520Clin.%2520Hypertens.%26date%3D2006%26volume%3D8%26spage%3DA80%26epage%3DA81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Krop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gool, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Aliskiren accumulates in renin secretory granules and binds plasma prorenin</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1076-1083&author=M.+Kropauthor=I.+M.+Garreldsauthor=J.+A.+de+Bruinauthor=J.+M.+G.+van+Goolauthor=N.+D.+L.+Fisherauthor=N.+K.+Hollenbergauthor=A.+H.+J.+Danser&title=Aliskiren+accumulates+in+renin+secretory+granules+and+binds+plasma+prorenin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrop%26aufirst%3DM.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3Dde%2BBruin%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2BGool%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DAliskiren%2520accumulates%2520in%2520renin%2520secretory%2520granules%2520and%2520binds%2520plasma%2520prorenin%26jtitle%3DHypertension%26date%3D2008%26volume%3D52%26spage%3D1076%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Feldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maschke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1681%2FASN.2007091030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18235083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFOhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=743-748&author=S.+Feldtauthor=U.+Maschkeauthor=R.+Dechendauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=The+putative+%28pro%29renin+receptor+blocker+HRP+fails+to+prevent+%28pro%29renin+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">The putative (pro)renin receptor blocker HRP fails to prevent (Pro)renin signaling</span></div><div class="casAuthors">Feldt, Sandra; Maschke, Ulrike; Dechend, Ralf; Luft, Friedrich C.; Muller, Dominik N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-748</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The prorenin/renin receptor is a recently discovered component of the renin-angiotensin system.  The effects of aliskiren, a direct inhibitor of human renin, were compared with the handle region decoy peptide (HRP), which blocks the prorenin/renin receptor, in double-transgenic rats overexpressing the human renin and angiotensinogen genes.  After 7 wk, all aliskiren-treated rats were alive, whereas mortality was 40% in vehicle-treated and 58% in HRP-treated rats.  Aliskiren but not the HRP reduced BP and normalized albuminuria, cystatin C, and neutrophil gelatinase-assocd. lipocalin, a marker of renal tubular damage, to the levels of nontransgenic controls.  In vitro, human renin and prorenin induced extracellular signal-regulated kinase 1/2 phosphorylation, independent of angiotensin II (AngII), in vascular smooth muscle cells.  Preincubation with the HRP or aliskiren did not prevent renin- and prorenin-induced extracellular signal-regulated kinase 1/2 phosphorylation, whereas the MAP kinase kinase (MEK1/2) inhibitor PD98059 prevented both.  In conclusion, renin inhibition but not treatment with the HRP protects against AngII-induced renal damage in double-transgenic rats.  In addn., the in vitro data do not support the use of the HRP to block AngII-independent prorenin- or renin-mediated effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0qHu0FLsi4LVg90H21EOLACvtfcHk0liSbeeZWXLpzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFOhsbo%253D&md5=c38fd5debbbe5e30f592ca8e7efd3db4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1681%2FASN.2007091030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2007091030%26sid%3Dliteratum%253Aachs%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DMaschke%26aufirst%3DU.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DThe%2520putative%2520%2528pro%2529renin%2520receptor%2520blocker%2520HRP%2520fails%2520to%2520prevent%2520%2528pro%2529renin%2520signaling%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2008%26volume%3D19%26spage%3D743%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Durvasula, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankland, S. J.</span><span> </span><span class="NLM_article-title">Activation of a local renin angiotensin system in podocytes by glucose</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">F830</span><span class="NLM_x">–</span> <span class="NLM_lpage">F839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=F830-F839&author=R.+V.+Durvasulaauthor=S.+J.+Shankland&title=Activation+of+a+local+renin+angiotensin+system+in+podocytes+by+glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurvasula%26aufirst%3DR.%2BV.%26aulast%3DShankland%26aufirst%3DS.%2BJ.%26atitle%3DActivation%2520of%2520a%2520local%2520renin%2520angiotensin%2520system%2520in%2520podocytes%2520by%2520glucose%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DF830%26epage%3DF839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1056%2FNEJMoa0708379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18525041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=2433-2446&author=H.+H.+Parvingauthor=F.+Perssonauthor=J.+B.+Lewisauthor=E.+J.+Lewisauthor=N.+K.+Hollenberg&title=Aliskiren+combined+with+losartan+in+type+2+diabetes+and+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span></div><div class="casAuthors">Parving, Hans-Henrik; Persson, Frederik; Lewis, Julia B.; Lewis, Edmund J.; Hollenberg, Norman K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2433-2446</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries.  We evaluated the renoprotective effects of dual blockade of the renin-angiotensin-aldosterone system by adding treatment with aliskiren, an oral direct renin inhibitor, to treatment with the maximal recommended dose of losartan (100 mg daily) and optimal antihypertensive therapy in patients who had hypertension and type 2 diabetes with nephropathy.  We enrolled 599 patients in this multinational, randomized, double-blind study.  After a 3-mo, open-label, run-in period during which patients received 100 mg of losartan daily, patients were randomly assigned to receive 6 mo of treatment with aliskiren (150 mg daily for 3 mo, followed by an increase in dosage to 300 mg daily for another 3 mo) or placebo, in addn. to losartan.  The primary outcome was a redn. in the ratio of albumin to creatinine, as measured in an early-morning urine sample, at 6 mo.  The baseline characteristics of the two groups were similar.  Treatment with 300 mg of aliskiren daily, as compared with placebo, reduced the mean urinary albumin-to-creatinine ratio by 20% (95% confidence interval, 9 to 30; P<0.001), with a redn. of 50% or more in 24.7% of the patients who received aliskiren as compared with 12.5% of those who received placebo (P<0.001).  A small difference in blood pressure was seen between the treatment groups by the end of the study period (systolic, 2 mm Hg lower [P = 0.07] and diastolic, 1 mm Hg lower [P = 0.08] in the aliskiren group).  The total nos. of adverse and serious adverse events were similar in the groups.  Aliskiren may have renoprotective effects that are independent of its blood pressure-lowering effect in patients with hypertension, type 2 diabetes, and nephropathy who are receiving the recommended renoprotective treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrVSPga0hzXrVg90H21EOLACvtfcHk0lgQ5N8x4rGN6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D&md5=e53fcda0023dbc3c567f412179cd3328</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0708379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0708379%26sid%3Dliteratum%253Aachs%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DLewis%26aufirst%3DJ.%2BB.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DAliskiren%2520combined%2520with%2520losartan%2520in%2520type%25202%2520diabetes%2520and%2520nephropathy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D2433%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Hsueh, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzau, V. J.</span><span> </span><span class="NLM_article-title">Characterization of inactive renin from human kidney and plasma: evidence of a renal source of circulating inactive renin</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1983&pages=506-517&author=W.+A.+Hsuehauthor=E.+J.+Carlsonauthor=V.+J.+Dzau&title=Characterization+of+inactive+renin+from+human+kidney+and+plasma%3A+evidence+of+a+renal+source+of+circulating+inactive+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DW.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%2BJ.%26aulast%3DDzau%26aufirst%3DV.%2BJ.%26atitle%3DCharacterization%2520of%2520inactive%2520renin%2520from%2520human%2520kidney%2520and%2520plasma%253A%2520evidence%2520of%2520a%2520renal%2520source%2520of%2520circulating%2520inactive%2520renin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1983%26volume%3D71%26spage%3D506%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Reudelhuber, T. L.; Mercure, C.; Ramla, D.; Methot, D.; Postonvd, A. Y.</span><span> </span><span class="NLM_article-title">Molecular Mechanisms of Processing and Sorting in Renin Secretion</span>. In  <span class="citation_source-book">Hypertension: Pathophysiology. Diagnosis and Management</span>; <span class="NLM_contrib-group">Laragh, J. H.; Brenner, B. M.</span>, Eds.; <span class="NLM_publisher-name">Raven Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1621</span>− <span class="NLM_lpage">1636</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=1621-1636&author=T.+L.+Reudelhuber&author=C.+Mercure&author=D.+Ramla&author=D.+Methot&author=A.+Y.+Postonvdauthor=J.+H.+Laragh&author=B.+M.+Brenner&title=Hypertension%3A+Pathophysiology.+Diagnosis+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DReudelhuber%26aufirst%3DT.%2BL.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Processing%2520and%2520Sorting%2520in%2520Renin%2520Secretion%26btitle%3DHypertension%253A%2520Pathophysiology.%2520Diagnosis%2520and%2520Management%26aulast%3DLaragh%26aufirst%3DJ.%2BH.%26pub%3DRaven%2520Press%26date%3D1995%26spage%3D1621%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Nielsen, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, K.</span><span> </span><span class="NLM_article-title">Is prorenin of physiological and clinical significance?</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-198812000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=3065410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADyaL1M7isVegtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1988&pages=949-958&author=A.+H.+Nielsenauthor=K.+Poulsen&title=Is+prorenin+of+physiological+and+clinical+significance%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Is prorenin of physiological and clinical significance?</span></div><div class="casAuthors">Nielsen A H; Poulsen K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hypertension</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">949-58</span>
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKDyYG80pVSZggzHGM8X5CfW6udTcc2eauaJIIWjbDOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7isVegtg%253D%253D&md5=490ce96b098da4714a6aec6cd7b682a6</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1097%2F00004872-198812000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-198812000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DA.%2BH.%26aulast%3DPoulsen%26aufirst%3DK.%26atitle%3DIs%2520prorenin%2520of%2520physiological%2520and%2520clinical%2520significance%253F%26jtitle%3DJ.%2520Hypertens.%26date%3D1988%26volume%3D6%26spage%3D949%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Luetscher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draemer, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryer-Ash, M.</span><span> </span><span class="NLM_article-title">Increased plasma inactive renin in diabetes mellitus</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1412</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1056%2FNEJM198505303122202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=3887168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADyaL2M7ovVWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=1985&pages=1412-1417&author=J.+A.+Luetscherauthor=F.+B.+Draemerauthor=D.+M.+Wilsonauthor=H.+C.+Schwartzauthor=M.+Bryer-Ash&title=Increased+plasma+inactive+renin+in+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications</span></div><div class="casAuthors">Luetscher J A; Kraemer F B; Wilson D M; Schwartz H C; Bryer-Ash M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1412-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">Plasma renin exists in an active form or as an inactive zymogen that resembles a prorenin present in homogenates of human kidneys.  We examined the relation of diabetes and its microvascular complications with the level of plasma inactive renin activated by dialysis to pH 3.3.  Plasma inactive renin was measured in 235 diabetic patients and 90 nondiabetic controls.  In the controls, the level of plasma inactive renin increased slightly with age but was never above 50 ng per milliliter per hour.  In young diabetic patients studied within three years of the onset of diabetes the concentration of inactive renin was normal, and in some older diabetics without complications it remained within the age-adjusted normal range for many years.  However, in patients with retinopathy or albuminuria, plasma inactive renin was above the normal range with few exceptions, reaching levels 50 to 200 per cent above the upper limits of normal in patients with nephropathy.  The frequency of neuropathy was also significantly higher among patients with levels above the normal range.  In 37 per cent of the diabetics followed during one to three years of conventional treatment, plasma inactive renin increased significantly, but in another group of diabetics under intensive treatment, the level rose in only 7 per cent and fell in 43 per cent.  We conclude that there is a close association between a high level of plasma inactive renin and the presence of microvascular complications, and that the level of inactive renin can be modified by intensive treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStMCQzWhuTntj_Vg2vObihfW6udTcc2eauaJIIWjbDOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7ovVWntw%253D%253D&md5=ba5e3803e524aac4624d22336fe41179</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1056%2FNEJM198505303122202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198505303122202%26sid%3Dliteratum%253Aachs%26aulast%3DLuetscher%26aufirst%3DJ.%2BA.%26aulast%3DDraemer%26aufirst%3DF.%2BB.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DSchwartz%26aufirst%3DH.%2BC.%26aulast%3DBryer-Ash%26aufirst%3DM.%26atitle%3DIncreased%2520plasma%2520inactive%2520renin%2520in%2520diabetes%2520mellitus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1985%26volume%3D312%26spage%3D1412%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Sealey, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catanzaro, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavin, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gahnem, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitarresi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laragh, J. H.</span><span> </span><span class="NLM_article-title">Specific prorenin/renin binding (ProBP): identification and characterization of a novel membrane site</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2F0895-7061%2896%2900092-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8735181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK28XktF2lsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=491-502&author=J.+E.+Sealeyauthor=D.+F.+Catanzaroauthor=T.+N.+Lavinauthor=F.+Gahnemauthor=T.+Pitarresiauthor=L.+F.+Huauthor=J.+H.+Laragh&title=Specific+prorenin%2Frenin+binding+%28ProBP%29%3A+identification+and+characterization+of+a+novel+membrane+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Specific prorenin / renin binding (ProBP): Identification and characterization of a novel membrane site</span></div><div class="casAuthors">Sealey, Jean E.; Catanzaro, Daniel F.; Lavin, Thomas N.; Gahnem, Fuad; Pitarresi, Tina; Hu, Lu-fei; Laragh, John H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-502</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Renin can be detected in cardiovascular and other tissues but it disappears after bilateral nephrectomy indicating that tissues can take up or bind renal renin from the circulation.  If renin uptake is the result of specific binding, plasma prorenin may be a natural antagonist of tissue directed renin-angiotensin systems.  To investigate if specific prorenin/renin uptake occurs in rat tissues, binding studies were performed with rat microsomal membrane prepns. using recombinant rat prorenin metabolically labeled with 35S-methionine as a probe.  A high affinity binding site for both renin and prorenin was identified.  Affinities for prorenin and renin were approx. 200 and 900 pmol/L, resp.  Binding was reversible, saturable, and pH and temp. dependent.  The relative binding capacities of membranes from various rat tissues were as follows (fmol/mg): renal cortex (55), liver (54), testis (63), lung (31), brain (18), renal medulla (15), adrenal (17), aorta (7), heart (4), and skeletal muscle (1).  Bound prorenin was displaced by rat and human renin or prorenin but not by the prosequence of rat prorenin, angiotensin I or II, rat or human angiotensinogen, the renin inhibitor SQ30697, atrial natriuretic factor, amylase, insulin, bovine serum albumin, Hb, heparin, lysozyme, ovalbumin, cytochrome C, pepsin, pepsinogen, RNase A, mannose-6-phosphate, α-Me mannoside, gonadotropin releasing hormone, or an antibody to hog renin binding protein.  These results demonstrate specific binding of prorenin to a site in rat tissues, herein named ProBP, that also binds renin.  It is possible that differences in prorenin/renin binding capacity det. the activity of tissue-directed renin-angiotensin systems and that prorenin is a natural antagonist.  Alternatively, a prorenin/renin receptor may have been identified that may function by transducing an intracellular signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM0L1WDIVlrLVg90H21EOLACvtfcHk0ljpHWYANlUkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktF2lsLc%253D&md5=2ab7238ba3a76444d6d04adb6ebfc10c</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2F0895-7061%2896%2900092-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0895-7061%252896%252900092-1%26sid%3Dliteratum%253Aachs%26aulast%3DSealey%26aufirst%3DJ.%2BE.%26aulast%3DCatanzaro%26aufirst%3DD.%2BF.%26aulast%3DLavin%26aufirst%3DT.%2BN.%26aulast%3DGahnem%26aufirst%3DF.%26aulast%3DPitarresi%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DL.%2BF.%26aulast%3DLaragh%26aufirst%3DJ.%2BH.%26atitle%3DSpecific%2520prorenin%252Frenin%2520binding%2520%2528ProBP%2529%253A%2520identification%2520and%2520characterization%2520of%2520a%2520novel%2520membrane%2520site%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D1996%26volume%3D9%26spage%3D491%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Campbell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentjin, A. J.</span><span> </span><span class="NLM_article-title">Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-199408000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=7814847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFels7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=879-890&author=D.+J.+Campbellauthor=A.+J.+Valentjin&title=Identification+of+vascular+renin-binding+proteins+by+chemical+cross-linking%3A+inhibition+of+binding+of+renin+by+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of vascular renin-binding proteins by chemical cross-linking: Inhibition of binding of renin by renin inhibitors</span></div><div class="casAuthors">Campbell, Duncan J.; Valentijn, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">879-90</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    </div><div class="casAbstract">The objective of this study was to investigate the mechanism of tissue uptake of renin.  The binding of [125l]-labeled renin to membranes prepd. from various rat tissues was examd.  [125I]-labeled renins were cross-linked to membranes with disuccinimidyl suberate and analyzed by SDS-PAGE followed by autoradiog.  Mesenteric artery membranes bound both [125I]-labeled rat renin and [125I]-labeled mouse submandibular gland renin.  Crosslinking expts. showed two bands, one of relative mol. mass approx. 105,000 and the other of approx. 75,000.  After taking into account the mol. wt. of renin, these bands represent renin-binding proteins of relative mol. mass approx. 70,000 and approx. 40,000, resp.  The highest level of these binding proteins was in the mesenteric artery; lower levels were found in the aorta, lung and renal medulla.  Renin-binding proteins were also identified in membranes prepd. from cultured rat aortic smooth muscle cells.  No binding proteins were identified in the kidney cortex, heart, adrenal capsule, adrenal medulla, peri-aortic brown adipose tissue, uterus or pituitary.  Binding of renin to mesenteric artery membranes was prevented by inhibitors of renin enzymic activity (H-77 and SQ 30697); this effect of H-77 showed a dose-dependence parallel to the inhibition of renin activity by this compd., suggesting that the binding of H-77 to the active site of renin prevents its binding to the membranes.  These studies provide evidence for a vascular renin-binding mechanism, which may play a role in the generation of angiotensin peptides in vasculature, and may thus be a determinant of blood pressure.  Moreover, one of the actions of inhibitors of renin enzymic activity in vivo may be to prevent the binding of renin to the vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9p00KL5SdG7Vg90H21EOLACvtfcHk0ljpHWYANlUkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFels7Y%253D&md5=c0bb1792aad7dd6b7df7df79d17c412b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1097%2F00004872-199408000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-199408000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DD.%2BJ.%26aulast%3DValentjin%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520vascular%2520renin-binding%2520proteins%2520by%2520chemical%2520cross-linking%253A%2520inhibition%2520of%2520binding%2520of%2520renin%2520by%2520renin%2520inhibitors%26jtitle%3DJ.%2520Hypertens.%26date%3D1994%26volume%3D12%26spage%3D879%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sraer, J. D.</span><span> </span><span class="NLM_article-title">Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fki.1996.511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8943472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1GhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=1897-1903&author=G.+Nguyenauthor=F.+Delarueauthor=J.+Berrouauthor=E.+Rondeauauthor=J.+D.+Sraer&title=Specific+receptor+binding+of+renin+on+human+mesangial+cells+in+culture+increases+plasminogen+activator+inhibitor-1+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen</span></div><div class="casAuthors">Nguyen, Genevieve; Delarue, Francoise; Berrou, Jeannig; Rondeau, Eric; Sraer, Jean-Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1897-1903</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen.  Some proteases possess a membrane receptor that focalizes their proteolytic activity on the cell surface and may mediate a proliferative effect, such as urokinase on glomerular epithelial cells.  Since some hypertensive states are assocd. with high concns. of renin and proliferation of arteriolar smooth muscle cells, we asked whether renin, an aspartyl-protease, would bind to mesangial cells that are smooth-muscle derived cells, which would induce their proliferation.  The binding of 125I labeled recombinant human renin (125I-R) was studied on human primary mesangial cells and mesangial cells immortalized by transfection with SV40-T antigen.  At 37°, the binding of 125I-R was time dependent and reached a plateau after two hours.  The 125I-R bound in a saturable and specific manner with a Kd = 0.4 nM and 1 nM and 8000 and 2000 binding sites/cell, for primary and immortalized cells, resp.  When binding expts. were performed in the presence RO 42-5892, a synthetic inhibitor of renin, RO 42-5892 could inhibit the specific binding of labeled renin only at concns. 1000 times superior to the IC 50, indicating that the renin-mesangial receptor interaction did not depend on the active site of renin.  Anal. by SDS-PAGE and autoradiog. of crosslinking expts. of 125I-R bound to a membrane prepn. showed a band of approx. 110 to 120 kDa, suggesting a Mr of 70 to 80 kDa for the renin receptor.  Incubation of mesangial cells with 100 nM renin for 24 h provoked a 100% increase of 3H thymidine incorporation that was not accompanied by an increase of the cell no., even after a seven day period of incubation.  However, the incubation of mesangial cells with renin for 24 h induced a significant increase (170% of control) of plasminogen activator inhibitor-1 (PAI1) antigen in the conditioned medium.  In conclusion, we have shown that human mesangial cells in culture express a specific receptor for renin, and that the binding of renin increases 3H thymidine incorporation independently of renin enzymic activity.  The absence of cell proliferation, the increase of 3H thymidine incorporation and the increase of PAI1 antigen suggest that the binding of renin can induce mesangial cell activation, which is reflected by a change in the fibrinolytic capacity of the cells.  The role of this receptor remains to be detd. in nephropathies and hypertensive states assocd. with high plasma/tissue renin concns., hypertrophy of mesangial or smooth muscle cells and extracellular matrix remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_934uhjKYybVg90H21EOLACvtfcHk0liAj7R3ksODcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1GhsA%253D%253D&md5=93bfc0c53dd443cba3d5bc4bc6b931d9</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1038%2Fki.1996.511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.1996.511%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDelarue%26aufirst%3DF.%26aulast%3DBerrou%26aufirst%3DJ.%26aulast%3DRondeau%26aufirst%3DE.%26aulast%3DSraer%26aufirst%3DJ.%2BD.%26atitle%3DSpecific%2520receptor%2520binding%2520of%2520renin%2520on%2520human%2520mesangial%2520cells%2520in%2520culture%2520increases%2520plasminogen%2520activator%2520inhibitor-1%2520antigen%26jtitle%3DKidney%2520Int.%26date%3D1996%26volume%3D50%26spage%3D1897%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Saris, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derkx, F. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalekamp, M. A. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Cardiomyocytes bind and activate native human prorenin: role of soluble mannose 6-phosphate receptors</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2001&pages=710-715&author=J.+J.+Sarisauthor=F.+H.+M.+Derkxauthor=J.+M.+J.+Lamersauthor=P.+R.+Saxenaauthor=M.+A.+D.+H.+Schalekampauthor=A.+H.+J.+Danser&title=Cardiomyocytes+bind+and+activate+native+human+prorenin%3A+role+of+soluble+mannose+6-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaris%26aufirst%3DJ.%2BJ.%26aulast%3DDerkx%26aufirst%3DF.%2BH.%2BM.%26aulast%3DLamers%26aufirst%3DJ.%2BM.%2BJ.%26aulast%3DSaxena%26aufirst%3DP.%2BR.%26aulast%3DSchalekamp%26aufirst%3DM.%2BA.%2BD.%2BH.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DCardiomyocytes%2520bind%2520and%2520activate%2520native%2520human%2520prorenin%253A%2520role%2520of%2520soluble%2520mannose%25206-phosphate%2520receptors%26jtitle%3DHypertension%26date%3D2001%26volume%3D37%26spage%3D710%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit149b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Saris, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Eijnden, M. M. E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalekamp, M. A. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=573-577&author=J.+J.+Sarisauthor=M.+M.+E.+D.+van+den+Eijndenauthor=J.+M.+J.+Lamersauthor=P.+R.+Saxenaauthor=M.+A.+D.+H.+Schalekampauthor=A.+H.+J.+Danser&title=Prorenin-induced+myocyte+proliferation%3A+no+role+for+intracellular+angiotensin+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaris%26aufirst%3DJ.%2BJ.%26aulast%3Dvan%2Bden%2BEijnden%26aufirst%3DM.%2BM.%2BE.%2BD.%26aulast%3DLamers%26aufirst%3DJ.%2BM.%2BJ.%26aulast%3DSaxena%26aufirst%3DP.%2BR.%26aulast%3DSchalekamp%26aufirst%3DM.%2BA.%2BD.%2BH.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DProrenin-induced%2520myocyte%2520proliferation%253A%2520no%2520role%2520for%2520intracellular%2520angiotensin%2520II%26jtitle%3DHypertension%26date%3D2002%26volume%3D39%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcklé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzhir, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sraer, J. D.</span><span> </span><span class="NLM_article-title">Pivotal role for the renin/prorenin receptor in angiotensin II production and cellular responses to renin</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=1417-1427&author=G.+Nguyenauthor=F.+Delarueauthor=C.+Burckl%C3%A9author=L.+Bouzhirauthor=T.+Gillerauthor=J.+D.+Sraer&title=Pivotal+role+for+the+renin%2Fprorenin+receptor+in+angiotensin+II+production+and+cellular+responses+to+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDelarue%26aufirst%3DF.%26aulast%3DBurckl%25C3%25A9%26aufirst%3DC.%26aulast%3DBouzhir%26aufirst%3DL.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DSraer%26aufirst%3DJ.%2BD.%26atitle%3DPivotal%2520role%2520for%2520the%2520renin%252Fprorenin%2520receptor%2520in%2520angiotensin%2520II%2520production%2520and%2520cellular%2520responses%2520to%2520renin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D1417%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Border, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">E810</span><span class="NLM_x">–</span> <span class="NLM_lpage">E819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2008&pages=E810-E819&author=J.+Zhangauthor=N.+A.+Nobleauthor=W.+A.+Borderauthor=R.+T.+Owensauthor=Y.+Huang&title=Receptor-dependent+prorenin+activation+and+induction+of+PAI-1+expression+in+vascular+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DNoble%26aufirst%3DN.%2BA.%26aulast%3DBorder%26aufirst%3DW.%2BA.%26aulast%3DOwens%26aufirst%3DR.%2BT.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DReceptor-dependent%2520prorenin%2520activation%2520and%2520induction%2520of%2520PAI-1%2520expression%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2008%26volume%3D295%26spage%3DE810%26epage%3DE819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vongamorntham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Border, W.</span><span> </span><span class="NLM_article-title">Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fsj.ki.5000011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=16374430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Wqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=105-113&author=Y.+Huangauthor=S.+Vongamornthamauthor=J.+Kastingauthor=D.+McQuillanauthor=R.+T.+Owensauthor=L.+Yuauthor=N.+A.+Nobleauthor=W.+Border&title=Renin+increases+mesangial+cell+transforming+growth+factor-%CE%B21+and+matrix+proteins+through+receptor-mediated%2C+angiotensin+II-independent+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms</span></div><div class="casAuthors">Huang, Y.; Wongamorntham, S.; Kasting, J.; McQuillan, D.; Owens, R. T.; Yu, L.; Noble, N. A.; Border, W.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent evidence suggesting a strong interplay between components of the renin-angiotensin system and key mediators of fibrosis led us to hypothesize that renin, independent of its enzymic action to enhance angiotensin (Ang) II synthesis, directly increases prodn. of the fibrogenic cytokine transforming growth factor (TGF)-β.  Human or rat mesangial cells (MCs) were treated with human recombinant renin (HrRenin) or rat recombinant renin (RrRenin) and the effects on TGF-β1, plasminogen activator inhibitor-type 1 (PAI-1), fibronectin (FN) and collagen 1 mRNA and protein were investigated.  Blockade of the rat MC renin receptor was achieved using siRNA.  HrRenin or RrRenin, at doses shown to be physiol. relevant, induced marked dose- and time-dependent increases in TGF-β1.  These effects were not altered by adding an inhibitor of renin's enzymic action (RO 42-5892), the Ang II receptor antagonist losartan or the Ang-converting enzyme inhibitor enalapril.  RrRenin also induced PAI-1, FN and collagen 1 mRNA and PAI-1 and FN protein in a dose-dependent manner.  Neutralizing antibodies to TGF-β partially blocked these effects.  Supernatant and cell lysate Ang I and Ang II levels were extremely low.  MC angiotensinogen mRNA was undetectable both with and without added renin.  Targeting of the rat renin receptor mRNA with siRNA blocked induction of TGF-β1.  We conclude that renin upregulates MC TGF-β1 through a receptor-mediated mechanism, independent of Ang II generation or action.  Renin-induced increases in TGF-β1 in turn stimulate increases in PAI-1, FN and collagen I.  Thus, renin may contribute to renal fibrotic disease, particularly when therapeutic Ang II blockade elevates plasma renin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbvVeEXdd79LVg90H21EOLACvtfcHk0li1rERzCZ4D5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Wqtw%253D%253D&md5=11d058756975831d5019413894aa46da</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.5000011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.5000011%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DVongamorntham%26aufirst%3DS.%26aulast%3DKasting%26aufirst%3DJ.%26aulast%3DMcQuillan%26aufirst%3DD.%26aulast%3DOwens%26aufirst%3DR.%2BT.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DNoble%26aufirst%3DN.%2BA.%26aulast%3DBorder%26aufirst%3DW.%26atitle%3DRenin%2520increases%2520mesangial%2520cell%2520transforming%2520growth%2520factor-%25CE%25B21%2520and%2520matrix%2520proteins%2520through%2520receptor-mediated%252C%2520angiotensin%2520II-independent%2520mechanisms%26jtitle%3DKidney%2520Int.%26date%3D2006%26volume%3D69%26spage%3D105%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasir, U .M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span> </span><span class="NLM_article-title">Human prorenin has “gate and handle” regions for its non-proteolytic activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">22217</span><span class="NLM_x">–</span> <span class="NLM_lpage">22222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22217-22222&author=F.+Suzukiauthor=M.+Hayakawaauthor=T.+Nakagawaauthor=U+.M.+Nasirauthor=A.+Ebiharaauthor=A.+Iwasawaauthor=Y.+Ishidaauthor=Y.+Nakamuraauthor=K.+Murakami&title=Human+prorenin+has+%E2%80%9Cgate+and+handle%E2%80%9D+regions+for+its+non-proteolytic+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DNasir%26aufirst%3DU%2B.M.%26aulast%3DEbihara%26aufirst%3DA.%26aulast%3DIwasawa%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DMurakami%26aufirst%3DK.%26atitle%3DHuman%2520prorenin%2520has%2520%25E2%2580%259Cgate%2520and%2520handle%25E2%2580%259D%2520regions%2520for%2520its%2520non-proteolytic%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22217%26epage%3D22222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Batenburg, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, R. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burckle, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2241</span><span class="NLM_x">–</span> <span class="NLM_lpage">2453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3282f05bae" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=2241-2453&author=W.+W.+Batenburgauthor=M.+Kropauthor=I.+M.+Garreldsauthor=R.+de+Vriesauthor=R.+J.+A.+de+Bruinauthor=C.+A.+Burckleauthor=D.+N.+M%C3%BCllerauthor=M.+Baderauthor=G.+Nguyenauthor=A.+H.+J.+Danser&title=Prorenin+is+the+endogenous+agonist+of+the+%28pro%29renin+receptor.+Binding+kinetics+of+renin+and+prorenin+in+rat+vascular+smooth+muscle+cells+overexpressing+the+human+%28pro%29renin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3282f05bae&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3282f05bae%26sid%3Dliteratum%253Aachs%26aulast%3DBatenburg%26aufirst%3DW.%2BW.%26aulast%3DKrop%26aufirst%3DM.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3Dde%2BVries%26aufirst%3DR.%26aulast%3Dde%2BBruin%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DBurckle%26aufirst%3DC.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DProrenin%2520is%2520the%2520endogenous%2520agonist%2520of%2520the%2520%2528pro%2529renin%2520receptor.%2520Binding%2520kinetics%2520of%2520renin%2520and%2520prorenin%2520in%2520rat%2520vascular%2520smooth%2520muscle%2520cells%2520overexpressing%2520the%2520human%2520%2528pro%2529renin%2520receptor%26jtitle%3DJ.%2520Hypertens.%26date%3D2007%26volume%3D25%26spage%3D2241%26epage%3D2453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Gratze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malchow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeske, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engeli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contrepas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plehm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Energy metabolism in human renin-gene transgenic rats: Does renin contribute to obesity?</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=516-523&author=P.+Gratzeauthor=M.+Boschmannauthor=F.+Dechendauthor=F.+Qadiauthor=J.+Malchowauthor=S.+Graeskeauthor=S.+Engeliauthor=J.+Jankeauthor=J.+Springerauthor=A.+Contrepasauthor=R.+Plehmauthor=S.+Klausauthor=G.+Nguyenauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=Energy+metabolism+in+human+renin-gene+transgenic+rats%3A+Does+renin+contribute+to+obesity%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGratze%26aufirst%3DP.%26aulast%3DBoschmann%26aufirst%3DM.%26aulast%3DDechend%26aufirst%3DF.%26aulast%3DQadi%26aufirst%3DF.%26aulast%3DMalchow%26aufirst%3DJ.%26aulast%3DGraeske%26aufirst%3DS.%26aulast%3DEngeli%26aufirst%3DS.%26aulast%3DJanke%26aufirst%3DJ.%26aulast%3DSpringer%26aufirst%3DJ.%26aulast%3DContrepas%26aufirst%3DA.%26aulast%3DPlehm%26aufirst%3DR.%26aulast%3DKlaus%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DEnergy%2520metabolism%2520in%2520human%2520renin-gene%2520transgenic%2520rats%253A%2520Does%2520renin%2520contribute%2520to%2520obesity%253F%26jtitle%3DHypertension%26date%3D2009%26volume%3D53%26spage%3D516%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Uehara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikibe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span> </span><span class="NLM_article-title">Late-onset obesity in mice transgenic for the human renin gene</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12736712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFSlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=723-727&author=S.+Ueharaauthor=M.+Tsuchidaauthor=T.+Kannoauthor=M.+Sasakiauthor=M.+Nishikibeauthor=A.+Fukamizu&title=Late-onset+obesity+in+mice+transgenic+for+the+human+renin+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Late-onset obesity in mice transgenic for the human renin gene</span></div><div class="casAuthors">Uehara, Sayuri; Tsuchida, Minoru; Kanno, Tetsuya; Sasaki, Minoru; Nishikibe, Masaru; Fukamizu, Akiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-727</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">We previously generated a strain of transgenic mice carrying the human renin gene, hRN8-12, in the background of C57BL/6j.  In this study, the authors discovered that hRN8-12 male mice, but not females, developed obesity starting at 15 wk of age.  The body wt. of 60-wk-old male transgenic mice was 2 times higher than that of age-matched wild-type mice.  Interestingly, male mice heterozygous for the human renin gene showed moderate wt. gain compared with transgenic and wild-type mice.  Obese hRN8-12 mice exhibited hyperglycemia, hyperinsulinemia, hyperleptinemia, and hyperlipidemia, and increase in wt. in the adipose tissue, liver, heart, and kidneys.  Histol. anal. demonstrated that fatty hRN8-12 mice developed hypertrophy of pancreatic islets and fatty liver.  These results suggested that hRN8-12 mice are assocd. with obesity dependent on the transgene dosage and should be a genetic model for late-onset obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs_uBLv_2zg7Vg90H21EOLACvtfcHk0lgyen3QTbssbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFSlt78%253D&md5=c8db23419c35e1e8822a124e1745550b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DS.%26aulast%3DTsuchida%26aufirst%3DM.%26aulast%3DKanno%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DNishikibe%26aufirst%3DM.%26aulast%3DFukamizu%26aufirst%3DA.%26atitle%3DLate-onset%2520obesity%2520in%2520mice%2520transgenic%2520for%2520the%2520human%2520renin%2520gene%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2003%26volume%3D11%26spage%3D723%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Burckle, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasc, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plehm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span> </span><span class="NLM_article-title">Elevated blood pressure and heart rate in human renin receptor transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=552-556&author=C.+A.+Burckleauthor=A.+H.+J.+Danserauthor=D.+N.+M%C3%BCllerauthor=I.+M.+Garreldsauthor=J.+M.+Gascauthor=E.+Popovaauthor=R.+Plehmauthor=J.+Petersauthor=M.+Baderauthor=G.+Nguyen&title=Elevated+blood+pressure+and+heart+rate+in+human+renin+receptor+transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurckle%26aufirst%3DC.%2BA.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3DGasc%26aufirst%3DJ.%2BM.%26aulast%3DPopova%26aufirst%3DE.%26aulast%3DPlehm%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DJ.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26atitle%3DElevated%2520blood%2520pressure%2520and%2520heart%2520rate%2520in%2520human%2520renin%2520receptor%2520transgenic%2520rats%26jtitle%3DHypertension%26date%3D2006%26volume%3D47%26spage%3D552%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Ichihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurauchi-Mito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneshiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, H.</span><span> </span><span class="NLM_article-title">Renin, prorenin and the kidney: a new chapter in an old saga</span> <span class="citation_source-journal">J. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19557706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=306-311&author=A.+Ichiharaauthor=M.+Sakodaauthor=A.+Kurauchi-Mitoauthor=Y.+Kaneshiroauthor=H.+Itoh&title=Renin%2C+prorenin+and+the+kidney%3A+a+new+chapter+in+an+old+saga"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Renin, prorenin and the kidney: a new chapter in an old saga</span></div><div class="casAuthors">Ichihara, Atsuhiro; Sakoda, Mariyo; Kurauchi-Mito, Asako; Kaneshiro, Yuki; Itoh, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-311</span>CODEN:
                <span class="NLM_cas:coden">JLNEEL</span>;
        ISSN:<span class="NLM_cas:issn">1121-8428</span>.
    
            (<span class="NLM_cas:orgname">Wichtig Editore</span>)
        </div><div class="casAbstract">A review.  The binding of prorenin to the (pro)renin receptor triggers 2 major pathways: a nonproteolytic conformational change in prorenin to its active form (angiotensin II-dependent pathway) and an intracellular pathway via the (pro)renin receptor itself (angiotensin II-independent pathway).  In diabetic animals, an increased plasma prorenin level not only causes the generation of angiotensin II via the angiotensin II-dependent pathway, it also stimulates the (pro)renin receptor's own intracellular signaling pathway in a manner that is independent of the generated angiotensin II.  Thus, the administration of a "handle" region peptide (HRP), which acts as a decoy peptide and competitively inhibits the binding of prorenin to the (pro)renin receptor, has a beneficial effect in the kidneys of diabetic animals with low plasma renin levels.  However, the benefits of HRP are slightly reduced in animal models of essential hypertension with relatively high plasma renin levels, and these benefits disappear altogether in animal models of hypertension with extremely high plasma renin levels.  Thus, in the kidneys of animal models of diabetes and/or hypertension, both renin and prorenin competitively bind to the (pro)renin receptor and contribute to the pathophysiol. of nephropathy.  Consequently, renin, prorenin and the (pro) renin receptor may be important therapeutic targets for the prevention and regression of nephropathy in patients with diabetes and/or hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoUEvjSQ3cLVg90H21EOLACvtfcHk0lgyen3QTbssbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WitbjJ&md5=d36818709eaa46d36ba1b89bd10b07f3</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIchihara%26aufirst%3DA.%26aulast%3DSakoda%26aufirst%3DM.%26aulast%3DKurauchi-Mito%26aufirst%3DA.%26aulast%3DKaneshiro%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DH.%26atitle%3DRenin%252C%2520prorenin%2520and%2520the%2520kidney%253A%2520a%2520new%2520chapter%2520in%2520an%2520old%2520saga%26jtitle%3DJ.%2520Nephrol.%26date%3D2009%26volume%3D22%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Feldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batenburg, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maschke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvakan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Febeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burckle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contrepas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=682-688&author=S.+Feldtauthor=W.+W.+Batenburgauthor=I.+Mazakauthor=U.+Maschkeauthor=M.+Wellnerauthor=H.+Kvakanauthor=R.+Dechendauthor=A.+Febelerauthor=C.+Burckleauthor=A.+Contrepasauthor=A.+H.+J.+Danserauthor=M.+Baderauthor=G.+Nguyenauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=Prorenin+and+renin-induced+extracellular+signal-regulated+kinase+1%2F2+activation+in+monocytes+is+not+blocked+by+aliskiren+or+the+handle-region+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DBatenburg%26aufirst%3DW.%2BW.%26aulast%3DMazak%26aufirst%3DI.%26aulast%3DMaschke%26aufirst%3DU.%26aulast%3DWellner%26aufirst%3DM.%26aulast%3DKvakan%26aufirst%3DH.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DFebeler%26aufirst%3DA.%26aulast%3DBurckle%26aufirst%3DC.%26aulast%3DContrepas%26aufirst%3DA.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DProrenin%2520and%2520renin-induced%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520activation%2520in%2520monocytes%2520is%2520not%2520blocked%2520by%2520aliskiren%2520or%2520the%2520handle-region%2520peptide%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D682%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Mercure, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silversides, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reudelhuber, T. L.</span><span> </span><span class="NLM_article-title">Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1062</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1062-1069&author=C.+Mercureauthor=G.+Prescottauthor=M.+J.+Lacombeauthor=D.+W.+Silversidesauthor=T.+L.+Reudelhuber&title=Chronic+increases+in+circulating+prorenin+are+not+associated+with+renal+or+cardiac+pathologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercure%26aufirst%3DC.%26aulast%3DPrescott%26aufirst%3DG.%26aulast%3DLacombe%26aufirst%3DM.%2BJ.%26aulast%3DSilversides%26aufirst%3DD.%2BW.%26aulast%3DReudelhuber%26aufirst%3DT.%2BL.%26atitle%3DChronic%2520increases%2520in%2520circulating%2520prorenin%2520are%2520not%2520associated%2520with%2520renal%2520or%2520cardiac%2520pathologies%26jtitle%3DHypertension%26date%3D2009%26volume%3D53%26spage%3D1062%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Peters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisk, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuttler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.</span><span> </span><span class="NLM_article-title">Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3282f0ab66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18090546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=102-109&author=B.+Petersauthor=O.+Griskauthor=B.+Becherauthor=H.+Wankaauthor=B.+Kuttlerauthor=J.+Ludemannauthor=G.+Lorenzauthor=R.+Rettigauthor=J.+J.+Mullinsauthor=J.+Peters&title=Dose-dependent+titration+of+prorenin+and+blood+pressure+in+Cyp1a1ren-2+transgenic+rats%3A+absence+of+prorenin-induced+glomerulosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-dependent titration of prorenin and blood pressure in Cyp1a1/ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis</span></div><div class="casAuthors">Peters, Barbara; Grisk, Olaf; Becher, Bertram; Wanka, Heike; Kuttler, Beate; Luedemann, Jan; Lorenz, Gerd; Rettig, Rainer; Mullins, John J.; Peters, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Prorenin has been assocd. with cardiovascular disease and the development of glomerulosclerosis via a renin/prorenin receptor.  In cyp1a1/ren-2 transgenic rats, prorenin levels and arterial pressure can be increased by oral administration of indole-3-carbinol (I3C).  The transgenic strain has been used as a model of malignant hypertension.  Methods: The present study was designed to test the hypotheses that (i) low doses of I3C would result in dose-dependent sustained increases in arterial pressure without signs of malignancy, making cyp1a1ren-2 transgenic rats a useful model to study nonmalignant hypertension, and (ii) cyp1a1ren-2 transgenic rats would develop glomerulosclerosis when they were chronically exposed to 0.125% I3C in their diet.  Results: I3C treatment for 2 wk resulted in increases of plasma prorenin concns. and arterial pressure in a dose-dependent manner.  Rats thrived well over a period of 12 wk on dietary I3C concns. (wt./wt.) of 0.125%.  Plasma prorenin concn. rose from 0.1±0.1 μg to 17.9±5.0 μg angiotensin I/mL per h (P < 0.01) and mean arterial pressure increased to a plateau of 170±5 mmHg (P < 0.001) between weeks 6 and 12.  After 12 wk of 0.125% I3C, rats exhibited moderate hypertensive renal vasculopathy, but no histol. signs of glomerulosclerosis.  Conclusions: The cyp1a1ren-2 transgenic rat model allows for chronic dose-dependent titrn. of arterial pressure by a simple and non-invasive intervention, making this strain a useful model to study malignant and nonmalignant arterial hypertension.  High circulating prorenin levels per se do not cause glomerulosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfUFxN4IRzsLVg90H21EOLACvtfcHk0lgRJkAgB9TxWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrjI&md5=4c36f176dbe727636d20cfab50051b24</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3282f0ab66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3282f0ab66%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DB.%26aulast%3DGrisk%26aufirst%3DO.%26aulast%3DBecher%26aufirst%3DB.%26aulast%3DWanka%26aufirst%3DH.%26aulast%3DKuttler%26aufirst%3DB.%26aulast%3DLudemann%26aufirst%3DJ.%26aulast%3DLorenz%26aufirst%3DG.%26aulast%3DRettig%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%26atitle%3DDose-dependent%2520titration%2520of%2520prorenin%2520and%2520blood%2520pressure%2520in%2520Cyp1a1ren-2%2520transgenic%2520rats%253A%2520absence%2520of%2520prorenin-induced%2520glomerulosclerosis%26jtitle%3DJ.%2520Hypertens.%26date%3D2008%26volume%3D26%26spage%3D102%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Batenburg, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, R. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gool, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1161%2FATVBAHA.108.164210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18388329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFOju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1151-1157&author=W.+W.+Batenburgauthor=R.+J.+A.+de+Bruinauthor=J.+M.+G.+van+Goolauthor=D.+N.+M%C3%BCllerauthor=M.+Baderauthor=G.+Nguyenauthor=A.+H.+J.+Danser&title=Aliskiren-binding+increases+the+half+life+of+renin+and+prorenin+in+rat+aortic+vascular+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren-Binding Increases the Half Life of Renin and Prorenin in Rat Aortic Vascular Smooth Muscle Cells</span></div><div class="casAuthors">Batenburg, Wendy W.; de Bruin, Rene J. A.; van Gool, Jeanette M. G.; Mueller, Dominik N.; Bader, Michael; Nguyen, Genevieve; Danser, A. H. Jan</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1151-1157</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Renin inhibition with aliskiren was reported to cause a greater rise in renin than other types of renin-angiotensin system blockade, thereby potentially leading to angiotensin generation or stimulation of the human (pro)renin receptor (h(P)RR).  Here we studied whether this rise in renin is attributable to an aliskiren-induced change in the prorenin conformation, allowing its detection in renin assays, or a change in renin/prorenin clearance.  We also investigated whether aliskiren affects (pro)renin binding to its receptors, using rat aortic vascular smooth muscle cells (VSMCs) overexpressing the h(P)RR.  A 48-h incubation with aliskiren at 4°C converted the prorenin conformation from "closed" to "open," thus allowing its recognition in active site-directed renin assays.  VSMCs accumulated (pro)renin through binding to mannose 6-phosphate receptors (M6PRs) and h(P)RRs.  Aliskiren did not affect binding at 4°C.  At 37°C, aliskiren increased (pro)renin accumulation up to 40-fold, and M6PR blockade prevented this.  Aliskiren increased the intracellular half life of prorenin 2 to 3 times.  Aliskiren allows the detection of prorenin as renin, and decreases renin/prorenin clearance.  Both phenomena may contribute to the "renin" surge during aliskiren treatment, but because they depend on aliskiren binding, they will not result in angiotensin generation.  Aliskiren does not affect (pro)renin binding to its receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWj4Wx1I38OLVg90H21EOLACvtfcHk0lgRJkAgB9TxWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFOju7w%253D&md5=877f46b58c65040e3447c5f969cd49cb</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.108.164210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.108.164210%26sid%3Dliteratum%253Aachs%26aulast%3DBatenburg%26aufirst%3DW.%2BW.%26aulast%3Dde%2BBruin%26aufirst%3DR.%2BJ.%2BA.%26aulast%3Dvan%2BGool%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DAliskiren-binding%2520increases%2520the%2520half%2520life%2520of%2520renin%2520and%2520prorenin%2520in%2520rat%2520aortic%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D1151%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Siragy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, D. C.</span><span> </span><span class="NLM_article-title">The development of the direct renin inhibitor aliskiren: treating hypertension and beyond</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F14728214.13.3.417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18764720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGksbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=417-430&author=H.+Siragyauthor=J.+Huangauthor=D.+C.+Lieb&title=The+development+of+the+direct+renin+inhibitor+aliskiren%3A+treating+hypertension+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The development of the direct renin inhibitor aliskiren: treating hypertension and beyond</span></div><div class="casAuthors">Siragy, Helmy; Huang, Jiqian; Lieb, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-430</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Direct renin inhibitors such as aliskiren offer a novel way of treating hypertension and its co-morbidities, conditions with a considerable prevalence, morbidity, and mortality worldwide.  The burden of hypertension worldwide and the role of the renin-angiotensin-aldosterone system in this disease will be reviewed.  Current treatments for hypertension and its co-morbidities that work by manipulating this system will be discussed.  The development of, and clin. trials involving, direct renin inhibitors will be reviewed, with a focus on aliskiren.  PubMed was utilized to search the most recent literature on the topics of the renin-angiotensin-aldosterone system, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone and aliskiren.  The direct renin inhibitors, including aliskiren, are new agents with great promise for the treatment of hypertension and its co-morbid conditions, including renal and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiscewUlIRULVg90H21EOLACvtfcHk0ljDyLcTxMNe2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGksbvE&md5=96962356e25f3f047bfa41bf540fbecd</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1517%2F14728214.13.3.417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.13.3.417%26sid%3Dliteratum%253Aachs%26aulast%3DSiragy%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLieb%26aufirst%3DD.%2BC.%26atitle%3DThe%2520development%2520of%2520the%2520direct%2520renin%2520inhibitor%2520aliskiren%253A%2520treating%2520hypertension%2520and%2520beyond%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26spage%3D417%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarugula, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieterich, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics and pharmacodynamics of aliskiren</span> <span class="citation_source-journal">Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.2165%2F00003088-200847080-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=515-531&author=S.+Vaidyanathanauthor=V.+Jarugulaauthor=H.+A.+Dieterichauthor=D.+Howardauthor=W.+P.+Dole&title=Clinical+pharmacokinetics+and+pharmacodynamics+of+aliskiren"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics and pharmacodynamics of aliskiren</span></div><div class="casAuthors">Vaidyanathan, Sujata; Jarugula, Venkateswar; Dieterich, Hans Armin; Howard, Dan; Dole, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">515-531</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Aliskiren is the first orally bioavailable direct renin inhibitor approved for the treatment of hypertension.  It acts at the point of activation of the renin-angiotensin-aldosterone system, or renin system, inhibiting the conversion of angiotensinogen to angiotensin I by renin and thereby reducing the formation of angiotensin II by angiotensin-converting enzyme (ACE) and ACE-independent pathways.  Aliskiren is a highly potent inhibitor of human renin in vitro (concn. of aliskiren that produces 50% inhibition of renin 0.6 nmol/L).  Aliskiren is rapidly absorbed following oral administration, with max. plasma concns. reached within 1-3 h.  The abs. bioavailability of aliskiren is 2.6%.  The binding of aliskiren to plasma proteins is moderate (47-51%) and is independent of the concn.  Once absorbed, aliskiren is eliminated through the hepatobiliary route as unchanged drug and, to a lesser extent, through oxidative metab. by cytochrome P 450 (CYP) 3A4.  Unchanged aliskiren accounts for approx. 80% of the drug in the plasma following oral administration, indicating low exposure to metabolites.  The two major oxidized metabolites of aliskiren account for less than 5% of the drug in the plasma at the time of the max. concn.  Aliskiren excretion is almost completely via the biliary/faecal route; 0.6% of the dose is recovered in the urine.  Steady-state plasma concns. of aliskiren are reached after 7-8 days of once-daily dosing, and the accumulation factor for aliskiren is approx. 2.  After reaching the peak, the aliskiren plasma concn. declines in a multiphasic fashion.  No clin. relevant effects of gender or race on the pharmacokinetics of aliskiren are obsd., and no adjustment of the initial aliskiren dose is required for elderly patients or for patients with renal or hepatic impairment.  Aliskiren showed no clin. significant increases in exposure during coadministration with a wide range of potential concomitant medications, although increases in exposure were obsd. with P-glycoprotein inhibitors.  Aliskiren does not inhibit or induce CYP isoenzyme or P-glycoprotein activity, although aliskiren is a substrate for P-glycoprotein, which contributes to its relatively low bioavailability.  Aliskiren is approved for the treatment of hypertension at once-daily doses of 150 mg and 300 mg.  Phase II and III clin. studies involving over 12 000 patients with hypertension have demonstrated that aliskiren provides effective long-term blood pressure (BP) lowering with a good safety and tolerability profile at these doses.  Aliskiren inhibits plasma renin activity (PRA) by up to 80% following both single and multiple oral-dose administration.  Similar redns. in PRA are obsd. when aliskiren is administered in combination with agents that alone increase PRA, including diuretics (hydrochlorothiazide, furosemide [frusemide]), ACE inhibitors (ramipril) and angiotensin receptor blockers (valsartan), despite greater increases in the plasma renin concn.  Moreover, PRA inhibition and BP redns. persist for 2-4 wk after stopping treatment, which is likely to be of benefit in patients with hypertension who occasionally miss a dose of medication.  Preliminary data on the antiproteinuric effects of aliskiren in type 2 diabetes mellitus suggest that renoprotective effects beyond BP lowering may be possible.  Further studies to evaluate the effects of aliskiren on cardiovascular outcomes and target organ protection are ongoing and will provide important new data on the role of direct renin inhibition in the management of hypertension and other cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOi0XS9g937rVg90H21EOLACvtfcHk0ljDyLcTxMNe2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOgu7fK&md5=e06e0184b56b84d51e945d67cd116831</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.2165%2F00003088-200847080-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200847080-00002%26sid%3Dliteratum%253Aachs%26aulast%3DVaidyanathan%26aufirst%3DS.%26aulast%3DJarugula%26aufirst%3DV.%26aulast%3DDieterich%26aufirst%3DH.%2BA.%26aulast%3DHoward%26aufirst%3DD.%26aulast%3DDole%26aufirst%3DW.%2BP.%26atitle%3DClinical%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520aliskiren%26jtitle%3DClin.%2520Pharm.%26date%3D2008%26volume%3D47%26spage%3D515%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Fisher, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Is there a future for renin inhibitors?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=417-426&author=N.+D.+Fisherauthor=N.+K.+Hollenberg&title=Is+there+a+future+for+renin+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DIs%2520there%2520a%2520future%2520for%2520renin%2520inhibitors%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D10%26spage%3D417%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jermany, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizot, M.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camisasca, R.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1365-2125.2006.02696.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17118124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlarug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=690-698&author=S.+Vaidyanathanauthor=J.+Jermanyauthor=C.+M.+Yehauthor=M.-N.+Bizotauthor=R.+Camisasca&title=Aliskiren%2C+a+novel+orally+effective+renin+inhibitor%2C+exhibits+similar+pharmacokinetics+and+pharmacodynamics+in+Japanese+and+Caucasian+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in japanese and Caucasian subjects</span></div><div class="casAuthors">Vaidyanathan, Sujata; Jermany, Joanne; Yeh, ChingMing; Bizot, Marie-Noelle; Camisasca, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">690-698</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension.  This study compared the pharmacokinetic and pharmacodynamic properties of aliskiren in Japanese and Caucasian subjects.  Methods: In this open-label, single-center, parallel-group, single- and multiple-dose study, 19 Japanese and 19 Caucasian healthy young male subjects received a single 300-mg oral dose of aliskiren on day 1 and then aliskiren 300 mg once daily on days 4-10.  Blood samples were collected for the measurement of plasma aliskiren concn., plasma renin concn. (PRC) and plasma renin activity (PRA).  Results: Pharmacokinetic parameters were comparable in Japanese and Caucasian subjects following administration of a single dose of aliskiren (ratio of geometric means: Cmax 1.12 [90% confidence interval Cl) 0.88, 1.43]; AUC0-72 h 1.19 [90% Cl 1.02, 1.39] and at steady state mean ratio: Cmax 1.30 (90% Cl 1.00, 1.70); AUC0-τ 1.16 (90% Cl 0.95, 1.41).  There was no notable difference in the plasma half-life of aliskiren between Japanese and Caucasian groups (29.7 ± 10.2 h and 32.0 ± 6.6 h, resp.).  At steady state, peak PRC level and AUC for the concn.-time plot were not significantly different between Japanese and Caucasian subjects (P = 0.64 and P = 0.80, resp.).  A single oral dose of aliskiren significantly reduced PRA to a similar extent in Japanese and Caucasian subjects (by 87.5% and 85.7%, resp., compared with baseline; P < 0.01).  Aliskiren was well tolerated by both ethnic groups.  Conclusions: The oral renin inhibitor aliskiren demonstrated similar pharmacokinetic and pharmacodynamic properties in Japanese and Caucasian subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooFoj4KsUq-LVg90H21EOLACvtfcHk0ljDyLcTxMNe2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlarug%253D%253D&md5=8ab2d4d3ebc2284f533cdc6ce34fd700</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2006.02696.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2006.02696.x%26sid%3Dliteratum%253Aachs%26aulast%3DVaidyanathan%26aufirst%3DS.%26aulast%3DJermany%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DC.%2BM.%26aulast%3DBizot%26aufirst%3DM.-N.%26aulast%3DCamisasca%26aufirst%3DR.%26atitle%3DAliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%252C%2520exhibits%2520similar%2520pharmacokinetics%2520and%2520pharmacodynamics%2520in%2520Japanese%2520and%2520Caucasian%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D62%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Waldmeier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaenzel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiberling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valencia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviere, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span> </span><span class="NLM_article-title">Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1418-1428&author=F.+Waldmeierauthor=U.+Glaenzelauthor=B.+Wirzauthor=L.+Obererauthor=D.+Schmidauthor=M.+Seiberlingauthor=J.+Valenciaauthor=G.+J.+Riviereauthor=P.+Endauthor=S.+Vaidyanathan&title=Absorption%2C+distribution%2C+metabolism%2C+and+elimination+of+the+direct+renin+inhibitor+aliskiren+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmeier%26aufirst%3DF.%26aulast%3DGlaenzel%26aufirst%3DU.%26aulast%3DWirz%26aufirst%3DB.%26aulast%3DOberer%26aufirst%3DL.%26aulast%3DSchmid%26aufirst%3DD.%26aulast%3DSeiberling%26aufirst%3DM.%26aulast%3DValencia%26aufirst%3DJ.%26aulast%3DRiviere%26aufirst%3DG.%2BJ.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DVaidyanathan%26aufirst%3DS.%26atitle%3DAbsorption%252C%2520distribution%252C%2520metabolism%252C%2520and%2520elimination%2520of%2520the%2520direct%2520renin%2520inhibitor%2520aliskiren%2520in%2520healthy%2520volunteers%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1418%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuerzner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. R.</span><span> </span><span class="NLM_article-title">Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100)</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=e1-e8&author=J.+Nussbergerauthor=G.+Wuerznerauthor=C.+Jensenauthor=H.+R.+Brunner&title=Angiotensin+II+suppression+in+humans+by+the+orally+active+renin+inhibitor+aliskiren+%28SPP100%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DWuerzner%26aufirst%3DG.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DBrunner%26aufirst%3DH.%2BR.%26atitle%3DAngiotensin%2520II%2520suppression%2520in%2520humans%2520by%2520the%2520orally%2520active%2520renin%2520inhibitor%2520aliskiren%2520%2528SPP100%2529%26jtitle%3DHypertension%26date%3D2002%26volume%3D39%26spage%3De1%26epage%3De8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Stanton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OBrien, E.</span><span> </span><span class="NLM_article-title">Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1137-1143&author=A.+Stantonauthor=C.+Jensenauthor=J.+Nussbergerauthor=E.+OBrien&title=Blood+pressure+lowering+in+essential+hypertension+with+an+oral+renin+inhibitor%2C+aliskiren"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DOBrien%26aufirst%3DE.%26atitle%3DBlood%2520pressure%2520lowering%2520in%2520essential%2520hypertension%2520with%2520an%2520oral%2520renin%2520inhibitor%252C%2520aliskiren%26jtitle%3DHypertension%26date%3D2003%26volume%3D42%26spage%3D1137%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Gradman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmieder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=1012-1018&author=A.+H.+Gradmanauthor=R.+E.+Schmiederauthor=R.+L.+Linsauthor=J.+Nussbergerauthor=Y.+Chiangauthor=M.+P.+Bedigian&title=Aliskiren%2C+a+novel+orally+effective+renin+inhibitor%2C+provides+dose-dependent+antihypertensive+efficacy+and+placebo-like+tolerability+in+hypertensive+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGradman%26aufirst%3DA.%2BH.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DLins%26aufirst%3DR.%2BL.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DY.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26atitle%3DAliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%252C%2520provides%2520dose-dependent%2520antihypertensive%2520efficacy%2520and%2520placebo-like%2520tolerability%2520in%2520hypertensive%2520patients%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D1012%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Andersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constance, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span> </span><span class="NLM_article-title">Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3282f3ad9a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18300872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=589-599&author=K.+Andersenauthor=M.+H.+Weinbergerauthor=B.+Eganauthor=C.+M.+Constanceauthor=M.+A.+Aliauthor=J.+Jinauthor=D.+L.+Keefe&title=Comparative+efficacy+and+safety+of+aliskiren%2C+an+oral+direct+renin+inhibitor%2C+and+ramipril+in+hypertension%3A+a+6-month%2C+randomized%2C+double-blind+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial</span></div><div class="casAuthors">Andersen, Karl; Weinberger, Myron H.; Egan, Brent; Constance, Christian M.; Ali, Mohammed A.; Jin, James; Keefe, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">589-599</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">This double-blind study compared long-term efficacy, safety and tolerability of the oral direct renin inhibitor aliskiren and the angiotensin-converting enzyme inhibitor ramipril alone and combined with hydrochlorothiazide in patients with hypertension.  After a 2- to 4-wk placebo run-in, 842 patients [mean sitting diastolic blood pressure (msDBP) 95-109 mmHg] were randomized to aliskiren 150 mg (n = 420) or ramipril 5 mg (n = 422).  Dose titrn. (to aliskiren 300 mg/ramipril 10 mg) and subsequent hydrochlorothiazide addn. (12.5 mg, titrated to 25 mg if required) were permitted at weeks 6, 12, 18 and 21 for inadequate blood pressure control.  Patients completing the 26-wk active-controlled treatment period were re-randomized to their existing regimen or placebo for a 4-wk double-blind withdrawal phase.  Of patients 687 (81.6%) completed the active treatment period.  At week 26, aliskiren-based therapy produced greater mean redns. in mean sitting systolic blood pressure (17.9 vs. 15.2 mmHg, P = 0.0036) and msDBP (13.2 vs. 12.0 mmHg, P = 0.025), and higher rates of systolic blood pressure control (< 140 mmHg; 72.5 vs. 64.1%, P = 0.0075) compared with ramipril-based therapy.  During withdrawal, blood pressure increased more rapidly after stopping ramipril than aliskiren-based therapy; median blood pressure reached 140/90 mmHg after 1 and 4 wk, resp.  Blood pressure redns. were maintained with continued active treatment.  Aliskiren therapy was well tolerated.  Overall adverse event rates were similar with aliskiren (61.3%) and ramipril (60.4%); cough was more frequent with ramipril (9.5%) than aliskiren (4.1%).  Aliskiren-based therapy was well tolerated and produced sustained blood pressure redns. in patients with hypertension over 6 mo, greater than those with ramipril-based therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzCXukAYUFb7Vg90H21EOLACvtfcHk0li9eBnVHkWMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWhur0%253D&md5=fdb781c89ae7a10ef13b96fabd56083f</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3282f3ad9a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3282f3ad9a%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DK.%26aulast%3DWeinberger%26aufirst%3DM.%2BH.%26aulast%3DEgan%26aufirst%3DB.%26aulast%3DConstance%26aufirst%3DC.%2BM.%26aulast%3DAli%26aufirst%3DM.%2BA.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26atitle%3DComparative%2520efficacy%2520and%2520safety%2520of%2520aliskiren%252C%2520an%2520oral%2520direct%2520renin%2520inhibitor%252C%2520and%2520ramipril%2520in%2520hypertension%253A%2520a%25206-month%252C%2520randomized%252C%2520double-blind%2520trial%26jtitle%3DJ.%2520Hypertens.%26date%3D2008%26volume%3D26%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Oh, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herron, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span> </span><span class="NLM_article-title">Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-h blood pressure control in patients with hypertension</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.jacc.2006.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17367658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtVagurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=1157-1163&author=B.+H.+Ohauthor=J.+Mitchellauthor=J.+R.+Herronauthor=J.+Chungauthor=M.+Khanauthor=D.+L.+Keefe&title=Aliskiren%2C+an+oral+renin+inhibitor%2C+provides+dose-dependent+efficacy+and+sustained+24-h+blood+pressure+control+in+patients+with+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension</span></div><div class="casAuthors">Oh, Byung-Hee; Mitchell, Jerry; Herron, James R.; Chung, Jenny; Khan, Mahmudul; Keefe, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1157-1163</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Sustained 24 H Blood Pressure Control in Patients With Hypertension Byung-Hee Oh, Jerry Mitchell, James R. Herron, Jenny Chung, Mahmudul Khan, Deborah L. Keefe The efficacy of the novel renin inhibitor aliskiren was investigated in a randomized, double-blind, placebo-controlled, dose-ranging study in 672 patients with mild-to-moderate hypertension.  Patients were randomized to receive aliskiren 150, 300, or 600 mg or placebo once daily for 8 wk.  Aliskiren 150, 300, and 600 mg significantly reduced office blood pressure by 13.0/10.3, 14.7/11.1, and 15.8/12.5 mm Hg (systolic/diastolic), resp., compared with 3.8/4.9 mm Hg with placebo (p < 0.0001).  The blood-pressure-lowering effect of aliskiren persisted for up to 2 wk after treatment withdrawal.  Aliskiren was well tolerated.  Aliskiren provides significant antihypertensive efficacy with no rebound effects on blood pressure after treatment withdrawal.  This dose-ranging study evaluated the antihypertensive efficacy and tolerability of aliskiren in patients with mild-to-moderate hypertension.  Low blood pressure (BP) control rates among patients with hypertension indicate a need for improved treatment options.  This study investigates aliskiren, the first in a new antihypertensive class called renin inhibitors.  Patients with mean sitting diastolic BP 95 to 109 mm Hg were randomized to aliskiren 150, 300, or 600 mg or placebo once daily for 8 wk.  Patients completing this treatment phase entered a 2-wk treatment-free withdrawal period.  Office BP was recorded at baseline, weeks 2, 4, 6, and 8 of treatment, and 4 days and 2 wk after cessation of treatment.  A subgroup of patients underwent ambulatory BP monitoring.  In total, 672 patients were randomized to treatment.  After 8 wk, aliskiren 150, 300, and 600 mg significantly reduced mean sitting BP (systolic/diastolic) by 13.0/10.3, 14.7/11.1, and 15.8/12.5 mm Hg, resp., vs. 3.8/4.9 mm Hg with placebo (all p < 0.0001 for systolic and diastolic BP).  The BP-lowering effect of aliskiren persisted for up to 2 wk after treatment withdrawal.  Aliskiren significantly reduced mean 24-h ambulatory BP (p < 0.0001 vs. placebo with all doses) exhibiting smooth, sustained effects and high trough-to-peak ratios.  Aliskiren was well tolerated; overall adverse event rates were 40.1%, 46.7%, and 52.4% with aliskiren 150, 300, and 600 mg, resp., and 43.0% with placebo.  Few patients discontinued treatment due to adverse events.  Aliskiren provides significant antihypertensive efficacy in patients with hypertension, with no rebound effects on blood pressure after treatment withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2x01d2tsmTLVg90H21EOLACvtfcHk0ljIhv_n0Jo98w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtVagurk%253D&md5=da790175baa20cb533685c91534723f2</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2006.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2006.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DB.%2BH.%26aulast%3DMitchell%26aufirst%3DJ.%26aulast%3DHerron%26aufirst%3DJ.%2BR.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26atitle%3DAliskiren%252C%2520an%2520oral%2520renin%2520inhibitor%252C%2520provides%2520dose-dependent%2520efficacy%2520and%2520sustained%252024-h%2520blood%2520pressure%2520control%2520in%2520patients%2520with%2520hypertension%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2007%26volume%3D49%26spage%3D1157%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmieder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, M. F.</span><span> </span><span class="NLM_article-title">Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1742-1241.2007.01473.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17590217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSks77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=1461-1468&author=J.+Nussbergerauthor=A.+H.+Gradmanauthor=R.+E.+Schmiederauthor=R.+L.+Linsauthor=Y.+Chiangauthor=M.+F.+Prescott&title=Plasma+renin+and+the+antihypertensive+effect+of+the+orally+active+renin+inhibitor+aliskiren+in+clinical+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension</span></div><div class="casAuthors">Nussberger, J.; Gradman, A. H.; Schmieder, R. E.; Lins, R. L.; Chiang, Y.; Prescott, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1461-1468</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension.  Methods: In 569 patients with mild-to-moderate hypertension, blood pressure (BP), plasma renin activity (PRA) and plasma renin concn. (PRC) were measured before and after 8 wk of double-blind treatment with once-daily oral doses of aliskiren (150, 300 or 600 mg), irbesartan 150 mg or placebo.  Results: Aliskiren 150, 300 and 600 mg and irbesartan 150 mg significantly reduced mean cuff sitting systolic BP (SBP) from baseline (p < 0.001 vs. placebo).  Aliskiren 150, 300 and 600 mg significantly reduced geometric mean PRA by 69%, 71% and 75% from baseline resp. (p < 0.05 vs. placebo).  Irbesartan 150 mg significantly increased PRA by 109% (p < 0.05 vs. placebo).  Aliskiren dose-dependently increased PRC from baseline by 157%, 246% and 497%, at 150, 300 and 600 mg resp., compared with a 9% decrease with placebo (p < 0.05).  PRC increased significantly more with aliskiren 300 and 600 mg compared with irbesartan 150 mg (105%; p < 0.05).  Regression anal. showed no significant correlations between baseline PRA and changes in SBP in any of the treatment groups, but interestingly, the slopes of the regression lines between changes in SBP and log-transformed baseline PRA were +2.0 for placebo and -1.5, -1.8 and -2.3 for aliskiren 150, 300 and 600 mg resp.  The slope for irbesartan 150 mg (-1.4) was similar to that for aliskiren 150 mg.  Conclusions: Aliskiren reduces SBP and PRA and increases PRC dose-dependently.  In contrast, irbesartan reduces SBP but increases both PRC and PRA.  As PRA is a measurement of angiotensin I-generating capacity, PRA can be used for measuring the ability of an antihypertensive agent to prevent the generation or action of Ang II, either directly (renin inhibitors, beta-blockers, central α2-agonists) or indirectly (AT1-receptor blockers, ACE inhibitors).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSuDKau1GN77Vg90H21EOLACvtfcHk0ljIhv_n0Jo98w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSks77F&md5=c67233ca3e9efee449240f92df4a65eb</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2007.01473.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2007.01473.x%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DGradman%26aufirst%3DA.%2BH.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DLins%26aufirst%3DR.%2BL.%26aulast%3DChiang%26aufirst%3DY.%26aulast%3DPrescott%26aufirst%3DM.%2BF.%26atitle%3DPlasma%2520renin%2520and%2520the%2520antihypertensive%2520effect%2520of%2520the%2520orally%2520active%2520renin%2520inhibitor%2520aliskiren%2520in%2520clinical%2520hypertension%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2007%26volume%3D61%26spage%3D1461%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Vergaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iervasi, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabutti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emdin, M.</span><span> </span><span class="NLM_article-title">Plasma renin activity is an independent prognostic factor in chronic heart failure</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">393</span><div class="note"><p class="first last"> (Abstract 2493)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=393&issue=Suppl.&author=G.+Vergaroauthor=M.+Fontanaauthor=R.+Polettiauthor=A.+Giannoniauthor=A.+L.+Iervasiauthor=L.+Masiauthor=C.+Mamminiauthor=A.+Gabuttiauthor=C.+Passinoauthor=M.+Emdin&title=Plasma+renin+activity+is+an+independent+prognostic+factor+in+chronic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVergaro%26aufirst%3DG.%26aulast%3DFontana%26aufirst%3DM.%26aulast%3DPoletti%26aufirst%3DR.%26aulast%3DGiannoni%26aufirst%3DA.%26aulast%3DIervasi%26aufirst%3DA.%2BL.%26aulast%3DMasi%26aufirst%3DL.%26aulast%3DMammini%26aufirst%3DC.%26aulast%3DGabutti%26aufirst%3DA.%26aulast%3DPassino%26aufirst%3DC.%26aulast%3DEmdin%26aufirst%3DM.%26atitle%3DPlasma%2520renin%2520activity%2520is%2520an%2520independent%2520prognostic%2520factor%2520in%2520chronic%2520heart%2520failure%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2008%26volume%3D29%26issue%3DSuppl%26spage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Chobanian, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakris, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, J. L.</span><span> </span><span class="NLM_article-title">Seventh report of the Joint National Committeee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1206-1252&author=A.+V.+Chobanianauthor=G.+L.+Bakrisauthor=H.+R.+Blackauthor=W.+C.+Cushmanauthor=L.+A.+Greenauthor=J.+L.+Izzo&title=Seventh+report+of+the+Joint+National+Committeee+on+Prevention%2C+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Pressure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChobanian%26aufirst%3DA.%2BV.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlack%26aufirst%3DH.%2BR.%26aulast%3DCushman%26aufirst%3DW.%2BC.%26aulast%3DGreen%26aufirst%3DL.%2BA.%26aulast%3DIzzo%26aufirst%3DJ.%2BL.%26atitle%3DSeventh%2520report%2520of%2520the%2520Joint%2520National%2520Committeee%2520on%2520Prevention%252C%2520Detection%252C%2520Evaluation%252C%2520and%2520Treatment%2520of%2520High%2520Blood%2520Pressure%26jtitle%3DHypertension%26date%3D2003%26volume%3D42%26spage%3D1206%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Villamil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrysant, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calhoun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisciano-Dimichino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3280103a6b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17143194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=217-226&author=A.+Villamilauthor=S.+G.+Chrysantauthor=D.+Calhounauthor=B.+Schoberauthor=H.+Hsuauthor=L.+Matrisciano-Dimichinoauthor=J.+Zhang&title=Renin+inhibition+with+aliskiren+provides+additive+antihypertensive+efficacy+when+used+in+combination+with+hydrochlorothiazide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide</span></div><div class="casAuthors">Villamil, Alberto; Chrysant, Steven G.; Calhoun, David; Schober, Bonnie; Hsu, Huang; Matrisciano-Dimichino, Linda; Zhang, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-226</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objectives: Aliskiren is a novel, orally active renin inhibitor.  Its antihypertensive efficacy and safety, alone and in combination with hydrochlorothiazide (HCTZ), were investigated in an 8-wk, double-blind, placebo-controlled trial in hypertensive patients.  The effects of these treatments on plasma renin activity (PRA) were also assessed.  Methods: A total of 2776 patients aged ≥ 18 years with mean sitting diastolic blood pressure (MSDBP) 95-109 mmHg were randomized to receive once-daily treatment with aliskiren (75, 150 or 300 mg), HCTZ (6.25, 12.5 or 25 mg), the combination of aliskiren and HCTZ, or placebo, in a factorial design.  The primary endpoint was the change in MSDBP from baseline to week 8.  PRA was assessed at these timepoints at selected study centers.  Results: Aliskiren monotherapy was superior to placebo (P < 0.001; overall Dunnett's test) in reducing MSDBP and mean sitting systolic blood pressure (MSSBP).  Combination treatment was superior to both component monotherapies in reducing BP (max. MSSBP/MSDBP redn. of 21.2/14.3 mmHg from baseline with aliskiren/HCTZ 300/25 mg), and resulted in more responders (patients with MSDBP < 90 mmHg and/or ≥ 10 mmHg redn.) and better control rates (patients achieving MSSBP/MSDBP < 140/90 mmHg) than either monotherapy.  Aliskiren monotherapy reduced PRA by up to 65% from baseline.  Although HCTZ monotherapy increased PRA by up to 72%, PRA decreased in all of the combination therapy groups.  All active treatments were well tolerated.  Conclusions: Aliskiren monotherapy demonstrated significant BP lowering, and its effect was considerably greater when combined with HCTZ.  Renin inhibition with aliskiren neutralized the compensatory rise in PRA induced by HCTZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv1Qg07ReJ97Vg90H21EOLACvtfcHk0lhJDF1TuEFTdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrnM&md5=ad221912f5a5bad6bbe4678554cea695</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3280103a6b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3280103a6b%26sid%3Dliteratum%253Aachs%26aulast%3DVillamil%26aufirst%3DA.%26aulast%3DChrysant%26aufirst%3DS.%2BG.%26aulast%3DCalhoun%26aufirst%3DD.%26aulast%3DSchober%26aufirst%3DB.%26aulast%3DHsu%26aufirst%3DH.%26aulast%3DMatrisciano-Dimichino%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DRenin%2520inhibition%2520with%2520aliskiren%2520provides%2520additive%2520antihypertensive%2520efficacy%2520when%2520used%2520in%2520combination%2520with%2520hydrochlorothiazide%26jtitle%3DJ.%2520Hypertens.%26date%3D2007%26volume%3D25%26spage%3D217%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulcahy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, A.</span><span> </span><span class="NLM_article-title">Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin converting enzyme inhibitor, or an angiotensin receptor blocker</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=276-284&author=E.+O%E2%80%99Brienauthor=J.+Bartonauthor=J.+Nussbergerauthor=D.+Mulcahyauthor=C.+Jensenauthor=P.+Dickerauthor=A.+Stanton&title=Aliskiren+reduces+blood+pressure+and+suppresses+plasma+renin+activity+in+combination+with+a+thiazide+diuretic%2C+an+angiotensin+converting+enzyme+inhibitor%2C+or+an+angiotensin+receptor+blocker"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DBarton%26aufirst%3DJ.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DMulcahy%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DDicker%26aufirst%3DP.%26aulast%3DStanton%26aufirst%3DA.%26atitle%3DAliskiren%2520reduces%2520blood%2520pressure%2520and%2520suppresses%2520plasma%2520renin%2520activity%2520in%2520combination%2520with%2520a%2520thiazide%2520diuretic%252C%2520an%2520angiotensin%2520converting%2520enzyme%2520inhibitor%252C%2520or%2520an%2520angiotensin%2520receptor%2520blocker%26jtitle%3DHypertension%26date%3D2007%26volume%3D49%26spage%3D276%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Oparil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarrows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satlin, A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomized, double-blind trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=221-229&author=S.+Oparilauthor=S.+A.+Yarrowsauthor=S.+Patelauthor=H.+Fangauthor=J.+Zhangauthor=A.+Satlin&title=Efficacy+and+safety+of+combined+use+of+aliskiren+and+valsartan+in+patients+with+hypertension%3A+a+randomized%2C+double-blind+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOparil%26aufirst%3DS.%26aulast%3DYarrows%26aufirst%3DS.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSatlin%26aufirst%3DA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520combined%2520use%2520of%2520aliskiren%2520and%2520valsartan%2520in%2520patients%2520with%2520hypertension%253A%2520a%2520randomized%252C%2520double-blind%2520trial%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Drummond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essop, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maboudian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span> </span><span class="NLM_article-title">Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy</span> <span class="citation_source-journal">J. Clin. Hypertens. (Greenwich)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1524-6175.2007.06614.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17917501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=742-750&author=W.+Drummondauthor=M.+A.+Mungerauthor=R.+Essopauthor=M.+Maboudianauthor=M.+Khanauthor=D.+L.+Keefe&title=Antihypertensive+efficacy+of+the+oral+direct+renin+inhibitor+aliskiren+as+add-on+therapy+in+patients+not+responding+to+amlodipine+monotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy</span></div><div class="casAuthors">Drummond, Waymon; Munger, Mark A.; Essop, Mohammed Rafique; Maboudian, Mojdeh; Khan, Mahmudul; Keefe, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hypertension (Shelton, CT, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">742-750</span>CODEN:
                <span class="NLM_cas:coden">JCHYFN</span>;
        ISSN:<span class="NLM_cas:issn">1524-6175</span>.
    
            (<span class="NLM_cas:orgname">Le Jacq Ltd.</span>)
        </div><div class="casAbstract">This study investigated the addn. of the direct renin inhibitor aliskiren to amlodipine in patients with mild to moderate hypertension that was inadequately controlled with amlodipine alone.  Following once-daily treatment with amlodipine 5 mg for 4 wk, patients whose hypertension responded inadequately to therapy (mean sitting diastolic blood pressure [DBP] 90-109 mm Hg) (n = 545) were randomized to 6 wk of double-blind treatment with amlodipine 5 mg plus aliskiren 150 mg, amlodipine 5 mg, or amlodipine 10 mg.  At the study's end, mean systolic blood pressure and DBP redns. with the combination of aliskiren 150 mg and amlodipine 5 mg (11.0/8.5 mm Hg) were significantly greater (P<.0001) than with amlodipine 5 mg (5.0/4.8 mm Hg)-the comparator group-but similar to amlodipine 10 mg (9.6/8.0 mm Hg).  All treatments were well tolerated.  Edema occurred more frequently with amlodipine 10 mg (11.2%) than with combination therapy (2.1%) or amlodipine 5 mg (3.4%).  In conclusion, aliskiren 150 mg plus amlodipine 5 mg shows similar but not better blood pressure-lowering efficacy when compared with amlodipine 10 mg in patients not completely responsive to amlodipine 5 mg; less edema was noted with combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhDWkxIUwMi7Vg90H21EOLACvtfcHk0ljommkFOC3elA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rt7%252FK&md5=d1d056861e2b735dd00bfe2d0dc6392c</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1111%2Fj.1524-6175.2007.06614.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1524-6175.2007.06614.x%26sid%3Dliteratum%253Aachs%26aulast%3DDrummond%26aufirst%3DW.%26aulast%3DMunger%26aufirst%3DM.%2BA.%26aulast%3DEssop%26aufirst%3DR.%26aulast%3DMaboudian%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26atitle%3DAntihypertensive%2520efficacy%2520of%2520the%2520oral%2520direct%2520renin%2520inhibitor%2520aliskiren%2520as%2520add-on%2520therapy%2520in%2520patients%2520not%2520responding%2520to%2520amlodipine%2520monotherapy%26jtitle%3DJ.%2520Clin.%2520Hypertens.%2520%2528Greenwich%2529%26date%3D2007%26volume%3D9%26spage%3D742%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukashevich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papst, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlöf, B.</span><span> </span><span class="NLM_article-title">Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=530-537&author=S.+D.+Solomonauthor=E.+Appelbauauthor=W.+J.+Manningauthor=A.+Vermaauthor=T.+Berglundauthor=V.+Lukashevichauthor=C.+C.+Papstauthor=B.+A.+Smithauthor=B.+Dahl%C3%B6f&title=Effect+of+the+direct+renin+inhibitor+aliskiren%2C+the+angiotensin+receptor+blocker+losartan%2C+or+both+on+left+ventricular+mass+in+patients+with+hypertension+and+left+ventricular+hypertrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DAppelbau%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DW.%2BJ.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DBerglund%26aufirst%3DT.%26aulast%3DLukashevich%26aufirst%3DV.%26aulast%3DPapst%26aufirst%3DC.%2BC.%26aulast%3DSmith%26aufirst%3DB.%2BA.%26aulast%3DDahl%25C3%25B6f%26aufirst%3DB.%26atitle%3DEffect%2520of%2520the%2520direct%2520renin%2520inhibitor%2520aliskiren%252C%2520the%2520angiotensin%2520receptor%2520blocker%2520losartan%252C%2520or%2520both%2520on%2520left%2520ventricular%2520mass%2520in%2520patients%2520with%2520hypertension%2520and%2520left%2520ventricular%2520hypertrophy%26jtitle%3DCirculation%26date%3D2009%26volume%3D119%26spage%3D530%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">McMurray, J. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggioni, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewsey, J.</span><span> </span><span class="NLM_article-title">Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure</span> <span class="citation_source-journal">Circ.: Heart Fail.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1161%2FCIRCHEARTFAILURE.107.740704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=17-24&author=J.+J.+V.+McMurrayauthor=B.+Pittauthor=R.+Latiniauthor=A.+P.+Maggioniauthor=S.+D.+Solomonauthor=D.+L.+Keefeauthor=J.+Fordauthor=A.+Vermaauthor=J.+Lewsey&title=Effects+of+the+oral+direct+renin+inhibitor+aliskiren+in+patients+with+symptomatic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure</span></div><div class="casAuthors">McMurray, John J. V.; Pitt, Bertram; Latini, Roberto; Maggioni, Aldo P.; Solomon, Scott D.; Keefe, Deborah L.; Ford, Jessica; Verma, Anil; Lewsey, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Loss of neg. feedback inhibition of renin release during chronic treatment with an angiotensin-converting enzyme (ACE) inhibitor leads to a compensatory rise in renin secretion and downstream components of the renin-angiotensin-aldosterone (RAAS) cascade.  This may overcome ACE inhibition but should be blocked by a direct renin inhibitor.  We studied the effects of adding the direct renin inhibitor aliskiren to an ACE inhibitor in patients with heart failure.  Patients with New York Heart Assocn. class II to IV heart failure, current or past history of hypertension, and plasma brain natriuretic peptide (BNP) concn. > 100 pg/mL who had been treated with an ACE inhibitor (or angiotensin receptor blocker) and β-blocker were randomized to 3 mo of treatment with placebo (n=146) or aliskiren 150 mg/d (n=156).  The primary efficacy outcome was the between-treatment difference in N-terminal pro-BNP (NT-proBNP).  Patients' mean age was 68 years, mean ejection fraction was 31%, and mean±SD systolic blood pressure was 129±17.4 mm Hg.  Sixty-two percent of the patients were in New York Heart Assocn. functional class II, and 33% were taking an aldosterone antagonist.  Plasma NT-proBNP rose by 762 ± 6123 pg/mL with placebo and fell by 244 ± 2025 pg/mL with aliskiren (P = 0.0106).  BNP and urinary (but not plasma) aldosterone were also reduced by aliskiren.  Clin. important differences in blood pressure and biochem. were not seen between aliskiren and placebo.  Addn. of aliskiren to an ACE inhibitor (or angiotensin receptor blocker) and β-blocker had favorable neurohumoral effects in heart failure and appeared to be well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodBEfopzuXjrVg90H21EOLACvtfcHk0lijqp3AvtjElw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFGnsLY%253D&md5=863de134998c48838bdc9502de2abbfa</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.107.740704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.107.740704%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%2BV.%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DLatini%26aufirst%3DR.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26aulast%3DFord%26aufirst%3DJ.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DLewsey%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520the%2520oral%2520direct%2520renin%2520inhibitor%2520aliskiren%2520in%2520patients%2520with%2520symptomatic%2520heart%2520failure%26jtitle%3DCirc.%253A%2520Heart%2520Fail.%26date%3D2008%26volume%3D1%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dembowsky, K.</span> Human Phase 0 Microdosing Studies. Practical Examples Using Renin Inhibitors. Evolution 2007, Monaco, October 1, 2007. <a href="http://www.xceleron.com/metadot/index.pl?id=3081&amp;isa=DBRow&amp;op=show&amp;dbview_id=3047#" class="extLink">http://www.xceleron.com/metadot/index.pl?id=3081&isa=DBRow&op=show&dbview_id=3047#</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dembowsky%2C+K.+Human+Phase+0+Microdosing+Studies.+Practical+Examples+Using+Renin+Inhibitors.+Evolution+2007%2C+Monaco%2C+October+1%2C+2007.+http%3A%2F%2Fwww.xceleron.com%2Fmetadot%2Findex.pl%3Fid%3D3081%26isa%3DDBRow%26op%3Dshow%26dbview_id%3D3047%23+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DDembowsky%26aufirst%3DK.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit182b"><span><span class="NLM_label">(b) </span> Speedel Annual General Meeting, April 15, 2008. <a href="http://www.speedel.com/assets/AGM_2008_presentation_2.pdf" class="extLink">http://www.speedel.com/assets/AGM_2008_presentation_2.pdf</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Speedel+Annual+General+Meeting%2C+April+15%2C+2008.+http%3A%2F%2Fwww.speedel.com%2Fassets%2FAGM_2008_presentation_2.pdf+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span>Vitae Pharmaceuticals Press Release, September 21, 2009: Vitae Initiates Phase 1 Trial of Novel Renin Inhibitor. In <i>Genetic Engineering & Biotechnology News</i>, September 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span>. <a href="http://www.genengnews.com/news/bnitem.aspx?name=63361020" class="extLink">http://www.genengnews.com/news/bnitem.aspx?name=63361020</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vitae+Pharmaceuticals+Press+Release%2C+September+21%2C+2009%3A+Vitae+Initiates+Phase+1+Trial+of+Novel+Renin+Inhibitor.+In+Genetic+Engineering+%26+Biotechnology+News%2C+September+21%2C+2009.+http%3A%2F%2Fwww.genengnews.com%2Fnews%2Fbnitem.aspx%3Fname%3D63361020+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2009%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184a"><span><span class="NLM_label">(a) </span> Actelion Annual Report 2008. <a href="http://www1.actelion.com/documents/corporate/annual_reports/AR_Actelion_InDetail_E.pdf" class="extLink">http://www1.actelion.com/documents/corporate/annual_reports/AR_Actelion_InDetail_E.pdf</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Actelion+Annual+Report+2008.+http%3A%2F%2Fwww1.actelion.com%2Fdocuments%2Fcorporate%2Fannual_reports%2FAR_Actelion_InDetail_E.pdf+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit184b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">A Study To Determine the Effectiveness and Tolerability of MK8141 in Patients with High Blood Pressure</span>; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, October 5,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://clinicaltrials.gov/ct2/show/study/NCT00543413" class="extLink">http://clinicaltrials.gov/ct2/show/study/NCT00543413</a>. Accessed December 21, 2009.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+To+Determine+the+Effectiveness+and+Tolerability+of+MK8141+in+Patients+with+High+Blood+Pressure%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+October+5%2C+2007%3B+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT00543413.+Accessed+December+21%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DA%2520Study%2520To%2520Determine%2520the%2520Effectiveness%2520and%2520Tolerability%2520of%2520MK8141%2520in%2520Patients%2520with%2520High%2520Blood%2520Pressure%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zeeuw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadanfar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissbach, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armbrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeffer, M. A.</span><span> </span><span class="NLM_article-title">Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1093%2Fndt%2Fgfn721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19145003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvFKjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=1663-1671&author=H.+H.+Parvingauthor=B.+M.+Brennerauthor=J.+J.+V.+McMurrayauthor=D.+de+Zeeuwauthor=S.+M.+Haffnerauthor=S.+D.+Solomonauthor=N.+Chaturvediauthor=M.+Ghadanfarauthor=N.+Weissbachauthor=Z.+Xiangauthor=J.+Armbrechtauthor=M.+A.+Pfeffer&title=Aliskiren+trial+in+type+2+diabetes+using+cardio-renal+endpoints+%28ALTITUDE%29%3A+rationale+and+study+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design</span></div><div class="casAuthors">Parving, Hans-Henrik; Brenner, Barry M.; McMurray, John. J. V.; de Zeeuw, Dick; Haffner, Steven M.; Solomon, Scott D.; Chaturvedi, Nish; Ghadanfar, Mathieu; Weissbach, Nicole; Xiang, Zhihua; Armbrecht, Juergen; Pfeffer, Marc A.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1663-1671</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Patients with type 2 diabetes are at increased risk of macro- and microvascular disease, and the presence of albuminuria and/or reduced kidney function further enhances macrovascular risk.  Angiotensin-converting-enzyme inhibitors reduce both macro- and microvascular events, yet the residual renal and cardiovascular risk still remains high.  Aliskiren a novel oral direct renin inhibitor that unlike ACEi and ARBs, lowers plasma renin activity, angiotensin I and angiotensin II levels, may thereby provide greater benefit compared to ACEi or ARB alone.  The primary objective of the ALTITUDE trial is to det. whether aliskiren 300 mg once daily, reduces cardiovascular and renal morbidity and mortality compared with placebo when added to conventional treatment (including ACEi or ARB).  ALTITUDE is an international, randomized, double-blind, placebo-controlled, parallel-group study, which will include three categories of high-risk patients with type 2 diabetes (aged ≥35 years): those with either urinary albumin/creatinine ratio (UACR) ≥200 mg/g; microalbuminuria (UACR) ≥20 <200 mg/g and eGFR ≥30 <60 mL/min/1.73 m2; and thirdly, those with a history of cardiovascular disease and eGFR ≥30 <60 mL/min/1.73 m2 with or without microalbuminuria.  ALTITUDE is an event driven trial that aims to randomize 8600 patients with a planned follow-up time of 48 mo.  The primary outcome measure is time to first event for the composite endpoint of cardiovascular death, resuscitated death, myocardial infarction, stroke, unplanned hospitalization for heart failure, onset of end-stage renal disease or doubling of baseline serum creatinine concn.  Secondary endpoints include a composite CV endpoint and a composite renal endpoint.  ALTITUDE will det. whether dual RAAS blockade with the direct renin inhibitor aliskiren in combination with an ACEi or ARB will reduce major morbidity and mortality in a broad range of high-risk patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2JtHWQfC-2bVg90H21EOLACvtfcHk0lgrgObowaCkAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvFKjsLs%253D&md5=108ef4ed089dd0d4462f16f47fe861a1</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfn721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfn721%26sid%3Dliteratum%253Aachs%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DBrenner%26aufirst%3DB.%2BM.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%2BV.%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DChaturvedi%26aufirst%3DN.%26aulast%3DGhadanfar%26aufirst%3DM.%26aulast%3DWeissbach%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DArmbrecht%26aufirst%3DJ.%26aulast%3DPfeffer%26aufirst%3DM.%2BA.%26atitle%3DAliskiren%2520trial%2520in%2520type%25202%2520diabetes%2520using%2520cardio-renal%2520endpoints%2520%2528ALTITUDE%2529%253A%2520rationale%2520and%2520study%2520design%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2009%26volume%3D24%26spage%3D1663%26epage%3D1671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':[],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22a','cit22b'],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b','cit36c','cit36d','cit36e'],'ref37':['cit37'],'ref38':['cit38a','cit38b','cit38c','cit38d'],'ref39':['cit39a','cit39b'],'ref40':['cit40a','cit40b'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47a','cit47b'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55a','cit55b','cit55c'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58a','cit58b','cit58c','cit58d','cit58e','cit58f','cit58g'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64a','cit64b'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68a','cit68b'],'ref69':['cit69'],'ref70':['cit70a','cit70b'],'ref71':['cit71'],'ref72':['cit72a','cit72b','cit72c'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75a','cit75b','cit75c'],'ref76':['cit76a','cit76b'],'ref77':['cit77a','cit77b','cit77c'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80a','cit80b'],'ref81':['cit81a','cit81b'],'ref82':['cit82'],'ref83':['cit83a','cit83b'],'ref84':['cit84'],'ref85':['cit85a','cit85b'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90a','cit90b'],'ref91':['cit91'],'ref92':['cit92a','cit92b'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97a','cit97b','cit97c'],'ref98':['cit98'],'ref99':['cit99a','cit99b'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129a','cit129b'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149a','cit149b'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182a','cit182b'],'ref183':['cit183'],'ref184':['cit184a','cit184b'],'ref185':['cit185']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 61 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Robin Kryštůfek, Pavel Šácha, Jana Starková, Jiří Brynda, Martin Hradilek, Eva Tloušt’ová, Justyna Grzymska, Wioletta Rut, Michael J. Boucher, Marcin Drąg, Pavel Majer, Miroslav Hájek, Pavlína Řezáčová, Hiten D. Madhani, Charles S. Craik, <span class="NLM_string-name hlFld-ContribAuthor">Jan Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6706-6719. <a href="https://doi.org/10.1021/acs.jmedchem.0c02177" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02177%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRe-emerging%252BAspartic%252BProtease%252BTargets%25253A%252BExamining%252BCryptococcus%252Bneoformans%252BMajor%252BAspartyl%252BPeptidase%252B1%252Bas%252Ba%252BTarget%252Bfor%252BAntifungal%252BDrug%252BDiscovery%26aulast%3DKry%25C5%25A1t%25C5%25AFfek%26aufirst%3DRobin%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D16122020%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6706%26epage%3D6719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Claas Strecker, <span class="NLM_string-name hlFld-ContribAuthor">Bernd Meyer</span>. </span><span class="cited-content_cbyCitation_article-title">Plasticity of the Binding Site of Renin: Optimized Selection of Protein Structures for Ensemble Docking. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (5)
                                     , 1121-1131. <a href="https://doi.org/10.1021/acs.jcim.8b00010" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPlasticity%252Bof%252Bthe%252BBinding%252BSite%252Bof%252BRenin%25253A%252BOptimized%252BSelection%252Bof%252BProtein%252BStructures%252Bfor%252BEnsemble%252BDocking%26aulast%3DStrecker%26aufirst%3DClaas%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09012018%26date%3D02052018%26date%3D23042018%26volume%3D58%26issue%3D5%26spage%3D1121%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatma H.  Al-Awadhi</span>, <span class="hlFld-ContribAuthor ">Brian K.  Law</span>, <span class="hlFld-ContribAuthor ">Valerie J.  Paul</span>, and <span class="hlFld-ContribAuthor ">Hendrik  Luesch</span>  . </span><span class="cited-content_cbyCitation_article-title">Grassystatins D–F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2017,</strong> <em>80 </em>
                                    (11)
                                     , 2969-2986. <a href="https://doi.org/10.1021/acs.jnatprod.7b00551" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.7b00551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.7b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.7b00551%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DGrassystatins%252BD%2525E2%252580%252593F%25252C%252BPotent%252BAspartic%252BProtease%252BInhibitors%252Bfrom%252BMarine%252BCyanobacteria%252Bas%252BPotential%252BAntimetastatic%252BAgents%252BTargeting%252BInvasive%252BBreast%252BCancer%26aulast%3DAl-Awadhi%26aufirst%3DFatma%2BH.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28062017%26date%3D31102017%26date%3D22112017%26volume%3D80%26issue%3D11%26spage%3D2969%26epage%3D2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Van der Poorten</span>, <span class="hlFld-ContribAuthor ">Astrid  Knuhtsen</span>, <span class="hlFld-ContribAuthor ">Daniel  Sejer Pedersen</span>, <span class="hlFld-ContribAuthor ">Steven  Ballet</span>, and <span class="hlFld-ContribAuthor ">Dirk  Tourwé</span>  . </span><span class="cited-content_cbyCitation_article-title">Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10865-10890. <a href="https://doi.org/10.1021/acs.jmedchem.6b01029" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSide%252BChain%252BCyclized%252BAromatic%252BAmino%252BAcids%25253A%252BGreat%252BTools%252Bas%252BLocal%252BConstraints%252Bin%252BPeptide%252Band%252BPeptidomimetic%252BDesign%26aulast%3DVan%2Bder%2BPoorten%26aufirst%3DOlivier%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12072016%26date%3D12102016%26date%3D22122016%26date%3D03102016%26volume%3D59%26issue%3D24%26spage%3D10865%26epage%3D10890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasuhiro  Imaeda</span>, <span class="hlFld-ContribAuthor ">Hidekazu  Tokuhara</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Fukase</span>, <span class="hlFld-ContribAuthor ">Ray  Kanagawa</span>, <span class="hlFld-ContribAuthor ">Yumiko  Kajimoto</span>, <span class="hlFld-ContribAuthor ">Keiji  Kusumoto</span>, <span class="hlFld-ContribAuthor ">Mitsuyo  Kondo</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Craig A.  Behnke</span>, and <span class="hlFld-ContribAuthor ">Takanobu  Kuroita</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 933-938. <a href="https://doi.org/10.1021/acsmedchemlett.6b00251" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00251%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BTAK-272%25253A%252BA%252BNovel%25252C%252BPotent%25252C%252Band%252BOrally%252BActive%252BRenin%252BInhibitor%26aulast%3DImaeda%26aufirst%3DYasuhiro%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28062016%26date%3D12092016%26date%3D14092016%26date%3D13102016%26date%3D12092016%26volume%3D7%26issue%3D10%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Newman</span> and <span class="hlFld-ContribAuthor ">Gordon M.  Cragg</span>  . </span><span class="cited-content_cbyCitation_article-title">Natural Products as Sources of New Drugs from 1981 to 2014. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2016,</strong> <em>79 </em>
                                    (3)
                                     , 629-661. <a href="https://doi.org/10.1021/acs.jnatprod.5b01055" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.5b01055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DNatural%252BProducts%252Bas%252BSources%252Bof%252BNew%252BDrugs%252Bfrom%252B1981%252Bto%252B2014%26aulast%3DNewman%26aufirst%3DDavid%2BJ.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D27112015%26date%3D07022016%26date%3D25032016%26volume%3D79%26issue%3D3%26spage%3D629%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Cini</span>, <span class="hlFld-ContribAuthor ">Luca  Banfi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Barreca</span>, <span class="hlFld-ContribAuthor ">Luca  Carcone</span>, <span class="hlFld-ContribAuthor ">Luciana  Malpezzi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Giovanni  Marras</span>, <span class="hlFld-ContribAuthor ">Marcello  Rasparini</span>, <span class="hlFld-ContribAuthor ">Renata  Riva</span>, <span class="hlFld-ContribAuthor ">Stephen  Roseblade</span>, <span class="hlFld-ContribAuthor ">Adele  Russo</span>, <span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>, <span class="hlFld-ContribAuthor ">Romina  Vitale</span>, and <span class="hlFld-ContribAuthor ">Antonio  Zanotti-Gerosa</span>  . </span><span class="cited-content_cbyCitation_article-title">Convergent Synthesis of the Renin Inhibitor Aliskiren Based on C5–C6 Disconnection and CO2H–NH2 Equivalence. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (2)
                                     , 270-283. <a href="https://doi.org/10.1021/acs.oprd.5b00396" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DConvergent%252BSynthesis%252Bof%252Bthe%252BRenin%252BInhibitor%252BAliskiren%252BBased%252Bon%252BC5%2525E2%252580%252593C6%252BDisconnection%252Band%252BCO2H%2525E2%252580%252593NH2%252BEquivalence%26aulast%3DCini%26aufirst%3DElena%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D30112015%26date%3D15012016%26date%3D19022016%26date%3D05012016%26volume%3D20%26issue%3D2%26spage%3D270%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keiichi  Murakami</span>, <span class="hlFld-ContribAuthor ">Yusuke  Sasano</span>, <span class="hlFld-ContribAuthor ">Masaki  Tomizawa</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Shibuya</span>, <span class="hlFld-ContribAuthor ">Eunsang  Kwon</span>, and <span class="hlFld-ContribAuthor ">Yoshiharu  Iwabuchi</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Enantioselective Organocatalytic Oxidative Kinetic Resolution of Secondary Alcohols Using Chiral Alkoxyamines as Precatalysts: Catalyst Structure, Active Species, and Substrate Scope. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (50)
                                     , 17591-17600. <a href="https://doi.org/10.1021/ja509766f" title="DOI URL">https://doi.org/10.1021/ja509766f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja509766f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja509766f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DHighly%252BEnantioselective%252BOrganocatalytic%252BOxidative%252BKinetic%252BResolution%252Bof%252BSecondary%252BAlcohols%252BUsing%252BChiral%252BAlkoxyamines%252Bas%252BPrecatalysts%25253A%252BCatalyst%252BStructure%25252C%252BActive%252BSpecies%25252C%252Band%252BSubstrate%252BScope%26aulast%3DMurakami%26aufirst%3DKeiichi%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D27092014%26date%3D05122014%26date%3D17122014%26date%3D20112014%26volume%3D136%26issue%3D50%26spage%3D17591%26epage%3D17600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jadel M.  Kratz</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>, <span class="hlFld-ContribAuthor ">Michael  Edtbauer</span>, <span class="hlFld-ContribAuthor ">Priyanka  Saxena</span>, <span class="hlFld-ContribAuthor ">Christina E.  Mair</span>, <span class="hlFld-ContribAuthor ">Julia  Kirchebner</span>, <span class="hlFld-ContribAuthor ">Barbara  Matuszczak</span>, <span class="hlFld-ContribAuthor ">Igor  Baburin</span>, <span class="hlFld-ContribAuthor ">Steffen  Hering</span>, and <span class="hlFld-ContribAuthor ">Judith M.  Rollinger</span>  . </span><span class="cited-content_cbyCitation_article-title">Experimentally Validated hERG Pharmacophore Models as Cardiotoxicity Prediction Tools. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (10)
                                     , 2887-2901. <a href="https://doi.org/10.1021/ci5001955" title="DOI URL">https://doi.org/10.1021/ci5001955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5001955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5001955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExperimentally%252BValidated%252BhERG%252BPharmacophore%252BModels%252Bas%252BCardiotoxicity%252BPrediction%252BTools%26aulast%3DKratz%26aufirst%3DJadel%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28032014%26date%3D18092014%26date%3D27102014%26date%3D22082014%26volume%3D54%26issue%3D10%26spage%3D2887%26epage%3D2901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Hanessian</span>, <span class="hlFld-ContribAuthor ">Etienne  Chénard</span>, <span class="hlFld-ContribAuthor ">Sébastien  Guesné</span>, and <span class="hlFld-ContribAuthor ">Jean-Philippe  Cusson</span>  . </span><span class="cited-content_cbyCitation_article-title">Conception and Evolution of Stereocontrolled Strategies toward Functionalized 8-Aryloctanoic Acids Related to the Total Synthesis of Aliskiren. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (20)
                                     , 9531-9545. <a href="https://doi.org/10.1021/jo5015195" title="DOI URL">https://doi.org/10.1021/jo5015195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5015195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5015195%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConception%252Band%252BEvolution%252Bof%252BStereocontrolled%252BStrategies%252Btoward%252BFunctionalized%252B8-Aryloctanoic%252BAcids%252BRelated%252Bto%252Bthe%252BTotal%252BSynthesis%252Bof%252BAliskiren%26aulast%3DHanessian%26aufirst%3DStephen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11072014%26date%3D06102014%26date%3D17102014%26volume%3D79%26issue%3D20%26spage%3D9531%26epage%3D9545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeru  Ehara</span>, <span class="hlFld-ContribAuthor ">Osamu  Irie</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Takanori  Kanazawa</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Philipp  Grosche</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Masaki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shimpei  Kawakami</span>, <span class="hlFld-ContribAuthor ">Kazuhide  Konishi</span>, <span class="hlFld-ContribAuthor ">Yuko  Hitomi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Toyao</span>, <span class="hlFld-ContribAuthor ">Hiroki  Gunji</span>, <span class="hlFld-ContribAuthor ">Frederic  Cumin</span>, <span class="hlFld-ContribAuthor ">Nikolaus  Schiering</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Randy L.  Webb</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>, and <span class="hlFld-ContribAuthor ">Fumiaki  Yokokawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (7)
                                     , 787-792. <a href="https://doi.org/10.1021/ml500137b" title="DOI URL">https://doi.org/10.1021/ml500137b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500137b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500137b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Based%252BDesign%252Bof%252BSubstituted%252BPiperidines%252Bas%252Ba%252BNew%252BClass%252Bof%252BHighly%252BEfficacious%252BOral%252BDirect%252BRenin%252BInhibitors%26aulast%3DEhara%26aufirst%3DTakeru%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05042014%26date%3D21042014%26date%3D08052014%26date%3D10072014%26date%3D21042014%26volume%3D5%26issue%3D7%26spage%3D787%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwige  Lorthiois</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Frederic  Cumin</span>, <span class="hlFld-ContribAuthor ">Claus  Ehrhardt</span>, <span class="hlFld-ContribAuthor ">Eric  Francotte</span>, <span class="hlFld-ContribAuthor ">Edgar  Jacoby</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Holger  Sellner</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Randy L.  Webb</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Ulrich  Hassiepen</span>, <span class="hlFld-ContribAuthor ">Paul  Richert</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, and <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Novel Potent trans-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2207-2217. <a href="https://doi.org/10.1021/jm3017078" title="DOI URL">https://doi.org/10.1021/jm3017078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3017078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3017078%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BNovel%252BPotent%252Btrans-3%25252C4-Disubstituted%252BPyrrolidine%252BInhibitors%252Bof%252Bthe%252BHuman%252BAspartic%252BProtease%252BRenin%252Bfrom%252Bin%252BSilico%252BThree-Dimensional%252B%2525283D%252529%252BPharmacophore%252BSearches%26aulast%3DLorthiois%26aufirst%3DEdwige%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D20112012%26date%3D15032013%26date%3D28032013%26date%3D20022013%26volume%3D56%26issue%3D6%26spage%3D2207%26epage%3D2217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, <span class="hlFld-ContribAuthor ">Robert D.  Mazzola</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Prescott  Leach</span>, <span class="hlFld-ContribAuthor ">Michael  Grzelak</span>, <span class="hlFld-ContribAuthor ">Lynn  Hyde</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Leonard  Favreau</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9331-9345. <a href="https://doi.org/10.1021/jm301039c" title="DOI URL">https://doi.org/10.1021/jm301039c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301039c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BValidation%252Bof%252BBicyclic%252BIminopyrimidinones%252BAs%252BBeta%252BAmyloid%252BCleaving%252BEnzyme-1%252B%252528BACE1%252529%252BInhibitors%25253A%252BConformational%252BConstraint%252Bto%252BFavor%252Ba%252BBioactive%252BConformation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D16072012%26date%3D01102012%26date%3D08112012%26date%3D18092012%26volume%3D55%26issue%3D21%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuji  Nakamura</span>, <span class="hlFld-ContribAuthor ">Teppei  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Ogawa</span>, <span class="hlFld-ContribAuthor ">Chie  Sugita</span>, <span class="hlFld-ContribAuthor ">Shojiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Tamaki</span>, <span class="hlFld-ContribAuthor ">Mizuki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yumi  Matsui</span>, <span class="hlFld-ContribAuthor ">Takahiro  Nagayama</span>, <span class="hlFld-ContribAuthor ">Kenichi  Manabe</span>, <span class="hlFld-ContribAuthor ">Makoto  Mizuno</span>, <span class="hlFld-ContribAuthor ">Noriko  Masubuchi</span>, <span class="hlFld-ContribAuthor ">Katsuyoshi  Chiba</span>, and <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (9)
                                     , 754-758. <a href="https://doi.org/10.1021/ml300168e" title="DOI URL">https://doi.org/10.1021/ml300168e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300168e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300168e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BDS-8108b%25252C%252Ba%252BNovel%252BOrally%252BBioavailable%252BRenin%252BInhibitor%26aulast%3DNakamura%26aufirst%3DYuji%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D26062012%26date%3D18082012%26date%3D23082012%26date%3D13092012%26date%3D18082012%26volume%3D3%26issue%3D9%26spage%3D754%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh A.  Barawkar</span>, <span class="hlFld-ContribAuthor ">Ashwin  Meru</span>, <span class="hlFld-ContribAuthor ">Anish  Bandyopadhyay</span>, <span class="hlFld-ContribAuthor ">Abir  Banerjee</span>, <span class="hlFld-ContribAuthor ">Anil M.  Deshpande</span>, <span class="hlFld-ContribAuthor ">Chandrashekhar  Athare</span>, <span class="hlFld-ContribAuthor ">Chandrasekhar  Koduru</span>, <span class="hlFld-ContribAuthor ">Goraksha  Khose</span>, <span class="hlFld-ContribAuthor ">Jayasagar  Gundu</span>, <span class="hlFld-ContribAuthor ">Koshu  Mahajan</span>, <span class="hlFld-ContribAuthor ">Pradeep  Patil</span>, <span class="hlFld-ContribAuthor ">Sachin R.  Kandalkar</span>, <span class="hlFld-ContribAuthor ">Sanjay  Niranjan</span>, <span class="hlFld-ContribAuthor ">Shubhangi  Bhosale</span>, <span class="hlFld-ContribAuthor ">Siddhartha  De</span>, <span class="hlFld-ContribAuthor ">Sudit  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Sumit  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Summon  Koul</span>, <span class="hlFld-ContribAuthor ">Umesh  Singh</span>, <span class="hlFld-ContribAuthor ">Anita  Chugh</span>, <span class="hlFld-ContribAuthor ">Venkata P.  Palle</span>, <span class="hlFld-ContribAuthor ">Kasim A.  Mookhtiar</span>, <span class="hlFld-ContribAuthor ">Joseph  Vacca</span>, <span class="hlFld-ContribAuthor ">Prasun K.  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Nargund</span>, <span class="hlFld-ContribAuthor ">Samuel D.  Wright</span>, <span class="hlFld-ContribAuthor ">Sophie  Roy</span>, <span class="hlFld-ContribAuthor ">Michael P.  Graziano</span>, <span class="hlFld-ContribAuthor ">Sheo B.  Singh</span>, <span class="hlFld-ContribAuthor ">Doris  Cully</span>, and <span class="hlFld-ContribAuthor ">Tian-Quan  Cai</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (12)
                                     , 919-923. <a href="https://doi.org/10.1021/ml2001938" title="DOI URL">https://doi.org/10.1021/ml2001938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml2001938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml2001938%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252BSelective%252BInhibitors%252Bof%252BLong%252BChain%252Bl-2-Hydroxy%252BAcid%252BOxidase%252BReduced%252BBlood%252BPressure%252Bin%252BDOCA%252BSalt-Treated%252BRats%26aulast%3DBarawkar%26aufirst%3DDinesh%2BA.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D17082011%26date%3D07102011%26date%3D14102011%26date%3D08122011%26date%3D07102011%26volume%3D2%26issue%3D12%26spage%3D919%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lanqi  Jia</span>, <span class="hlFld-ContribAuthor ">Robert D.  Simpson</span>, <span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Zhenrong  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Salvacion  Cacatian</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Joan  Guo</span>, <span class="hlFld-ContribAuthor ">Alexey  Ishchenko</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>, <span class="hlFld-ContribAuthor ">Zhongren  Wu</span>, <span class="hlFld-ContribAuthor ">Brian M.  McKeever</span>, <span class="hlFld-ContribAuthor ">Yuri  Bukhtiyarov</span>, <span class="hlFld-ContribAuthor ">Judith A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Doe</span>, <span class="hlFld-ContribAuthor ">Richard K.  Harrison</span>, <span class="hlFld-ContribAuthor ">Gerard M.  McGeehan</span>, <span class="hlFld-ContribAuthor ">Lawrence W.  Dillard</span>, <span class="hlFld-ContribAuthor ">John J.  Baldwin</span>, and <span class="hlFld-ContribAuthor ">David A.  Claremon</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (10)
                                     , 747-751. <a href="https://doi.org/10.1021/ml200137x" title="DOI URL">https://doi.org/10.1021/ml200137x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200137x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200137x%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BVTP-27999%25252C%252Ban%252BAlkyl%252BAmine%252BRenin%252BInhibitor%252Bwith%252BPotential%252Bfor%252BClinical%252BUtility%26aulast%3DJia%26aufirst%3DLanqi%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D09062011%26date%3D09082011%26date%3D16082011%26date%3D13102011%26date%3D09082011%26volume%3D2%26issue%3D10%26spage%3D747%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Louis-Charles  Campeau</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Dolman</span>, <span class="hlFld-ContribAuthor ">Danny  Gauvreau</span>, <span class="hlFld-ContribAuthor ">Ed  Corley</span>, <span class="hlFld-ContribAuthor ">Jinchu  Liu</span>, <span class="hlFld-ContribAuthor ">Erin N.  Guidry</span>, <span class="hlFld-ContribAuthor ">Stéphane G.  Ouellet</span>, <span class="hlFld-ContribAuthor ">Dietrich  Steinhuebel</span>, <span class="hlFld-ContribAuthor ">Mark  Weisel</span>, and <span class="hlFld-ContribAuthor ">Paul D.  O’Shea</span>  . </span><span class="cited-content_cbyCitation_article-title">Convergent Kilo-Scale Synthesis of a Potent Renin Inhibitor for the Treatment of Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2011,</strong> <em>15 </em>
                                    (5)
                                     , 1138-1148. <a href="https://doi.org/10.1021/op2001063" title="DOI URL">https://doi.org/10.1021/op2001063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op2001063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop2001063%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DConvergent%252BKilo-Scale%252BSynthesis%252Bof%252Ba%252BPotent%252BRenin%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHypertension%26aulast%3DCampeau%26aufirst%3DLouis-Charles%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D18042011%26date%3D24062011%26date%3D16092011%26volume%3D15%26issue%3D5%26spage%3D1138%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatma H.  Al-Awadhi</span>, <span class="hlFld-ContribAuthor ">Hendrik  Luesch</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting eukaryotic proteases for natural products-based drug development. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2020,</strong> <em>37 </em>
                                    (6)
                                     , 827-860. <a href="https://doi.org/10.1039/C9NP00060G" title="DOI URL">https://doi.org/10.1039/C9NP00060G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NP00060G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NP00060G%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DTargeting%252Beukaryotic%252Bproteases%252Bfor%252Bnatural%252Bproducts-based%252Bdrug%252Bdevelopment%26aulast%3DAl-Awadhi%26aufirst%3DFatma%2BH.%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D6%26spage%3D827%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnappa  Ramya</span>, <span class="hlFld-ContribAuthor ">Ramalingam  Suresh</span>, <span class="hlFld-ContribAuthor ">Honnavalli Yogish  Kumar</span>, <span class="hlFld-ContribAuthor ">B.R. Prashantha  Kumar</span>, <span class="hlFld-ContribAuthor ">N.B. Sridhara  Murthy</span>. </span><span class="cited-content_cbyCitation_article-title">Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 115466. <a href="https://doi.org/10.1016/j.bmc.2020.115466" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115466%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDecades-old%252Brenin%252Binhibitors%252Bare%252Bstill%252Bstruggling%252Bto%252Bfind%252Ba%252Bniche%252Bin%252Bantihypertensive%252Btherapy.%252BA%252Bfleeting%252Blook%252Bat%252Bthe%252Bold%252Band%252Bthe%252Bpromising%252Bnew%252Bmolecules%26aulast%3DRamya%26aufirst%3DKrishnappa%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D115466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yannick  Marc</span>, <span class="hlFld-ContribAuthor ">Solène Emmanuelle  Boitard</span>, <span class="hlFld-ContribAuthor ">Fabrice  Balavoine</span>, <span class="hlFld-ContribAuthor ">Michel  Azizi</span>, <span class="hlFld-ContribAuthor ">Catherine  Llorens-Cortes</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Cardiology</span><span> <strong>2020,</strong> <em>36 </em>
                                    (5)
                                     , 721-731. <a href="https://doi.org/10.1016/j.cjca.2020.03.005" title="DOI URL">https://doi.org/10.1016/j.cjca.2020.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cjca.2020.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cjca.2020.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Cardiology%26atitle%3DTargeting%252BBrain%252BAminopeptidase%252BA%25253A%252BA%252BNew%252BStrategy%252Bfor%252Bthe%252BTreatment%252Bof%252BHypertension%252Band%252BHeart%252BFailure%26aulast%3DMarc%26aufirst%3DYannick%26date%3D2020%26volume%3D36%26issue%3D5%26spage%3D721%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lakshmanan  Loganathan</span>, <span class="hlFld-ContribAuthor ">Karthikeyan  Muthusamy</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Drug Interaction Potentials and Binding Modes on Direct Renin Inhibitors: A Computational Modeling Studies. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (8)
                                     , 919-938. <a href="https://doi.org/10.2174/1570180815666180827113622" title="DOI URL">https://doi.org/10.2174/1570180815666180827113622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180815666180827113622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180815666180827113622%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DInvestigation%252Bof%252BDrug%252BInteraction%252BPotentials%252Band%252BBinding%252BModes%252Bon%252BDirect%252BRenin%252BInhibitors%25253A%252BA%252BComputational%252BModeling%252BStudies%26aulast%3DLoganathan%26aufirst%3DLakshmanan%26date%3D2019%26volume%3D16%26issue%3D8%26spage%3D919%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reza  Ranjbar</span>, <span class="hlFld-ContribAuthor ">Mojtaba  Shafiee</span>, <span class="hlFld-ContribAuthor ">AmirReza  Hesari</span>, <span class="hlFld-ContribAuthor ">Gordon A.  Ferns</span>, <span class="hlFld-ContribAuthor ">Faezeh  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Amir  Avan</span>. </span><span class="cited-content_cbyCitation_article-title">The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2019,</strong> <em>234 </em>
                                    (3)
                                     , 2277-2295. <a href="https://doi.org/10.1002/jcp.27205" title="DOI URL">https://doi.org/10.1002/jcp.27205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.27205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.27205%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DThe%252Bpotential%252Btherapeutic%252Buse%252Bof%252Brenin%2525E2%252580%252593angiotensin%252Bsystem%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DRanjbar%26aufirst%3DReza%26date%3D2019%26date%3D2018%26volume%3D234%26issue%3D3%26spage%3D2277%26epage%3D2295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidekazu  Tokuhara</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Imaeda</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Fukase</span>, <span class="hlFld-ContribAuthor ">Koichi  Iwanaga</span>, <span class="hlFld-ContribAuthor ">Naohiro  Taya</span>, <span class="hlFld-ContribAuthor ">Koji  Watanabe</span>, <span class="hlFld-ContribAuthor ">Ray  Kanagawa</span>, <span class="hlFld-ContribAuthor ">Keisuke  Matsuda</span>, <span class="hlFld-ContribAuthor ">Yumiko  Kajimoto</span>, <span class="hlFld-ContribAuthor ">Keiji  Kusumoto</span>, <span class="hlFld-ContribAuthor ">Mitsuyo  Kondo</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Craig A.  Behnke</span>, <span class="hlFld-ContribAuthor ">Takanobu  Kuroita</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3261-3286. <a href="https://doi.org/10.1016/j.bmc.2018.04.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbenzimidazole%252Bderivatives%252Bas%252Borally%252Bactive%252Brenin%252Binhibitors%25253A%252BOptimization%252Bof%252B3%25252C5-disubstituted%252Bpiperidine%252Bto%252Bimprove%252Bpharmacokinetic%252Bprofile%26aulast%3DTokuhara%26aufirst%3DHidekazu%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3261%26epage%3D3286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mokgethwa Bruce  Marakalala</span>, <span class="hlFld-ContribAuthor ">Edwin M  Mmutlane</span>, <span class="hlFld-ContribAuthor ">Henok H  Kinfe</span>. </span><span class="cited-content_cbyCitation_article-title">β-Hydroxy sulfides and their syntheses. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 1668-1692. <a href="https://doi.org/10.3762/bjoc.14.143" title="DOI URL">https://doi.org/10.3762/bjoc.14.143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.143%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%2525CE%2525B2-Hydroxy%252Bsulfides%252Band%252Btheir%252Bsyntheses%26aulast%3DMarakalala%26aufirst%3DMokgethwa%2BBruce%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D1668%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Étienne  Chénard</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Cusson</span>, <span class="hlFld-ContribAuthor ">Stephen  Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic asymmetric Friedel–Crafts synthesis of 1,1′-diaryl-2-substituted 4-pentenes enables stereoselective access to functionalized tetrahydronaphthalenes. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2017,</strong> <em>95 </em>
                                    (12)
                                     , 1323-1331. <a href="https://doi.org/10.1139/cjc-2017-0393" title="DOI URL">https://doi.org/10.1139/cjc-2017-0393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/cjc-2017-0393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fcjc-2017-0393%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DCatalytic%252Basymmetric%252BFriedel%2525E2%252580%252593Crafts%252Bsynthesis%252Bof%252B1%25252C1%2525E2%252580%2525B2-diaryl-2-substituted%252B4-pentenes%252Benables%252Bstereoselective%252Baccess%252Bto%252Bfunctionalized%252Btetrahydronaphthalenes%26aulast%3DCh%25C3%25A9nard%26aufirst%3D%25C3%2589tienne%26date%3D2017%26volume%3D95%26issue%3D12%26spage%3D1323%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian G.  Lawhorn</span>, <span class="hlFld-ContribAuthor ">Tritin  Tran</span>, <span class="hlFld-ContribAuthor ">Victor S.  Hong</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Morgan</span>, <span class="hlFld-ContribAuthor ">BaoChau T.  Le</span>, <span class="hlFld-ContribAuthor ">Mark R.  Harpel</span>, <span class="hlFld-ContribAuthor ">Larry  Jolivette</span>, <span class="hlFld-ContribAuthor ">Elsie  Diaz</span>, <span class="hlFld-ContribAuthor ">Benjamin  Schwartz</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Gross</span>, <span class="hlFld-ContribAuthor ">Thaddeus  Tomaszek</span>, <span class="hlFld-ContribAuthor ">Simon  Semus</span>, <span class="hlFld-ContribAuthor ">Nestor  Concha</span>, <span class="hlFld-ContribAuthor ">Angela  Smallwood</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Holt</span>, <span class="hlFld-ContribAuthor ">Lara S.  Kallander</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (21)
                                     , 4838-4843. <a href="https://doi.org/10.1016/j.bmcl.2017.09.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Brenin%252Binhibitors%252Bcontaining%252Ba%252Bsimple%252Baspartate%252Bbinding%252Bmoiety%252Bthat%252Bimparts%252Breduced%252BP450%252Binhibition%26aulast%3DLawhorn%26aufirst%3DBrian%2BG.%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4838%26epage%3D4843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian S.  Cloudsdale</span>, <span class="hlFld-ContribAuthor ">John K.  Dickson</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Barta</span>, <span class="hlFld-ContribAuthor ">Brian S.  Grella</span>, <span class="hlFld-ContribAuthor ">Emilie D.  Smith</span>, <span class="hlFld-ContribAuthor ">John L.  Kulp</span>, <span class="hlFld-ContribAuthor ">Frank  Guarnieri</span>, <span class="hlFld-ContribAuthor ">John L.  Kulp</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of renin inhibitors guided by simulated annealing of chemical potential simulations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (15)
                                     , 3947-3963. <a href="https://doi.org/10.1016/j.bmc.2017.05.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.05.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.05.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Brenin%252Binhibitors%252Bguided%252Bby%252Bsimulated%252Bannealing%252Bof%252Bchemical%252Bpotential%252Bsimulations%26aulast%3DCloudsdale%26aufirst%3DIan%2BS.%26date%3D2017%26volume%3D25%26issue%3D15%26spage%3D3947%26epage%3D3963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiovascular System (C). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-50. <a href="https://doi.org/10.1002/14356007.a05_289.pub3" title="DOI URL">https://doi.org/10.1002/14356007.a05_289.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.a05_289.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.a05_289.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DCardiovascular%252BSystem%252B%252528C%252529%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D50%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michiko  Tawada</span>, <span class="hlFld-ContribAuthor ">Shinkichi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Imaeda</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Oki</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Craig A.  Behnke</span>, <span class="hlFld-ContribAuthor ">Mitsuyo  Kondo</span>, <span class="hlFld-ContribAuthor ">Naoki  Tarui</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Takanobu  Kuroita</span>, <span class="hlFld-ContribAuthor ">Masaki  Tomimoto</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approach of fragment-based lead discovery applied to renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (22)
                                     , 6066-6074. <a href="https://doi.org/10.1016/j.bmc.2016.09.065" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.09.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.09.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.09.065%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bapproach%252Bof%252Bfragment-based%252Blead%252Bdiscovery%252Bapplied%252Bto%252Brenin%252Binhibitors%26aulast%3DTawada%26aufirst%3DMichiko%26date%3D2016%26volume%3D24%26issue%3D22%26spage%3D6066%26epage%3D6074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iwona  Winiecka</span>, <span class="hlFld-ContribAuthor ">Paweł  Jaworski</span>, <span class="hlFld-ContribAuthor ">Aleksander Paweł  Mazurek</span>, <span class="hlFld-ContribAuthor ">Dorota  Marszałek</span>, <span class="hlFld-ContribAuthor ">Anna  Goldnik</span>, <span class="hlFld-ContribAuthor ">Daniel  Sokulski</span>. </span><span class="cited-content_cbyCitation_article-title">Novel renin inhibitors containing derivatives of N-alkylleucyl-
              β
              -hydroxy-
              γ
              -amino acids. </span><span class="cited-content_cbyCitation_journal-name">Journal of Peptide Science</span><span> <strong>2016,</strong> <em>22 </em>
                                    (2)
                                     , 106-115. <a href="https://doi.org/10.1002/psc.2846" title="DOI URL">https://doi.org/10.1002/psc.2846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/psc.2846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpsc.2846%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Peptide%2520Science%26atitle%3DNovel%252Brenin%252Binhibitors%252Bcontaining%252Bderivatives%252Bof%252BN-alkylleucyl-%252B%2525CE%2525B2%252B-hydroxy-%252B%2525CE%2525B3%252B-amino%252Bacids%26aulast%3DWiniecka%26aufirst%3DIwona%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D2%26spage%3D106%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Rüdisser</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">An Integrated Approach for Fragment-Based Lead Discovery: Virtual, NMR, and High-Throughput Screening Combined with Structure-Guided Design. Application to the Aspartyl Protease Renin.. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 447-486. <a href="https://doi.org/10.1002/9783527683604.ch19" title="DOI URL">https://doi.org/10.1002/9783527683604.ch19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch19%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252BIntegrated%252BApproach%252Bfor%252BFragment-Based%252BLead%252BDiscovery%25253A%252BVirtual%25252C%252BNMR%25252C%252Band%252BHigh-Throughput%252BScreening%252BCombined%252Bwith%252BStructure-Guided%252BDesign.%252BApplication%252Bto%252Bthe%252BAspartyl%252BProtease%252BRenin.%26aulast%3DR%25C3%25BCdisser%26aufirst%3DSimon%26date%3D2016%26date%3D2016%26spage%3D447%26epage%3D486%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruben  Vardanyan</span>, <span class="hlFld-ContribAuthor ">Victor  Hruby</span>. </span><span class="cited-content_cbyCitation_article-title">Antihypertensive Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 329-356. <a href="https://doi.org/10.1016/B978-0-12-411492-0.00022-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-411492-0.00022-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411492-0.00022-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411492-0.00022-5%26sid%3Dliteratum%253Aachs%26atitle%3DAntihypertensive%252BDrugs%26aulast%3DVardanyan%26aufirst%3DRuben%26date%3D2016%26spage%3D329%26epage%3D356%26pub%3DElsevier%26atitle%3DSynthesis%252Bof%252BBest-Seller%252BDrugs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Gambini</span>, <span class="hlFld-ContribAuthor ">Luca  Rizzi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Pedretti</span>, <span class="hlFld-ContribAuthor ">Orazio  Taglialatela-Scafati</span>, <span class="hlFld-ContribAuthor ">Mario  Carucci</span>, <span class="hlFld-ContribAuthor ">Andrea  Pancotti</span>, <span class="hlFld-ContribAuthor ">Corinna  Galli</span>, <span class="hlFld-ContribAuthor ">Martin  Read</span>, <span class="hlFld-ContribAuthor ">Emanuele  Giurisato</span>, <span class="hlFld-ContribAuthor ">Sergio  Romeo</span>, <span class="hlFld-ContribAuthor ">Ilaria  Russo</span>, . </span><span class="cited-content_cbyCitation_article-title">Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0142509. <a href="https://doi.org/10.1371/journal.pone.0142509" title="DOI URL">https://doi.org/10.1371/journal.pone.0142509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0142509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0142509%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DPicomolar%252BInhibition%252Bof%252BPlasmepsin%252BV%25252C%252Ban%252BEssential%252BMalaria%252BProtease%25252C%252BAchieved%252BExploiting%252Bthe%252BPrime%252BRegion%26aulast%3DGambini%26aufirst%3DLuca%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0142509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rotimi E.  Aluko</span>, <span class="hlFld-ContribAuthor ">Abraham T.  Girgih</span>, <span class="hlFld-ContribAuthor ">Rong  He</span>, <span class="hlFld-ContribAuthor ">Sunday  Malomo</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Marina  Offengenden</span>, <span class="hlFld-ContribAuthor ">Jianping  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides. </span><span class="cited-content_cbyCitation_journal-name">Food Research International</span><span> <strong>2015,</strong> <em>77 </em>, 10-16. <a href="https://doi.org/10.1016/j.foodres.2015.03.029" title="DOI URL">https://doi.org/10.1016/j.foodres.2015.03.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodres.2015.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodres.2015.03.029%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Research%2520International%26atitle%3DStructural%252Band%252Bfunctional%252Bcharacterization%252Bof%252Byellow%252Bfield%252Bpea%252Bseed%252B%252528Pisum%252Bsativum%252BL.%252529%252Bprotein-derived%252Bantihypertensive%252Bpeptides%26aulast%3DAluko%26aufirst%3DRotimi%2BE.%26date%3D2015%26volume%3D77%26spage%3D10%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaowei  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoan  Wen</span>, <span class="hlFld-ContribAuthor ">Yan-yan  Chen</span>, <span class="hlFld-ContribAuthor ">Chen  Shi</span>, <span class="hlFld-ContribAuthor ">Chengzhe  Gao</span>, <span class="hlFld-ContribAuthor ">Yong  Wu</span>, <span class="hlFld-ContribAuthor ">Li-jun  Wang</span>, <span class="hlFld-ContribAuthor ">Xiu-hong  Yang</span>, <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of highly potent renin inhibitors potentially interacting with the S3′ subsite of renin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>103 </em>, 269-288. <a href="https://doi.org/10.1016/j.ejmech.2015.08.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bhighly%252Bpotent%252Brenin%252Binhibitors%252Bpotentially%252Binteracting%252Bwith%252Bthe%252BS3%2525E2%252580%2525B2%252Bsubsite%252Bof%252Brenin%26aulast%3DSun%26aufirst%3DXiaowei%26date%3D2015%26volume%3D103%26spage%3D269%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Inhibitors of Aspartic Acid Proteases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 19-66. <a href="https://doi.org/10.1002/9783527665211.ch2" title="DOI URL">https://doi.org/10.1002/9783527665211.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527665211.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527665211.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BInhibitors%252Bof%252BAspartic%252BAcid%252BProteases%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2015%26date%3D2015%26spage%3D19%26epage%3D66%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DStructure-Based%252BDesign%252Bof%252BDrugs%252Band%252BOther%252BBioactive%252BMolecules%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwige  Lorthiois</span>, <span class="hlFld-ContribAuthor ">Frederic  Cumin</span>, <span class="hlFld-ContribAuthor ">Claus  Ehrhardt</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Holger  Sellner</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Eric  Francotte</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">trans -(3 S ,4 S )-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: Prime site exploration using an amino linker. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (8)
                                     , 1782-1786. <a href="https://doi.org/10.1016/j.bmcl.2015.02.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3Dtrans%252B-%2525283%252BS%252B%25252C4%252BS%252B%252529-Disubstituted%252Bpyrrolidines%252Bas%252Binhibitors%252Bof%252Bthe%252Bhuman%252Baspartyl%252Bprotease%252Brenin.%252BPart%252BI%25253A%252BPrime%252Bsite%252Bexploration%252Busing%252Ban%252Bamino%252Blinker%26aulast%3DLorthiois%26aufirst%3DEdwige%26date%3D2015%26volume%3D25%26issue%3D8%26spage%3D1782%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Holger  Sellner</span>, <span class="hlFld-ContribAuthor ">Sylvain  Cottens</span>, <span class="hlFld-ContribAuthor ">Frédéric  Cumin</span>, <span class="hlFld-ContribAuthor ">Claus  Ehrhardt</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Edwige  Lorthiois</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Randy L.  Webb</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">trans -3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: Prime site exploration using an oxygen linker. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (8)
                                     , 1787-1791. <a href="https://doi.org/10.1016/j.bmcl.2015.02.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3Dtrans%252B-3%25252C4-Disubstituted%252Bpyrrolidines%252Bas%252Binhibitors%252Bof%252Bthe%252Bhuman%252Baspartyl%252Bprotease%252Brenin.%252BPart%252BII%25253A%252BPrime%252Bsite%252Bexploration%252Busing%252Ban%252Boxygen%252Blinker%26aulast%3DSellner%26aufirst%3DHolger%26date%3D2015%26volume%3D25%26issue%3D8%26spage%3D1787%26epage%3D1791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elke  Persch</span>, <span class="hlFld-ContribAuthor ">Oliver  Dumele</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Molekulare Erkennung in chemischen und biologischen Systemen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (11)
                                     , 3341-3382. <a href="https://doi.org/10.1002/ange.201408487" title="DOI URL">https://doi.org/10.1002/ange.201408487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201408487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201408487%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DMolekulare%252BErkennung%252Bin%252Bchemischen%252Bund%252Bbiologischen%252BSystemen%26aulast%3DPersch%26aufirst%3DElke%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D11%26spage%3D3341%26epage%3D3382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elke  Persch</span>, <span class="hlFld-ContribAuthor ">Oliver  Dumele</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Recognition in Chemical and Biological Systems. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (11)
                                     , 3290-3327. <a href="https://doi.org/10.1002/anie.201408487" title="DOI URL">https://doi.org/10.1002/anie.201408487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201408487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201408487%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DMolecular%252BRecognition%252Bin%252BChemical%252Band%252BBiological%252BSystems%26aulast%3DPersch%26aufirst%3DElke%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D11%26spage%3D3290%26epage%3D3327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Newman</span>, <span class="hlFld-ContribAuthor ">Gordon M.  Cragg</span>, <span class="hlFld-ContribAuthor ">David G.I.  Kingston</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Products as Pharmaceuticals and Sources for Lead Structures**Note: This chapter reflects the opinions of the authors, not necessarily those of the US Government. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 101-139. <a href="https://doi.org/10.1016/B978-0-12-417205-0.00005-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-417205-0.00005-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417205-0.00005-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417205-0.00005-5%26sid%3Dliteratum%253Aachs%26atitle%3DNatural%252BProducts%252Bas%252BPharmaceuticals%252Band%252BSources%252Bfor%252BLead%252BStructures%252A%252ANote%25253A%252BThis%252Bchapter%252Breflects%252Bthe%252Bopinions%252Bof%252Bthe%252Bauthors%25252C%252Bnot%252Bnecessarily%252Bthose%252Bof%252Bthe%252BUS%252BGovernment%26aulast%3DNewman%26aufirst%3DDavid%2BJ.%26date%3D2015%26spage%3D101%26epage%3D139%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2015%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azusa  Kondoh</span>, <span class="hlFld-ContribAuthor ">Masahiro  Terada</span>. </span><span class="cited-content_cbyCitation_article-title">Brønsted base-catalyzed α-oxygenation of carbonyl compounds utilizing the [1,2]-phospha-Brook rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2015,</strong> <em>2 </em>
                                    (7)
                                     , 801-805. <a href="https://doi.org/10.1039/C5QO00108K" title="DOI URL">https://doi.org/10.1039/C5QO00108K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5QO00108K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5QO00108K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DBr%2525C3%2525B8nsted%252Bbase-catalyzed%252B%2525CE%2525B1-oxygenation%252Bof%252Bcarbonyl%252Bcompounds%252Butilizing%252Bthe%252B%25255B1%25252C2%25255D-phospha-Brook%252Brearrangement%26aulast%3DKondoh%26aufirst%3DAzusa%26date%3D2015%26date%3D2015%26volume%3D2%26issue%3D7%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. S. Hari Narayana  Moorthy</span>, <span class="hlFld-ContribAuthor ">Natércia F.  Brás</span>, <span class="hlFld-ContribAuthor ">Maria J.  Ramos</span>, <span class="hlFld-ContribAuthor ">Pedro A.  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">Binding mode prediction and identification of new lead compounds from natural products as renin and angiotensin converting enzyme inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (38)
                                     , 19550-19568. <a href="https://doi.org/10.1039/C4RA00856A" title="DOI URL">https://doi.org/10.1039/C4RA00856A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA00856A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA00856A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DBinding%252Bmode%252Bprediction%252Band%252Bidentification%252Bof%252Bnew%252Blead%252Bcompounds%252Bfrom%252Bnatural%252Bproducts%252Bas%252Brenin%252Band%252Bangiotensin%252Bconverting%252Benzyme%252Binhibitors%26aulast%3DMoorthy%26aufirst%3DN.%2BS.%2BHari%2BNarayana%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D38%26spage%3D19550%26epage%3D19568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Shashidhar N.  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehending renin inhibitor’s binding affinity using structure-based approaches. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (24)
                                     , 6667-6672. <a href="https://doi.org/10.1016/j.bmcl.2013.10.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.10.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.10.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.10.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComprehending%252Brenin%252Binhibitor%2525E2%252580%252599s%252Bbinding%252Baffinity%252Busing%252Bstructure-based%252Bapproaches%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6667%26epage%3D6672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fumiaki  Yokokawa</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 673-690. <a href="https://doi.org/10.1517/17460441.2013.791279" title="DOI URL">https://doi.org/10.1517/17460441.2013.791279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.791279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.791279%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Bprogress%252Bon%252Bthe%252Bdiscovery%252Bof%252Bnon-peptidic%252Bdirect%252Brenin%252Binhibitors%252Bfor%252Bthe%252Bclinical%252Bmanagement%252Bof%252Bhypertension%26aulast%3DYokokawa%26aufirst%3DFumiaki%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D673%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuji  Nakamura</span>, <span class="hlFld-ContribAuthor ">Teppei  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Ogawa</span>, <span class="hlFld-ContribAuthor ">Hidenori  Namiki</span>, <span class="hlFld-ContribAuthor ">Sayaka  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Asano</span>, <span class="hlFld-ContribAuthor ">Chie  Sugita</span>, <span class="hlFld-ContribAuthor ">Akiyoshi  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Shojiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Tamaki</span>, <span class="hlFld-ContribAuthor ">Yoko  Nagai</span>, <span class="hlFld-ContribAuthor ">Shin-ichi  Inoue</span>, <span class="hlFld-ContribAuthor ">Takahiro  Nagayama</span>, <span class="hlFld-ContribAuthor ">Mikio  Kato</span>, <span class="hlFld-ContribAuthor ">Katsuyoshi  Chiba</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Takasuna</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (11)
                                     , 3175-3196. <a href="https://doi.org/10.1016/j.bmc.2013.03.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DLead%252Boptimization%252Bof%252B5-amino-6-%2525282%25252C2-dimethyl-5-oxo-4-phenylpiperazin-1-yl%252529-4-hydroxyhexanamides%252Bto%252Breduce%252Ba%252Bcardiac%252Bsafety%252Bissue%25253A%252BDiscovery%252Bof%252BDS-8108b%25252C%252Ban%252Borally%252Bactive%252Brenin%252Binhibitor%26aulast%3DNakamura%26aufirst%3DYuji%26date%3D2013%26volume%3D21%26issue%3D11%26spage%3D3175%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Drago R.  Sliskovic</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiovascular Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 141-204. <a href="https://doi.org/10.1002/9781118354483.ch5" title="DOI URL">https://doi.org/10.1002/9781118354483.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118354483.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118354483.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DCardiovascular%252BDrugs%26aulast%3DSliskovic%26aufirst%3DDrago%2BR.%26date%3D2013%26date%3D2013%26spage%3D141%26epage%3D204%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2013%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rianne A. G.  Harmsen</span>, <span class="hlFld-ContribAuthor ">Annfrid  Sivertsen</span>, <span class="hlFld-ContribAuthor ">Davide  Michetti</span>, <span class="hlFld-ContribAuthor ">Bjørn Olav  Brandsdal</span>, <span class="hlFld-ContribAuthor ">Leiv K.  Sydnes</span>, <span class="hlFld-ContribAuthor ">Bengt Erik  Haug</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and docking of novel piperidine renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2013,</strong> <em>144 </em>
                                    (4)
                                     , 479-494. <a href="https://doi.org/10.1007/s00706-012-0903-5" title="DOI URL">https://doi.org/10.1007/s00706-012-0903-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-012-0903-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-012-0903-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%252Band%252Bdocking%252Bof%252Bnovel%252Bpiperidine%252Brenin%252Binhibitors%26aulast%3DHarmsen%26aufirst%3DRianne%2BA.%2BG.%26date%3D2013%26date%3D2013%26volume%3D144%26issue%3D4%26spage%3D479%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">N
              -(Carboxyalkyl)-α-Amino Acid Amides (Prils). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 335-340. <a href="https://doi.org/10.1002/9783527645640.ch53" title="DOI URL">https://doi.org/10.1002/9783527645640.ch53</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527645640.ch53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527645640.ch53%26sid%3Dliteratum%253Aachs%26atitle%3DN%252B-%252528Carboxyalkyl%252529-%2525CE%2525B1-Amino%252BAcid%252BAmides%252B%252528Prils%252529%26date%3D2013%26date%3D2013%26spage%3D335%26epage%3D340%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DLead%252BOptimization%252Bfor%252BMedicinal%252BChemists%26aulast%3DZaragoza%2BD%25C3%25B6rwald%26aufirst%3DFlorencio%26date%3D2012%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>. </span><span class="cited-content_cbyCitation_article-title">Computational modeling and design of renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (2)
                                     , 460-465. <a href="https://doi.org/10.1016/j.bmcl.2012.11.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.11.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.11.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComputational%252Bmodeling%252Band%252Bdesign%252Bof%252Brenin%252Binhibitors%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2013%26volume%3D23%26issue%3D2%26spage%3D460%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Débora  Pacheco Homem</span>, <span class="hlFld-ContribAuthor ">Rogério  Flores</span>, <span class="hlFld-ContribAuthor ">Priscilla  Tosqui</span>, <span class="hlFld-ContribAuthor ">Thiago  de Castro Rozada</span>, <span class="hlFld-ContribAuthor ">Ernani  Abicht Basso</span>, <span class="hlFld-ContribAuthor ">Arquimedes  Gasparotto Junior</span>, <span class="hlFld-ContribAuthor ">Flavio  Augusto Vicente Seixas</span>. </span><span class="cited-content_cbyCitation_article-title">Homology modeling of dihydrofolate reductase from T. gondii bonded to antagonists: molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2013,</strong> <em>9 </em>
                                    (6)
                                     , 1308. <a href="https://doi.org/10.1039/c3mb25530a" title="DOI URL">https://doi.org/10.1039/c3mb25530a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3mb25530a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3mb25530a%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DHomology%252Bmodeling%252Bof%252Bdihydrofolate%252Breductase%252Bfrom%252BT.%252Bgondii%252Bbonded%252Bto%252Bantagonists%25253A%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DPacheco%2BHomem%26aufirst%3DD%25C3%25A9bora%26date%3D2013%26volume%3D9%26issue%3D6%26spage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yutaka  Mori</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Ogawa</span>, <span class="hlFld-ContribAuthor ">Akiyoshi  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Yuji  Nakamura</span>, <span class="hlFld-ContribAuthor ">Chie  Sugita</span>, <span class="hlFld-ContribAuthor ">Shojiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Tamaki</span>, <span class="hlFld-ContribAuthor ">Yumi  Matsui</span>, <span class="hlFld-ContribAuthor ">Mizuki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Takahiro  Nagayama</span>, <span class="hlFld-ContribAuthor ">Yoko  Nagai</span>, <span class="hlFld-ContribAuthor ">Shin-ichi  Inoue</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7677-7682. <a href="https://doi.org/10.1016/j.bmcl.2012.09.103" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.09.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.09.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.09.103%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252Bnew%252B%2525283S%25252C5R%252529-5-%25255B4-%2525282-chlorophenyl%252529-2%25252C2-dimethyl-5-oxopiperazin-1-yl%25255Dpiperidine-3-carboxamides%252Bas%252Bpotent%252Brenin%252Binhibitors%26aulast%3DMori%26aufirst%3DYutaka%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7677%26epage%3D7682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Dinca</span>, <span class="hlFld-ContribAuthor ">Philip  Hartmann</span>, <span class="hlFld-ContribAuthor ">Jakub  Smrček</span>, <span class="hlFld-ContribAuthor ">Ina  Dix</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Ullrich  Jahn</span>. </span><span class="cited-content_cbyCitation_article-title">General and Efficient α-Oxygenation of Carbonyl Compounds by TEMPO Induced by Single-Electron-Transfer Oxidation of Their Enolates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>2012 </em>
                                    (24)
                                     , 4461-4482. <a href="https://doi.org/10.1002/ejoc.201200736" title="DOI URL">https://doi.org/10.1002/ejoc.201200736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201200736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201200736%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGeneral%252Band%252BEfficient%252B%2525CE%2525B1-Oxygenation%252Bof%252BCarbonyl%252BCompounds%252Bby%252BTEMPO%252BInduced%252Bby%252BSingle-Electron-Transfer%252BOxidation%252Bof%252BTheir%252BEnolates%26aulast%3DDinca%26aufirst%3DEmanuela%26date%3D2012%26date%3D2012%26volume%3D2012%26issue%3D24%26spage%3D4461%26epage%3D4482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh A.  Barawkar</span>, <span class="hlFld-ContribAuthor ">Anish  Bandyopadhyay</span>, <span class="hlFld-ContribAuthor ">Anil  Deshpande</span>, <span class="hlFld-ContribAuthor ">Summon  Koul</span>, <span class="hlFld-ContribAuthor ">Sachin  Kandalkar</span>, <span class="hlFld-ContribAuthor ">Pradeep  Patil</span>, <span class="hlFld-ContribAuthor ">Goraksha  Khose</span>, <span class="hlFld-ContribAuthor ">Samir  Vyas</span>, <span class="hlFld-ContribAuthor ">Mahesh  Mone</span>, <span class="hlFld-ContribAuthor ">Shubhangi  Bhosale</span>, <span class="hlFld-ContribAuthor ">Umesh  Singh</span>, <span class="hlFld-ContribAuthor ">Siddhartha  De</span>, <span class="hlFld-ContribAuthor ">Ashwin  Meru</span>, <span class="hlFld-ContribAuthor ">Jayasagar  Gundu</span>, <span class="hlFld-ContribAuthor ">Anita  Chugh</span>, <span class="hlFld-ContribAuthor ">Venkata P.  Palle</span>, <span class="hlFld-ContribAuthor ">Kasim A.  Mookhtiar</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, <span class="hlFld-ContribAuthor ">Prasun K.  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Nargund</span>, <span class="hlFld-ContribAuthor ">Samuel D.  Wright</span>, <span class="hlFld-ContribAuthor ">Sophie  Roy</span>, <span class="hlFld-ContribAuthor ">Michael P.  Graziano</span>, <span class="hlFld-ContribAuthor ">Doris  Cully</span>, <span class="hlFld-ContribAuthor ">Tian-Quan  Cai</span>, <span class="hlFld-ContribAuthor ">Sheo B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain l-2-hydroxy acid oxidase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (13)
                                     , 4341-4347. <a href="https://doi.org/10.1016/j.bmcl.2012.05.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazole%252Bcarboxylic%252Bacids%252Bas%252Bpotent%252Binhibitors%252Bof%252Brat%252Blong%252Bchain%252Bl-2-hydroxy%252Bacid%252Boxidase%26aulast%3DBarawkar%26aufirst%3DDinesh%2BA.%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4341%26epage%3D4347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre-André  Fournier</span>, <span class="hlFld-ContribAuthor ">Mélissa  Arbour</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Cauchon</span>, <span class="hlFld-ContribAuthor ">Austin  Chen</span>, <span class="hlFld-ContribAuthor ">Amandine  Chefson</span>, <span class="hlFld-ContribAuthor ">Yves  Ducharme</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Falgueyret</span>, <span class="hlFld-ContribAuthor ">Sébastien  Gagné</span>, <span class="hlFld-ContribAuthor ">Erich  Grimm</span>, <span class="hlFld-ContribAuthor ">Yongxin  Han</span>, <span class="hlFld-ContribAuthor ">Robert  Houle</span>, <span class="hlFld-ContribAuthor ">Patrick  Lacombe</span>, <span class="hlFld-ContribAuthor ">Jean-François  Lévesque</span>, <span class="hlFld-ContribAuthor ">Dwight  MacDonald</span>, <span class="hlFld-ContribAuthor ">Bruce  Mackay</span>, <span class="hlFld-ContribAuthor ">Dan  McKay</span>, <span class="hlFld-ContribAuthor ">M. David  Percival</span>, <span class="hlFld-ContribAuthor ">Yeeman  Ramtohul</span>, <span class="hlFld-ContribAuthor ">René  St-Jacques</span>, <span class="hlFld-ContribAuthor ">Sylvie  Toulmond</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of potent, isoxazole-containing renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (8)
                                     , 2670-2674. <a href="https://doi.org/10.1016/j.bmcl.2012.03.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.03.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.03.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bpotent%25252C%252Bisoxazole-containing%252Brenin%252Binhibitors%26aulast%3DFournier%26aufirst%3DPierre-Andr%25C3%25A9%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2670%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip A  Carpino</span>, <span class="hlFld-ContribAuthor ">Declan  Flynn</span>. </span><span class="cited-content_cbyCitation_article-title">Review of companies and drug classes in the 2007–2011 antihypertensive patent literature. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2012,</strong> <em>1 </em>
                                    (1)
                                     , 45-64. <a href="https://doi.org/10.4155/ppa.12.5" title="DOI URL">https://doi.org/10.4155/ppa.12.5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.12.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.12.5%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DReview%252Bof%252Bcompanies%252Band%252Bdrug%252Bclasses%252Bin%252Bthe%252B2007%2525E2%252580%2525932011%252Bantihypertensive%252Bpatent%252Bliterature%26aulast%3DCarpino%26aufirst%3DPhilip%2BA%26date%3D2012%26volume%3D1%26issue%3D1%26spage%3D45%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Shashidhar N.  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">An integrated computational workflow for efficient and quantitative modeling of renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (2)
                                     , 851-858. <a href="https://doi.org/10.1016/j.bmc.2011.11.063" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.11.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.11.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.11.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bintegrated%252Bcomputational%252Bworkflow%252Bfor%252Befficient%252Band%252Bquantitative%252Bmodeling%252Bof%252Brenin%252Binhibitors%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2012%26volume%3D20%26issue%3D2%26spage%3D851%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Robert D.  Simpson</span>, <span class="hlFld-ContribAuthor ">Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Zhenrong  Xu</span>, <span class="hlFld-ContribAuthor ">Salvacion  Cacatian</span>, <span class="hlFld-ContribAuthor ">Lanqi  Jia</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Flaherty</span>, <span class="hlFld-ContribAuthor ">Joan  Guo</span>, <span class="hlFld-ContribAuthor ">Alexey  Ishchenko</span>, <span class="hlFld-ContribAuthor ">Zhongren  Wu</span>, <span class="hlFld-ContribAuthor ">Brian M.  McKeever</span>, <span class="hlFld-ContribAuthor ">Boyd B.  Scott</span>, <span class="hlFld-ContribAuthor ">Yuri  Bukhtiyarov</span>, <span class="hlFld-ContribAuthor ">Jennifer  Berbaum</span>, <span class="hlFld-ContribAuthor ">Reshma  Panemangalore</span>, <span class="hlFld-ContribAuthor ">Ross  Bentley</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Doe</span>, <span class="hlFld-ContribAuthor ">Richard K.  Harrison</span>, <span class="hlFld-ContribAuthor ">Gerard M.  McGeehan</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>, <span class="hlFld-ContribAuthor ">Lawrence W.  Dillard</span>, <span class="hlFld-ContribAuthor ">John J.  Baldwin</span>, <span class="hlFld-ContribAuthor ">David A.  Claremon</span>. </span><span class="cited-content_cbyCitation_article-title">Biphenyl/diphenyl ether renin inhibitors: Filling the S1 pocket of renin via the S3 pocket. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (16)
                                     , 4836-4843. <a href="https://doi.org/10.1016/j.bmcl.2011.06.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiphenyl%25252Fdiphenyl%252Bether%252Brenin%252Binhibitors%25253A%252BFilling%252Bthe%252BS1%252Bpocket%252Bof%252Brenin%252Bvia%252Bthe%252BS3%252Bpocket%26aulast%3DYuan%26aufirst%3DJing%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4836%26epage%3D4843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ovidiu C.  Baltatu</span>, <span class="hlFld-ContribAuthor ">Luciana A.  Campos</span>, <span class="hlFld-ContribAuthor ">Michael  Bader</span>. </span><span class="cited-content_cbyCitation_article-title">Local renin–angiotensin system and the brain—A continuous quest for knowledge. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2011,</strong> <em>32 </em>
                                    (5)
                                     , 1083-1086. <a href="https://doi.org/10.1016/j.peptides.2011.02.008" title="DOI URL">https://doi.org/10.1016/j.peptides.2011.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2011.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2011.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3DLocal%252Brenin%2525E2%252580%252593angiotensin%252Bsystem%252Band%252Bthe%252Bbrain%2525E2%252580%252594A%252Bcontinuous%252Bquest%252Bfor%252Bknowledge%26aulast%3DBaltatu%26aufirst%3DOvidiu%2BC.%26date%3D2011%26volume%3D32%26issue%3D5%26spage%3D1083%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heinrich  Rueeger</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Rondeau</span>, <span class="hlFld-ContribAuthor ">Clive  McCarthy</span>, <span class="hlFld-ContribAuthor ">Henrik  Möbitz</span>, <span class="hlFld-ContribAuthor ">Marina  Tintelnot-Blomley</span>, <span class="hlFld-ContribAuthor ">Ulf  Neumann</span>, <span class="hlFld-ContribAuthor ">Sandrine  Desrayaud</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (7)
                                     , 1942-1947. <a href="https://doi.org/10.1016/j.bmcl.2011.02.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.02.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.02.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bbased%252Bdesign%25252C%252Bsynthesis%252Band%252BSAR%252Bof%252Bcyclic%252Bhydroxyethylamine%252B%252528HEA%252529%252BBACE-1%252Binhibitors%26aulast%3DRueeger%26aufirst%3DHeinrich%26date%3D2011%26volume%3D21%26issue%3D7%26spage%3D1942%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jahan B.  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Somayeh  Pirhadi</span>. </span><span class="cited-content_cbyCitation_article-title">Docking alignment-3D-QSAR of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Collection of Czechoslovak Chemical Communications</span><span> <strong>2011,</strong> <em>76 </em>
                                    (12)
                                     , 1447-1469. <a href="https://doi.org/10.1135/cccc2011070" title="DOI URL">https://doi.org/10.1135/cccc2011070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1135/cccc2011070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1135%2Fcccc2011070%26sid%3Dliteratum%253Aachs%26jtitle%3DCollection%2520of%2520Czechoslovak%2520Chemical%2520Communications%26atitle%3DDocking%252Balignment-3D-QSAR%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bpotent%252Band%252Bnon-chiral%252Bindole-3-carboxamide-based%252Brenin%252Binhibitors%26aulast%3DGhasemi%26aufirst%3DJahan%2BB.%26date%3D2011%26date%3D2011%26volume%3D76%26issue%3D12%26spage%3D1447%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Renin−angiotensin system (RAS).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> (aliskiren), the first marketed direct renin inhibitor (DRI).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Second generation peptide-based peptidomimetic DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0016.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Aspartic Protease TSAs and Basic Amine TS Surrogates (Preferred Absolute Configurations Shown)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of rh-renin in complex with inhibitor <b>1</b> (orange). Renin is shown in gray (ribbon diagram and surface) with the side chains of the catalytic aspartates Asp<sub>32</sub> and Asp<sub>215</sub> with gray carbon atoms (flap residues Ser<sub>76</sub> and Thr<sub>77</sub> were omitted from the surface calculation). The peptide-based peptidomimetic <b>4</b> (CGP38560) is shown superimposed (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0018.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. 4-Phenylpiperidine DRIs discovered by high-throughput screening (HTS).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0019.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 2,4-Diaminopyrimidine-based DRIs originating from HTS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0020.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Peptide-based macrocyclic and (S<sub>3</sub>−S<sub>1</sub>)-topological DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0021.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nonpeptide (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetic TSAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0022.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (S<sub>3</sub>−S<sub>1</sub>)-Topological tripeptide-based amino alcohol DRI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0023.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Topological (P<sub>3</sub>−P<sub>1</sub>)-Pharmacophores Used in Combination with Five- and Six-Membered Center Basic TS Surrogate Scaffolds of Non-Peptide DRIs (See Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, and <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0024.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Renin inhibitor (P<sub>3</sub>−P<sub>1</sub>)-pharmacophores incorporating basic residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0025.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Conformational rigidity of the large contiguous S<sub>3</sub>−S<sub>1</sub> binding site of renin, as illustrated by the overlay of several X-ray crystal structures of enzyme-bound inhibitors from distinct compound classes. Shown are the hydrophobic side chains lining the boundaries of S<sub>3</sub> (Thr<sub>12</sub>, Gln<sub>13</sub>, <u class="uu">Pro</u><sub>111</sub>, <u class="uu">Phe</u><sub>112</sub>, <u class="uu">Leu</u><sub>114</sub>, <u class="uu">Ala</u><sub>115</sub>, <u class="uu">Phe</u><sub>117</sub>, Ser<sub>219</sub>) and S<sub>1</sub> (<u class="uu">Val</u><sub>30,</sub> Asp<sub>32</sub>, <u class="uu">Tyr</u><sub>75</sub>, Thr<sub>77</sub>, <u class="uu">Phe</u><sub>112</sub>, <u class="uu">Phe</u><sub>117</sub>, <u class="uu">Val</u><sub>120</sub>, Asp<sub>215</sub>; the residues shown in the figure are underlined), as observed for <b>1</b> (orange), the GRAB peptidomimetic <b>52</b> (gray), the 2,4-diaminopyrimidine <b>34</b>, and the <i>N</i>-ureapiperidine <b>38</b>. Inhibitors <b>34</b> and <b>38</b> were omitted for clarity. A partial ribbon diagram is shown for the complex with <b>1</b> (gray) and in addition for the flap β-hairpin as observed for <b>52</b> (dark gray). Phe<sub>112</sub> in the complex with <b>52</b> (flap pocket binder) is shifted significantly with respect to the other complexes. Large movements are observed only for the flap β-hairpin (e.g., 5.1 Å for the Cα of Tyr<sub>75</sub> in the complex with <b>1</b> vs <b>52</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0026.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Hydrogen-bond interactions of the (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetic <b>28</b> (gray) and a close analogue of <b>22</b> (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v12">2v12</a>),<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> as well as peptidic inhibitor <b>4</b> (green), with Thr<sub>77</sub> of the flap β-turn. Portions of the enzyme chain in the complex with <b>28</b> are shown as a ribbon diagram in gray, and the Thr<sub>77</sub> side chains in the different complexes are shown with the color coding of the respective inhibitors. Flap domains are in closed conformations. The hydroxyl of the flap Tyr<sub>75</sub> (cyan) in complex with the GRAB peptidomimetic <b>32</b> (inhibitor not shown) is in a similar position as the Thr<sub>77</sub> hydroxyl (0.9 Å distance) in complex with <b>28</b>. The H-bond between the carbonyl of <b>28</b> and the Thr<sub>77</sub> hydroxyl is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0027.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Early examples of DRIs binding to the S<sub>3</sub><sup>sp</sup> subpocket of renin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0001.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (S<sub>3</sub>−S<sub>1</sub>)-topological peptidomimetics binding to the nonsubstrate S<sub>3</sub><sup>sp</sup> pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0002.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Illustration of the conformational rigidity of the renin S<sub>3</sub><sup>sp</sup> pocket. Shown are the superimposed X-ray structures of rh-renin in complex with <b>1</b> (orange) (protein ribbon diagram in gray), <i>N</i>-benzylindole <b>29</b> (brown), and the <i>N</i>-ethylacetamide-substituted 2,4-diaminopyrimidine <b>34</b> (gray). Of the key side chains lining the boundaries of S<sub>3</sub><sup>sp</sup> (Thr<sub>12</sub>, Gln<sub>13</sub>, <u class="uu">Tyr</u><sub>14</sub>, <u class="uu">Val</u><sub>30</sub>, <u class="uu">Tyr</u><sub>155</sub>, <u class="uu">Thr</u><sub>216</sub>, Gly<sub>217</sub>, <u class="uu">Ser</u><sub>219</sub>, and <u class="uu">Ala</u><sub>303</sub>) those underlined are shown with the color codes used for the inhibitors. In addition, the corresponding side chains are shown for the renin complexes with inhibitor <b>4</b> (green), the <i>N</i>-hydroxypropyl analogue of 2-ketopiperazine <b>48</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fs4">2fs4</a>, cyan), and native renin (yellow).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The H-bond of the methoxypropoxy side chain of <b>1</b> to the backbone amide nitrogen of Tyr<sub>14</sub> is highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0003.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. 3,4-Piperidine GRAB peptidomimetics: P<sub>3</sub><sup>sp</sup> side chain approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0004.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Overlay of different chemotype basic amine TS surrogate DRIs interacting with Asp<sub>32</sub> and Asp<sub>215</sub> of the catalytic center. Inhibitors shown are <b>1</b> (orange), the GRAB peptidomimetic <b>33</b> (yellow), the 2,4-diaminopyrimidine <b>34</b> (gray), and the ψ[CH<sub>2</sub>NH]-reduced isostere <b>38</b> (green). For the rh-renin−<b>1</b> complex, residues Asp<sub>32</sub>/Asp<sub>215</sub> and a partial ribbon diagram are shown. To better distinguish the inhibitors, portions of their structures were omitted and nitrogen atoms were colored using different shades of blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0005.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Early prototype 4-phenylpiperidine TS surrogate DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0006.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. 2,4-Diaminopyrimidine-based peptidomimetics (IC<sub>50</sub> in buffer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0007.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Non-peptide peptidomimetic ψ[CH<sub>2</sub>NH]-reduced amide isosteres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0008.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Advanced 3,4-piperidine-based GRAB peptidomimetics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0009.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Piperidine-derived GRAB peptidomimetic inhibitors (IC<sub>50</sub> in buffer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0010.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Second generation GRAB peptidomimetic DRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0011.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Superposition of X-ray structures of rh-renin complexed with GRAB peptidomimetics <b>33</b> (orange) and <b>51</b> (gray) binding to the open flap conformational topography. Partial peptide backbones and the side chains for Trp<sub>39</sub>, Leu<sub>73</sub>, and Tyr<sub>75</sub> are shown for the two complexes using the same color code. The corresponding portions of the rh-renin−<b>1</b> complex are overlaid in brown. For the complex with <b>51</b> the portion of the active site behind the inhibitor is shown as a transparent surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/medium/jm-2009-01885s_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0012.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Non-peptide peptidomimetic DRIs binding to the S<sub>2</sub> pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm901885s/production/images/large/jm-2009-01885s_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901885s&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 185 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Tigerstedt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, P. G.</span><span> </span><span class="NLM_article-title">Niere und Kreislauf</span> <span class="citation_source-journal">Skand. Arch. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1898</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1748-1716.1898.tb00272.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1898&pages=223-271&author=R.+Tigerstedtauthor=P.+G.+Bergman&title=Niere+und+Kreislauf"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1748-1716.1898.tb00272.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1748-1716.1898.tb00272.x%26sid%3Dliteratum%253Aachs%26aulast%3DTigerstedt%26aufirst%3DR.%26aulast%3DBergman%26aufirst%3DP.%2BG.%26atitle%3DNiere%2520und%2520Kreislauf%26jtitle%3DSkand.%2520Arch.%2520Physiol.%26date%3D1898%26volume%3D8%26spage%3D223%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Aurell, M.</span><span> </span><span class="NLM_article-title">The renin−angiotensin system: the centenary jubilee</span> <span class="citation_source-journal">Blood Pressure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=71-75&author=M.+Aurell&title=The+renin%E2%88%92angiotensin+system%3A+the+centenary+jubilee"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAurell%26aufirst%3DM.%26atitle%3DThe%2520renin%25E2%2588%2592angiotensin%2520system%253A%2520the%2520centenary%2520jubilee%26jtitle%3DBlood%2520Pressure%26date%3D1998%26volume%3D7%26spage%3D71%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Skeggs, L. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, N. P.</span><span> </span><span class="NLM_article-title">The preparation, purification, and amino acid sequence of a polypeptide renin substrate</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1957&pages=439-453&author=L.+T.+Skeggsauthor=J.+R.+Kahnauthor=K.+Lentzauthor=N.+P.+Shumway&title=The+preparation%2C+purification%2C+and+amino+acid+sequence+of+a+polypeptide+renin+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%2BT.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DLentz%26aufirst%3DK.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DThe%2520preparation%252C%2520purification%252C%2520and%2520amino%2520acid%2520sequence%2520of%2520a%2520polypeptide%2520renin%2520substrate%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1957%26volume%3D106%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Azizi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Renin inhibition with aliskiren: Where are we now, and where are we going?</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F01.hjh.0000202812.72341.99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=16508564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslamtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=243-256&author=M.+Aziziauthor=R.+Webbauthor=J.+Nussbergerauthor=N.+K.+Hollenberg&title=Renin+inhibition+with+aliskiren%3A+Where+are+we+now%2C+and+where+are+we+going%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition with aliskiren: where are we now, and where are we going?</span></div><div class="casAuthors">Azizi, Michel; Webb, Randy; Nussberger, Juerg; Hollenberg, Norman K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-256</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  With the development of aliskiren, blockade of the renin-angiotensin-aldosterone system (RAAS) at the level of the interaction of renin with a substrate has become a clin. reality.  This review covers the specific features of the first agent likely to achieve widespread clin. exposure, aliskiren.  The potential of renin inhibition must be viewed in the context of the remarkable efficacy of both angiotensin-converting enzyme (ACE) inhibition and angiotensin receptor blockers (ARBs).  The implications of blockade of the renin system at its rate-limiting step are reviewed, with the therapeutic implications for both the renin inhibitor employed alone or the renin inhibitor combined with an ACE inhibitor or ARB.  The relevant and necessary studies are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRs5P2dISfLVg90H21EOLACvtfcHk0lg9BINhfM_Rag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslamtL0%253D&md5=56802278b84a703062e1940dc910b910</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2F01.hjh.0000202812.72341.99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.hjh.0000202812.72341.99%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DR.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DRenin%2520inhibition%2520with%2520aliskiren%253A%2520Where%2520are%2520we%2520now%252C%2520and%2520where%2520are%2520we%2520going%253F%26jtitle%3DJ.%2520Hypertens.%26date%3D2006%26volume%3D24%26spage%3D243%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sever, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azizi, M.</span><span> </span><span class="NLM_article-title">Managing cardiovascular and renal risk: the potential of direct renin inhibition</span> <span class="citation_source-journal">J. Renin−Angiotensin−Aldosterone Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1177%2F1470320309104662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19502253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVChtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=65-76&author=P.+S.+Severauthor=A.+H.+Gradmanauthor=M.+Azizi&title=Managing+cardiovascular+and+renal+risk%3A+the+potential+of+direct+renin+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Managing cardiovascular and renal risk: the potential of direct renin inhibition</span></div><div class="casAuthors">Sever, Peter S.; Gradman, Alan H.; Azizi, Michel</div><div class="citationInfo"><span class="NLM_cas:title">JRAAS</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-76</span>CODEN:
                <span class="NLM_cas:coden">JRAAAG</span>;
        ISSN:<span class="NLM_cas:issn">1470-3203</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Aliskiren is the first direct renin inhibitor for the treatment of hypertension.  Clin. experience from studies in over 14,000 patients has shown that aliskiren, alone or in combination with other antihypertensive therapies, provides effective blood pressure lowering with a good safety and tolerability profile.  The ultimate aim of antihypertensive therapy, however, is to reduce the risk of adverse cardiovascular and renal outcomes.  The effect of aliskiren on surrogate markers of organ damage and clin. outcomes is being assessed in the ongoing ASPIRE HIGHER program, the largest clin. trials program in the cardio-renal disease area.  Results from the ALOFT, AVOID and ALLAY studies suggest that aliskiren has pos. effects on markers of cardiovascular and renal damage in patients with type 2 diabetes and nephropathy, heart failure and left ventricular hypertrophy.  ASPIRE HIGHER also includes four large-scale studies assessing the potential outcome benefits of aliskiren, and the results of these trials will help define the clin. utility of aliskiren in the treatment of cardiovascular and renal diseases.  In this article, we review the antihypertensive efficacy of aliskiren and explore its potential in the management of cardiovascular and renal risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDBNL9_Fo57Vg90H21EOLACvtfcHk0liphWw9UoCS7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVChtL7M&md5=13512d8238309e35df87ac1bd0d39b17</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1177%2F1470320309104662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1470320309104662%26sid%3Dliteratum%253Aachs%26aulast%3DSever%26aufirst%3DP.%2BS.%26aulast%3DGradman%26aufirst%3DA.%2BH.%26aulast%3DAzizi%26aufirst%3DM.%26atitle%3DManaging%2520cardiovascular%2520and%2520renal%2520risk%253A%2520the%2520potential%2520of%2520direct%2520renin%2520inhibition%26jtitle%3DJ.%2520Renin%25E2%2588%2592Angiotensin%25E2%2588%2592Aldosterone%2520Syst.%26date%3D2009%26volume%3D10%26spage%3D65%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Brown, M. J.</span><span> </span><span class="NLM_article-title">Direct renin inhibition−a new way of targeting the renin system</span> <span class="citation_source-journal">J. Renin−Angiotensin−Aldosterone Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span><span class="NLM_x">–</span> <span class="NLM_lpage">S11</span><div class="note"><p class="first last">. The terminology “direct renin inhibition” indicates an action that directly involves renin inhibition rather than an “indirect inhibition” that can occur somewhere along the pathway and will result in suppression of the cascade and eventually of renin release. The term DRI does not refer to the mechanism of ligand−enzyme interaction, e.g., active site vs allosteric site binders. To the best of our knowledge, allosteric renin inhibitors have not been reported to date.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=S7-S11&author=M.+J.+Brown&title=Direct+renin+inhibition%E2%88%92a+new+way+of+targeting+the+renin+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26atitle%3DDirect%2520renin%2520inhibition%25E2%2588%2592a%2520new%2520way%2520of%2520targeting%2520the%2520renin%2520system%26jtitle%3DJ.%2520Renin%25E2%2588%2592Angiotensin%25E2%2588%2592Aldosterone%2520Syst.%26date%3D2006%26volume%3D7%26spage%3DS7%26epage%3DS11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ong, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, B. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S. L.</span><span> </span><span class="NLM_article-title">Prevalence, awareness, treatment, and control of hypertension among United States adults 1999−2004</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=69-75&author=K.+L.+Ongauthor=B.+M.+Y.+Cheungauthor=Y.+B.+Manauthor=C.+P.+Lauauthor=K.+S.+L.+Lam&title=Prevalence%2C+awareness%2C+treatment%2C+and+control+of+hypertension+among+United+States+adults+1999%E2%88%922004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOng%26aufirst%3DK.%2BL.%26aulast%3DCheung%26aufirst%3DB.%2BM.%2BY.%26aulast%3DMan%26aufirst%3DY.%2BB.%26aulast%3DLau%26aufirst%3DC.%2BP.%26aulast%3DLam%26aufirst%3DK.%2BS.%2BL.%26atitle%3DPrevalence%252C%2520awareness%252C%2520treatment%252C%2520and%2520control%2520of%2520hypertension%2520among%2520United%2520States%2520adults%25201999%25E2%2588%25922004%26jtitle%3DHypertension%26date%3D2007%26volume%3D49%26spage%3D69%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kearney, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muntner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span> </span><span class="NLM_article-title">Global burden of hypertension: analysis of worldwide data</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0140-6736%2805%2917741-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=15652604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FislCjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=217-223&author=P.+M.+Kearneyauthor=M.+Wheltonauthor=K.+Reynoldsauthor=P.+Muntnerauthor=P.+K.+Wheltonauthor=H.+He&title=Global+burden+of+hypertension%3A+analysis+of+worldwide+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Global burden of hypertension: analysis of worldwide data</span></div><div class="casAuthors">Kearney Patricia M; Whelton Megan; Reynolds Kristi; Muntner Paul; Whelton Paul K; He Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9455</span>),
    <span class="NLM_cas:pages">217-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition.  We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.  METHODS:  We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles.  We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples.  All data were obtained independently by two investigators with a standardised protocol and data-collection form.  RESULTS:  Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]).  The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries.  The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion).  INTERPRETATION:  Hypertension is an important public-health challenge worldwide.  Prevention, detection, treatment, and control of this condition should receive high priority.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmyTZQBk0Ftv6xYuD7tu2XfW6udTcc2eZai7OlRz57JLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FislCjsg%253D%253D&md5=e48f0f930ce08e584b231cc4eda055da</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2917741-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252917741-1%26sid%3Dliteratum%253Aachs%26aulast%3DKearney%26aufirst%3DP.%2BM.%26aulast%3DWhelton%26aufirst%3DM.%26aulast%3DReynolds%26aufirst%3DK.%26aulast%3DMuntner%26aufirst%3DP.%26aulast%3DWhelton%26aufirst%3DP.%2BK.%26aulast%3DHe%26aufirst%3DH.%26atitle%3DGlobal%2520burden%2520of%2520hypertension%253A%2520analysis%2520of%2520worldwide%2520data%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D217%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ondetti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, D. W.</span><span> </span><span class="NLM_article-title">Inhibition of the renin angiotensin system: a new approach to the therapy of hypertension</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00136a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=355-361&author=M.+A.+Ondettiauthor=D.+W.+Cushman&title=Inhibition+of+the+renin+angiotensin+system%3A+a+new+approach+to+the+therapy+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm00136a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00136a001%26sid%3Dliteratum%253Aachs%26aulast%3DOndetti%26aufirst%3DM.%2BA.%26aulast%3DCushman%26aufirst%3DD.%2BW.%26atitle%3DInhibition%2520of%2520the%2520renin%2520angiotensin%2520system%253A%2520a%2520new%2520approach%2520to%2520the%2520therapy%2520of%2520hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D355%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Timmermans, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncia, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, W. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. L.</span><span> </span><span class="NLM_article-title">Angiotensin II receptor antagonists: from discovery to antihypertensive drugs</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl., III</span><span class="NLM_x">) </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1991&pages=136-142&issue=Suppl.%2C+III&author=P.+B.+Timmermansauthor=D.+J.+Cariniauthor=A.+T.+Chiuauthor=J.+V.+Dunciaauthor=W.+A.+Priceauthor=G.+J.+Wellsauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=A.+L.+Johnson&title=Angiotensin+II+receptor+antagonists%3A+from+discovery+to+antihypertensive+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%26aulast%3DCarini%26aufirst%3DD.%2BJ.%26aulast%3DChiu%26aufirst%3DA.%2BT.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DPrice%26aufirst%3DW.%2BA.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DJohnson%26aufirst%3DA.%2BL.%26atitle%3DAngiotensin%2520II%2520receptor%2520antagonists%253A%2520from%2520discovery%2520to%2520antihypertensive%2520drugs%26jtitle%3DHypertension%26date%3D1991%26volume%3D18%26issue%3DSuppl.%252C%2520III%26spage%3D136%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span> </span><span class="NLM_article-title">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0006-291X%2803%2901451-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12927775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2003&pages=698-705&author=J.+M.+Woodauthor=J.+Maibaumauthor=J.+Rahuelauthor=M.+G.+Gr%C3%BCtterauthor=N.+C.+Cohenauthor=V.+Rasettiauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=S.+Stutzauthor=W.+Fuhrerauthor=W.+Schillingauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=H.+P.+Baumauthor=C.+R.+Schnellauthor=P.+Heroldauthor=R.+Mahauthor=C.+Jensenauthor=E.+O%E2%80%99Brienauthor=A.+Stantonauthor=M.+P.+Bedigian&title=Structure-based+design+of+aliskiren%2C+a+novel+orally+effective+renin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span></div><div class="casAuthors">Wood, Jeanette M.; Maibaum, Juergen; Rahuel, Joseph; Gruetter, Markus G.; Cohen, Nissim-Claude; Rasetti, Vittorio; Rueger, Heinrich; Goeschke, Richard; Stutz, Stefan; Fuhrer, Walter; Schilling, Walter; Rigollier, Pascal; Yamaguchi, Yasuchika; Cumin, Frederic; Baum, Hans-Peter; Schnell, Christian R.; Herold, Peter; Mah, Robert; Jensen, Chris; O'Brien, Eoin; Stanton, Alice; Bedigian, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Hypertension is a major risk factor for cardiovascular diseases such as stroke, myocardial infarction, and heart failure, the leading causes of death in the Western world.  Inhibitors of the renin-angiotensin system (RAS) have proven to be successful treatments for hypertension.  As renin specifically catalyzes the rate-limiting step of the RAS, it represents the optimal target for RAS inhibition.  Several peptide-like renin inhibitors have been synthesized previously, but poor pharmacokinetic properties meant that these compds. were not clin. useful.  We employed a combination of mol. modeling and crystallog. structure anal. to design renin inhibitors lacking the extended peptide-like backbone of earlier inhibitors, for improved pharmacokinetic properties.  This led to the discovery of aliskiren, a highly potent and selective inhibitor of human renin in vitro, and in vivo; once-daily oral doses of aliskiren inhibit renin and lower blood pressure in sodium-depleted marmosets and hypertensive human patients.  Aliskiren represents the first in a novel class of renin inhibitors with the potential for treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5YmV3cdr0LVg90H21EOLACvtfcHk0liU-MlUDIsScQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D&md5=20b71ca3ccfe2324752cb2bb541d9ba2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901451-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901451-7%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DHerold%26aufirst%3DP.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DStanton%26aufirst%3DA.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26atitle%3DStructure-based%2520design%2520of%2520aliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D308%26spage%3D698%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span> </span><span class="NLM_article-title">Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4832</span><span class="NLM_x">–</span> <span class="NLM_lpage">4844</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070316i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4832-4844&author=J.+Maibaumauthor=S.+Stutzauthor=R.+G%C3%B6schkeauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=J.+Rahuelauthor=H.+P.+Baumauthor=N.+C.+Cohenauthor=C.+R.+Schnellauthor=W.+Fuhrerauthor=M.+G.+Gr%C3%BCtterauthor=W.+Schillingauthor=J.+M.+Wood&title=Structural+modification+of+the+P2%E2%80%B2+position+of+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamides%3A+the+discovery+of+aliskiren%2C+a+potent+nonpeptide+human+renin+inhibitor+active+after+once+daily+dosing+in+marmosets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm070316i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070316i%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520modification%2520of%2520the%2520P2%25E2%2580%25B2%2520position%2520of%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamides%253A%2520the%2520discovery%2520of%2520aliskiren%252C%2520a%2520potent%2520nonpeptide%2520human%2520renin%2520inhibitor%2520active%2520after%2520once%2520daily%2520dosing%2520in%2520marmosets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4832%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span> </span><span class="NLM_article-title">Case history on Tekturna/Rasilez (aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span> <span class="citation_source-journal">Annu. Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0065-7743%2809%2904405-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=105-127&author=J.+Maibaumauthor=D.+L.+Feldman&title=Case+history+on+Tekturna%2FRasilez+%28aliskiren%29%2C+a+highly+efficacious+direct+oral+renin+inhibitor+as+a+new+therapy+for+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Case history on Tekturna Rasilez (Aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span></div><div class="casAuthors">Maibaum, Jurgen; Feldman, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-127</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The rationale for the use of direct renin inhibitors, pre-clin. models to study direct renin inhibitors, and the early renin inhibitor program at Ciba-Geigy are shown.  The first convergent and scalable synthesis development, pre-clin. properties of aliskiren, effects of aliskiren in disease models, and clin. studies with aliskiren are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOCbXc9SNs7LVg90H21EOLACvtfcHk0lj2t0__IJTHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM&md5=7fb4459d367392233e0569a8809a3f41</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2809%2904405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252809%252904405-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26atitle%3DCase%2520history%2520on%2520Tekturna%252FRasilez%2520%2528aliskiren%2529%252C%2520a%2520highly%2520efficacious%2520direct%2520oral%2520renin%2520inhibitor%2520as%2520a%2520new%2520therapy%2520for%2520hypertension%26jtitle%3DAnnu.%2520Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D105%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. R.</span><span> </span><span class="NLM_article-title">Aliskiren: the first renin inhibitor for clinical treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnrd2550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18340340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=399-410&author=C.+Jensenauthor=P.+Heroldauthor=H.+R.+Brunner&title=Aliskiren%3A+the+first+renin+inhibitor+for+clinical+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren: the first renin inhibitor for clinical treatment</span></div><div class="casAuthors">Jensen, Chris; Herold, Peter; Brunner, Hans Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-410</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The renin-angiotensin system, which is a key regulator of blood pressure, has been successfully targeted by several classes of drugs for the treatment of cardiovascular disease.  However, renin - the protease at the top of the cascade - although highly attractive as a target, has also proved to be challenging.  Here, we describe how these challenges were tackled in the discovery and development of aliskiren, the first renin inhibitor to be approved for clin. use.  The first evidence of the existence of renin was presented over 100 years ago.  However, the importance of renin and the renin-angiotensin system in the pathogenesis of cardiovascular disease was only fully realized in the 1970s.  It was another 20 years before the first inhibitors of renin were available for clin. research.  Here, we describe the discovery and development of aliskiren, an orally active renin inhibitor, which became the first drug in its class to receive regulatory approval.  In 2007, it was approved for the treatment of hypertension by the US Food and Drug Administration and the European Medicines Agency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwW8kGNQazBbVg90H21EOLACvtfcHk0lj2t0__IJTHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbg%253D&md5=891d7f8266f9b03954ae40e028a8cd42</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd2550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2550%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DHerold%26aufirst%3DP.%26aulast%3DBrunner%26aufirst%3DH.%2BR.%26atitle%3DAliskiren%253A%2520the%2520first%2520renin%2520inhibitor%2520for%2520clinical%2520treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D399%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yokokawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000−2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span><div class="note"><p class="first last">. A total of 62 new patents claiming novel renin inhibitors have been disclosed in the years 2008−2009, as based on a search in SciFinder. For more recent reports on DRI clinical development compounds, see refs <a onclick="showRef(event, 'ref182 ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref182 ref183 ref184">182−184</a></p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F13543776.18.6.581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1OktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=581-602&author=F.+Yokokawaauthor=J.+Maibaum&title=Recent+advances+in+the+discovery+of+non-peptidic+direct+renin+inhibitors+as+antihypertensives%3A+new+patent+applications+in+years+2000%E2%88%922008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000 - 2008</span></div><div class="casAuthors">Yokokawa, Fumiaki; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">581-602</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The renin-angiotensin-aldosterone system (RAAS) is essential for the regulation of blood pressure and may play a crit. role in the pathogenesis of cardiovascular diseases.  A strong rationale suggests a more efficient control of RAAS by direct rather than downstream blockade of renin, an angiotensinogen-specific aspartic protease acting at the first, rate-limiting step of the pathway.  Vast research efforts since the late 1970s have aimed at developing clin. useful renin inhibitors for the treatment of hypertension and assocd. co-morbidities.  In 2007, aliskiren (Tekturna, Rasilez; Novartis) was launched as the first orally efficacious direct renin inhibitor.  The evolution of non-peptide renin inhibitors interacting with non-substrate recognition sites of the enzyme, such as aliskiren and the 4-aryl-piperidines, during the 1990s encouraged an increasing no. of pharmaceutical companies to resume, or newly embark on, drug discovery programs.  Objective: This review summarizes the various structural design concepts and the apparent focus of activities presently employed to develop follow-up generations of oral renin inhibitors.  Methods: Information was collected from patents, scientific literatures and public sources disclosed during the years 2000 - 2008.  Results/conclusion: The structural diversity of small-mol. inhibitors has further increased, including novel basic surrogate transition-state mimetic motifs.  Several inhibitors emerged as (pre)clin. candidates, the most advanced having entered Phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_YIMBZDqTyrVg90H21EOLACvtfcHk0ljZ-y3f0KW0nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1OktrY%253D&md5=101c7650e96d98257a9cb7d4d7028060</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.6.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.6.581%26sid%3Dliteratum%253Aachs%26aulast%3DYokokawa%26aufirst%3DF.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520non-peptidic%2520direct%2520renin%2520inhibitors%2520as%2520antihypertensives%253A%2520new%2520patent%2520applications%2520in%2520years%25202000%25E2%2588%25922008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D581%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Pilz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shagdarsuren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=569-576&author=B.+Pilzauthor=E.+Shagdarsurenauthor=M.+Wellnerauthor=A.+Fiebelerauthor=R.+Dechendauthor=P.+Gratzeauthor=S.+Meinersauthor=D.+L.+Feldmanauthor=R.+L.+Webbauthor=I.+M.+Garreldsauthor=A.+H.+J.+Danserauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=Aliskiren%2C+a+human+renin+inhibitor%2C+ameliorates+cardiac+and+renal+damage+in+double-transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPilz%26aufirst%3DB.%26aulast%3DShagdarsuren%26aufirst%3DE.%26aulast%3DWellner%26aufirst%3DM.%26aulast%3DFiebeler%26aufirst%3DA.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DGratze%26aufirst%3DP.%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DAliskiren%252C%2520a%2520human%2520renin%2520inhibitor%252C%2520ameliorates%2520cardiac%2520and%2520renal%2520damage%2520in%2520double-transgenic%2520rats%26jtitle%3DHypertension%26date%3D2005%26volume%3D46%26spage%3D569%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">A revised definition of “peptide-derived peptidomimetic” and “non-peptide peptidomimetic” protease inhibitors has been proposed by Rich et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Non-peptide peptidomimetics can be further distinguished in two major classes: those accessing exclusively the substrate-derived extended β-strand binding active site topography and those binding to a distinct active site conformational topography not recognized by substrate-derived inhibitors. We use this terminology throughout the discussion in this article.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tice, C. M.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=155-167&author=C.+M.+Tice&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26atitle%3DRenin%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kasai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span> </span><span class="NLM_article-title">Cardiovascular agents: renin inhibitors and factor Xa inhibitors</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=47-85&author=A.+Kasaiauthor=R.+Subediauthor=M.+Stierauthor=D.+D.+Holsworth&title=Cardiovascular+agents%3A+renin+inhibitors+and+factor+Xa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DA.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DCardiovascular%2520agents%253A%2520renin%2520inhibitors%2520and%2520factor%2520Xa%2520inhibitors%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D73%26spage%3D47%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Inhibitors of Aspartic Proteinases</span>. In  <span class="citation_source-book">Research Monographs in Cell and Tissue Physiology, Vol. 12, Proteinase Inhibitors</span>; <span class="NLM_contrib-group">Barrett, A. J.; Salvesen, G.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>pp <span class="NLM_fpage">179</span>− <span class="NLM_lpage">217</span> and references therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=179-217&author=D.+H.+Richauthor=A.+J.+Barrett&author=G+Salvesen&title=Research+Monographs+in+Cell+and+Tissue+Physiology%2C+Vol.+12%2C+Proteinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DInhibitors%2520of%2520Aspartic%2520Proteinases%26btitle%3DResearch%2520Monographs%2520in%2520Cell%2520and%2520Tissue%2520Physiology%252C%2520Vol.%252012%252C%2520Proteinase%2520Inhibitors%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26pub%3DElsevier%26date%3D1986%26spage%3D179%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1002%2Fmed.2610100203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1990&pages=173-236&author=W.+J.+Greenlee&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610100203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610100203%26sid%3Dliteratum%253Aachs%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DRenin%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1990%26volume%3D2%26spage%3D173%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Hypertension: Treatment by Blockade of the Renin−Angiotensin System</span>. In  <span class="citation_source-book">Proceedings of the 14th International Symposium on Medicinal Chemistry</span>; <span class="NLM_contrib-group">Awouters, F.</span>, Ed.; <span class="NLM_publisher-name">Elsevier Science</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">97</span>− <span class="NLM_lpage">107</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0165-7208%2897%2980056-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=97-107&author=W.+J.+Greenleeauthor=F.+Awouters&title=Proceedings+of+the+14th+International+Symposium+on+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2FS0165-7208%2897%2980056-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0165-7208%252897%252980056-6%26sid%3Dliteratum%253Aachs%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DHypertension%253A%2520Treatment%2520by%2520Blockade%2520of%2520the%2520Renin%25E2%2588%2592Angiotensin%2520System%26btitle%3DProceedings%2520of%2520the%252014th%2520International%2520Symposium%2520on%2520Medicinal%2520Chemistry%26aulast%3DAwouters%26aufirst%3DF.%26pub%3DElsevier%2520Science%26date%3D1997%26spage%3D97%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raddatz, P.</span><span> </span><span class="NLM_article-title">Recent developments in renin inhibitors: Part 1</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F13543776.4.5.489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVClsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=489-504&author=P.+Raddatz&title=Recent+developments+in+renin+inhibitors%3A+Part+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in renin inhibitors: Part 1</span></div><div class="casAuthors">Raddatz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">489-504</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">0962-2594</span>.
    </div><div class="casAbstract">A review with 153 refs. of recent developments in the renin inhibitor area including patent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2QLVLR4dumrVg90H21EOLACvtfcHk0lj_W_HqxkxFeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVClsLw%253D&md5=41be029416257e40e416bb774db7f632</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1517%2F13543776.4.5.489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.4.5.489%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DP.%26atitle%3DRecent%2520developments%2520in%2520renin%2520inhibitors%253A%2520Part%25201%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D1994%26volume%3D4%26spage%3D489%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raddatz, P.</span><span> </span><span class="NLM_article-title">Recent developments in renin inhibitors: Part II</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F13543776.4.11.1347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2MXitlGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=1347-1359&author=P.+Raddatz&title=Recent+developments+in+renin+inhibitors%3A+Part+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in renin inhibitors: part II</span></div><div class="casAuthors">Raddatz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1347-59</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">0962-2594</span>.
    </div><div class="casAbstract">A review with 75 refs. of the structures and activities of renin inhibitors that are under exptl. and clin. investigation and that have been proposed in recent patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqypp6bYZgmD7Vg90H21EOLACvtfcHk0lj_W_HqxkxFeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlGrt70%253D&md5=45a597b2c93aeb2d1dc7fcef27e85d63</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1517%2F13543776.4.11.1347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.4.11.1347%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DP.%26atitle%3DRecent%2520developments%2520in%2520renin%2520inhibitors%253A%2520Part%2520II%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D1994%26volume%3D4%26spage%3D1347%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Progr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0079-6468%2808%2970452-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8577921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2MXpt12it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1995&pages=37-114&author=S.+H.+Rosenberg&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibitors</span></div><div class="casAuthors">Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-114</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 296 refs. on renin-angiotensin system and pharmacol. of renin inhibitors as antihypertensive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_7GRpnwZ6bVg90H21EOLACvtfcHk0liGacq4JVbocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpt12it7g%253D&md5=82740dd1db4822d1bb67357172af6199</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970452-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970452-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DRenin%2520inhibitors%26jtitle%3DProgr.%2520Med.%2520Chem.%26date%3D1995%26volume%3D32%26spage%3D37%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rosenberg, S. H.; Boyd, S. A.</span><span> </span><span class="NLM_article-title">Renin Inhibitors</span>. In  <span class="citation_source-book">Antihypertensive Drugs</span>; <span class="NLM_contrib-group">Van Zwieten, P. A.; Greenlee, W. J.</span>, Eds.; <span class="NLM_publisher-name">Harwood</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">77</span>− <span class="NLM_lpage">111</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=77-111&author=S.+H.+Rosenberg&author=S.+A.+Boydauthor=P.+A.+Van+Zwieten&author=W.+J.+Greenlee&title=Antihypertensive+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DRenin%2520Inhibitors%26btitle%3DAntihypertensive%2520Drugs%26aulast%3DVan%2BZwieten%26aufirst%3DP.%2BA.%26pub%3DHarwood%26date%3D1997%26spage%3D77%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinert, H. D.</span><span> </span><span class="NLM_article-title">Renin inhibitors</span> <span class="citation_source-journal">Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2F0-306-47384-4_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9760674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=7-28&author=S.+H.+Rosenbergauthor=H.+D.+Kleinert&title=Renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibitors</span></div><div class="casAuthors">Rosenberg, Saul H.; Kleinert, Hollis D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">Integration of Pharmaceutical Discovery and Development</span>),
    <span class="NLM_cas:pages">7-28</span>CODEN:
                <span class="NLM_cas:coden">PHBIEB</span>;
        ISSN:<span class="NLM_cas:issn">1078-0467</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">A review with many refs.  The authors illustrate the decision-making processes that are assocd. with a drug discovery effort.  The success of the renin inhibitor project was the direct result of the tight integration of the medicinal chem. biochem., pharmacol. and pharmacokinetics groups.  As obstacles arose, a variety of approaches, often simultaneous, were taken to overcome them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFJHD3ufSbsrVg90H21EOLACvtfcHk0liGacq4JVbocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFyrsLc%253D&md5=a86ce0dbd58c744a2a79a649da6db952</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1007%2F0-306-47384-4_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F0-306-47384-4_2%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DKleinert%26aufirst%3DH.%2BD.%26atitle%3DRenin%2520inhibitors%26jtitle%3DPharm.%2520Biotechnol.%26date%3D1998%26volume%3D11%26spage%3D7%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Appelt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacquet, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhry, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howland, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathardekar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzoni, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oatley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoettlin, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villafranca, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span> </span><span class="NLM_article-title">Design of enzyme inhibitors using iterative protein crystallographic analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1925</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00111a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3MXksVCltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1925-1934&author=K.+Appeltauthor=R.+J.+Bacquetauthor=C.+A.+Bartlettauthor=C.+L.+Boothauthor=S.+T.+Freerauthor=M.+A.+Fuhryauthor=M.+R.+Gehringauthor=S.+M.+Herrmannauthor=E.+F.+Howlandauthor=C.+A.+Jansonauthor=T.+R.+Jonesauthor=C.-C.+Kanauthor=V.+Kathardekarauthor=K.+K.+Lewisauthor=G.+P.+Marzoniauthor=D.+A.+Matthewsauthor=C.+Mohrauthor=E.+W.+Moomawauthor=C.+A.+Morseauthor=S.+J.+Oatleyauthor=R.+C.+Ogdenauthor=M.+R.+Reddyauthor=S.+H.+Reichauthor=W.+S.+Schoettlinauthor=W.+W.+Smithauthor=M.+D.+Varneyauthor=J.+E.+Villafrancaauthor=R.+W.+Wardauthor=S.+Webberauthor=S.+E.+Webberauthor=K.+M.+Welchauthor=J.+White&title=Design+of+enzyme+inhibitors+using+iterative+protein+crystallographic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Design of enzyme inhibitors using iterative protein crystallographic analysis</span></div><div class="casAuthors">Appelt, Krzysztof; Bacquet, Russell J.; Bartlett, Charlotte A.; Booth, Carol L. J.; Freer, Stephan T.; Fuhry, Mary Ann M.; Gehring, Michael R.; Herrmann, Steven M.; Howland, Eleanor F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1925-34</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review and discussion with 48 refs., of successful applications of an iterative cycle of ligand design, synthesis, biochem. evaluation, and crystallog. anal. of the protein-ligand complex in the development of enzyme inhibitors.  Three series of structurally distinct compds. have been designed as inhibitors of Escherichia coli thymidylate synthase.  The ability to study in detail the binding mode of each successive mol. in a series greatly facilitates the anal. of those forces which dominate receptor-ligand interactions.  The methodol. described may speed the discovery of lead compds. and assist their development into drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxFzVLiIumNLVg90H21EOLACvtfcHk0ljd89HSnkOFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVCltLs%253D&md5=59843c2d15034277e136820850660265</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm00111a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00111a001%26sid%3Dliteratum%253Aachs%26aulast%3DAppelt%26aufirst%3DK.%26aulast%3DBacquet%26aufirst%3DR.%2BJ.%26aulast%3DBartlett%26aufirst%3DC.%2BA.%26aulast%3DBooth%26aufirst%3DC.%2BL.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26aulast%3DFuhry%26aufirst%3DM.%2BA.%26aulast%3DGehring%26aufirst%3DM.%2BR.%26aulast%3DHerrmann%26aufirst%3DS.%2BM.%26aulast%3DHowland%26aufirst%3DE.%2BF.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DKan%26aufirst%3DC.-C.%26aulast%3DKathardekar%26aufirst%3DV.%26aulast%3DLewis%26aufirst%3DK.%2BK.%26aulast%3DMarzoni%26aufirst%3DG.%2BP.%26aulast%3DMatthews%26aufirst%3DD.%2BA.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DMoomaw%26aufirst%3DE.%2BW.%26aulast%3DMorse%26aufirst%3DC.%2BA.%26aulast%3DOatley%26aufirst%3DS.%2BJ.%26aulast%3DOgden%26aufirst%3DR.%2BC.%26aulast%3DReddy%26aufirst%3DM.%2BR.%26aulast%3DReich%26aufirst%3DS.%2BH.%26aulast%3DSchoettlin%26aufirst%3DW.%2BS.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DVarney%26aufirst%3DM.%2BD.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26aulast%3DWard%26aufirst%3DR.%2BW.%26aulast%3DWebber%26aufirst%3DS.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWelch%26aufirst%3DK.%2BM.%26aulast%3DWhite%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520enzyme%2520inhibitors%2520using%2520iterative%2520protein%2520crystallographic%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1925%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">The rise of fragment-based drug discovery</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnchem.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=21378847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=187-192&author=C.+W.+Murrayauthor=D.+C.+Rees&title=The+rise+of+fragment-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of fragment-based drug discovery</span></div><div class="casAuthors">Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The search for new drugs is plagued by high attrition rates at all stages in research and development.  Chemists have an opportunity to tackle this problem because attrition can be traced back, in part, to the quality of the chem. leads.  Fragment-based drug discovery (FBDD) is a new approach, increasingly used in the pharmaceutical industry, for reducing attrition and providing leads for previously intractable biol. targets.  FBDD identifies low-mol.-wt. ligands (∼150 Da) that bind to biol. important macromols.  The three-dimensional exptl. binding mode of these fragments is detd. using X-ray crystallog. or NMR spectroscopy, and is used to facilitate their optimization into potent mols. with drug-like properties.  Compared with high-throughput-screening, the fragment approach requires fewer compds. to be screened, and, despite the lower initial potency of the screening hits, offers more efficient and fruitful optimization campaigns.  Here, we review the rise of FBDD, including its application to discovering clin. candidates against targets for which other chem. approaches have struggled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3ip2FKcYJbVg90H21EOLACvtfcHk0ljd89HSnkOFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D&md5=0bd1a40fd927cce9200f0fa296a7462f</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1038%2Fnchem.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.217%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DThe%2520rise%2520of%2520fragment-based%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">de Kloe, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span> </span><span class="NLM_article-title">Transforming fragments into candidates: small becomes big in medicinal chemistry</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.drudis.2009.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19443265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD1MvmtFOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=630-646&author=G.+E.+de+Kloeauthor=D.+Baileyauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Transforming+fragments+into+candidates%3A+small+becomes+big+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming fragments into candidates: small becomes big in medicinal chemistry</span></div><div class="casAuthors">de Kloe Gerdien E; Bailey David; Leurs Rob; de Esch Iwan J P</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">630-46</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fragment-based drug discovery (FBDD) represents a logical and efficient approach to lead discovery and optimisation.  It can draw on structural, biophysical and biochemical data, incorporating a wide range of inputs, from precise mode-of-binding information on specific fragments to wider ranging pharmacophoric screening surveys using traditional HTS approaches.  It is truly an enabling technology for the imaginative medicinal chemist.  In this review, we analyse a representative set of 23 published FBDD studies that describe how low molecular weight fragments are being identified and efficiently transformed into higher molecular weight drug candidates.  FBDD is now becoming warmly endorsed by industry as well as academia and the focus on small interacting molecules is making a big scientific impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPxy6qg7uE4oxhnOQkIHOxfW6udTcc2eZVAEoz3pSMOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvmtFOquw%253D%253D&md5=10ed9629dece190be12712f4862b3699</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.03.009%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BKloe%26aufirst%3DG.%2BE.%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DTransforming%2520fragments%2520into%2520candidates%253A%2520small%2520becomes%2520big%2520in%2520medicinal%2520chemistry%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D630%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analog inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00381a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=263-273&author=D.+H.+Rich&title=Pepstatin-derived+inhibitors+of+aspartic+proteinases.+A+close+look+at+an+apparent+transition-state+analog+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00381a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00381a001%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DPepstatin-derived%2520inhibitors%2520of%2520aspartic%2520proteinases.%2520A%2520close%2520look%2520at%2520an%2520apparent%2520transition-state%2520analog%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D263%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Guruprasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanaraj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span> </span><span class="NLM_article-title">Aspartic proteinases: the structures and functions of a versatile superfamily of enzymes</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=329-341&author=K.+Guruprasadauthor=V.+Dhanarajauthor=M.+Grovesauthor=T.+L.+Blundell&title=Aspartic+proteinases%3A+the+structures+and+functions+of+a+versatile+superfamily+of+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuruprasad%26aufirst%3DK.%26aulast%3DDhanaraj%26aufirst%3DV.%26aulast%3DGroves%26aufirst%3DM.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DAspartic%2520proteinases%253A%2520the%2520structures%2520and%2520functions%2520of%2520a%2520versatile%2520superfamily%2520of%2520enzymes%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D1995%26volume%3D2%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_contrib-group">Dunn, B.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the pepsin-like family of aspartic peptidases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4431</span><span class="NLM_x">–</span> <span class="NLM_lpage">4458</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010167q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFWhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4431-4458&author=B.+Dunn&title=Structure+and+mechanism+of+the+pepsin-like+family+of+aspartic+peptidases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the pepsin-like family of aspartic peptidases</span></div><div class="casAuthors">Dunn, Ben M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4431-4458</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include the cloning and expression of new aspartic endopeptidases, structural aspects of aspartic peptidases, the N-terminal prosegment region of aspartic peptidases, active site engineering, substrate and inhibitor design, and synthetic and naturally occurring inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU2C94Lnni_LVg90H21EOLACvtfcHk0lgH_VMjws2PgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFWhtLk%253D&md5=0e6b1f501111075667ea562d9d3ca132</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fcr010167q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010167q%26sid%3Dliteratum%253Aachs%26aulast%3DDunn%26aufirst%3DB.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520pepsin-like%2520family%2520of%2520aspartic%2520peptidases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4431%26epage%3D4458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><div class="note"><p class="first last">See also the following: </p></div><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span> </span><span class="NLM_article-title">Molecular recognition of protein−ligand complexes: applications to drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr960370z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=1359-1472&author=R.+E.+Babineauthor=S.+L.+Bender&title=Molecular+recognition+of+protein%E2%88%92ligand+complexes%3A+applications+to+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fcr960370z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr960370z%26sid%3Dliteratum%253Aachs%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DBender%26aufirst%3DS.%2BL.%26atitle%3DMolecular%2520recognition%2520of%2520protein%25E2%2588%2592ligand%2520complexes%253A%2520applications%2520to%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D1359%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cooper, J. B.</span><span> </span><span class="NLM_article-title">Aspartic proteinases in disease: a structural perspective</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.2174%2F1389450024605382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=11958298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFSmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=155-173&author=J.+B.+Cooper&title=Aspartic+proteinases+in+disease%3A+a+structural+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aspartic proteinases in disease: a structural perspective</span></div><div class="casAuthors">Cooper, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-173</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The aspartic proteinases are a family of enzymes involved in a no. of important biol. processes.  In animals the enzyme renin has a hypertensive action through its role in the renin-angiotensin system.  The retroviral aspartic proteinases, such as the HIV proteinase, are essential for maturation of the virus particle and inhibitors have a proven therapeutic record in the treatment of AIDS.  The lysosomal aspartic proteinase cathepsin D has been implicated in tumorigenesis and the stomach enzyme pepsin, which plays a major physiol. role in hydrolysis of acid-denatured proteins, is responsible for much of the tissue damage in peptic ulcer disease.  Since aspartic proteinases also play major roles in amyloid disease, malaria and common fungal infections such as candidiasis, inhibitors to these enzymes are much sought after as potential therapeutic agents.  In all aspartic proteinases, the catalytic aspartate residues are involved in an intricate arrangement of hydrogen bonds involving a solvent mol. which is presumed to be water.  The catalytic mechanism is thought to involve nucleophilic attack of the active site water mol. on the scissile bond carbonyl generating a tetrahedral gem-diol intermediate.  The design of inhibitors generally involves the use of short oligopeptides contg. a transition state analog which mimic this tetrahedral intermediate.  The application of structure-based drug design to members of the aspartic proteinase family is the main subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWCNtimORwbVg90H21EOLACvtfcHk0lheF8a2qFUGpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFSmsLg%253D&md5=30264f31342e6be9ef5a591e9526ba08</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1389450024605382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450024605382%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DJ.%2BB.%26atitle%3DAspartic%2520proteinases%2520in%2520disease%253A%2520a%2520structural%2520perspective%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2002%26volume%3D3%26spage%3D155%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010425b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=541-558&author=M.+G.+Bursavichauthor=D.+H.+Rich&title=Designing+non-peptide+peptidomimetics+in+the+21st+century%3A+inhibitors+targeting+conformational+ensembles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Non-Peptide Peptidomimetics in the 21st Century: Inhibitors Targeting Conformational Ensembles</span></div><div class="casAuthors">Bursavich, Matthew G.; Rich, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The goal of this Perspective is to outline for medicinal chemists the potential impact of receptor conformational mobility on rational drug design.  While others have postulated receptor-based conformational selection of ligands and successfully designed inhibitors to emulate the -strand binding motif of native ligands , we show that novel protein conformations (not obsd. in either native or enzyme-inhibitor complexes) can be exploited to create nonpeptide enzyme inhibitors.  We begin with a review of the development of peptidomimetic aspartic peptidase inhibitors and conclude with a new proposal for discovering fundamentally novel nonpeptide peptidomimetics by targeting conformational ensembles.  Although we focus on the aspartic peptidases, the lessons derived therein are applicable to other peptidase and receptor-ligand systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1URmBiLvD97Vg90H21EOLACvtfcHk0lheF8a2qFUGpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D&md5=8f00dc08b4d51c3021dd22a247bd56c0</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fjm010425b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010425b%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DDesigning%2520non-peptide%2520peptidomimetics%2520in%2520the%252021st%2520century%253A%2520inhibitors%2520targeting%2520conformational%2520ensembles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D541%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, C. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">From peptides to non-peptide peptidomimetics: design and synthesis of new piperidine inhibitors of aspartic peptidases</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2320</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol016092u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=2317-2320&author=M.+G.+Bursavichauthor=C.+W+Westauthor=D.+H.+Rich&title=From+peptides+to+non-peptide+peptidomimetics%3A+design+and+synthesis+of+new+piperidine+inhibitors+of+aspartic+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1021%2Fol016092u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016092u%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DWest%26aufirst%3DC.%2BW%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DFrom%2520peptides%2520to%2520non-peptide%2520peptidomimetics%253A%2520design%2520and%2520synthesis%2520of%2520new%2520piperidine%2520inhibitors%2520of%2520aspartic%2520peptidases%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D2317%26epage%3D2320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dhanaraj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dealwis, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badasso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibanda, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driessen, H. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobart, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, D. J.</span><span> </span><span class="NLM_article-title">X-ray analyses of peptide−inhibitor complexes define the structural basis of specificity for human and mouse renins</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1992&pages=466-472&author=V.+Dhanarajauthor=C.+G.+Dealwisauthor=C.+Frazaoauthor=M.+Badassoauthor=B.+L.+Sibandaauthor=I.+J.+Tickleauthor=J.+B.+Cooperauthor=H.+P.+C.+Driessenauthor=M.+Newmanauthor=C.+Aguilarauthor=S.+P.+Woodauthor=T.+L.+Blundellauthor=P.+M.+Hobartauthor=K.+F.+Geogheganauthor=M.+J.+Ammiratiauthor=D.+E.+Danleyauthor=B.+A.+O%E2%80%99Connorauthor=D.+J.+Hoover&title=X-ray+analyses+of+peptide%E2%88%92inhibitor+complexes+define+the+structural+basis+of+specificity+for+human+and+mouse+renins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhanaraj%26aufirst%3DV.%26aulast%3DDealwis%26aufirst%3DC.%2BG.%26aulast%3DFrazao%26aufirst%3DC.%26aulast%3DBadasso%26aufirst%3DM.%26aulast%3DSibanda%26aufirst%3DB.%2BL.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DCooper%26aufirst%3DJ.%2BB.%26aulast%3DDriessen%26aufirst%3DH.%2BP.%2BC.%26aulast%3DNewman%26aufirst%3DM.%26aulast%3DAguilar%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DS.%2BP.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DHobart%26aufirst%3DP.%2BM.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DAmmirati%26aufirst%3DM.%2BJ.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%2BA.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26atitle%3DX-ray%2520analyses%2520of%2520peptide%25E2%2588%2592inhibitor%2520complexes%2520define%2520the%2520structural%2520basis%2520of%2520specificity%2520for%2520human%2520and%2520mouse%2520renins%26jtitle%3DNature%26date%3D1992%26volume%3D357%26spage%3D466%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sielecki, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carilli, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewicki, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span> </span><span class="NLM_article-title">Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 Å resolution</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1989&pages=1346-1351&author=A.+R.+Sieleckiauthor=K.+Hayakawaauthor=M.+Fujinagaauthor=M.+E.+P.+Murphyauthor=M.+Fraserauthor=A.+K.+Muirauthor=C.+T.+Carilliauthor=J.+A.+Lewickiauthor=J.+D.+Baxterauthor=M.+N.+G.+James&title=Structure+of+recombinant+human+renin%2C+a+target+for+cardiovascular-active+drugs%2C+at+2.5+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%2BP.%26aulast%3DFraser%26aufirst%3DM.%26aulast%3DMuir%26aufirst%3DA.%2BK.%26aulast%3DCarilli%26aufirst%3DC.%2BT.%26aulast%3DLewicki%26aufirst%3DJ.%2BA.%26aulast%3DBaxter%26aufirst%3DJ.%2BD.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26atitle%3DStructure%2520of%2520recombinant%2520human%2520renin%252C%2520a%2520target%2520for%2520cardiovascular-active%2520drugs%252C%2520at%25202.5%2520%25C3%2585%2520resolution%26jtitle%3DScience%26date%3D1989%26volume%3D243%26spage%3D1346%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestle, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1991&pages=227-236&author=J.+Rahuelauthor=J.+P.+Priestleauthor=M.+G.+Gr%C3%BCtter&title=The+crystal+structures+of+recombinant+glycosylated+human+renin+alone+and+in+complex+with+a+transition+state+analog+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DPriestle%26aufirst%3DJ.%2BP.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DThe%2520crystal%2520structures%2520of%2520recombinant%2520glycosylated%2520human%2520renin%2520alone%2520and%2520in%2520complex%2520with%2520a%2520transition%2520state%2520analog%2520inhibitor%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D1991%26volume%3D107%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wolfenden, R.</span><span> </span><span class="NLM_article-title">Transition state analog inhibitors and enzyme catalysis</span> <span class="citation_source-journal">Annu. Rev. Biophys. Bioengin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1146%2Fannurev.bb.05.060176.001415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=7991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaE28Xksleqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1976&pages=271-306&author=R.+Wolfenden&title=Transition+state+analog+inhibitors+and+enzyme+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Transition state analog inhibitors and enzyme catalysis</span></div><div class="casAuthors">Wolfenden, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Bioengineering</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-306</span>CODEN:
                <span class="NLM_cas:coden">ABPBBK</span>;
        ISSN:<span class="NLM_cas:issn">0084-6589</span>.
    </div><div class="casAbstract">A review with 164 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFTfzop2iX3rVg90H21EOLACvtfcHk0li8-OSNmrcb4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xksleqt7w%253D&md5=2f12e20cf2c68d7fff5189b6a96653e9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bb.05.060176.001415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bb.05.060176.001415%26sid%3Dliteratum%253Aachs%26aulast%3DWolfenden%26aufirst%3DR.%26atitle%3DTransition%2520state%2520analog%2520inhibitors%2520and%2520enzyme%2520catalysis%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Bioengin.%26date%3D1976%26volume%3D5%26spage%3D271%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wiley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Peptidomimetics derived from natural products</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1002%2Fmed.2610130305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8483337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3sXksVSjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=327-384&author=R.+A.+Wileyauthor=D.+H.+Rich&title=Peptidomimetics+derived+from+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetics derived from natural products</span></div><div class="casAuthors">Wiley, Robert A.; Rich, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-84</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review with 220 refs.  Peptidomimetics are small, nonpeptide substances designed to contain the information contained in peptides.  This review discusses natural-product-derived enzyme inhibitors and receptor-binding substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr36L31ICJj9bVg90H21EOLACvtfcHk0li8-OSNmrcb4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVSjt70%253D&md5=d71e8fdaf4203047bb773c0637a1ccc6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610130305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610130305%26sid%3Dliteratum%253Aachs%26aulast%3DWiley%26aufirst%3DR.%2BA.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DPeptidomimetics%2520derived%2520from%2520natural%2520products%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D1993%26volume%3D13%26spage%3D327%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hoover, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosati, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinman, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindra, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiapane, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockel, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocerini, M. R.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors of human renin with high oral bioavailability</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1995&pages=167-180&author=D.+J.+Hooverauthor=B.+A.+Lefkerauthor=R.+L.+Rosatiauthor=R.+T.+Westerauthor=E.+F.+Kleinmanauthor=J.+S.+Bindraauthor=W.+F.+Holtauthor=W.+R.+Murphyauthor=M.+L.+Mangiapaneauthor=G.+M.+Hockelauthor=I.+H.+Williamsauthor=W.+H.+Smithauthor=M.+J.+Gumkowskiauthor=R.+M.+Shepardauthor=M.+J.+Gardnerauthor=M.+R.+Nocerini&title=Discovery+of+inhibitors+of+human+renin+with+high+oral+bioavailability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DRosati%26aufirst%3DR.%2BL.%26aulast%3DWester%26aufirst%3DR.%2BT.%26aulast%3DKleinman%26aufirst%3DE.%2BF.%26aulast%3DBindra%26aufirst%3DJ.%2BS.%26aulast%3DHolt%26aufirst%3DW.%2BF.%26aulast%3DMurphy%26aufirst%3DW.%2BR.%26aulast%3DMangiapane%26aufirst%3DM.%2BL.%26aulast%3DHockel%26aufirst%3DG.%2BM.%26aulast%3DWilliams%26aufirst%3DI.%2BH.%26aulast%3DSmith%26aufirst%3DW.%2BH.%26aulast%3DGumkowski%26aufirst%3DM.%2BJ.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DGardner%26aufirst%3DM.%2BJ.%26aulast%3DNocerini%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520human%2520renin%2520with%2520high%2520oral%2520bioavailability%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1995%26volume%3D362%26spage%3D167%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span> </span><span class="NLM_article-title">Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS1074-5521%2899%2989004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=10074464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=127-131&author=C.+Oefnerauthor=A.+Binggeliauthor=V.+Breuauthor=D.+Burauthor=J.-P.+Clozelauthor=A.+D%E2%80%99Arcyauthor=A.+Dornauthor=W.+Fischliauthor=F.+Gr%C3%BCningerauthor=R.+G%C3%BCllerauthor=G.+Hirthauthor=H.+P.+M%C3%A4rkiauthor=S.+Mathewsauthor=M.+M%C3%BCllerauthor=R.+G.+Ridleyauthor=H.+Stadlerauthor=E.+Vieiraauthor=M.+Wilhelmauthor=F.+K.+Winklerauthor=W.+Wostl&title=Renin+inhibition+by+substituted+piperidines%3A+a+novel+paradigm+for+the+inhibition+of+monomeric+aspartic+proteinases%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?</span></div><div class="casAuthors">Oefner, C.; Binggeli, A.; Breu, V.; Bur, D.; Clozel, J.-P.; D'Arcy, A.; Dorn, A.; Fischli, W.; Gruninger, F.; Guller, R.; Hirth, G.; Marki, H. P.; Mathews, S.; Muller, M.; Ridley, R. G.; Stadler, H.; Vieira, E.; Wilhelm, M.; Winkler, F. K.; Wostl, W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">127-131</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">The aspartic proteinase renin catalyzes the first and rate-limiting step in the conversion of angiotensinogen to the hormone angiotensin II, and therefore plays an important physiol. role in the regulation of blood pressure.  Numerous potent peptidomimetic inhibitors of this important drug target have been developed, but none of these compds. have progressed past clin. phase II trials.  Limited oral bioavailability or excessive prodn. costs have prevented these inhibitors from becoming new antihypertensive drugs.  We were interested in developing new nonpeptidomimetic renin inhibitors.  High-throughput screening of the Roche compd. library identified a simple 3,4-disubstituted piperidine lead compd.  We detd. the crystal structures of recombinant human renin complexed with two representatives of this new class.  Binding of these substituted piperidine derivs. is accompanied by major induced-fit adaptations around the enzyme's active site.  The efficient optimization of the piperidine inhibitors was facilitated by structural anal. of the renin active site in two renin-inhibitor complexes (some of the piperidine derivs. have picomolar affinities for renin).  These structural changes provide the basis for a novel paradigm for inhibition of monomeric aspartic proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIEMz9YB6oLVg90H21EOLACvtfcHk0lj4QNV1wJrYug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D&md5=071dd0984f8880eb09ee26c878d47e61</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2989004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252989004-8%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DClozel%26aufirst%3DJ.-P.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DMathews%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DRidley%26aufirst%3DR.%2BG.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DWostl%26aufirst%3DW.%26atitle%3DRenin%2520inhibition%2520by%2520substituted%2520piperidines%253A%2520a%2520novel%2520paradigm%2520for%2520the%2520inhibition%2520of%2520monomeric%2520aspartic%2520proteinases%253F%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span> </span><span class="NLM_article-title">Substituted piperidines: highly potent renin inhibitors due to induced fit adaptation of the active site</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1397-1402&author=E.+Vieiraauthor=A.+Binggeliauthor=V.+Breuauthor=D.+Burauthor=W.+Fischliauthor=R.+G%C3%BCllerauthor=G.+Hirthauthor=H.+P.+M%C3%A4rkiauthor=M.+M%C3%BCllerauthor=C.+Oefnerauthor=M.+Scaloneauthor=H.+Stadlerauthor=M.+Wilhelmauthor=W.+Wostl&title=Substituted+piperidines%3A+highly+potent+renin+inhibitors+due+to+induced+fit+adaptation+of+the+active+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26atitle%3DSubstituted%2520piperidines%253A%2520highly%2520potent%2520renin%2520inhibitors%2520due%2520to%2520induced%2520fit%2520adaptation%2520of%2520the%2520active%2520site%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1397%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span> </span><span class="NLM_article-title">Piperidine−renin inhibitors compounds with improved physicochemical properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1403-1408&author=R.+G%C3%BCllerauthor=A.+Binggeliauthor=V.+Breuauthor=D.+Burauthor=W.+Fischliauthor=G.+Hirthauthor=C.+Jennyauthor=M.+Kansyauthor=F.+Montavonauthor=M.+M%C3%BCllerauthor=C.+Oefnerauthor=H.+Stadlerauthor=E.+Vieiraauthor=M.+Wilhelmauthor=W.+Wostlauthor=H.+P.+M%C3%A4rki&title=Piperidine%E2%88%92renin+inhibitors+compounds+with+improved+physicochemical+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DJenny%26aufirst%3DC.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMontavon%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26atitle%3DPiperidine%25E2%2588%2592renin%2520inhibitors%2520compounds%2520with%2520improved%2520physicochemical%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1403%26epage%3D1408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohner-Lang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebeli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foricher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanwald-Ducray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdenaire, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand-Chou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, R.</span><span> </span><span class="NLM_article-title">Piperidine renin inhibitors: from leads to drug candidates</span> <span class="citation_source-journal">Il Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=21-27&author=H.+P.+M%C3%A4rkiauthor=A.+Binggeliauthor=B.+Bittnerauthor=V.+Bohner-Langauthor=V.+Breuauthor=D.+Burauthor=P.+Coassoloauthor=J.+P.+Clozelauthor=A.+D%E2%80%99Arcyauthor=H.+Doebeliauthor=W.+Fischliauthor=C.+Funkauthor=J.+Foricherauthor=T.+Gillerauthor=F.+Gr%C3%BCningerauthor=A.+Guenziauthor=R.+G%C3%BCllerauthor=T.+Hartungauthor=G.+Hirthauthor=C.+Jennyauthor=M.+Kansyauthor=U.+Klinkhammerauthor=T.+Laveauthor=B.+Lohriauthor=F.+C.+Luftauthor=E.+M.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=M.+M%C3%BCllerauthor=F.+Montavonauthor=C.+Oefnerauthor=C.+Qiuauthor=A.+Reichelauthor=P.+Sanwald-Ducrayauthor=M.+Scaloneauthor=M.+Schleimerauthor=R.+Schmidauthor=H.+Stadlerauthor=A.+Treiberauthor=O.+Valdenaireauthor=E.+Vieiraauthor=P.+Waldmeierauthor=R.+Wiegand-Chouauthor=M.+Wilhelmauthor=W.+Wostlauthor=M.+Zellauthor=R.+Zell&title=Piperidine+renin+inhibitors%3A+from+leads+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DB.%26aulast%3DBohner-Lang%26aufirst%3DV.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DCoassolo%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDoebeli%26aufirst%3DH.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DForicher%26aufirst%3DJ.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DGuenzi%26aufirst%3DA.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DJenny%26aufirst%3DC.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKlinkhammer%26aufirst%3DU.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DLohri%26aufirst%3DB.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DMontavon%26aufirst%3DF.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DReichel%26aufirst%3DA.%26aulast%3DSanwald-Ducray%26aufirst%3DP.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DSchleimer%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DR.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DValdenaire%26aufirst%3DO.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWaldmeier%26aufirst%3DP.%26aulast%3DWiegand-Chou%26aufirst%3DR.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DZell%26aufirst%3DR.%26atitle%3DPiperidine%2520renin%2520inhibitors%253A%2520from%2520leads%2520to%2520drug%2520candidates%26jtitle%3DIl%2520Farmaco%26date%3D2001%26volume%3D56%26spage%3D21%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bittner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenroth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavé, T.</span><span> </span><span class="NLM_article-title">Preformulation approaches to improve the oral bioavailability of two novel piperidine renin inhibitors in dog</span> <span class="citation_source-journal">Arzneim.-Forsch./Drug Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36e&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12236046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36e&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVentLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2002&pages=593-599&author=B.+Bittnerauthor=R.+Chouauthor=M.+Schleimerauthor=B.+Morgenrothauthor=M.+Zellauthor=T.+Lav%C3%A9&title=Preformulation+approaches+to+improve+the+oral+bioavailability+of+two+novel+piperidine+renin+inhibitors+in+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36eR"><div class="casContent"><span class="casTitleNuber">36e</span><div class="casTitle"><span class="NLM_cas:atitle">Preformulation approaches to improve the oral bioavailability of two novel piperidine renin inhibitors in dog</span></div><div class="casAuthors">Bittner, Beate; Chou, Ruby; Schleimer, Michael; Morgenroth, Brita; Zell, Manfred; Lave, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">593-599</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">Different exptl. formulations based on aq. and oily systems, water miscible solvents, and solid dispersions were investigated for their potential to increase the oral bioavailability (F) of 2 novel piperidine renin inhibitors (R)-1-methoxy-3-[(3S,4R,5R)-4-[4-[3-(2-methoxybenzyloxy)propoxy]phenyl]-5-(4-methoxy-naphthalen-2-ylmethoxy)-piperidin-3-yloxy]propan-2-ol (Ro-X1) and (R)-3-[(3S,4R,5R)-4-[4-[3-(2-methoxybenzyloxy)propoxyphenyl]-5-(4-methoxynaphthalen-2-ylmethoxy)piperidin-3-ylmethoxy]propane-1,2-diol] (Ro-X2) in dogs compared to their administration as acidic aq. soln.  The compds. were characterized by a low soly. at pH 7 (Ro-X1: 3 μg/mL, Ro-X2: 24 μg/mL) and a high lipophilicity (Ro-X1: LogP 5.7, Ro-X2: LogP = 3.7).  For Ro-X1 oil-based vehicles resulted in an improvement in the oral bioavailability compared to the aq. soln. (F = 6 %) with the best result being achieved with a soln. in Capmul (F = 14.6%).  By contrast, for Ro-X2 the highest bioavailability (F = 27.1%) was achieved using an aq. soln.  Computer simulations based on the physicochem. parameters of the compds. only predicted that the fraction of compd. absorbed in man should be almost quant. for Ro-X2 and only about 28% for Ro-Xl.  Other factors such as extensive gut and/or hepatic metab. as well as exclusion by intestinal transporters such as p-glycoprotein, rather than incomplete solubilization in the gut, are the major reasons for the limited oral bioavailability of both compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYXcXITiH2xbVg90H21EOLACvtfcHk0lhiD5d6z254sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVentLg%253D&md5=ca2ed32b43a1a7ba109b9b0998836389</span></div><a href="/servlet/linkout?suffix=cit36e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBittner%26aufirst%3DB.%26aulast%3DChou%26aufirst%3DR.%26aulast%3DSchleimer%26aufirst%3DM.%26aulast%3DMorgenroth%26aufirst%3DB.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DLav%25C3%25A9%26aufirst%3DT.%26atitle%3DPreformulation%2520approaches%2520to%2520improve%2520the%2520oral%2520bioavailability%2520of%2520two%2520novel%2520piperidine%2520renin%2520inhibitors%2520in%2520dog%26jtitle%3DArzneim.-Forsch.%252FDrug%2520Res.%26date%3D2002%26volume%3D52%26spage%3D593%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Keserü, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C3%BCauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belliotti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3575</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3575-3580&author=D.+D.+Holsworthauthor=M.+Jalaieauthor=T.+Belliottiauthor=C.+Caiauthor=W.+Collardauthor=S.+Ferreiraauthor=N.+A.+Powellauthor=M.+Stierauthor=E.+Zhangauthor=P.+McConnellauthor=I.+Mochalkinauthor=M.+J.+Ryanauthor=J.+Bryantauthor=T.+Liauthor=A.+Kasaniauthor=R.+Subediauthor=S.+N.+Maitiauthor=J.+J.+Edmunds&title=Discovery+of+6-ethyl-2%2C4-diaminopyrimidine-based+small+molecule+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DBelliotti%26aufirst%3DT.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DCollard%26aufirst%3DW.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DKasani%26aufirst%3DA.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DMaiti%26aufirst%3DS.%2BN.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%25206-ethyl-2%252C4-diaminopyrimidine-based%2520small%2520molecule%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3575%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciske, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Huis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastronardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5912-5949&author=N.+A.+Powellauthor=F.+L.+Ciskeauthor=C.+Caiauthor=D.+D.+Holsworthauthor=K.+Mennenauthor=C.+A.+Van+Huisauthor=M.+Jalaieauthor=J.+Dayauthor=M.+Mastronardiauthor=P.+McConnellauthor=I.+Mochalkinauthor=E.+Zhangauthor=M.+J.+Ryanauthor=J.+Bryantauthor=W.+Collardauthor=S.+Ferreiraauthor=C.+Guauthor=R.+Collinsauthor=J.+J.+Edmunds&title=Rational+design+of+6-%282%2C4-diaminopyrimidinyl%29-1%2C4-benzoxazin-3-ones+as+small+molecule+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DCiske%26aufirst%3DF.%2BL.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DMennen%26aufirst%3DK.%26aulast%3DVan%2BHuis%26aufirst%3DC.%2BA.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DJ.%26aulast%3DMastronardi%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DCollard%26aufirst%3DW.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DRational%2520design%2520of%25206-%25282%252C4-diaminopyrimidinyl%2529-1%252C4-benzoxazin-3-ones%2520as%2520small%2520molecule%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5912%26epage%3D5949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sarver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peevers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciske, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagadorn, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastronardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Huis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span> </span><span class="NLM_article-title">Binding thermodynamics of substituted diaminopyrimidine renin inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2007&pages=30-40&author=R.+W.+Sarverauthor=J.+Peeversauthor=W.+L.+Codyauthor=F.+L.+Ciskeauthor=J.+Dyerauthor=S.+D.+Emersonauthor=J.+C.+Hagadornauthor=D.+D.+Holsworthauthor=M.+Jalaieauthor=M.+Kaufmanauthor=M.+Mastronardiauthor=P.+McConnellauthor=N.+A.+Powellauthor=J.+Quinauthor=C.+A.+Van+Huisauthor=E.+Zhangauthor=I.+Mochalkin&title=Binding+thermodynamics+of+substituted+diaminopyrimidine+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarver%26aufirst%3DR.%2BW.%26aulast%3DPeevers%26aufirst%3DJ.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DCiske%26aufirst%3DF.%2BL.%26aulast%3DDyer%26aufirst%3DJ.%26aulast%3DEmerson%26aufirst%3DS.%2BD.%26aulast%3DHagadorn%26aufirst%3DJ.%2BC.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DMastronardi%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DVan%2BHuis%26aufirst%3DC.%2BA.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DMochalkin%26aufirst%3DI.%26atitle%3DBinding%2520thermodynamics%2520of%2520substituted%2520diaminopyrimidine%2520renin%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2007%26volume%3D360%26spage%3D30%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Holsworth, D. D.; Bury, M.; Cody, W. L.; Emerson, D.; Van Huis, C.; Jalaie, M.; Kaufman, M.; McConnell, P.; Powell, N. A.; Sahasrabudhe, P.; Sarver, R. W.; Thanabal, V.; Zhang, E.</span><span> </span><span class="NLM_article-title">NMR Auxillary Binding Screen for Lead Optimization: Design of Novel Renin Inhibitors That Access Both the S2 and S3 Pockets of Renin</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 231st National Meeting of the American Chemical Society: Atlanta, GA, March 26−30,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span><span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>MEDI-086.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+D.+Holsworth&author=M.+Bury&author=W.+L.+Cody&author=D.+Emerson&author=C.+Van+Huis&author=M.+Jalaie&author=M.+Kaufman&author=P.+McConnell&author=N.+A.+Powell&author=P.+Sahasrabudhe&author=R.+W.+Sarver&author=V.+Thanabal&author=E.+Zhang&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DNMR%2520Auxillary%2520Binding%2520Screen%2520for%2520Lead%2520Optimization%253A%2520Design%2520of%2520Novel%2520Renin%2520Inhibitors%2520That%2520Access%2520Both%2520the%2520S2%2520and%2520S3%2520Pockets%2520of%2520Renin%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2006%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacatian, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishchenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panemangalore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Design and optimization of renin inhibitors: orally bioavailable alkyl amines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3541</span><span class="NLM_x">–</span> <span class="NLM_lpage">3545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3541-3545&author=C.+M.+Ticeauthor=Z.+Xuauthor=J.+Yuanauthor=R.+D.+Simpsonauthor=S.+T.+Cacatianauthor=P.+T.+Flahertyauthor=W.+Zhaoauthor=J.+Guoauthor=A.+Ishchenkoauthor=S.+B.+Singhauthor=Z.+Wuauthor=B.+B.+Scottauthor=Y.+Bukhtiyarovauthor=J.+Berbaumauthor=J.+Masonauthor=R.+Panemangaloreauthor=M.+G.+Cappielloauthor=D.+Muellerauthor=R.+K.+Harrisonauthor=G.+M.+McGeehanauthor=L.+W.+Dillardauthor=J.+J.+Baldwinauthor=D.+A.+Claremon&title=Design+and+optimization+of+renin+inhibitors%3A+orally+bioavailable+alkyl+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DCacatian%26aufirst%3DS.%2BT.%26aulast%3DFlaherty%26aufirst%3DP.%2BT.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DBerbaum%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DPanemangalore%26aufirst%3DR.%26aulast%3DCappiello%26aufirst%3DM.%2BG.%26aulast%3DMueller%26aufirst%3DD.%26aulast%3DHarrison%26aufirst%3DR.%2BK.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DDesign%2520and%2520optimization%2520of%2520renin%2520inhibitors%253A%2520orally%2520bioavailable%2520alkyl%2520amines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3541%26epage%3D3545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacatian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishchenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panemangalore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Optimization of orally bioavailable alkyl amine renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=694-699&author=Z.+Xuauthor=S.+Cacatianauthor=J.+Yuanauthor=R.+D.+Simpsonauthor=L.+Jiaauthor=W.+Zhaoauthor=C.+M.+Ticeauthor=P.+T.+Flahertyauthor=J.+Guoauthor=A.+Ishchenkoauthor=S.+B.+Singhauthor=Z.+Wuauthor=B.+M.+McKeeverauthor=B.+B.+Scottauthor=Y.+Bukhtiyarovauthor=J.+Berbaumauthor=J.+Masonauthor=R.+Panemangaloreauthor=M.+G.+Cappielloauthor=R.+Bentleyauthor=C.+P.+Doeauthor=R.+K.+Harrisonauthor=G.+M.+McGeehanauthor=L.+W.+Dillardauthor=J.+J.+Baldwinauthor=D.+A.+Claremon&title=Optimization+of+orally+bioavailable+alkyl+amine+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DCacatian%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DFlaherty%26aufirst%3DP.%2BT.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DBerbaum%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DPanemangalore%26aufirst%3DR.%26aulast%3DCappiello%26aufirst%3DM.%2BG.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHarrison%26aufirst%3DR.%2BK.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DOptimization%2520of%2520orally%2520bioavailable%2520alkyl%2520amine%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D694%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hills, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Progress toward a practical BACE-1 inhibitor</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17659479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFCnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=383-391&author=I.+D.+Hillsauthor=J.+P.+Vacca&title=Progress+toward+a+practical+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward a practical BACE-1 inhibitor</span></div><div class="casAuthors">Hills, Ivory D.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-391</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Over the last six years, numerous research groups in both academia and industry have synthesized inhibitors of β-amyloid cleaving enzyme-1 (BACE-1) in the hope of developing a therapy to halt or even reverse the progression of Alzheimer's disease.  While several compds. have been demonstrated to be potent in vitro inhibitors of BACE-1, only a small subset of these compds. are able to satisfy other practical considerations essential for the development of a preclin. drug candidate.  These considerations include selectivity of the inhibitor toward BACE-1 over other enzymes, cellular activity, and in vivo activity in an animal model.  This review will summarize the recent development of BACE-1 inhibitors with particular focus placed on inhibitors that address some of the requirements necessary for a practical drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ5yiuIeRYybVg90H21EOLACvtfcHk0lhcnU6d0sXRyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFCnsrc%253D&md5=56a59c856df6eee2bb7105b4af699655</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHills%26aufirst%3DI.%2BD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DProgress%2520toward%2520a%2520practical%2520BACE-1%2520inhibitor%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D383%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1002%2Fmed.20132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18651582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=295-338&author=R.+Silvestri&title=Boom+in+the+development+of+non-peptidic+%CE%B2-secretase+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-338</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  β-Amyloid cleaving enzyme-1 (BACE1) has become a significant target for the therapy of Alzheimer's disease.  After the discovery of the first non-peptidomimetic β-secretase inhibitors by Takeda Chems. in 2001, several research teams focused on SAR development of these agents.  The non-peptidic BACE1 inhibitors may potentially overcome the classical problems assocd. with the peptide structure of first generation, such as blood-brain barrier crossing, poor oral bioavailability and susceptibility to P-glycoprotein transport.  In the past 6 years a boom in research of non-peptidic BACE1 inhibitors has disseminated findings over hundreds of publications and patents.  The rapidly growing literature has been reviewed with particular emphasis on literature of pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmzl8ONz3LVg90H21EOLACvtfcHk0lhcnU6d0sXRyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D&md5=1e92f25f055def1c1c56b3650f4cc40a</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1002%2Fmed.20132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20132%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DBoom%2520in%2520the%2520development%2520of%2520non-peptidic%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D295%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28%CE%B2-secretase%29+complexed+with+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528%25CE%25B2-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeiser, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Evolution of tertiary carbinamine BACE-1 inhibitors: Aβ reduction in rhesus CSF upon oral dosing</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=37-40&author=P.+G.+Nantermetauthor=H.+A.+Rajapakseauthor=M.+G.+Stantonauthor=S.+R.+Staufferauthor=J.+C.+Barrowauthor=A.+R.+Gregroauthor=K.+P.+Mooreauthor=M.+A.+Steinbeiserauthor=J.+Swestockauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=G.+B.+McGaugheyauthor=D.+Colussiauthor=M.-T.+Laiauthor=S.+Sankaranarayananauthor=A.+J.+Simonauthor=S.+Munshiauthor=J.+J.+Cookauthor=M.+A.+Holahanauthor=M.+S.+Michenerauthor=J.+P.+Vacca&title=Evolution+of+tertiary+carbinamine+BACE-1+inhibitors%3A+A%CE%B2+reduction+in+rhesus+CSF+upon+oral+dosing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DSteinbeiser%26aufirst%3DM.%2BA.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DEvolution%2520of%2520tertiary%2520carbinamine%2520BACE-1%2520inhibitors%253A%2520A%25CE%25B2%2520reduction%2520in%2520rhesus%2520CSF%2520upon%2520oral%2520dosing%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D37%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Target Family-Directed Masterkeys in Chemogenomics</span>. In  <span class="citation_source-book">Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective</span>; <span class="NLM_contrib-group">Kubinyi, H.; Mueller, G.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">7</span>− <span class="NLM_lpage">41</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=7-41&author=G.+M%C3%BCllerauthor=H.+Kubinyi&author=G.+Mueller&title=Chemogenomics+in+Drug+Discovery%3A+A+Medicinal+Chemistry+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DTarget%2520Family-Directed%2520Masterkeys%2520in%2520Chemogenomics%26btitle%3DChemogenomics%2520in%2520Drug%2520Discovery%253A%2520A%2520Medicinal%2520Chemistry%2520Perspective%26aulast%3DKubinyi%26aufirst%3DH.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D7%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Foundling, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibanda, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norey, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span> </span><span class="NLM_article-title">High resolution X-ray analyses of renin inhibitor−aspartic proteinase complexes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=1987&pages=349-352&author=S.+I.+Foundlingauthor=J.+Cooperauthor=F.+E.+Watsonauthor=A.+Cleasbyauthor=L.+H.+Pearlauthor=B.+L.+Sibandaauthor=A.+Hemmingsauthor=S.+P.+Woodauthor=T.+L.+Blundellauthor=M.+J.+Vallerauthor=C.+G.+Noreyauthor=J.+Kayauthor=J.+Bogerauthor=B.+M.+Dunnauthor=B.+J.+Leckieauthor=D.+M.+Jonesauthor=B.+Atrashauthor=A.+Hallettauthor=M.+Szelke&title=High+resolution+X-ray+analyses+of+renin+inhibitor%E2%88%92aspartic+proteinase+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoundling%26aufirst%3DS.%2BI.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DF.%2BE.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DSibanda%26aufirst%3DB.%2BL.%26aulast%3DHemmings%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DS.%2BP.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DValler%26aufirst%3DM.%2BJ.%26aulast%3DNorey%26aufirst%3DC.%2BG.%26aulast%3DKay%26aufirst%3DJ.%26aulast%3DBoger%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26aulast%3DLeckie%26aufirst%3DB.%2BJ.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DHallett%26aufirst%3DA.%26aulast%3DSzelke%26aufirst%3DM.%26atitle%3DHigh%2520resolution%2520X-ray%2520analyses%2520of%2520renin%2520inhibitor%25E2%2588%2592aspartic%2520proteinase%2520complexes%26jtitle%3DNature%26date%3D1987%26volume%3D327%26spage%3D349%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foundling, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span> </span><span class="NLM_article-title">On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5585</span><span class="NLM_x">–</span> <span class="NLM_lpage">5590</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00392a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1987&pages=5585-5590&author=T.+L.+Blundellauthor=J.+Cooperauthor=S.+I.+Foundlingauthor=D.+M.+Jonesauthor=B.+Atrashauthor=M.+Szelke&title=On+the+rational+design+of+renin+inhibitors%3A+X-ray+studies+of+aspartic+proteinases+complexed+with+transition-state+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbi00392a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00392a001%26sid%3Dliteratum%253Aachs%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DFoundling%26aufirst%3DS.%2BI.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DSzelke%26aufirst%3DM.%26atitle%3DOn%2520the%2520rational%2520design%2520of%2520renin%2520inhibitors%253A%2520X-ray%2520studies%2520of%2520aspartic%2520proteinases%2520complexed%2520with%2520transition-state%2520analogs%26jtitle%3DBiochemistry%26date%3D1987%26volume%3D26%26spage%3D5585%26epage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Brotherton-Pleiss, C. E.; Newman, S. R.; Waterbury, L. D.; Schwartzberg, M. S.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Conformationally Restricted Renin Inhibitors</span>.  <span class="citation_source-book">Peptides: Chemistry and Biology</span>, Proceedings of the 12th American Peptide Symposium, Cambridge, MA, 1991; <span class="NLM_contrib-group">Smith, J. A.; Rivier, J. E.</span>, Eds.; <span class="NLM_publisher-name">Escom Science</span>, <span class="NLM_publisher-loc">Leiden, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">816</span>− <span class="NLM_lpage">817</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=816-817&author=C.+E.+Brotherton-Pleiss&author=S.+R.+Newman&author=L.+D.+Waterbury&author=M.+S.+Schwartzbergauthor=J.+A.+Smith&author=J.+E.+Rivier&title=Peptides%3A+Chemistry+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrotherton-Pleiss%26aufirst%3DC.%2BE.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Conformationally%2520Restricted%2520Renin%2520Inhibitors%26btitle%3DPeptides%253A%2520Chemistry%2520and%2520Biology%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26pub%3DEscom%2520Science%26date%3D1992%26spage%3D816%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Plummer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahripour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltenbronn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E.A .</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbaugh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapundalo, S. T.</span><span> </span><span class="NLM_article-title">Design and synthesis of renin inhibitors: Incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2893-2905&author=M.+S.+Plummerauthor=A.+Shahripourauthor=J.+S.+Kaltenbronnauthor=E.A+.+Lunneyauthor=B.+A.+Steinbaughauthor=J.+M.+Hambyauthor=H.+W.+Hamiltonauthor=T.+K.+Sawyerauthor=C.+Humbletauthor=A.+M.+Dohertyauthor=M.+D.+Taylorauthor=G.+Hingoraniauthor=B.+L.+Batleyauthor=S.+T.+Rapundalo&title=Design+and+synthesis+of+renin+inhibitors%3A+Incorporation+of+transition-state+isostere+side+chains+that+span+from+the+S1+to+the+S3+binding+pockets+and+examination+of+P3-modified+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DShahripour%26aufirst%3DA.%26aulast%3DKaltenbronn%26aufirst%3DJ.%2BS.%26aulast%3DLunney%26aufirst%3DE.A%2B.%26aulast%3DSteinbaugh%26aufirst%3DB.%2BA.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DHamilton%26aufirst%3DH.%2BW.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DHingorani%26aufirst%3DG.%26aulast%3DBatley%26aufirst%3DB.%2BL.%26aulast%3DRapundalo%26aufirst%3DS.%2BT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520renin%2520inhibitors%253A%2520Incorporation%2520of%2520transition-state%2520isostere%2520side%2520chains%2520that%2520span%2520from%2520the%2520S1%2520to%2520the%2520S3%2520binding%2520pockets%2520and%2520examination%2520of%2520P3-modified%2520renin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2893%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Plummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapundalo, S. T.</span><span> </span><span class="NLM_article-title">Peptidomimetic inhibitors of renin incorporating topographically modified isosteres spanning the P1(<b>→</b>P3)-P1 sites</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2119</span><span class="NLM_x">–</span> <span class="NLM_lpage">2124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=2119-2124&author=M.+Plummerauthor=J.+M.+Hambyauthor=G.+Hingoraniauthor=B.+L.+Batleyauthor=S.+T.+Rapundalo&title=Peptidomimetic+inhibitors+of+renin+incorporating+topographically+modified+isosteres+spanning+the+P1%28%E2%86%92P3%29-P1+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DHingorani%26aufirst%3DG.%26aulast%3DBatley%26aufirst%3DB.%2BL.%26aulast%3DRapundalo%26aufirst%3DS.%2BT.%26atitle%3DPeptidomimetic%2520inhibitors%2520of%2520renin%2520incorporating%2520topographically%2520modified%2520isosteres%2520spanning%2520the%2520P1%2528%25E2%2586%2592P3%2529-P1%2520sites%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D2119%26epage%3D2124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hada, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneddon, S. F.</span><span> </span><span class="NLM_article-title">Rational design, synthesis and X-ray structure of renin inhibitors with extended P1 side-chains</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2623</span><span class="NLM_x">–</span> <span class="NLM_lpage">2626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2623-2626&author=B.+A.+Lefkerauthor=W.+A.+Hadaauthor=A.+S.+Wrightauthor=W.+H.+Martinauthor=I.+A.+Stockauthor=G.+K.+Schulteauthor=J.+Panditauthor=D.+E.+Danleyauthor=M.+J.+Ammiratiauthor=S.+F.+Sneddon&title=Rational+design%2C+synthesis+and+X-ray+structure+of+renin+inhibitors+with+extended+P1+side-chains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DStock%26aufirst%3DI.%2BA.%26aulast%3DSchulte%26aufirst%3DG.%2BK.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DAmmirati%26aufirst%3DM.%2BJ.%26aulast%3DSneddon%26aufirst%3DS.%2BF.%26atitle%3DRational%2520design%252C%2520synthesis%2520and%2520X-ray%2520structure%2520of%2520renin%2520inhibitors%2520with%2520extended%2520P1%2520side-chains%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D2623%26epage%3D2626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgiarini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Novel 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4818</span><span class="NLM_x">–</span> <span class="NLM_lpage">4831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070314y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4818-4831&author=R.+G%C3%B6schkeauthor=S.+Stutzauthor=V.+Rasettiauthor=N.+C.+Cohenauthor=J.+Rahuelauthor=P.+Rigollierauthor=H.+P.+Baumauthor=P.+Forgiariniauthor=C.+R.+Schnellauthor=T.+Wagnerauthor=M.+G.+Gr%C3%BCtterauthor=W.+Fuhrerauthor=W.+Schillingauthor=F.+Cuminauthor=J.+M.+Woodauthor=J.+Maibaum&title=Novel+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamide+transition+state+peptidomimetics+are+potent+and+orally+active+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm070314y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070314y%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DForgiarini%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DNovel%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamide%2520transition%2520state%2520peptidomimetics%2520are%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4818%26epage%3D4831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W. D.</span><span> </span><span class="NLM_article-title">Druggability indices for protein targets derived from NMR-based screening data</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2518</span><span class="NLM_x">–</span> <span class="NLM_lpage">2525</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049131r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslajtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2518-2525&author=P.+J.+Hajdukauthor=J.+R.+Huthauthor=S.+W.+D.+Fesik&title=Druggability+indices+for+protein+targets+derived+from+NMR-based+screening+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability Indices for Protein Targets Derived from NMR-Based Screening Data</span></div><div class="casAuthors">Hajduk, Philip J.; Huth, Jeffrey R.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2518-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An anal. of heteronuclear-NMR-based screening data is used to derive relationships between the ability of small mols. to bind to a protein and various parameters that describe the protein binding site.  It is found that a simple model including terms for polar and apolar surface area, surface complexity, and pocket dimensions accurately predicts the exptl. screening hit rates with an R2 of 0.72, an adjusted R2 of 0.65, and a leave-one-out Q2 of 0.56.  Application of the model to predict the druggability of protein targets not used in the training set correctly classified 94% of the proteins for which high-affinity, noncovalent, druglike leads have been reported.  In addn. to understanding the pocket characteristics that contribute to high-affinity binding, the relationships that have been defined allow for quant. comparative analyses of protein binding sites for use in target assessment and validation, virtual ligand screening, and structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0d3V84DZMK7Vg90H21EOLACvtfcHk0ljrCdXif8RJfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslajtr0%253D&md5=134793e571e8ef1858a734c1a15ce343</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm049131r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049131r%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DFesik%26aufirst%3DS.%2BW.%2BD.%26atitle%3DDruggability%2520indices%2520for%2520protein%2520targets%2520derived%2520from%2520NMR-based%2520screening%2520data%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2518%26epage%3D2525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS1074-5521%2800%2900134-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=10903938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=493-504&author=J.+Rahuelauthor=V.+Rasettiauthor=J.+Maibaumauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=N.+C.+Cohenauthor=S.+Stutzauthor=F.+Cuminauthor=W.+Fuhrerauthor=J.+M.+Woodauthor=M.+G.+Gr%C3%BCtter&title=Structure-based+drug+design%3A+the+discovery+of+novel+nonpeptide+orally+active+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span></div><div class="casAuthors">Rahuel, J.; Rasetti, V.; Maibaum, J.; Rueger, H.; Goschke, R.; Cohen, N-C.; Stutz, S.; Cumin, F.; Fuhrer, W.; Wood, J. M.; Grutter, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The aspartic proteinase renin plays an important physiol. role in the regulation of blood pressure.  It catalyzes the first step in the conversion of angiotensinogen to the hormone angiotensin II.  In the past, potent peptide inhibitors of renin have been developed, but none of these compds. has made it to the end of clin. trials.  Our primary aim was to develop novel nonpeptide inhibitors.  Based on the available structural information concerning renin-substrate interactions, we synthesized inhibitors in which the peptide portion was replaced by lipophilic moieties that interact with the large hydrophobic S1/S3-binding pocket in renin.  Results: Crystal structure anal. of renin-inhibitor complexes combined with computational methods were employed in the medicinal-chem. optimization process.  Structure anal. revealed that the newly designed inhibitors bind as predicted to the S1/S3 pocket.  In addn., however, these compds. interact with a hitherto unrecognized large, distinct, sub-pocket of the enzyme that extends from the S3-binding site towards the hydrophobic core of the enzyme.  Binding to the S3sp sub-pocket was essential for high binding affinity.  This unprecedented binding mode guided the drug-design process in which the mostly hydrophobic interactions within subsite S3sp were optimized.  Conclusions: Our design approach led to compds. with high in vitro affinity and specificity for renin, favorable bioavailability and excellent oral efficacy in lowering blood pressure in primates.  These renin inhibitors are therefore potential therapeutic agents for the treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp__RrHxd--o7Vg90H21EOLACvtfcHk0ljrCdXif8RJfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D&md5=69eb034c059696b97faf830727ce924a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900134-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900134-4%26sid%3Dliteratum%253Aachs%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DStructure-based%2520drug%2520design%253A%2520the%2520discovery%2520of%2520novel%2520nonpeptide%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Cooper, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foundling, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champness, J. N.</span><span> </span><span class="NLM_article-title">A rational approach to the design of antihypertensives: X-ray studies of complexes between aspartic proteinases and aminoalcohol renin inhibitors</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1988&pages=308-313&author=J.+B.+Cooperauthor=S.+I.+Foundlingauthor=T.+L.+Blundellauthor=R.+J.+Arrowsmithauthor=C.+J.+Harrisauthor=J.+N.+Champness&title=A+rational+approach+to+the+design+of+antihypertensives%3A+X-ray+studies+of+complexes+between+aspartic+proteinases+and+aminoalcohol+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A rational approach to the design of antihypertensives:  x-ray studies of complexes between aspartic proteinases and aminoalcohol renin inhibitors</span></div><div class="casAuthors">Cooper, J. B.; Foundling, S. I.; Blundell, T. L.; Arrowsmith, R. J.; Harris, C. J.; Champness, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Special Publication - Royal Society of Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">Top. Med. Chem.</span>),
    <span class="NLM_cas:pages">308-13</span>CODEN:
                <span class="NLM_cas:coden">SROCDO</span>;
        ISSN:<span class="NLM_cas:issn">0260-6291</span>.
    </div><div class="casAbstract">X-ray studies of the primary structure of the complex of the diastereoisomers BW 624 and BW 625 (tetrapeptide inhibitors of renin) with endothiapepsin (an aspartic proteinase homologous to renin) are described.  As the co-crystals of the BW 624 complex were isomorphous with the native enzyme, the structure was solved using the difference Fourier method and least squares refinement.  Crystals of the BW 625 complex were not isomorphous, but mol. replacement methods were used to obtain a promising difference map at 2.2 Å.  The interactions between the aminoalc. inhibitor (BW 625) and endothiapepsin are essentially the same as those obsd. with reduced bond and hydroxyethylene inhibitors.  The different conformation of the P3' Phe relative to polar sidechains at this subsite indicates that this is yet another pocket where the substrate is allowed sufficient flexibility to optimize favorable interactions with the enzyme.  Structure-activity relations are discussed for inhibition of renin by peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNjhzDtF0jlbVg90H21EOLACvtfcHk0lg97_UjbrW01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCit7Y%253D&md5=68bbf2f504b53b5ea7eaa335628f97e7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DJ.%2BB.%26aulast%3DFoundling%26aufirst%3DS.%2BI.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DChampness%26aufirst%3DJ.%2BN.%26atitle%3DA%2520rational%2520approach%2520to%2520the%2520design%2520of%2520antihypertensives%253A%2520X-ray%2520studies%2520of%2520complexes%2520between%2520aspartic%2520proteinases%2520and%2520aminoalcohol%2520renin%2520inhibitors%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D1988%26volume%3D65%26spage%3D308%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champness, J. N.</span><span> </span><span class="NLM_article-title">The discovery and design of substrate-based proteinase inhibitors−problems and lessons from the development of renin inhibitors as potential antihypertensive drugs</span> <span class="citation_source-journal">Spec. Publ.−R. Soc. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">Mol. Recognit.: Chem. Biochem. Probl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3cXhtlWktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1989&pages=112-122&issue=Mol.+Recognit.%3A+Chem.+Biochem.+Probl.&author=R.+J.+Arrowsmithauthor=C.+J.+Harrisauthor=D.+E.+Daviesauthor=J.+A.+Mortonauthor=J.+G.+Dannauthor=J.+N.+Champness&title=The+discovery+and+design+of+substrate-based+proteinase+inhibitors%E2%88%92problems+and+lessons+from+the+development+of+renin+inhibitors+as+potential+antihypertensive+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and design of substrate-based proteinase inhibitors - problems and lessons from the development of renin inhibitors as potential antihypertensive drugs</span></div><div class="casAuthors">Arrowsmith, R. J.; Harris, C. J.; Davies, D. E.; Morton, J. A.; Dann, J. G.; Champness, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Special Publication - Royal Society of Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Mol. Recognit.:  Chem. Biochem. Probl.</span>),
    <span class="NLM_cas:pages">112-22</span>CODEN:
                <span class="NLM_cas:coden">SROCDO</span>;
        ISSN:<span class="NLM_cas:issn">0260-6291</span>.
    </div><div class="casAbstract">A review with 12 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGEGBdwLrHTLVg90H21EOLACvtfcHk0lg97_UjbrW01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtlWktr0%253D&md5=b408676430ea002d941b5b99a8d03e80</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DMorton%26aufirst%3DJ.%2BA.%26aulast%3DDann%26aufirst%3DJ.%2BG.%26aulast%3DChampness%26aufirst%3DJ.%2BN.%26atitle%3DThe%2520discovery%2520and%2520design%2520of%2520substrate-based%2520proteinase%2520inhibitors%25E2%2588%2592problems%2520and%2520lessons%2520from%2520the%2520development%2520of%2520renin%2520inhibitors%2520as%2520potential%2520antihypertensive%2520drugs%26jtitle%3DSpec.%2520Publ.%25E2%2588%2592R.%2520Soc.%2520Chem.%26date%3D1989%26volume%3D78%26issue%3DMol.%2520Recognit.%253A%2520Chem.%2520Biochem.%2520Probl%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaMont, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaine, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanelli, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stabilito, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. V.</span><span> </span><span class="NLM_article-title">A uniquely potent renin inhibitor and its unanticipated plasma binding component</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00150a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1755-1756&author=B.+E.+Evansauthor=K.+E.+Rittleauthor=M.+G.+Bockauthor=C.+D.+Bennettauthor=R.+M.+DiPardoauthor=J.+Bogerauthor=M.+Poeauthor=E.+H.+Ulmauthor=B.+I.+LaMontauthor=E.+H.+Blaineauthor=G.+M.+Fanelliauthor=I.+I.+Stabilitoauthor=D.+V.+Veber&title=A+uniquely+potent+renin+inhibitor+and+its+unanticipated+plasma+binding+component"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm00150a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00150a001%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DBennett%26aufirst%3DC.%2BD.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DBoger%26aufirst%3DJ.%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DLaMont%26aufirst%3DB.%2BI.%26aulast%3DBlaine%26aufirst%3DE.%2BH.%26aulast%3DFanelli%26aufirst%3DG.%2BM.%26aulast%3DStabilito%26aufirst%3DI.%2BI.%26aulast%3DVeber%26aufirst%3DD.%2BV.%26atitle%3DA%2520uniquely%2520potent%2520renin%2520inhibitor%2520and%2520its%2520unanticipated%2520plasma%2520binding%2520component%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1755%26epage%3D1756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bezencon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3702</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900022f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3689-3702&author=O.+Bezenconauthor=D.+Burauthor=T.+Wellerauthor=S.+Richard-Bildsteinauthor=L.+Reme%C5%88author=T.+Sifferlenauthor=O.+Corminboeufauthor=C.+Grisostomiauthor=C.+Bossauthor=L.+Pradeauthor=S.+Delahyeauthor=A.+Treiberauthor=P.+Stricknerauthor=C.+Binkertauthor=P.+Hessauthor=B.+Steinerauthor=W.+Fischli&title=Design+and+preparation+of+potent%2C+nonpeptidic%2C+bioavailable+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1021%2Fjm900022f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900022f%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DDelahye%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520potent%252C%2520nonpeptidic%252C%2520bioavailable%2520renin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3689%26epage%3D3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bezencon, O.; Bur, D.; Weller, T.; Richard-Bildstein, S.; Remen, L.; Sifferlen, T.; Corminboeuf, O.; Grisostomi, C.; Prade, L.; Delahaye, S.; Treiber, A.; Strickner, P.; Hess, P.; Steiner, B.; Fischli, W.</span><span> </span><span class="NLM_article-title">Potent, Non-Peptidic, Bioavailable Renin Inhibitors</span>. Presented at the 20th International Symposium on Medicinal Chemistry, EFMC-ISMC 2008, Vienna, Austria, Aug 31−Sep 4,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Poster P012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=O.+Bezencon&author=D.+Bur&author=T.+Weller&author=S.+Richard-Bildstein&author=L.+Remen&author=T.+Sifferlen&author=O.+Corminboeuf&author=C.+Grisostomi&author=L.+Prade&author=S.+Delahaye&author=A.+Treiber&author=P.+Strickner&author=P.+Hess&author=B.+Steiner&author=W.+Fischli&title=Potent%2C+Non-Peptidic%2C+Bioavailable+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26atitle%3DPotent%252C%2520Non-Peptidic%252C%2520Bioavailable%2520Renin%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezencon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">New classes of potent and bioavailable human renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6762</span><span class="NLM_x">–</span> <span class="NLM_lpage">6765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6762-6765&author=L.+Reme%C5%88author=O.+Bezenconauthor=S.+Richard-Bildsteinauthor=D.+Burauthor=L.+Pradeauthor=O.+Corminboeufauthor=C.+Bossauthor=C.+Grisostomiauthor=T.+Sifferlenauthor=P.+Stricknerauthor=P.+Hessauthor=S.+Delahyeauthor=A.+Treiberauthor=T.+Wellerauthor=C.+Binkertauthor=B.+Steinerauthor=W.+Fischli&title=New+classes+of+potent+and+bioavailable+human+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DBezencon%26aufirst%3DO.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DDelahye%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DNew%2520classes%2520of%2520potent%2520and%2520bioavailable%2520human%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6762%26epage%3D6765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">The P1 <i>N</i>-isopropyl motif bearing hydroxyethylene dipeptide isostere analogs of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4863</span><span class="NLM_x">–</span> <span class="NLM_lpage">4867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4863-4867&author=Y.+Yamaguchiauthor=K.+Menearauthor=N.-C.+Cohenauthor=R.+Mahauthor=F.+Cuminauthor=C.+Schnellauthor=J.+M.+Woodauthor=J.+Maibaum&title=The+P1+N-isopropyl+motif+bearing+hydroxyethylene+dipeptide+isostere+analogs+of+aliskiren+are+in+vitro+potent+inhibitors+of+the+human+aspartyl+protease+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DThe%2520P1%2520N-isopropyl%2520motif%2520bearing%2520hydroxyethylene%2520dipeptide%2520isostere%2520analogs%2520of%2520aliskiren%2520are%2520in%2520vitro%2520potent%2520inhibitors%2520of%2520the%2520human%2520aspartyl%2520protease%2520renin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4863%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Levens, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, R. M.</span><span> </span><span class="NLM_article-title">Role of the intrarenal renin−angiotensin system in the control of renal function</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1981&pages=157-167&author=N.+R.+Levensauthor=M.+J.+Peachauthor=R.+M.+Carey&title=Role+of+the+intrarenal+renin%E2%88%92angiotensin+system+in+the+control+of+renal+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevens%26aufirst%3DN.%2BR.%26aulast%3DPeach%26aufirst%3DM.%2BJ.%26aulast%3DCarey%26aufirst%3DR.%2BM.%26atitle%3DRole%2520of%2520the%2520intrarenal%2520renin%25E2%2588%2592angiotensin%2520system%2520in%2520the%2520control%2520of%2520renal%2520function%26jtitle%3DCirc.%2520Res.%26date%3D1981%26volume%3D48%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=59-68&author=W.+L.+Codyauthor=D.+D.+Holsworthauthor=N.+A.+Powellauthor=M.+Jalaieauthor=E.+Zhangauthor=W.+Wangauthor=B.+Samasauthor=J.+Bryantauthor=R.+Ostroskiauthor=M.+J.+Ryanauthor=J.+J.+Edmunds&title=The+discovery+and+preparation+of+disubstituted+novel+amino-aryl-piperidine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DOstroski%26aufirst%3DR.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520discovery%2520and%2520preparation%2520of%2520disubstituted%2520novel%2520amino-aryl-piperidine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D59%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2371</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2371-2374&author=N.+A.+Powellauthor=E.+H.+Clayauthor=D.+D.+Holsworthauthor=J.+W.+Bryantauthor=M.+J.+Ryanauthor=M.+Jalaieauthor=E.+Zhangauthor=J.+J.+Edmunds&title=Equipotent+activity+in+both+enantiomers+of+a+series+of+ketopiperazine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DClay%26aufirst%3DE.%2BH.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DBryant%26aufirst%3DJ.%2BW.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DEquipotent%2520activity%2520in%2520both%2520enantiomers%2520of%2520a%2520series%2520of%2520ketopiperazine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2371%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downing, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Discovery of novel non-peptidic ketopiperazine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2657-2664&author=D.+D.+Holsworthauthor=N.+A.+Powellauthor=D.+M.+Downingauthor=C.+Caiauthor=W.+L.+Codyauthor=J.+M.+Ryanauthor=R.+Ostroskiauthor=M.+Jalaieauthor=J.+W.+Bryantauthor=J.+J.+Edmunds&title=Discovery+of+novel+non-peptidic+ketopiperazine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DDowning%26aufirst%3DD.%2BM.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DRyan%26aufirst%3DJ.%2BM.%26aulast%3DOstroski%26aufirst%3DR.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DJ.%2BW.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520non-peptidic%2520ketopiperazine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2657%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Benzyl ether structure−activity relationships in a series of ketopiperazine-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4713</span><span class="NLM_x">–</span> <span class="NLM_lpage">4716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4713-4716&author=N.+A.+Powellauthor=E.+H.+Clayauthor=D.+D.+Holsworthauthor=J.+W.+Bryantauthor=M.+J.+Ryanauthor=M.+Jalaieauthor=J.+J.+Edmunds&title=Benzyl+ether+structure%E2%88%92activity+relationships+in+a+series+of+ketopiperazine-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DClay%26aufirst%3DE.%2BH.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DBryant%26aufirst%3DJ.%2BW.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DBenzyl%2520ether%2520structure%25E2%2588%2592activity%2520relationships%2520in%2520a%2520series%2520of%2520ketopiperazine-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4713%26epage%3D4716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downing, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erasga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, S.</span><span> </span><span class="NLM_article-title">Ketopiperazine-based renin inhibitors: optimization of the “C” ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2500</span><span class="NLM_x">–</span> <span class="NLM_lpage">2504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2500-2504&author=D.+D.+Holsworthauthor=C.+Caiauthor=X.-M.+Chengauthor=W.+L.+Codyauthor=D.+M.+Downingauthor=N.+Erasgaauthor=C.+Leeauthor=N.+A.+Powellauthor=J.+J.+Edmundsauthor=M.+Stierauthor=M.+Jalaieauthor=E.+Zhangauthor=P.+McConnellauthor=M.+J.+Ryanauthor=J.+Bryantauthor=T.+Liauthor=A.+Kasaniauthor=E.+Hallauthor=R.+Subediauthor=M.+Rahimauthor=S.+Maiti&title=Ketopiperazine-based+renin+inhibitors%3A+optimization+of+the+%E2%80%9CC%E2%80%9D+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DX.-M.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DDowning%26aufirst%3DD.%2BM.%26aulast%3DErasga%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DKasani%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DE.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DRahim%26aufirst%3DM.%26aulast%3DMaiti%26aufirst%3DS.%26atitle%3DKetopiperazine-based%2520renin%2520inhibitors%253A%2520optimization%2520of%2520the%2520%25E2%2580%259CC%25E2%2580%259D%2520ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2500%26epage%3D2504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cai, C.; Bryant, J.; Cheng, X. M.; Cody, W. L.; Collard, W.; Downing, D. M.; Erasga, N.; Ferreira, S.; Hall, E.; Holsworth, D. D.; Jalaie, M.; Kasani, A.; Lee, C.; Li, T.; Maiti, S.; McConnell, P.; Powell, N. A.; Rahim, M.; Ryan, M.; Stier, M. A.; Subedi, R.; Zhang, E.; Edmunds, J. J.</span><span> </span><span class="NLM_article-title">Ketopiperazine-Based Renin Inhibitors: Incorporation of Indole Rings</span>. Presented at the 231st National Meeting of the American Chemical Society, Atlanta, GA, March 26−30,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>MEDI-091. PDB code <span class="NLM_ext-link">2g27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+Cai&author=J.+Bryant&author=X.+M.+Cheng&author=W.+L.+Cody&author=W.+Collard&author=D.+M.+Downing&author=N.+Erasga&author=S.+Ferreira&author=E.+Hall&author=D.+D.+Holsworth&author=M.+Jalaie&author=A.+Kasani&author=C.+Lee&author=T.+Li&author=S.+Maiti&author=P.+McConnell&author=N.+A.+Powell&author=M.+Rahim&author=M.+Ryan&author=M.+A.+Stier&author=R.+Subedi&author=E.+Zhang&author=J.+J.+Edmunds&title=Ketopiperazine-Based+Renin+Inhibitors%3A+Incorporation+of+Indole+Rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DC.%26atitle%3DKetopiperazine-Based%2520Renin%2520Inhibitors%253A%2520Incorporation%2520of%2520Indole%2520Rings%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Gu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voorman, R. L.</span><span> </span><span class="NLM_article-title">Metabolic aromatization of <i>N</i>-alkyl-1,2,3,4-tetrahydroquinoline substructures to quinolinium by human liver microsomes and horseradish peroxidase</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2044</span><span class="NLM_x">–</span> <span class="NLM_lpage">2055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=2044-2055&author=C.+Guauthor=R.+Collinsauthor=D.+D.+Holsworthauthor=G.+S.+Walkerauthor=R.+L.+Voorman&title=Metabolic+aromatization+of+N-alkyl-1%2C2%2C3%2C4-tetrahydroquinoline+substructures+to+quinolinium+by+human+liver+microsomes+and+horseradish+peroxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DVoorman%26aufirst%3DR.%2BL.%26atitle%3DMetabolic%2520aromatization%2520of%2520N-alkyl-1%252C2%252C3%252C4-tetrahydroquinoline%2520substructures%2520to%2520quinolinium%2520by%2520human%2520liver%2520microsomes%2520and%2520horseradish%2520peroxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D2044%26epage%3D2055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ehara, T.; Grosche, P.; Irie, O.; Iwaki, Y.; Kanazawa, T.; Kawakami, S.; Konishi, K.; Mogi, M.; Suzuki, M.; Yokokawa, F.</span><span> </span><span class="NLM_article-title">Preparation of 3,5-Substituted Piperidine Compounds as Renin Inhibitors</span>. PCT Int. Appl. WO 2007/077005A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Ehara&author=P.+Grosche&author=O.+Irie&author=Y.+Iwaki&author=T.+Kanazawa&author=S.+Kawakami&author=K.+Konishi&author=M.+Mogi&author=M.+Suzuki&author=F.+Yokokawa&title=Preparation+of+3%2C5-Substituted+Piperidine+Compounds+as+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEhara%26aufirst%3DT.%26atitle%3DPreparation%2520of%25203%252C5-Substituted%2520Piperidine%2520Compounds%2520as%2520Renin%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Herold, P.; Mah, R.; Tschinke, V.; Stutz, S.; Stojanovic, A.; Marti, C.; Behnke, D.; Jelakovic, S.</span><span> </span><span class="NLM_article-title">Preparation of 5-Amino-4-hydroxy-7-[imidazo[1,2-<i>a</i>]pyridin-6-ylmethyl]-8-methylnonanamides and Related Compounds as Renin Inhibitors for Treatment of Hypertension</span>. PCT Int. Appl. WO2007/031558A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+Herold&author=R.+Mah&author=V.+Tschinke&author=S.+Stutz&author=A.+Stojanovic&author=C.+Marti&author=D.+Behnke&author=S.+Jelakovic&title=Preparation+of+5-Amino-4-hydroxy-7-%5Bimidazo%5B1%2C2-a%5Dpyridin-6-ylmethyl%5D-8-methylnonanamides+and+Related+Compounds+as+Renin+Inhibitors+for+Treatment+of+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHerold%26aufirst%3DP.%26atitle%3DPreparation%2520of%25205-Amino-4-hydroxy-7-%255Bimidazo%255B1%252C2-a%255Dpyridin-6-ylmethyl%255D-8-methylnonanamides%2520and%2520Related%2520Compounds%2520as%2520Renin%2520Inhibitors%2520for%2520Treatment%2520of%2520Hypertension%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span> </span><span class="NLM_article-title">Renin inhibitor SC-51106 complexed with human renin: discovery of a new binding site adjacent to P3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=909-918&author=G.+J.+Hansonauthor=M.+Clareauthor=N.+L.+Summersauthor=L.+W.+Limauthor=D.+J.+Neidhartauthor=H.+S.+Shiehauthor=A.+M.+Stevens&title=Renin+inhibitor+SC-51106+complexed+with+human+renin%3A+discovery+of+a+new+binding+site+adjacent+to+P3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DSummers%26aufirst%3DN.%2BL.%26aulast%3DLim%26aufirst%3DL.%2BW.%26aulast%3DNeidhart%26aufirst%3DD.%2BJ.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26atitle%3DRenin%2520inhibitor%2520SC-51106%2520complexed%2520with%2520human%2520renin%253A%2520discovery%2520of%2520a%2520new%2520binding%2520site%2520adjacent%2520to%2520P3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1994%26volume%3D2%26spage%3D909%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, G.</span><span> </span><span class="NLM_article-title">High resolution crystal structures of recombinant human renin in complex with polyhydroxymonoamide inhibitors</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1995&pages=211-222&author=L.+Tongauthor=S.+Pavauthor=D.+Lamarreauthor=L.+Piloteauthor=S.+LaPlanteauthor=P.+C.+Andersonauthor=G.+Jung&title=High+resolution+crystal+structures+of+recombinant+human+renin+in+complex+with+polyhydroxymonoamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DPilote%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DJung%26aufirst%3DG.%26atitle%3DHigh%2520resolution%2520crystal%2520structures%2520of%2520recombinant%2520human%2520renin%2520in%2520complex%2520with%2520polyhydroxymonoamide%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D250%26spage%3D211%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Lefker, B.</span><span> </span><span class="NLM_article-title">Structure Based Drug Design. Rational Design of Non-Peptide Enzyme Inhibitors</span>. Presented at the 1st Winter Conference on Medicinal and Bioorganic Chemistry, Steamboat Springs, CO, January 29−February 2,<span class="NLM_x"> </span><span class="NLM_year">1995</span>. <div class="note"><p class="first last">The author (J.M.) is grateful to Dr. Hans-Peter Märki (Hoffman-La Roche, Basel, Switzerland) for bringing this paper to his attention and to Dr. Bruce Lefker (Pfizer, Groton, CT) for providing a copy of the 1995 presentation. The X-ray structure of <b>27</b> in complex with renin has not been published to date.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=B.+Lefker&title=Structure+Based+Drug+Design.+Rational+Design+of+Non-Peptide+Enzyme+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLefker%26aufirst%3DB.%26atitle%3DStructure%2520Based%2520Drug%2520Design.%2520Rational%2520Design%2520of%2520Non-Peptide%2520Enzyme%2520Inhibitors%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="note"><p class="first last">For the first report on the presence of the S<sub>3</sub> subpocket (S<sub>3</sub><sup>sp</sup>) in BACE-1: </p></div><div class="NLM_citation" id="rightTab-cit64a"><span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen-Dodson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadikonda, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6117</span><span class="NLM_x">–</span> <span class="NLM_lpage">6119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6117-6119&author=C.+A.+Coburnauthor=S.+J.+Stachelauthor=Y.-M.+Liauthor=D.+M.+Rushauthor=T.+G.+Steeleauthor=E.+Chen-Dodsonauthor=M.+K.+Hollowayauthor=M.+Xuauthor=Q.+Huangauthor=M.-T.+Laiauthor=J.+DiMuzioauthor=M.-C.+Crouthamelauthor=X.-P.+Shiauthor=V.+Sardanaauthor=Z.+Chenauthor=S.+Munshiauthor=L.+Kuoauthor=G.+M.+Makaraauthor=D.+A.+Annisauthor=P.+K.+Tadikondaauthor=H.+M.+Nashauthor=J.+P.+Vacca&title=Identification+of+a+small+molecule+nonpeptide+active+site+%CE%B2-secretase+inhibitor+that+displays+a+nontraditional+binding+mode+for+aspartyl+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64a&amp;dbid=16384&amp;doi=10.1021%2Fjm049388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049388p%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DRush%26aufirst%3DD.%2BM.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DChen-Dodson%26aufirst%3DE.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DShi%26aufirst%3DX.-P.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DTadikonda%26aufirst%3DP.%2BK.%26aulast%3DNash%26aufirst%3DH.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DIdentification%2520of%2520a%2520small%2520molecule%2520nonpeptide%2520active%2520site%2520%25CE%25B2-secretase%2520inhibitor%2520that%2520displays%2520a%2520nontraditional%2520binding%2520mode%2520for%2520aspartyl%2520proteases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6117%26epage%3D6119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit64b"><span><div class="note"><p class="first last">See also the following: </p></div><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeiser, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collusi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1788-1792&author=S.+R.+Staufferauthor=M.+G.+Stantonauthor=A.+R.+Gregroauthor=M.+A.+Steinbeiserauthor=J.+R.+Shafferauthor=P.+G.+Nantermetauthor=J.+C.+Barrowauthor=K.+E.+Rittleauthor=D.+Collusiauthor=A.+S.+Espesethauthor=M.-T.+Laiauthor=B.+L.+Pietrakauthor=M.+K.+Hollowayauthor=G.+B.+McGaugheyauthor=S.+K.+Munshiauthor=J.+H.+Hochmanauthor=A.+J.+Simonauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=Discovery+and+SAR+of+isonicotinamide+BACE-1+inhibitors+that+bind+%CE%B2-secretase+in+a+N-terminal+10s-loop+down+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DSteinbeiser%26aufirst%3DM.%2BA.%26aulast%3DShaffer%26aufirst%3DJ.%2BR.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DCollusi%26aufirst%3DD.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520isonicotinamide%2520BACE-1%2520inhibitors%2520that%2520bind%2520%25CE%25B2-secretase%2520in%2520a%2520N-terminal%252010s-loop%2520down%2520conformation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1788%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Parry, M. J.; Russel, A. B.; Szelke, M.</span><span> </span><span class="NLM_article-title">Bio-Isosteres of a Peptide Renin Inhibitor</span>. In  <span class="citation_source-book">Chemistry and Biology of Peptides</span>; <span class="NLM_contrib-group">Meinehofer, J.</span>, Ed.; <span class="NLM_publisher-name">Ann Arbor Science Publishers</span>: <span class="NLM_publisher-loc">Ann Arbor, MI</span>,<span class="NLM_x"> </span><span class="NLM_year">1972</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">541</span>− <span class="NLM_lpage">544</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1972&pages=541-544&author=M.+J.+Parry&author=A.+B.+Russel&author=M.+Szelkeauthor=J.+Meinehofer&title=Chemistry+and+Biology+of+Peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DM.%2BJ.%26atitle%3DBio-Isosteres%2520of%2520a%2520Peptide%2520Renin%2520Inhibitor%26btitle%3DChemistry%2520and%2520Biology%2520of%2520Peptides%26aulast%3DMeinehofer%26aufirst%3DJ.%26pub%3DAnn%2520Arbor%2520Science%2520Publishers%26date%3D1972%26spage%3D541%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Szelke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sueiras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, A. F.</span><span> </span><span class="NLM_article-title">Potent new inhibitors of human renin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=1982&pages=555-557&author=M.+Szelkeauthor=B.+Leckieauthor=A.+Hallettauthor=D.+M.+Jonesauthor=J.+Sueirasauthor=B.+Atrashauthor=A.+F.+Lever&title=Potent+new+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzelke%26aufirst%3DM.%26aulast%3DLeckie%26aufirst%3DB.%26aulast%3DHallett%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DSueiras%26aufirst%3DJ.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DLever%26aufirst%3DA.%2BF.%26atitle%3DPotent%2520new%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DNature%26date%3D1982%26volume%3D299%26spage%3D555%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Webb, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhem, P. J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span> </span><span class="NLM_article-title">A study of the renin inhibitor H142 in man</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-198512000-00013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=3910726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaL28Xht1ektLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=653-658&author=D.+J.+Webbauthor=P.+J.+O.+Manhemauthor=S.+G.+Ballauthor=G.+Inglisauthor=B.+J.+Leckieauthor=A.+F.+Leverauthor=J.+J.+Mortonauthor=J.+I.+S.+Robertsonauthor=G.+D.+Murrayauthor=J.+M%C3%A9nardauthor=A.+Hallettauthor=D.+M.+Jonesauthor=M.+Szelke&title=A+study+of+the+renin+inhibitor+H142+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A study of the renin inhibitor H142 in man</span></div><div class="casAuthors">Webb, David J.; Manhem, Per J. O.; Ball, Stephen G.; Inglis, Gordon; Leckie, Brenda J.; Lever, Anthony F.; Morton, James J.; Robertson, J. Ian S.; Murray, Gordon D.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-8</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    </div><div class="casAbstract">The inhibitor of human renin  [9015-94-5], H142 (I)  [85139-12-4] was studied in male volunteers.  On three occasions, in random order, volunteers were infused with 5% dextrose or with I at 1.0 or 2.5 mg/kg per h for 30 min while supine and thereafter with dextrose for 11/2 h.  There was a marked redn. in plasma active renin concn. as assayed by an enzyme-kinetic method, with parallel falls in the circulating concns. of angiotensin I  [9041-90-1] and II  [11128-99-7], all of which rebounded transiently to values above basal after the I infusion was stopped.  In contrast, total renin concn. as measured by radio-immunoassay rose whereas angiotensin I and II fell, subsiding when I was discontinued.  There was a slight but significant increase in plasma noradrenaline  [51-41-2] as renin became inhibited; plasma adrenaline  [51-43-4] was unchanged.  I produced a slight fall in systolic blood pressure (SBP) and a clearer, highly significant, dose-related fall in diastolic blood pressure (DBP).  There was a modest but significant increase in the heart rate.  These studies confirm I as an effective inhibitor of human renin in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2GrO3_cUeLVg90H21EOLACvtfcHk0liuAFoCv_nikA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1ektLo%253D&md5=d85492fac52a9755ab4113e087c44d14</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1097%2F00004872-198512000-00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-198512000-00013%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DD.%2BJ.%26aulast%3DManhem%26aufirst%3DP.%2BJ.%2BO.%26aulast%3DBall%26aufirst%3DS.%2BG.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DLeckie%26aufirst%3DB.%2BJ.%26aulast%3DLever%26aufirst%3DA.%2BF.%26aulast%3DMorton%26aufirst%3DJ.%2BJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BI.%2BS.%26aulast%3DMurray%26aufirst%3DG.%2BD.%26aulast%3DM%25C3%25A9nard%26aufirst%3DJ.%26aulast%3DHallett%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DSzelke%26aufirst%3DM.%26atitle%3DA%2520study%2520of%2520the%2520renin%2520inhibitor%2520H142%2520in%2520man%26jtitle%3DJ.%2520Hypertens.%26date%3D1985%26volume%3D3%26spage%3D653%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68a"><span><span class="NLM_contrib-group">James, M. N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielecki, A. R.</span><span> </span><span class="NLM_article-title">Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3701</span><span class="NLM_x">–</span> <span class="NLM_lpage">3713</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00335a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1985&pages=3701-3713&author=M.+N.+G.+Jamesauthor=A.+R.+Sielecki&title=Stereochemical+analysis+of+peptide+bond+hydrolysis+catalyzed+by+the+aspartic+proteinase+penicillopepsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1021%2Fbi00335a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00335a045%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26atitle%3DStereochemical%2520analysis%2520of%2520peptide%2520bond%2520hydrolysis%2520catalyzed%2520by%2520the%2520aspartic%2520proteinase%2520penicillopepsin%26jtitle%3DBiochemistry%26date%3D1985%26volume%3D24%26spage%3D3701%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit68b"><span><div class="note"><p class="first last">The high-resolution X-ray structure of porcine pepsinogen (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2psg">2psg</a>) has shown the N-terminal sequence of the zymogen to fold back into the intact active site conformation, forming electrostatic interactions of the Lys<sub>36</sub> side chain amine with both Asp<sub>32</sub> and Asp<sub>215</sub> as a self-inhibitory mechanism preventing substrate binding: </p></div><span class="NLM_contrib-group">Sielecki, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span> </span><span class="NLM_article-title">Refined structure of porcine pepsinogen at 1.8 Å resolution</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1991&pages=671-692&author=A.+R.+Sieleckiauthor=M.+Fujinagaauthor=R.+J.+Readauthor=M.+N.+G.+James&title=Refined+structure+of+porcine+pepsinogen+at+1.8+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26atitle%3DRefined%2520structure%2520of%2520porcine%2520pepsinogen%2520at%25201.8%2520%25C3%2585%2520resolution%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1991%26volume%3D219%26spage%3D671%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Boger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohr, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaine, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanelli, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorn, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaMont, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassil, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabilito, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boparai, A. S.</span><span> </span><span class="NLM_article-title">Novel renin inhibitors containing the amino acid statine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=1983&pages=81-84&author=J.+Bogerauthor=N.+S.+Lohrauthor=E.+H.+Ulmauthor=M.+Poeauthor=E.+H.+Blaineauthor=G.+M.+Fanelliauthor=T.-Y.+Linauthor=L.+S.+Payneauthor=T.+W.+Schornauthor=B.+I.+LaMontauthor=T.+C.+Vassilauthor=I.+I.+Sabilitoauthor=D.+F.+Veberauthor=D.+H.+Richauthor=A.+S.+Boparai&title=Novel+renin+inhibitors+containing+the+amino+acid+statine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DJ.%26aulast%3DLohr%26aufirst%3DN.%2BS.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DBlaine%26aufirst%3DE.%2BH.%26aulast%3DFanelli%26aufirst%3DG.%2BM.%26aulast%3DLin%26aufirst%3DT.-Y.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DLaMont%26aufirst%3DB.%2BI.%26aulast%3DVassil%26aufirst%3DT.%2BC.%26aulast%3DSabilito%26aufirst%3DI.%2BI.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DRich%26aufirst%3DD.%2BH.%26aulast%3DBoparai%26aufirst%3DA.%2BS.%26atitle%3DNovel%2520renin%2520inhibitors%2520containing%2520the%2520amino%2520acid%2520statine%26jtitle%3DNature%26date%3D1983%26volume%3D303%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sueiras-Diaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. J.</span><span> </span><span class="NLM_article-title">Potent in vivo inhibitors of rat renin: analogs of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site</span> <span class="citation_source-journal">J. Pept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1399-3011.1997.tb01465.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9352462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2sXmslGhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1997&pages=239-247&author=J.+Sueiras-Diazauthor=D.+M.+Jonesauthor=M.+Szelkeauthor=B.+J.+Leckieauthor=S.+R.+Beattieauthor=C.+Beattieauthor=J.+J.+Morton&title=Potent+in+vivo+inhibitors+of+rat+renin%3A+analogs+of+human+and+rat+angiotensinogen+sequences+containing+different+classes+of+pseudodipeptides+at+the+scissile+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70aR"><div class="casContent"><span class="casTitleNuber">70a</span><div class="casTitle"><span class="NLM_cas:atitle">Potent in vivo inhibitors of rat renin: analogs of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site</span></div><div class="casAuthors">Sueiras-Diaz, Javier; Jones, D. Michael; Szelke, Michael; Leckie, Brenda J.; Beattie, Sheila R.; Beattie, C.; Morton, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-247</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">Using solid-phase methodol., peptides based on the 8-14 or 6-14 human and rat angiotensinogen sequences were prepd. contg. the following different isosteric units at the P1-P1' cleavage site: Leu-ψ[CH2NH]Leu, Leu-ψ[CH(OH)CH2]Val, Leu-ψ[CH(OH)CH2]Leu, and Leu-ψ[CH(NH2)CH2]Val.  In vitro, peptide Piv-His-Pro-Phe-His-Leu-ψ[CH(OH)CH2]Leu-Tyr-Tyr-Ser-NH2 (XXI) is the most potent inhibitor of rat plasma renin reported, having IC50 = 0.21 nM; it is a much weaker inhibitor of human renin (IC50 = 45 nM).  Peptide Boc-His-Pro-Phe-His-Leu-ψ[CH(OH)CH2] Leu-Val-Ile-His-NH2 (XX) was a highly effective inhibitor of rat renin in vivo.  When infused (1 mg/kg/h) into two-kidney, one-clip chronic renal hypertensive rats, XX lowered blood pressure and suppressed both plasma renin and angiotensin II.  When given as a bolus (1 mg/kg) there was a divergence between the rapid rebound of renin levels and blood pressure, which remained suppressed.  These results indicate that potent in vivo inhibitors of rat renin could be useful not only in examg. the role of circulating renin but also in elucidating the equally important involvement of extracirculatory renin pools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1-xeo5_guWbVg90H21EOLACvtfcHk0liuAFoCv_nikA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslGhs7Y%253D&md5=0d581adc8da8b1ff4f61ddf57ae0b589</span></div><a href="/servlet/linkout?suffix=cit70a&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.1997.tb01465.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.1997.tb01465.x%26sid%3Dliteratum%253Aachs%26aulast%3DSueiras-Diaz%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DSzelke%26aufirst%3DM.%26aulast%3DLeckie%26aufirst%3DB.%2BJ.%26aulast%3DBeattie%26aufirst%3DS.%2BR.%26aulast%3DBeattie%26aufirst%3DC.%26aulast%3DMorton%26aufirst%3DJ.%2BJ.%26atitle%3DPotent%2520in%2520vivo%2520inhibitors%2520of%2520rat%2520renin%253A%2520analogs%2520of%2520human%2520and%2520rat%2520angiotensinogen%2520sequences%2520containing%2520different%2520classes%2520of%2520pseudodipeptides%2520at%2520the%2520scissile%2520site%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D1997%26volume%3D50%26spage%3D239%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit70b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, D. M.; Leckie, B. J.; Svensson, L.; Szelke, M.</span><span> </span><span class="NLM_article-title">A Novel Non-Hydrolyzable Isostere of the Peptide Transition State and a New Synthesis of the Hydroxy-ethylene Isostere</span>.  <span class="citation_source-book">Peptides: Chemistry, Structure and Biology</span>, Proceedings of the 11th Peptide Symposium; <span class="NLM_publisher-name">Escom</span>: <span class="NLM_publisher-loc">Leiden, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">971</span>− <span class="NLM_lpage">972</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=971-972&author=D.+M.+Jones&author=B.+J.+Leckie&author=L.+Svensson&author=M.+Szelke&title=Peptides%3A+Chemistry%2C+Structure+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BM.%26atitle%3DA%2520Novel%2520Non-Hydrolyzable%2520Isostere%2520of%2520the%2520Peptide%2520Transition%2520State%2520and%2520a%2520New%2520Synthesis%2520of%2520the%2520Hydroxy-ethylene%2520Isostere%26btitle%3DPeptides%253A%2520Chemistry%252C%2520Structure%2520and%2520Biology%26pub%3DEscom%26date%3D1990%26spage%3D971%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fucini, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinger, M. D.</span><span> </span><span class="NLM_article-title">Aminoethylenes, a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509142" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=839-842&author=W.+Yangauthor=W.+Luauthor=Y.+Luauthor=M.+Zhongauthor=J.+Sunauthor=A.+E.+Thomasauthor=J.+M.+Wilkinsonauthor=R.+V.+Fuciniauthor=M.+Lamauthor=M.+Randalauthor=X.-P.+Shiauthor=J.+W.+Jacobsauthor=R.+S.+McDowellauthor=E.+M.+Gordonauthor=M.+D.+Ballinger&title=Aminoethylenes%2C+a+tetrahedral+intermediate+isostere+yielding+potent+inhibitors+of+the+aspartyl+protease+BACE-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm0509142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509142%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DA.%2BE.%26aulast%3DWilkinson%26aufirst%3DJ.%2BM.%26aulast%3DFucini%26aufirst%3DR.%2BV.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DRandal%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.-P.%26aulast%3DJacobs%26aufirst%3DJ.%2BW.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DGordon%26aufirst%3DE.%2BM.%26aulast%3DBallinger%26aufirst%3DM.%2BD.%26atitle%3DAminoethylenes%252C%2520a%2520tetrahedral%2520intermediate%2520isostere%2520yielding%2520potent%2520inhibitors%2520of%2520the%2520aspartyl%2520protease%2520BACE-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D839%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, M.; Sueiras-Diaz, J.; Szelke, M.; Leckie, B.; Beattie, S.</span><span> </span><span class="NLM_article-title">Renin Inhibitors Containing the Novel Amino Acid 3-Aminodeoxystatine</span>.  <span class="citation_source-book">Peptides: Structure and Function</span>, Proceedings of the 9th American Peptide Symposium; <span class="NLM_publisher-name">Pierce Chemical Company</span>: <span class="NLM_publisher-loc">Rockford, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">1985</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">759</span>− <span class="NLM_lpage">762</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=759-762&author=M.+Jones&author=J.+Sueiras-Diaz&author=M.+Szelke&author=B.+Leckie&author=S.+Beattie&title=Peptides%3A+Structure+and+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%26atitle%3DRenin%2520Inhibitors%2520Containing%2520the%2520Novel%2520Amino%2520Acid%25203-Aminodeoxystatine%26btitle%3DPeptides%253A%2520Structure%2520and%2520Function%26pub%3DPierce%2520Chemical%2520Company%26date%3D1985%26spage%3D759%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit72b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lister, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. J.</span><span> </span><span class="NLM_article-title">Novel renin inhibitors: synthesis of aminostatine and comparison with statine-containing analogs</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1986&pages=755-757&author=R.+J.+Arrowsmithauthor=K.+Carterauthor=J.+G.+Dannauthor=D.+E.+Daviesauthor=C.+J.+Harrisauthor=J.+A.+Mortonauthor=P.+Listerauthor=J.+A.+Robinsonauthor=D.+J.+Williams&title=Novel+renin+inhibitors%3A+synthesis+of+aminostatine+and+comparison+with+statine-containing+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DCarter%26aufirst%3DK.%26aulast%3DDann%26aufirst%3DJ.%2BG.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DMorton%26aufirst%3DJ.%2BA.%26aulast%3DLister%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BJ.%26atitle%3DNovel%2520renin%2520inhibitors%253A%2520synthesis%2520of%2520aminostatine%2520and%2520comparison%2520with%2520statine-containing%2520analogs%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1986%26volume%3D10%26spage%3D755%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit72c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Thaisrivongs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schostarez, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pals, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. R.</span><span> </span><span class="NLM_article-title">alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin-inhibitory peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1837</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00393a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1837-1842&author=S.+Thaisrivongsauthor=H.+J.+Schostarezauthor=D.+T.+Palsauthor=S.+R.+Turner&title=alpha%2Calpha-Difluoro-beta-aminodeoxystatine-containing+renin-inhibitory+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72c&amp;dbid=16384&amp;doi=10.1021%2Fjm00393a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00393a026%26sid%3Dliteratum%253Aachs%26aulast%3DThaisrivongs%26aufirst%3DS.%26aulast%3DSchostarez%26aufirst%3DH.%2BJ.%26aulast%3DPals%26aufirst%3DD.%2BT.%26aulast%3DTurner%26aufirst%3DS.%2BR.%26atitle%3Dalpha%252Calpha-Difluoro-beta-aminodeoxystatine-containing%2520renin-inhibitory%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1837%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Bradbury, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivett, J. E.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-<i>a</i>]pyrazine derivatives with human renin inhibitory activity. 3. Synthesis and biological properties of aminodeoxystatine and difluorostatone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=151-157&author=R.+H.+Bradburyauthor=J.+E.+Rivett&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyrazine+derivatives+with+human+renin+inhibitory+activity.+3.+Synthesis+and+biological+properties+of+aminodeoxystatine+and+difluorostatone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a022%26sid%3Dliteratum%253Aachs%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DRivett%26aufirst%3DJ.%2BE.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyrazine%2520derivatives%2520with%2520human%2520renin%2520inhibitory%2520activity.%25203.%2520Synthesis%2520and%2520biological%2520properties%2520of%2520aminodeoxystatine%2520and%2520difluorostatone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Dann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J. A.</span><span> </span><span class="NLM_article-title">Human renin: a new class of inhibitors</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1986&pages=71-77&author=J.+G.+Dannauthor=D.+K.+Stammersauthor=C.+J.+Harrisauthor=R.+J.+Arrowsmithauthor=D.+E.+Daviesauthor=G.+W.+Hardyauthor=J.+A.+Morton&title=Human+renin%3A+a+new+class+of+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDann%26aufirst%3DJ.%2BG.%26aulast%3DStammers%26aufirst%3DD.%2BK.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DHardy%26aufirst%3DG.%2BW.%26aulast%3DMorton%26aufirst%3DJ.%2BA.%26atitle%3DHuman%2520renin%253A%2520a%2520new%2520class%2520of%2520inhibitors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1986%26volume%3D134%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arrowsmith, R. J.; Dann, J. G.; Davies, D. E.; Fogden, Y. C.; Harris, C. J.; Morton, J. A.; Ogden, H.</span><span> </span><span class="NLM_article-title">Inhibitors of Human Renin: Synthesis and Comparative SAR of P3-P1 Tripeptide-Based Aminoalcohols</span>.  <span class="citation_source-book">Peptides 1988</span>, Proceedings of the 20th European Peptide Symposium, Sep 4−9, 1988; <span class="NLM_publisher-name">W. de Gruyter</span>: <span class="NLM_publisher-name">Berlin, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">1989</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">393</span>− <span class="NLM_lpage">395</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&pages=393-395&author=R.+J.+Arrowsmith&author=J.+G.+Dann&author=D.+E.+Davies&author=Y.+C.+Fogden&author=C.+J.+Harris&author=J.+A.+Morton&author=H.+Ogden&title=Peptides+1988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DR.%2BJ.%26atitle%3DInhibitors%2520of%2520Human%2520Renin%253A%2520Synthesis%2520and%2520Comparative%2520SAR%2520of%2520P3-P1%2520Tripeptide-Based%2520Aminoalcohols%26btitle%3DPeptides%25201988%26pub%3DW.%2520de%2520Gruyter%26pub%3DBerlin%252C%2520Germany%26date%3D1989%26spage%3D393%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit75b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Breipohl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeman, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoelkens, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegmann, H.</span><span> </span><span class="NLM_article-title">Studies on renin inhibitors</span> <span class="citation_source-journal">Spec. Publ.−R. Soc. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">Top. Med. Chem.</span><span class="NLM_x">) </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaL1cXkvVGnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1988&pages=101-127&issue=Top.+Med.+Chem.&author=G.+Breipohlauthor=R.+Geigerauthor=S.+Henkeauthor=H.+W.+Kleemanauthor=J.+Knolleauthor=D.+Ruppertauthor=B.+A.+Schoelkensauthor=H.+Urbachauthor=A.+Wagnerauthor=H.+Wegmann&title=Studies+on+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75bR"><div class="casContent"><span class="casTitleNuber">75b</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on renin inhibitors</span></div><div class="casAuthors">Breipohl, G.; Geiger, R.; Henke, S.; Kleeman, H. W.; Knolle, J.; Ruppert, D.; Schoelkens, B. A.; Urbach, H.; Wagner, A.; Wegmann, H.</div><div class="citationInfo"><span class="NLM_cas:title">Special Publication - Royal Society of Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">Top. Med. Chem.</span>),
    <span class="NLM_cas:pages">101-27</span>CODEN:
                <span class="NLM_cas:coden">SROCDO</span>;
        ISSN:<span class="NLM_cas:issn">0260-6291</span>.
    </div><div class="casAbstract">A review with 36 refs. and discussion of the authors' results on prepn. of peptides and their renin-inhibiting activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps3jr6697XsbVg90H21EOLACvtfcHk0ljbkQGFOAHO4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvVGnurY%253D&md5=5dcae63db5bf9f8a63bc54c9cbce25d5</span></div><a href="/servlet/linkout?suffix=cit75b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreipohl%26aufirst%3DG.%26aulast%3DGeiger%26aufirst%3DR.%26aulast%3DHenke%26aufirst%3DS.%26aulast%3DKleeman%26aufirst%3DH.%2BW.%26aulast%3DKnolle%26aufirst%3DJ.%26aulast%3DRuppert%26aufirst%3DD.%26aulast%3DSchoelkens%26aufirst%3DB.%2BA.%26aulast%3DUrbach%26aufirst%3DH.%26aulast%3DWagner%26aufirst%3DA.%26aulast%3DWegmann%26aufirst%3DH.%26atitle%3DStudies%2520on%2520renin%2520inhibitors%26jtitle%3DSpec.%2520Publ.%25E2%2588%2592R.%2520Soc.%2520Chem.%26date%3D1988%26volume%3D65%26issue%3DTop.%2520Med.%2520Chem%26spage%3D101%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit75c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luly, J. R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderquist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perun, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span> </span><span class="NLM_article-title">New inhibitors of human renin that contain novel Leu-Val replacements</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00392a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1609-1616&author=J.+R+Lulyauthor=N.+Yiauthor=J.+Soderquistauthor=H.+Steinauthor=J.+Cohenauthor=T.+J.+Perunauthor=J.+J.+Plattner&title=New+inhibitors+of+human+renin+that+contain+novel+Leu-Val+replacements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75c&amp;dbid=16384&amp;doi=10.1021%2Fjm00392a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00392a015%26sid%3Dliteratum%253Aachs%26aulast%3DLuly%26aufirst%3DJ.%2BR%26aulast%3DYi%26aufirst%3DN.%26aulast%3DSoderquist%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DH.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DPerun%26aufirst%3DT.%2BJ.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DNew%2520inhibitors%2520of%2520human%2520renin%2520that%2520contain%2520novel%2520Leu-Val%2520replacements%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1609%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wlodawer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vondrasek, J.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 protease: a major success of structure-assisted drug design</span> <span class="citation_source-journal">Annu. Rev. Biophys. Biomol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1146%2Fannurev.biophys.27.1.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9646869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1cXktVSltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1998&pages=249-284&author=A.+Wlodawerauthor=J.+Vondrasek&title=Inhibitors+of+HIV-1+protease%3A+a+major+success+of+structure-assisted+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76aR"><div class="casContent"><span class="casTitleNuber">76a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 protease: a major success of structure-assisted drug design</span></div><div class="casAuthors">Wlodawer, Alexander; Vondrasek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Biomolecular Structure</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">249-284</span>CODEN:
                <span class="NLM_cas:coden">ABBSE4</span>;
        ISSN:<span class="NLM_cas:issn">1056-8700</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">Retroviral protease (PR) from the human immunodeficiency virus type 1 (HIV-1) was identified over a decade ago as a potential target for structure-based drug design.  This effort was very successful.  Four drugs are already approved, and others are undergoing clin. trials.  The techniques used in this remarkable example of structure-assisted drug design included crystallog., NMR, computational studies, and advanced chem. synthesis.  The development of these drugs is discussed.  Other approaches to designing HIV-1 PR inhibitors, based on the concepts of symmetry and on the replacement of a H2O mol. that had been found tetrahedrally coordinated between the enzyme and the inhibitors, are also discussed.  The emergence of drug-induced mutations of HIV-1 PR leads to rapid loss of potency of the existing drugs and to the need to continue the development process.  The structural basis of drug resistance and the ways of overcoming this phenomenon are mentioned.  A review with 137 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogX9NcjolGjLVg90H21EOLACvtfcHk0lgCInE0O4twTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVSltLo%253D&md5=127d0908067674c91336aaf388b7b63d</span></div><a href="/servlet/linkout?suffix=cit76a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biophys.27.1.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biophys.27.1.249%26sid%3Dliteratum%253Aachs%26aulast%3DWlodawer%26aufirst%3DA.%26aulast%3DVondrasek%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease%253A%2520a%2520major%2520success%2520of%2520structure-assisted%2520drug%2520design%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D1998%26volume%3D27%26spage%3D249%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit76b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wlodawer, A.</span><span> </span><span class="NLM_article-title">Rational approach to AIDS drug design through structural biology</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=595-614&author=A.+Wlodawer&title=Rational+approach+to+AIDS+drug+design+through+structural+biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWlodawer%26aufirst%3DA.%26atitle%3DRational%2520approach%2520to%2520AIDS%2520drug%2520design%2520through%2520structural%2520biology%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D595%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zürcher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschalk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Exploring the flap pocket of the antimalarial target plasmepsin II: the “55 % rule” applied to enzymes</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=237-240&author=M.+Z%C3%BCrcherauthor=T.+Gottschalkauthor=S.+Meyerauthor=D.+Burauthor=F.+Diederich&title=Exploring+the+flap+pocket+of+the+antimalarial+target+plasmepsin+II%3A+the+%E2%80%9C55+%25+rule%E2%80%9D+applied+to+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DM.%26aulast%3DGottschalk%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DExploring%2520the%2520flap%2520pocket%2520of%2520the%2520antimalarial%2520target%2520plasmepsin%2520II%253A%2520the%2520%25E2%2580%259C55%2520%2525%2520rule%25E2%2580%259D%2520applied%2520to%2520enzymes%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D237%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit77b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bjelic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nervall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez-de-Teran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ersmark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaqvist, J.</span><span> </span><span class="NLM_article-title">Computational inhibitor design against malaria plasmepsins</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2285</span><span class="NLM_x">–</span> <span class="NLM_lpage">2305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2Fs00018-007-7102-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17585371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFygtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=2285-2305&author=S.+Bjelicauthor=M.+Nervallauthor=H.+Gutierrez-de-Teranauthor=K.+Ersmarkauthor=A.+Hallbergauthor=J.+Aaqvist&title=Computational+inhibitor+design+against+malaria+plasmepsins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77bR"><div class="casContent"><span class="casTitleNuber">77b</span><div class="casTitle"><span class="NLM_cas:atitle">Computational inhibitor design against malaria plasmepsins</span></div><div class="casAuthors">Bjelic, S.; Nervall, M.; Gutierrez-de-Teran, H.; Ersmark, K.; Hallberg, A.; Aaqvist, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2285-2305</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Plasmepsins are aspartic proteases involved in the degrdn. of the host cell Hb that is used as a food source by the malaria parasite.  Plasmepsins are highly promising as drug targets, esp. when combined with the inhibition of falcipains that are also involved in Hb catabolism.  In this review, we discuss the mechanism of plasmepsins I-IV in view of the interest in transition state mimetics as potential compds. for lead development.  Inhibitor development against plasmepsin II as well as relevant crystal structures are summarized in order to give an overview of the field.  Application of computational techniques, esp. binding affinity prediction by the linear interaction energy method, in the development of malarial plasmepsin inhibitors has been highly successful and is discussed in detail.  Homol. modeling and mol. docking have been useful in the current inhibitor design project, and the combination of such methods with binding free energy calcns. is analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKmqtG9_aZMbVg90H21EOLACvtfcHk0lgCInE0O4twTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFygtr3E&md5=d2e8487a0151e1c18e9ffafa30294199</span></div><a href="/servlet/linkout?suffix=cit77b&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7102-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7102-2%26sid%3Dliteratum%253Aachs%26aulast%3DBjelic%26aufirst%3DS.%26aulast%3DNervall%26aufirst%3DM.%26aulast%3DGutierrez-de-Teran%26aufirst%3DH.%26aulast%3DErsmark%26aufirst%3DK.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DAaqvist%26aufirst%3DJ.%26atitle%3DComputational%2520inhibitor%2520design%2520against%2520malaria%2520plasmepsins%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26spage%3D2285%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit77c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luksch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, N.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, W. E.</span><span> </span><span class="NLM_article-title">Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1323</span><span class="NLM_x">–</span> <span class="NLM_lpage">1336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1323-1336&author=T.+Lukschauthor=N.-S.+Chanauthor=S.+Brassauthor=C.+A.+Sotrifferauthor=G.+Klebeauthor=W.+E.+Diederich&title=Computer-aided+design+and+synthesis+of+nonpeptidic+plasmepsin+II+and+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DN.-S.%26aulast%3DBrass%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DDiederich%26aufirst%3DW.%2BE.%26atitle%3DComputer-aided%2520design%2520and%2520synthesis%2520of%2520nonpeptidic%2520plasmepsin%2520II%2520and%2520IV%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1323%26epage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopcho, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falahatpisheh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L.</span><span> </span><span class="NLM_article-title">Novel inhibition of porcine pepsin by a substituted piperidine. Preference for one of the enzyme conformers</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">28677</span><span class="NLM_x">–</span> <span class="NLM_lpage">28682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=28677-28682&author=J.+Marcinkevicieneauthor=L.+M.+Kopchoauthor=T.+Yangauthor=R.+A.+Copelandauthor=B.+M.+Glassauthor=A.+P.+Combsauthor=N.+Falahatpishehauthor=L.+Thompson&title=Novel+inhibition+of+porcine+pepsin+by+a+substituted+piperidine.+Preference+for+one+of+the+enzyme+conformers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DKopcho%26aufirst%3DL.%2BM.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DGlass%26aufirst%3DB.%2BM.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DFalahatpisheh%26aufirst%3DN.%26aulast%3DThompson%26aufirst%3DL.%26atitle%3DNovel%2520inhibition%2520of%2520porcine%2520pepsin%2520by%2520a%2520substituted%2520piperidine.%2520Preference%2520for%2520one%2520of%2520the%2520enzyme%2520conformers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D28677%26epage%3D28682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Specker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böttcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebenow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=106-117&author=E.+Speckerauthor=J.+B%C3%B6ttcherauthor=S.+Brassauthor=A.+Heineauthor=H.+Lilieauthor=A.+Schoopauthor=G.+M%C3%BCllerauthor=N.+Griebenowauthor=G.+Klebe&title=Unexpected+novel+binding+mode+of+pyrrolidine-based+aspartyl+protease+inhibitors%3A+design%2C+synthesis+and+crystal+structure+in+complex+with+HIV+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DBrass%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DLilie%26aufirst%3DH.%26aulast%3DSchoop%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26aulast%3DGriebenow%26aufirst%3DN.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DUnexpected%2520novel%2520binding%2520mode%2520of%2520pyrrolidine-based%2520aspartyl%2520protease%2520inhibitors%253A%2520design%252C%2520synthesis%2520and%2520crystal%2520structure%2520in%2520complex%2520with%2520HIV%2520protease%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D106%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80a"><span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6259</span><span class="NLM_x">–</span> <span class="NLM_lpage">6262</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800914n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6259-6262&author=J.+C.+Barrowauthor=S.+R.+Staufferauthor=K.+E.+Rittleauthor=P.+L.+Ngoauthor=Z.+Yangauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=S.+Munshiauthor=G.+B.+McGaugheyauthor=M.+K.+Hollowayauthor=A.+J.+Simonauthor=E.+A.+Priceauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.-T.+Laiauthor=A.+S.+Espesethauthor=M.+Xuauthor=Q.+Huangauthor=A.+Wolfeauthor=B.+Pietrakauthor=P.+Zuckauthor=D.+A.+Levorseauthor=D.+Hazudaauthor=J.+P.+Vacca&title=Discovery+and+X-ray+crystallographic+analysis+of+a+spiropiperidine+iminohydantoin+inhibitor+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80a&amp;dbid=16384&amp;doi=10.1021%2Fjm800914n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800914n%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DLevorse%26aufirst%3DD.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520X-ray%2520crystallographic%2520analysis%2520of%2520a%2520spiropiperidine%2520iminohydantoin%2520inhibitor%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6259%26epage%3D6262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit80b"><span><div class="note"><p class="first last">See also: </p></div><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enderle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span> </span><span class="NLM_article-title">Tyramine fragment binding to BACE-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1304-1307&author=A.+Kuglstatterauthor=M.+Stahlauthor=J.-U.+Petersauthor=W.+Huberauthor=M.+Stihleauthor=D.+Schlatterauthor=J.+Benzauthor=A.+Rufauthor=D.+Rothauthor=T.+Enderleauthor=M.+Hennig&title=Tyramine+fragment+binding+to+BACE-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DD.%26aulast%3DEnderle%26aufirst%3DT.%26aulast%3DHennig%26aufirst%3DM.%26atitle%3DTyramine%2520fragment%2520binding%2520to%2520BACE-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1304%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to β-Secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1116-1123&author=C.+W.+Murrayauthor=O.+Callaghanauthor=G.+Chessariauthor=A.+Cleasbyauthor=M.+Congreveauthor=M.+Fredericksonauthor=M.+J.+Hartshornauthor=R.+McMenaminauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+%CE%B2-Secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening by X-ray Crystallography to β-Secretase</span></div><div class="casAuthors">Murray, Christopher W.; Callaghan, Owen; Chessari, Gianni; Cleasby, Anne; Congreve, Miles; Frederickson, Martyn; Hartshorn, Michael J.; McMenamin, Rachel; Patel, Sahil; Wallis, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1116-1123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes an application of fragment screening to the aspartyl protease enzyme, β-secretase (BACE-1), using high throughput x-ray crystallog.  Three distinct chemotypes were identified by X-ray crystallog. as binding to the catalytic aspartates either via an aminoheterocycle (such as 2-aminoquinoline), a piperidine, or an aliph. hydroxyl group.  The fragment hits were weak inhibitors of BACE-1 in the millimolar range but were of interest because most of them displayed relatively good ligand efficiencies.  The aminoheterocycles exhibited a novel recognition motif that has not been seen before with aspartic proteases.  Virtual screening around this motif identified an aminopyridine with increased potency and attractive growth points for further elaboration using structure-based drug design.  The companion paper illustrates how sub-micromolar inhibitors were developed starting from this fragment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZHjESbj93LVg90H21EOLACvtfcHk0liUtuX22-7Ntg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D&md5=1ff92bcf5bcb8f265709e3571e25ae8e</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1021%2Fjm0611962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611962%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520%25CE%25B2-Secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1116%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">BACE-1 inhibition by a series of ψ[CH<sub>2</sub>NH] reduced amide isosteres</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3635</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3635-3638&author=C.+A.+Coburnauthor=S.+J.+Stachelauthor=K.+G.+Jonesauthor=T.+G.+Steeleauthor=D.+M.+Rushauthor=J.+DiMuzioauthor=B.+L.+Pietrakauthor=M.-T.+Laiauthor=Q.+Huangauthor=J.+Linebergerauthor=L.+Jinauthor=S.+Munshiauthor=M.+K.+Hollowayauthor=A.+Espesethauthor=A.+Simonauthor=D.+Hazudaauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=BACE-1+inhibition+by+a+series+of+%CF%88%5BCH2NH%5D+reduced+amide+isosteres"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DK.%2BG.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DRush%26aufirst%3DD.%2BM.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DBACE-1%2520inhibition%2520by%2520a%2520series%2520of%2520%25CF%2588%255BCH2NH%255D%2520reduced%2520amide%2520isosteres%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3635%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baldwin, J. J.; Claremon, D. A.; Tice, C.; Cacatian, S.; Dillard, L .W.; Ishchenko, A. V.; Yuan, J.; Xu, Z.; McGeehan, G.; Simpson, R. D.; Singh, S. B.; Zhao, W.; Flaherty, P. T.</span><span> </span><span class="NLM_article-title">Piperidine Derivatives as Aspartic Protease Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Aspartic Protease Mediated Diseases</span>. PCT Int. Appl. WO2007/070201A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+J.+Baldwin&author=D.+A.+Claremon&author=C.+Tice&author=S.+Cacatian&author=L+.W.+Dillard&author=A.+V.+Ishchenko&author=J.+Yuan&author=Z.+Xu&author=G.+McGeehan&author=R.+D.+Simpson&author=S.+B.+Singh&author=W.+Zhao&author=P.+T.+Flaherty&title=Piperidine+Derivatives+as+Aspartic+Protease+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Aspartic+Protease+Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPiperidine%2520Derivatives%2520as%2520Aspartic%2520Protease%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Aspartic%2520Protease%2520Mediated%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit83b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See, for example, the following:</p></div><span class="NLM_contrib-group">Baldwin, J. J.; Cacatian, S.; Claremon, D.; Dillard, L. W.; Flaherty, P. T.; Ghavimi-Alagha, B.; Ghirlanda, D.; Ishchenko, A. V.; Kallander, L. S.; Lawhorn, B.; Lu, Q.; Mcgeehan, G.; Terrell, L. R.; Zhang, J.; Leach, C. A.; Stoy, P.; Patterson, J. R.; Simpson, R. D.; Singh, S. B.; Tice, C.; Xu, Z.; Yuan, C. C. K.; Zhao, W.</span><span> </span><span class="NLM_article-title">Preparation of Substituted Benzoylpiperidine Derivatives and Analogs as Renin Inhibitors</span>. PCT Int. Appl. WO2008/124575A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+J.+Baldwin&author=S.+Cacatian&author=D.+Claremon&author=L.+W.+Dillard&author=P.+T.+Flaherty&author=B.+Ghavimi-Alagha&author=D.+Ghirlanda&author=A.+V.+Ishchenko&author=L.+S.+Kallander&author=B.+Lawhorn&author=Q.+Lu&author=G.+Mcgeehan&author=L.+R.+Terrell&author=J.+Zhang&author=C.+A.+Leach&author=P.+Stoy&author=J.+R.+Patterson&author=R.+D.+Simpson&author=S.+B.+Singh&author=C.+Tice&author=Z.+Xu&author=C.+C.+K.+Yuan&author=W.+Zhao&title=Preparation+of+Substituted+Benzoylpiperidine+Derivatives+and+Analogs+as+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPreparation%2520of%2520Substituted%2520Benzoylpiperidine%2520Derivatives%2520and%2520Analogs%2520as%2520Renin%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Blichstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span> </span><span class="NLM_article-title">X-ray structure of plasmepsin II complexed with a potent achiral inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">23837</span><span class="NLM_x">–</span> <span class="NLM_lpage">23843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1074%2Fjbc.M501519200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=15840589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlKhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23837-23843&author=L.+Pradeauthor=A.+F.+Jonesauthor=C.+Bossauthor=S.+Richard-Blichsteinauthor=S.+Meyerauthor=S.+Binkertauthor=D.+Bur&title=X-ray+structure+of+plasmepsin+II+complexed+with+a+potent+achiral+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Structure of Plasmepsin II Complexed with a Potent Achiral Inhibitor</span></div><div class="casAuthors">Prade, Lars; Jones, Andrew F.; Boss, Christoph; Richard-Bildstein, Sylvia; Meyer, Solange; Binkert, Christoph; Bur, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">23837-23843</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The malaria parasite Plasmodium falciparum degrades host cell Hb inside an acidic food vacuole during the blood stage of the infectious cycle.  A no. of aspartic proteinases called plasmepsins (PMs) have been identified to play important roles in this degrdn. process and therefore generated significant interest as new antimalarial targets.  Several x-ray structures of PMII have been described previously, but thus far, structure-guided drug design has been hampered by the fact that only inhibitors comprising a statine moiety or derivs. thereof have been published.  The authors' drug discovery efforts to find innovative, cheap, and easily synthesized inhibitors against aspartic proteinases yielded some highly potent non-peptidic achiral inhibitors.  A highly resolved (1.6 Å) x-ray structure of PMII is presented, featuring a potent achiral inhibitor in an unprecedented orientation, contacting the catalytic aspartates indirectly via the "catalytic" water.  Major side chain rearrangements in the active site occur, which open up a new pocket and allow a new binding mode of the inhibitor.  Moreover, a second inhibitor mol. could be located unambiguously in the active site of PMII.  These newly obtained structural insights will further guide the authors' attempts to improve compd. properties eventually leading to the identification of mols. suitable as antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe_jI7n_4mJbVg90H21EOLACvtfcHk0li6XT0t0Z9oCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlKhs7s%253D&md5=a0e68be3942c9ab9849f6175b9731465</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501519200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501519200%26sid%3Dliteratum%253Aachs%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DA.%2BF.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DRichard-Blichstein%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26atitle%3DX-ray%2520structure%2520of%2520plasmepsin%2520II%2520complexed%2520with%2520a%2520potent%2520achiral%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D23837%26epage%3D23843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mervaala, E. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=389-395&author=E.+M.+A.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=J.+K.+Parkauthor=F.+Schmidtauthor=M.+Lohnauthor=V.+Breuauthor=D.+Dragunauthor=D.+Gantenauthor=H.+Hallerauthor=F.+C.+Luft&title=Monocyte+infiltration+and+adhesion+molecules+in+a+rat+model+of+high+human+renin+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMervaala%26aufirst%3DE.%2BM.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DLohn%26aufirst%3DM.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DDragun%26aufirst%3DD.%26aulast%3DGanten%26aufirst%3DD.%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DMonocyte%2520infiltration%2520and%2520adhesion%2520molecules%2520in%2520a%2520rat%2520model%2520of%2520high%2520human%2520renin%2520hypertension%26jtitle%3DHypertension%26date%3D1999%26volume%3D33%26spage%3D389%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit85b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mervaala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Blood pressure-independent effects in rats with human renin and angiotensinogen genes</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=587-594&author=E.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=F.+Schmidtauthor=J.+K.+Parkauthor=V.+Grossauthor=M.+Baderauthor=V.+Breuauthor=D.+Gantenauthor=H.+Hallerauthor=F.+C.+Luft&title=Blood+pressure-independent+effects+in+rats+with+human+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMervaala%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DGross%26aufirst%3DV.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DGanten%26aufirst%3DD.%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DBlood%2520pressure-independent%2520effects%2520in%2520rats%2520with%2520human%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DHypertension%26date%3D2000%26volume%3D35%26spage%3D587%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0liFT2wjOjpAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Boehr, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussinov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, P. E.</span><span> </span><span class="NLM_article-title">The role of dynamic conformational ensembles in biomolecular recognition</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnchembio.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19841628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=789-796&author=D.+D.+Boehrauthor=R.+Nussinovauthor=P.+E.+Wright&title=The+role+of+dynamic+conformational+ensembles+in+biomolecular+recognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The role of dynamic conformational ensembles in biomolecular recognition</span></div><div class="casAuthors">Boehr, David D.; Nussinov, Ruth; Wright, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">789-796</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mol. recognition by biomols. is central to all biol. processes.  For the past 50 yr, the 'induced fit' hypothesis of D. E. Koshland (1958) has been the textbook explanation for mol. recognition events.  However, recent exptl. evidence supports an alternative mechanism.  The 'conformational selection' model postulates that all conformations pre-exist, and that the ligand selects the most favored conformation.  Following binding, the ensemble undergoes a population shift, redistributing the conformational states.  Both conformational selection and induced fit appear to play roles.  Following binding by a primary conformational selection event, optimization of side-chain and backbone interactions is likely to proceed by an induced fit mechanism.  Conformational selection has been obsd. for protein-ligand, protein-protein, protein-DNA, protein-RNA and RNA-ligand interactions.  These data support a new mol. recognition paradigm for processes as diverse as signaling, catalysis, gene regulation, and protein aggregation in disease, which has the potential to significantly impact researchers' views and strategies in drug design, biomol. engineering, and mol. evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGputCrvx3HqSLVg90H21EOLACvtfcHk0liFT2wjOjpAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsLrJ&md5=984e03a4380d9dafd19048a4b45589c6</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.232%26sid%3Dliteratum%253Aachs%26aulast%3DBoehr%26aufirst%3DD.%2BD.%26aulast%3DNussinov%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DP.%2BE.%26atitle%3DThe%2520role%2520of%2520dynamic%2520conformational%2520ensembles%2520in%2520biomolecular%2520recognition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D789%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Isothermal titration calorimetry: controlling binding forces in lead optimization</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=295-299&author=E.+Freire&title=Isothermal+titration+calorimetry%3A+controlling+binding+forces+in+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DIsothermal%2520titration%2520calorimetry%253A%2520controlling%2520binding%2520forces%2520in%2520lead%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D295%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Brenke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozakov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, G.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beglov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landon, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajda, S.</span><span> </span><span class="NLM_article-title">Fragment-based identification of druggable “hot-spots” of proteins using Fourier domain correlation techniques</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=621-627&author=R.+Brenkeauthor=D.+Kozakovauthor=G.-Y.+Chuangauthor=D.+Beglovauthor=D.+Hallauthor=M.+R.+Landonauthor=C.+Mattosauthor=S.+Vajda&title=Fragment-based+identification+of+druggable+%E2%80%9Chot-spots%E2%80%9D+of+proteins+using+Fourier+domain+correlation+techniques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrenke%26aufirst%3DR.%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DChuang%26aufirst%3DG.-Y.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DLandon%26aufirst%3DM.%2BR.%26aulast%3DMattos%26aufirst%3DC.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DFragment-based%2520identification%2520of%2520druggable%2520%25E2%2580%259Chot-spots%25E2%2580%259D%2520of%2520proteins%2520using%2520Fourier%2520domain%2520correlation%2520techniques%26jtitle%3DBioinformatics%26date%3D2009%26volume%3D25%26spage%3D621%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dash, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M.</span><span> </span><span class="NLM_article-title">Aspartic peptidase inhibitors: implications in drug development</span> <span class="citation_source-journal">Crit. Rev. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1080%2F713609213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12749695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlKitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=89-119&author=C.+Dashauthor=A.+Kulkarniauthor=B.+Dunnauthor=M.+Rao&title=Aspartic+peptidase+inhibitors%3A+implications+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90aR"><div class="casContent"><span class="casTitleNuber">90a</span><div class="casTitle"><span class="NLM_cas:atitle">Aspartic peptidase inhibitors: Implications in drug development</span></div><div class="casAuthors">Dash, Chandravanu; Kulkarni, Aarohi; Dunn, Ben; Rao, Mala</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-119</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">CRC Press LLC</span>)
        </div><div class="casAbstract">A review.  The last decade has witnessed an effervescence of research interest in the development of potent inhibitors of various aspartic peptidases.  As an enzyme family, aspartic peptidases are relatively a small group that has received enormous interest because of their significant roles in human diseases like involvement of renin in hypertension, cathepsin D in metastasis of breast cancer, β-Secretase in Alzheimer's Disease, plasmepsins in malaria, HIV-1 peptidase in acquired immune deficiency syndrome, and secreted aspartic peptidases in candidal infections.  There have been developments on clin. active inhibitors of HIV-1 peptidase, which have been licensed for the treatment of AIDS.  The inhibitors of plasmepsins and renin are considered a viable therapeutic strategy for the treatment of malaria and hypertension.  Relatively few inhibitors of cathepsin D have been reported, partly because of its uncertain role as a viable target for therapeutic intervention.  The β-secretase inhibitors OM99-2 and OM003 were designed based on the substrate specificity information.  The present article is a comprehensive state-of-the-art review describing the aspartic peptidase inhibitors illustrating the recent developments in the area.  In addn., the homologies between the reported inhibitor sequences have been analyzed.  The understanding of the structure-function relationships of aspartic peptidases and inhibitors will have a direct impact on the design of new inhibitor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruhIW2rMcEoLVg90H21EOLACvtfcHk0likU-uYbUTvnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlKitLk%253D&md5=5d4c58c9b985ede5f657f10fe6af4f92</span></div><a href="/servlet/linkout?suffix=cit90a&amp;dbid=16384&amp;doi=10.1080%2F713609213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F713609213%26sid%3Dliteratum%253Aachs%26aulast%3DDash%26aufirst%3DC.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DDunn%26aufirst%3DB.%26aulast%3DRao%26aufirst%3DM.%26atitle%3DAspartic%2520peptidase%2520inhibitors%253A%2520implications%2520in%2520drug%2520development%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D38%26spage%3D89%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit90b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zaidi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalbacher, H.</span><span> </span><span class="NLM_article-title">Emerging functional roles of cathepsin E</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=327-330&author=N.+Zaidiauthor=C.+Hermannauthor=T.+Herrmannauthor=H.+Kalbacher&title=Emerging+functional+roles+of+cathepsin+E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZaidi%26aufirst%3DN.%26aulast%3DHermann%26aufirst%3DC.%26aulast%3DHerrmann%26aufirst%3DT.%26aulast%3DKalbacher%26aufirst%3DH.%26atitle%3DEmerging%2520functional%2520roles%2520of%2520cathepsin%2520E%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D377%26spage%3D327%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Rao, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapundalo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutchko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B. M.</span><span> </span><span class="NLM_article-title">Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1′-P2′ variation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2614</span><span class="NLM_x">–</span> <span class="NLM_lpage">2620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00070a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2614-2620&author=C.+M.+Raoauthor=P.+E.+Scarboroughauthor=J.+Kayauthor=B.+Batleyauthor=S.+Rapundaloauthor=S.+Klutchkoauthor=M.+D.+Taylorauthor=E.+A.+Lunneyauthor=C.+C.+Humbletauthor=B.+M.+Dunn&title=Specificity+in+the+binding+of+inhibitors+to+the+active+site+of+human%2Fprimate+aspartic+proteinases%3A+analysis+of+P2-P1-P1%E2%80%B2-P2%E2%80%B2+variation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm00070a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00070a004%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DC.%2BM.%26aulast%3DScarborough%26aufirst%3DP.%2BE.%26aulast%3DKay%26aufirst%3DJ.%26aulast%3DBatley%26aufirst%3DB.%26aulast%3DRapundalo%26aufirst%3DS.%26aulast%3DKlutchko%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DHumblet%26aufirst%3DC.%2BC.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26atitle%3DSpecificity%2520in%2520the%2520binding%2520of%2520inhibitors%2520to%2520the%2520active%2520site%2520of%2520human%252Fprimate%2520aspartic%2520proteinases%253A%2520analysis%2520of%2520P2-P1-P1%25E2%2580%25B2-P2%25E2%2580%25B2%2520variation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2614%26epage%3D2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Faller, B.; Urban, L.</span>, Eds.  <span class="citation_source-book">Hit and Lead Profiling, Identification and Optimization of Drug-like Molecules</span>. Methods and Principles in Medicinal Chemistry, Vol.  <span class="NLM_volume">43</span>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Faller&author=L.+Urban&title=Hit+and+Lead+Profiling%2C+Identification+and+Optimization+of+Drug-like+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFaller%26aufirst%3DB.%26btitle%3DHit%2520and%2520Lead%2520Profiling%252C%2520Identification%2520and%2520Optimization%2520of%2520Drug-like%2520Molecules%26volume%3D43%26pub%3DWiley-VCH%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit92b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hamon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Techer-Etienne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Coq, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzaoui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span> </span><span class="NLM_article-title">In vitro safety pharmacology profiling: What else beyond hERG?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.4155%2Ffmc.09.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=645-665&author=J.+Hamonauthor=S.+Whitebreadauthor=V.+Techer-Etienneauthor=H.+Le+Coqauthor=K.+Azzaouiauthor=L.+Urban&title=In+vitro+safety+pharmacology+profiling%3A+What+else+beyond+hERG%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92bR"><div class="casContent"><span class="casTitleNuber">92b</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro safety pharmacology profiling: what else beyond hERG?</span></div><div class="casAuthors">Hamon, Jacques; Whitebread, Steven; Techer-Etienne, Valerie; Le Coq, Helene; Azzaoui, Kamal; Urban, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">645-665</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the main reasons for drug failures in clin. development, or postmarket launch, is lacking or compromised safety margins at therapeutic doses.  Organ toxicity with poorly defined mechanisms and adverse drug reactions assocd. with on- and off-target effects are the major contributors to safety-related shortfalls of many clin. drug candidates.  Therefore, to avoid high attrition rates in clin. trials, it is imperative to test compds. for potential adverse reactions during early drug discovery.  Beyond a small no. of targets assocd. with clin. acknowledged adverse drug reactions, there is little consensus on other targets that are important to consider at an early stage for in vitro safety pharmacol. assessment.  We consider here a limited no. of safety-related targets, from different target families, which were selected as part of in vitro safety pharmacol. profiling panels integrated in the drug-development process at Novartis.  The best way to assess these targets, using a biochem. or a functional readout, is discussed.  In particular, the importance of using cell-based profiling assays for the characterization of an agonist action at some GPCRs is highlighted.  A careful design of in vitro safety pharmacol. profiling panels allows better prediction of potential adverse effects of new chem. entities early in the drug-discovery process.  This contributes to the selection of the best candidate for clin. development and, ultimately, should contribute to a decreased attrition rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdXUdqWitZC7Vg90H21EOLACvtfcHk0lixaFzjQIMwSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgtbbJ&md5=85e16bf431d07804e6bce443ffab0ed6</span></div><a href="/servlet/linkout?suffix=cit92b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.51%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DWhitebread%26aufirst%3DS.%26aulast%3DTecher-Etienne%26aufirst%3DV.%26aulast%3DLe%2BCoq%26aufirst%3DH.%26aulast%3DAzzaoui%26aufirst%3DK.%26aulast%3DUrban%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520safety%2520pharmacology%2520profiling%253A%2520What%2520else%2520beyond%2520hERG%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D645%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span> </span><span class="NLM_article-title">Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research ?</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=61-71&author=K.+Beaumontauthor=D.+A.+Smith&title=Does+human+pharmacokinetic+prediction+add+significant+value+to+compound+selection+in+drug+discovery+research+%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26atitle%3DDoes%2520human%2520pharmacokinetic%2520prediction%2520add%2520significant%2520value%2520to%2520compound%2520selection%2520in%2520drug%2520discovery%2520research%2520%253F%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D61%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lixaFzjQIMwSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lgZHSaD0tb3LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Major, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszewski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosebury, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowala, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadley, R.</span><span> </span><span class="NLM_article-title">A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes</span> <span class="citation_source-journal">Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2Fs10557-008-6131-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18679781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=469-478&author=T.+C.+Majorauthor=B.+Olszewskiauthor=W.+Roseburyauthor=C.+Okerbergauthor=T.+Carlsonauthor=R.+Ostroskiauthor=R.+Schroederauthor=M.+C.+Kowalaauthor=R.+Leadley&title=A+nonpeptide%2C+piperidine+renin+inhibitor+provides+renal+and+cardiac+protection+in+double-transgenic+mice+expressing+human+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">A Nonpeptide, Piperidine Renin Inhibitor Provides Renal and Cardiac Protection in Double-Transgenic Mice Expressing Human Renin and Angiotensinogen Genes</span></div><div class="casAuthors">Major, Terry C.; Olszewski, Bronia; Rosebury, Wendy; Okerberg, Carlin; Carlson, Tage; Ostroski, Robert; Schroeder, Richard; Kowala, Mark C.; Leadley, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Drugs and Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">469-478</span>CODEN:
                <span class="NLM_cas:coden">CDTHET</span>;
        ISSN:<span class="NLM_cas:issn">0920-3206</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Controlling hypertension by angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), mechanisms that inhibit later pathway steps in the renin-angiotensin system (RAS), have clin. afforded protection against cardiac and renal disease.  In order to det. if blocking the RAS rate-limiting step of angiotensin II generation via renin inhibition could afford similar end organ protection in a human-relevant preclin. model, this study investigated the cardiac and renal effects of a nonpeptide, piperidine renin inhibitor (RI; 100 mg/kg/day PO) in double transgenic mice (dTGM) which express both human renin and angiotensinogen genes.  RI was compared to the ARB, candesartan (3 mg/kg/day PO), and to the ACEI, enalapril (60 mg/kg/day PO) in a 4-wk dosing paradigm.  These doses of RI, ACEI and ARB were previously found to normalize mean blood pressure (MBP) to 110 + 3, 109 + 7 and 107 + 6 mmHg, resp., after 1 day of treatment.  In the dTGM, PRA, plasma aldosterone, GFR, microalbuminuria and left ventricular free wall thickness (LVH) were higher than in the wild type C57BL/6 mice.  Microalbuminuria and LVH were significantly reduced by 93% and 9% for the RI, 83% and 13% for enalapril and 73% and 6% for candesartan, resp.  PRA and aldosterone were reduced by the RI 56% and 23%, resp.  These results suggest that the RI provides protection against cardiac and renal disease, similar to ARB and ACEI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps963vjFKgbLVg90H21EOLACvtfcHk0lgZHSaD0tb3LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb%252FE&md5=78d52f0c5777984736d2c1e9ba99892f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2Fs10557-008-6131-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10557-008-6131-x%26sid%3Dliteratum%253Aachs%26aulast%3DMajor%26aufirst%3DT.%2BC.%26aulast%3DOlszewski%26aufirst%3DB.%26aulast%3DRosebury%26aufirst%3DW.%26aulast%3DOkerberg%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DOstroski%26aufirst%3DR.%26aulast%3DSchroeder%26aufirst%3DR.%26aulast%3DKowala%26aufirst%3DM.%2BC.%26aulast%3DLeadley%26aufirst%3DR.%26atitle%3DA%2520nonpeptide%252C%2520piperidine%2520renin%2520inhibitor%2520provides%2520renal%2520and%2520cardiac%2520protection%2520in%2520double-transgenic%2520mice%2520expressing%2520human%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DCardiovasc.%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D469%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rossenbacker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priori, S.</span><span> </span><span class="NLM_article-title">New insights into the long-QT syndrome</span> <span class="citation_source-journal">Rev. Esp. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97a&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1157%2F13108271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97a&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17663850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97a&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD2svmvFyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=675-682&author=T.+Rossenbackerauthor=S.+Priori&title=New+insights+into+the+long-QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97aR"><div class="casContent"><span class="casTitleNuber">97a</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the long-QT syndrome</span></div><div class="casAuthors">Rossenbacker Tom; Priori Silvia G</div><div class="citationInfo"><span class="NLM_cas:title">Revista espanola de cardiologia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">675-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA9TlTJBl0iCXXDYhVZBdlfW6udTcc2eazCXnQAlQ9Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svmvFyitQ%253D%253D&md5=b7a76770e9c3ca8ac20e7a085b3e68e4</span></div><a href="/servlet/linkout?suffix=cit97a&amp;dbid=16384&amp;doi=10.1157%2F13108271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1157%252F13108271%26sid%3Dliteratum%253Aachs%26aulast%3DRossenbacker%26aufirst%3DT.%26aulast%3DPriori%26aufirst%3DS.%26atitle%3DNew%2520insights%2520into%2520the%2520long-QT%2520syndrome%26jtitle%3DRev.%2520Esp.%2520Cardiol.%26date%3D2007%26volume%3D60%26spage%3D675%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit97b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ponti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a COMFA study of hERG K<sup>+</sup> channel blockers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3844</span><span class="NLM_x">–</span> <span class="NLM_lpage">3853</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3844-3853&author=A.+Cavalliauthor=E.+Poluzziauthor=F.+De+Pontiauthor=M.+Recanatini&title=Toward+a+pharmacophore+for+drugs+inducing+the+long+QT+syndrome%3A+insights+from+a+COMFA+study+of+hERG+K%2B+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97bR"><div class="casContent"><span class="casTitleNuber">97b</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers</span></div><div class="casAuthors">Cavalli, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio; Recanatini, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3844-3853</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present a pharmacophore for QT-prolonging drugs, along with a 3D QSAR (CoMFA) study for a series of very structurally variegate HERG K+ channel blockers.  The blockade of HERG K+ channels is one of the most important mol. mechanisms through which QT-prolonging drugs increase cardiac action potential duration.  Since QT prolongation is one of the most undesirable side effects of drugs, we first tried to identify the min. set of mol. features responsible for this action and then we attempted to develop a quant. model correlating the 3D stereoelectronic characteristics of the mols. with their HERG blocking potency.  Having considered an initial set of 31 QT-prolonging drugs for which the HERG K+ channel blocking activity was measured on mammalian transfected cells, we started the construction of a theor. screening tool able to predict whether a new mol. can interact with the HERG channel and eventually induce the long QT syndrome.  This in silico tool might be useful in the design of new drug candidates devoid of the physicochem. features likely to cause the above-mentioned side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WFt3kf6ZVLVg90H21EOLACvtfcHk0ljZ48_HhOBCiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D&md5=5e980476ccc9a8a6244aaab230eeb701</span></div><a href="/servlet/linkout?suffix=cit97b&amp;dbid=16384&amp;doi=10.1021%2Fjm0208875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208875%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPoluzzi%26aufirst%3DE.%26aulast%3DDe%2BPonti%26aufirst%3DF.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DToward%2520a%2520pharmacophore%2520for%2520drugs%2520inducing%2520the%2520long%2520QT%2520syndrome%253A%2520insights%2520from%2520a%2520COMFA%2520study%2520of%2520hERG%2520K%252B%2520channel%2520blockers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3844%26epage%3D3853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit97c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pearlstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">Understanding the structure−activity relationship of the human ether-a-go-go-related gene cardiac K<sup>+</sup> channel. A model for bad behavior</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2017</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2017-2022&author=R.+Pearlsteinauthor=R.+Vazauthor=D.+Rampe&title=Understanding+the+structure%E2%88%92activity+relationship+of+the+human+ether-a-go-go-related+gene+cardiac+K%2B+channel.+A+model+for+bad+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97c&amp;dbid=16384&amp;doi=10.1021%2Fjm0205651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205651%26sid%3Dliteratum%253Aachs%26aulast%3DPearlstein%26aufirst%3DR.%26aulast%3DVaz%26aufirst%3DR.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DUnderstanding%2520the%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520the%2520human%2520ether-a-go-go-related%2520gene%2520cardiac%2520K%252B%2520channel.%2520A%2520model%2520for%2520bad%2520behavior%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2017%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Ayalasomayajula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flannery, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieterich, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span> </span><span class="NLM_article-title">Effects of aliskiren, a direct renin inhibitor, on cardiac repolarization and conduction in healthy subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1177%2F0091270008319330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18490495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFyht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=799-811&author=S.+Ayalasomayajulaauthor=C.-M.+Yehauthor=S.+Vaidyanathanauthor=B.+Flanneryauthor=H.+A.+Dieterichauthor=D.+Howardauthor=M.+P.+Bedigianauthor=W.+P.+Dole&title=Effects+of+aliskiren%2C+a+direct+renin+inhibitor%2C+on+cardiac+repolarization+and+conduction+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of aliskiren, a direct renin inhibitor, on cardiac repolarization and conduction in healthy subjects</span></div><div class="casAuthors">Ayalasomayajula, Surya; Yeh, Ching-Ming; Vaidyanathan, Sujata; Flannery, Brian; Dieterich, Hans Armin; Howard, Dan; Bedigian, Martin P.; Dole, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">799-811</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">This multicenter, double-blind study evaluated the effects of aliskiren, a direct renin inhibitor approved for hypertension, on cardiac repolarization and conduction.  Healthy volunteers (n = 298) were randomized to aliskiren 300 mg, aliskiren 1200 mg, moxifloxacin 400 mg (pos. control), or placebo once daily for 7 days.  Digitized electrocardiograms were obtained at baseline and day 7 of treatment over 23 h postdose.  Placebo-adjusted mean changes from baseline in QTcF (Fridericia cor.), QTcI (individualized correction), PR, and QRS intervals were compared at each time point (time-matched anal.) and for values averaged across the dosing period (baseline-averaged anal.).  In time-matched anal., mean changes in QTcF with aliskiren were below predefined limits for QTc prolongation (mean increase <5 ms; upper 90% confidence interval [CI] <10 ms) except aliskiren 1200 mg at 23 h (5.2 ms; 90% CI 2.2, 8.1).  With moxifloxacin, significant QTcF prolongation occurred at most time points, confirming the sensitivity of the assay.  Baseline-averaged anal. was consistent with time-matched anal.  Instances of QTcF interval >450 ms or a >30-ms increase from baseline with aliskiren (≤1 %) were similar or lower than placebo (≤4 %).  Results were similar for QTcI.  Aliskiren had no effect on PR or QRS duration.  In conclusion, aliskiren at the highest approved dose (300 mg) and a 4-fold higher dose had no effect on cardiac repolarization or conduction in healthy volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozwxY7oDfZurVg90H21EOLACvtfcHk0ljZ48_HhOBCiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFyht7Y%253D&md5=c60c2b5f1f563bf5830d75239539c396</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1177%2F0091270008319330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270008319330%26sid%3Dliteratum%253Aachs%26aulast%3DAyalasomayajula%26aufirst%3DS.%26aulast%3DYeh%26aufirst%3DC.-M.%26aulast%3DVaidyanathan%26aufirst%3DS.%26aulast%3DFlannery%26aufirst%3DB.%26aulast%3DDieterich%26aufirst%3DH.%2BA.%26aulast%3DHoward%26aufirst%3DD.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26aulast%3DDole%26aufirst%3DW.%2BP.%26atitle%3DEffects%2520of%2520aliskiren%252C%2520a%2520direct%2520renin%2520inhibitor%252C%2520on%2520cardiac%2520repolarization%2520and%2520conduction%2520in%2520healthy%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D48%26spage%3D799%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harootunian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, J. E.</span><span> </span><span class="NLM_article-title">Characterization of voltage-gated sodium-channel lockers by electrical stimulation and fluorescence detection of membrane potential</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=439-446&author=C.-J.+Huangauthor=A.+Harootunianauthor=M.+P.+Maherauthor=C.+Quanauthor=C.+D.+Rajauthor=K.+McCormackauthor=R.+Numannauthor=P.+A.+Negulescuauthor=J.+E.+Gonz%C3%A1lez&title=Characterization+of+voltage-gated+sodium-channel+lockers+by+electrical+stimulation+and+fluorescence+detection+of+membrane+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-J.%26aulast%3DHarootunian%26aufirst%3DA.%26aulast%3DMaher%26aufirst%3DM.%2BP.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DRaj%26aufirst%3DC.%2BD.%26aulast%3DMcCormack%26aufirst%3DK.%26aulast%3DNumann%26aufirst%3DR.%26aulast%3DNegulescu%26aufirst%3DP.%2BA.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DJ.%2BE.%26atitle%3DCharacterization%2520of%2520voltage-gated%2520sodium-channel%2520lockers%2520by%2520electrical%2520stimulation%2520and%2520fluorescence%2520detection%2520of%2520membrane%2520potential%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D439%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit99b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Balser, J. R.</span><span> </span><span class="NLM_article-title">The cardiac sodium channel: gating function and molecular pharmacology</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99b&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1006%2Fjmcc.2000.1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99b&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=11273715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99b&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFyls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=599-613&author=J.+R.+Balser&title=The+cardiac+sodium+channel%3A+gating+function+and+molecular+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99bR"><div class="casContent"><span class="casTitleNuber">99b</span><div class="casTitle"><span class="NLM_cas:atitle">The Cardiac Sodium Channel: Gating Function and Molecular Pharmacology</span></div><div class="casAuthors">Balser, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">599-613</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 127 refs.  Cardiac sodium (Na) channels are dynamic mols. that undergo rapid structural changes in response to the changing elec. field in the myocardium.  Inherited mutations in SCN5A, the gene encoding the cardiac Na channel, provoke life-threatening cardiac arrhythmias, often by modifying these voltage-dependent conformational changes.  These disorders (i.e. the long QT syndrome and Brugada syndrome) may serve as valuable models for understanding the mechanistic linkages between Na channel dysfunction and cardiac arrhythmias in more common, acquired conditions such as cardiac ischemia.  In addn., the balance between therapeutic and adverse effects from Na channel blockade by antiarrhythmic compds. may be shifted by subtle alterations in Na channel function.  This review examines recent studies that tie key loci in the Na channel primary sequence to its dynamic function, while examg. the emerging themes linking Na channel structure, function, and pharmacol. to inherited and acquired disorders of cardiac excitability.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPSEXQi3ImrVg90H21EOLACvtfcHk0lhOx92DVqPPaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFyls70%253D&md5=a32e6cdeb2ec35bf8b26c91ee69162b0</span></div><a href="/servlet/linkout?suffix=cit99b&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2000.1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2000.1346%26sid%3Dliteratum%253Aachs%26aulast%3DBalser%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520cardiac%2520sodium%2520channel%253A%2520gating%2520function%2520and%2520molecular%2520pharmacology%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2001%26volume%3D33%26spage%3D599%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Splawski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timothy, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachse, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span> </span><span class="NLM_article-title">Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8089</span><span class="NLM_x">–</span> <span class="NLM_lpage">8096</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8089-8096&author=I.+Splawskiauthor=K.+W.+Timothyauthor=N.+Decherauthor=P.+Kumarauthor=F.+B.+Sachseauthor=A.+H.+Beggsauthor=M.+C.+Sanguinettiauthor=M.+T.+Keating&title=Severe+arrhythmia+disorder+caused+by+cardiac+L-type+calcium+channel+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSplawski%26aufirst%3DI.%26aulast%3DTimothy%26aufirst%3DK.%2BW.%26aulast%3DDecher%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DSachse%26aufirst%3DF.%2BB.%26aulast%3DBeggs%26aufirst%3DA.%2BH.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26atitle%3DSevere%2520arrhythmia%2520disorder%2520caused%2520by%2520cardiac%2520L-type%2520calcium%2520channel%2520mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D8089%26epage%3D8096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Oliver, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, F.</span><span> </span><span class="NLM_article-title">Unique specificity of mouse angiotensinogen to homologous renin</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">926</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=4288259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaF28XksF2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1966&pages=923-926&author=W.+J.+Oliverauthor=F.+Gross&title=Unique+specificity+of+mouse+angiotensinogen+to+homologous+renin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Unique specificity of mouse angiotensinogen to homologous renin</span></div><div class="casAuthors">Oliver, W. J.; Gross, F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-6</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">Angiotensinogen contained in mouse plasma reacted exclusively with mouse kidney ext. contg. renin to release angiotensin.  Renin or kidney exts. from other species (pig, rat, hamster, rabbit), as well as from man, did not liberate angiotensin when incubated with the mouse plasma substrate.  The specificity of the mouse angiotensinogen for homologous renin was not due to inactivation of the heterologous renin, since hog renin retained its enzymic activity for other substrates after incubation with mouse plasma.  Plasma from nephrectomized mice, when incubated with mouse kidney ext., gave 6-7-fold higher yields of angiotensin-like substances than did plasma from normal mice.  Subcutaneous administration of deoxycorticosterone acetate (200 mg./kg. weekly) in conjunction with salt loading (1% saline as drinking fluid) for 3 weeks reduced renin activity in mouse kidney exts., but not as markedly as in rats.  That the bond of mouse angiotensinogen was not split by heterologous renin enzymes was suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc3viPm-bN5LVg90H21EOLACvtfcHk0lhOx92DVqPPaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XksF2isb4%253D&md5=a7d94301d114292cdb3eef61a5879153</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DW.%2BJ.%26aulast%3DGross%26aufirst%3DF.%26atitle%3DUnique%2520specificity%2520of%2520mouse%2520angiotensinogen%2520to%2520homologous%2520renin%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1966%26volume%3D122%26spage%3D923%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frishman, W. H.</span><span> </span><span class="NLM_article-title">Renin inhibition: a novel therapy for cardiovascular disease</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1996&pages=1024-1034&author=C.+Linauthor=W.+H.+Frishman&title=Renin+inhibition%3A+a+novel+therapy+for+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3DRenin%2520inhibition%253A%2520a%2520novel%2520therapy%2520for%2520cardiovascular%2520disease%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1996%26volume%3D131%26spage%3D1024%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgiarini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, K. G.</span><span> </span><span class="NLM_article-title">Effects of a specific and long-acting renin inhibitor in the marmoset</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1985&pages=797-803&author=J.+M.+Woodauthor=N.+Gulatiauthor=P.+Forgiariniauthor=W.+Fuhrerauthor=K.+G.+Hofbauer&title=Effects+of+a+specific+and+long-acting+renin+inhibitor+in+the+marmoset"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DGulati%26aufirst%3DN.%26aulast%3DForgiarini%26aufirst%3DP.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DHofbauer%26aufirst%3DK.%2BG.%26atitle%3DEffects%2520of%2520a%2520specific%2520and%2520long-acting%2520renin%2520inhibitor%2520in%2520the%2520marmoset%26jtitle%3DHypertension%26date%3D1985%26volume%3D7%26spage%3D797%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-200502000-00025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=15662231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=417-426&author=J.+M.+Woodauthor=C.+R.+Schnellauthor=F.+Cuminauthor=J.+Menardauthor=R.+L.+Webb&title=Aliskiren%2C+a+novel%2C+orally+effective+renin+inhibitor%2C+lowers+blood+pressure+in+marmosets+and+spontaneously+hypertensive+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats</span></div><div class="casAuthors">Wood, Jeanette M.; Schnell, Christian R.; Cumin, Frederic; Menard, Joel; Webb, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-426</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Aliskiren is a new renin inhibitor of a novel structural class that has recently been shown to be efficacious in hypertensive patients after once-daily oral dosing.  We report the results of animal expts. performed in marmosets and rats to characterize aliskiren before its recent investigation in humans.  The effects of aliskiren were investigated in sodium-depleted marmosets (oral dosing) and in spontaneously hypertensive rats (dosing via s.c. osmotic minipumps).  Blood pressure (BP) and heart rate were measured by radiotelemetry.  In sodium-depleted marmosets, single oral doses of aliskiren (1-30 mg/kg) dose-dependently lowered BP.  At a dose of 3 mg/kg, peak effects were obsd. 1 h after dosing (-30±4 mmHg, n = 6) and the response persisted for more than 12 h.  A single oral dose of 3 mg/kg aliskiren was more effective than the same dose of either remikiren or zankiren, two orally active renin inhibitors previously tested in humans.  Aliskiren (10 mg/kg) was at least as effective as equal doses of the AT1-receptor blocker valsartan or the angiotensin-converting enzyme inhibitor benazepril.  In spontaneously hypertensive rats, aliskiren dose-dependently (10-100 mg/kg per day) decreased BP.  Aliskiren also potentiated the antihypertensive effects of low doses of valsartan or benazeprilat (1 or 3 mg/kg per day).  Aliskiren is an orally effective, long-lasting renin inhibitor that shows antihypertensive efficacy in animals superior to previous renin inhibitors and at least equiv. to angiotensin-converting enzyme inhibitors and AT1-receptor blockers.  Aliskiren may therefore represent an effective, novel approach to the treatment of hypertension and related disorders, alone or in combination with other antihypertensive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWe-dL5dfgb7Vg90H21EOLACvtfcHk0lgxRtTxPTxmHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFCgtw%253D%253D&md5=a18e83e1bac88fc6195f70d0f8986996</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1097%2F00004872-200502000-00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200502000-00025%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26atitle%3DAliskiren%252C%2520a%2520novel%252C%2520orally%2520effective%2520renin%2520inhibitor%252C%2520lowers%2520blood%2520pressure%2520in%2520marmosets%2520and%2520spontaneously%2520hypertensive%2520rats%26jtitle%3DJ.%2520Hypertens.%26date%3D2005%26volume%3D23%26spage%3D417%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Fossa, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePasquale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winslow, R. L.</span><span> </span><span class="NLM_article-title">Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1994&pages=422-428&author=A.+A.+Fossaauthor=M.+J.+DePasqualeauthor=L.+J.+Ringerauthor=R.+L.+Winslow&title=Synergistic+effect+on+reduction+in+blood+pressure+with+coadministration+of+a+renin+inhibitor+or+an+angiotensin-converting+enzyme+inhibitor+with+an+angiotensin+II+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFossa%26aufirst%3DA.%2BA.%26aulast%3DDePasquale%26aufirst%3DM.%2BJ.%26aulast%3DRinger%26aufirst%3DL.%2BJ.%26aulast%3DWinslow%26aufirst%3DR.%2BL.%26atitle%3DSynergistic%2520effect%2520on%2520reduction%2520in%2520blood%2520pressure%2520with%2520coadministration%2520of%2520a%2520renin%2520inhibitor%2520or%2520an%2520angiotensin-converting%2520enzyme%2520inhibitor%2520with%2520an%2520angiotensin%2520II%2520receptor%2520antagonist%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1994%26volume%3D33%26spage%3D422%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Ohkubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakehi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">5153</span><span class="NLM_x">–</span> <span class="NLM_lpage">5157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=5153-5157&author=H.+Ohkuboauthor=H.+Kawakamiauthor=Y.+Kakehiauthor=T.+Takumiauthor=H.+Araiauthor=Y.+Yokotaauthor=M.+Iwaiauthor=Y.+Tanabeauthor=M.+Masuauthor=J.+Hataauthor=H.+Iwaoauthor=H.+Okamotoauthor=M.+Yokoyamaauthor=T.+Nomuraauthor=M.+Katsukiauthor=S.+Nakanishi&title=Generation+of+transgenic+mice+with+elevated+blood+pressure+by+introduction+of+the+rat+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DH.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DKakehi%26aufirst%3DY.%26aulast%3DTakumi%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYokota%26aufirst%3DY.%26aulast%3DIwai%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DY.%26aulast%3DMasu%26aufirst%3DM.%26aulast%3DHata%26aufirst%3DJ.%26aulast%3DIwao%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DKatsuki%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DGeneration%2520of%2520transgenic%2520mice%2520with%2520elevated%2520blood%2520pressure%2520by%2520introduction%2520of%2520the%2520rat%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D5153%26epage%3D5157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Bohlender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippoldt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span> </span><span class="NLM_article-title">High human renin hypertension in transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=428-434&author=J.+Bohlenderauthor=A.+Fukamizuauthor=A.+Lippoldtauthor=T.+Nomuraauthor=R.+Dietzauthor=J.+Menardauthor=K.+Murakamiauthor=F.+C.+Luftauthor=D.+Ganten&title=High+human+renin+hypertension+in+transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohlender%26aufirst%3DJ.%26aulast%3DFukamizu%26aufirst%3DA.%26aulast%3DLippoldt%26aufirst%3DA.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DR.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DGanten%26aufirst%3DD.%26atitle%3DHigh%2520human%2520renin%2520hypertension%2520in%2520transgenic%2520rats%26jtitle%3DHypertension%26date%3D1997%26volume%3D29%26spage%3D428%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Shimokama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haraoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span> </span><span class="NLM_article-title">The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis</span> <span class="citation_source-journal">Virchows Arch</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1007%2Fs004280050152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=9504863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK1cXos12isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=1998&pages=169-175&author=T.+Shimokamaauthor=S.+Haraokaauthor=H.+Horiguchiauthor=F.+Sugiyamaauthor=K.+Murakamiauthor=T.+Watanabe&title=The+Tsukuba+hypertensive+mouse+%28transgenic+mouse+carrying+human+genes+for+both+renin+and+angiotensinogen%29+as+a+model+of+human+malignant+hypertension%3A+development+of+lesions+and+morphometric+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis</span></div><div class="casAuthors">Shimokama, Tatsuro; Haraoka, Seij; Horiguchi, Hisashi; Sugiyama, Fumihiro; Murakami, Kazuo; Watanabe, T.</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-175</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The renin-angiotensin system has a pivotal role in hypertension.  The Tsukuba hypertensive mouse (THM; a transgenic mouse carrying human genes for both renin and angiotensinogen) was generated to allow further examn. of the renin-angiotensin system in a variety of pathol. conditions.  We evaluated the development of renal lesions in these mice and in controls by morphometric, immunohistochem. and ultrastructural methods.  Blood pressure was significantly higher in THM than in control mice; 1 yr after birth, it was ∼40 mmHg higher.  The kidney-to-body wt. ratio was also higher in THM than in control.  Morphometric anal. revealed that the glomerular sclerosis index was significantly elevated in THM with 10 of the glomeruli sclerotic at 18 mo.  The grade of vascular lesion and the frequency of fibrinoid arteritis of the kidney exhibited the same tendency as the glomerular sclerosis index.  Murine renin was located exclusively in the juxtaglomerular app., whereas human renin was expressed not only in the juxtaglomerular app., but also in periarteriolar smooth muscle cells and in mesangial and epithelial cells of the glomeruli.  Light and electron microscopy revealed significant fibrinoid arteritis of the kidney in THM and also "onion skinning", both pathognomonic for malignant nephrosclerosis.  THM may be an excellent model of human malignant hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog-D9cPZEPrrVg90H21EOLACvtfcHk0lhTpDARMEcG4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXos12isg%253D%253D&md5=e86071b97857a9dac36c760258d3c119</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1007%2Fs004280050152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004280050152%26sid%3Dliteratum%253Aachs%26aulast%3DShimokama%26aufirst%3DT.%26aulast%3DHaraoka%26aufirst%3DS.%26aulast%3DHoriguchi%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DF.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26atitle%3DThe%2520Tsukuba%2520hypertensive%2520mouse%2520%2528transgenic%2520mouse%2520carrying%2520human%2520genes%2520for%2520both%2520renin%2520and%2520angiotensinogen%2529%2520as%2520a%2520model%2520of%2520human%2520malignant%2520hypertension%253A%2520development%2520of%2520lesions%2520and%2520morphometric%2520analysis%26jtitle%3DVirchows%2520Arch%26date%3D1998%26volume%3D432%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shagdarsuren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Low dose inhibitor and low dose AT1 receptor blocker therapy ameliorate target organ change in rats harbouring renin and angiotensinogen genes</span> <span class="citation_source-journal">J. Renin−Angiotenin−Aldosterone Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=81-84&author=R.+Dechendauthor=E.+Shagdarsurenauthor=P.+Gratzeauthor=A.+Fiebelerauthor=B.+Pilzauthor=S.+Meinersauthor=W.+Dererauthor=D.+L.+Feldmanauthor=R.+L.+Webbauthor=D.+N.+M%C3%BCller&title=Low+dose+inhibitor+and+low+dose+AT1+receptor+blocker+therapy+ameliorate+target+organ+change+in+rats+harbouring+renin+and+angiotensinogen+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DShagdarsuren%26aufirst%3DE.%26aulast%3DGratze%26aufirst%3DP.%26aulast%3DFiebeler%26aufirst%3DA.%26aulast%3DPilz%26aufirst%3DB.%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DDerer%26aufirst%3DW.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DLow%2520dose%2520inhibitor%2520and%2520low%2520dose%2520AT1%2520receptor%2520blocker%2520therapy%2520ameliorate%2520target%2520organ%2520change%2520in%2520rats%2520harbouring%2520renin%2520and%2520angiotensinogen%2520genes%26jtitle%3DJ.%2520Renin%25E2%2588%2592Angiotenin%25E2%2588%2592Aldosterone%2520Syst.%26date%3D2007%26volume%3D8%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contrepas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span> </span><span class="NLM_article-title">Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=130-136&author=D.+L.+Feldmanauthor=L.+Jinauthor=H.+Xuanauthor=A.+Contrepasauthor=Y.+Zhouauthor=R.+L.+Webbauthor=D.+N.+M%C3%BCllerauthor=S.+Feldtauthor=F.+Cuminauthor=W.+Maniaraauthor=E.+Persohnauthor=H.+Schuetzauthor=A.+H.+J.+Danserauthor=G.+Nguyen&title=Effects+of+aliskiren+on+blood+pressure%2C+albuminuria%2C+and+%28pro%29renin+receptor+expression+in+diabetic+TG%28mRen-2%2927+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DXuan%26aufirst%3DH.%26aulast%3DContrepas%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DSchuetz%26aufirst%3DH.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DNguyen%26aufirst%3DG.%26atitle%3DEffects%2520of%2520aliskiren%2520on%2520blood%2520pressure%252C%2520albuminuria%252C%2520and%2520%2528pro%2529renin%2520receptor%2520expression%2520in%2520diabetic%2520TG%2528mRen-2%252927%2520rats%26jtitle%3DHypertension%26date%3D2008%26volume%3D52%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Kelly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, R. E.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2398</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2398-2404&author=D.+J.+Kellyauthor=Y.+Zhangauthor=G.+Moeauthor=G.+Naikauthor=R.+E.+Gilbert&title=Aliskiren%2C+a+novel+renin+inhibitor%2C+is+renoprotective+in+a+model+of+advanced+diabetic+nephropathy+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoe%26aufirst%3DG.%26aulast%3DNaik%26aufirst%3DG.%26aulast%3DGilbert%26aufirst%3DR.%2BE.%26atitle%3DAliskiren%252C%2520a%2520novel%2520renin%2520inhibitor%252C%2520is%2520renoprotective%2520in%2520a%2520model%2520of%2520advanced%2520diabetic%2520nephropathy%2520in%2520rats%26jtitle%3DDiabetologia%26date%3D2007%26volume%3D50%26spage%3D2398%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Lastra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habibi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley-Connell, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manrique, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, J. R.</span><span> </span><span class="NLM_article-title">Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">2561</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2009&pages=2561-2568&author=G.+Lastraauthor=J.+Habibiauthor=A.+T.+Whaley-Connellauthor=C.+Manriqueauthor=M.+R.+Haydenauthor=J.+Rehmerauthor=K.+Patelauthor=C.+Ferrarioauthor=J.+R.+Sowers&title=Direct+renin+inhibition+improves+systemic+insulin+resistance+and+skeletal+muscle+glucose+transport+in+a+transgenic+rodent+model+of+tissue+renin+overexpression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLastra%26aufirst%3DG.%26aulast%3DHabibi%26aufirst%3DJ.%26aulast%3DWhaley-Connell%26aufirst%3DA.%2BT.%26aulast%3DManrique%26aufirst%3DC.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DRehmer%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DFerrario%26aufirst%3DC.%26aulast%3DSowers%26aufirst%3DJ.%2BR.%26atitle%3DDirect%2520renin%2520inhibition%2520improves%2520systemic%2520insulin%2520resistance%2520and%2520skeletal%2520muscle%2520glucose%2520transport%2520in%2520a%2520transgenic%2520rodent%2520model%2520of%2520tissue%2520renin%2520overexpression%26jtitle%3DEndocrinology%26date%3D2009%26volume%3D150%26spage%3D2561%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Habibi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley-Connell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarco, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karuparthi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, J. R.</span><span> </span><span class="NLM_article-title">Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">5643</span><span class="NLM_x">–</span> <span class="NLM_lpage">5653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=5643-5653&author=J.+Habibiauthor=A.+Whaley-Connellauthor=M.+R.+Haydenauthor=V.+G.+DeMarcoauthor=R.+Schneiderauthor=S.+D.+Sowersauthor=P.+Karuparthiauthor=C.+M.+Ferrarioauthor=J.+R.+Sowers&title=Renin+inhibition+attenuates+insulin+resistance%2C+oxidative+stress%2C+and+pancreatic+remodeling+in+the+transgenic+Ren2+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHabibi%26aufirst%3DJ.%26aulast%3DWhaley-Connell%26aufirst%3DA.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DDeMarco%26aufirst%3DV.%2BG.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSowers%26aufirst%3DS.%2BD.%26aulast%3DKaruparthi%26aufirst%3DP.%26aulast%3DFerrario%26aufirst%3DC.%2BM.%26aulast%3DSowers%26aufirst%3DJ.%2BR.%26atitle%3DRenin%2520inhibition%2520attenuates%2520insulin%2520resistance%252C%2520oxidative%2520stress%252C%2520and%2520pancreatic%2520remodeling%2520in%2520the%2520transgenic%2520Ren2%2520rat%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D5643%26epage%3D5653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Whaley-Connell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habibi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarco, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowers, J. R.</span><span> </span><span class="NLM_article-title">Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">E103</span><span class="NLM_x">–</span> <span class="NLM_lpage">E109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2008&pages=E103-E109&author=A.+Whaley-Connellauthor=J.+Habibiauthor=S.+A.+Cooperauthor=V.+G.+DeMarcoauthor=M.+R.+Haydenauthor=C.+S.+Stumpauthor=D.+Linkauthor=C.+M.+Ferrarioauthor=J.+R.+Sowers&title=Effect+of+renin+inhibition+and+AT1R+blockade+on+myocardial+remodeling+in+the+transgenic+Ren2+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhaley-Connell%26aufirst%3DA.%26aulast%3DHabibi%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DS.%2BA.%26aulast%3DDeMarco%26aufirst%3DV.%2BG.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DStump%26aufirst%3DC.%2BS.%26aulast%3DLink%26aufirst%3DD.%26aulast%3DFerrario%26aufirst%3DC.%2BM.%26aulast%3DSowers%26aufirst%3DJ.%2BR.%26atitle%3DEffect%2520of%2520renin%2520inhibition%2520and%2520AT1R%2520blockade%2520on%2520myocardial%2520remodeling%2520in%2520the%2520transgenic%2520Ren2%2520rat%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2008%26volume%3D295%26spage%3DE103%26epage%3DE109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Direct renin inhibition with aliskiren in hypertension and target organ damage</span> <span class="citation_source-journal">Clin. J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD2svotF2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=221-228&author=D.+N.+M%C3%BCllerauthor=F.+C.+Luft&title=Direct+renin+inhibition+with+aliskiren+in+hypertension+and+target+organ+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Direct renin inhibition with aliskiren in hypertension and target organ damage</span></div><div class="casAuthors">Muller Dominik N; Luft Friedrich C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical journal of the American Society of Nephrology : CJASN</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">221-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Joint National Committee and the World Health Organization are in agreement that hypertension in most patients who are treated is controlled inadequately and that rates of cardiovascular morbidity remain high.  Additional pharmacologic treatments could ameliorate this situation.  The renin-angiotensin-aldosterone system has been a highly successful pharmacologic target, as the system is strongly implicated in the development of hypertension-related target organ damage.  However, compensatory increases in plasma renin levels that lead to adjustments in angiotensin production and conversion present limitations for existing renin-angiotensin-aldosterone system inhibitors.  A once-daily, orally effective, small-molecule renin inhibitor, aliskiren, is now available to address angiotensin production directly at its rate-limiting step.  Studies in humans attest to an effective BP-lowering effect, a side effect profile no different from AT1 receptor blockers, and the option of combination therapies.  A novel animal model of high human renin hypertension in the rat attest to target organ protection.  Because angiotensin receptor blockade, angiotensin-converting enzyme inhibition, calcium channel blockade, and diuretic therapy all lead to sharp increases in plasma renin activity, aliskiren offers a novel circumvention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_VeHAyBnlYJotVjB3IRIyfW6udTcc2eaoC9cbkXAYELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svotF2itw%253D%253D&md5=b86d2df441ff4fd985bd488dbbc17702</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DDirect%2520renin%2520inhibition%2520with%2520aliskiren%2520in%2520hypertension%2520and%2520target%2520organ%2520damage%26jtitle%3DClin.%2520J.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2006%26volume%3D1%26spage%3D221%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rateri, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnigo, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oesterling, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassis, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugherty, A.</span><span> </span><span class="NLM_article-title">Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=984-993&author=H.+Luauthor=D.+L.+Rateriauthor=D.+L.+Feldmanauthor=R.+J.+Charnigoauthor=A.+Fukamizuauthor=J.+Ishidaauthor=E.+G.+Oesterlingauthor=L.+A.+Cassisauthor=A.+Daugherty&title=Renin+inhibition+reduces+hypercholesterolemia-induced+atherosclerosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DRateri%26aufirst%3DD.%2BL.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DCharnigo%26aufirst%3DR.%2BJ.%26aulast%3DFukamizu%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DJ.%26aulast%3DOesterling%26aufirst%3DE.%2BG.%26aulast%3DCassis%26aufirst%3DL.%2BA.%26aulast%3DDaugherty%26aufirst%3DA.%26atitle%3DRenin%2520inhibition%2520reduces%2520hypercholesterolemia-induced%2520atherosclerosis%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubert, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzourene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haypz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzolai, L.</span><span> </span><span class="NLM_article-title">Renin inhibition by aliskiren prevents atherosclerosis progression</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1306-1311&author=J.+Nussbergerauthor=J.+F.+Aubertauthor=K.+Bouzoureneauthor=M.+Pellegrinauthor=D.+Haypzauthor=L.+Mazzolai&title=Renin+inhibition+by+aliskiren+prevents+atherosclerosis+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DAubert%26aufirst%3DJ.%2BF.%26aulast%3DBouzourene%26aufirst%3DK.%26aulast%3DPellegrin%26aufirst%3DM.%26aulast%3DHaypz%26aufirst%3DD.%26aulast%3DMazzolai%26aufirst%3DL.%26atitle%3DRenin%2520inhibition%2520by%2520aliskiren%2520prevents%2520atherosclerosis%2520progression%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D1306%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Imanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujioka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikejima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takarada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitabata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muragaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akasaka, T.</span><span> </span><span class="NLM_article-title">Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=563-572&author=T.+Imanishiauthor=H.+Tsujiokaauthor=H.+Ikejimaauthor=A.+Kuroiauthor=S.+Takaradaauthor=H.+Kitabataauthor=T.+Tanimotoauthor=Y.+Muragakiauthor=S.+Mochizukiauthor=M.+Gotoauthor=K.+Yoshidaauthor=T.+Akasaka&title=Renin+inhibitor+aliskiren+improves+impaired+nitric+oxide+bioavailability+and+protects+against+atherosclerotic+changes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImanishi%26aufirst%3DT.%26aulast%3DTsujioka%26aufirst%3DH.%26aulast%3DIkejima%26aufirst%3DH.%26aulast%3DKuroi%26aufirst%3DA.%26aulast%3DTakarada%26aufirst%3DS.%26aulast%3DKitabata%26aufirst%3DH.%26aulast%3DTanimoto%26aufirst%3DT.%26aulast%3DMuragaki%26aufirst%3DY.%26aulast%3DMochizuki%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DAkasaka%26aufirst%3DT.%26atitle%3DRenin%2520inhibitor%2520aliskiren%2520improves%2520impaired%2520nitric%2520oxide%2520bioavailability%2520and%2520protects%2520against%2520atherosclerotic%2520changes%26jtitle%3DHypertension%26date%3D2008%26volume%3D52%26spage%3D563%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Luft, F. C.</span><span> </span><span class="NLM_article-title">Renin inhibition and atherosclerosis</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1093%2Fndt%2Fgfn184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18430802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADC%252BD1cvotVOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=2474-2476&author=F.+C.+Luft&title=Renin+inhibition+and+atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition and atherosclerosis</span></div><div class="casAuthors">Luft Friedrich C</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2474-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-SZnNmcTbrT69zv1FsJFMfW6udTcc2earbn0-w2E5hbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvotVOjtQ%253D%253D&md5=5915d59bb13a0e21b75553ea5e25b211</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfn184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfn184%26sid%3Dliteratum%253Aachs%26aulast%3DLuft%26aufirst%3DF.%2BC.%26atitle%3DRenin%2520inhibition%2520and%2520atherosclerosis%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2008%26volume%3D23%26spage%3D2474%26epage%3D2476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span> </span><span class="NLM_article-title">The intracellular renin−angiotensin system: a new paradigm</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.tem.2007.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17509892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFejtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=208-214&author=R.+Kumarauthor=V.+P.+Singhauthor=K.+M.+Baker&title=The+intracellular+renin%E2%88%92angiotensin+system%3A+a+new+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The intracellular renin-angiotensin system: A new paradigm</span></div><div class="casAuthors">Kumar, Rajesh; Singh, Vivek P.; Baker, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  More than a century after its discovery, the physiol. implications of the renin-angiotensin system (RAS) continue to expand, with the identification of new components, functions and subsystems.  These advancements have led to better management and understanding of a broad range of cardiovascular and metabolic disorders.  The RAS has traditionally been viewed as a circulatory system, involved in the short-term regulation of vol. and blood pressure homeostasis.  Recently, local RASs have been described as regulators of chronic tissue effects.  Most recently, studies have provided evidence of a complete, functional RAS within cells, described as an intracrine' or intracellular system.  A more comprehensive understanding of the intracellular RAS provides for new strategies in system regulation and a more efficacious approach to the management of RAS-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra2J0RmYOdpbVg90H21EOLACvtfcHk0lh7JYmyN12lkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFejtr0%253D&md5=cd0c44454a684204c2c7323ead88bae7</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2007.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2007.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26atitle%3DThe%2520intracellular%2520renin%25E2%2588%2592angiotensin%2520system%253A%2520a%2520new%2520paradigm%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D18%26spage%3D208%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Cook, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re, R. N.</span><span> </span><span class="NLM_article-title">In vitro evidence for an intracellular site of angiotensin action</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2001&pages=1138-1146&author=J.+L.+Cookauthor=Z.+Zhangauthor=R.+N.+Re&title=In+vitro+evidence+for+an+intracellular+site+of+angiotensin+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRe%26aufirst%3DR.%2BN.%26atitle%3DIn%2520vitro%2520evidence%2520for%2520an%2520intracellular%2520site%2520of%2520angiotensin%2520action%26jtitle%3DCirc.%2520Res.%26date%3D2001%26volume%3D89%26spage%3D1138%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Activation of the intracellular renin−angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">H1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">H1684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=H1675-H1684&author=V.+P.+Singhauthor=K.+M.+Bakerauthor=R.+Kumar&title=Activation+of+the+intracellular+renin%E2%88%92angiotensin+system+in+cardiac+fibroblasts+by+high+glucose%3A+role+in+extracellular+matrix+production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DActivation%2520of%2520the%2520intracellular%2520renin%25E2%2588%2592angiotensin%2520system%2520in%2520cardiac%2520fibroblasts%2520by%2520high%2520glucose%253A%2520role%2520in%2520extracellular%2520matrix%2520production%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DH1675%26epage%3DH1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khode, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3297</span><span class="NLM_x">–</span> <span class="NLM_lpage">3306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=3297-3306&author=V.+P.+Singhauthor=B.+Leauthor=R.+Khodeauthor=K.+M.+Bakerauthor=R.+Kumar&title=Intracellular+angiotensin+II+production+in+diabetic+rats+is+correlated+with+cardiomyocyte+apoptosis%2C+oxidative+stress%2C+and+cardiac+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DLe%26aufirst%3DB.%26aulast%3DKhode%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DIntracellular%2520angiotensin%2520II%2520production%2520in%2520diabetic%2520rats%2520is%2520correlated%2520with%2520cardiomyocyte%2520apoptosis%252C%2520oxidative%2520stress%252C%2520and%2520cardiac%2520fibrosis%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D3297%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Navar, L. G.; Langford, H. G.</span><span> </span><span class="NLM_article-title">Effects of Angiotensin on the Renal Circulation</span>. In  <span class="citation_source-book">Angiotensin</span>; <span class="NLM_contrib-group">Page, I. H.; Bumpus, F. M.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1974</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">455</span>− <span class="NLM_lpage">474</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1974&pages=455-474&author=L.+G.+Navar&author=H.+G.+Langfordauthor=I.+H.+Page&author=F.+M.+Bumpus&title=Angiotensin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNavar%26aufirst%3DL.%2BG.%26atitle%3DEffects%2520of%2520Angiotensin%2520on%2520the%2520Renal%2520Circulation%26btitle%3DAngiotensin%26aulast%3DPage%26aufirst%3DI.%2BH.%26pub%3DSpringer-Verlag%26date%3D1974%26spage%3D455%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Johnston, C. I.</span><span> </span><span class="NLM_article-title">Angiotensin Converting Enzyme Inhibitors</span>. In  <span class="citation_source-book">Handbook of Hypertension. Clinical Pharmacology of Antihypertensive Drugs</span>; <span class="NLM_contrib-group">Doyle, A. E.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">1984</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">5</span>, pp  <span class="NLM_fpage">272</span>− <span class="NLM_lpage">311</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=272-311&author=C.+I.+Johnstonauthor=A.+E.+Doyle&title=Handbook+of+Hypertension.+Clinical+Pharmacology+of+Antihypertensive+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DC.%2BI.%26atitle%3DAngiotensin%2520Converting%2520Enzyme%2520Inhibitors%26btitle%3DHandbook%2520of%2520Hypertension.%2520Clinical%2520Pharmacology%2520of%2520Antihypertensive%2520Drugs%26aulast%3DDoyle%26aufirst%3DA.%2BE.%26pub%3DElsevier%26date%3D1984%26volume%3D5%26spage%3D272%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Zimmerman, B. G.</span><span> </span><span class="NLM_article-title">Blocking and agonistic actions of angiotensin antagonists in normotensive and hypertensive dogs</span> <span class="citation_source-journal">Cardiovasc. Med. N.Y.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1979&pages=231-241&author=B.+G.+Zimmerman&title=Blocking+and+agonistic+actions+of+angiotensin+antagonists+in+normotensive+and+hypertensive+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmerman%26aufirst%3DB.%2BG.%26atitle%3DBlocking%2520and%2520agonistic%2520actions%2520of%2520angiotensin%2520antagonists%2520in%2520normotensive%2520and%2520hypertensive%2520dogs%26jtitle%3DCardiovasc.%2520Med.%2520N.Y.%26date%3D1979%26volume%3D4%26spage%3D231%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Neisius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, K. G.</span><span> </span><span class="NLM_article-title">Renal vasodilatation after inhibition of renin or converting enzyme in marmoset</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">H897</span><span class="NLM_x">–</span> <span class="NLM_lpage">H902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1986&pages=H897-H902&author=D.+Neisiusauthor=J.+M.+Woodauthor=K.+G.+Hofbauer&title=Renal+vasodilatation+after+inhibition+of+renin+or+converting+enzyme+in+marmoset"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeisius%26aufirst%3DD.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DHofbauer%26aufirst%3DK.%2BG.%26atitle%3DRenal%2520vasodilatation%2520after%2520inhibition%2520of%2520renin%2520or%2520converting%2520enzyme%2520in%2520marmoset%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1986%26volume%3D251%26spage%3DH897%26epage%3DH902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Verburg, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinert, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chekal, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadam, J. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, G. A.</span><span> </span><span class="NLM_article-title">Renal hemodynamic and excretory responses to renin inhibition induced by A-64662</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=2179529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK3cXhslajsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1990&pages=449-455&author=K.+M.+Verburgauthor=H.+D.+Kleinertauthor=M.+A.+Chekalauthor=J.+R.+C.+Kadamauthor=G.+A.+Young&title=Renal+hemodynamic+and+excretory+responses+to+renin+inhibition+induced+by+A-64662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Renal hemodynamic and excretory responses to renin inhibition induced by A-64662</span></div><div class="casAuthors">Verburg, Kenneth M.; Kleinert, Hollis D.; Chekal, Marcia A.; Kadam, Jill R. C.; Young, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-55</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Systemic A 64662 (I) infusion in sodium-depleted anesthetized monkeys elicits dose-related increases in renal blood flow.  Renal vasodilation accompanied inhibition of plasma renin activity and preceded changes in mean arterial pressure.  Changes in glomerular filtration rate were not obsd. resulting in a fall in the filtration fraction.  Renal excretory function was unaltered during A-64662 infusion except when hypotension was obsd.  The results are compatible with the concept that the renal hemodynamic and excretory effects of A-64662 are related, at least in part, to renin inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3ynC_4cFeYLVg90H21EOLACvtfcHk0lgWssjNoMC6tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslajsb4%253D&md5=1d2c81efbf701476f9b04766895f455e</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerburg%26aufirst%3DK.%2BM.%26aulast%3DKleinert%26aufirst%3DH.%2BD.%26aulast%3DChekal%26aufirst%3DM.%2BA.%26aulast%3DKadam%26aufirst%3DJ.%2BR.%2BC.%26aulast%3DYoung%26aufirst%3DG.%2BA.%26atitle%3DRenal%2520hemodynamic%2520and%2520excretory%2520responses%2520to%2520renin%2520inhibition%2520induced%2520by%2520A-64662%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1990%26volume%3D252%26spage%3D449%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Amrani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branca, Z.</span><span> </span><span class="NLM_article-title">Ro 42-5892 is a potent orally active renin inhibitor in primates</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1991&pages=22-31&author=W.+Fischliauthor=J.+P.+Clozelauthor=K.+El+Amraniauthor=W.+Wostlauthor=W.+Neidhartauthor=H.+Stadlerauthor=Z.+Branca&title=Ro+42-5892+is+a+potent+orally+active+renin+inhibitor+in+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DEl%2BAmrani%26aufirst%3DK.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DBranca%26aufirst%3DZ.%26atitle%3DRo%252042-5892%2520is%2520a%2520potent%2520orally%2520active%2520renin%2520inhibitor%2520in%2520primates%26jtitle%3DHypertension%26date%3D1991%26volume%3D18%26spage%3D22%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit129b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span> </span><span class="NLM_article-title">Ciprokiren (Ro 44-9375): a renin inhibitor with increasing effects on chronic treatment</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=163-169&author=W.+Fischliauthor=J.+P.+Clozelauthor=V.+Breuauthor=S.+Buchmannauthor=S.+Mathewsauthor=H.+Stadlerauthor=E.+Vieiraauthor=W.+Wostl&title=Ciprokiren+%28Ro+44-9375%29%3A+a+renin+inhibitor+with+increasing+effects+on+chronic+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DS.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWostl%26aufirst%3DW.%26atitle%3DCiprokiren%2520%2528Ro%252044-9375%2529%253A%2520a%2520renin%2520inhibitor%2520with%2520increasing%2520effects%2520on%2520chronic%2520treatment%26jtitle%3DHypertension%26date%3D1994%26volume%3D24%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">Comparative effects of three different potent renin inhibitors in primates</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=9-17&author=J.+P.+Clozelauthor=W.+Fischli&title=Comparative+effects+of+three+different+potent+renin+inhibitors+in+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DComparative%2520effects%2520of%2520three%2520different%2520potent%2520renin%2520inhibitors%2520in%2520primates%26jtitle%3DHypertension%26date%3D1993%26volume%3D22%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Richter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R. C.</span><span> </span><span class="NLM_article-title">Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=243-254&author=W.+F.+Richterauthor=B.+R.+Whitbyauthor=R.+C.+Chou&title=Distribution+of+remikiren%2C+a+potent+orally+active+inhibitor+of+human+renin%2C+in+laboratory+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DW.%2BF.%26aulast%3DWhitby%26aufirst%3DB.%2BR.%26aulast%3DChou%26aufirst%3DR.%2BC.%26atitle%3DDistribution%2520of%2520remikiren%252C%2520a%2520potent%2520orally%2520active%2520inhibitor%2520of%2520human%2520renin%252C%2520in%2520laboratory%2520animals%26jtitle%3DXenobiotica%26date%3D1996%26volume%3D26%26spage%3D243%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">El Amrani, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, J. B.</span><span> </span><span class="NLM_article-title">Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=231-239&author=A.+K.+El+Amraniauthor=J.+Menardauthor=M.+F.+Gonzalesauthor=J.+B.+Michel&title=Effects+of+blocking+the+angiotensin+II+receptor%2C+converting+enzyme%2C+and+renin+activity+on+the+renal+hemodynamics+of+normotensive+guinea+pigs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BAmrani%26aufirst%3DA.%2BK.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DGonzales%26aufirst%3DM.%2BF.%26aulast%3DMichel%26aufirst%3DJ.%2BB.%26atitle%3DEffects%2520of%2520blocking%2520the%2520angiotensin%2520II%2520receptor%252C%2520converting%2520enzyme%252C%2520and%2520renin%2520activity%2520on%2520the%2520renal%2520hemodynamics%2520of%2520normotensive%2520guinea%2520pigs%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1993%26volume%3D22%26spage%3D231%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Cordero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1991&pages=510-516&author=P.+Corderoauthor=N.+D.+Fisherauthor=T.+J.+Mooreauthor=R.+Gleasonauthor=G.+H.+Williamsauthor=N.+K.+Hollenberg&title=Renal+and+endocrine+responses+to+a+renin+inhibitor%2C+enalkiren%2C+in+normal+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCordero%26aufirst%3DP.%26aulast%3DFisher%26aufirst%3DN.%2BD.%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DGleason%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DRenal%2520and%2520endocrine%2520responses%2520to%2520a%2520renin%2520inhibitor%252C%2520enalkiren%252C%2520in%2520normal%2520humans%26jtitle%3DHypertension%26date%3D1991%26volume%3D17%26spage%3D510%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kifor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaboury, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Responses to converting enzyme and renin inhibition</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1994&pages=44-51&author=N.+D.+L.+Fisherauthor=D.+Allanauthor=I.+Kiforauthor=C.+L.+Gabouryauthor=G.+H.+Williamsauthor=T.+J.+Mooreauthor=N.+K.+Hollenberg&title=Responses+to+converting+enzyme+and+renin+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DAllan%26aufirst%3DD.%26aulast%3DKifor%26aufirst%3DI.%26aulast%3DGaboury%26aufirst%3DC.%2BL.%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DResponses%2520to%2520converting%2520enzyme%2520and%2520renin%2520inhibition%26jtitle%3DHypertension%26date%3D1994%26volume%3D23%26spage%3D44%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N.</span><span> </span><span class="NLM_article-title">Renal vascular responses to renin inhibition with zankiren in men</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2F0009-9236%2895%2990160-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=7697952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2MXlt1ektLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=342-348&author=N.+D.+L.+Fisherauthor=N.+Hollenberg&title=Renal+vascular+responses+to+renin+inhibition+with+zankiren+in+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Renal vascular responses to renin inhibition with zankiren in men</span></div><div class="casAuthors">Fisher, Naomi D. L.; Hollenberg, Norman</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-8</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Renin inhibition represents an alternative to angiotensin-converting enzyme (ACE) inhibition for pharmacol. interruption of the renin-angiotensin system.  In addn. to inhibiting the formation of angiotensin II, ACE inhibitors also inhibit the degrdn. of kinin and result in accumulation of powerful renal vasodilator prostaglandins and bradykinin.  We were therefore surprised by the large renal vasodilator response achieved with the renin inhibitor enalkiren, because substrate-specific renin inhibitors reduce the formation of angiotensin II without affecting other vasodilator mechanisms.  To det. whether previous findings were reflective of the renin inhibitor class, we studied 12 healthy men on a sodium-restricted diet, each of whom received two or three escalating oral doses of zankiren, a new agent.  Plasma renin activity decreased with the smallest dose (5 mg), and this effect was sustained.  The increase in renal plasma flow was clearly related to dose (r = 0.86, F = 9.67), reaching a max. of 134 ± 26 mL/min/1.73 m2 at 250 mg, the highest dose.  Renin inhibition exerts a remarkable renal vasodilator action, perhaps reflecting the lipophilicity of the agents developed to date, an action that may have clin. implications for the prevention of renal injury in patients at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjANAaP52o-LVg90H21EOLACvtfcHk0liwzIMKgtOG-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlt1ektLs%253D&md5=f7550a73b4aceb2539f8fdfec715ca8a</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2F0009-9236%2895%2990160-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9236%252895%252990160-4%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DHollenberg%26aufirst%3DN.%26atitle%3DRenal%2520vascular%2520responses%2520to%2520renin%2520inhibition%2520with%2520zankiren%2520in%2520men%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D57%26spage%3D342%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=3199-3205&author=N.+D.+L.+Fisherauthor=A.+H.+J.+Danserauthor=J.+Nussbergerauthor=W.+P.+Doleauthor=N.+K.+Hollenberg&title=Renal+and+hormonal+responses+to+direct+renin+inhibition+with+aliskiren+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DDole%26aufirst%3DW.%2BP.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DRenal%2520and%2520hormonal%2520responses%2520to%2520direct%2520renin%2520inhibition%2520with%2520aliskiren%2520in%2520healthy%2520humans%26jtitle%3DCirculation%26date%3D2008%26volume%3D117%26spage%3D3199%26epage%3D3205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Feldman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miserendino-Moltini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span> </span><span class="NLM_article-title">Renal localization of the renin inhibitor aliskiren</span> <span class="citation_source-journal">J. Clin. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">A80</span><span class="NLM_x">–</span> <span class="NLM_lpage">A81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=A80-A81&author=D.+L.+Feldmanauthor=E.+Persohnauthor=H.+Schuetzauthor=L.+Jinauthor=R.+Miserendino-Moltiniauthor=H.+Xuanauthor=S.+Zhuangauthor=W.+Zhou&title=Renal+localization+of+the+renin+inhibitor+aliskiren"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DSchuetz%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMiserendino-Moltini%26aufirst%3DR.%26aulast%3DXuan%26aufirst%3DH.%26aulast%3DZhuang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DW.%26atitle%3DRenal%2520localization%2520of%2520the%2520renin%2520inhibitor%2520aliskiren%26jtitle%3DJ.%2520Clin.%2520Hypertens.%26date%3D2006%26volume%3D8%26spage%3DA80%26epage%3DA81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Krop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gool, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, N. D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Aliskiren accumulates in renin secretory granules and binds plasma prorenin</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1076-1083&author=M.+Kropauthor=I.+M.+Garreldsauthor=J.+A.+de+Bruinauthor=J.+M.+G.+van+Goolauthor=N.+D.+L.+Fisherauthor=N.+K.+Hollenbergauthor=A.+H.+J.+Danser&title=Aliskiren+accumulates+in+renin+secretory+granules+and+binds+plasma+prorenin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrop%26aufirst%3DM.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3Dde%2BBruin%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2BGool%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DFisher%26aufirst%3DN.%2BD.%2BL.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DAliskiren%2520accumulates%2520in%2520renin%2520secretory%2520granules%2520and%2520binds%2520plasma%2520prorenin%26jtitle%3DHypertension%26date%3D2008%26volume%3D52%26spage%3D1076%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Feldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maschke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1681%2FASN.2007091030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18235083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFOhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=743-748&author=S.+Feldtauthor=U.+Maschkeauthor=R.+Dechendauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=The+putative+%28pro%29renin+receptor+blocker+HRP+fails+to+prevent+%28pro%29renin+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">The putative (pro)renin receptor blocker HRP fails to prevent (Pro)renin signaling</span></div><div class="casAuthors">Feldt, Sandra; Maschke, Ulrike; Dechend, Ralf; Luft, Friedrich C.; Muller, Dominik N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-748</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The prorenin/renin receptor is a recently discovered component of the renin-angiotensin system.  The effects of aliskiren, a direct inhibitor of human renin, were compared with the handle region decoy peptide (HRP), which blocks the prorenin/renin receptor, in double-transgenic rats overexpressing the human renin and angiotensinogen genes.  After 7 wk, all aliskiren-treated rats were alive, whereas mortality was 40% in vehicle-treated and 58% in HRP-treated rats.  Aliskiren but not the HRP reduced BP and normalized albuminuria, cystatin C, and neutrophil gelatinase-assocd. lipocalin, a marker of renal tubular damage, to the levels of nontransgenic controls.  In vitro, human renin and prorenin induced extracellular signal-regulated kinase 1/2 phosphorylation, independent of angiotensin II (AngII), in vascular smooth muscle cells.  Preincubation with the HRP or aliskiren did not prevent renin- and prorenin-induced extracellular signal-regulated kinase 1/2 phosphorylation, whereas the MAP kinase kinase (MEK1/2) inhibitor PD98059 prevented both.  In conclusion, renin inhibition but not treatment with the HRP protects against AngII-induced renal damage in double-transgenic rats.  In addn., the in vitro data do not support the use of the HRP to block AngII-independent prorenin- or renin-mediated effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0qHu0FLsi4LVg90H21EOLACvtfcHk0lhKnEQsdgZaMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFOhsbo%253D&md5=c38fd5debbbe5e30f592ca8e7efd3db4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1681%2FASN.2007091030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2007091030%26sid%3Dliteratum%253Aachs%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DMaschke%26aufirst%3DU.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DThe%2520putative%2520%2528pro%2529renin%2520receptor%2520blocker%2520HRP%2520fails%2520to%2520prevent%2520%2528pro%2529renin%2520signaling%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2008%26volume%3D19%26spage%3D743%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Durvasula, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankland, S. J.</span><span> </span><span class="NLM_article-title">Activation of a local renin angiotensin system in podocytes by glucose</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">F830</span><span class="NLM_x">–</span> <span class="NLM_lpage">F839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=F830-F839&author=R.+V.+Durvasulaauthor=S.+J.+Shankland&title=Activation+of+a+local+renin+angiotensin+system+in+podocytes+by+glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurvasula%26aufirst%3DR.%2BV.%26aulast%3DShankland%26aufirst%3DS.%2BJ.%26atitle%3DActivation%2520of%2520a%2520local%2520renin%2520angiotensin%2520system%2520in%2520podocytes%2520by%2520glucose%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DF830%26epage%3DF839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1056%2FNEJMoa0708379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18525041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=2433-2446&author=H.+H.+Parvingauthor=F.+Perssonauthor=J.+B.+Lewisauthor=E.+J.+Lewisauthor=N.+K.+Hollenberg&title=Aliskiren+combined+with+losartan+in+type+2+diabetes+and+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span></div><div class="casAuthors">Parving, Hans-Henrik; Persson, Frederik; Lewis, Julia B.; Lewis, Edmund J.; Hollenberg, Norman K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2433-2446</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries.  We evaluated the renoprotective effects of dual blockade of the renin-angiotensin-aldosterone system by adding treatment with aliskiren, an oral direct renin inhibitor, to treatment with the maximal recommended dose of losartan (100 mg daily) and optimal antihypertensive therapy in patients who had hypertension and type 2 diabetes with nephropathy.  We enrolled 599 patients in this multinational, randomized, double-blind study.  After a 3-mo, open-label, run-in period during which patients received 100 mg of losartan daily, patients were randomly assigned to receive 6 mo of treatment with aliskiren (150 mg daily for 3 mo, followed by an increase in dosage to 300 mg daily for another 3 mo) or placebo, in addn. to losartan.  The primary outcome was a redn. in the ratio of albumin to creatinine, as measured in an early-morning urine sample, at 6 mo.  The baseline characteristics of the two groups were similar.  Treatment with 300 mg of aliskiren daily, as compared with placebo, reduced the mean urinary albumin-to-creatinine ratio by 20% (95% confidence interval, 9 to 30; P<0.001), with a redn. of 50% or more in 24.7% of the patients who received aliskiren as compared with 12.5% of those who received placebo (P<0.001).  A small difference in blood pressure was seen between the treatment groups by the end of the study period (systolic, 2 mm Hg lower [P = 0.07] and diastolic, 1 mm Hg lower [P = 0.08] in the aliskiren group).  The total nos. of adverse and serious adverse events were similar in the groups.  Aliskiren may have renoprotective effects that are independent of its blood pressure-lowering effect in patients with hypertension, type 2 diabetes, and nephropathy who are receiving the recommended renoprotective treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrVSPga0hzXrVg90H21EOLACvtfcHk0lhKnEQsdgZaMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D&md5=e53fcda0023dbc3c567f412179cd3328</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0708379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0708379%26sid%3Dliteratum%253Aachs%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DLewis%26aufirst%3DJ.%2BB.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DAliskiren%2520combined%2520with%2520losartan%2520in%2520type%25202%2520diabetes%2520and%2520nephropathy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D2433%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Hsueh, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzau, V. J.</span><span> </span><span class="NLM_article-title">Characterization of inactive renin from human kidney and plasma: evidence of a renal source of circulating inactive renin</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1983&pages=506-517&author=W.+A.+Hsuehauthor=E.+J.+Carlsonauthor=V.+J.+Dzau&title=Characterization+of+inactive+renin+from+human+kidney+and+plasma%3A+evidence+of+a+renal+source+of+circulating+inactive+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DW.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%2BJ.%26aulast%3DDzau%26aufirst%3DV.%2BJ.%26atitle%3DCharacterization%2520of%2520inactive%2520renin%2520from%2520human%2520kidney%2520and%2520plasma%253A%2520evidence%2520of%2520a%2520renal%2520source%2520of%2520circulating%2520inactive%2520renin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1983%26volume%3D71%26spage%3D506%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Reudelhuber, T. L.; Mercure, C.; Ramla, D.; Methot, D.; Postonvd, A. Y.</span><span> </span><span class="NLM_article-title">Molecular Mechanisms of Processing and Sorting in Renin Secretion</span>. In  <span class="citation_source-book">Hypertension: Pathophysiology. Diagnosis and Management</span>; <span class="NLM_contrib-group">Laragh, J. H.; Brenner, B. M.</span>, Eds.; <span class="NLM_publisher-name">Raven Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1621</span>− <span class="NLM_lpage">1636</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=1621-1636&author=T.+L.+Reudelhuber&author=C.+Mercure&author=D.+Ramla&author=D.+Methot&author=A.+Y.+Postonvdauthor=J.+H.+Laragh&author=B.+M.+Brenner&title=Hypertension%3A+Pathophysiology.+Diagnosis+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DReudelhuber%26aufirst%3DT.%2BL.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Processing%2520and%2520Sorting%2520in%2520Renin%2520Secretion%26btitle%3DHypertension%253A%2520Pathophysiology.%2520Diagnosis%2520and%2520Management%26aulast%3DLaragh%26aufirst%3DJ.%2BH.%26pub%3DRaven%2520Press%26date%3D1995%26spage%3D1621%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Nielsen, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, K.</span><span> </span><span class="NLM_article-title">Is prorenin of physiological and clinical significance?</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-198812000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=3065410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADyaL1M7isVegtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1988&pages=949-958&author=A.+H.+Nielsenauthor=K.+Poulsen&title=Is+prorenin+of+physiological+and+clinical+significance%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Is prorenin of physiological and clinical significance?</span></div><div class="casAuthors">Nielsen A H; Poulsen K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hypertension</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">949-58</span>
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKDyYG80pVSZggzHGM8X5CfW6udTcc2ebrX8rQerMYLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7isVegtg%253D%253D&md5=490ce96b098da4714a6aec6cd7b682a6</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1097%2F00004872-198812000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-198812000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DA.%2BH.%26aulast%3DPoulsen%26aufirst%3DK.%26atitle%3DIs%2520prorenin%2520of%2520physiological%2520and%2520clinical%2520significance%253F%26jtitle%3DJ.%2520Hypertens.%26date%3D1988%26volume%3D6%26spage%3D949%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Luetscher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draemer, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryer-Ash, M.</span><span> </span><span class="NLM_article-title">Increased plasma inactive renin in diabetes mellitus</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1412</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1056%2FNEJM198505303122202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=3887168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A280%3ADyaL2M7ovVWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=1985&pages=1412-1417&author=J.+A.+Luetscherauthor=F.+B.+Draemerauthor=D.+M.+Wilsonauthor=H.+C.+Schwartzauthor=M.+Bryer-Ash&title=Increased+plasma+inactive+renin+in+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications</span></div><div class="casAuthors">Luetscher J A; Kraemer F B; Wilson D M; Schwartz H C; Bryer-Ash M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1412-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">Plasma renin exists in an active form or as an inactive zymogen that resembles a prorenin present in homogenates of human kidneys.  We examined the relation of diabetes and its microvascular complications with the level of plasma inactive renin activated by dialysis to pH 3.3.  Plasma inactive renin was measured in 235 diabetic patients and 90 nondiabetic controls.  In the controls, the level of plasma inactive renin increased slightly with age but was never above 50 ng per milliliter per hour.  In young diabetic patients studied within three years of the onset of diabetes the concentration of inactive renin was normal, and in some older diabetics without complications it remained within the age-adjusted normal range for many years.  However, in patients with retinopathy or albuminuria, plasma inactive renin was above the normal range with few exceptions, reaching levels 50 to 200 per cent above the upper limits of normal in patients with nephropathy.  The frequency of neuropathy was also significantly higher among patients with levels above the normal range.  In 37 per cent of the diabetics followed during one to three years of conventional treatment, plasma inactive renin increased significantly, but in another group of diabetics under intensive treatment, the level rose in only 7 per cent and fell in 43 per cent.  We conclude that there is a close association between a high level of plasma inactive renin and the presence of microvascular complications, and that the level of inactive renin can be modified by intensive treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStMCQzWhuTntj_Vg2vObihfW6udTcc2ebrX8rQerMYLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7ovVWntw%253D%253D&md5=ba5e3803e524aac4624d22336fe41179</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1056%2FNEJM198505303122202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198505303122202%26sid%3Dliteratum%253Aachs%26aulast%3DLuetscher%26aufirst%3DJ.%2BA.%26aulast%3DDraemer%26aufirst%3DF.%2BB.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DSchwartz%26aufirst%3DH.%2BC.%26aulast%3DBryer-Ash%26aufirst%3DM.%26atitle%3DIncreased%2520plasma%2520inactive%2520renin%2520in%2520diabetes%2520mellitus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1985%26volume%3D312%26spage%3D1412%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Sealey, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catanzaro, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavin, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gahnem, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitarresi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laragh, J. H.</span><span> </span><span class="NLM_article-title">Specific prorenin/renin binding (ProBP): identification and characterization of a novel membrane site</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2F0895-7061%2896%2900092-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8735181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK28XktF2lsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=491-502&author=J.+E.+Sealeyauthor=D.+F.+Catanzaroauthor=T.+N.+Lavinauthor=F.+Gahnemauthor=T.+Pitarresiauthor=L.+F.+Huauthor=J.+H.+Laragh&title=Specific+prorenin%2Frenin+binding+%28ProBP%29%3A+identification+and+characterization+of+a+novel+membrane+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Specific prorenin / renin binding (ProBP): Identification and characterization of a novel membrane site</span></div><div class="casAuthors">Sealey, Jean E.; Catanzaro, Daniel F.; Lavin, Thomas N.; Gahnem, Fuad; Pitarresi, Tina; Hu, Lu-fei; Laragh, John H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-502</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Renin can be detected in cardiovascular and other tissues but it disappears after bilateral nephrectomy indicating that tissues can take up or bind renal renin from the circulation.  If renin uptake is the result of specific binding, plasma prorenin may be a natural antagonist of tissue directed renin-angiotensin systems.  To investigate if specific prorenin/renin uptake occurs in rat tissues, binding studies were performed with rat microsomal membrane prepns. using recombinant rat prorenin metabolically labeled with 35S-methionine as a probe.  A high affinity binding site for both renin and prorenin was identified.  Affinities for prorenin and renin were approx. 200 and 900 pmol/L, resp.  Binding was reversible, saturable, and pH and temp. dependent.  The relative binding capacities of membranes from various rat tissues were as follows (fmol/mg): renal cortex (55), liver (54), testis (63), lung (31), brain (18), renal medulla (15), adrenal (17), aorta (7), heart (4), and skeletal muscle (1).  Bound prorenin was displaced by rat and human renin or prorenin but not by the prosequence of rat prorenin, angiotensin I or II, rat or human angiotensinogen, the renin inhibitor SQ30697, atrial natriuretic factor, amylase, insulin, bovine serum albumin, Hb, heparin, lysozyme, ovalbumin, cytochrome C, pepsin, pepsinogen, RNase A, mannose-6-phosphate, α-Me mannoside, gonadotropin releasing hormone, or an antibody to hog renin binding protein.  These results demonstrate specific binding of prorenin to a site in rat tissues, herein named ProBP, that also binds renin.  It is possible that differences in prorenin/renin binding capacity det. the activity of tissue-directed renin-angiotensin systems and that prorenin is a natural antagonist.  Alternatively, a prorenin/renin receptor may have been identified that may function by transducing an intracellular signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM0L1WDIVlrLVg90H21EOLACvtfcHk0ljtiEysUHiNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktF2lsLc%253D&md5=2ab7238ba3a76444d6d04adb6ebfc10c</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2F0895-7061%2896%2900092-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0895-7061%252896%252900092-1%26sid%3Dliteratum%253Aachs%26aulast%3DSealey%26aufirst%3DJ.%2BE.%26aulast%3DCatanzaro%26aufirst%3DD.%2BF.%26aulast%3DLavin%26aufirst%3DT.%2BN.%26aulast%3DGahnem%26aufirst%3DF.%26aulast%3DPitarresi%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DL.%2BF.%26aulast%3DLaragh%26aufirst%3DJ.%2BH.%26atitle%3DSpecific%2520prorenin%252Frenin%2520binding%2520%2528ProBP%2529%253A%2520identification%2520and%2520characterization%2520of%2520a%2520novel%2520membrane%2520site%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D1996%26volume%3D9%26spage%3D491%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Campbell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentjin, A. J.</span><span> </span><span class="NLM_article-title">Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2F00004872-199408000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=7814847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFels7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=879-890&author=D.+J.+Campbellauthor=A.+J.+Valentjin&title=Identification+of+vascular+renin-binding+proteins+by+chemical+cross-linking%3A+inhibition+of+binding+of+renin+by+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of vascular renin-binding proteins by chemical cross-linking: Inhibition of binding of renin by renin inhibitors</span></div><div class="casAuthors">Campbell, Duncan J.; Valentijn, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">879-90</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    </div><div class="casAbstract">The objective of this study was to investigate the mechanism of tissue uptake of renin.  The binding of [125l]-labeled renin to membranes prepd. from various rat tissues was examd.  [125I]-labeled renins were cross-linked to membranes with disuccinimidyl suberate and analyzed by SDS-PAGE followed by autoradiog.  Mesenteric artery membranes bound both [125I]-labeled rat renin and [125I]-labeled mouse submandibular gland renin.  Crosslinking expts. showed two bands, one of relative mol. mass approx. 105,000 and the other of approx. 75,000.  After taking into account the mol. wt. of renin, these bands represent renin-binding proteins of relative mol. mass approx. 70,000 and approx. 40,000, resp.  The highest level of these binding proteins was in the mesenteric artery; lower levels were found in the aorta, lung and renal medulla.  Renin-binding proteins were also identified in membranes prepd. from cultured rat aortic smooth muscle cells.  No binding proteins were identified in the kidney cortex, heart, adrenal capsule, adrenal medulla, peri-aortic brown adipose tissue, uterus or pituitary.  Binding of renin to mesenteric artery membranes was prevented by inhibitors of renin enzymic activity (H-77 and SQ 30697); this effect of H-77 showed a dose-dependence parallel to the inhibition of renin activity by this compd., suggesting that the binding of H-77 to the active site of renin prevents its binding to the membranes.  These studies provide evidence for a vascular renin-binding mechanism, which may play a role in the generation of angiotensin peptides in vasculature, and may thus be a determinant of blood pressure.  Moreover, one of the actions of inhibitors of renin enzymic activity in vivo may be to prevent the binding of renin to the vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9p00KL5SdG7Vg90H21EOLACvtfcHk0lhXT3MNv7vZ7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFels7Y%253D&md5=c0bb1792aad7dd6b7df7df79d17c412b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1097%2F00004872-199408000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-199408000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DD.%2BJ.%26aulast%3DValentjin%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520vascular%2520renin-binding%2520proteins%2520by%2520chemical%2520cross-linking%253A%2520inhibition%2520of%2520binding%2520of%2520renin%2520by%2520renin%2520inhibitors%26jtitle%3DJ.%2520Hypertens.%26date%3D1994%26volume%3D12%26spage%3D879%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sraer, J. D.</span><span> </span><span class="NLM_article-title">Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fki.1996.511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=8943472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1GhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=1897-1903&author=G.+Nguyenauthor=F.+Delarueauthor=J.+Berrouauthor=E.+Rondeauauthor=J.+D.+Sraer&title=Specific+receptor+binding+of+renin+on+human+mesangial+cells+in+culture+increases+plasminogen+activator+inhibitor-1+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen</span></div><div class="casAuthors">Nguyen, Genevieve; Delarue, Francoise; Berrou, Jeannig; Rondeau, Eric; Sraer, Jean-Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1897-1903</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen.  Some proteases possess a membrane receptor that focalizes their proteolytic activity on the cell surface and may mediate a proliferative effect, such as urokinase on glomerular epithelial cells.  Since some hypertensive states are assocd. with high concns. of renin and proliferation of arteriolar smooth muscle cells, we asked whether renin, an aspartyl-protease, would bind to mesangial cells that are smooth-muscle derived cells, which would induce their proliferation.  The binding of 125I labeled recombinant human renin (125I-R) was studied on human primary mesangial cells and mesangial cells immortalized by transfection with SV40-T antigen.  At 37°, the binding of 125I-R was time dependent and reached a plateau after two hours.  The 125I-R bound in a saturable and specific manner with a Kd = 0.4 nM and 1 nM and 8000 and 2000 binding sites/cell, for primary and immortalized cells, resp.  When binding expts. were performed in the presence RO 42-5892, a synthetic inhibitor of renin, RO 42-5892 could inhibit the specific binding of labeled renin only at concns. 1000 times superior to the IC 50, indicating that the renin-mesangial receptor interaction did not depend on the active site of renin.  Anal. by SDS-PAGE and autoradiog. of crosslinking expts. of 125I-R bound to a membrane prepn. showed a band of approx. 110 to 120 kDa, suggesting a Mr of 70 to 80 kDa for the renin receptor.  Incubation of mesangial cells with 100 nM renin for 24 h provoked a 100% increase of 3H thymidine incorporation that was not accompanied by an increase of the cell no., even after a seven day period of incubation.  However, the incubation of mesangial cells with renin for 24 h induced a significant increase (170% of control) of plasminogen activator inhibitor-1 (PAI1) antigen in the conditioned medium.  In conclusion, we have shown that human mesangial cells in culture express a specific receptor for renin, and that the binding of renin increases 3H thymidine incorporation independently of renin enzymic activity.  The absence of cell proliferation, the increase of 3H thymidine incorporation and the increase of PAI1 antigen suggest that the binding of renin can induce mesangial cell activation, which is reflected by a change in the fibrinolytic capacity of the cells.  The role of this receptor remains to be detd. in nephropathies and hypertensive states assocd. with high plasma/tissue renin concns., hypertrophy of mesangial or smooth muscle cells and extracellular matrix remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_934uhjKYybVg90H21EOLACvtfcHk0lhXT3MNv7vZ7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1GhsA%253D%253D&md5=93bfc0c53dd443cba3d5bc4bc6b931d9</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1038%2Fki.1996.511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.1996.511%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDelarue%26aufirst%3DF.%26aulast%3DBerrou%26aufirst%3DJ.%26aulast%3DRondeau%26aufirst%3DE.%26aulast%3DSraer%26aufirst%3DJ.%2BD.%26atitle%3DSpecific%2520receptor%2520binding%2520of%2520renin%2520on%2520human%2520mesangial%2520cells%2520in%2520culture%2520increases%2520plasminogen%2520activator%2520inhibitor-1%2520antigen%26jtitle%3DKidney%2520Int.%26date%3D1996%26volume%3D50%26spage%3D1897%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Saris, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derkx, F. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalekamp, M. A. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Cardiomyocytes bind and activate native human prorenin: role of soluble mannose 6-phosphate receptors</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2001&pages=710-715&author=J.+J.+Sarisauthor=F.+H.+M.+Derkxauthor=J.+M.+J.+Lamersauthor=P.+R.+Saxenaauthor=M.+A.+D.+H.+Schalekampauthor=A.+H.+J.+Danser&title=Cardiomyocytes+bind+and+activate+native+human+prorenin%3A+role+of+soluble+mannose+6-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaris%26aufirst%3DJ.%2BJ.%26aulast%3DDerkx%26aufirst%3DF.%2BH.%2BM.%26aulast%3DLamers%26aufirst%3DJ.%2BM.%2BJ.%26aulast%3DSaxena%26aufirst%3DP.%2BR.%26aulast%3DSchalekamp%26aufirst%3DM.%2BA.%2BD.%2BH.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DCardiomyocytes%2520bind%2520and%2520activate%2520native%2520human%2520prorenin%253A%2520role%2520of%2520soluble%2520mannose%25206-phosphate%2520receptors%26jtitle%3DHypertension%26date%3D2001%26volume%3D37%26spage%3D710%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit149b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Saris, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Eijnden, M. M. E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalekamp, M. A. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=573-577&author=J.+J.+Sarisauthor=M.+M.+E.+D.+van+den+Eijndenauthor=J.+M.+J.+Lamersauthor=P.+R.+Saxenaauthor=M.+A.+D.+H.+Schalekampauthor=A.+H.+J.+Danser&title=Prorenin-induced+myocyte+proliferation%3A+no+role+for+intracellular+angiotensin+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaris%26aufirst%3DJ.%2BJ.%26aulast%3Dvan%2Bden%2BEijnden%26aufirst%3DM.%2BM.%2BE.%2BD.%26aulast%3DLamers%26aufirst%3DJ.%2BM.%2BJ.%26aulast%3DSaxena%26aufirst%3DP.%2BR.%26aulast%3DSchalekamp%26aufirst%3DM.%2BA.%2BD.%2BH.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DProrenin-induced%2520myocyte%2520proliferation%253A%2520no%2520role%2520for%2520intracellular%2520angiotensin%2520II%26jtitle%3DHypertension%26date%3D2002%26volume%3D39%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcklé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzhir, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sraer, J. D.</span><span> </span><span class="NLM_article-title">Pivotal role for the renin/prorenin receptor in angiotensin II production and cellular responses to renin</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=1417-1427&author=G.+Nguyenauthor=F.+Delarueauthor=C.+Burckl%C3%A9author=L.+Bouzhirauthor=T.+Gillerauthor=J.+D.+Sraer&title=Pivotal+role+for+the+renin%2Fprorenin+receptor+in+angiotensin+II+production+and+cellular+responses+to+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDelarue%26aufirst%3DF.%26aulast%3DBurckl%25C3%25A9%26aufirst%3DC.%26aulast%3DBouzhir%26aufirst%3DL.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DSraer%26aufirst%3DJ.%2BD.%26atitle%3DPivotal%2520role%2520for%2520the%2520renin%252Fprorenin%2520receptor%2520in%2520angiotensin%2520II%2520production%2520and%2520cellular%2520responses%2520to%2520renin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D1417%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Border, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">E810</span><span class="NLM_x">–</span> <span class="NLM_lpage">E819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2008&pages=E810-E819&author=J.+Zhangauthor=N.+A.+Nobleauthor=W.+A.+Borderauthor=R.+T.+Owensauthor=Y.+Huang&title=Receptor-dependent+prorenin+activation+and+induction+of+PAI-1+expression+in+vascular+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DNoble%26aufirst%3DN.%2BA.%26aulast%3DBorder%26aufirst%3DW.%2BA.%26aulast%3DOwens%26aufirst%3DR.%2BT.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DReceptor-dependent%2520prorenin%2520activation%2520and%2520induction%2520of%2520PAI-1%2520expression%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2008%26volume%3D295%26spage%3DE810%26epage%3DE819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vongamorntham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Border, W.</span><span> </span><span class="NLM_article-title">Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1038%2Fsj.ki.5000011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=16374430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Wqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=105-113&author=Y.+Huangauthor=S.+Vongamornthamauthor=J.+Kastingauthor=D.+McQuillanauthor=R.+T.+Owensauthor=L.+Yuauthor=N.+A.+Nobleauthor=W.+Border&title=Renin+increases+mesangial+cell+transforming+growth+factor-%CE%B21+and+matrix+proteins+through+receptor-mediated%2C+angiotensin+II-independent+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms</span></div><div class="casAuthors">Huang, Y.; Wongamorntham, S.; Kasting, J.; McQuillan, D.; Owens, R. T.; Yu, L.; Noble, N. A.; Border, W.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent evidence suggesting a strong interplay between components of the renin-angiotensin system and key mediators of fibrosis led us to hypothesize that renin, independent of its enzymic action to enhance angiotensin (Ang) II synthesis, directly increases prodn. of the fibrogenic cytokine transforming growth factor (TGF)-β.  Human or rat mesangial cells (MCs) were treated with human recombinant renin (HrRenin) or rat recombinant renin (RrRenin) and the effects on TGF-β1, plasminogen activator inhibitor-type 1 (PAI-1), fibronectin (FN) and collagen 1 mRNA and protein were investigated.  Blockade of the rat MC renin receptor was achieved using siRNA.  HrRenin or RrRenin, at doses shown to be physiol. relevant, induced marked dose- and time-dependent increases in TGF-β1.  These effects were not altered by adding an inhibitor of renin's enzymic action (RO 42-5892), the Ang II receptor antagonist losartan or the Ang-converting enzyme inhibitor enalapril.  RrRenin also induced PAI-1, FN and collagen 1 mRNA and PAI-1 and FN protein in a dose-dependent manner.  Neutralizing antibodies to TGF-β partially blocked these effects.  Supernatant and cell lysate Ang I and Ang II levels were extremely low.  MC angiotensinogen mRNA was undetectable both with and without added renin.  Targeting of the rat renin receptor mRNA with siRNA blocked induction of TGF-β1.  We conclude that renin upregulates MC TGF-β1 through a receptor-mediated mechanism, independent of Ang II generation or action.  Renin-induced increases in TGF-β1 in turn stimulate increases in PAI-1, FN and collagen I.  Thus, renin may contribute to renal fibrotic disease, particularly when therapeutic Ang II blockade elevates plasma renin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbvVeEXdd79LVg90H21EOLACvtfcHk0ljeKvbgrVxpew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Wqtw%253D%253D&md5=11d058756975831d5019413894aa46da</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.5000011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.5000011%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DVongamorntham%26aufirst%3DS.%26aulast%3DKasting%26aufirst%3DJ.%26aulast%3DMcQuillan%26aufirst%3DD.%26aulast%3DOwens%26aufirst%3DR.%2BT.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DNoble%26aufirst%3DN.%2BA.%26aulast%3DBorder%26aufirst%3DW.%26atitle%3DRenin%2520increases%2520mesangial%2520cell%2520transforming%2520growth%2520factor-%25CE%25B21%2520and%2520matrix%2520proteins%2520through%2520receptor-mediated%252C%2520angiotensin%2520II-independent%2520mechanisms%26jtitle%3DKidney%2520Int.%26date%3D2006%26volume%3D69%26spage%3D105%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasir, U .M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span> </span><span class="NLM_article-title">Human prorenin has “gate and handle” regions for its non-proteolytic activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">22217</span><span class="NLM_x">–</span> <span class="NLM_lpage">22222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22217-22222&author=F.+Suzukiauthor=M.+Hayakawaauthor=T.+Nakagawaauthor=U+.M.+Nasirauthor=A.+Ebiharaauthor=A.+Iwasawaauthor=Y.+Ishidaauthor=Y.+Nakamuraauthor=K.+Murakami&title=Human+prorenin+has+%E2%80%9Cgate+and+handle%E2%80%9D+regions+for+its+non-proteolytic+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DNasir%26aufirst%3DU%2B.M.%26aulast%3DEbihara%26aufirst%3DA.%26aulast%3DIwasawa%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DMurakami%26aufirst%3DK.%26atitle%3DHuman%2520prorenin%2520has%2520%25E2%2580%259Cgate%2520and%2520handle%25E2%2580%259D%2520regions%2520for%2520its%2520non-proteolytic%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22217%26epage%3D22222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Batenburg, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, R. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burckle, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2241</span><span class="NLM_x">–</span> <span class="NLM_lpage">2453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3282f05bae" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=2241-2453&author=W.+W.+Batenburgauthor=M.+Kropauthor=I.+M.+Garreldsauthor=R.+de+Vriesauthor=R.+J.+A.+de+Bruinauthor=C.+A.+Burckleauthor=D.+N.+M%C3%BCllerauthor=M.+Baderauthor=G.+Nguyenauthor=A.+H.+J.+Danser&title=Prorenin+is+the+endogenous+agonist+of+the+%28pro%29renin+receptor.+Binding+kinetics+of+renin+and+prorenin+in+rat+vascular+smooth+muscle+cells+overexpressing+the+human+%28pro%29renin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3282f05bae&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3282f05bae%26sid%3Dliteratum%253Aachs%26aulast%3DBatenburg%26aufirst%3DW.%2BW.%26aulast%3DKrop%26aufirst%3DM.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3Dde%2BVries%26aufirst%3DR.%26aulast%3Dde%2BBruin%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DBurckle%26aufirst%3DC.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DProrenin%2520is%2520the%2520endogenous%2520agonist%2520of%2520the%2520%2528pro%2529renin%2520receptor.%2520Binding%2520kinetics%2520of%2520renin%2520and%2520prorenin%2520in%2520rat%2520vascular%2520smooth%2520muscle%2520cells%2520overexpressing%2520the%2520human%2520%2528pro%2529renin%2520receptor%26jtitle%3DJ.%2520Hypertens.%26date%3D2007%26volume%3D25%26spage%3D2241%26epage%3D2453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Gratze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malchow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeske, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engeli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contrepas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plehm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Energy metabolism in human renin-gene transgenic rats: Does renin contribute to obesity?</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=516-523&author=P.+Gratzeauthor=M.+Boschmannauthor=F.+Dechendauthor=F.+Qadiauthor=J.+Malchowauthor=S.+Graeskeauthor=S.+Engeliauthor=J.+Jankeauthor=J.+Springerauthor=A.+Contrepasauthor=R.+Plehmauthor=S.+Klausauthor=G.+Nguyenauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=Energy+metabolism+in+human+renin-gene+transgenic+rats%3A+Does+renin+contribute+to+obesity%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGratze%26aufirst%3DP.%26aulast%3DBoschmann%26aufirst%3DM.%26aulast%3DDechend%26aufirst%3DF.%26aulast%3DQadi%26aufirst%3DF.%26aulast%3DMalchow%26aufirst%3DJ.%26aulast%3DGraeske%26aufirst%3DS.%26aulast%3DEngeli%26aufirst%3DS.%26aulast%3DJanke%26aufirst%3DJ.%26aulast%3DSpringer%26aufirst%3DJ.%26aulast%3DContrepas%26aufirst%3DA.%26aulast%3DPlehm%26aufirst%3DR.%26aulast%3DKlaus%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DEnergy%2520metabolism%2520in%2520human%2520renin-gene%2520transgenic%2520rats%253A%2520Does%2520renin%2520contribute%2520to%2520obesity%253F%26jtitle%3DHypertension%26date%3D2009%26volume%3D53%26spage%3D516%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Uehara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikibe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span> </span><span class="NLM_article-title">Late-onset obesity in mice transgenic for the human renin gene</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=12736712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFSlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=723-727&author=S.+Ueharaauthor=M.+Tsuchidaauthor=T.+Kannoauthor=M.+Sasakiauthor=M.+Nishikibeauthor=A.+Fukamizu&title=Late-onset+obesity+in+mice+transgenic+for+the+human+renin+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Late-onset obesity in mice transgenic for the human renin gene</span></div><div class="casAuthors">Uehara, Sayuri; Tsuchida, Minoru; Kanno, Tetsuya; Sasaki, Minoru; Nishikibe, Masaru; Fukamizu, Akiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-727</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">We previously generated a strain of transgenic mice carrying the human renin gene, hRN8-12, in the background of C57BL/6j.  In this study, the authors discovered that hRN8-12 male mice, but not females, developed obesity starting at 15 wk of age.  The body wt. of 60-wk-old male transgenic mice was 2 times higher than that of age-matched wild-type mice.  Interestingly, male mice heterozygous for the human renin gene showed moderate wt. gain compared with transgenic and wild-type mice.  Obese hRN8-12 mice exhibited hyperglycemia, hyperinsulinemia, hyperleptinemia, and hyperlipidemia, and increase in wt. in the adipose tissue, liver, heart, and kidneys.  Histol. anal. demonstrated that fatty hRN8-12 mice developed hypertrophy of pancreatic islets and fatty liver.  These results suggested that hRN8-12 mice are assocd. with obesity dependent on the transgene dosage and should be a genetic model for late-onset obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs_uBLv_2zg7Vg90H21EOLACvtfcHk0ljsXkFdEGYuFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFSlt78%253D&md5=c8db23419c35e1e8822a124e1745550b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DS.%26aulast%3DTsuchida%26aufirst%3DM.%26aulast%3DKanno%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DNishikibe%26aufirst%3DM.%26aulast%3DFukamizu%26aufirst%3DA.%26atitle%3DLate-onset%2520obesity%2520in%2520mice%2520transgenic%2520for%2520the%2520human%2520renin%2520gene%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2003%26volume%3D11%26spage%3D723%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Burckle, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrelds, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasc, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plehm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span> </span><span class="NLM_article-title">Elevated blood pressure and heart rate in human renin receptor transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=552-556&author=C.+A.+Burckleauthor=A.+H.+J.+Danserauthor=D.+N.+M%C3%BCllerauthor=I.+M.+Garreldsauthor=J.+M.+Gascauthor=E.+Popovaauthor=R.+Plehmauthor=J.+Petersauthor=M.+Baderauthor=G.+Nguyen&title=Elevated+blood+pressure+and+heart+rate+in+human+renin+receptor+transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurckle%26aufirst%3DC.%2BA.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DGarrelds%26aufirst%3DI.%2BM.%26aulast%3DGasc%26aufirst%3DJ.%2BM.%26aulast%3DPopova%26aufirst%3DE.%26aulast%3DPlehm%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DJ.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26atitle%3DElevated%2520blood%2520pressure%2520and%2520heart%2520rate%2520in%2520human%2520renin%2520receptor%2520transgenic%2520rats%26jtitle%3DHypertension%26date%3D2006%26volume%3D47%26spage%3D552%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Ichihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurauchi-Mito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneshiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, H.</span><span> </span><span class="NLM_article-title">Renin, prorenin and the kidney: a new chapter in an old saga</span> <span class="citation_source-journal">J. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19557706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=306-311&author=A.+Ichiharaauthor=M.+Sakodaauthor=A.+Kurauchi-Mitoauthor=Y.+Kaneshiroauthor=H.+Itoh&title=Renin%2C+prorenin+and+the+kidney%3A+a+new+chapter+in+an+old+saga"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Renin, prorenin and the kidney: a new chapter in an old saga</span></div><div class="casAuthors">Ichihara, Atsuhiro; Sakoda, Mariyo; Kurauchi-Mito, Asako; Kaneshiro, Yuki; Itoh, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-311</span>CODEN:
                <span class="NLM_cas:coden">JLNEEL</span>;
        ISSN:<span class="NLM_cas:issn">1121-8428</span>.
    
            (<span class="NLM_cas:orgname">Wichtig Editore</span>)
        </div><div class="casAbstract">A review.  The binding of prorenin to the (pro)renin receptor triggers 2 major pathways: a nonproteolytic conformational change in prorenin to its active form (angiotensin II-dependent pathway) and an intracellular pathway via the (pro)renin receptor itself (angiotensin II-independent pathway).  In diabetic animals, an increased plasma prorenin level not only causes the generation of angiotensin II via the angiotensin II-dependent pathway, it also stimulates the (pro)renin receptor's own intracellular signaling pathway in a manner that is independent of the generated angiotensin II.  Thus, the administration of a "handle" region peptide (HRP), which acts as a decoy peptide and competitively inhibits the binding of prorenin to the (pro)renin receptor, has a beneficial effect in the kidneys of diabetic animals with low plasma renin levels.  However, the benefits of HRP are slightly reduced in animal models of essential hypertension with relatively high plasma renin levels, and these benefits disappear altogether in animal models of hypertension with extremely high plasma renin levels.  Thus, in the kidneys of animal models of diabetes and/or hypertension, both renin and prorenin competitively bind to the (pro)renin receptor and contribute to the pathophysiol. of nephropathy.  Consequently, renin, prorenin and the (pro) renin receptor may be important therapeutic targets for the prevention and regression of nephropathy in patients with diabetes and/or hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoUEvjSQ3cLVg90H21EOLACvtfcHk0lhkIiLqHDZAFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WitbjJ&md5=d36818709eaa46d36ba1b89bd10b07f3</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIchihara%26aufirst%3DA.%26aulast%3DSakoda%26aufirst%3DM.%26aulast%3DKurauchi-Mito%26aufirst%3DA.%26aulast%3DKaneshiro%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DH.%26atitle%3DRenin%252C%2520prorenin%2520and%2520the%2520kidney%253A%2520a%2520new%2520chapter%2520in%2520an%2520old%2520saga%26jtitle%3DJ.%2520Nephrol.%26date%3D2009%26volume%3D22%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Feldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batenburg, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maschke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvakan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Febeler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burckle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contrepas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span> </span><span class="NLM_article-title">Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=682-688&author=S.+Feldtauthor=W.+W.+Batenburgauthor=I.+Mazakauthor=U.+Maschkeauthor=M.+Wellnerauthor=H.+Kvakanauthor=R.+Dechendauthor=A.+Febelerauthor=C.+Burckleauthor=A.+Contrepasauthor=A.+H.+J.+Danserauthor=M.+Baderauthor=G.+Nguyenauthor=F.+C.+Luftauthor=D.+N.+M%C3%BCller&title=Prorenin+and+renin-induced+extracellular+signal-regulated+kinase+1%2F2+activation+in+monocytes+is+not+blocked+by+aliskiren+or+the+handle-region+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DBatenburg%26aufirst%3DW.%2BW.%26aulast%3DMazak%26aufirst%3DI.%26aulast%3DMaschke%26aufirst%3DU.%26aulast%3DWellner%26aufirst%3DM.%26aulast%3DKvakan%26aufirst%3DH.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DFebeler%26aufirst%3DA.%26aulast%3DBurckle%26aufirst%3DC.%26aulast%3DContrepas%26aufirst%3DA.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26atitle%3DProrenin%2520and%2520renin-induced%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520activation%2520in%2520monocytes%2520is%2520not%2520blocked%2520by%2520aliskiren%2520or%2520the%2520handle-region%2520peptide%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D682%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Mercure, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silversides, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reudelhuber, T. L.</span><span> </span><span class="NLM_article-title">Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1062</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1062-1069&author=C.+Mercureauthor=G.+Prescottauthor=M.+J.+Lacombeauthor=D.+W.+Silversidesauthor=T.+L.+Reudelhuber&title=Chronic+increases+in+circulating+prorenin+are+not+associated+with+renal+or+cardiac+pathologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercure%26aufirst%3DC.%26aulast%3DPrescott%26aufirst%3DG.%26aulast%3DLacombe%26aufirst%3DM.%2BJ.%26aulast%3DSilversides%26aufirst%3DD.%2BW.%26aulast%3DReudelhuber%26aufirst%3DT.%2BL.%26atitle%3DChronic%2520increases%2520in%2520circulating%2520prorenin%2520are%2520not%2520associated%2520with%2520renal%2520or%2520cardiac%2520pathologies%26jtitle%3DHypertension%26date%3D2009%26volume%3D53%26spage%3D1062%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Peters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisk, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuttler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.</span><span> </span><span class="NLM_article-title">Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3282f0ab66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18090546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=102-109&author=B.+Petersauthor=O.+Griskauthor=B.+Becherauthor=H.+Wankaauthor=B.+Kuttlerauthor=J.+Ludemannauthor=G.+Lorenzauthor=R.+Rettigauthor=J.+J.+Mullinsauthor=J.+Peters&title=Dose-dependent+titration+of+prorenin+and+blood+pressure+in+Cyp1a1ren-2+transgenic+rats%3A+absence+of+prorenin-induced+glomerulosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-dependent titration of prorenin and blood pressure in Cyp1a1/ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis</span></div><div class="casAuthors">Peters, Barbara; Grisk, Olaf; Becher, Bertram; Wanka, Heike; Kuttler, Beate; Luedemann, Jan; Lorenz, Gerd; Rettig, Rainer; Mullins, John J.; Peters, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Prorenin has been assocd. with cardiovascular disease and the development of glomerulosclerosis via a renin/prorenin receptor.  In cyp1a1/ren-2 transgenic rats, prorenin levels and arterial pressure can be increased by oral administration of indole-3-carbinol (I3C).  The transgenic strain has been used as a model of malignant hypertension.  Methods: The present study was designed to test the hypotheses that (i) low doses of I3C would result in dose-dependent sustained increases in arterial pressure without signs of malignancy, making cyp1a1ren-2 transgenic rats a useful model to study nonmalignant hypertension, and (ii) cyp1a1ren-2 transgenic rats would develop glomerulosclerosis when they were chronically exposed to 0.125% I3C in their diet.  Results: I3C treatment for 2 wk resulted in increases of plasma prorenin concns. and arterial pressure in a dose-dependent manner.  Rats thrived well over a period of 12 wk on dietary I3C concns. (wt./wt.) of 0.125%.  Plasma prorenin concn. rose from 0.1±0.1 μg to 17.9±5.0 μg angiotensin I/mL per h (P < 0.01) and mean arterial pressure increased to a plateau of 170±5 mmHg (P < 0.001) between weeks 6 and 12.  After 12 wk of 0.125% I3C, rats exhibited moderate hypertensive renal vasculopathy, but no histol. signs of glomerulosclerosis.  Conclusions: The cyp1a1ren-2 transgenic rat model allows for chronic dose-dependent titrn. of arterial pressure by a simple and non-invasive intervention, making this strain a useful model to study malignant and nonmalignant arterial hypertension.  High circulating prorenin levels per se do not cause glomerulosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfUFxN4IRzsLVg90H21EOLACvtfcHk0lg-_poug2onhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrjI&md5=4c36f176dbe727636d20cfab50051b24</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3282f0ab66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3282f0ab66%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DB.%26aulast%3DGrisk%26aufirst%3DO.%26aulast%3DBecher%26aufirst%3DB.%26aulast%3DWanka%26aufirst%3DH.%26aulast%3DKuttler%26aufirst%3DB.%26aulast%3DLudemann%26aufirst%3DJ.%26aulast%3DLorenz%26aufirst%3DG.%26aulast%3DRettig%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.%26atitle%3DDose-dependent%2520titration%2520of%2520prorenin%2520and%2520blood%2520pressure%2520in%2520Cyp1a1ren-2%2520transgenic%2520rats%253A%2520absence%2520of%2520prorenin-induced%2520glomerulosclerosis%26jtitle%3DJ.%2520Hypertens.%26date%3D2008%26volume%3D26%26spage%3D102%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Batenburg, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, R. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gool, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danser, A. H. J.</span><span> </span><span class="NLM_article-title">Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1161%2FATVBAHA.108.164210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18388329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFOju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1151-1157&author=W.+W.+Batenburgauthor=R.+J.+A.+de+Bruinauthor=J.+M.+G.+van+Goolauthor=D.+N.+M%C3%BCllerauthor=M.+Baderauthor=G.+Nguyenauthor=A.+H.+J.+Danser&title=Aliskiren-binding+increases+the+half+life+of+renin+and+prorenin+in+rat+aortic+vascular+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren-Binding Increases the Half Life of Renin and Prorenin in Rat Aortic Vascular Smooth Muscle Cells</span></div><div class="casAuthors">Batenburg, Wendy W.; de Bruin, Rene J. A.; van Gool, Jeanette M. G.; Mueller, Dominik N.; Bader, Michael; Nguyen, Genevieve; Danser, A. H. Jan</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1151-1157</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Renin inhibition with aliskiren was reported to cause a greater rise in renin than other types of renin-angiotensin system blockade, thereby potentially leading to angiotensin generation or stimulation of the human (pro)renin receptor (h(P)RR).  Here we studied whether this rise in renin is attributable to an aliskiren-induced change in the prorenin conformation, allowing its detection in renin assays, or a change in renin/prorenin clearance.  We also investigated whether aliskiren affects (pro)renin binding to its receptors, using rat aortic vascular smooth muscle cells (VSMCs) overexpressing the h(P)RR.  A 48-h incubation with aliskiren at 4°C converted the prorenin conformation from "closed" to "open," thus allowing its recognition in active site-directed renin assays.  VSMCs accumulated (pro)renin through binding to mannose 6-phosphate receptors (M6PRs) and h(P)RRs.  Aliskiren did not affect binding at 4°C.  At 37°C, aliskiren increased (pro)renin accumulation up to 40-fold, and M6PR blockade prevented this.  Aliskiren increased the intracellular half life of prorenin 2 to 3 times.  Aliskiren allows the detection of prorenin as renin, and decreases renin/prorenin clearance.  Both phenomena may contribute to the "renin" surge during aliskiren treatment, but because they depend on aliskiren binding, they will not result in angiotensin generation.  Aliskiren does not affect (pro)renin binding to its receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWj4Wx1I38OLVg90H21EOLACvtfcHk0lg-_poug2onhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFOju7w%253D&md5=877f46b58c65040e3447c5f969cd49cb</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.108.164210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.108.164210%26sid%3Dliteratum%253Aachs%26aulast%3DBatenburg%26aufirst%3DW.%2BW.%26aulast%3Dde%2BBruin%26aufirst%3DR.%2BJ.%2BA.%26aulast%3Dvan%2BGool%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DDanser%26aufirst%3DA.%2BH.%2BJ.%26atitle%3DAliskiren-binding%2520increases%2520the%2520half%2520life%2520of%2520renin%2520and%2520prorenin%2520in%2520rat%2520aortic%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D1151%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Siragy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, D. C.</span><span> </span><span class="NLM_article-title">The development of the direct renin inhibitor aliskiren: treating hypertension and beyond</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1517%2F14728214.13.3.417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18764720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGksbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=417-430&author=H.+Siragyauthor=J.+Huangauthor=D.+C.+Lieb&title=The+development+of+the+direct+renin+inhibitor+aliskiren%3A+treating+hypertension+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The development of the direct renin inhibitor aliskiren: treating hypertension and beyond</span></div><div class="casAuthors">Siragy, Helmy; Huang, Jiqian; Lieb, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-430</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Direct renin inhibitors such as aliskiren offer a novel way of treating hypertension and its co-morbidities, conditions with a considerable prevalence, morbidity, and mortality worldwide.  The burden of hypertension worldwide and the role of the renin-angiotensin-aldosterone system in this disease will be reviewed.  Current treatments for hypertension and its co-morbidities that work by manipulating this system will be discussed.  The development of, and clin. trials involving, direct renin inhibitors will be reviewed, with a focus on aliskiren.  PubMed was utilized to search the most recent literature on the topics of the renin-angiotensin-aldosterone system, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone and aliskiren.  The direct renin inhibitors, including aliskiren, are new agents with great promise for the treatment of hypertension and its co-morbid conditions, including renal and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiscewUlIRULVg90H21EOLACvtfcHk0lg-_poug2onhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGksbvE&md5=96962356e25f3f047bfa41bf540fbecd</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1517%2F14728214.13.3.417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.13.3.417%26sid%3Dliteratum%253Aachs%26aulast%3DSiragy%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLieb%26aufirst%3DD.%2BC.%26atitle%3DThe%2520development%2520of%2520the%2520direct%2520renin%2520inhibitor%2520aliskiren%253A%2520treating%2520hypertension%2520and%2520beyond%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26spage%3D417%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarugula, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieterich, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics and pharmacodynamics of aliskiren</span> <span class="citation_source-journal">Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.2165%2F00003088-200847080-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=515-531&author=S.+Vaidyanathanauthor=V.+Jarugulaauthor=H.+A.+Dieterichauthor=D.+Howardauthor=W.+P.+Dole&title=Clinical+pharmacokinetics+and+pharmacodynamics+of+aliskiren"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics and pharmacodynamics of aliskiren</span></div><div class="casAuthors">Vaidyanathan, Sujata; Jarugula, Venkateswar; Dieterich, Hans Armin; Howard, Dan; Dole, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">515-531</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Aliskiren is the first orally bioavailable direct renin inhibitor approved for the treatment of hypertension.  It acts at the point of activation of the renin-angiotensin-aldosterone system, or renin system, inhibiting the conversion of angiotensinogen to angiotensin I by renin and thereby reducing the formation of angiotensin II by angiotensin-converting enzyme (ACE) and ACE-independent pathways.  Aliskiren is a highly potent inhibitor of human renin in vitro (concn. of aliskiren that produces 50% inhibition of renin 0.6 nmol/L).  Aliskiren is rapidly absorbed following oral administration, with max. plasma concns. reached within 1-3 h.  The abs. bioavailability of aliskiren is 2.6%.  The binding of aliskiren to plasma proteins is moderate (47-51%) and is independent of the concn.  Once absorbed, aliskiren is eliminated through the hepatobiliary route as unchanged drug and, to a lesser extent, through oxidative metab. by cytochrome P 450 (CYP) 3A4.  Unchanged aliskiren accounts for approx. 80% of the drug in the plasma following oral administration, indicating low exposure to metabolites.  The two major oxidized metabolites of aliskiren account for less than 5% of the drug in the plasma at the time of the max. concn.  Aliskiren excretion is almost completely via the biliary/faecal route; 0.6% of the dose is recovered in the urine.  Steady-state plasma concns. of aliskiren are reached after 7-8 days of once-daily dosing, and the accumulation factor for aliskiren is approx. 2.  After reaching the peak, the aliskiren plasma concn. declines in a multiphasic fashion.  No clin. relevant effects of gender or race on the pharmacokinetics of aliskiren are obsd., and no adjustment of the initial aliskiren dose is required for elderly patients or for patients with renal or hepatic impairment.  Aliskiren showed no clin. significant increases in exposure during coadministration with a wide range of potential concomitant medications, although increases in exposure were obsd. with P-glycoprotein inhibitors.  Aliskiren does not inhibit or induce CYP isoenzyme or P-glycoprotein activity, although aliskiren is a substrate for P-glycoprotein, which contributes to its relatively low bioavailability.  Aliskiren is approved for the treatment of hypertension at once-daily doses of 150 mg and 300 mg.  Phase II and III clin. studies involving over 12 000 patients with hypertension have demonstrated that aliskiren provides effective long-term blood pressure (BP) lowering with a good safety and tolerability profile at these doses.  Aliskiren inhibits plasma renin activity (PRA) by up to 80% following both single and multiple oral-dose administration.  Similar redns. in PRA are obsd. when aliskiren is administered in combination with agents that alone increase PRA, including diuretics (hydrochlorothiazide, furosemide [frusemide]), ACE inhibitors (ramipril) and angiotensin receptor blockers (valsartan), despite greater increases in the plasma renin concn.  Moreover, PRA inhibition and BP redns. persist for 2-4 wk after stopping treatment, which is likely to be of benefit in patients with hypertension who occasionally miss a dose of medication.  Preliminary data on the antiproteinuric effects of aliskiren in type 2 diabetes mellitus suggest that renoprotective effects beyond BP lowering may be possible.  Further studies to evaluate the effects of aliskiren on cardiovascular outcomes and target organ protection are ongoing and will provide important new data on the role of direct renin inhibition in the management of hypertension and other cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOi0XS9g937rVg90H21EOLACvtfcHk0lg-_poug2onhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOgu7fK&md5=e06e0184b56b84d51e945d67cd116831</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.2165%2F00003088-200847080-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200847080-00002%26sid%3Dliteratum%253Aachs%26aulast%3DVaidyanathan%26aufirst%3DS.%26aulast%3DJarugula%26aufirst%3DV.%26aulast%3DDieterich%26aufirst%3DH.%2BA.%26aulast%3DHoward%26aufirst%3DD.%26aulast%3DDole%26aufirst%3DW.%2BP.%26atitle%3DClinical%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520aliskiren%26jtitle%3DClin.%2520Pharm.%26date%3D2008%26volume%3D47%26spage%3D515%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Fisher, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Is there a future for renin inhibitors?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=417-426&author=N.+D.+Fisherauthor=N.+K.+Hollenberg&title=Is+there+a+future+for+renin+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DIs%2520there%2520a%2520future%2520for%2520renin%2520inhibitors%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D10%26spage%3D417%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jermany, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizot, M.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camisasca, R.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1365-2125.2006.02696.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17118124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlarug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=690-698&author=S.+Vaidyanathanauthor=J.+Jermanyauthor=C.+M.+Yehauthor=M.-N.+Bizotauthor=R.+Camisasca&title=Aliskiren%2C+a+novel+orally+effective+renin+inhibitor%2C+exhibits+similar+pharmacokinetics+and+pharmacodynamics+in+Japanese+and+Caucasian+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in japanese and Caucasian subjects</span></div><div class="casAuthors">Vaidyanathan, Sujata; Jermany, Joanne; Yeh, ChingMing; Bizot, Marie-Noelle; Camisasca, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">690-698</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension.  This study compared the pharmacokinetic and pharmacodynamic properties of aliskiren in Japanese and Caucasian subjects.  Methods: In this open-label, single-center, parallel-group, single- and multiple-dose study, 19 Japanese and 19 Caucasian healthy young male subjects received a single 300-mg oral dose of aliskiren on day 1 and then aliskiren 300 mg once daily on days 4-10.  Blood samples were collected for the measurement of plasma aliskiren concn., plasma renin concn. (PRC) and plasma renin activity (PRA).  Results: Pharmacokinetic parameters were comparable in Japanese and Caucasian subjects following administration of a single dose of aliskiren (ratio of geometric means: Cmax 1.12 [90% confidence interval Cl) 0.88, 1.43]; AUC0-72 h 1.19 [90% Cl 1.02, 1.39] and at steady state mean ratio: Cmax 1.30 (90% Cl 1.00, 1.70); AUC0-τ 1.16 (90% Cl 0.95, 1.41).  There was no notable difference in the plasma half-life of aliskiren between Japanese and Caucasian groups (29.7 ± 10.2 h and 32.0 ± 6.6 h, resp.).  At steady state, peak PRC level and AUC for the concn.-time plot were not significantly different between Japanese and Caucasian subjects (P = 0.64 and P = 0.80, resp.).  A single oral dose of aliskiren significantly reduced PRA to a similar extent in Japanese and Caucasian subjects (by 87.5% and 85.7%, resp., compared with baseline; P < 0.01).  Aliskiren was well tolerated by both ethnic groups.  Conclusions: The oral renin inhibitor aliskiren demonstrated similar pharmacokinetic and pharmacodynamic properties in Japanese and Caucasian subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooFoj4KsUq-LVg90H21EOLACvtfcHk0liWIREGWjiCTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlarug%253D%253D&md5=8ab2d4d3ebc2284f533cdc6ce34fd700</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2006.02696.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2006.02696.x%26sid%3Dliteratum%253Aachs%26aulast%3DVaidyanathan%26aufirst%3DS.%26aulast%3DJermany%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DC.%2BM.%26aulast%3DBizot%26aufirst%3DM.-N.%26aulast%3DCamisasca%26aufirst%3DR.%26atitle%3DAliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%252C%2520exhibits%2520similar%2520pharmacokinetics%2520and%2520pharmacodynamics%2520in%2520Japanese%2520and%2520Caucasian%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D62%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Waldmeier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaenzel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiberling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valencia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviere, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidyanathan, S.</span><span> </span><span class="NLM_article-title">Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1418-1428&author=F.+Waldmeierauthor=U.+Glaenzelauthor=B.+Wirzauthor=L.+Obererauthor=D.+Schmidauthor=M.+Seiberlingauthor=J.+Valenciaauthor=G.+J.+Riviereauthor=P.+Endauthor=S.+Vaidyanathan&title=Absorption%2C+distribution%2C+metabolism%2C+and+elimination+of+the+direct+renin+inhibitor+aliskiren+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmeier%26aufirst%3DF.%26aulast%3DGlaenzel%26aufirst%3DU.%26aulast%3DWirz%26aufirst%3DB.%26aulast%3DOberer%26aufirst%3DL.%26aulast%3DSchmid%26aufirst%3DD.%26aulast%3DSeiberling%26aufirst%3DM.%26aulast%3DValencia%26aufirst%3DJ.%26aulast%3DRiviere%26aufirst%3DG.%2BJ.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DVaidyanathan%26aufirst%3DS.%26atitle%3DAbsorption%252C%2520distribution%252C%2520metabolism%252C%2520and%2520elimination%2520of%2520the%2520direct%2520renin%2520inhibitor%2520aliskiren%2520in%2520healthy%2520volunteers%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1418%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuerzner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. R.</span><span> </span><span class="NLM_article-title">Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100)</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=e1-e8&author=J.+Nussbergerauthor=G.+Wuerznerauthor=C.+Jensenauthor=H.+R.+Brunner&title=Angiotensin+II+suppression+in+humans+by+the+orally+active+renin+inhibitor+aliskiren+%28SPP100%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DWuerzner%26aufirst%3DG.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DBrunner%26aufirst%3DH.%2BR.%26atitle%3DAngiotensin%2520II%2520suppression%2520in%2520humans%2520by%2520the%2520orally%2520active%2520renin%2520inhibitor%2520aliskiren%2520%2528SPP100%2529%26jtitle%3DHypertension%26date%3D2002%26volume%3D39%26spage%3De1%26epage%3De8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Stanton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OBrien, E.</span><span> </span><span class="NLM_article-title">Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1137-1143&author=A.+Stantonauthor=C.+Jensenauthor=J.+Nussbergerauthor=E.+OBrien&title=Blood+pressure+lowering+in+essential+hypertension+with+an+oral+renin+inhibitor%2C+aliskiren"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DOBrien%26aufirst%3DE.%26atitle%3DBlood%2520pressure%2520lowering%2520in%2520essential%2520hypertension%2520with%2520an%2520oral%2520renin%2520inhibitor%252C%2520aliskiren%26jtitle%3DHypertension%26date%3D2003%26volume%3D42%26spage%3D1137%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Gradman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmieder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span> </span><span class="NLM_article-title">Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=1012-1018&author=A.+H.+Gradmanauthor=R.+E.+Schmiederauthor=R.+L.+Linsauthor=J.+Nussbergerauthor=Y.+Chiangauthor=M.+P.+Bedigian&title=Aliskiren%2C+a+novel+orally+effective+renin+inhibitor%2C+provides+dose-dependent+antihypertensive+efficacy+and+placebo-like+tolerability+in+hypertensive+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGradman%26aufirst%3DA.%2BH.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DLins%26aufirst%3DR.%2BL.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DY.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26atitle%3DAliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%252C%2520provides%2520dose-dependent%2520antihypertensive%2520efficacy%2520and%2520placebo-like%2520tolerability%2520in%2520hypertensive%2520patients%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D1012%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Andersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constance, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span> </span><span class="NLM_article-title">Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3282f3ad9a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=18300872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=589-599&author=K.+Andersenauthor=M.+H.+Weinbergerauthor=B.+Eganauthor=C.+M.+Constanceauthor=M.+A.+Aliauthor=J.+Jinauthor=D.+L.+Keefe&title=Comparative+efficacy+and+safety+of+aliskiren%2C+an+oral+direct+renin+inhibitor%2C+and+ramipril+in+hypertension%3A+a+6-month%2C+randomized%2C+double-blind+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial</span></div><div class="casAuthors">Andersen, Karl; Weinberger, Myron H.; Egan, Brent; Constance, Christian M.; Ali, Mohammed A.; Jin, James; Keefe, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">589-599</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">This double-blind study compared long-term efficacy, safety and tolerability of the oral direct renin inhibitor aliskiren and the angiotensin-converting enzyme inhibitor ramipril alone and combined with hydrochlorothiazide in patients with hypertension.  After a 2- to 4-wk placebo run-in, 842 patients [mean sitting diastolic blood pressure (msDBP) 95-109 mmHg] were randomized to aliskiren 150 mg (n = 420) or ramipril 5 mg (n = 422).  Dose titrn. (to aliskiren 300 mg/ramipril 10 mg) and subsequent hydrochlorothiazide addn. (12.5 mg, titrated to 25 mg if required) were permitted at weeks 6, 12, 18 and 21 for inadequate blood pressure control.  Patients completing the 26-wk active-controlled treatment period were re-randomized to their existing regimen or placebo for a 4-wk double-blind withdrawal phase.  Of patients 687 (81.6%) completed the active treatment period.  At week 26, aliskiren-based therapy produced greater mean redns. in mean sitting systolic blood pressure (17.9 vs. 15.2 mmHg, P = 0.0036) and msDBP (13.2 vs. 12.0 mmHg, P = 0.025), and higher rates of systolic blood pressure control (< 140 mmHg; 72.5 vs. 64.1%, P = 0.0075) compared with ramipril-based therapy.  During withdrawal, blood pressure increased more rapidly after stopping ramipril than aliskiren-based therapy; median blood pressure reached 140/90 mmHg after 1 and 4 wk, resp.  Blood pressure redns. were maintained with continued active treatment.  Aliskiren therapy was well tolerated.  Overall adverse event rates were similar with aliskiren (61.3%) and ramipril (60.4%); cough was more frequent with ramipril (9.5%) than aliskiren (4.1%).  Aliskiren-based therapy was well tolerated and produced sustained blood pressure redns. in patients with hypertension over 6 mo, greater than those with ramipril-based therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzCXukAYUFb7Vg90H21EOLACvtfcHk0ljoRBpjiJw2xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWhur0%253D&md5=fdb781c89ae7a10ef13b96fabd56083f</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3282f3ad9a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3282f3ad9a%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DK.%26aulast%3DWeinberger%26aufirst%3DM.%2BH.%26aulast%3DEgan%26aufirst%3DB.%26aulast%3DConstance%26aufirst%3DC.%2BM.%26aulast%3DAli%26aufirst%3DM.%2BA.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26atitle%3DComparative%2520efficacy%2520and%2520safety%2520of%2520aliskiren%252C%2520an%2520oral%2520direct%2520renin%2520inhibitor%252C%2520and%2520ramipril%2520in%2520hypertension%253A%2520a%25206-month%252C%2520randomized%252C%2520double-blind%2520trial%26jtitle%3DJ.%2520Hypertens.%26date%3D2008%26volume%3D26%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Oh, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herron, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span> </span><span class="NLM_article-title">Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-h blood pressure control in patients with hypertension</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1016%2Fj.jacc.2006.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17367658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtVagurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=1157-1163&author=B.+H.+Ohauthor=J.+Mitchellauthor=J.+R.+Herronauthor=J.+Chungauthor=M.+Khanauthor=D.+L.+Keefe&title=Aliskiren%2C+an+oral+renin+inhibitor%2C+provides+dose-dependent+efficacy+and+sustained+24-h+blood+pressure+control+in+patients+with+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension</span></div><div class="casAuthors">Oh, Byung-Hee; Mitchell, Jerry; Herron, James R.; Chung, Jenny; Khan, Mahmudul; Keefe, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1157-1163</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Sustained 24 H Blood Pressure Control in Patients With Hypertension Byung-Hee Oh, Jerry Mitchell, James R. Herron, Jenny Chung, Mahmudul Khan, Deborah L. Keefe The efficacy of the novel renin inhibitor aliskiren was investigated in a randomized, double-blind, placebo-controlled, dose-ranging study in 672 patients with mild-to-moderate hypertension.  Patients were randomized to receive aliskiren 150, 300, or 600 mg or placebo once daily for 8 wk.  Aliskiren 150, 300, and 600 mg significantly reduced office blood pressure by 13.0/10.3, 14.7/11.1, and 15.8/12.5 mm Hg (systolic/diastolic), resp., compared with 3.8/4.9 mm Hg with placebo (p < 0.0001).  The blood-pressure-lowering effect of aliskiren persisted for up to 2 wk after treatment withdrawal.  Aliskiren was well tolerated.  Aliskiren provides significant antihypertensive efficacy with no rebound effects on blood pressure after treatment withdrawal.  This dose-ranging study evaluated the antihypertensive efficacy and tolerability of aliskiren in patients with mild-to-moderate hypertension.  Low blood pressure (BP) control rates among patients with hypertension indicate a need for improved treatment options.  This study investigates aliskiren, the first in a new antihypertensive class called renin inhibitors.  Patients with mean sitting diastolic BP 95 to 109 mm Hg were randomized to aliskiren 150, 300, or 600 mg or placebo once daily for 8 wk.  Patients completing this treatment phase entered a 2-wk treatment-free withdrawal period.  Office BP was recorded at baseline, weeks 2, 4, 6, and 8 of treatment, and 4 days and 2 wk after cessation of treatment.  A subgroup of patients underwent ambulatory BP monitoring.  In total, 672 patients were randomized to treatment.  After 8 wk, aliskiren 150, 300, and 600 mg significantly reduced mean sitting BP (systolic/diastolic) by 13.0/10.3, 14.7/11.1, and 15.8/12.5 mm Hg, resp., vs. 3.8/4.9 mm Hg with placebo (all p < 0.0001 for systolic and diastolic BP).  The BP-lowering effect of aliskiren persisted for up to 2 wk after treatment withdrawal.  Aliskiren significantly reduced mean 24-h ambulatory BP (p < 0.0001 vs. placebo with all doses) exhibiting smooth, sustained effects and high trough-to-peak ratios.  Aliskiren was well tolerated; overall adverse event rates were 40.1%, 46.7%, and 52.4% with aliskiren 150, 300, and 600 mg, resp., and 43.0% with placebo.  Few patients discontinued treatment due to adverse events.  Aliskiren provides significant antihypertensive efficacy in patients with hypertension, with no rebound effects on blood pressure after treatment withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2x01d2tsmTLVg90H21EOLACvtfcHk0ljoRBpjiJw2xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtVagurk%253D&md5=da790175baa20cb533685c91534723f2</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2006.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2006.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DB.%2BH.%26aulast%3DMitchell%26aufirst%3DJ.%26aulast%3DHerron%26aufirst%3DJ.%2BR.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26atitle%3DAliskiren%252C%2520an%2520oral%2520renin%2520inhibitor%252C%2520provides%2520dose-dependent%2520efficacy%2520and%2520sustained%252024-h%2520blood%2520pressure%2520control%2520in%2520patients%2520with%2520hypertension%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2007%26volume%3D49%26spage%3D1157%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmieder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, M. F.</span><span> </span><span class="NLM_article-title">Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1742-1241.2007.01473.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17590217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSks77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=1461-1468&author=J.+Nussbergerauthor=A.+H.+Gradmanauthor=R.+E.+Schmiederauthor=R.+L.+Linsauthor=Y.+Chiangauthor=M.+F.+Prescott&title=Plasma+renin+and+the+antihypertensive+effect+of+the+orally+active+renin+inhibitor+aliskiren+in+clinical+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension</span></div><div class="casAuthors">Nussberger, J.; Gradman, A. H.; Schmieder, R. E.; Lins, R. L.; Chiang, Y.; Prescott, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1461-1468</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension.  Methods: In 569 patients with mild-to-moderate hypertension, blood pressure (BP), plasma renin activity (PRA) and plasma renin concn. (PRC) were measured before and after 8 wk of double-blind treatment with once-daily oral doses of aliskiren (150, 300 or 600 mg), irbesartan 150 mg or placebo.  Results: Aliskiren 150, 300 and 600 mg and irbesartan 150 mg significantly reduced mean cuff sitting systolic BP (SBP) from baseline (p < 0.001 vs. placebo).  Aliskiren 150, 300 and 600 mg significantly reduced geometric mean PRA by 69%, 71% and 75% from baseline resp. (p < 0.05 vs. placebo).  Irbesartan 150 mg significantly increased PRA by 109% (p < 0.05 vs. placebo).  Aliskiren dose-dependently increased PRC from baseline by 157%, 246% and 497%, at 150, 300 and 600 mg resp., compared with a 9% decrease with placebo (p < 0.05).  PRC increased significantly more with aliskiren 300 and 600 mg compared with irbesartan 150 mg (105%; p < 0.05).  Regression anal. showed no significant correlations between baseline PRA and changes in SBP in any of the treatment groups, but interestingly, the slopes of the regression lines between changes in SBP and log-transformed baseline PRA were +2.0 for placebo and -1.5, -1.8 and -2.3 for aliskiren 150, 300 and 600 mg resp.  The slope for irbesartan 150 mg (-1.4) was similar to that for aliskiren 150 mg.  Conclusions: Aliskiren reduces SBP and PRA and increases PRC dose-dependently.  In contrast, irbesartan reduces SBP but increases both PRC and PRA.  As PRA is a measurement of angiotensin I-generating capacity, PRA can be used for measuring the ability of an antihypertensive agent to prevent the generation or action of Ang II, either directly (renin inhibitors, beta-blockers, central α2-agonists) or indirectly (AT1-receptor blockers, ACE inhibitors).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSuDKau1GN77Vg90H21EOLACvtfcHk0ljoRBpjiJw2xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSks77F&md5=c67233ca3e9efee449240f92df4a65eb</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2007.01473.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2007.01473.x%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DGradman%26aufirst%3DA.%2BH.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DLins%26aufirst%3DR.%2BL.%26aulast%3DChiang%26aufirst%3DY.%26aulast%3DPrescott%26aufirst%3DM.%2BF.%26atitle%3DPlasma%2520renin%2520and%2520the%2520antihypertensive%2520effect%2520of%2520the%2520orally%2520active%2520renin%2520inhibitor%2520aliskiren%2520in%2520clinical%2520hypertension%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2007%26volume%3D61%26spage%3D1461%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Vergaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iervasi, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabutti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emdin, M.</span><span> </span><span class="NLM_article-title">Plasma renin activity is an independent prognostic factor in chronic heart failure</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">393</span><div class="note"><p class="first last"> (Abstract 2493)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=393&issue=Suppl.&author=G.+Vergaroauthor=M.+Fontanaauthor=R.+Polettiauthor=A.+Giannoniauthor=A.+L.+Iervasiauthor=L.+Masiauthor=C.+Mamminiauthor=A.+Gabuttiauthor=C.+Passinoauthor=M.+Emdin&title=Plasma+renin+activity+is+an+independent+prognostic+factor+in+chronic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVergaro%26aufirst%3DG.%26aulast%3DFontana%26aufirst%3DM.%26aulast%3DPoletti%26aufirst%3DR.%26aulast%3DGiannoni%26aufirst%3DA.%26aulast%3DIervasi%26aufirst%3DA.%2BL.%26aulast%3DMasi%26aufirst%3DL.%26aulast%3DMammini%26aufirst%3DC.%26aulast%3DGabutti%26aufirst%3DA.%26aulast%3DPassino%26aufirst%3DC.%26aulast%3DEmdin%26aufirst%3DM.%26atitle%3DPlasma%2520renin%2520activity%2520is%2520an%2520independent%2520prognostic%2520factor%2520in%2520chronic%2520heart%2520failure%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2008%26volume%3D29%26issue%3DSuppl%26spage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Chobanian, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakris, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, J. L.</span><span> </span><span class="NLM_article-title">Seventh report of the Joint National Committeee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1206-1252&author=A.+V.+Chobanianauthor=G.+L.+Bakrisauthor=H.+R.+Blackauthor=W.+C.+Cushmanauthor=L.+A.+Greenauthor=J.+L.+Izzo&title=Seventh+report+of+the+Joint+National+Committeee+on+Prevention%2C+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Pressure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChobanian%26aufirst%3DA.%2BV.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlack%26aufirst%3DH.%2BR.%26aulast%3DCushman%26aufirst%3DW.%2BC.%26aulast%3DGreen%26aufirst%3DL.%2BA.%26aulast%3DIzzo%26aufirst%3DJ.%2BL.%26atitle%3DSeventh%2520report%2520of%2520the%2520Joint%2520National%2520Committeee%2520on%2520Prevention%252C%2520Detection%252C%2520Evaluation%252C%2520and%2520Treatment%2520of%2520High%2520Blood%2520Pressure%26jtitle%3DHypertension%26date%3D2003%26volume%3D42%26spage%3D1206%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Villamil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrysant, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calhoun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisciano-Dimichino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1097%2FHJH.0b013e3280103a6b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17143194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=217-226&author=A.+Villamilauthor=S.+G.+Chrysantauthor=D.+Calhounauthor=B.+Schoberauthor=H.+Hsuauthor=L.+Matrisciano-Dimichinoauthor=J.+Zhang&title=Renin+inhibition+with+aliskiren+provides+additive+antihypertensive+efficacy+when+used+in+combination+with+hydrochlorothiazide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide</span></div><div class="casAuthors">Villamil, Alberto; Chrysant, Steven G.; Calhoun, David; Schober, Bonnie; Hsu, Huang; Matrisciano-Dimichino, Linda; Zhang, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-226</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objectives: Aliskiren is a novel, orally active renin inhibitor.  Its antihypertensive efficacy and safety, alone and in combination with hydrochlorothiazide (HCTZ), were investigated in an 8-wk, double-blind, placebo-controlled trial in hypertensive patients.  The effects of these treatments on plasma renin activity (PRA) were also assessed.  Methods: A total of 2776 patients aged ≥ 18 years with mean sitting diastolic blood pressure (MSDBP) 95-109 mmHg were randomized to receive once-daily treatment with aliskiren (75, 150 or 300 mg), HCTZ (6.25, 12.5 or 25 mg), the combination of aliskiren and HCTZ, or placebo, in a factorial design.  The primary endpoint was the change in MSDBP from baseline to week 8.  PRA was assessed at these timepoints at selected study centers.  Results: Aliskiren monotherapy was superior to placebo (P < 0.001; overall Dunnett's test) in reducing MSDBP and mean sitting systolic blood pressure (MSSBP).  Combination treatment was superior to both component monotherapies in reducing BP (max. MSSBP/MSDBP redn. of 21.2/14.3 mmHg from baseline with aliskiren/HCTZ 300/25 mg), and resulted in more responders (patients with MSDBP < 90 mmHg and/or ≥ 10 mmHg redn.) and better control rates (patients achieving MSSBP/MSDBP < 140/90 mmHg) than either monotherapy.  Aliskiren monotherapy reduced PRA by up to 65% from baseline.  Although HCTZ monotherapy increased PRA by up to 72%, PRA decreased in all of the combination therapy groups.  All active treatments were well tolerated.  Conclusions: Aliskiren monotherapy demonstrated significant BP lowering, and its effect was considerably greater when combined with HCTZ.  Renin inhibition with aliskiren neutralized the compensatory rise in PRA induced by HCTZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv1Qg07ReJ97Vg90H21EOLACvtfcHk0lhsI8UOi9n6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrnM&md5=ad221912f5a5bad6bbe4678554cea695</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e3280103a6b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e3280103a6b%26sid%3Dliteratum%253Aachs%26aulast%3DVillamil%26aufirst%3DA.%26aulast%3DChrysant%26aufirst%3DS.%2BG.%26aulast%3DCalhoun%26aufirst%3DD.%26aulast%3DSchober%26aufirst%3DB.%26aulast%3DHsu%26aufirst%3DH.%26aulast%3DMatrisciano-Dimichino%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DRenin%2520inhibition%2520with%2520aliskiren%2520provides%2520additive%2520antihypertensive%2520efficacy%2520when%2520used%2520in%2520combination%2520with%2520hydrochlorothiazide%26jtitle%3DJ.%2520Hypertens.%26date%3D2007%26volume%3D25%26spage%3D217%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulcahy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, A.</span><span> </span><span class="NLM_article-title">Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin converting enzyme inhibitor, or an angiotensin receptor blocker</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=276-284&author=E.+O%E2%80%99Brienauthor=J.+Bartonauthor=J.+Nussbergerauthor=D.+Mulcahyauthor=C.+Jensenauthor=P.+Dickerauthor=A.+Stanton&title=Aliskiren+reduces+blood+pressure+and+suppresses+plasma+renin+activity+in+combination+with+a+thiazide+diuretic%2C+an+angiotensin+converting+enzyme+inhibitor%2C+or+an+angiotensin+receptor+blocker"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DBarton%26aufirst%3DJ.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DMulcahy%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DDicker%26aufirst%3DP.%26aulast%3DStanton%26aufirst%3DA.%26atitle%3DAliskiren%2520reduces%2520blood%2520pressure%2520and%2520suppresses%2520plasma%2520renin%2520activity%2520in%2520combination%2520with%2520a%2520thiazide%2520diuretic%252C%2520an%2520angiotensin%2520converting%2520enzyme%2520inhibitor%252C%2520or%2520an%2520angiotensin%2520receptor%2520blocker%26jtitle%3DHypertension%26date%3D2007%26volume%3D49%26spage%3D276%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Oparil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarrows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satlin, A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomized, double-blind trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=221-229&author=S.+Oparilauthor=S.+A.+Yarrowsauthor=S.+Patelauthor=H.+Fangauthor=J.+Zhangauthor=A.+Satlin&title=Efficacy+and+safety+of+combined+use+of+aliskiren+and+valsartan+in+patients+with+hypertension%3A+a+randomized%2C+double-blind+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOparil%26aufirst%3DS.%26aulast%3DYarrows%26aufirst%3DS.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSatlin%26aufirst%3DA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520combined%2520use%2520of%2520aliskiren%2520and%2520valsartan%2520in%2520patients%2520with%2520hypertension%253A%2520a%2520randomized%252C%2520double-blind%2520trial%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Drummond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essop, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maboudian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span> </span><span class="NLM_article-title">Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy</span> <span class="citation_source-journal">J. Clin. Hypertens. (Greenwich)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1111%2Fj.1524-6175.2007.06614.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=17917501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=742-750&author=W.+Drummondauthor=M.+A.+Mungerauthor=R.+Essopauthor=M.+Maboudianauthor=M.+Khanauthor=D.+L.+Keefe&title=Antihypertensive+efficacy+of+the+oral+direct+renin+inhibitor+aliskiren+as+add-on+therapy+in+patients+not+responding+to+amlodipine+monotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy</span></div><div class="casAuthors">Drummond, Waymon; Munger, Mark A.; Essop, Mohammed Rafique; Maboudian, Mojdeh; Khan, Mahmudul; Keefe, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hypertension (Shelton, CT, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">742-750</span>CODEN:
                <span class="NLM_cas:coden">JCHYFN</span>;
        ISSN:<span class="NLM_cas:issn">1524-6175</span>.
    
            (<span class="NLM_cas:orgname">Le Jacq Ltd.</span>)
        </div><div class="casAbstract">This study investigated the addn. of the direct renin inhibitor aliskiren to amlodipine in patients with mild to moderate hypertension that was inadequately controlled with amlodipine alone.  Following once-daily treatment with amlodipine 5 mg for 4 wk, patients whose hypertension responded inadequately to therapy (mean sitting diastolic blood pressure [DBP] 90-109 mm Hg) (n = 545) were randomized to 6 wk of double-blind treatment with amlodipine 5 mg plus aliskiren 150 mg, amlodipine 5 mg, or amlodipine 10 mg.  At the study's end, mean systolic blood pressure and DBP redns. with the combination of aliskiren 150 mg and amlodipine 5 mg (11.0/8.5 mm Hg) were significantly greater (P<.0001) than with amlodipine 5 mg (5.0/4.8 mm Hg)-the comparator group-but similar to amlodipine 10 mg (9.6/8.0 mm Hg).  All treatments were well tolerated.  Edema occurred more frequently with amlodipine 10 mg (11.2%) than with combination therapy (2.1%) or amlodipine 5 mg (3.4%).  In conclusion, aliskiren 150 mg plus amlodipine 5 mg shows similar but not better blood pressure-lowering efficacy when compared with amlodipine 10 mg in patients not completely responsive to amlodipine 5 mg; less edema was noted with combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhDWkxIUwMi7Vg90H21EOLACvtfcHk0lhsI8UOi9n6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rt7%252FK&md5=d1d056861e2b735dd00bfe2d0dc6392c</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1111%2Fj.1524-6175.2007.06614.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1524-6175.2007.06614.x%26sid%3Dliteratum%253Aachs%26aulast%3DDrummond%26aufirst%3DW.%26aulast%3DMunger%26aufirst%3DM.%2BA.%26aulast%3DEssop%26aufirst%3DR.%26aulast%3DMaboudian%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26atitle%3DAntihypertensive%2520efficacy%2520of%2520the%2520oral%2520direct%2520renin%2520inhibitor%2520aliskiren%2520as%2520add-on%2520therapy%2520in%2520patients%2520not%2520responding%2520to%2520amlodipine%2520monotherapy%26jtitle%3DJ.%2520Clin.%2520Hypertens.%2520%2528Greenwich%2529%26date%3D2007%26volume%3D9%26spage%3D742%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukashevich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papst, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlöf, B.</span><span> </span><span class="NLM_article-title">Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=530-537&author=S.+D.+Solomonauthor=E.+Appelbauauthor=W.+J.+Manningauthor=A.+Vermaauthor=T.+Berglundauthor=V.+Lukashevichauthor=C.+C.+Papstauthor=B.+A.+Smithauthor=B.+Dahl%C3%B6f&title=Effect+of+the+direct+renin+inhibitor+aliskiren%2C+the+angiotensin+receptor+blocker+losartan%2C+or+both+on+left+ventricular+mass+in+patients+with+hypertension+and+left+ventricular+hypertrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DAppelbau%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DW.%2BJ.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DBerglund%26aufirst%3DT.%26aulast%3DLukashevich%26aufirst%3DV.%26aulast%3DPapst%26aufirst%3DC.%2BC.%26aulast%3DSmith%26aufirst%3DB.%2BA.%26aulast%3DDahl%25C3%25B6f%26aufirst%3DB.%26atitle%3DEffect%2520of%2520the%2520direct%2520renin%2520inhibitor%2520aliskiren%252C%2520the%2520angiotensin%2520receptor%2520blocker%2520losartan%252C%2520or%2520both%2520on%2520left%2520ventricular%2520mass%2520in%2520patients%2520with%2520hypertension%2520and%2520left%2520ventricular%2520hypertrophy%26jtitle%3DCirculation%26date%3D2009%26volume%3D119%26spage%3D530%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">McMurray, J. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggioni, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefe, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewsey, J.</span><span> </span><span class="NLM_article-title">Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure</span> <span class="citation_source-journal">Circ.: Heart Fail.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1161%2FCIRCHEARTFAILURE.107.740704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=17-24&author=J.+J.+V.+McMurrayauthor=B.+Pittauthor=R.+Latiniauthor=A.+P.+Maggioniauthor=S.+D.+Solomonauthor=D.+L.+Keefeauthor=J.+Fordauthor=A.+Vermaauthor=J.+Lewsey&title=Effects+of+the+oral+direct+renin+inhibitor+aliskiren+in+patients+with+symptomatic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure</span></div><div class="casAuthors">McMurray, John J. V.; Pitt, Bertram; Latini, Roberto; Maggioni, Aldo P.; Solomon, Scott D.; Keefe, Deborah L.; Ford, Jessica; Verma, Anil; Lewsey, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Loss of neg. feedback inhibition of renin release during chronic treatment with an angiotensin-converting enzyme (ACE) inhibitor leads to a compensatory rise in renin secretion and downstream components of the renin-angiotensin-aldosterone (RAAS) cascade.  This may overcome ACE inhibition but should be blocked by a direct renin inhibitor.  We studied the effects of adding the direct renin inhibitor aliskiren to an ACE inhibitor in patients with heart failure.  Patients with New York Heart Assocn. class II to IV heart failure, current or past history of hypertension, and plasma brain natriuretic peptide (BNP) concn. > 100 pg/mL who had been treated with an ACE inhibitor (or angiotensin receptor blocker) and β-blocker were randomized to 3 mo of treatment with placebo (n=146) or aliskiren 150 mg/d (n=156).  The primary efficacy outcome was the between-treatment difference in N-terminal pro-BNP (NT-proBNP).  Patients' mean age was 68 years, mean ejection fraction was 31%, and mean±SD systolic blood pressure was 129±17.4 mm Hg.  Sixty-two percent of the patients were in New York Heart Assocn. functional class II, and 33% were taking an aldosterone antagonist.  Plasma NT-proBNP rose by 762 ± 6123 pg/mL with placebo and fell by 244 ± 2025 pg/mL with aliskiren (P = 0.0106).  BNP and urinary (but not plasma) aldosterone were also reduced by aliskiren.  Clin. important differences in blood pressure and biochem. were not seen between aliskiren and placebo.  Addn. of aliskiren to an ACE inhibitor (or angiotensin receptor blocker) and β-blocker had favorable neurohumoral effects in heart failure and appeared to be well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodBEfopzuXjrVg90H21EOLACvtfcHk0ljEbJ9iQaMhkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFGnsLY%253D&md5=863de134998c48838bdc9502de2abbfa</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.107.740704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.107.740704%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%2BV.%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DLatini%26aufirst%3DR.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DKeefe%26aufirst%3DD.%2BL.%26aulast%3DFord%26aufirst%3DJ.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DLewsey%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520the%2520oral%2520direct%2520renin%2520inhibitor%2520aliskiren%2520in%2520patients%2520with%2520symptomatic%2520heart%2520failure%26jtitle%3DCirc.%253A%2520Heart%2520Fail.%26date%3D2008%26volume%3D1%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dembowsky, K.</span> Human Phase 0 Microdosing Studies. Practical Examples Using Renin Inhibitors. Evolution 2007, Monaco, October 1, 2007. <a href="http://www.xceleron.com/metadot/index.pl?id=3081&amp;isa=DBRow&amp;op=show&amp;dbview_id=3047#" class="extLink">http://www.xceleron.com/metadot/index.pl?id=3081&isa=DBRow&op=show&dbview_id=3047#</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dembowsky%2C+K.+Human+Phase+0+Microdosing+Studies.+Practical+Examples+Using+Renin+Inhibitors.+Evolution+2007%2C+Monaco%2C+October+1%2C+2007.+http%3A%2F%2Fwww.xceleron.com%2Fmetadot%2Findex.pl%3Fid%3D3081%26isa%3DDBRow%26op%3Dshow%26dbview_id%3D3047%23+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DDembowsky%26aufirst%3DK.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit182b"><span><span class="NLM_label">(b) </span> Speedel Annual General Meeting, April 15, 2008. <a href="http://www.speedel.com/assets/AGM_2008_presentation_2.pdf" class="extLink">http://www.speedel.com/assets/AGM_2008_presentation_2.pdf</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Speedel+Annual+General+Meeting%2C+April+15%2C+2008.+http%3A%2F%2Fwww.speedel.com%2Fassets%2FAGM_2008_presentation_2.pdf+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span>Vitae Pharmaceuticals Press Release, September 21, 2009: Vitae Initiates Phase 1 Trial of Novel Renin Inhibitor. In <i>Genetic Engineering & Biotechnology News</i>, September 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span>. <a href="http://www.genengnews.com/news/bnitem.aspx?name=63361020" class="extLink">http://www.genengnews.com/news/bnitem.aspx?name=63361020</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vitae+Pharmaceuticals+Press+Release%2C+September+21%2C+2009%3A+Vitae+Initiates+Phase+1+Trial+of+Novel+Renin+Inhibitor.+In+Genetic+Engineering+%26+Biotechnology+News%2C+September+21%2C+2009.+http%3A%2F%2Fwww.genengnews.com%2Fnews%2Fbnitem.aspx%3Fname%3D63361020+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2009%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184a"><span><span class="NLM_label">(a) </span> Actelion Annual Report 2008. <a href="http://www1.actelion.com/documents/corporate/annual_reports/AR_Actelion_InDetail_E.pdf" class="extLink">http://www1.actelion.com/documents/corporate/annual_reports/AR_Actelion_InDetail_E.pdf</a> (accessed December 21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Actelion+Annual+Report+2008.+http%3A%2F%2Fwww1.actelion.com%2Fdocuments%2Fcorporate%2Fannual_reports%2FAR_Actelion_InDetail_E.pdf+%28accessed+December+21%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit184b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">A Study To Determine the Effectiveness and Tolerability of MK8141 in Patients with High Blood Pressure</span>; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, October 5,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://clinicaltrials.gov/ct2/show/study/NCT00543413" class="extLink">http://clinicaltrials.gov/ct2/show/study/NCT00543413</a>. Accessed December 21, 2009.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+To+Determine+the+Effectiveness+and+Tolerability+of+MK8141+in+Patients+with+High+Blood+Pressure%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+October+5%2C+2007%3B+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT00543413.+Accessed+December+21%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DA%2520Study%2520To%2520Determine%2520the%2520Effectiveness%2520and%2520Tolerability%2520of%2520MK8141%2520in%2520Patients%2520with%2520High%2520Blood%2520Pressure%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zeeuw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadanfar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissbach, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armbrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeffer, M. A.</span><span> </span><span class="NLM_article-title">Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Fjm901885s&amp;key=10.1093%2Fndt%2Fgfn721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Fjm901885s&amp;key=19145003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Fjm901885s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvFKjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=1663-1671&author=H.+H.+Parvingauthor=B.+M.+Brennerauthor=J.+J.+V.+McMurrayauthor=D.+de+Zeeuwauthor=S.+M.+Haffnerauthor=S.+D.+Solomonauthor=N.+Chaturvediauthor=M.+Ghadanfarauthor=N.+Weissbachauthor=Z.+Xiangauthor=J.+Armbrechtauthor=M.+A.+Pfeffer&title=Aliskiren+trial+in+type+2+diabetes+using+cardio-renal+endpoints+%28ALTITUDE%29%3A+rationale+and+study+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design</span></div><div class="casAuthors">Parving, Hans-Henrik; Brenner, Barry M.; McMurray, John. J. V.; de Zeeuw, Dick; Haffner, Steven M.; Solomon, Scott D.; Chaturvedi, Nish; Ghadanfar, Mathieu; Weissbach, Nicole; Xiang, Zhihua; Armbrecht, Juergen; Pfeffer, Marc A.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1663-1671</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Patients with type 2 diabetes are at increased risk of macro- and microvascular disease, and the presence of albuminuria and/or reduced kidney function further enhances macrovascular risk.  Angiotensin-converting-enzyme inhibitors reduce both macro- and microvascular events, yet the residual renal and cardiovascular risk still remains high.  Aliskiren a novel oral direct renin inhibitor that unlike ACEi and ARBs, lowers plasma renin activity, angiotensin I and angiotensin II levels, may thereby provide greater benefit compared to ACEi or ARB alone.  The primary objective of the ALTITUDE trial is to det. whether aliskiren 300 mg once daily, reduces cardiovascular and renal morbidity and mortality compared with placebo when added to conventional treatment (including ACEi or ARB).  ALTITUDE is an international, randomized, double-blind, placebo-controlled, parallel-group study, which will include three categories of high-risk patients with type 2 diabetes (aged ≥35 years): those with either urinary albumin/creatinine ratio (UACR) ≥200 mg/g; microalbuminuria (UACR) ≥20 <200 mg/g and eGFR ≥30 <60 mL/min/1.73 m2; and thirdly, those with a history of cardiovascular disease and eGFR ≥30 <60 mL/min/1.73 m2 with or without microalbuminuria.  ALTITUDE is an event driven trial that aims to randomize 8600 patients with a planned follow-up time of 48 mo.  The primary outcome measure is time to first event for the composite endpoint of cardiovascular death, resuscitated death, myocardial infarction, stroke, unplanned hospitalization for heart failure, onset of end-stage renal disease or doubling of baseline serum creatinine concn.  Secondary endpoints include a composite CV endpoint and a composite renal endpoint.  ALTITUDE will det. whether dual RAAS blockade with the direct renin inhibitor aliskiren in combination with an ACEi or ARB will reduce major morbidity and mortality in a broad range of high-risk patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2JtHWQfC-2bVg90H21EOLACvtfcHk0ljEbJ9iQaMhkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvFKjsLs%253D&md5=108ef4ed089dd0d4462f16f47fe861a1</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfn721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfn721%26sid%3Dliteratum%253Aachs%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DBrenner%26aufirst%3DB.%2BM.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%2BV.%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DChaturvedi%26aufirst%3DN.%26aulast%3DGhadanfar%26aufirst%3DM.%26aulast%3DWeissbach%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DArmbrecht%26aufirst%3DJ.%26aulast%3DPfeffer%26aufirst%3DM.%2BA.%26atitle%3DAliskiren%2520trial%2520in%2520type%25202%2520diabetes%2520using%2520cardio-renal%2520endpoints%2520%2528ALTITUDE%2529%253A%2520rationale%2520and%2520study%2520design%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2009%26volume%3D24%26spage%3D1663%26epage%3D1671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v12" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v12','PDB','2v12'); return false;">PDB: 2v12</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fs4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fs4','PDB','2fs4'); return false;">PDB: 2fs4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2g26" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2g26','PDB','2g26'); return false;">PDB: 2g26</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1qrp" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1qrp','PDB','1qrp'); return false;">PDB: 1qrp</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1lyb" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1lyb','PDB','1lyb'); return false;">PDB: 1lyb</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1tzs" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1tzs','PDB','1tzs'); return false;">PDB: 1tzs</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ren" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ren','PDB','2ren'); return false;">PDB: 2ren</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z','PDB','2v0z'); return false;">PDB: 2v0z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rne" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rne','PDB','1rne'); return false;">PDB: 1rne</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v11" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v11','PDB','2v11'); return false;">PDB: 2v11</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v16" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v16','PDB','2v16'); return false;">PDB: 2v16</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2g1r" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2g1r','PDB','2g1r'); return false;">PDB: 2g1r</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gw5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3gw5','PDB','3gw5'); return false;">PDB: 3gw5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g70" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g70','PDB','3g70'); return false;">PDB: 3g70</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g6z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g6z','PDB','3g6z'); return false;">PDB: 3g6z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1pr8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1pr8','PDB','1pr8'); return false;">PDB: 1pr8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uhq" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uhq','PDB','1uhq'); return false;">PDB: 1uhq</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2psg" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2psg','PDB','2psg'); return false;">PDB: 2psg</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901885s&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-21%3Barticle%3Aarticle%3A10.1021%2Fjm901885s%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901885s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799db290e6f3c52","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
